Citrus Sinensis ID: 004580

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740----
Protein Sequence
MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccEEEEEEcccccccccEEEEEEcccccEEEEEcccccccccccEEEEEEEcccEEEEcccccEEEEEcccccccccEEEEcccccEEEEEcccccccccEEEccccccccccccccEEEEEEcccccEEEEEcccccccccccEEEEEEEccccEEEEEEccEEEEEEccccccEEEccccccccEEEEEEEEcccEEEEEEEEccccEEEEEEEcccccEEEEEEEcccccEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccEEccccccccccEEEEEcccccccccEEEEcccccHHHHHHHHcccccccccccccccccccEEEEcccccccccccccccccEEEEEEccccccccEEEEEEEEEEHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHHHccHHEEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccEEEEccccccHHHHcccccEEEccEEEEEEEEEEEEEccccccccccccccccHHHccccHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEccccEEEEEEccccccccccEEEEEccccEEEEEEccccEEEEccccccccccEEEEEccccEEEEEcccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEcccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccEEccccccccccccccccccccccccccccEEcccccccccccEEEEcccccccccccEEcccccHHHHHHHHHHcccEEEEEEcccccccEEEEEEccHHHHHHccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHcccccHHHccEEEEEEcccccccccccccccccccccEcHHHHHHHHccccccccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccHHHcEEcccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHEEcccccccccccccccHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
MAILPCFSIFCSLILSLSVKVSLaadtvtpasfirdgekLVSFSQRfelgffspgksksrylGIWFRQVPDTVVWVAnrdrpisdhnavltisnkgnlvllnqtngtiwstnvfsevknpvaqlrddgnlvirdnssgnttesylwqsfdyptdtlLQGMKMGWDLKNRLERYLsswqsdddpspgkftsrleikvipkmcifngsvkfacsgqwngAAFVSAISYTNFLYEQYLVENQDeisywyepfnrpsimtlklnpsglltrqiwnnngndwdlvfsfpdeycgkygycganticspdqkpiceclegfklkskfnqtgpikcershssecigghqfikldnirapdFIEVFLNKSMNLQQCAAECLKnctcrayansnvtegsgclmwfgdlldanrptrnftgqsvyirvpasetgkRKLLWILVILVLplvllpsfyifcrrrrnckeketenmetdQDLLAFDInmgittrtnefgevngdgkdkgkdswlplFSLASVAAATENFSMQcklgeggfgpvykgrllnGQEVAVKRLssqsgqgleEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILeympnksldvflfdptkkrllgWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLldmdmnpkisdfglarmfggdelqgntkrivgtygymspeyaldglfsiksdVFSFGILMLETLsgkkntgvynadsfnllgyvsnkslHFYLIFSE
Flexible Loop (DISEMBL)
MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGffspgksksrylGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPvaqlrddgnlvirdnssgnttesylwQSFDYPTDTLLQGMKMGWDLKNRLERYLSswqsdddpspgkFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIrvpasetgkrKLLWILVILVLPLVLLPSFYIFCRRRRNCKeketenmetdqdlLAFDINMGITTrtnefgevngdGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Low Complexity Region (SEG)
MAILPcfsifcslilslsvkvslAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKllwilvilvlplvllpSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Disordered region (IsUnstruct)
**ILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNS*GNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSW**********FTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNC************DLLAFDINMGITTRTNEFGEV********KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK***********EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIF**
Disordered Region (DISOPRED)
**ILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVF******V*QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGIT****************GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Disordered Region (DISEMBL)
MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLS***********KFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Disordered Region (DISPRO)
MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNE************KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	744	2.2.26 [Sep-21-2011]
O81905	850	Receptor-like serine/thre	yes	no	0.935	0.818	0.445	1e-166
Q9S972	847	Receptor-like serine/thre	no	no	0.920	0.808	0.452	1e-165
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.927	0.828	0.436	1e-164
O81832	783	G-type lectin S-receptor-	no	no	0.880	0.836	0.432	1e-161
Q39086	843	Receptor-like serine/thre	no	no	0.922	0.813	0.446	1e-161
O81906	849	G-type lectin S-receptor-	no	no	0.955	0.837	0.431	1e-161
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.926	0.815	0.434	1e-161
Q09092	857	Putative serine/threonine	N/A	no	0.961	0.834	0.423	1e-154
P0DH86	853	G-type lectin S-receptor-	no	no	0.930	0.811	0.431	1e-152
O81833	815	G-type lectin S-receptor-	no	no	0.905	0.826	0.433	1e-152

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  585 bits (1508), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 326/732 (44%), Positives = 457/732 (62%), Gaps = 36/732 (4%)

Query: 22  SLAADTVTPAS--FIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVAN 78
           S++A+T++ +    I     +VS    FELGFF PG     YLGIW++ +   T VWVAN
Sbjct: 26  SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85

Query: 79  RDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNP-VAQLRDDGNLVIRDNS 136
           RD P+S     L IS+  NLV+L+Q++  +WSTN+   +V++P VA+L D+GN V+RD S
Sbjct: 86  RDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143

Query: 137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
             +  +  LWQSFD+PTDTLL  MK+GWD K    R++ SW+S DDPS G F+ +LE + 
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203

Query: 197 IPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIM 255
            P++ ++N   +   SG WNG  F        F Y  +    +++E++Y +         
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263

Query: 256 TLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFK 315
            L ++ SGLL R  W     +W+  +  P + C +Y  CG    C  +  P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323

Query: 316 LKSKFN---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECL 372
            ++      + G   C R     C GG  F++L  ++ PD     +++ + +++C  +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383

Query: 373 KNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLW 429
           ++C C A+AN+++   GSGC+ W G+L D     RN+   GQ +Y+R+ A++   ++   
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439

Query: 430 ILVI---LVLPLVLLPSFYIFCRRRRNCKEKETENMET---DQDLLAFDINMG---ITTR 480
             +I   + + ++LL SF IF   +R  K+K +  +ET   D  L + D+ M    I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKR--KQKRSILIETPIVDHQLRSRDLLMNEVVISSR 497

Query: 481 TNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
            +   E N D      D  LPL     VA AT NFS   KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551

Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
           AVKRLS  S QG +EFKNE+ LIA+LQH NLV+LL CCV+ GEK+LI EY+ N SLD  L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611

Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
           FD ++   L WQ R  II GIA+GLLYLHQ SRFRIIHRDLKASN+LLD  M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671

Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY 720
           +AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G Y
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731

Query: 721 NAD-SFNLLGYV 731
           N+D   NLLG V
Sbjct: 732 NSDRDLNLLGCV 743

Involved in the regulation of cellular expansion and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  581 bits (1498), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 330/730 (45%), Positives = 450/730 (61%), Gaps = 45/730 (6%)

Query: 27  TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
           + T +  I   + ++S SQ FELGFF+P  S   YLGIW++ +P  T VWVANRD P+S 
Sbjct: 31  SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
            N  L IS+  NLV+ +Q++  +WSTN+   +V++PVA +L D GN V+RD S  N    
Sbjct: 91  SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148

Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNR-LERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCI 202
           +LWQSFD+PTDTLL  MKMGWD K+    R L SW++ DDPS G F+++L     P+  I
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208

Query: 203 FNGSVKFACSGQWNGAAFVSAISYTNFLY-EQYLVENQDEISYWYEPFNRPSIMT-LKLN 260
           +N       SG W G  F S        Y +    EN  ++ Y Y   N+ +I + L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYR-VNKTNIYSILSLS 267

Query: 261 PSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKF 320
            +GLL R  W      W  ++  P + C  Y  CG    C  +  PIC C++GF+     
Sbjct: 268 STGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFE---PM 324

Query: 321 NQTGPIK-----CERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNC 375
           N+   ++     C R     C G   F++L  +R PD  E  ++K + L++C   CLK C
Sbjct: 325 NEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGC 384

Query: 376 TCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLWILV 432
            C A+AN+++  G SGC++W G L D     RN+   GQ +Y+RV A +   +++    +
Sbjct: 385 NCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSKKI 440

Query: 433 I---LVLPLVLLPSFYIFCRRRRNCKEKETENMET-------DQDLLAFDINMGITTRTN 482
           I   + + ++LL SF IF   +R  K+K +  ++T        QD L  ++     + T+
Sbjct: 441 IGSSIGVSILLLLSFIIFHFWKR--KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498

Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAV 542
           +        ++K     LPL    ++A AT NFS   KLG+GGFG VYKG LL+G+E+AV
Sbjct: 499 K--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAV 550

Query: 543 KRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
           KRLS  S QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD  LFD
Sbjct: 551 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 610

Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
            T+   L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+A
Sbjct: 611 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 670

Query: 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
           R+FG +E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN+
Sbjct: 671 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 730

Query: 723 D-SFNLLGYV 731
           +   NLLG+V
Sbjct: 731 NRDLNLLGFV 740

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  579 bits (1492), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 320/733 (43%), Positives = 450/733 (61%), Gaps = 43/733 (5%)

Query: 23  LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDR 81
           ++ DT+     +RDGE ++S  +RF  GFFS G S+ RY+GIW+ Q+   T+VWVANRD 
Sbjct: 17  ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76

Query: 82  PISDHNAVLTISNKGNLVLLNQTNGT--IWSTNVFSEVKNP--VAQLRDDGNLVIRDNSS 137
           PI+D + ++  SN+GNL +    N T  IWSTNV   +  P  VA L D GNLV+ D  +
Sbjct: 77  PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136

Query: 138 GNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVI 197
           G +     W+SFD+PTDT L  M++G+  K+ L+R L+SW+S  DP  G    R+E +  
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192

Query: 198 PKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDEISYWYEPFNRPSIMT 256
           P++ ++ G   +   G W G  +         +++    V N+DE+S+ Y   +   I  
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252

Query: 257 LKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC-SPDQKPI-CECLEGF 314
             +N +G + R  W      W+  +S P E C  Y +CG N  C SP  K   C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312

Query: 315 KLK---SKFNQTGPIKC-ERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAE 370
           + K     F +     C ++  +S C     F+KL  ++ PD  +  ++ ++ L++C   
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372

Query: 371 CLKNCTCRAYANS--NVTEGS-GCLMWFGDLLDANRPTRNFTGQSVYIRVPASE------ 421
           CLKNC+C AYA++      G+ GCL W G +LDA   T   +GQ  YIRV   E      
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDAR--TYLNSGQDFYIRVDKEELARWNR 430

Query: 422 ---TGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGIT 478
              +GKR++L IL+ L+  ++LL +  +FC  R   K     +   +   + FD      
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLL-TVILFCVVRERRKSNRHRSSSANFAPVPFD------ 483

Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQ 538
                F E     +DK ++  LPLF L ++ AAT NFS Q KLG GGFGPVYKG L N  
Sbjct: 484 -----FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRM 538

Query: 539 EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598
           E+AVKRLS  SGQG+EEFKNE+ LI+KLQHRNLV++LGCCVE  EK+L+ EY+PNKSLD 
Sbjct: 539 EIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDY 598

Query: 599 FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658
           F+F   ++  L W  R+ I+ GIA+G+LYLHQ SR RIIHRDLKASN+LLD +M PKISD
Sbjct: 599 FIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISD 658

Query: 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG 718
           FG+AR+FGG++++G T R+VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++GKKN+ 
Sbjct: 659 FGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA 718

Query: 719 VYNADSFNLLGYV 731
            ++ +S NL+G++
Sbjct: 719 -FHEESSNLVGHI 730

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  570 bits (1470), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 319/737 (43%), Positives = 445/737 (60%), Gaps = 82/737 (11%)

Query: 13  LILSL--SVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP 70
           LI+SL  ++ ++ A D +     ++DG+ +VS    FE+GFFSPG S++RYLGIW++++ 
Sbjct: 10  LIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKIS 69

Query: 71  -DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVF-----SEVKNPVAQL 124
             TVVWVANRD P+ D +  L +S  G+L L N  N  IWS++       + ++NP+ Q+
Sbjct: 70  LQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQI 129

Query: 125 RDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS 184
            D GNLV+R+  SG+  + Y+WQS DYP D  L GMK G +    L R+L+SW++ DDPS
Sbjct: 130 LDTGNLVVRN--SGDD-QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPS 186

Query: 185 PGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEIS 243
            G +T++++   +P+  +   SV    +G WNG  F    +   N +Y    V  ++E+ 
Sbjct: 187 TGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVY 246

Query: 244 YWYEPFNRPSIMT-LKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSP 302
           Y Y+  N PS++T ++LNP+G L R  W +N   W+   S   + C +Y  CG+   C+ 
Sbjct: 247 YTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNI 305

Query: 303 DQKPICECLEGFKLKSKFNQTG---PIKCERSHSSECIGGHQ-FIKLDNIRAPDFIEVFL 358
           ++ P C CL+GF  K+            C R    +C  G   F+K+  ++ PD    + 
Sbjct: 306 NESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWY 365

Query: 359 NKSMNLQQCAAECLKNCTCRAYANSNVTE-GSGCLMWFGDLLDANRPTRNFTGQSVYIRV 417
           +K+M+L +C   CL+NCTC AY+  ++ + G GC++WFGDL+D      N  GQ +Y+R+
Sbjct: 366 DKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNEN--GQDLYVRL 423

Query: 418 PAS--ETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINM 475
            +S  ET +R+                        R + +++E E++E            
Sbjct: 424 ASSEIETLQRE----------------------SSRVSSRKQEEEDLE------------ 449

Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
                                   LP   L +V+ AT  FS   KLG+GGFGPVYKG L 
Sbjct: 450 ------------------------LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLA 485

Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
            GQEVAVKRLS  S QG+EEFKNE+ LIAKLQHRNLVK+LG CV++ E++LI EY PNKS
Sbjct: 486 CGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKS 545

Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
           LD F+FD  ++R L W  RV II+GIA+G+LYLH+ SR RIIHRDLKASNVLLD DMN K
Sbjct: 546 LDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAK 605

Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           ISDFGLAR  GGDE + NT R+VGTYGYMSPEY +DG FS+KSDVFSFG+L+LE +SG++
Sbjct: 606 ISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRR 665

Query: 716 NTGVYNAD-SFNLLGYV 731
           N G  N +   NLLG+ 
Sbjct: 666 NRGFRNEEHKLNLLGHA 682

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  570 bits (1469), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 324/725 (44%), Positives = 454/725 (62%), Gaps = 39/725 (5%)

Query: 27  TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
           + T +  I   + ++S SQ FELGFF+P  S   YLGIW++ +P  T VWVANRD P+S 
Sbjct: 31  SATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
            N  L IS   NLV+ +Q++  +WSTN+   +V++PVA +L D+GN ++RD+++      
Sbjct: 91  SNGTLKISG-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN-----R 144

Query: 144 YLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIF 203
            LWQSFD+PTDTLL  MK+GWD K    R L SW++ DDPS G+F+++LE    P+  I 
Sbjct: 145 LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYIC 204

Query: 204 NGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMT-LKLNP 261
           +       SG WNG  F S        Y  Y    +++E++Y Y   N+ ++ + L LN 
Sbjct: 205 SKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYR-INKTNLYSRLYLNS 263

Query: 262 SGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN 321
           +GLL R  W      W  ++  P + C  Y  CG    C  +  P C C++GFK  ++  
Sbjct: 264 AGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQA 323

Query: 322 ---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCR 378
              + G   C R     C G   F +L  ++ PD     +++ + L+ C   CL++C C 
Sbjct: 324 WDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCT 383

Query: 379 AYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETGKRKLLWILVI-- 433
           A+AN+++  G SGC++W  ++LD     RN+   GQ +Y+R+ A+E   +++    +I  
Sbjct: 384 AFANADIRNGGSGCVIWTREILDM----RNYAKGGQDLYVRLAAAELEDKRIKNEKIIGS 439

Query: 434 -LVLPLVLLPSFYIFC---RRRRNCKEKETENMET--DQDLLAFDINMGITTRTNEFGEV 487
            + + ++LL SF IF    R+++     +T N++    QD L  D+ +     T++    
Sbjct: 440 SIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSK---- 495

Query: 488 NGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS 547
               + K +   LPL  L ++A AT NFS   KLG+GGFG VYKGRLL+G+E+AVKRLS 
Sbjct: 496 ----EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSK 551

Query: 548 QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR 607
            S QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD  LFD T+  
Sbjct: 552 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 611

Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
            L WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG 
Sbjct: 612 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 671

Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFN 726
           +E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++   N
Sbjct: 672 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 731

Query: 727 LLGYV 731
           LLG+V
Sbjct: 732 LLGFV 736

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  570 bits (1469), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 324/751 (43%), Positives = 468/751 (62%), Gaps = 40/751 (5%)

Query: 8   SIFCSLILSLSV-KVSLAADTVTPASFIRDG---EKLVSFSQRFELGFFSPGKSKSRYLG 63
           S++ SL L   + + S+AA+T+     +RDG   + LVS  + FELGFFSPG S  R+LG
Sbjct: 8   SLYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67

Query: 64  IWFRQVPD-TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEV---KN 119
           IW+  + D  VVWVANR  PISD + VL ISN GNLVLL+  N T+WS+N+ S      N
Sbjct: 68  IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127

Query: 120 PVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQS 179
            V  + D GN V+    S   T+  +W+SF++PTDT L  M++  + +        SW+S
Sbjct: 128 RVVSIHDTGNFVL----SETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183

Query: 180 DDDPSPGKFTSRLEIKVIPKMCIFNGS-VKFACSGQWNGAAFVSAISY---TNFLYEQYL 235
           + DPSPG ++  ++    P++ ++ G+  +   SGQWN A F    +    TN+LY   L
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243

Query: 236 VENQDE---ISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYG 292
               DE   + + Y P +   ++  K+  +G      WN     W    S PD  C +Y 
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303

Query: 293 YCGANTICS-PDQKPICECLEGFKLKSKFN------QTGPIKCERSHSSECIGGHQFIKL 345
            CG   IC       IC C+ G++  S  N      +  P+KCER+ S   +G  +F+ L
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTL 360

Query: 346 DNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPT 405
            +++ PDF E+  +  ++ + C   CL+NC+C AY+   +  G GC++W  DL+D  +  
Sbjct: 361 KSVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFE 416

Query: 406 RNFTGQSVYIRVPASETG--KRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE--N 461
               G S++IR+  SE G  ++  + ++V +++ ++L+  F +   R +  K+       
Sbjct: 417 AG--GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCG 474

Query: 462 METDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCK 520
             TD  ++  D+     T +   G V+   + K  + S LP+FSL ++A AT +F  + +
Sbjct: 475 KNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENE 534

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           LG GGFGPVYKG L +G+E+AVKRLS +SGQG++EFKNE++LIAKLQHRNLV+LLGCC E
Sbjct: 535 LGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFE 594

Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
             EK+L+ EYMPNKSLD FLFD TK+ L+ W+ R +IIEGIA+GLLYLH+ SR RIIHRD
Sbjct: 595 GEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRD 654

Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDV 700
           LK SNVLLD +MNPKISDFG+AR+FGG++ + NT R+VGTYGYMSPEYA++GLFS+KSDV
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDV 714

Query: 701 FSFGILMLETLSGKKNTGVYNADSFNLLGYV 731
           +SFG+L+LE +SGK+NT + +++  +L+GY 
Sbjct: 715 YSFGVLLLEIVSGKRNTSLRSSEHGSLIGYA 745

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  567 bits (1462), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 321/739 (43%), Positives = 461/739 (62%), Gaps = 50/739 (6%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDRPIS 84
           +T+  +  ++DG+ + S  +RF  GFFS G SK RY+GIW+ QV + T+VWVANRD PI+
Sbjct: 23  NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82

Query: 85  DHNAVLTISNKGNLVLLNQTNGT--IWSTNVFSEVKNP--VAQLRDDGNLVIRDNSSGNT 140
           D + ++  S +GNL +    NGT  IWST+V   ++ P  VA+L D GNLV+ D  +G +
Sbjct: 83  DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142

Query: 141 TESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKM 200
                W+SF++PT+TLL  MK G+  ++ ++R ++SW+S  DP  G  T R+E +  P+M
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198

Query: 201 CIFNGSVKFACSGQWNGAAFVSAISYTN-FLYEQYLVENQDEISYWYEPFNRPSIMTLKL 259
            ++ G   +  +G W G  +      TN F++    V N DE+S  Y   +      + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258

Query: 260 NPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC--SPDQKPICECLEGFKLK 317
           N +G L R  WN     W   +S P++ C  Y +CG N  C  +  +K  C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318

Query: 318 SK---FNQTGPIKCERSHS-SECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK 373
           +    F +     C R  + S C G   F KL  ++ P+   V ++ ++ L++C   CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378

Query: 374 NCTCRAYANS---NVTEGSGCLMWFGDLLDANRPTRNF--TGQSVYIRVPASE------- 421
           NC+C AYA++   +     GCL W G++LD    TR +  +GQ  Y+RV  SE       
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLD----TRTYLSSGQDFYLRVDKSELARWNGN 434

Query: 422 --TGKRKLLWILVILV-LPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLA---FDINM 475
             +GK++L+ IL+ L+ + ++LL SF+ + R+RR  +  ++  +       A   FD+  
Sbjct: 435 GASGKKRLVLILISLIAVVMLLLISFHCYLRKRR--QRTQSNRLRKAPSSFAPSSFDLED 492

Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
                  E         DK +   LPLF L+++A AT NF+ Q KLG GGFGPVYKG L 
Sbjct: 493 SFILEELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQ 543

Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
           NG E+AVKRLS  SGQG+EEFKNE+ LI+KLQHRNLV++LGCCVE  EK+L+ EY+PNKS
Sbjct: 544 NGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKS 603

Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
           LD F+F   ++  L W  R+ II GI +G+LYLHQ SR RIIHRDLKASNVLLD +M PK
Sbjct: 604 LDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPK 663

Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           I+DFGLAR+FGG++++G+T R+VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++GK+
Sbjct: 664 IADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKR 723

Query: 716 NTGVYNADSFNLLGYVSNK 734
           N+  Y  +S NL+ ++ ++
Sbjct: 724 NSAFYE-ESLNLVKHIWDR 741

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  544 bits (1402), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 317/749 (42%), Positives = 454/749 (60%), Gaps = 34/749 (4%)

Query: 1   MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSR 60
           M+ L  F +   +  +LS+ ++  + T +    I   + LVS    FE+GFF   ++ SR
Sbjct: 13  MSFLLVFVVMILIHPALSIYINTLSSTESLT--ISSNKTLVSPGSIFEVGFF---RTNSR 67

Query: 61  -YLGIWFRQVPD-TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVF--SE 116
            YLG+W+++V D T VWVANRD P+S+    L IS   NLVLL+ +N  +W TN+   +E
Sbjct: 68  WYLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNE 126

Query: 117 VKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSS 176
               VA+L  +GN V+RD+S+ + +E YLWQSFDYPTDTLL  MK+G++LK  L R+L+S
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTS 185

Query: 177 WQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQY-L 235
           W+S DDPS G F+ +LE + +P+  +   +     SG WNG  F          Y  Y  
Sbjct: 186 WRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNF 245

Query: 236 VENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFP-DEYCGKYGYC 294
           +EN +E++Y +   N      L L   G   R  W  +   W+  +S P D  C  Y  C
Sbjct: 246 IENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMC 305

Query: 295 GANTICSPDQKPICECLEGFKLKS--KFNQ-TGPIKCERSHSSECIGGHQFIKLDNIRAP 351
           G    C  +  P+C C++GF  ++  +++Q      C R     C  G  F ++  ++ P
Sbjct: 306 GPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLP 364

Query: 352 DFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDA-NRPTRNFT 409
           +     +++S+ +++C   C+ +C C A+AN+++  G SGC++W   L D  N  T    
Sbjct: 365 ETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAID 424

Query: 410 GQSVYIRVPASETGKRK----LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE--NME 463
           GQ +Y+R+ A++  K++     +  L + V  L+LL  F ++ R+++  K       N +
Sbjct: 425 GQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQ 484

Query: 464 TDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGE 523
            +Q+L    +N  + +   EF      G+ K ++  LPL  + +V  ATENFS   KLG+
Sbjct: 485 RNQNL---PMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQ 536

Query: 524 GGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583
           GGFG VYKGRLL+G+E+AVKRLS  S QG +EF NE+ LIA+LQH NLV++LGCC+E  E
Sbjct: 537 GGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDE 596

Query: 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
           K+LI EY+ N SLD +LF  T++  L W  R  I  G+A+GLLYLHQ SRFRIIHRDLK 
Sbjct: 597 KMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKV 656

Query: 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
           SN+LLD +M PKISDFG+AR+F  DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSF
Sbjct: 657 SNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSF 716

Query: 704 GILMLETLSGKKNTGVYNADSFN-LLGYV 731
           G+++LE +SGKKN G YN D  N LL YV
Sbjct: 717 GVIVLEIVSGKKNRGFYNLDYENDLLSYV 745

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  540 bits (1390), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 319/740 (43%), Positives = 447/740 (60%), Gaps = 48/740 (6%)

Query: 15  LSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TV 73
           LS+SV    A +++T    I   + +VS    FELGFF      S YLGIW++++   T 
Sbjct: 28  LSISVNTLSATESLT----ISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTY 82

Query: 74  VWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPV-AQLRDDGNLVI 132
           VWVANRD P+S+   +L ISN  NLV+L+ ++  +WSTN+   V++ V A+L D+GN V+
Sbjct: 83  VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141

Query: 133 RDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRL 192
           R  S  N ++ +LWQSFD+PTDTLL  MK+G D K  L R+++SW+S  DPS G F  +L
Sbjct: 142 R-GSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKL 200

Query: 193 EIKVIPKMCIFNGSVKFACSGQWNGAAFVSAIS---YTNFLYEQYLVENQDEISYWYEPF 249
           E   +P+   F   ++   SG W+G  F   +    + + +Y     EN++E++Y +   
Sbjct: 201 ETLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVT 258

Query: 250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICE 309
           +  S   L +N  G L   +W     +W++ +  P + C  YG CG    C     P C 
Sbjct: 259 DHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCN 318

Query: 310 CLEGFK-LKSKFNQTGPI--KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQ 366
           C++GF+ L  +   +G +  +C R     C G  +F +L N++ P      ++K + L++
Sbjct: 319 CIKGFQPLSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDKRIGLKE 377

Query: 367 CAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFT--GQSVYIRVPASETG 423
           C  +C  +C C AYANS++  G SGC++W G+     R  RN+   GQ +++R+ A+E G
Sbjct: 378 CEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFG 433

Query: 424 KRKLLWILVILVL---PLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTR 480
           +R+ +   +I ++    L+L+ SF I+C  ++  K              A    +G   R
Sbjct: 434 ERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRAR-----------ATAAPIGYRDR 482

Query: 481 TNEFGEVNGDGKDKGK-------DSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR 533
             E    NG     G+       D  LPL    +V  ATENFS    LG GGFG VYKGR
Sbjct: 483 IQELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGR 542

Query: 534 LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN 593
           LL+GQE+AVKRLS  S QG  EFKNE+ LIA+LQH NLV+LL CC+   EKILI EY+ N
Sbjct: 543 LLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLEN 602

Query: 594 KSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
            SLD  LF+ T+    L WQ R +II GIA+GLLYLHQ SRF+IIHRDLKASNVLLD +M
Sbjct: 603 GSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNM 662

Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            PKISDFG+AR+F  DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S
Sbjct: 663 TPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVS 722

Query: 713 GKKNTGVYNA-DSFNLLGYV 731
           GK+N G +N+    NLLGY 
Sbjct: 723 GKRNRGFHNSGQDNNLLGYT 742

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  538 bits (1386), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 318/734 (43%), Positives = 448/734 (61%), Gaps = 60/734 (8%)

Query: 21  VSLAADTVTPASFIRDGEKLVSFSQRFELGFFS---PGKSKSRYLGIWFRQVPDTVVWVA 77
           V+L  + +TP  F++DG+ L S  Q F+LGFFS     + + R+LG+W+ + P  VVWVA
Sbjct: 21  VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVA 79

Query: 78  NRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEV-----KNPVAQLRDDGNLVI 132
           NR+ P+   +  L +S+ G+L L +  +  +WS++  S        NP+ ++   GNL+ 
Sbjct: 80  NRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI- 138

Query: 133 RDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRL 192
               S +  E+ LWQSFDYP +T+L GMK+G + K ++E  LSSW++  DPSPG FT  L
Sbjct: 139 ----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSL 194

Query: 193 EIKVIPKMCIF-NGSVKFACS-GQWNGAAFVSA--ISYTNFLYEQYLVENQDEISYWYEP 248
           + + +P++ +  NG   ++   G WNG +F  A  +   N L++     +  E++Y + P
Sbjct: 195 DTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP 254

Query: 249 FNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQK--P 306
            +R  +  L LN +G L R I  +  N W L  + P++ C  Y  CGA  +C  + K  P
Sbjct: 255 RHR-IVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICGAYAVCGINSKNTP 312

Query: 307 ICECLEGFKLKS--KFN-QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLN--KS 361
            C CL+GFK KS  K+N   G   C     + C     F+K   ++ PD    + +    
Sbjct: 313 SCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNE 372

Query: 362 MNLQQCAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPAS 420
           M L+ C  +C  NC+C AYAN+++ EG  GCL+WFGDL+D  R   +F GQ VYIR+  +
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDM-REYSSF-GQDVYIRMGFA 430

Query: 421 --ETGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGIT 478
             E   R+++ ++V  V+ + ++      C R++  K    EN              GI 
Sbjct: 431 KIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRK-----------GIE 479

Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQ 538
                            +D  LP+F   +++ AT++FS    LG GGFGPVYKG+L +GQ
Sbjct: 480 E----------------EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQ 523

Query: 539 EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598
           E+AVKRLS+ SGQG+EEFKNE+ LIAKLQHRNLV+LLGCC++  E +LI EYMPNKSLD 
Sbjct: 524 EIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDF 583

Query: 599 FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD 658
           F+FD  +   L W+ R+ II G+A+G+LYLHQ SR RIIHRDLKA NVLLD DMNPKISD
Sbjct: 584 FIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISD 643

Query: 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG 718
           FGLA+ FGGD+ + +T R+VGTYGYM PEYA+DG FS+KSDVFSFG+L+LE ++GK N G
Sbjct: 644 FGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRG 703

Query: 719 VYNAD-SFNLLGYV 731
             +AD   NLLG+V
Sbjct: 704 FRHADHDLNLLGHV 717

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	744
224115098	802	predicted protein [Populus trichocarpa]	0.924	0.857	0.495	0.0
359493711	1081	PREDICTED: G-type lectin S-receptor-like	0.900	0.619	0.490	0.0
224126243	836	predicted protein [Populus trichocarpa]	0.928	0.826	0.491	0.0
224122858	831	predicted protein [Populus trichocarpa]	0.936	0.838	0.476	0.0
224124250	820	predicted protein [Populus trichocarpa]	0.918	0.832	0.478	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.922	0.844	0.464	0.0
224113149	820	predicted protein [Populus trichocarpa]	0.930	0.843	0.473	0.0
356514895	821	PREDICTED: G-type lectin S-receptor-like	0.942	0.853	0.484	0.0
255587572	822	S-locus-specific glycoprotein S6 precurs	0.966	0.874	0.471	1e-180
356545291	824	PREDICTED: G-type lectin S-receptor-like	0.916	0.827	0.487	1e-180

>gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa]

 Score =  696 bits (1796), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/745 (49%), Positives = 475/745 (63%), Gaps = 57/745 (7%)

Query: 1   MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSR 60
           M  LP F  F +L +     +S +AD +TP   ++DG+ L+S SQ FELGFFSPG SK R
Sbjct: 1   MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60

Query: 61  YLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNP 120
           Y+GIW+++ P+TVVWVANR+ P++DH  VLTI N+GNLVLL+Q    IWS+N  S +  P
Sbjct: 61  YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120

Query: 121 VAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSD 180
           VAQL D GNLV+RDN S   TESY WQSFD P+DTLL GMK+GW+LK   ERYL +W+S 
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180

Query: 181 DDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQD 240
            DPSPG FT RL+I  +P++ I  GSVK   SG WNG  F       N ++E  LV N+D
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240

Query: 241 EISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
           EI Y Y   N      L LN SG + R +     + W  ++S P + C  YG CGAN IC
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300

Query: 301 SPDQKPICECLEGFKLKSKF-----NQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIE 355
                PICECL+GFK   +      N  G  KCE   + +C  G  F+KL  ++ PD +E
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360

Query: 356 VFLNKSMNLQQCAAECLKNCTCRAYANSNVT---EGSGCLMWFGDLLDANRPTRNFTGQS 412
             LN+SMNL++C AEC KNC+C A+A +N++   +GSGCLMWFG+L+D    + +  GQ 
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQD 420

Query: 413 VYIRVPASE-----TGKRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQD 467
           ++IRVPASE     + KRK +    ++     LL  F     RR+       E ME    
Sbjct: 421 IHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSGMDRRK-------EGMEA--- 470

Query: 468 LLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFG 527
                                            PLF L ++A AT NF+    +G GGFG
Sbjct: 471 ---------------------------------PLFDLDTIATATNNFAPDSIIGAGGFG 497

Query: 528 PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI 587
            VYKG+LL GQE+AVK+LS  SGQG+EEF+NE++LIAKLQHRNLV LLG C+ + E++LI
Sbjct: 498 SVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLI 557

Query: 588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647
            EYMPNKSLD F+FD  +  LLGW+ R  II GIA+GLLYLHQ S+ +I+HRDLK SNVL
Sbjct: 558 YEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVL 617

Query: 648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
           LD ++ PKISDFGLAR+ G D  +  T+R++GTYGYM+PEYA+DG FS+KSDVFS G+L+
Sbjct: 618 LDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLL 677

Query: 708 LETLSGKKNTGVYNAD-SFNLLGYV 731
           LE +SGKKN G  + D   +LLG+ 
Sbjct: 678 LEIISGKKNRGFVHPDHHHHLLGHA 702

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  660 bits (1703), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/722 (49%), Positives = 452/722 (62%), Gaps = 52/722 (7%)

Query: 25  ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
           AD++     I D E LVS  Q FELGFFSPG SK+RYLGIW++  P T VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355

Query: 85  DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
           D   VLTI N G LVLLNQ+   IWS N+    +NPVAQL + GNLV+RD S+  T++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414

Query: 145 LWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFN 204
           +WQSFD P+DT+L GMK+GW+LK  L+R L+SW+S DDPS G F+   +I V+P + +  
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474

Query: 205 GSVKFACSGQWNGAAFVSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGL 264
           GS K   SG WNG  F       N +Y+   V N DE+   YE  N   I  L LN SG 
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534

Query: 265 LTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSK----- 319
           L R +     + WD ++S P E C  YG+CGAN IC   +  ICECL GF  KS+     
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594

Query: 320 FNQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRA 379
           FN +    C R    +C     F+K+  ++ PD I+  +   ++L++C   CL NC+C A
Sbjct: 595 FNTSS--GCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTA 652

Query: 380 YANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETG------KRKLLWILVI 433
           YA +N     GCLMW GDL+D    T     + +YIR+  SE G      K+KL+ ILVI
Sbjct: 653 YAYTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712

Query: 434 LVLPLVL---LPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGD 490
                +L   L  ++ F ++R          M TDQ+                       
Sbjct: 713 STFSGILTLGLSFWFRFWKKR---------TMGTDQE----------------------- 740

Query: 491 GKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
              K ++  LPLF L ++A AT NFS   K+G GGFG VYKG L  G  VAVKRLS  S 
Sbjct: 741 --SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798

Query: 551 QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 610
           QG++EFKNE +LIAKLQH+NLV+LLGCC++  E+IL+ EYMPNKSLD F+FD  ++ LL 
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858

Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
           W  R  I+ GIA+GLLYLHQ SRF+IIHRDLK SN+LLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLG 729
           +  TKRIVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +SG+KN G  + D   NLLG
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLG 978

Query: 730 YV 731
           + 
Sbjct: 979 HA 980

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa]

 Score =  659 bits (1700), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/741 (49%), Positives = 476/741 (64%), Gaps = 50/741 (6%)

Query: 7   FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
           FS FC+            A+T+T +  IRDG    LVS    FELGFFSPG S++RY+GI
Sbjct: 12  FSRFCN-----------TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 60

Query: 65  WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
           W++ +P  TVVWVANR+ PI+D +  L + N GNLVL++  N T+ WS+N     ++ + 
Sbjct: 61  WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMG 120

Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
           +L D GNLV+RD    N+  SYLWQSFDYP+DT+L GMK+GWDL+  L+R LS+W+S DD
Sbjct: 121 ELLDSGNLVLRDEKDVNSG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDD 179

Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFV-SAISYTNFLYEQYLVENQDE 241
           PS G FT   +++  P++ I+ GS K+  SG WNG  F   A    N ++    V+N +E
Sbjct: 180 PSSGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEE 239

Query: 242 ISYWYEPFNRPSIMTLKLNPSGLLTRQ--IWNNNGNDWDLVFSFPDEYCGKYGYCGANTI 299
           + Y Y   N+  I  L +N +    RQ   WN     W+L    P +YC  Y  CGA   
Sbjct: 240 VYYTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGN 299

Query: 300 CSPDQKPICECLEGFKLKS--KFNQTGPIK-CERSHSSECIGGHQFIKLDNIRAPDFIEV 356
           C   Q P+CECLE F  KS   +N     + C R+   +C  G  F+K   ++ PD    
Sbjct: 300 CIISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNS 359

Query: 357 FLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT--GQSVY 414
           ++NK+MNL++C ++CL+NC+C AY  +++ E SGC +WFGDL+D     R F   GQ +Y
Sbjct: 360 WVNKTMNLKECRSKCLQNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIY 415

Query: 415 IRVPASETG------KRKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDL 468
           IR+ ASE+       K ++   L I V   +LL ++YIF         K TE ++     
Sbjct: 416 IRMNASESSECLSLIKMEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSF 466

Query: 469 LAF----DINMGITTRTNEFGEVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLG 522
           L      D +  ++ +T    E N D  D G  +D  LPLF   ++A AT  FS+  K+G
Sbjct: 467 LLVYHVCDSHSLLSEKTGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIG 525

Query: 523 EGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582
           EGGFGPVYKG L +GQE+AVK LS  SGQGL EFKNE++LI KLQHRNLVKLLGCC++  
Sbjct: 526 EGGFGPVYKGTLEDGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGE 585

Query: 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642
           EKIL+ EYMPN+SLD F+FD T+ +LL W  R +II GIA+GLLYLHQ SR RI+HRDLK
Sbjct: 586 EKILVYEYMPNRSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLK 645

Query: 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFS 702
           ASNVLLD DMNPKISDFGLARM GGD+ +GNT R++GTYGYM+PEYA DGLFS+KSDVFS
Sbjct: 646 ASNVLLDKDMNPKISDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFS 705

Query: 703 FGILMLETLSGKKNTGVYNAD 723
           FGILMLE +SGKK+ G Y+ D
Sbjct: 706 FGILMLEIISGKKSRGFYHPD 726

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/737 (47%), Positives = 471/737 (63%), Gaps = 40/737 (5%)

Query: 12  SLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD 71
           S++  LS+  S A +++     + DG+ LVS    FELGFFSPG S++RY+GIW++++  
Sbjct: 18  SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76

Query: 72  -TVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
            TVVWVANR+ P++D + +L   + GNL  +N TNGTIWS+N+     NPVAQL D GNL
Sbjct: 77  FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136

Query: 131 VIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTS 190
           V+R  +  N  E++LWQSFDYP D+ L GMK G      L RYL+SW+S  DPS GK+T+
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195

Query: 191 RLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEISYWYEPF 249
           +L+   +P+  +  GSV    SG WNG  F   I+   N +Y    V NQ+EI Y Y+  
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255

Query: 250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICE 309
           N   +  + L+P G+L R  W +   DW L  +   + C ++  CGA+ +C+ +  P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315

Query: 310 CLEGFKLKSKFNQTGP---IKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQ 366
           CL+ F+ KS    T       C R    +C  G  FIK   I+ PD  + + NK++NL++
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375

Query: 367 CAAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRV-------P 418
           C   CLKNC+C AYAN +V +G SGC++WFGDL+D  +   N  GQ +YIR+       P
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNEN--GQDIYIRIAASVIDKP 433

Query: 419 ASETGKRKLLWILV---ILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINM 475
               GK+++  I++   ++   L+ L  F  F R+ +  +     N+ T+ +        
Sbjct: 434 VKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE-------- 485

Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL 535
               RT E          + +D  LPLF LA++  AT  FS+  KLG+GGFGPVYKG L 
Sbjct: 486 --QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQ 534

Query: 536 NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS 595
           +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLVKLLGCC+E  E++LI EYMPNKS
Sbjct: 535 DGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKS 594

Query: 596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK 655
           LD F+FD  +  LL W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +MNPK
Sbjct: 595 LDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPK 654

Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           ISDFG+AR FGGDE   NT RIVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +SG+K
Sbjct: 655 ISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRK 714

Query: 716 NTGVYNAD-SFNLLGYV 731
           N G  +A+   NLLG+ 
Sbjct: 715 NRGFRHAEHKLNLLGHA 731

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa]

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/744 (47%), Positives = 470/744 (63%), Gaps = 61/744 (8%)

Query: 7   FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
           FS FC+            A+T+T +  IRDG    LVS    FELGFFSPG S++RY+GI
Sbjct: 18  FSRFCN-----------TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 66

Query: 65  WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
           W++ +P  TVVWVANR+ PI+D +  L + N GN VL++  N T+ WS+N     ++ + 
Sbjct: 67  WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMG 126

Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
           +L+D GNLV+RD    N+   YLWQSFDYP+DTLL GMK+GWDL+  L+R LS+W+S DD
Sbjct: 127 ELQDSGNLVLRDEKDDNSG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDD 185

Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDE 241
           PS G FT   +++  P++ ++ GS K+  SG WNG  F   ++   N ++    V++ +E
Sbjct: 186 PSSGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEE 245

Query: 242 ISYWYEPFNRPSIMTLKLNPSGLL-TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
           + Y Y   N+  I  + +N +     R  WN     W L  + P +YC  Y  CGA   C
Sbjct: 246 VYYTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNC 305

Query: 301 SPDQKPICECLEGFKLKS--KFNQTGPIK-CERSHSSECIGGHQFIKLDNIRAPDFIEVF 357
              Q P+C+CLE F  +S   +N     K C R+   +C  G  F+K   ++ PD    +
Sbjct: 306 IMSQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSW 365

Query: 358 LNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT--GQSVYI 415
           +NK+MNL++C ++CL+NC+C AY  +N+ E SGC +WFGDL+D     R F+  GQ +YI
Sbjct: 366 VNKTMNLKECRSKCLQNCSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYI 421

Query: 416 RVPASETGKRKLLWI-------LVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDL 468
           R+ ASE+  +    I       L I V   +LL ++YIF R+ ++      EN + D   
Sbjct: 422 RLNASESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQIDSG- 480

Query: 469 LAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGP 528
                                      +D  LPLF   ++A AT  FS   KLGEGGFGP
Sbjct: 481 -------------------------PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGP 515

Query: 529 VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588
           VYKG L +GQE+A K LS  SGQGL EFKNE++LI KLQHRNLVKLLGCC++  EKIL+ 
Sbjct: 516 VYKGTLEDGQEIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVY 575

Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
           EYMPNKSLD F+FD T+ +LL W  R +II GIA+GLLYLHQ SR RI+HRDLKASNVLL
Sbjct: 576 EYMPNKSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLL 635

Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
           D DMNPKISDFGLARMFGGD+ +GNT R+VGTYGYM+PEYA DGLFS+KSDVFSFGILML
Sbjct: 636 DKDMNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILML 695

Query: 709 ETLSGKKNTGVYNAD-SFNLLGYV 731
           E +SGKK+ G  + D S +L+G+ 
Sbjct: 696 EIISGKKSRGFCHPDHSLSLIGHA 719

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  644 bits (1660), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/750 (46%), Positives = 470/750 (62%), Gaps = 64/750 (8%)

Query: 3   ILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYL 62
           ++  +S+F S++     K+S A D +     +RDGE LVS    FELGFF+P  S SRYL
Sbjct: 6   VIFVYSLFFSIL-----KISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYL 60

Query: 63  GIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVA 122
           G+W+++ P TVVWVANR  PIS+    L ++++G LVLLN TN  +WS+N  + V+NPVA
Sbjct: 61  GLWYKKSPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVA 120

Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
           QL D GNLV+RD +  N  +++LWQSFDYP DTLL GMK+G +L   L  +LSSW+  ++
Sbjct: 121 QLLDSGNLVVRDGND-NKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKEN 179

Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDE 241
           P+PG+FT  ++++  P++ +   +      G WNG  F        + +Y    V N++E
Sbjct: 180 PAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNE 239

Query: 242 ISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICS 301
           + + +E  N      L + PSGL+    W++  NDW +  +   + C  Y  CGAN  C 
Sbjct: 240 VYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCD 299

Query: 302 PDQKPICECLEGFKLKSKF-----NQTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEV 356
            +  P+C+CL+GF  KS       N TG   C R    +C     F     ++ PD    
Sbjct: 300 SNSSPVCDCLDGFIHKSPTEWNSQNWTG--GCIRRTPLDCTDKDGFQSYTGVKLPDTSSS 357

Query: 357 FLNKSMNLQQCAAECLKNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNFTGQSVYI 415
           + + S +L +C   C++NC+C AYAN +    GSGCL WFGDL+D  R      GQ +YI
Sbjct: 358 WYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYI 415

Query: 416 RVPASETG-----KRK------LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMET 464
           R+ AS++G     KRK      ++   VIL   +++L    +FC RRR  ++        
Sbjct: 416 RLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILG--IVFCIRRRKHRK-------- 465

Query: 465 DQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGE 523
                                  NG+ +D+ ++   LP+  L ++  AT+NFS   KLGE
Sbjct: 466 -----------------------NGNFEDRKEEEMELPMLDLTTIEHATDNFSSSKKLGE 502

Query: 524 GGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE 583
           GGFG VYKG L+ GQE+AVKRLS  SGQGL EFKNE++LIAKLQHRNLVKLLGCC+ + E
Sbjct: 503 GGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDE 562

Query: 584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
           K+LI EYMPN+SLD F+FDPT+++ L W  R  II+GIA+GLLYLHQ SR RIIHRD+KA
Sbjct: 563 KMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKA 622

Query: 644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
           SN+LLD ++NPKISDFGLARMFGGD+ + NTKR+VGTYGYMSPEYALDG FS+KSDVFSF
Sbjct: 623 SNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSF 682

Query: 704 GILMLETLSGKKNTGVYNAD--SFNLLGYV 731
           G+L+LE +SGKKN G  + D    NLLG+ 
Sbjct: 683 GVLVLEIVSGKKNRGFCHPDYNQKNLLGHA 712

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/741 (47%), Positives = 466/741 (62%), Gaps = 49/741 (6%)

Query: 7   FSIFCSLILSLSVKVSLAADTVTPASFIRDG--EKLVSFSQRFELGFFSPGKSKSRYLGI 64
           FS FC+            A+T+T +  + DG    LVS    FELGFFSPG S++RY+GI
Sbjct: 12  FSRFCN-----------TANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGI 60

Query: 65  WFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTI-WSTNVFSEVKNPVA 122
           W++ +P  TVVWVANR+ PI+D +  L + N GNLVL++  N T+ WS+N     ++ + 
Sbjct: 61  WYKNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMG 120

Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDD 182
           +L D GNLV+RD    N+   YLWQSFDYP+DTLL GMK+GWDL+  L+R LS+W+S DD
Sbjct: 121 ELLDSGNLVLRDEKDANSG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDD 179

Query: 183 PSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLVENQDE 241
           PS G FT   +++  P++ ++ GS ++  SG WNG  F        N ++    V++ +E
Sbjct: 180 PSSGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEE 239

Query: 242 ISYWYEPFNRPSIMTLKLNPSGLL-TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTIC 300
           + Y Y   N+  I  + +N S     R  WN     W L  + P +YC  Y  CGA   C
Sbjct: 240 VYYTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNC 299

Query: 301 SPDQKPICECLEGFKLKSKFNQTG---PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVF 357
              Q P+CECLE F  KS  +         C R+   +C  G  F+K   ++ PD    +
Sbjct: 300 IISQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSW 359

Query: 358 LNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRV 417
           +NK+MNL++C + CL+NC+C AY  +N+ E SGC +WFGDL+D  +      GQ +YIR+
Sbjct: 360 VNKTMNLKECRSICLENCSCMAYTATNIKERSGCAIWFGDLIDITQLPA--AGQEIYIRM 417

Query: 418 PASETGKRKLLWILV------ILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAF 471
            ASE+ +   L ++       I V   +LL ++YIF R+ +                L  
Sbjct: 418 NASESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAK----------------LIG 461

Query: 472 DINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYK 531
            + +   +   E  +++   K+   D  LPLF   ++A AT  FS   KLGEGGFGPVYK
Sbjct: 462 KVTLTAFSNREENDQIDSGPKE---DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYK 518

Query: 532 GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM 591
           G L +GQE+A K  S  SGQG+ EFKNE++LI KLQHRNLVKLLGCC++  EKIL+ EYM
Sbjct: 519 GTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYM 578

Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
           PNKSLD F+FD T+  LL W  R +II GIA+GLLYLHQ SR RI+HRDLKASNVLLD D
Sbjct: 579 PNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKD 638

Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
           MNPKISDFGLARMFGGD+ +GNT R+VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +
Sbjct: 639 MNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEII 698

Query: 712 SGKKNTGVYNAD-SFNLLGYV 731
           SGKK+ G Y+ D S +L+G+ 
Sbjct: 699 SGKKSRGFYHPDHSLSLIGHA 719

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/751 (48%), Positives = 470/751 (62%), Gaps = 50/751 (6%)

Query: 1   MAILPCFSIFCSLILSLSVKVSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGK-SKS 59
           MA L    I  S ++  S     A D +     + D   LVS    FELGFF+PG  S +
Sbjct: 1   MAFL-VIVILVSKLIFFSSNFLAATDMINQFQSLEDNTTLVSNDGTFELGFFTPGSTSPN 59

Query: 60  RYLGIWFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGT-IWSTNVFSEV 117
           RYLGIW++ +P  TVVWVANRD PI D+++ L+I+  GN +LLNQ N T IWSTN  ++ 
Sbjct: 60  RYLGIWYKNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKA 119

Query: 118 KNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSW 177
              VAQL D GNLV+RD    N  E+Y WQSFDYP+DT L GMK GWDLK  L R L++W
Sbjct: 120 SLVVAQLLDSGNLVLRDEKDNNP-ENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAW 178

Query: 178 QSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAAFVSAISY-TNFLYEQYLV 236
           ++ DDPS G FT+       P+  ++ G+ ++  SG W+G  F  + S  TN +    +V
Sbjct: 179 KNWDDPSSGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVV 238

Query: 237 ENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQ--IWNNNGNDWDLVFSFPDEYCGKYGYC 294
            N+DE    Y   ++  I  + +N + L  RQ   WN +   W +    P + C  Y  C
Sbjct: 239 SNKDEFYATYSMIDKSLISRVVVNQT-LYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTC 297

Query: 295 GANTICSPDQKPICECLEGFKLKSKFNQTG---PIKCERSHSSECIGGHQ--FIKLDNIR 349
           GA  IC   Q P+C CL+GFK KS  N T       C  + +  C+  ++  F K  N++
Sbjct: 298 GAFGICVAGQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLK 357

Query: 350 APDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVT-EGSGCLMWFGDLLDANRPTRNF 408
           APD    ++N SM L +C  +C +NC+C AYAN ++  EGSGC +WFGDLLD  R   N 
Sbjct: 358 APDTERSWVNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDI-RLIPN- 415

Query: 409 TGQSVYIRVPASET-----GKRKLLWILVILV-LPLVLLPSFYIFCRRRRNCKEKETENM 462
            GQ +YIR+  SET      K+K++ I  I+  +   LL   +I+    +N KE      
Sbjct: 416 AGQDLYIRLAVSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKE------ 469

Query: 463 ETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLG 522
                     I +GI  + NE          + +D  LPLF L S+A AT++FS   KLG
Sbjct: 470 ----------IILGIEVKNNE---------SQQEDFELPLFDLVSIAQATDHFSDHNKLG 510

Query: 523 EGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG 582
           EGGFGPVYKG L +G EVAVKRLS  SGQGL+EFKNE+ML AKLQHRNLVK+LGCC+++ 
Sbjct: 511 EGGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKEFKNEVMLCAKLQHRNLVKVLGCCIQEN 570

Query: 583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642
           EK+LI EYM NKSLDVFLFD  + +LL W  R  II  IA+GLLYLHQ SR RIIHRDLK
Sbjct: 571 EKLLIYEYMANKSLDVFLFDSDRSKLLDWPKRFYIINRIARGLLYLHQDSRLRIIHRDLK 630

Query: 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFS 702
           ASNVLLD +MNPKISDFGLARM GGD+++G T+R+VGTYGYM+PEYA DGLFSIKSDVFS
Sbjct: 631 ASNVLLDNEMNPKISDFGLARMCGGDQIEGKTRRVVGTYGYMAPEYAFDGLFSIKSDVFS 690

Query: 703 FGILMLETLSGKKNTGVYNADSF--NLLGYV 731
           FG+L+LE +SGKKN  ++  + +  NL+G+ 
Sbjct: 691 FGVLLLEIVSGKKNNRLFYPNDYNNNLIGHA 721

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  637 bits (1644), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 352/746 (47%), Positives = 469/746 (62%), Gaps = 27/746 (3%)

Query: 19  VKVSLAA-DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWV 76
           ++VS A  +T+ P   ++DGE L+S    FELGFFS G S+SRYLGIW++++P  TVVWV
Sbjct: 2   LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61

Query: 77  ANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNS 136
            NR+ P  D+  VL ++ +G ++L N T G IWS+N     KNPV QL D GNL+++D  
Sbjct: 62  GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKD-G 120

Query: 137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
           +GN  ++ +WQSFD+P +TLL  MK+GW+L   L RYL+SW+S DDP+ G F+  ++++ 
Sbjct: 121 NGNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180

Query: 197 IPKMCIFNGSVKFACSGQWNGAAFVSAISYT-NFLYEQYLVENQDEISYWYEPFNRPSIM 255
            P++ +  G      SG WNG  F  +     N ++    V N+ EI Y YE  N   + 
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240

Query: 256 TLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFK 315
            L ++  G L R  W +    W L FS P + C  Y  CGA   C+ +  P+C CLEGF 
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300

Query: 316 LKSKFNQTGPI---KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECL 372
            KS  + +       C R     C  G  F KL  ++ PD    +++ SM+L++C   CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360

Query: 373 KNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRK------ 426
           +NC+C AYANS++  GSGCL+WF  L+D  + T    GQ +YIR+ ASE  K K      
Sbjct: 361 RNCSCLAYANSDI-RGSGCLLWFDHLIDMRKFTEG--GQDLYIRIAASELAKGKSHGKRV 417

Query: 427 -LLWILVILVLPLVLLPSFYIFCRRRRNCKEKETE-NMETDQDLLAFDINMGITTRTNEF 484
            ++   +I+ + +  L S     +R+RN   +     +      + F I  G+   T  +
Sbjct: 418 AIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKET--Y 475

Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 544
            E  GD   K +D+ L  F L ++  AT NFS   KLGEGGFGPVYKG LL+GQE+AVKR
Sbjct: 476 IENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKR 534

Query: 545 LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT 604
           LS  SGQG +EFKNE++LIA+LQHRNLVKLLGCC+   EK+LI EYMPNKSLD F+FD  
Sbjct: 535 LSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKK 594

Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
           +  LL W     II GIA+GLLYLHQ SR RIIHRDLKASN+LLD DMNPKISDFGLAR 
Sbjct: 595 RSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLART 654

Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD- 723
           FG D+   NTKR+VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +SGK+N G  + D 
Sbjct: 655 FGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDH 714

Query: 724 SFNLLGY-----VSNKSLHFYLIFSE 744
           S NLLG+     +  ++L  +  FS+
Sbjct: 715 SLNLLGHAWRLWMEERALELFDKFSQ 740

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356545291|ref|XP_003541077.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 359/736 (48%), Positives = 468/736 (63%), Gaps = 54/736 (7%)

Query: 22  SLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKS--RYLGIWFRQVP-DTVVWVAN 78
           ++A DT+T + F+ D   LVS +  FELGFF+PG S S  RY+GIW++ +P  T+VWVAN
Sbjct: 20  AVATDTITQSEFLEDNTTLVSNNGTFELGFFTPGSSSSPNRYVGIWYKNIPIRTLVWVAN 79

Query: 79  RDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSG 138
           RD PI D+++ L+I+ +GNLVL+NQ N  IWSTN  ++    VAQL D GNLV+RD    
Sbjct: 80  RDNPIKDNSSKLSINTQGNLVLVNQNNTVIWSTNTTAKASLVVAQLLDSGNLVLRDEKDT 139

Query: 139 NTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIP 198
           N  E+YLWQSFDYP+DT L GMK+GWDLK  L  +L++W++ DDPSPG FT        P
Sbjct: 140 NP-ENYLWQSFDYPSDTFLPGMKLGWDLKKGLNWFLTAWKNWDDPSPGDFTRSTLHTNNP 198

Query: 199 KMCIFNGSVKFACSGQWNGAAF-----VSAISYTNFLYEQYLVENQDEISYWYEPFNRPS 253
           +  ++ G+ ++  SG W+G  F     VS+ S TN+     +V N+DE    Y   ++  
Sbjct: 199 EEVMWKGTTQYYRSGPWDGIGFSGIPSVSSDSNTNYT----IVSNKDEFYITYSLIDKSL 254

Query: 254 IMTLKLNPSGLLTRQI-WNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLE 312
           I  + +N +    +++ WN +   W +    P ++C +Y  CGA  IC   Q P C+CL+
Sbjct: 255 ISRVVMNQTRYARQRLAWNIDSQTWRVSSELPTDFCDQYNICGAFGICVIGQAPACKCLD 314

Query: 313 GFKLKSKFNQTG---PIKCERSHSSEC--IGGHQFIKLDNIRAPDFIEVFLNKSMNLQQC 367
           GFK KS  N T       C  + +  C   G   F K  N++ PD    ++N +M L +C
Sbjct: 315 GFKPKSPRNWTQMSWNQGCVHNQTWSCRKKGRDGFNKFSNVKVPDTRRSWVNANMTLDEC 374

Query: 368 AAECLKNCTCRAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGK-- 424
             +C +NC+C AYANS++  G SGC +WF DLLD  R   N  GQ +YIR+  SET +  
Sbjct: 375 KNKCWENCSCTAYANSDIKGGGSGCAIWFSDLLDI-RLMPN-AGQDLYIRLAMSETAQQY 432

Query: 425 -------RKLLWILVILVLPLVLLPSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGI 477
                  +K + ++   V  ++ +   +IF       K KE              I  GI
Sbjct: 433 QEAKHSSKKKVVVIASTVSSVIAILLIFIFIYWSYKNKNKE--------------IITGI 478

Query: 478 TTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNG 537
             + N         K + +D  LPLF LAS+A AT NFS   KLGEGGFGPVYKG L  G
Sbjct: 479 EGKNN---------KSQQEDFELPLFDLASIAHATNNFSNDNKLGEGGFGPVYKGILPYG 529

Query: 538 QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
           QEVAVKRLS  S QGL+EFKNE+ML A+LQHRNLVK+LGCC++  EK+LI EYM NKSLD
Sbjct: 530 QEVAVKRLSETSRQGLKEFKNEVMLCAELQHRNLVKVLGCCIQDDEKLLIYEYMANKSLD 589

Query: 598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657
           VFLFD ++ +LL W  R  II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +MNPKIS
Sbjct: 590 VFLFDSSQGKLLDWPKRFCIINGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 649

Query: 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717
           DFGLARM GGD+++G T R+VGTYGYM+PEYA DG+FSIKSDVFSFG+L+LE +SGKKN 
Sbjct: 650 DFGLARMCGGDQIEGKTSRVVGTYGYMAPEYAFDGIFSIKSDVFSFGVLLLEIVSGKKNR 709

Query: 718 GVYNADSFNLLGYVSN 733
                D  NL+G+VS+
Sbjct: 710 LFSPNDYNNLIGHVSD 725

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	744
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.362	0.344	0.613	9.8e-159
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.931	0.818	0.450	1.7e-155
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.922	0.807	0.445	5.6e-155
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.924	0.816	0.446	6.5e-154
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.326	0.298	0.635	1.5e-151
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.932	0.817	0.436	2.7e-148
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.918	0.811	0.415	1.1e-137
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.310	0.287	0.620	3.5e-137
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.323	0.299	0.607	8.5e-134
TAIR|locus:2197709	809	AT1G61480 [Arabidopsis thalian	0.313	0.288	0.581	3.3e-132

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 814 (291.6 bits), Expect = 9.8e-159, Sum P(2) = 9.8e-159
 Identities = 167/272 (61%), Positives = 199/272 (73%)

Query:   460 ENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQC 519
             E  E  QDL     +  I T   E   V+   K + +D  LP   L +V+ AT  FS   
Sbjct:   411 EYNENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGN 469

Query:   520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
             KLG+GGFGPVYKG L  GQEVAVKRLS  S QG+EEFKNE+ LIAKLQHRNLVK+LG CV
Sbjct:   470 KLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCV 529

Query:   580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
             ++ E++LI EY PNKSLD F+FD  ++R L W  RV II+GIA+G+LYLH+ SR RIIHR
Sbjct:   530 DEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHR 589

Query:   640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
             DLKASNVLLD DMN KISDFGLAR  GGDE + NT R+VGTYGYMSPEY +DG FS+KSD
Sbjct:   590 DLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSD 649

Query:   700 VFSFGILMLETLSGKKNTGVYNAD-SFNLLGY 730
             VFSFG+L+LE +SG++N G  N +   NLLG+
Sbjct:   650 VFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGH 681

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1516 (538.7 bits), Expect = 1.7e-155, P = 1.7e-155
 Identities = 325/722 (45%), Positives = 440/722 (60%)

Query:    27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
             + T +  I   + ++S SQ FELGFF+P  S   YLGIW++ +P  T VWVANRD P+S 
Sbjct:    31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90

Query:    86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
              N  L IS+  NLV+ +Q++  +WSTN+   +V++PVA +L D GN V+RD S  N    
Sbjct:    91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148

Query:   144 YLWQSFDYPTDTLLQGMKMGWDLKNR-LERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCI 202
             +LWQSFD+PTDTLL  MKMGWD K+    R L SW++ DDPS G F+++L     P+  I
Sbjct:   149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208

Query:   203 FNG-SVKFACSGQWNGAAFVSAISYTNFLY-EQYLVENQDEISYWYEPFNRPSIMT-LKL 259
             +N  S+ +  SG W G  F S        Y +    EN  ++ Y Y   N+ +I + L L
Sbjct:   209 YNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYR-VNKTNIYSILSL 266

Query:   260 NPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSK 319
             + +GLL R  W      W  ++  P + C  Y  CG    C  +  PIC C++GF+  ++
Sbjct:   267 SSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNE 326

Query:   320 FN--QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTC 377
                 +   + C R     C G   F++L  +R PD  E  ++K + L++C   CLK C C
Sbjct:   327 QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNC 386

Query:   378 RAYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKXXXXXXXXXX 436
              A+AN+++  G SGC++W G L D     +   GQ +Y+RV A +   ++          
Sbjct:   387 TAFANTDIRNGGSGCVIWSGGLFDIRNYAKG--GQDLYVRVAAGDLEDKRIKSKKIIGSS 444

Query:   437 XXXXXX---SFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKD 493
                      SF IF   +R  K+K +  ++T       D+     +  NE  + +     
Sbjct:   445 IGVSILLLLSFIIFHFWKR--KQKRSITIQTP----IVDLVRSQDSLMNELVKASRSYTS 498

Query:   494 K-GKDSWL--PLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
             K  K  +L  PL    ++A AT NFS   KLG+GGFG VYKG LL+G+E+AVKRLS  S 
Sbjct:   499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558

Query:   551 QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 610
             QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD  LFD T+   L 
Sbjct:   559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618

Query:   611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
             WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG +E 
Sbjct:   619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678

Query:   671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLG 729
             + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++   NLLG
Sbjct:   679 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 738

Query:   730 YV 731
             +V
Sbjct:   739 FV 740

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1511 (537.0 bits), Expect = 5.6e-155, P = 5.6e-155
 Identities = 319/716 (44%), Positives = 437/716 (61%)

Query:    34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANRDRPISDHNAVLTI 92
             I     +VS    FELGFF PG     YLGIW++ +   T VWVANRD P+S     L I
Sbjct:    40 ISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKI 99

Query:    93 SNKGNLVLLNQTNGTIWSTNVFS-EVKNP-VAQLRDDGNLVIRDNSSGNTTESYLWQSFD 150
             S+  NLV+L+Q++  +WSTN+   +V++P VA+L D+GN V+RD S  +  +  LWQSFD
Sbjct:   100 SDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-SKNSAPDGVLWQSFD 157

Query:   151 YPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFA 210
             +PTDTLL  MK+GWD K    R++ SW+S DDPS G F+ +LE +  P++ ++N   +  
Sbjct:   158 FPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMY 217

Query:   211 CSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQI 269
              SG WNG  F        F Y  +    +++E++Y +          L ++ SGLL R  
Sbjct:   218 RSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFT 277

Query:   270 WNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN---QTGPI 326
             W     +W+  +  P + C +Y  CG    C  +  P+C C++GFK ++      + G  
Sbjct:   278 WIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSD 337

Query:   327 KCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVT 386
              C R     C GG  F++L  ++ PD     +++ + +++C  +CL++C C A+AN+++ 
Sbjct:   338 GCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIR 397

Query:   387 -EGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETG---KRKXXXXXXXXXXXXXXXX 442
               GSGC+ W G+L D     +   GQ +Y+R+ A++      R                 
Sbjct:   398 GSGSGCVTWTGELFDIRNYAKG--GQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLL 455

Query:   443 SFYIFCRRRRNCKEKETENMET---DQDLLAFDINMG---ITTRTNEFGEVNGDGKDKGK 496
             SF IF   +R  K+K +  +ET   D  L + D+ M    I++R +   E N D      
Sbjct:   456 SFIIFFLWKR--KQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTD------ 507

Query:   497 DSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEF 556
             D  LPL     VA AT NFS   KLG+GGFG VYKG+LL+GQE+AVKRLS  S QG +EF
Sbjct:   508 DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEF 567

Query:   557 KNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
             KNE+ LIA+LQH NLV+LL CCV+ GEK+LI EY+ N SLD  LFD ++   L WQ R  
Sbjct:   568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627

Query:   617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
             II GIA+GLLYLHQ SRFRIIHRDLKASN+LLD  M PKISDFG+AR+FG DE + NT++
Sbjct:   628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRK 687

Query:   677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLLGYV 731
             +VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G YN+D   NLLG V
Sbjct:   688 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCV 743

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1501 (533.4 bits), Expect = 6.5e-154, P = 6.5e-154
 Identities = 323/723 (44%), Positives = 444/723 (61%)

Query:    27 TVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVP-DTVVWVANRDRPISD 85
             + T +  I   + ++S SQ FELGFF+P  S   YLGIW++ +P  T VWVANRD P+S 
Sbjct:    31 SATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90

Query:    86 HNAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVA-QLRDDGNLVIRDNSSGNTTES 143
              N  L IS   NLV+ +Q++  +WSTN+   +V++PVA +L D+GN ++RD+++      
Sbjct:    91 SNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN-----R 144

Query:   144 YLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIF 203
              LWQSFD+PTDTLL  MK+GWD K    R L SW++ DDPS G+F+++LE    P+  I 
Sbjct:   145 LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYIC 204

Query:   204 NGSVKFACSGQWNGAAFVSAISYTNFLYEQY-LVENQDEISYWYEPFNRPSIMT-LKLNP 261
             +       SG WNG  F S        Y  Y    +++E++Y Y   N+ ++ + L LN 
Sbjct:   205 SKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYR-INKTNLYSRLYLNS 263

Query:   262 SGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKSKFN 321
             +GLL R  W      W  ++  P + C  Y  CG    C  +  P C C++GFK  ++  
Sbjct:   264 AGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQA 323

Query:   322 ---QTGPIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCR 378
                + G   C R     C G   F +L  ++ PD     +++ + L+ C   CL++C C 
Sbjct:   324 WDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCT 383

Query:   379 AYANSNVTEG-SGCLMWFGDLLDANRPTRNFTGQSVYIRVPASET-GKR--KXXXXXXXX 434
             A+AN+++  G SGC++W  ++LD     +   GQ +Y+R+ A+E   KR           
Sbjct:   384 AFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIKNEKIIGSSI 441

Query:   435 XXXXXXXXSFYIFCRRRRNCKEK---ETENMET--DQDLLAFDINMGITTRTNEFGEVNG 489
                     SF IF   +R  K     +T N++    QD L  D+   + +R    G  + 
Sbjct:   442 GVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDV---VVSRR---GYTSK 495

Query:   490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
             + K +  +  LPL  L ++A AT NFS   KLG+GGFG VYKGRLL+G+E+AVKRLS  S
Sbjct:   496 EKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMS 553

Query:   550 GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL 609
              QG +EF NE+ LIAKLQH NLV+LLGCCV++GEK+LI EY+ N SLD  LFD T+   L
Sbjct:   554 SQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNL 613

Query:   610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
              WQ R  II GIA+GLLYLHQ SR RIIHRDLKASNVLLD +M PKISDFG+AR+FG +E
Sbjct:   614 NWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREE 673

Query:   670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-SFNLL 728
              + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SGK+N G YN++   NLL
Sbjct:   674 TEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLL 733

Query:   729 GYV 731
             G+V
Sbjct:   734 GFV 736

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 811 (290.5 bits), Expect = 1.5e-151, Sum P(2) = 1.5e-151
 Identities = 157/247 (63%), Positives = 195/247 (78%)

Query:   489 GDGKDKG---KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL 545
             G+   KG   +D  LP+F   +++ AT++FS    LG GGFGPVYKG+L +GQE+AVKRL
Sbjct:   471 GENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRL 530

Query:   546 SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK 605
             S+ SGQG+EEFKNE+ LIAKLQHRNLV+LLGCC++  E +LI EYMPNKSLD F+FD  +
Sbjct:   531 SANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERR 590

Query:   606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665
                L W+ R+ II G+A+G+LYLHQ SR RIIHRDLKA NVLLD DMNPKISDFGLA+ F
Sbjct:   591 STELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSF 650

Query:   666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD-S 724
             GGD+ + +T R+VGTYGYM PEYA+DG FS+KSDVFSFG+L+LE ++GK N G  +AD  
Sbjct:   651 GGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHD 710

Query:   725 FNLLGYV 731
              NLLG+V
Sbjct:   711 LNLLGHV 717

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
 Identities = 320/733 (43%), Positives = 451/733 (61%)

Query:    24 AADTVTPASFIRDG---EKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPD-TVVWVANR 79
             AA+T+     +RDG   + LVS  + FELGFFSPG S  R+LGIW+  + D  VVWVANR
Sbjct:    25 AANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANR 84

Query:    80 DRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEV---KNPVAQLRDDGNLVIRDNS 136
               PISD + VL ISN GNLVLL+  N T+WS+N+ S      N V  + D GN V+ +  
Sbjct:    85 ATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD 144

Query:   137 SGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKV 196
                 T+  +W+SF++PTDT L  M++  + +        SW+S+ DPSPG ++  ++   
Sbjct:   145 ----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSG 200

Query:   197 IPKMCIFNGS-VKFACSGQWNGAAF--VSAISY-TNFLYEQYLVENQDE---ISYWYEPF 249
              P++ ++ G+  +   SGQWN A F  +  +S  TN+LY   L    DE   + + Y P 
Sbjct:   201 APEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPS 260

Query:   250 NRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICS-PDQKPIC 308
             +   ++  K+  +G      WN     W    S PD  C +Y  CG   IC       IC
Sbjct:   261 DPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGIC 320

Query:   309 ECLEGFKLKSKFNQT-G-----PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSM 362
              C+ G++  S  N + G     P+KCER+ S   +G  +F+ L +++ PDF E+  +  +
Sbjct:   321 SCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLKSVKLPDF-EIPEHNLV 376

Query:   363 NLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASET 422
             + + C   CL+NC+C AY+   +  G GC++W  DL+D  +      G S++IR+  SE 
Sbjct:   377 DPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEAG--GSSLHIRLADSEV 431

Query:   423 GK-RKXXXXXXXXXXXXXXXXS-FYIFCRRRRNCKEKETE--NMETDQDLLAFDINMGIT 478
             G+ RK                  F +   R +  K+         TD  ++  D+     
Sbjct:   432 GENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKE 491

Query:   479 TRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNG 537
             T +   G V+   + K  + S LP+FSL ++A AT +F  + +LG GGFGPVYKG L +G
Sbjct:   492 TTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDG 551

Query:   538 QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
             +E+AVKRLS +SGQG++EFKNE++LIAKLQHRNLV+LLGCC E  EK+L+ EYMPNKSLD
Sbjct:   552 REIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLD 611

Query:   598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS 657
              FLFD TK+ L+ W+ R +IIEGIA+GLLYLH+ SR RIIHRDLK SNVLLD +MNPKIS
Sbjct:   612 FFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKIS 671

Query:   658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT 717
             DFG+AR+FGG++ + NT R+VGTYGYMSPEYA++GLFS+KSDV+SFG+L+LE +SGK+NT
Sbjct:   672 DFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNT 731

Query:   718 GVYNADSFNLLGY 730
              + +++  +L+GY
Sbjct:   732 SLRSSEHGSLIGY 744

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1348 (479.6 bits), Expect = 1.1e-137, P = 1.1e-137
 Identities = 298/717 (41%), Positives = 420/717 (58%)

Query:    34 IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQV-PDTVVWVANRDRPISDHNAVLTI 92
             IR+G+ L+S  + FELGFF+P  S  RY+GIW++ + P TVVWVANR++P+ DH   L I
Sbjct:    38 IREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKI 97

Query:    93 SNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152
             ++ GNLV++N  N TIWSTNV  E  N VA L   G+LV+  +S       + W+SF+ P
Sbjct:    98 ADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDSD---RRKWYWESFNNP 154

Query:   153 TDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACS 212
             TDT L GM++  +      R    W+S+ DPSPGK++  ++     ++ I+ G  +   S
Sbjct:   155 TDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRS 214

Query:   213 GQWNGAAFVSA---ISYTNFLYEQYLVENQDE---ISYWYEPFNRPSIMTLKLNPSGLLT 266
             G WN A F      + +TN++Y   L    D    + + Y   +    +   + P G+  
Sbjct:   215 GPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEE 274

Query:   267 RQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPI----CECLEGFKL--KSKF 320
             +  WN +  +W+L+   P   C KY  CG  ++C  D K      C C++GF+   + ++
Sbjct:   275 QFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCD-DSKEFDSGKCSCIDGFEPVHQDQW 333

Query:   321 NQTG-PIKCERSHSSEC----IGGHQ--FIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK 373
             N       C+R     C    + G +  F  L  I+ PDF  V L+   N + C   C +
Sbjct:   334 NNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NSETCKDVCAR 391

Query:   374 NCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKXXXXXXX 433
             +C+C+AYA   +  G GC++W  DL+D     R   G S+ IR+  S+ G  K       
Sbjct:   392 DCSCKAYA---LVVGIGCMIWTRDLIDMEHFERG--GNSINIRLAGSKLGGGKENSTLWI 446

Query:   434 XXXXXXXXXSFYIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKD 493
                         +        K+     +   +D+   DI       ++    + GD  D
Sbjct:   447 IVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVD 506

Query:   494 KGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL 553
                D  LP+FS  SVA+AT +F+ + KLG+GGFG VYKG    G+E+AVKRLS +S QGL
Sbjct:   507 T-PD--LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGL 563

Query:   554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA 613
             EEFKNE++LIAKLQHRNLV+LLGCC+E  EK+L+ EYMPNKSLD FLFD +K+  L W+ 
Sbjct:   564 EEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRK 623

Query:   614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
             R  +I GIA+GLLYLH+ SR +IIHRDLKASN+LLD +MNPKISDFG+AR+F   +   N
Sbjct:   624 RWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHAN 683

Query:   674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
             T R+VGTYGYM+PEYA++G+FS KSDV+SFG+L+LE +SG+KN      D  +L+GY
Sbjct:   684 TIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGY 740

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 3.5e-137, Sum P(2) = 3.5e-137
 Identities = 144/232 (62%), Positives = 180/232 (77%)

Query:   500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE 559
             L  F + ++  AT NFS+  KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG EEF NE
Sbjct:   476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535

Query:   560 MMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
             ++LI+KLQHRNLV++LGCC+E+ EK+LI E+M NKSLD FLFD  K+  + W  R  II+
Sbjct:   536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595

Query:   620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
             GIA+GLLYLH  SR R+IHRDLK SN+LLD  MNPKISDFGLARM+ G E Q NT+R+VG
Sbjct:   596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655

Query:   680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV-YNADSFNLLGY 730
             T GYMSPEYA  G+FS KSD++SFG+LMLE +SG+K +   Y  +   L+ Y
Sbjct:   656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAY 707

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 756 (271.2 bits), Expect = 8.5e-134, Sum P(2) = 8.5e-134
 Identities = 147/242 (60%), Positives = 186/242 (76%)

Query:   490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
             +G ++   S +  F + ++  AT NFS   KLG+GGFGPVYKG+L++G+E+ VKRL+S S
Sbjct:   463 NGFERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSS 522

Query:   550 GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL 609
             GQG EEF NE+ LI+KLQHRNLV+LLG C++  EK+LI E+M NKSLD+F+FDP  K  L
Sbjct:   523 GQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFEL 582

Query:   610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
              W  R  II+GIA+GLLYLH+ SR R+IHRDLK SN+LLD  MNPKISDFGLARMF G +
Sbjct:   583 DWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQ 642

Query:   670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK-NTGVYNADSFNLL 728
              Q NT+R+VGT GYMSPEYA  GLFS KSD++SFG+LMLE +SGK+ +  +Y  +S  LL
Sbjct:   643 YQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLL 702

Query:   729 GY 730
              Y
Sbjct:   703 AY 704

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 3.3e-132, Sum P(2) = 3.3e-132
 Identities = 136/234 (58%), Positives = 178/234 (76%)

Query:   498 SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK 557
             S L  F + ++  AT+NFS+  KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG EEF 
Sbjct:   479 SGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 538

Query:   558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
             NE++LI+KLQH+NLV++LGCC+E  E++L+ E++ NKSLD FLFD  K+  + W  R  I
Sbjct:   539 NEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNI 598

Query:   618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
             IEGIA+GL YLH+ S  R+IHRDLK SN+LLD  MNPKISDFGLARM+ G E Q NT+R+
Sbjct:   599 IEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 658

Query:   678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV-YNADSFNLLGY 730
              GT GYM+PEYA  G+FS KSD++SFG+++LE ++G+K +   Y      LL Y
Sbjct:   659 AGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAY 712

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81905	SD18_ARATH	2, ., 7, ., 1, 1, ., 1	0.4453	0.9354	0.8188	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	744
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-41
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	1e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-38
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	1e-37
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-35
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-34
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-27
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-23
pfam08276	66	pfam08276, PAN_2, PAN-like domain	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-22
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-21
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-21
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-17
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	4e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
PTZ00163	230	PTZ00163, PTZ00163, hypothetical protein; Provisio	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  183 bits (467), Expect = 7e-53
 Identities = 79/204 (38%), Positives = 115/204 (56%), Gaps = 13/204 (6%)

Query: 516 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHR 569
           ++  KLGEG FG VYKG L         EVAVK L    S Q +EEF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLLG C E+   ++++EYMP   L  +L    + + L     ++    IA+G+ YL 
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPEY 688
             S+   IHRDL A N L+  ++  KISDFGL+R ++  D  +    ++     +M+PE 
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +G F+ KSDV+SFG+L+ E  +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  182 bits (465), Expect = 1e-52
 Identities = 79/205 (38%), Positives = 110/205 (53%), Gaps = 16/205 (7%)

Query: 516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHR 569
           ++  KLGEG FG VYKG+L         EVAVK L    S Q +EEF  E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLLG C E+    +++EYM    L  +L     K  L     ++    IA+G+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPE 687
                  IHRDL A N L+  ++  KISDFGL+R    D+   +   K  +    +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPE 173

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
              +G F+ KSDV+SFG+L+ E  +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  176 bits (449), Expect = 2e-50
 Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 16/205 (7%)

Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKL 574
           KLGEG FG VYKG+L        EVAVK L    S +  ++F  E  ++ KL H N+V+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           LG C E+    L+LEYM    L  +L      F   +K  L  +  ++    IA+G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPE 687
              S+ + +HRDL A N L+  D+  KISDFGL+R ++  D  +  T   +    +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
              DG+F+ KSDV+SFG+L+ E  +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  175 bits (447), Expect = 4e-50
 Identities = 77/208 (37%), Positives = 109/208 (52%), Gaps = 17/208 (8%)

Query: 515 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQH 568
             +  KLGEG FG VYKG L         +VAVK L   +  +  EEF  E  ++ KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N+V+LLG C +     ++ EYMP   L  FL        L  +  + +   IA+G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRIVGTYGYMS 685
              S+   +HRDL A N L+  ++  KISDFGL+R    D+    +G  K  +    +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE   DG F+ KSDV+SFG+L+ E  + 
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (434), Expect = 8e-49
 Identities = 77/193 (39%), Positives = 108/193 (55%), Gaps = 11/193 (5%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LGEGGFG VY  R    G++VA+K +    S   LEE   E+ ++ KL H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
            ++    L++EY    SL   L +   K  L     + I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 639 RDLKASNVLLD-MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSI 696
           RDLK  N+LLD  +   K++DFGL+++   D+    T  IVGT  YM+PE  L  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 697 KSDVFSFGILMLE 709
           KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (431), Expect = 8e-48
 Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLG G FG VYK +    G+ VAVK L   S+  +  +  + E+ ++ +L H N+V+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              ++    L++EY     L  +L   ++   L       I   I +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS 695
           IHRDLK  N+LLD +   KI+DFGLA+         +    VGT  YM+PE  L G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 696 IKSDVFSFGILMLETLSGK 714
            K DV+S G+++ E L+GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (415), Expect = 1e-45
 Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 21/207 (10%)

Query: 515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +  KLGEG FG VY  R    G+ VA+K +   +  +  E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLY 627
           +L     ++ +  L++EY     L   L         + R    Q        I   L Y
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH      I+HRDLK  N+LLD D + K++DFGLAR     E        VGT  YM+PE
Sbjct: 113 LHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
             L   +    D++S G+++ E L+GK
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 7e-41
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
             LG G FG VY       G+ +AVK   LS  S + LE  + E+ +++ LQH N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           G   ++ +  L   LEY+   SL   L           R    Q        I +GL YL
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAYL 117

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      I+HRD+K +N+L+D D   K++DFG A+  G  E    T  + GT  +M+PE 
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                +   +D++S G  ++E  +GK
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  144 bits (364), Expect = 1e-40
 Identities = 54/115 (46%), Positives = 71/115 (61%), Gaps = 6/115 (5%)

Query: 70  PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
             TVVWVANR  P++D +  L + + GNLVL +     +WS+N   +    VA L+DDGN
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60

Query: 130 LVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS 184
           LV+ DNS        LWQSFD+PTDTLL G K G ++     R L+SW+S+ DPS
Sbjct: 61  LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (360), Expect = 3e-38
 Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+G+GGFG VYK R    G+EVA+K +  +S +  E+  NE+ ++ K +H N+VK  G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARVTIIEGIAQGLLYLHQYSRFRII 637
           +++ E  +++E+    SL   L   T + L     A   + + + +GL YLH      II
Sbjct: 67  LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIA--YVCKELLKGLEYLHSN---GII 120

Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+KA+N+LL  D   K+ DFGL+              +VGT  +M+PE      +  K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 698 SDVFSFGILMLETLSGK 714
           +D++S GI  +E   GK
Sbjct: 178 ADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  135 bits (342), Expect = 1e-37
 Identities = 50/119 (42%), Positives = 66/119 (55%), Gaps = 6/119 (5%)

Query: 34  IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTIS 93
           +  G+ LVS    FELGFF        Y  I ++    TVVWVANRD P S  +  LT+ 
Sbjct: 4   LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62

Query: 94  NKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP 152
           + GNLV+ + +   +WS+N      N V  L DDGNLV+ D+       ++LWQSFDYP
Sbjct: 63  SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  139 bits (352), Expect = 5e-37
 Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+ G      +VAVK L   +    E F  E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64

Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L   C  + E I I+ EYM   SL  FL     K+L      V +   IA+G+ YL   
Sbjct: 65  QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
                IHRDL A N+L+  ++  KI+DFGLAR+   DE    +G    I  T    +PE 
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175

Query: 689 ALDGLFSIKSDVFSFGILMLE 709
           A  G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 2e-36
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G G FG VYKG  L  G  VA+K++S +    + L+    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +VK +G         +ILEY  N SL   +  F P  + L+        +  + QGL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAYL 115

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H+     +IHRD+KA+N+L   D   K++DFG+A           +  +VGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                 S  SD++S G  ++E L+G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  135 bits (341), Expect = 1e-35
 Identities = 73/207 (35%), Positives = 109/207 (52%), Gaps = 20/207 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E F+++ KLG G FG V++G   N   VA+K L S      ++F+ E+  + +L+H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGL 625
            L   C       +I E M   SL  FL  P  + L       +  Q        +A+G+
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            YL +      IHRDL A N+L+  D+  K++DFGLAR+   D    + K+I   Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE A  G FS KSDV+SFGIL+ E  +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  135 bits (341), Expect = 2e-35
 Identities = 69/203 (33%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVK 573
           +LGEG FG V   R        G++VAVK L+ S   Q   +F+ E+ ++  L H N+VK
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 574 LLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
             G C + G +   LI+EY+P+ SL  +L     +  L      +    I +G+ YL   
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLGSQ 128

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYA 689
              R IHRDL A N+L++ +   KISDFGLA++     D            + Y +PE  
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FS  SDV+SFG+ + E  +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  127 bits (320), Expect = 2e-34
 Identities = 52/120 (43%), Positives = 69/120 (57%), Gaps = 7/120 (5%)

Query: 32  SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLT 91
           + +  G+ LVS +  FELGFF+       Y  I ++    TVVWVANRD P+SD +  LT
Sbjct: 2   NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59

Query: 92  ISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151
           + + GNLVL +     +WS+N      N V  L DDGNLVI D+       ++LWQSFDY
Sbjct: 60  LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114

Length = 114

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  124 bits (313), Expect = 1e-31
 Identities = 75/213 (35%), Positives = 110/213 (51%), Gaps = 25/213 (11%)

Query: 521 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
           LGEG FG VYKG L   N +     VA+K L  +   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIEG 620
           LLG C ++    ++ EY+ +  L  FL              D T K  L     + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG 679
           IA G+ YL   S    +HRDL A N L+   +  KISDFGL+R ++  D  +  +K ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              +M PE  L G F+ +SD++SFG+++ E  S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  124 bits (314), Expect = 1e-31
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           K+GEG  G VYK      G+EVA+K  RL  Q+ + +    NE++++   +H N+V    
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82

Query: 577 CCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
             +   E  +++EYM   SL D+        R+   Q    +   + QGL YLH      
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQI-AYVCREVLQGLEYLHS---QN 136

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +IHRD+K+ N+LL  D + K++DFG A      + +     +VGT  +M+PE      + 
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 696 IKSDVFSFGILMLETLSG 713
            K D++S GI+ +E   G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  122 bits (309), Expect = 3e-31
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 13/206 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRN 570
            +      LG+G  G VYK R    G+  A+K++      +  ++   E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV--TIIEGIAQGLLYL 628
           +VK  G   ++GE  ++LEYM   SL   L     K++      V   I   I +GL YL
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      IIHRD+K SN+L++     KI+DFG++++   +         VGT  YMSPE 
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                +S  +D++S G+ +LE   GK
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 3e-30
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 15/203 (7%)

Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +         VA+K L  ++  +  +E  +E  ++A + H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           LG C+    ++ LI + MP   L  ++ +      +G Q  +     IA+G+ YL +   
Sbjct: 75  LGICL--SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK-- 128

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
            R++HRDL A NVL+    + KI+DFGLA++   DE + + +       +M+ E  L  +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 694 FSIKSDVFSFGILMLETLS-GKK 715
           ++ KSDV+S+G+ + E ++ G K
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  119 bits (300), Expect = 4e-30
 Identities = 77/210 (36%), Positives = 109/210 (51%), Gaps = 22/210 (10%)

Query: 521 LGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLV 572
           LG G FG VY+G   +          VAVK L   +  Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARVTIIEGIAQGLLYL 628
           KLLG C+    + +I+E M    L  +L D   +R    LL  +  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 629 HQYSRFRIIHRDLKASNVLL-----DMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYG 682
            Q      IHRDL A N L+     D D   KI DFGLAR ++  D  +   + ++    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +M+PE  LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 8e-30
 Identities = 74/213 (34%), Positives = 108/213 (50%), Gaps = 17/213 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH-R 569
           ++ +  KLGEG FG VY  R  + + VA+K L+ +     + +E F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKL     ++G   L++EY+   SL+  L    +K  L     + I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGD----ELQGNTKRIVGTYGYM 684
                 IIHRD+K  N+LLD D    K+ DFGLA++         +       VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 685 SPEYALDGLF---SIKSDVFSFGILMLETLSGK 714
           +PE  L       S  SD++S GI + E L+G 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  117 bits (296), Expect = 2e-29
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVK 573
           LGEG FG V+ G   + +       VAVK L   +     + F+ E  L+   QH N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL---------LGWQARVTIIEGIA 622
             G C E    I++ EYM +  L+ FL    P    L         L     + I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-- 680
            G++YL   +    +HRDL   N L+  D+  KI DFG++R    D    +  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 681 --YGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
               +M PE  +   F+ +SDV+SFG+++ E  + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 9e-29
 Identities = 71/197 (36%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +  KLG G FG V++G   N   VAVK L   +    ++F  E  ++ KL+H  L++L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 577 CCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
            C    E I I+ E M   SL  +L      R L     + +   +A G+ YL   +   
Sbjct: 69  VCT-LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN--- 123

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDG 692
            IHRDL A NVL+  +   K++DFGLAR+   D  +       G      + +PE AL  
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179

Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 16/200 (8%)

Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V +GRL L G++   VA+K L +  S +   +F  E  ++ +  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 576 GCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           G  V +   ++I+ EYM N SLD FL +   K        V ++ GIA G+ YL   S  
Sbjct: 72  GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK--RIVGTYGYMSPEYALDG 692
             +HRDL A N+L++ ++  K+SDFGL+R     E    TK  +I     + +PE     
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183

Query: 693 LFSIKSDVFSFGILMLETLS 712
            F+  SDV+SFGI+M E +S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 2e-28
 Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG V  G    GQ+VAVK L   S    + F  E  ++  L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKR-LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
                ++ EYM   SL  +L   ++ R ++    ++     + +G+ YL +      +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYALDGLFSIK 697
           DL A NVL+  D+  K+SDFGLA+    +  QG      G     + +PE   +  FS K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTK 179

Query: 698 SDVFSFGILMLETLS 712
           SDV+SFGIL+ E  S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 18/201 (8%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+G+G FG VYKG L    EVAVK   S     L  +F  E  ++ +  H N+VKL+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 579 VEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           V++    +++E +P  SL  FL       T K+LL            A G+ YL   +  
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA------AAGMEYLESKN-- 113

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYALDG 692
             IHRDL A N L+  +   KISDFG++R   G    +    K+I     + +PE    G
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYG 170

Query: 693 LFSIKSDVFSFGILMLETLSG 713
            ++ +SDV+S+GIL+ ET S 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  113 bits (284), Expect = 5e-28
 Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
           +F +  K+G+G FG V+K  R  + +  A+K+  LS  + +  EE  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL---LGWQARVTIIEGIAQGLLY 627
           +++     +++G+  +++EY  N  L   L     + L     W+  + I+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH     +I+HRD+K+ N+ LD   N KI D G+A++   +    NT  IVGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
              D  ++ KSDV++ G+++ E  +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  113 bits (285), Expect = 6e-28
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 23/207 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           ++G+G FG VY  R   +G+   +K   LS+ S +  E+  NE+ ++ KL H N++K   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-----TIIEGIAQ---GLLYL 628
              E+G+  +++EY     L   +    KK+    +         I++   Q    L YL
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKI----KKQK---KEGKPFPEEQILDWFVQLCLALKYL 119

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H  SR +I+HRD+K  N+ L  +   K+ DFG++++         T  +VGT  Y+SPE 
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
             +  ++ KSD++S G ++ E  + K 
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 1e-27
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEF----KNEMMLIAKLQHR 569
           +    ++GEG +G VYK R    G+ VA+K++  ++ +  E F      E+ L+ KL+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58

Query: 570 NLVKLLGCCVE--QGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           N+V+L        +G   ++ EYM +       S +V   +   K  +         + +
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---------KQL 109

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
            +GL YLH      I+HRD+K SN+L++ D   K++DFGLAR +        T R++ T 
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165

Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            Y  PE  L    +  + D++S G ++ E   GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (279), Expect = 2e-27
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  L  ++VA+K +  +     E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           E+    L+ E+M +  L  +L    ++     +  + +   + +G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (278), Expect = 3e-27
 Identities = 70/197 (35%), Positives = 98/197 (49%), Gaps = 11/197 (5%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           LG G FG V+ G+     +VA+K +   +    ++F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
           Q    ++ EYM N  L  +L    +K  LG +  + +   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           L A N L+  D   K+SDFGLAR    D+      TK  V    +  PE      FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182

Query: 699 DVFSFGILMLETLSGKK 715
           DV+SFG+LM E  S  K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (279), Expect = 3e-27
 Identities = 78/205 (38%), Positives = 101/205 (49%), Gaps = 16/205 (7%)

Query: 517 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRN 570
               LGEG FG V  Y     N   G+ VAVK L  + GQ     +K E+ ++  L H N
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 571 LVKLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +VK  GCC EQG K   LI+EY+P  SL  +L     K  L     +   + I +G+ YL
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPE 687
           H       IHRDL A NVLLD D   KI DFGLA+    G E     +       + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
              +  FS  SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  111 bits (279), Expect = 4e-27
 Identities = 73/231 (31%), Positives = 117/231 (50%), Gaps = 26/231 (11%)

Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLI 563
             ++ ++   LG G FG VY+G  R  +G     +VAVK L  S S Q   +F  E +++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIE 619
           +K  H+N+V+L+G   E+  + ++LE M    L  FL +    P +   L  +  +    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGDELQGNTK 675
            +A+G  YL +      IHRD+ A N LL         KI+DFG+AR ++     +   +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGV 719
            ++    +M PE  LDG+F+ K+DV+SFG+L+ E  S       G+ N  V
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  110 bits (277), Expect = 4e-27
 Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  KLG G FG V+ G      +VA+K L   S    E F  E  L+ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L    V   E I I+ EYM N SL  FL  P   +L      + +   IA+G+ ++   
Sbjct: 65  RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
            R   IHRDL+A+N+L+   +  KI+DFGLAR+   +E    +G    I  T    +PE 
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
              G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  110 bits (277), Expect = 5e-27
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E F +  KLGEG +G VYK      GQ VA+K +  +    L+E   E+ ++ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60

Query: 572 VKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           VK  G   +  +  +++EY    S  D  +   T K L   +    I+    +GL YLH 
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEI-AAILYQTLKGLEYLHS 117

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               + IHRD+KA N+LL+ +   K++DFG++        + NT  ++GT  +M+PE   
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
           +  ++ K+D++S GI  +E   GK
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  109 bits (274), Expect = 1e-26
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 23/224 (10%)

Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLL 575
           +LG G  G V K      G+ +AVK +  +        K  +    ++ K     +V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 576 GCCVEQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           G     G+  + +EYM   SLD  L        +R+LG      I   + +GL YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
           + +IIHRD+K SN+L++     K+ DFG++    G  +    K  VGT  YM+PE     
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGN 174

Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADS---FNLLGYVSN 733
            +S+KSD++S G+ ++E  +G+      N      F LL Y+ N
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 71/204 (34%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LG G FG V KG   + +G+E  VAVK L       G +EF  E  ++A+L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           G C  +   +L++E  P   L  +L          L     +V      A G+ YL    
Sbjct: 63  GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARM--FGGDELQGNT--KRIVGTYGYMSPEY 688
            F  +HRDL A NVLL      KISDFG++R    G D  +  T  +  +  Y   +PE 
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
              G FS KSDV+S+G+ + E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 68/199 (34%), Positives = 101/199 (50%), Gaps = 14/199 (7%)

Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R  + G+  A+K L  +     + +E    E  +++++ H  +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
              +  EK+ L+LEY P   L   L    + R    +AR    E I   L YLH      
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLHSL---G 113

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           II+RDLK  N+LLD D + K++DFGLA+    +  + NT    GT  Y++PE  L   + 
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171

Query: 696 IKSDVFSFGILMLETLSGK 714
              D +S G+L+ E L+GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 4e-26
 Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 24/227 (10%)

Query: 521 LGEGGFGPVYKGRL----LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LGEG FG V +G+L     +  +VAVK  +L   +   +EEF +E   +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 575 LGCCVEQGEK------ILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGL 625
           +G C E          ++IL +M +  L  FL           L  Q  +  +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL-QGNTKRIVGTYGY 683
            YL   S    IHRDL A N +L  DM   ++DFGL++ ++ GD   QG   ++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNADSFNLL 728
           ++ E   D +++ KSDV++FG+ M E  +  +    GV N + ++ L
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  107 bits (269), Expect = 7e-26
 Identities = 78/216 (36%), Positives = 112/216 (51%), Gaps = 29/216 (13%)

Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++   L EEFK+E M+ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIE 619
            LLG   ++    +I  Y  +  L  FL              D T K  L     V I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTKR 676
            IA G+ +L   S   ++H+DL   NVL+   +N KISD GL R ++  D  +L GN+  
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +    +MSPE  + G FSI SD++S+G+++ E  S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  107 bits (268), Expect = 9e-26
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 521 LGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVK 573
           LG G FG V+  +    +E      V VK L     + L+ EF+ E+ +  KL H+N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
           LLG C E     +ILEY     L  FL       +  K   L  + +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           L   S  R +HRDL A N L+      K+S   L++     E       ++    +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
              +  FS KSDV+SFG+LM E  +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  106 bits (266), Expect = 2e-25
 Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 38/237 (16%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS------SQSGQGLEEFKNEMMLIAKLQHRNLVK 573
           LG G F   Y+ R +  G  +AVK+++      S+  + +E  + E+ L+A+L H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +LG   E     L +E+M   S+   L  +   K+ ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 632 SRFRIIHRDLKASNVLLD-MDMNPKISDFGLA-----RMFGGDELQGNTKRIVGTYGYMS 685
              +IIHRD+K +N+L+D      +I+DFG A     +  G  E QG   +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIF 742
           PE      +    DV+S G +++E  + K     +NA+           S H  LIF
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAE---------KHSNHLALIF 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  106 bits (265), Expect = 3e-25
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 521 LGEGGFGPVYKGR---LLNGQE---VAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVK 573
           +G+G FG V++ R   LL  +    VAVK L  + S     +F+ E  L+A+  H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------------------LGWQAR 614
           LLG C       L+ EYM    L+ FL   + +                     L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGN 673
           + I + +A G+ YL   S  + +HRDL   N L+  +M  KI+DFGL+R ++  D  + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               +    +M PE      ++ +SDV+++G+++ E  S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 4e-25
 Identities = 70/208 (33%), Positives = 106/208 (50%), Gaps = 30/208 (14%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK----NEMMLIAKLQHRNLVKL 574
           KLGEG +G VYK R    G+ VA+K++  +     E        E+ L+ +L+H N+VKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
           L        K+ L+ EY  +  L  +L        P   + + +Q        + +GL Y
Sbjct: 64  LDVIH-TERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAY 113

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   RI+HRDLK  N+L++ D   K++DFGLAR F G  L+  T  +V T  Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168

Query: 688 YAL-DGLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (262), Expect = 4e-25
 Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
             E+  +  KLG G FG V+ G      +VAVK L   +    E F  E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           LV+L     E+   I + EYM   SL  FL D  + R L     V +   +A G+ Y+  
Sbjct: 63  LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPE 687
             R   IHRDL+++N+L+   +  KI+DFGLAR+   +E    QG    I  T    +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
            AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  104 bits (261), Expect = 4e-25
 Identities = 78/201 (38%), Positives = 108/201 (53%), Gaps = 15/201 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64

Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L     E  E I I+ EYM   SL  FL     K L   Q  V +   IA G+ Y+   
Sbjct: 65  QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE-- 119

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
            R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE 
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 174

Query: 689 ALDGLFSIKSDVFSFGILMLE 709
           AL G F+IKSDV+SFGIL+ E
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE 195

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  103 bits (259), Expect = 8e-25
 Identities = 80/224 (35%), Positives = 116/224 (51%), Gaps = 14/224 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     ++    +I EYM   SL  FL      ++L     +     IA+G+ Y+    
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
           R   IHRDL+A+NVL+   +  KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 177

Query: 691 DGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLL--GY 730
            G F+IKSDV+SFGIL+ E ++  K    G+ N+D  + L  GY
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (260), Expect = 9e-25
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 8/207 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           +++ +   +G G    VY    L N ++VA+KR+   +    ++E + E+  +++  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VK     V   E  L++ Y+   SL   +     +  L      T+++ + +GL YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
             +   IHRD+KA N+LL  D + KI+DFG++     GGD  +   K  VGT  +M+PE 
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 689 ALDGL-FSIKSDVFSFGILMLETLSGK 714
                 +  K+D++SFGI  +E  +G 
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + + +  +LG+G FG VYK +    G   A K +  +S + LE+F  E+ ++++ +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V L      + +  +++E+    +LD  +    ++ L   Q R  +   + + L +LH 
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEY 688
               ++IHRDLKA N+LL +D + K++DFG++       LQ   KR   +GT  +M+PE 
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPEV 174

Query: 689 AL-----DGLFSIKSDVFSFGILMLE 709
                  D  +  K+D++S GI ++E
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQHRNLVKLLG 576
           K+GEG +G VYK R  L G+ VA+K++  +            E+ L+ +L H N++KLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
               +G+  L+ E+M +  L   +         +  +   +Q        + QGL + H 
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQ--------LLQGLAFCHS 116

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +    I+HRDLK  N+L++ +   K++DFGLAR FG           V T  Y +PE  L
Sbjct: 117 H---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLL 171

Query: 691 -DGLFSIKSDVFSFGILMLETLSGK 714
            D  +S   D++S G +  E LS +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 11/197 (5%)

Query: 516 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +M+ KLG G +G VY+G        VAVK L   +   +EEF  E  ++ +++H NLV+L
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C  +    +I E+M   +L  +L +   ++ +     + +   I+  + YL + +  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDG 692
             IHRDL A N L+  +   K++DFGL+R+  GD        K  +    + +PE     
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180

Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 181 KFSIKSDVWAFGVLLWE 197

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  104 bits (260), Expect = 2e-24
 Identities = 72/241 (29%), Positives = 116/241 (48%), Gaps = 30/241 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +  ++   LGEG FG V K   +          VAVK L    + + L +  +EM ++  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD---------------PTKKRLL 609
           + +H+N++ LLG C ++G   +++EY  + +L  FL                 P +   L
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET--L 129

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             +  V+    +A+G+ +L      + IHRDL A NVL+  D   KI+DFGLAR     +
Sbjct: 130 TQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+L+ E  TL G    G+   + F L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 728 L 728
           L
Sbjct: 247 L 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 30/213 (14%)

Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKR--LSSQSGQG-------LEEFKNEMMLIAKLQHRN 570
           +G G FG VY G    +G+ +AVK+  L S S          L+    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGL 625
           +V+ LG  ++     + LEY+P  S+   L     F+ T  R          +  I +GL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKR--IVGTY 681
            YLH  +R  IIHRD+K +N+L+D     KISDFG+++    + L    N  R  + G+ 
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            +M+PE      ++ K+D++S G L++E L+GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  102 bits (255), Expect = 4e-24
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 21/204 (10%)

Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G +G VY  R L+ Q  +A+K +  +  + ++    E+ L + L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 580 EQGEKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTII---EGIAQGLLYLHQYSR 633
           E G   + +E +P  SL   L   + P K          TII   + I +GL YLH    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN------EQTIIFYTKQILEGLKYLHDN-- 127

Query: 634 FRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
            +I+HRD+K  NVL++      KISDFG ++   G  +   T+   GT  YM+PE    G
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKG 184

Query: 693 L--FSIKSDVFSFGILMLETLSGK 714
              +   +D++S G  ++E  +GK
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 5e-24
 Identities = 65/241 (26%), Positives = 115/241 (47%), Gaps = 35/241 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS--SQSGQGLEEFKNEMMLIA 564
           E  ++  +LG+G FG VY+G             VA+K ++  +   + +E F NE  ++ 
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMK 64

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYM-------------PNKSLDVFLFDPTKKRLLGW 611
           +    ++V+LLG        ++++E M             P    +  L  PT ++ +  
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL 670
            A       IA G+ YL      + +HRDL A N ++  D+  KI DFG+ R ++  D  
Sbjct: 125 AAE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           +   K ++    +M+PE   DG+F+ KSDV+SFG+++ E  TL+ +   G+ N +    +
Sbjct: 176 RKGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234

Query: 729 G 729
            
Sbjct: 235 I 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 73/199 (36%), Positives = 107/199 (53%), Gaps = 25/199 (12%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
            +GEG FG V +G    GQ+VAVK +        + F  E  ++ KL H+NLV+LLG  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIAQGLLYLHQYSR 633
             G  I ++E M   +L  FL   T+ R L     V++I+       +A+G+ YL     
Sbjct: 70  HNGLYI-VMELMSKGNLVNFL--RTRGRAL-----VSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
            +++HRDL A N+L+  D   K+SDFGLAR+  G     N+K  V    + +PE      
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKK 173

Query: 694 FSIKSDVFSFGILMLETLS 712
           FS KSDV+S+G+L+ E  S
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 25/236 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           E      +LGEG  G V K RL N   + A+K +++     L+ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 571 LVKLLGCCVE--QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGIA 622
           +VK  G  ++       + +EY    SLD        K++     R+       I E + 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-----KKVKKRGGRIGEKVLGKIAESVL 115

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           +GL YLH     +IIHRD+K SN+LL      K+ DFG++    G+ +        GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGK---KNTGVYNADSFNLLGYVSNKS 735
           YM+PE      +SI SDV+S G+ +LE    +      G        LL Y+ N  
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  101 bits (254), Expect = 1e-23
 Identities = 84/241 (34%), Positives = 120/241 (49%), Gaps = 28/241 (11%)

Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLI 563
           +   +   LGEG FG V         K R      VAVK L    + + L +  +EM L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLL 609
             + +H+N++ LLG C ++G   +I+EY    +L  FL           FD TK  +  L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   SR R IHRDL A NVL+  D   KI+DFGLAR     +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFGILM E  TL G    G+   + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 728 L 728
           L
Sbjct: 249 L 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 93.9 bits (234), Expect = 2e-23
 Identities = 28/65 (43%), Positives = 45/65 (69%)

Query: 336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWF 395
           C GG  F++L N++ PD     +++S+ L++C   CL NC+C AYA +++  GSGCL+W 
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60

Query: 396 GDLLD 400
           G+L+D
Sbjct: 61  GELVD 65

Length = 66

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (249), Expect = 2e-23
 Identities = 76/203 (37%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  +  KLG+G FG V+ G      +VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLV 64

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L     E+   I + E+M   SL  FL +   K L   Q  V +   IA G+ Y+    
Sbjct: 65  PLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE--- 119

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   IHRDL+A+N+L+  ++  KI+DFGLAR+   +E    QG    I     + +PE A
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEAA 175

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
           L G F+IKSDV+SFGIL+ E ++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 29/205 (14%)

Query: 521 LGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 576 GCCVEQGEK--ILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
           G C   G +   L++EY+P  SL  +L       D  K  L   Q        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYM 684
           L      R +HRDL   N+L++ +   KI DFGL ++   D+ +    R  G    + Y 
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178

Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
           +PE   +  FS+ SDV+SFG+++ E
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYE 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 10/203 (4%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
             NF ++ K+G+G F  VYK   LL+G+ VA+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARVTIIEGIAQGLL 626
           H N++K L   +E  E  ++LE      L   +    K KRL+  +        +   L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           ++H     RI+HRD+K +NV +      K+ D GL R F       ++   VGT  YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175

Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
           E   +  ++ KSD++S G L+ E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  100 bits (249), Expect = 5e-23
 Identities = 74/216 (34%), Positives = 118/216 (54%), Gaps = 14/216 (6%)

Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + L+ + MP+  L  ++ +   K  +G Q  +     IA+G++YL +    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLAR+  GDE + N         +M+ E      F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T  GK   G+   +  +LL
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 99.3 bits (247), Expect = 6e-23
 Identities = 79/251 (31%), Positives = 121/251 (48%), Gaps = 39/251 (15%)

Query: 514 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRLSSQSGQG-LEEFKNEMMLIAKL 566
           N  +   LGEG FG V K     L G+     VAVK L   +    L +  +E  L+ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--------------------- 605
            H +++KL G C + G  +LI+EY    SL  FL +  K                     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665
           +R L     ++    I++G+ YL   +  +++HRDL A NVL+      KISDFGL+R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 666 GGDE--LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
             ++  ++ +  RI     +M+ E   D +++ +SDV+SFG+L+ E  TL G    G+  
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 722 ADSFNLL--GY 730
              FNLL  GY
Sbjct: 236 ERLFNLLKTGY 246

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 6e-23
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+G FG VY    ++ G+E+AVK+      S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            GC  +     + +EYMP  S+   L  +    + +     R      I +G+ YLH   
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH--- 121

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALD 691
              I+HRD+K +N+L D   N K+ DFG ++        G   + V GT  +MSPE    
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +  K+DV+S G  ++E L+ K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 74/208 (35%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQYSRFRII 637
           +Q    ++ EYM N  L  +L +   KR    Q  + + + + +G+ YL   Q+     I
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122

Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLF 694
           HRDL A N L+D     K+SDFGL+R    DE   +    VG+     +  PE  L   F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178

Query: 695 SIKSDVFSFGILMLETLS-GKKNTGVYN 721
           S KSDV++FG+LM E  S GK     +N
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFN 206

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 21/204 (10%)

Query: 520 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
           KLG+G FG V +G           VAVK L S      +++F  E  ++  L H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII----EGIAQGLLYLHQ 630
            G  V     +++ E  P  SL   L        L     ++ +      IA G+ YL  
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
               R IHRDL A N+LL  D   KI DFGL R      D         V  + + +PE 
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                FS  SDV+ FG+ + E  +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLV 572
           F++   +G+G FG VYK       Q VA+K +   ++   +E+ + E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           K  G  ++  +  +I+EY    S      D  K   L       I+  +  GL YLH+  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGYMSPEYA 689
               IHRD+KA+N+LL  + + K++DFG++      +L     +    VGT  +M+PE  
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 21/212 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL 566
           +  ++   L EG FG ++ G L++      +EV VK +   + +  +     E  L+  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDP-----TKKRLLGWQARVTIIEG 620
            H+N++ +L  C+E GE   +L    N   L +FL           + L  Q  V +   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE--LQGNTKRI 677
           IA G+ YLH+     +IH+D+ A N ++D ++  KI+D  L+R +F  D   L  N  R 
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           V    +M+ E  ++  +S  SDV+SFG+L+ E
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 51/226 (22%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN-----------EMM 561
            +    KLGEG +  VYK R    G+ VA+K++       L E K            E+ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMP--------NKSLDVFLFDPTKKRLLGWQA 613
           L+ +L+H N++ LL     +    L+ E+M         +KS+   L     K  +    
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKSYM-LM- 110

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
                    +GL YLH      I+HRDLK +N+L+  D   K++DFGLAR FG    +  
Sbjct: 111 -------TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160

Query: 674 TKRIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
            +  V T  Y +PE     LF  +      D++S G +  E L   
Sbjct: 161 HQ--VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 22/218 (10%)

Query: 517 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           ++ +LGEG FG V+      LL  Q+   VAVK L   S    ++F+ E  L+  LQH++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARVTII 618
           +V+  G C E    +++ EYM +  L+ FL    P  K L          L     + I 
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             IA G++YL   +    +HRDL   N L+   +  KI DFG++R     +      R +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
               +M PE  L   F+ +SD++SFG+++ E  + GK+
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 96.6 bits (240), Expect = 5e-22
 Identities = 64/198 (32%), Positives = 110/198 (55%), Gaps = 17/198 (8%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           +LG+G FG VYK +    G   A K + ++S + LE++  E+ ++A   H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
              G+  +++E+ P  ++D  + +   + L   Q +V I   + + L YLH     +IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYAL-----D 691
           RDLKA NVLL +D + K++DFG++       ++   +R   +GT  +M+PE  +     D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 692 GLFSIKSDVFSFGILMLE 709
             +  K+D++S GI ++E
Sbjct: 190 TPYDYKADIWSLGITLIE 207

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.0 bits (239), Expect = 7e-22
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 37/217 (17%)

Query: 521 LGEGGFGPVYKG-RLLNGQEVAVK----------RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           +G+G +G VY    +  G+ +AVK          R  S+    ++  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIA 622
           N+V+ LG   E  E+ L   LEY+P  S+   L     F+    R    Q        + 
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRIVGT 680
           +GL YLH      I+HRDLKA N+L+D D   KISDFG+++    D++  N     + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173

Query: 681 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSGKK 715
             +M+PE        +S K D++S G ++LE  +G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 96.3 bits (240), Expect = 7e-22
 Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 35/222 (15%)

Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SSQSGQGLEEFKNEMM 561
           KLGEG FG V+       Q+                 VAVK L    S    E+F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 613
           ++++L   N+ +LLG C       +I+EYM N  L+ FL              + L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
            + +   IA G+ YL        +HRDL   N L+  +   KI+DFG++R ++  D   +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           QG   R      +M+ E  L G F+ KSDV++FG+ + E L+
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.0 bits (236), Expect = 8e-22
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH 568
           A   +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58

Query: 569 RNLVKLLGCCVEQ-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
            NLV+LLG  VE+ G   ++ EYM   SL  +L     + +LG    +     + + + Y
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           L   +    +HRDL A NVL+  D   K+SDFGL +       Q   K  V    + +PE
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPE 169

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
              +  FS KSDV+SFGIL+ E  S
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 71/203 (34%), Positives = 106/203 (52%), Gaps = 18/203 (8%)

Query: 521 LGEGGFGPV----YKGRLLN-GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
           LGEG FG V    Y     N G++VAVK L  +SG   + + K E+ ++  L H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQ 630
            G C E G     LI+E++P+ SL  +L  P  K  +  + ++     I +G+ YL   Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYA 689
           Y     +HRDL A NVL++ +   KI DFGL +    D+     K  + +   + +PE  
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
           +   F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 33/219 (15%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK-----NEMMLIAKL-QHRNLVK 573
           +GEG F  V   +     +E A+K L  +  Q ++E K      E  ++ +L  H  ++K
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           L     ++     +LEY PN  L  ++    K   L  +        I   L YLH    
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL------------------QGNTK 675
             IIHRDLK  N+LLD DM+ KI+DFG A++   +                    +    
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             VGT  Y+SPE   +      SD+++ G ++ + L+GK
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V+ G+     +VA+K ++ +     E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    ++ E+M N  L  +L    ++  L     +++ + + +G+ YL + S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPEYALDGL 693
           DL A N L+      K+SDFG+ R    DE          + G      +  PE      
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177

Query: 694 FSIKSDVFSFGILMLETLSGKK 715
           +S KSDV+SFG+LM E  +  K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 20/203 (9%)

Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLS----SQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VY+G  L +G   AVK +S     Q+GQ  +++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           LG   E+    + LE +P  SL   L  +    + ++    R      I  GL YLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD- 691
           R   +HRD+K +N+L+D +   K++DFG+A+           K   G+  +M+PE     
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
           G + + +D++S G  +LE  +GK
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 68/204 (33%), Positives = 109/204 (53%), Gaps = 21/204 (10%)

Query: 521 LGEGGFGPVYKGRLL--NGQEV--AVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G+G FG VY G L+  +GQ++  AVK L+  +  + +E+F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 576 GCCV-EQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+      PT K L+G+  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
               + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 29/207 (14%)

Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V++G L + G++   VA+K L    + +  ++F +E  ++ +  H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           G   +    ++I EYM N +LD +L D     +  +L+G      ++ GIA G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
           S    +HRDL A N+L++ ++  K+SDFGL+R+     L+ + +    T G      + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTA 178

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE      F+  SDV+SFGI+M E +S
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVK 573
           +LGE  FG +YKG L      + Q VA+K L    + Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLF--------------DPTKKRLLGWQARVTIIE 619
           LLG   ++    ++ EY+    L  FL               D T K  L     + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIV 678
            IA G+ YL   S F  +H+DL A N+L+   ++ KISD GL+R ++  D  +   K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               +M PE  + G FS  SD++SFG+++ E  S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 19/197 (9%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
           ++G G FG VY  R +   + VA+K++S    Q  E++++   E+  + +L+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           GC + +    L++EY    + D+   +  KK L   +    I  G  QGL YLH + R  
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEI-AAICHGALQGLAYLHSHER-- 136

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
            IHRD+KA N+LL      K++DFG A +        N+   VGT  +M+PE  L   +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMDEG 189

Query: 693 LFSIKSDVFSFGILMLE 709
            +  K DV+S GI  +E
Sbjct: 190 QYDGKVDVWSLGITCIE 206

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G FG V+KG L +   VAVK       Q L+ +F +E  ++ +  H N+VKL+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           ++    +++E +P    D   F   KK  L  +  V      A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 640 DLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           DL A N L+  +   KISDFG++R    G       K+I     + +PE    G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175

Query: 699 DVFSFGILMLETLS 712
           DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 94.3 bits (234), Expect = 5e-21
 Identities = 75/233 (32%), Positives = 118/233 (50%), Gaps = 28/233 (12%)

Query: 521 LGEGGFGPVYKGRLLNGQE--------VAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V     +   +        VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++PT+  +  L ++  V+ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 93.2 bits (231), Expect = 6e-21
 Identities = 73/229 (31%), Positives = 121/229 (52%), Gaps = 29/229 (12%)

Query: 521 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LGEG FG V +G+L       +VAVK  +++  +   +E+F +E + + +  H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 576 GCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARVTIIEGIAQ 623
           G C++  E       ++IL +M +  L  FL      RL      L  Q  V  +  IA 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDEL-QGNTKRIVGTY 681
           G+ YL   S    IHRDL A N +L+ +MN  ++DFGL+ +++ GD   QG   ++    
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PV 178

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
            +++ E   D +++ KSDV+SFG+ M E  T       GV N++ ++ L
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 87.7 bits (218), Expect = 8e-21
 Identities = 39/113 (34%), Positives = 54/113 (47%), Gaps = 11/113 (9%)

Query: 212 SGQWNGAAF-----VSAISYTNFLYEQYLVENQDEISYWYEPFNRPSIMT-LKLNPSGLL 265
           SG WNG  F     +  +SY  + +     EN +E+ Y Y      SI + L L+  G L
Sbjct: 3   SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYR-MTNNSIYSRLTLSSEGSL 57

Query: 266 TRQIWNNNGNDWDLVFSFPDEYCGKYGYCGANTICSPDQKPICECLEGFKLKS 318
            R  W  N  DW+L +S P + C  YG CG    C  +  P C C++GF  K+
Sbjct: 58  ERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 33/209 (15%)

Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  GRL L G+    VA+K L +  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIAQGLLYLH 629
           G   +    +++ EYM N SLD FL    +K       + T+I+      GIA G+ YL 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
             S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R     G      +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRW 175

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +PE      F+  SDV+S+GI+M E +S
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 27/207 (13%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLL 575
           K+GEG +G VYK R  L G+ VA+K  RL ++  +G+      E+ L+ +L H N+V+LL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64

Query: 576 GCCVEQGEKI-LILEYMP---NKSLD---VFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
              V    K+ L+ E++     K +D   +   DP   +   +Q    +++GIA    Y 
Sbjct: 65  DV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----LLQGIA----YC 115

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H +   R++HRDLK  N+L+D +   K++DFGLAR F G  ++  T  +V T  Y +PE 
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEI 170

Query: 689 ALDG-LFSIKSDVFSFGILMLETLSGK 714
            L    +S   D++S G +  E ++ +
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 25/206 (12%)

Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V +GRL L G+    VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 576 GCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           G   +    ++I E+M N +LD FL      F   +  L+G      ++ GIA G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVG------MLRGIAAGMKYL- 122

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSP 686
             S    +HRDL A N+L++ ++  K+SDFGL+R    D         +G      + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
           E      F+  SDV+S+GI+M E +S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 30/236 (12%)

Query: 515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           F++   LG+G FG V + +L     + Q+VAVK L +   S   +EEF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 569 RNLVKLLGCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRL------LGWQARVT 616
            N++KL+G  +    K      ++IL +M +  L  FL      R+      L  Q  V 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDEL-QGNT 674
            +  IA G+ YL   S    IHRDL A N +L+ +M   ++DFGL++ ++ GD   QG  
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
            ++     +++ E   D +++  SDV++FG+ M E  T       GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 25/216 (11%)

Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+G FG VY       GR L  ++V     S ++ + +   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTII-----EGIAQGLLY 627
            GC  ++ EK L   +EYMP  S+        K +L  + A    +       I +G+ Y
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSP 686
           LH      I+HRD+K +N+L D   N K+ DFG ++      + G   R + GT  +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
           E      +  K+DV+S G  ++E L+ K     Y A
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 520 KLGEGGFGPVYK-GRLLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
            +G+G FG V K  R  +G+ +  K +   + + +  ++  +E+ ++ +L+H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 577 CCV-EQGEKI-LILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLH--- 629
             +    + + +++EY     L   +      +K +        I   + Q LL L+   
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI----EEEFIWRILTQLLLALYECH 122

Query: 630 --QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
                   ++HRDLK +N+ LD + N K+ DFGLA++ G D      K  VGT  YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPE 180

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                 +  KSD++S G L+ E  +  
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 21/220 (9%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           ++G G FG VY  R + N + VA+K++S    QS +  ++   E+  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           GC + +    L++EY    + D+       K+ L       +  G  QGL YLH ++   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
           +IHRD+KA N+LL      K+ DFG A       +       VGT  +M+PE  L   +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189

Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVS 732
            +  K DV+S GI  +E    ++   ++N ++ + L +++
Sbjct: 190 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 21/210 (10%)

Query: 514 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
           +F +  KLG+G +G VYK  RL + Q  A+K   L S S +  E+  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 571 LVK-----LLGCCVEQGEKILILEYMPNKSLDVFLFDPTK-KRLLGWQARVTIIEGIAQG 624
           ++      L G  +      +++EY P   L   +    K ++L+  Q    I   + +G
Sbjct: 61  IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L  LH+    +I+HRDLK++N+LL  +   KI D G++++      +   K  +GT  YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +S KSD++S G L+ E  +  
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR-----LLGWQARVTIIEGIAQGLLY 627
           KL    V +    +I E+M   SL  FL      +     L+ + A+      IA+G+ +
Sbjct: 65  KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMS 685
           + Q +    IHRDL+A+N+L+   +  KI+DFGLAR+   +E    T R    +   + +
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTA 171

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE    G F+IKSDV+SFGIL++E ++
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.7 bits (227), Expect = 3e-20
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 34/226 (15%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           N  ++ +LGEG FG V+     N    Q+   VAVK L   S    ++F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQAR 614
           H ++VK  G CVE    I++ EYM +  L+ FL               P +   L     
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
           + I + IA G++YL   +    +HRDL   N L+  ++  KI DFG++R    D    + 
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDY 175

Query: 675 KRIVG----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
            R+ G       +M PE  +   F+ +SDV+S G+++ E  + GK+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           EN+    K+GEG  G V   R   +G++VAVK +  +  Q  E   NE++++   QH+N+
Sbjct: 24  ENY---IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V++    +   E  +++E++   +L     D   +  L  +   T+ E + Q L YLH  
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQ 136

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
               +IHRD+K+ ++LL +D   K+SDFG       D  +   K +VGT  +M+PE    
Sbjct: 137 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISR 191

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +  + D++S GI+++E + G+
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.7 bits (225), Expect = 6e-20
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 35/222 (15%)

Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQGLE-EFKNEMM 561
           KLGEG FG V+       ++                 VAVK L   + +    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------FDPTKKRLLGWQA 613
           ++++L+  N+++LL  C+      +I EYM N  L+ FL         +      + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
            + +   IA G+ YL   S    +HRDL   N L+  +   KI+DFG++R ++ GD   +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           QG   R V    +MS E  L G F+  SDV++FG+ + E L+
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.0 bits (226), Expect = 6e-20
 Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 34/219 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSSQSGQGLEE-FKNEMMLIAK 565
            N S    LG G FG V +     L       +VAVK L   +     E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVT 616
           L  H N+V LLG C   G  ++I EY           +  + FL   T + LL +  +V 
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQV- 150

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGN 673
                A+G+ +L   +    IHRDL A NVLL      KI DFGLAR    D    ++GN
Sbjct: 151 -----AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202

Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +  V    +M+PE   + +++ +SDV+S+GIL+ E  S
Sbjct: 203 ARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 33/209 (15%)

Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG------LEEFKNEMMLIAKLQHRNLV 572
           ++GEG  G V+K +    G+ VA+K+++ +  +G      L E K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 573 KLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           KLL         +L++EYMP+      +  +  L +   K  +       +++G+A    
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA---- 113

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y+H      I+HRDLK +N+L+  D   KI+DFGLAR+F  +E +  + + V T  Y +P
Sbjct: 114 YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAP 169

Query: 687 EYALDGL--FSIKSDVFSFGILMLETLSG 713
           E  L G   +    D+++ G +  E L+G
Sbjct: 170 EL-LYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.1 bits (223), Expect = 6e-20
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+ + VA+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLD-VFLFDPTKKRLLG----WQARVTIIEGIAQG 624
           N++K L   +E  E  ++LE      L  +  +   +KRL+     W+  V +   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
               H +SR R++HRD+K +NV +      K+ D GL R F       ++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
           SPE   +  ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 90.9 bits (225), Expect = 6e-20
 Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 28/233 (12%)

Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           +D  +     + ++  V+ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +    T   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 90.5 bits (224), Expect = 7e-20
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 520 KLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
           +LGEG FG V+     N         VAVK L   +    ++F+ E  L+  LQH ++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL-----------LGWQARVTIIEG 620
             G C +    I++ EYM +  L+ FL    P    L           LG    + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG- 679
           IA G++YL   +    +HRDL   N L+  ++  KI DFG++R    D    +  R+ G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184

Query: 680 ---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKK 715
                 +M PE  +   F+ +SDV+SFG+++ E  + GK+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 43/230 (18%)

Query: 520 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSSQSGQGLE-EFKNEMM 561
           KLGEG FG V+   ++N Q+                 VAVK L   + +    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------------FDPTKKR 607
           ++++L+  N+++LLG CV++    +I EYM N  L+ FL                P    
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 608 LL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-M 664
           L    + + + +   IA G+ YL   S    +HRDL   N L+  ++  KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 665 FGGD--ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + GD   +QG   R V    +M+ E  L G F+  SDV++FG+ + E L 
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           K+GEG +G VYKGR    GQ VA+K  RL S+          E+ L+ +LQH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 577 CCVEQGEKILILEYMP---NKSLDVF----LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
             +++    LI E++     K LD        D    +   +Q        I QG+L+ H
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ--------ILQGILFCH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                R++HRDLK  N+L+D     K++DFGLAR F G  ++  T  +V T  Y +PE  
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVL 173

Query: 690 LDG-LFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E  + K
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.7 bits (222), Expect = 9e-20
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG VYKG     +EV A+K +  +  +  +E+ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + +  G  ++  +  +I+EY+   S LD+    P ++  +      TI+  I +GL YLH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                R IHRD+KA+NVLL    + K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 9e-20
 Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 21/202 (10%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQH---RNLVKLL 575
           +G G +G VY+G+ +  G+ VA+K ++  +    + + + E+ L+++L+     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 576 GCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           G  ++     +I+EY    S+   +   P  ++ +       II  +   L Y+H+    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYIHKVG-- 121

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYGYMSPEYALDG 692
            +IHRD+KA+N+L+    N K+ DFG+A +      Q ++KR   VGT  +M+PE   +G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176

Query: 693 -LFSIKSDVFSFGILMLETLSG 713
             +  K+D++S GI + E  +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 21/225 (9%)

Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQHRN 570
           F+   ++G G FG VY  R +   EV A+K++S    Q  E++++   E+  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
            ++  GC + +    L++EY    + D  L +  KK L   +    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           ++   +IHRD+KA N+LL      K++DFG A +             VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194

Query: 691 ---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVS 732
              +G +  K DV+S GI  +E    ++   ++N ++ + L +++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 237

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 90.0 bits (223), Expect = 1e-19
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 10/214 (4%)

Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L ++ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q     E   NE+
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + +H N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 68  LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       ++ + +T  +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 60/214 (28%), Positives = 112/214 (52%), Gaps = 10/214 (4%)

Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L ++ S+    + ++   K+G+G  G V+    +  GQEVA+K+++ Q     E   NE+
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ +L++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ NVLL MD + K++DFG       ++ + +T  +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           NF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +   R++HRDLK  N+L++ +   K++DFGLAR F G  ++  T  +V T  Y +PE  L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173

Query: 691 DG-LFSIKSDVFSFGILMLETLSGK 714
               +S   D++S G +  E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 72/233 (30%), Positives = 115/233 (49%), Gaps = 32/233 (13%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           NF    KLGEG +  VYKGR    G+ VA+K   L ++ G      + E+ L+ +L+H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 571 LVKLLGCCVEQGEKILILEYMPN---KSLDVF----LFDPTKKRLLGWQARVTIIEGIAQ 623
           +V+L      + + +L+ EYM     K +D        DP   +   +Q        + +
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYG 682
           G+ + H+    R++HRDLK  N+L++     K++DFGLAR FG   +  NT    V T  
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLW 165

Query: 683 YMSPEYALDG-LFSIKSDVFSFGILMLETLSGKK-NTGVYNADS----FNLLG 729
           Y +P+  L    +S   D++S G +M E ++G+    G  N D     F ++G
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC- 577
           +GEG +G VYK R    GQ VA+K +        EE K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 578 -----CVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVT------IIEGIAQGL 625
                     +  L++E     S+ D+       K L     R+       I+    +GL
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            YLH+    ++IHRD+K  N+LL  +   K+ DFG++        + NT   +GT  +M+
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMA 181

Query: 686 PE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
           PE        D  +  +SDV+S GI  +E   GK
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 25/208 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E++ +  ++G G +G VYK R +  G+ VA+K +  + G   E  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF--LFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           V   G  + + +  +++EY    SL D++     P  +  + +  R T+     +GL YL
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT--KR--IVGTYGYM 684
           H+      IHRD+K +N+LL  D + K++DFG++           T  KR   +GT  +M
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWM 168

Query: 685 SPEYA---LDGLFSIKSDVFSFGILMLE 709
           +PE A     G +  K D+++ GI  +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.4 bits (221), Expect = 2e-19
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 10/214 (4%)

Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+K+++ Q     E   NE+
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       ++ + +T  +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)

Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG V+KG  +   +     VA+K +  +SG Q  +E  + M+ +  L H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLY 627
           LG C   G  + L+ +  P  SL   +       DP  +RLL W  +      IA+G+ Y
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYY 124

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           L ++   R++HR+L A N+LL  D   +I+DFG+A +   D+ +           +M+ E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
             L G ++ +SDV+S+G+ + E +S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 20/206 (9%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL------EEFKNEMMLIAKLQHRNLVKL 574
           LG+G +G VY G    GQ +AVK++   +   L      E+ + E+ L+  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           LG C++     + +E++P  S+   L  F P  + +     +  I++G+A    YLH   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV----GTYGYMSPEY 688
              ++HRD+K +NV+L  +   K+ DFG AR      L G    ++    GT  +M+PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +  +  KSD++S G  + E  +GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 28/233 (12%)

Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +      VAVK L    + + L +  +EM ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +++EY    +L  +L           FD  K  +  L ++  V+ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    G+   + F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.0 bits (220), Expect = 3e-19
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)

Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       +  Q     +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 19/187 (10%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKL 566
              ++ +  KLGEG FG VYK R +  G+ VA+K++   + + G  +   + E+ ++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 567 QHRNLVKLLGCCVEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           +H N+V L+   VE+ +K         ++  YM +  L   L +P   +L   Q +   +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIK-CYM 121

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + +G+ YLH+     I+HRD+KA+N+L+D     KI+DFGLAR + G           
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 679 GTYGYMS 685
           GT  Y +
Sbjct: 179 GTRKYTN 185

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 87.3 bits (216), Expect = 4e-19
 Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR----NLV 572
           +LG G FG V KG  ++   Q +VA+K L +++ + + +   EMM  A++ H+     +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +++G C E    +L++E      L+ FL    KK  +     V ++  ++ G+ YL   +
Sbjct: 59  RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               +HRDL A NVLL      KISDFGL++  G D+      R  G +   + +PE   
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171

Query: 691 DGLFSIKSDVFSFGILMLETLS-GKK 715
              FS +SDV+S+GI M E  S G+K
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 34/214 (15%)

Query: 520 KLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG--LEEFKNEMMLIAKLQHRNLVKLLG 576
           K+G G FG VY    L+  E+ AVK +  Q      ++E  +EM ++  L+H NLVK  G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGIAQGLLYLHQ 630
             V + +  + +EY    +L+  L      R+L     V       ++EG+A    YLH 
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELL---EHGRIL--DEHVIRVYTLQLLEGLA----YLHS 117

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG------GDELQGNTKRIVGTYGYM 684
           +    I+HRD+K +N+ LD +   K+ DFG A          G+E+Q     + GT  YM
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYM 170

Query: 685 SPEYALDGLFSIK---SDVFSFGILMLETLSGKK 715
           +PE    G        +D++S G ++LE  +GK+
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 11/198 (5%)

Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGFG V   ++   G+  A K+L  +     +G +   NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               + +  L++  M    L   +++  +      +A     + I  GL +LHQ    RI
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RDLK  NVLLD   N +ISD GLA    G       K   GT GYM+PE     ++  
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 697 KSDVFSFGILMLETLSGK 714
             D F+ G  + E ++G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 13/146 (8%)

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +V   G  + +    + +E+M   SLD       P    +LG      I   + +GL YL
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
             Y+  RI+HRD+K SN+L++     K+ DFG++    G+ +       VGT  YMSPE 
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
              G +++KSDV+S GI ++E   GK
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.7 bits (217), Expect = 7e-19
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 32/248 (12%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQSGQG-LEEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K R+       + A+KR+   + +    +F  E+ ++ KL  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARV 615
            N++ LLG C  +G   L +EY P+ +L  FL        DP      +    L  Q  +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                +A+G+ YL Q    + IHRDL A N+L+  +   KI+DFGL+R   G E+    K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179

Query: 676 RIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--G 729
           + +G     +M+ E     +++  SDV+S+G+L+ E  +L G    G+  A+ +  L  G
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Query: 730 YVSNKSLH 737
           Y   K L+
Sbjct: 240 YRLEKPLN 247

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 25/202 (12%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           +LG+G FG VYK +    G   A K + ++S + LE++  E+ ++A   H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
             +    +++E+    ++D  + +  ++ L   Q RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL-- 690
           RDLKA N+L  +D + K++DFG++          NT+ I      +GT  +M+PE  +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 691 ---DGLFSIKSDVFSFGILMLE 709
              D  +  K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV 579
           +G G +G VYKGR +   ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 580 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           ++       +  L++E+    S+   L   TK   L  +    I   I +GL +LHQ+  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL--- 690
            ++IHRD+K  NVLL  +   K+ DFG++     D   G     +GT  +M+PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 691 --DGLFSIKSDVFSFGILMLETLSG 713
             D  +  KSD++S GI  +E   G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEF--KNEMMLIAKLQHRNLVKLLGC 577
           +G G FG V+  R    Q  V +K++  +     E    +NE  ++  L H N+++    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +E    ++++EY P  +L  ++    +KR        TI+    Q LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 638 HRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           HRDLK  N+LLD   M  KI DFG++++      +     +VGT  Y+SPE      ++ 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 697 KSDVFSFGILMLETLSGKK 715
           KSD+++ G ++ E  S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 34/221 (15%)

Query: 520 KLGEGGFGPVYKGRLLNGQE---------------VAVKRLSSQ-SGQGLEEFKNEMMLI 563
           KLGEG FG V+        E               VAVK L +  +     +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL---------GWQAR 614
           ++L++ N+++LLG CV      +I EYM N  L+ FL     +                 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQ 671
           + +   IA G+ YL   +    +HRDL   N L+      KI+DFG++R ++ GD   +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G   R V    +M+ E  L G F+  SDV++FG+ + E  +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 32/214 (14%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQ-HRN 570
           + +  +LG+G FG VY  R    G+ VA+K++  +     EE  N  E+  + KL  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 571 LVKLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           +VKL     E  E   + EYM        K      F  +  R + +Q        I QG
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQ--------ILQG 111

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN---TKRIVGTY 681
           L ++H++  F   HRDLK  N+L+      KI+DFGLAR     E++     T   V T 
Sbjct: 112 LAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTR 162

Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            Y +PE  L    +S   D+++ G +M E  + +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 33/216 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN----EMMLIAKLQ 567
             + +   +GEG +G V K R    G+ VA+K+         E+ K     E+ ++ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIA 622
           H N+V L      +G   L+ EY+    L++         P   R   WQ        + 
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR----IV 678
           Q + Y H      IIHRD+K  N+L+      K+ DFG AR      L+          V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162

Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSG 713
            T  Y +PE  + D  +    DV++ G +M E L G
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL-----GWQARVTIIEGIAQG 624
           N++K     +E  E  ++LE      L   +    K++ L      W+  V +   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
               H +SR R++HRD+K +NV +      K+ D GL R F       ++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
           SPE   +  ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 85.5 bits (211), Expect = 5e-18
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 21/220 (9%)

Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
           ++G G FG VY     +  E VAVK++S    Q  E++++   E+  + +L+H N ++  
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           GC +++    L++EY    + D+       K+ L       I  G  QGL YLH ++   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
           +IHRD+KA N+LL      K++DFG A               VGT  +M+PE  L   +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 693 LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVS 732
            +  K DV+S GI  +E    ++   ++N ++ + L +++
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQHR 569
           +F +   +G+G FG V   +  + +++ A+K ++ Q        +N   E  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 570 NLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            LV L     +  E + L+++ +    L   L    K +    Q +  I E I   L YL
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      IIHRD+K  N+LLD   +  I+DF +A     D     T    GT GYM+PE 
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
                +S+  D +S G+   E L GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 28/220 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKL-Q 567
           E+   +  +GEG FG V +  +         A+K L   + +    +F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVT---- 616
           H N++ LLG C  +G   + +EY P  +L  FL        DP   +  G  + +T    
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 617 --IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
                 +A G+ YL   S  + IHRDL A NVL+  ++  KI+DFGL+R   G+E+    
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173

Query: 675 KRIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           K+ +G     +M+ E     +++ KSDV+SFG+L+ E +S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 61/205 (29%), Positives = 111/205 (54%), Gaps = 13/205 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG V+KG     Q+V A+K +  +  +  +E+ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + K  G  ++  +  +I+EY+   S LD+    P  +  +      T+++ I +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   IHRD+KA+NVLL    + K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)

Query: 513 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL 566
            N+ +   LG G FG VY       GR L  ++V     S ++ + +   + E+ L+  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 567 QHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQA---RVT--IIE 619
           +H  +V+  GC  +  EK L   +EYMP  S+        K +L  + A    VT     
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTR 113

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIV 678
            I QG+ YLH      I+HRD+K +N+L D   N K+ DFG ++      + G   K + 
Sbjct: 114 QILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA 722
           GT  +MSPE      +  K+DV+S    ++E L+ K     Y A
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 521 LGEGGFGP--VYK----GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+G FG   +Y+      L+  +EV + RLS +      +  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               ++    ++ +EY    +L   +    K +L   +  +  +  I   + Y+H+    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            I+HRD+K  N+ L      K+ DFG++++ G +     T  +VGT  YMSPE      +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178

Query: 695 SIKSDVFSFGILMLETLSGKK 715
           + KSD+++ G ++ E L+ K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 12/204 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
                  K+GEG  G V      + G++VAVK++  +  Q  E   NE++++   QH N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           V++    +   E  +++E++   +L D+     T  R+   Q   T+   + + L +LH 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHA 133

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                +IHRD+K+ ++LL  D   K+SDFG       +  +   K +VGT  +M+PE   
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVIS 188

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
              +  + D++S GI+++E + G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 24/208 (11%)

Query: 520 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSSQSGQGLEEFKNEMMLIAK----LQHRNLV 572
           +LG G FG V KG  ++   ++ VAVK L + +       K+E++  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +++G C E    +L++E      L+ FL    K + +  +    ++  ++ G+ YL + +
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
               +HRDL A NVLL      KISDFGL++  G DE     + + K  V  Y   +PE 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169

Query: 689 ALDGLFSIKSDVFSFGILMLETLS-GKK 715
                FS KSDV+SFG+LM E  S G+K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.7 bits (209), Expect = 9e-18
 Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 12/198 (6%)

Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL +    
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER--- 128

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G DE + + +       +M+ E  L  ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 189 THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 25/215 (11%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SSQSGQGLEEFKNEMMLIAKLQ 567
           N+ +   LG+G FG VY     + G+E+AVK++     S ++ + +   + E+ L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 568 HRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQA---RVT--IIEG 620
           H  +V+  GC  +  E+ L   +E+MP  S+        K +L  + A    VT      
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQ 114

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIVG 679
           I +G+ YLH      I+HRD+K +N+L D   N K+ DFG ++      L G   K + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T  +MSPE      +  K+D++S G  ++E L+ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 13/205 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +  +  +  +E+ + E+ ++++     
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + K  G  ++  +  +I+EY+   S LD+    P  +  +      TI+  I +GL YLH
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   IHRD+KA+NVLL      K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 74/235 (31%), Positives = 119/235 (50%), Gaps = 35/235 (14%)

Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMMLI 563
           A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 564 AKLQHRNLVKLLGCCVEQGEKIL-ILEYMPNKSLDVFLFD-------------PTKKRLL 609
            +    ++V+LLG  V QG+  L I+E M    L  +L               P+ K+++
Sbjct: 64  KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
                      IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D
Sbjct: 123 QMAGE------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
             +   K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 174 YYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 19/200 (9%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQ---HRNLVKL 574
           +GEG +G VYK R L  G+ VA+K++    S +G+      E+ L+ +L+   H N+V+L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 575 LGCC-VEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           L  C   + ++     L+ E++ ++ L  +L    K  L     +  ++  + +G+ +LH
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   RI+HRDLK  N+L+  D   KI+DFGLAR++     +     +V T  Y +PE  
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178

Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L   ++   D++S G +  E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 24/206 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
           K+GEG +G VYK R  +  + +A+K++   Q  +G+      E+ L+ ++QH N+V+L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 577 CCVEQGEKILILEYMP---NKSLDV---FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
               +    L+ EY+     K +D    F  +P   +   +Q    I+ GIA    Y H 
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120

Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +   R++HRDLK  N+L+D   N  K++DFGLAR F G  ++  T  +V T  Y +PE  
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175

Query: 690 LDGL-FSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 26/207 (12%)

Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G+L   +++  KRL  +  +G E    E  ++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-------RLLGWQARVTIIEGIAQGLLY 627
                 + +  L++  M    L   +++  ++       R   + A+      I  GL +
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEH 112

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LHQ    RII+RDLK  NVLLD D N +ISD GLA      + Q  TK   GT G+M+PE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPE 167

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                 +    D F+ G+ + E ++ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 11/197 (5%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGC 577
           ++G G FG V+ GRL  +   VAVK         L+ +F  E  ++ +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
           C ++    +++E +       FL   T+   L  +  + ++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           HRDL A N L+      KISDFG++R    G     G  K+I     + +PE    G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 696 IKSDVFSFGILMLETLS 712
            +SDV+SFGIL+ E  S
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 49/203 (24%)

Query: 515 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SSQSGQGLEEFK-NEMMLIAKLQH 568
           + ++  +G G +G VYK +  N   G+E A+K+     +   G+ +    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 569 RNLVKLLGCCVEQGEKI--LILEYMPNKSLDVFLF----------DPTKKRLLGWQARVT 616
            N+V L+   +E  +K   L+ +Y  +    +  F              K LL WQ    
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMF------- 665
               I  G+ YLH  S + ++HRDLK +N+L+  +       KI D GLAR+F       
Sbjct: 117 ----ILNGVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 666 -GGDELQGNTKRIVGTYGYMSPE 687
              D        +V T  Y +PE
Sbjct: 170 ADLD-------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 76.3 bits (188), Expect = 4e-17
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 11/94 (11%)

Query: 325 PIKCERSHSSECIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSN 384
           P+ C    S+       F+KL +++ PD        +++L++C   CL NC+C AYA +N
Sbjct: 2   PLNCGGDGST-----DGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN 54

Query: 385 VTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVP 418
                GCL+W G L +      +  G ++Y+R+ 
Sbjct: 55  G--SGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS--GQGLEE-FKNEMMLIAKLQHRNLVKLLG 576
           LG GGFG V   ++ +     A+K +  +     G +E   +E  ++ +  H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              ++    +++EY     L   L D  +     + AR   I  +     YLH      I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG---I 114

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           I+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y++PE  L+  +  
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171

Query: 697 KSDVFSFGILMLETLSGK 714
             D +S GIL+ E L+G+
Sbjct: 172 SVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 81.3 bits (200), Expect = 6e-17
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)

Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVK 573
           +GEG FG V K      G  ++     +K  +S+      +F  E+ ++ KL  H N++ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVT------IIEG 620
           LLG C  +G   L +EY P+ +L  FL        DP         + ++          
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ YL   S+ + IHRDL A N+L+  +   KI+DFGL+R   G E+    K+ +G 
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 172

Query: 681 YG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               +M+ E     +++  SDV+S+G+L+ E +S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 14/211 (6%)

Query: 520 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL 574
            +GEG FG VY+G       ++  VAVK   + +   + E+F  E  ++ +  H ++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G   E    I ++E  P   L  +L     K  L   + +     ++  L YL   S+ 
Sbjct: 73  IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R +HRD+ A NVL+      K+ DFGL+R    +     +K  +    +M+PE      F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185

Query: 695 SIKSDVFSFGILMLETLS-GKKN-TGVYNAD 723
           +  SDV+ FG+ M E L  G K   GV N D
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 16/203 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E+F +  ++G G +G VYK R +N G+  A+K +  + G+     + E++++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           V   G  + + +  + +E+    SL D++ +  P  +  + + +R T+     QGL YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   +HRD+K +N+LL  + + K++DFG++            K  +GT  +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 690 L---DGLFSIKSDVFSFGILMLE 709
                G ++   D+++ GI  +E
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 30/207 (14%)

Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           G +G V+  +    G   A+K +          +++   E  ++++ Q   +VKL     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62

Query: 580 EQGEKILIL--EYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            QG+K L L  EY+P   L   L      D          AR+ I E I   L YLH   
Sbjct: 63  -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLA------RMFGGDELQGNTKRIVGTYGYMSP 686
              IIHRDLK  N+L+D + + K++DFGL+      R    ++ +   KRIVGT  Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E  L    S   D +S G ++ E L G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 45/227 (19%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKN------------EMMLIAK 565
           LGEG +G V K    L G+ VA+K+  +   S    ++ +             E+ ++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPN---KSLD--VFLFDPTKKRLLGWQARVTIIEG 620
           ++H N++ L+   VE     L+++ M +   K +D  + L +   K +L  Q        
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ-------- 127

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI--- 677
           I  GL  LH++     +HRDL  +N+ ++     KI+DFGLAR +G         +    
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 678 ---------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
                    V T  Y +PE  +    +    D++S G +  E L+GK
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 514 NFSMQCKLGEGGFGPVY--KGRLLNGQEVAVK-RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + +  K+GEG FG +Y  K +  +   V  +  L+    +  E  K E++L+AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           +V       E G   +++EY     L          LF  ++ ++L W  +      I+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           GL ++H     +I+HRD+K+ N+ L  + M  K+ DFG+AR          T   VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
           Y+SPE   +  ++ K+D++S G ++ E
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYE 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 64/228 (28%), Positives = 116/228 (50%), Gaps = 21/228 (9%)

Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLS-SQSGQGLEEFKNEMMLI 563
           + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------DPTKKRLLGWQARVT 616
                 ++V+LLG   +    ++++E M +  L  +L        +   +     Q  + 
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTK 675
           +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
            ++     M+PE   DG+F+  SD++SFG+++ E  +L+ +   G+ N
Sbjct: 181 GLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 515 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK 565
           + +Q +LG+G FG VY         + RL   +E+ V  L+        +   E  L++K
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSK 58

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQ 623
           L H  +VK     +E+    +I EY   + LD  L     T K L    +   + E   Q
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFIQ 114

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            LL +H   + RI+HRDLKA N+ L  ++  KI DFG++R+  G      T    GT  Y
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE 709
           MSPE      +  KSD++S G ++ E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 82.6 bits (204), Expect = 4e-16
 Identities = 74/306 (24%), Positives = 122/306 (39%), Gaps = 57/306 (18%)

Query: 418 PASETGKRKLLWILV---ILVLPLVLLPSF-YIFCRRRRNCKEKETENMETDQDLLAFDI 473
           P     K    W  +   +    ++ L +F ++F R R N + K  EN +   +L  FD 
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676

Query: 474 NMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCK----LGEGGFGPV 529
                                         S  S +    +     K    +  G  G  
Sbjct: 677 ------------------------------SKVSKSITINDILSSLKEENVISRGKKGAS 706

Query: 530 YKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL 588
           YKG+ + NG +  VK ++  +     E  +    + KLQH N+VKL+G C  +    LI 
Sbjct: 707 YKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIH 762

Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
           EY+  K+L   L      R L W+ R  I  GIA+ L +LH      ++  +L    +++
Sbjct: 763 EYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816

Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
           D    P +    L  +   D        I  +  Y++PE       + KSD++ FG++++
Sbjct: 817 DGKDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILI 869

Query: 709 ETLSGK 714
           E L+GK
Sbjct: 870 ELLTGK 875

Length = 968

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + L+ + MP   L  ++ +   K  +G Q  +     IA+G+ YL +    
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLAR+   DE + +         +M+ E  L   F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 189 THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 20/202 (9%)

Query: 520 KLGEGGFGPVYKGRLLN--GQEVAVKRL---SSQSGQGLEEFKNEMML--IAKLQHRNLV 572
           ++GEG +G V+K R L   G+ VA+KR+   + + G  L   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 573 KLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           +L   C       + +  L+ E++ ++ L  +L D   +  +  +    ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH +   R++HRDLK  N+L+      K++DFGLAR++     Q     +V T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 688 YALDGLFSIKSDVFSFGILMLE 709
             L   ++   D++S G +  E
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            ++ +  ++G G +G VYK R L  G+  AVK +  + G      + E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVF-LFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           V   G  + + +  + +EY    SL D++ +  P  +  + +  R T+     QGL YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   +HRD+K +N+LL  + + K++DFG+A            K  +GT  +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178

Query: 690 L---DGLFSIKSDVFSFGILMLE 709
               +G ++   D+++ GI  +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 9e-16
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 15/203 (7%)

Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFK---NEMMLIAKLQHRN 570
           F +  ++G+GG+G V+  +  +  E VA+KR+       L E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           LVKLL    +     L +EY+P       L       L    AR  + E     +  LH+
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                 IHRDLK  N L+D   + K++DFGL++  G          +VG+  YM+PE   
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171

Query: 691 DGLFSIKSDVFSFGILMLETLSG 713
              +    D +S G ++ E L G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 22/212 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQH 568
           + +    ++ EG +G VY+ R    G+ VA+K+L     + G  +   + E+ ++ KLQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 569 RNLVKLLGCCVEQG-EKI-LILEYMPN--KSLDVFLFDPTKKRLLGWQARV-TIIEGIAQ 623
            N+V +    V    +KI +++EY+ +  KSL     +  K+  L  Q+ V  ++  +  
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQLLS 117

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G+ +LH      I+HRDLK SN+LL+     KI DFGLAR + G  L+  T+ +V T  Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWY 172

Query: 684 MSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
            +PE  L    +S   D++S G +  E L+ K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV 579
           +G G +G VYKGR +   ++A  ++   +    EE K E+ ++ K   HRN+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 580 EQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           ++       +  L++E+    S+   L   TK   L       I   I +GL +LH +  
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL--- 690
            ++IHRD+K  NVLL  +   K+ DFG++     D   G     +GT  +M+PE      
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 691 --DGLFSIKSDVFSFGILMLETLSG 713
             D  +  +SD++S GI  +E   G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 39/212 (18%)

Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           ++G G  G VYK      G+  A+K +  +       +   E+ ++  + H N+VK    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 578 CVEQGEKILILEYMPNKSLD-------VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
               GE  ++LE+M   SL+        FL D  ++          I+ GIA    YLH 
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY-- 688
             R  I+HRD+K SN+L++   N KI+DFG++R+        N+   VGT  YMSPE   
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERIN 241

Query: 689 ------ALDGLFSIKSDVFSFGILMLETLSGK 714
                 A DG      D++S G+ +LE   G+
Sbjct: 242 TDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 38/213 (17%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           ++GEG +G VY+ R   +G+ VA+K++   + + G  +   + E+ L+  L+H N+V+L 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 576 GCCV-EQGEKI-LILEY-----------MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
              V +  + I L++EY           MP        F  ++ + L  Q        + 
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FSESQVKCLMLQ--------LL 118

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           +GL YLH    F IIHRDLK SN+LL      KI+DFGLAR + G   +  T ++V T  
Sbjct: 119 RGLQYLH--ENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173

Query: 683 YMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           Y +PE  L       + D+++ G ++ E L+ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 32/213 (15%)

Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMM-LIAKLQHR---NLVK 573
            +LG G +G V K R +  G  +AVKR+ +      +E K  +M L   ++       V 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVT 64

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVF---LFDP---TKKRLLGWQARVTIIEGIAQGLLY 627
             G    +G+  + +E M + SLD F   ++D      + +LG      I   I + L Y
Sbjct: 65  FYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEY 118

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSP 686
           LH  S+  +IHRD+K SNVL++ +   K+ DFG++    G  +    K I  G   YM+P
Sbjct: 119 LH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAP 172

Query: 687 EYALDGL-----FSIKSDVFSFGILMLETLSGK 714
           E  ++       + +KSDV+S GI M+E  +G+
Sbjct: 173 E-RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 21/200 (10%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ----SGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LG G FG V   R     +  A+K LS        Q +E   NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGLLYLHQYSR 633
           G   +     L++EY+P   L    F   +K  R     AR    + +   L YLH    
Sbjct: 68  GSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD- 121

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
             I++RDLK  N+LLD D   KI+DFG A+      ++G T  + GT  Y++PE  L   
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKG 174

Query: 694 FSIKSDVFSFGILMLETLSG 713
           +    D ++ GIL+ E L+G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 39/212 (18%)

Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           +G G +G V        G++VA+K+LS +  Q     K    E+ L+  + H N++ LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 577 CCVEQGEKILILEYMPNKSL----DVFLFDP---------TKKRLLGWQARVTIIEGIAQ 623
                        + P  SL    DV+L             K + L       ++  I +
Sbjct: 82  V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           GL Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWY 181

Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
            +PE  L+ +   ++ D++S G +M E L+GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 30/210 (14%)

Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN---LVKLLG 576
           +G G FG V K      G  +AVKR+ S      E+ +  M L   ++  +   +VK  G
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 577 CCVEQGEKILILEYMPNKSLDVF---LFDPTKKRL----LGWQARVTIIEGIAQGLLYLH 629
               +G+  + +E M + SLD F   +++  K  +    LG  A  T+     + L YL 
Sbjct: 71  ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATV-----KALNYLK 124

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMSPE- 687
           +    +IIHRD+K SN+LLD + N K+ DFG++    G  +    K R  G   YM+PE 
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPER 178

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
               A DG + ++SDV+S GI + E  +GK
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 30/209 (14%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQG-----LEEFKNEMMLIAKLQHRNLV 572
           K+G+G FG V+K R     Q VA+K+ L     +G     L E K    ++  L+H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74

Query: 573 KLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            L+  C  +            L+ E+  +  L   L +   K  L       +++ +  G
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNG 131

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG---GDELQGNTKRIVGTY 681
           L Y+H   R +I+HRD+KA+N+L+  D   K++DFGLAR F      +    T R+V T 
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TL 187

Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            Y  PE  L +  +    D++  G +M E
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 16/196 (8%)

Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G  G VYK   LL  + +AVK +       L+ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
             +    +  E+M   SLDV+   P  + +LG   R+ +   + +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIP--EHVLG---RIAV--AVVKGLTYLWS---LKILH 118

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           RD+K SN+L++     K+ DFG++       +    K  VGT  YM+PE      + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 699 DVFSFGILMLETLSGK 714
           DV+S GI  +E   G+
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 521 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LG G FG + +G  +L + +E  VA+  L +  S +    F  E + + +  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G        +++ EYM N +LD FL    + +L+  Q  + ++ G+A G+ YL   S   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQL-MGMLPGLASGMKYL---SEMG 127

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS---------P 686
            +H+ L A  VL++ D+  KIS F           +    +    Y  MS         P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177

Query: 687 EYALDGLFSIKSDVFSFGILMLETLS 712
           E      FS  SDV+SFGI+M E +S
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.5 bits (189), Expect = 6e-15
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 44/225 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMML 562
             + +  KLG+G +G V+K       + VA+K++        + F+N         E+M 
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59

Query: 563 IAKL-QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           + +L  H N+VKLL     + +K   L+ EYM     +  L    +  +L    +  I+ 
Sbjct: 60  LQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-- 677
            + + L Y+H  S   +IHRDLK SN+LL+ D   K++DFGLAR     EL+ N +    
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169

Query: 678 ---VGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
              V T  Y +PE     L          D++S G ++ E L GK
Sbjct: 170 TDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 520 KLGEGGFGPV-YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+GEG  G V        G++VAVK++  +  Q  E   NE++++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +   E  +++E++   +L     D      +  +   T+   + + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           RD+K+ ++LL  D   K+SDFG       +  +   K +VGT  +M+PE      +  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 699 DVFSFGILMLETLSGK 714
           D++S GI+++E + G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+GEG  G V    +  +G+ VAVK++  +  Q  E   NE++++   QH N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +   E  +++E++   +L     D      +  +    +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           RD+K+ ++LL  D   K+SDFG        E+    K +VGT  +M+PE      +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 699 DVFSFGILMLETLSGK 714
           D++S GI+++E + G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 31/238 (13%)

Query: 486 EVNGDGKDKGKD-----SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
           E + D      D       +P    A    A+  +++   L  G  G V+      GQ  
Sbjct: 34  EYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPD 92

Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
            V     Q G  L E     ML+  + H +++++    V      ++L   P+ S D++ 
Sbjct: 93  PVVLKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYT 145

Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
           +   + R L     + I + I +GL YLH     RIIHRD+K  N+ ++      I D G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202

Query: 661 LAR------MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            A+       F G         + GT    +PE      ++ K+D++S GI++ E L+
Sbjct: 203 AAQFPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL--EEFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V K +      +  ++L     +     +   E+ ++ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L +  +  + +LG   +V+I   + +GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                +S++SD++S G+ ++E   G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--EMMLIAKLQ-HRNLVKL 574
            K+GEG F  V K +    G+  A+K +  +  + LE+  N  E+  + +L  H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 575 LGCCVEQ--GEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARV-TIIEGIAQGLLYLH 629
           +    ++  G   L+ E M     D+ L++  K  KR L  + RV + +  + + L ++H
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              R  I HRD+K  N+L+  D   K++DFG  R  G       T+ I  T  Y +PE  
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170

Query: 690 L-DGLFSIKSDVFSFGILMLETLS 712
           L DG +  K D+++ G +  E LS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 19/206 (9%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLE-EFKNEMMLIAKLQ---HRNLVK 573
           ++G G +G VYK R   +G  VA+K +  Q+ + GL      E+ L+ +L+   H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 574 LLGCC----VEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           L+  C     ++  K+ L+ E++ ++ L  +L D      L  +    ++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      I+HRDLK  N+L+      K++DFGLAR++     Q     +V T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
            L   ++   D++S G +  E    K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 27/206 (13%)

Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLYLH 629
                 +    L+L  M    L   +++       ++R + + A +T       GL  LH
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLEDLH 119

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
              R RI++RDLK  N+LLD   + +ISD GLA  +  G+ ++G     VGT GYM+PE 
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +  ++   D +  G L+ E + GK
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   + +  KR+  + G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLYLH 629
                 +    L+L  M    L   +++       ++R L + A       I  GL  LH
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
           + +    ++RDLK  N+LLD   + +ISD GLA ++  G+ ++G     VGT GYM+PE 
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +  +++  D +  G L+ E + G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                 +    L+L  M    L   ++   +      +A     E I  GL  LHQ    
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           RI++RDLK  N+LLD   + +ISD GLA  +  G  ++G     VGT GYM+PE   +  
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177

Query: 694 FSIKSDVFSFGILMLETLSGK 714
           ++   D ++ G L+ E ++G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 25/216 (11%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK----NEMMLIAKLQHR 569
           F +  ++GEG +G VYK R    G+ VA+K++   + +  E F      E+ ++ +L HR
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----------QARVTIIE 619
           N+V L     +   K   L++  +K     +F+     L+G               + ++
Sbjct: 67  NIVNLKEIVTD---KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            + +GL Y H+ +    +HRD+K SN+LL+     K++DFGLAR++  +E +  T +++ 
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
           T  Y  PE  L +  +    DV+S G ++ E  + K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           ++      +G G FG V+  R  ++    A+K ++       +  +   NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             +++L     +Q    +++EY+P   L  F +     R           E I   L YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      I++RDLK  N+LLD + + K++DFG A+     +L+  T  + GT  Y++PE 
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168

Query: 689 ALDGLFSIKS-------DVFSFGILMLETLSGK 714
                  I+S       D ++ GIL+ E L G 
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.9 bits (179), Expect = 9e-14
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN----- 558
             +V   T  +     +G G FG V   R  L GQ VA+K++       ++ F       
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54

Query: 559 ----EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
               E+ L+  L+H N++ L    +   E I  +  +    L   L      R L  Q  
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-----MFGGDE 669
              +  I +GL Y+H      ++HRDLK SN+L++ + + KI DFGLAR     M G   
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG--- 164

Query: 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
                   V T  Y +PE  L    + ++ D++S G +  E L GK
Sbjct: 165 -------YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 21/156 (13%)

Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLSSQS-GQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
           K+GEG +G V+K +     E VA+KR+      +G+      E+ L+ +L+H+N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                 +  L+ EY  ++ L  +        DP   +   +Q        + +GL + H 
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHS 117

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           +    ++HRDLK  N+L++ +   K++DFGLAR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 21/150 (14%)

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK------RLLGWQARVTIIEGIAQG 624
           +V   G     GE  + +E+M   SLD  L    KK       +LG   +++I   + +G
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPENILG---KISI--AVLRG 111

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L YL +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YM
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 165

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           SPE      ++++SD++S G+ ++E   G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 9/96 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           I  GL +LH+     II+RDLK  NVLLD + + KI+DFG+ +  + GG      T    
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      +    D ++ G+L+ E L+G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  ++H N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 576 -----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                   +E   ++    Y+    +   L +  K + L  +    +I  + +GL Y+H 
Sbjct: 81  DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                IIHRDLK SNV ++ D   +I DFGLAR    DE+ G     V T  Y +PE  L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188

Query: 691 DGL-FSIKSDVFSFGILMLETLSGK 714
           + + ++   D++S G +M E L GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEEF--KNEMMLIAKLQHRNLVKL 574
           LG+G FG V+  R +     GQ  A+K L   + +  +    K E  ++A++ H  +VKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-IEGIAQGLLYLHQYSR 633
                 +G+  LIL+++    L    F    K ++  +  V   +  +A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
             II+RDLK  N+LLD + + K++DFGL++     E +       GT  YM+PE      
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRG 174

Query: 694 FSIKSDVFSFGILMLETLSG 713
            +  +D +SFG+LM E L+G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.0 bits (179), Expect = 4e-13
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 26/194 (13%)

Query: 537 GQEVAVKRLSSQSGQGLEE---FKNEMMLIAKLQHRNLVKLL--GCCVEQGEKILILEYM 591
           G EVA+K L + + +   +   F+ E  L A+L H N+V LL  G     G    + EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEG---IAQGLLYLHQYSRFRIIHRDLKASNVLL 648
           P ++L         + +L     +   E    + Q L  L       I+HRDLK  N+++
Sbjct: 62  PGRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

Query: 649 ---DMDMNPKISDFGLARMFGG----DELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDV 700
               +  + K+ DFG+  +  G    D      T  ++GT  Y +PE       +  SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 701 FSFGILMLETLSGK 714
           +++G++ LE L+G+
Sbjct: 173 YAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           IA GL +LH      II+RDLK  NV+LD + + KI+DFG+ +  +FGG      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      +    D ++FG+L+ E L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGLEEFKNEMMLIAK 565
           NF +   LG G +G V+  R ++G +     A+K L      Q  +  E  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQ 623
           ++    +  L    +   K+ LIL+Y+    L    F    +R    +  V I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L +LH   +  II+RD+K  N+LLD + +  ++DFGL++ F  DE++       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172

Query: 684 MSPEYAL--DGLFSIKSDVFSFGILMLETLSG 713
           M+P+     DG      D +S G+LM E L+G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 27/206 (13%)

Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KRL  +SG+ +   + E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----RLLGWQARVTIIEGIAQGLLYLH 629
                 +    L++  M    L   +++  ++     R++ + A+      I  G+L+LH
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY 688
                 I++RD+K  NVLLD   N ++SD GLA  +  G  +   T+R  GT GYM+PE 
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR-AGTNGYMAPEI 165

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +  +S   D F+ G  + E ++G+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFK--NEMMLIAKL 566
           AAT   +++ KLGEG +  VYKG   +NGQ VA+K +S ++ +G+  F    E  L+  L
Sbjct: 3   AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60

Query: 567 QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIE 619
           +H N+V LL   +   E +  + EYM +  L  ++        P   RL  +Q       
Sbjct: 61  KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            + +GL Y+H      I+HRDLK  N+L+      K++DFGLAR       Q  +  +V 
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165

Query: 680 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           T  Y  P+  L    +S   D++  G + +E L G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 53/154 (34%), Positives = 75/154 (48%), Gaps = 22/154 (14%)

Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
            KLGEG +  VYKGR  L GQ VA+K  RL  + G      + E  L+  L+H N+V L 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69

Query: 576 GCCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                +    L+ EY+ +  L  ++            RL  +Q        + +GL Y H
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
           Q    R++HRDLK  N+L+      K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 55/202 (27%), Positives = 105/202 (51%), Gaps = 17/202 (8%)

Query: 520 KLGEGGFGPVYKGRLL----NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
           K+GEG FG   K  L+    +G++  +K +  S  S +  EE + E+ +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
                 E G   ++++Y      D++     ++ +L  + +  I++   Q  L L     
Sbjct: 64  YQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQ--ILDWFVQICLALKHVHD 119

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDG 692
            +I+HRD+K+ N+ L  D   K+ DFG+AR+     EL    +  +GT  Y+SPE   + 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICENR 176

Query: 693 LFSIKSDVFSFGILMLETLSGK 714
            ++ KSD+++ G ++ E  + K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 520 KLGEGGFGPVYKG---RLLNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           ++G G FG V  G   R ++   V VK L +S +      F  E+    +L H N+++ L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT--IIEGIAQGLLYLHQYSR 633
           G C+E    +L+LE+ P   L  +L           Q  V   +   +A GLL+LHQ   
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYA--- 689
              IH DL   N  L  D++ KI D+GLA   +  D         V    +++PE     
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177

Query: 690 ----LDGLFSIKSDVFSFGILMLE 709
               L    + KS+++S G+ M E
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWE 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 521 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----SQSGQGLEEFKNEMMLIAK-LQ 567
           LG G FG VYK         LL  +E+ V   +      +  + + +  +E+ +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H N+V+     +E     ++++ +    L + F     KK+    +    I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           YLH+  R  I+HRDL  +N++L  D    I+DFGLA+    +        +VGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCP 182

Query: 687 EYALDGLFSIKSDVFSFGILMLET 710
           E   +  +  K+DV++FG ++ + 
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 519 CKLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLL 575
            K+GEG +G V+K R    GQ VA+K+ + S+    +++    E+ ++ +L+H NLV L+
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
                + +  L+ EY  +  L+    +P   R +       II    Q + + H+++   
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLF 694
            IHRD+K  N+L+      K+ DFG AR+  G     +    V T  Y +PE  + D  +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178

Query: 695 SIKSDVFSFGILMLETLSG 713
               DV++ G +  E L+G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 9e-13
 Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 37/211 (17%)

Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 578 CVEQGEKILILEYMPNKSL----DVFLF---------DPTKKRLLGWQARVTIIEGIAQG 624
                       + P +SL    DV+L          +  K + L       +I  I +G
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184

Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 13/158 (8%)

Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVT 616
           E+ ++ +     +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVS 109

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
           I   + +GL YL +  + +I+HRD+K SN+L++     K+ DFG++    G  +      
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 161

Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            VGT  YMSPE      +S++SD++S G+ ++E   G+
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 33/245 (13%)

Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLLGC 577
           CK+G G +G VYK +  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 578 CVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY-----LHQ 630
            +   ++   L+ +Y  +    +  F    K     +  V +  G+ + LLY     +H 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGD-ELQGNTKRIVGTYGYM 684
                ++HRDLK +N+L+ M   P     KI+D G AR+F    +   +   +V T+ Y 
Sbjct: 124 LHANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK----------KNTGVYNADS----FNLLG 729
           +PE  L      K+ D+++ G +  E L+ +          K +  Y+ D     FN++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 730 YVSNK 734
           + ++K
Sbjct: 243 FPADK 247

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGLEEFKNEMMLIAK 565
           NF +   LG G +G V+  R + G +     A+K L      Q  +  E  + E  ++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           ++    +  L    +   K+ LIL+Y+    L   L+   ++     + RV I E I   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAE-IVLA 117

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L +LHQ     II+RD+K  N+LLD + +  ++DFGL++ F  +E +       GT  YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173

Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLSG 713
           +PE      G      D +S G+L  E L+G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 38/211 (18%)

Query: 521 LGEGGFGPV----YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM------MLIAKLQHRN 570
           LG G FG V    YK     G+  A+K L        +E ++ M            +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           LV L  C   +     ++EY     L      DVF    ++ R + + A V +      G
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYG 682
           L YLH+    +I++RDLK  N+LLD +   KI+DFGL +  M  GD     T    GT  
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +++PE   +  ++   D +  G+L+ E L G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKL 566
             +     +GEG +G V        G +VA+K++S    Q      L E K    ++ + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60

Query: 567 QHRNLVKLLGC----CVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           +H N++ +L        E    + ++ E M        L+   K + L        +  I
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI---V 678
            +GL Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR+   D    +T  +   V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170

Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
            T  Y +PE  L+     K+ D++S G ++ E LS +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 51/149 (34%), Positives = 71/149 (47%), Gaps = 9/149 (6%)

Query: 520 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           ++G G FG V  G +       +V VK L  S S Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV--TIIEGIAQGLLYLHQYSR 633
           G C E    +L++E+ P   L  +L    K  L+         +   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA 662
              IH DL   N LL  D+  KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 29/230 (12%)

Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           +  L S+   T+ + +   +G+G +G VYK     +G   AVK L   S    EE + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 561 MLIAKL-QHRNLVKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            ++  L  H N+VK  G   +      G+  L+LE     S+   +     K LL    R
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124

Query: 615 VT------IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
           +       I+ G   GL +LH     RIIHRD+K +N+LL  +   K+ DFG++      
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 669 ELQGNTKRIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLETLSG 713
            L+ NT   VGT  +M+PE        D  +  + DV+S GI  +E   G
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E ++   ++G G +G V        G++VA+K+LS   QS    +    E+ L+  +QH 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDV--FLFDPTKKRLLGWQARVTIIEGI 621
           N++ LL             +  L++ YM      +        K + L +Q        +
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
             GL Y+H      IIHRDLK  N+ ++ D   KI DFGLAR     E+ G     V T 
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178

Query: 682 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
            Y +PE  L+ +   ++ D++S G +M E L+GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHR 569
           E +     +GEG +G V K +    GQ VA+K+ L S+  + +++    E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP------TKKRLLGWQARVTIIEGIAQ 623
           NLV L+     +    L+ E++ +  LD     P        ++ L +Q    I+ GI  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYG 682
              + H ++   IIHRD+K  N+L+      K+ DFG AR      E+  +    V T  
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRW 165

Query: 683 YMSPEYAL-DGLFSIKSDVFSFGILMLETLSG 713
           Y +PE  + D  +    D+++ G L+ E L+G
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 27/207 (13%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM--LIAKLQHR--NLVKLL 575
           +G G  G VYK R    G  +AVK++     +  EE K  +M   +    H    +VK  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 576 GCCVEQGEKILILEYMPN--KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           G  +   +  + +E M      L   +  P  + +LG   ++T+   I + L YL +  +
Sbjct: 81  GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG---KMTV--AIVKALHYLKE--K 133

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALD- 691
             +IHRD+K SN+LLD   N K+ DFG++ R+    + +  T R  G   YM+PE  +D 
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPE-RIDP 188

Query: 692 ----GLFSIKSDVFSFGILMLETLSGK 714
                 + I++DV+S GI ++E  +G+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 8/191 (4%)

Query: 521 LGEGGFG-PVYKGRLLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           +GEG FG  +    + + Q+ A+K +   +S   +E+ + E +L+AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
              G   +++EY     L   +    + +L       TI++   Q  L +      R++H
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPED---TILQWFVQMCLGVQHIHEKRVLH 123

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           RD+K+ N+ L  +   K+ DFG AR+         T   VGT  Y+ PE   +  ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181

Query: 699 DVFSFGILMLE 709
           D++S G ++ E
Sbjct: 182 DIWSLGCILYE 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 5e-12
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 49/220 (22%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMMLIAKLQHRN 570
           +G G +G V        G++VA+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 571 LVKLL-----GCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARVTIIE 619
           ++ LL         +  +  ++ E M        KS           + L        + 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS----------PQPLTDDHIQYFLY 110

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRI 677
            I +GL YLH      +IHRDLK SN+L++ + + KI DFGLAR    DE +    T+ +
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 678 VGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGK 714
           V T  Y +PE  L       +I  D++S G +  E L+ K
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                 +    L+L  M    L   +++         +A     E +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           RI++RDLK  N+LLD   + +ISD GLA ++  G+ ++G     VGT GYM+PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 694 FSIKSDVFSFGILMLETLSGK 714
           ++   D +  G L+ E + G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 39/99 (39%), Positives = 58/99 (58%), Gaps = 9/99 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRI 677
           +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN +  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           V    +M+PE   D +++++SDV+S+GIL+ E  S  K+
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 521 LGEGGFGPVYKGRLLNGQE----VAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLV 572
           LG+GG+G V++ R + G +     A+K L      ++ +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 573 KLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
            L+      G+  LILEY+    L        +F+ D     L            I+  L
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL----------SEISLAL 113

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN--TKRIVGTYGY 683
            +LHQ     II+RDLK  N+LLD   + K++DFGL +    + +     T    GT  Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           M+PE  +        D +S G LM + L+G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLGEG +  VYKGR  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    L+ EY+ +K L  +L D      +        +  + +GL Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL-F 694
           +HRDLK  N+L++     K++DFGLAR      +   T    V T  Y  P+  L    +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 695 SIKSDVFSFGILMLETLSGK 714
           S + D++  G +  E  +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 38/195 (19%)

Query: 537 GQEVAVKRLSSQSGQGLEEFKN---------EMMLIAKLQHRNLVKLLGCCVEQ------ 581
           GQ VA+K+LS         F+N         E++L+  + H+N++ LL     Q      
Sbjct: 41  GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93

Query: 582 GEKILILEYMPNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
            +  L++E M      V   D   +R+  L +Q        +  G+ +LH      IIHR
Sbjct: 94  QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHR 142

Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVD 199

Query: 700 VFSFGILMLETLSGK 714
           ++S G +M E + G 
Sbjct: 200 IWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHRN-LVKLL 575
           K+GEG +G VYK R    G+ VA+K+       +G+      E+ L+  L     +V+LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 576 GCCVEQGEK-------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG----IAQG 624
              VE  E+        L+ EY+     D+  F  +  R  G       I+     + +G
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGY 683
           + + H++    ++HRDLK  N+L+D      KI+D GL R F    ++  T  IV T  Y
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWY 177

Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
            +PE  L    +S   D++S G +  E    
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 74/260 (28%), Positives = 111/260 (42%), Gaps = 72/260 (27%)

Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +  + + VAVK L  + G    E+K  M    +LI    H N
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72

Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPT----------------KKR 607
           +V LLG C + G  ++ I+EY    +L  +L      F P                 K+R
Sbjct: 73  VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 608 LL-----------GWQA--RVTIIEGIAQG-------------LLYLHQYSR---F---- 634
           L            G+     ++ +E   +G             + Y  Q +R   F    
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDG 692
           + IHRDL A N+LL  +   KI DFGLAR      D ++    R+     +M+PE   D 
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250

Query: 693 LFSIKSDVFSFGILMLETLS 712
           +++ +SDV+SFG+L+ E  S
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLGEG +  V+KGR  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                    L+ EY+ +K L  ++ D     ++        +  I +GL Y H   R ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYAL-DGLF 694
           +HRDLK  N+L++     K++DFGLAR      +   T    V T  Y  P+  L    +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 695 SIKSDVFSFGILMLETLSGK 714
           S + D++  G +  E  SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQHRNLVKLLGC 577
           +G+G +G V   R   +G++  +K+L+ ++    E    + E  L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 578 CV-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              E G   +++ +     L   L +   K L   Q     ++ IA  L YLH+     I
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           +HRDLK  NV L      K+ D G+AR+        +T  ++GT  YMSPE   +  ++ 
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181

Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
           KSDV++ G  + E  + K     +NA   N L Y
Sbjct: 182 KSDVWALGCCVYEMATLKH---AFNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           I  GL +LH+     II+RDLK  NVLLD D + KI+DFG+ +  M G    +G      
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      ++   D +SFG+L+ E L G+
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 521 LGEGGFGPVYKGRLLN-GQEVAV-----KRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +G GGFG VY  R  + G+  A+     KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +       +K+  IL+ M    L   L     F   + R    +    II G+       
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE----IILGLE------ 111

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166

Query: 689 ALDGL-FSIKSDVFSFGILMLETLSG 713
              G+ +   +D FS G ++ + L G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 29/201 (14%)

Query: 524 GGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN----EMMLIAKLQHRNLVKLLGCC 578
           G FG VY  +    G   A+K L         +  N      +++ + +   + KL    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLG-----WQARVTIIEGIAQGLLYLHQYSR 633
             +    L++EY+        +      + LG     W A+  I E +  G+  LHQ   
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG- 117

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
             IIHRD+K  N+L+D   + K++DFGL+R   G E     K+ VGT  Y++PE  + G+
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGV 168

Query: 694 FSIK-SDVFSFGILMLETLSG 713
              K SD +S G ++ E L G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 521 LGEGGFGPV-YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           +G G +G V        G +VA+K+L    QS    +    E+ L+  ++H N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 578 CVEQGEKILILEYMPNKSLDVF----LFDP---------TKKRLLGWQARVTIIEGIAQG 624
                       + P+ SLD F    L  P          K   L       ++  + +G
Sbjct: 83  ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK  N+ ++ D   KI DFGLAR     E+ G     V T  Y 
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYR 182

Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 33/245 (13%)

Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLLGC 577
           CK+G G +G VYK +  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 578 CVEQGEK--ILILEYMPNKSLDVFLF----DPTKKRLLGWQARV-TIIEGIAQGLLYLHQ 630
            +   ++   L+ +Y  +    +  F       KK +   ++ V +++  I  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGD-ELQGNTKRIVGTYGYM 684
                ++HRDLK +N+L+ M   P     KI+D G AR+F    +   +   +V T+ Y 
Sbjct: 127 N---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK----------KNTGVYNADS----FNLLG 729
           +PE  L      K+ D+++ G +  E L+ +          K +  ++ D     F+++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242

Query: 730 YVSNK 734
           + ++K
Sbjct: 243 FPADK 247

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLGEG +  VYKG+  +NG+ VA+K  RL  + G      + E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 577 CCVEQGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
               +    L+ EY+ +  L  ++        P   +L  +Q        + +GL Y+HQ
Sbjct: 71  IIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIHQ 121

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYA 689
             R+ I+HRDLK  N+L+      K++DFGLAR      +  +T    V T  Y  P+  
Sbjct: 122 --RY-ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 690 LDGL-FSIKSDVFSFGILMLETLSG 713
           L    +S   D++  G + +E + G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           I +GL YLH      I+HRD+K  N+L++ +   KI DFGLAR+   DE +  T+ +V  
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 681 YGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
           Y Y +PE  L G   ++   D++S G +  E L  +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)

Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN----EMMLIAKLQHRNLVKLL 575
           +GEG +G V K R    +E VA+K+         EE K     E+ ++  L+  N+V+L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
                +G+  L+ EY+    L++    P    +   + R  I + I      +H   +  
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKA----IHWCHKND 120

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           I+HRD+K  N+L+  +   K+ DFG AR    +    N    V T  Y SPE  L   + 
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 696 IKSDVFSFGILMLETLSGK 714
              D++S G ++ E   G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
           LG+G FG V   RL  +G+  AVK L        ++ +  M    +L     H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQYSR 633
            CC +  +++  ++E++    L   +F   K R    +AR       I   L++LH    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALD 691
             II+RDLK  NVLLD + + K++DFG+ +  +F G      T    GT  Y++PE   +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170

Query: 692 GLFSIKSDVFSFGILMLETLSG 713
            L+    D ++ G+L+ E L G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 521 LGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +G GGFG VY       G++   + +  KR+  + G+ L   +  M+ +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +       +K+  IL+ M    L   L     F   + R    +    II G+       
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE----IILGLE------ 111

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166

Query: 689 ALDGL-FSIKSDVFSFGILMLETLSG 713
              G  +   +D FS G ++ + L G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 68/261 (26%), Positives = 104/261 (39%), Gaps = 73/261 (27%)

Query: 521 LGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +          +   VAVK L  + G    E K  M    +LI    H N
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72

Query: 571 LVKLLGCCVE-QGEKILILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQ 623
           +V LLG C +  G  ++I+E+    +L  FL      F P +++    + R   +   ++
Sbjct: 73  VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 624 G-------------------------------------------LLYLHQYSR------- 633
                                                       + Y  Q +R       
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALD 691
            + IHRDL A N+LL  +   KI DFGLAR      D ++  + R+     +M+PE   D
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFD 250

Query: 692 GLFSIKSDVFSFGILMLETLS 712
            +++ +SDV+SFG+L+ E  S
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGLEEFKNEMMLIAK 565
           NF +   LG G +G V+  R + G +     A+K L      Q  + +E  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQ 623
           ++    +  L    +   K+ LIL+Y+    +   L+    +R    +  V    G I  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L +LH   +  I++RD+K  N+LLD + +  ++DFGL++ F  +E +  T    GT  Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172

Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSGKKNT 717
           M+PE         K+ D +S GIL+ E        TL G++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 521 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSSQSGQGLEEFKNEMMLIAKLQHRN 570
           LG+G F  +YKG L           GQEV+V   +     +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           LVKL G CV   E I++ EY+    LDVFL        L W+  V   + +A  L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119

Query: 631 YSRFRIIHRDLKASNVLL---DMDMNP----KISDFGLARMFGG-DELQGNTKRIVGTYG 682
               +++H ++   N+L+    ++       K+SD G+       +E     +RI     
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169

Query: 683 YMSPEYALDGLFSIKS--DVFSFGILMLETLSGKK 715
           +++PE   +G  S+    D +SFG  +LE  S  +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)

Query: 537 GQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILIL 588
           G  VAVK+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL 648
           E M      V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156

Query: 649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
             D   KI DFGLAR    + +   T  +V  Y Y +PE  L   +    D++S G +M 
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213

Query: 709 ETLSG 713
           E + G
Sbjct: 214 ELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 21/203 (10%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQHRNLVKLL 575
           LG+G FG V+   L    Q  A+K L        ++ +  M+    L    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQYSR 633
            C  +  E +  ++EY+    L +F      K  L    R T     I  GL +LH    
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDL---PRATFYAAEIICGLQFLHSKG- 116

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALD 691
             I++RDLK  N+LLD D + KI+DFG+ +  M G       T    GT  Y++PE  L 
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLG 170

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             ++   D +SFG+L+ E L G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFK-NEMMLIAKLQHR----NL 571
           +LG+G +G VYK      G  +A+K  RL       L+E K N++++   + H+     +
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPYI 61

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V   G    +G   + +EYM   SLD           +       I   + +GL +L + 
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
               IIHRD+K +NVL++ +   K+ DFG++    G+ +    K  +G   YM+PE    
Sbjct: 121 -EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKS 175

Query: 689 ---ALDGLFSIKSDVFSFGILMLETLSGK 714
                +  ++++SDV+S G+ +LE   G+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 31/198 (15%)

Query: 537 GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL--------------LGCCVEQG 582
            + VAVK++     Q ++    E+ +I +L H N+VK+              +G   E  
Sbjct: 30  DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 583 EKILILEYMPNKSLDVFLFDPTKK---RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
              ++ EYM     +V    P  +   RL  +Q        + +GL Y+H  +   ++HR
Sbjct: 90  SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138

Query: 640 DLKASNVLLDM-DMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           DLK +NV ++  D+  KI DFGLAR+       +G     + T  Y SP   L      K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198

Query: 698 S-DVFSFGILMLETLSGK 714
           + D+++ G +  E L+GK
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
           +G+G +G V+K     NG + AVK L        EE + E  ++  L  H N+VK  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 579 ----VEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ----GLLYLH 629
               V+ G+++ L+LE     S+   +    K+   G +    II  I      GL +LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYILHEALMGLQHLH 141

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY- 688
                + IHRD+K +N+LL  +   K+ DFG++       L+ NT   VGT  +M+PE  
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI 196

Query: 689 ----ALDGLFSIKSDVFSFGILMLETLSG 713
                LD  +  + DV+S GI  +E   G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+G FG V    L    EV A+K L          ++    E  ++A       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 577 CCVEQGEKIL-ILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           CC +  +++  ++EY+    L   +     FD  + R   + A VT+       L++LH+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF--YAAEVTL------ALMFLHR 114

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEY 688
           +    +I+RDLK  N+LLD + + K++DFG+ +  +  G      T    GT  Y++PE 
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEI 167

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +  +    D ++ G+LM E ++G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
           +A+G+ +L   SR + IHRDL A N+LL  +   KI DFGLAR      D ++    R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLGEG +  V+KGR  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    L+ EY+ +   D+  +      L+        +  + +GL Y H   + +I
Sbjct: 71  IIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL-F 694
           +HRDLK  N+L++     K++DFGLAR      +   T    V T  Y  P+  L    +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 695 SIKSDVFSFGILMLETLSGK 714
           S   D++  G ++ E  +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRI 677
           +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN +  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           V    +M+PE   + +++ +SDV+S+GIL+ E  S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 9e-10
 Identities = 32/93 (34%), Positives = 53/93 (56%)

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           Q LL +H      +IHRD+K++N+LL  +   K+ DFG ++M+         +   GT  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           Y++PE      +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
           +G+G FG V   +   +G+  AVK L  ++    +E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +  +K+  +L+Y+    L  F     ++     +AR    E IA  L YLH     
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  N+LLD   +  ++DFGL +   G E    T    GT  Y++PE      +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 695 SIKSDVFSFGILMLETLSG 713
               D +  G ++ E L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSSQS---GQGLEEFKNEMMLIAKLQ 567
           E+F+    LG G FG V      N     VA+KR         + ++   +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H   V L G   ++    L+LE++       FL     +R   +   V      AQ +L 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLI 143

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
                   I++RDLK  N+LLD D   K++DFG A++     +   T  + GT  Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198

Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             L+      +D ++ GI + E L G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 20/185 (10%)

Query: 538 QEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILE 589
           + VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
            M      V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++ 
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153

Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 710 TLSGK 714
            +  K
Sbjct: 211 MVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
           +G+G FG V    R  +G   AVK L  ++    +E  + M    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +  EK+  +L+Y+    L  F     ++  L  +AR    E +A  + YLH  +  
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  N+LLD   +  ++DFGL +   G E +  T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 695 SIKSDVFSFGILMLETLSG 713
               D +  G ++ E L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           IA GL +LH      II+RDLK  NV+LD + + KI+DFG+ +    D +   TK   GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             Y++PE      +    D ++FG+L+ E L+G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 20/185 (10%)

Query: 538 QEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILE 589
           + VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
            M      V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++ 
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160

Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 710 TLSGK 714
            + G 
Sbjct: 218 MIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLLYLH 629
           LV L  C        L++EY+    L   +F   ++R L  + AR    E I   L +LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPE 687
           +     II+RDLK  NVLLD D + K++D+G+ +  +  GD     T    GT  Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                 +    D ++ G+LM E ++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 61/236 (25%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------SQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +G G FG V+  R  +  +V A+K L        +Q      E   +++  A      +V
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADAD--SPWIV 64

Query: 573 KLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG------IAQG 624
           KL      Q E+ L  ++EYMP   L            +    R  +         IA+ 
Sbjct: 65  KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA--------RMFGGDELQGNTKR 676
           +L L    +   IHRD+K  N+L+D D + K++DFGL         R +  ++      R
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 677 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                               VGT  Y++PE      + ++ D +S G+++ E L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+G FG V    L   G+  AVK L          +E    E  ++A       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 577 CCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           C  +  E +  ++E++    L   + D  K R   ++A     E I  GL +LH      
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           II+RDLK  NV+LD D + KI+DFG+ +  +FG            GT  Y++PE      
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172

Query: 694 FSIKSDVFSFGILMLETLSGK 714
           ++   D +SFG+L+ E L G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLL 626
           H  LV L  C   +     ++EY+    L   +F   ++R L  + AR    E I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           YLH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y+
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYI 163

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D ++ G+LM E ++G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 49/230 (21%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ-SGQGL--EEFKNEMMLIAKLQHRNLVKLL 575
            +G+GG G VY     +  + VA+K++    S   L  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG--WQ---------------ARVTII 618
             C   G+   +   MP      ++   T K LL   WQ               A ++I 
Sbjct: 69  SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-----LQGN 673
             I   + Y+H  S+  ++HRDLK  N+LL +     I D+G A     +E     +  +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 674 TK-----------RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +           +IVGT  YM+PE  L    S  +D+++ G+++ + L+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
           I  GL Y+H  +   ++HRDLK  N+L++ D   KI DFGLAR F     E  G     V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
            T  Y +PE  L      K+ DV+S G ++ E L  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 14/222 (6%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R   +G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +     ++EY+    L    F  +++R+            I   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RDLK  N++LD D + KI+DFGL +   G       K   GT  Y++PE   D  +  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEDIKF 214

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 46/224 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM---------- 561
           E+F +   +G G FG V   R  + ++V A+K LS          K EM+          
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92

Query: 562 ---LIAKLQHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL--FDPTKKRLLGWQAR 614
              ++A      +V+L      Q +K L  ++EYMP   L   +  +D  +K    W AR
Sbjct: 93  ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGN 673
               E +   L  +H       IHRD+K  N+LLD   + K++DFG   +M     ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201

Query: 674 TKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSG 713
           T   VGT  Y+SPE       DG +  + D +S G+ + E L G
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 32/191 (16%)

Query: 533 RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE--- 589
           RL+  +  A  R + Q        +NE++ + +L H N++K+        E+IL  E   
Sbjct: 194 RLIAKRVKAGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANT 238

Query: 590 YMPNKSLDV----FLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK 642
           YM  +  D     F++D     K R L  Q R  I++ +   + Y+H     ++IHRD+K
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIK 294

Query: 643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVF 701
             N+ L+ D    + DFG A  F   E +      VGT    SPE  A DG   I +D++
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIW 352

Query: 702 SFGILMLETLS 712
           S G+++L+ LS
Sbjct: 353 SCGLILLDMLS 363

Length = 501

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           I+ GL +LH+     II+RDLK  NV+LD + + KI+DFG+ +  M  G      T+   
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      +    D +++G+L+ E L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 521 LGEGGFGPVYKG--------RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           LG+G F  ++KG          L+  EV +K L        E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              G CV   E I++ EY+   SLD +L        + W+  V   + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA--KQLAWALHFLEDKG 120

Query: 633 RFRIIHRDLKASNVLL-----DMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
              + H ++ A NVLL         NP   K+SD G++      E+    +RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSG 713
            PE   +    S+ +D +SFG  + E  SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +    +HRDL A NVLL      KI DFGLAR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D L++  SDV+S+GIL+ E  S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 38/118 (32%), Positives = 58/118 (49%), Gaps = 6/118 (5%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           I   L YLH  S   +++RDLK  N++LD D + KI+DFGL +   G +     K   GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             Y++PE   D  +    D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 215

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 51.8 bits (124), Expect = 1e-08
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)

Query: 338 GGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK-NCTCRAYANSNVTEGSGCLMW-F 395
               F++L N + P F  + ++   +L++CA++CL  NC+CR++  +N T   GCL+W  
Sbjct: 2   SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT--KGCLLWSE 58

Query: 396 GDLLDANRPTRNFTGQSVYIRV 417
             L DA        G  +Y ++
Sbjct: 59  SSLGDA--RLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIEGIAQGLL 626
           H  LV L  C   +     ++E++    L   +F   ++R L  + AR    E I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           +LH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYI 163

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D ++ G+LM E ++G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 18/211 (8%)

Query: 516 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHR 569
            +   +G+         + K +      VAVK+  L S S + L+  + E++   +LQH 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N++  +   +   E  ++   M   S +  L        L   A   I++ +   L Y+H
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQ----GNTKRIVGTYGYM 684
                  IHR +KAS++LL  D    +S    +  M    + Q       K  V    ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 685 SPEYALDGL--FSIKSDVFSFGILMLETLSG 713
           SPE     L  ++ KSD++S GI   E  +G
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 2/93 (2%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
            A+ L  L    +F +I+RDLK  N+LLD   +  + DFGL ++   D+ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             Y++PE  L   ++   D ++ G+L+ E L+G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 7/118 (5%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           I   L YLH      +++RD+K  N++LD D + KI+DFGL +    D      K   GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             Y++PE   D  +    D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 214

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 51/219 (23%)

Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGC- 577
           +G G FG VY+   ++  E VA+K++         ++KN E++++  L H N++ L    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128

Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLDVFLFDPTKKRLLGWQARVTI 617
              C ++ EK +    ++E++P             N +L +FL      +L  +Q     
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLAR-MFGGDELQGNTK 675
              + + L Y+H  S+F I HRDLK  N+L+D + +  K+ DFG A+ +  G   Q +  
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229

Query: 676 RIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
            I   + Y +PE  L    ++   D++S G ++ E + G
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           I   L YLH      +++RDLK  N++LD D + KI+DFGL +   G       K   GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
             Y++PE   D  +    D +  G++M E + G+     YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 51/222 (22%)

Query: 514 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL 566
           +F M   LG G FG V    +KG    G+  A+K L  +     + ++    E  ++ +L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 567 QHRNLVKLLGCCVEQGEKILILEYM---------------PNKSLDVFLFDPTKKRLLGW 611
            H  +V ++    ++     +LE++               PN   DV  F         +
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN---DVAKF---------Y 123

Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
            A + +         YLH      II+RDLK  N+LLD   + K++DFG A+     ++ 
Sbjct: 124 HAELVL------AFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVP 169

Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             T  + GT  Y++PE           D ++ G+L+ E ++G
Sbjct: 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           + +GL Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR     E        V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 681 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGK 714
             Y +PE  L   +   +I  DV+S G +  E L  K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 29/226 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQH 568
           E++ +   +G G FG V   R  + Q+V   +L S+           F  E  ++A    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 569 RNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQG 624
             +V+L   C  Q +K L  ++EYMP   L   +  +D  +K    W    T     A+ 
Sbjct: 103 PWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEV 151

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGY 683
           +L L       +IHRD+K  N+LLD   + K++DFG   +M     ++ +T   VGT  Y
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDY 209

Query: 684 MSPEY----ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
           +SPE       DG +  + D +S G+ + E L G  +T  Y ADS 
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 15/167 (8%)

Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           E+ ++  + HR ++ L+        K  +   MP    D+F +   +   L  +  +TI 
Sbjct: 136 EIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + + L YLH      IIHRD+K  N+ LD   N  + DFG A                
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 679 GTYGYMSPEY-ALDGLFSIKSDVFSFGILMLE------TLSGKKNTG 718
           GT    SPE  ALD  +  K+D++S G+++ E      TL GK+   
Sbjct: 249 GTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 8/100 (8%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVG 679
           IA+ +L +H   +   +HRD+K  NVLLDM+ + +++DFG   +M     +Q +    VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165

Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETLSGK 714
           T  Y+SPE   A++   G +  + D +S G+ M E L G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 13/198 (6%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
           +G+G FG V   R    ++  AVK L  ++    +E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
                  +   +L+Y+    L  F     ++  L  +AR    E IA  L YLH      
Sbjct: 63  FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           I++RDLK  N+LLD   +  ++DFGL +     E  G T    GT  Y++PE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 696 IKSDVFSFGILMLETLSG 713
              D +  G ++ E L G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 3/94 (3%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           IA+ +L L    ++ I++RDLK  N+LLD   +  + DFGL++    D    NT    GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159

Query: 681 YGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
             Y++PE  LD   ++   D +S G+L+ E   G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           ++G G FG V    +     VA   VK L ++ S +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKR----LLGWQARVTIIEGIAQGLLYLHQY 631
           G CVE    +L+ EY     L  +L      R    LL  Q        IA G+ ++H++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC---EIAAGVTHMHKH 118

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +    +H DL   N  L  D+  K+ D+G+    +  D ++    + V    +++PE   
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174

Query: 691 ---DGLFSIK----SDVFSFGILMLE 709
               GL + +    S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 8/100 (8%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVG 679
           +A+ +L +    +   +HRD+K  NVLLD + + +++DFG   R+     +Q N    VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETLSGK 714
           T  Y+SPE   A++   G +  + D +S G+ M E L G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 521 LGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRNLVKLL 575
           +G+G FG V    R L+G+  AVK L  +     +E K+ M    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRF 634
                  +   +L+++    L    F   ++R     +AR    E IA  L YLH     
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---I 115

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            I++RDLK  N+LLD   +  ++DFGL +   G      T    GT  Y++PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 695 SIKSDVFSFGILMLETLSG 713
               D +  G ++ E L G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 529 VYKGRLLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK- 584
           +YKG   N +EV ++            ++  +NE+  + ++   N++K+ G  ++  +  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 585 ---ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL 641
               LILEY     L   L    K++ L ++ ++ +     +GL  L++Y+     +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149

Query: 642 KASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS---IKS 698
            + + L+  +   KI   GL ++     L     + V    Y S +   D +FS   IK 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203

Query: 699 DVFSFGILMLETLSGK---KN---TGVYNA 722
           D++S G+++ E  +GK   +N     +Y+ 
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Length = 283

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A G+ +L   +    +HRDL A NVL+      KI DFGLAR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSG 713
             +M+PE   + L++  SDV+SFGIL+ E  TL G
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 6e-07
 Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 42/242 (17%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA-----KLQHRNLVKL 574
           K+G G FG V+  +    QE    +  + S +GL+E +   ++I      +L+H+N+V+ 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLG---WQARVTIIEGIAQGLLYLH 629
           +   + +  + L  ++E+     L   +    K  + G     A V I   +   L Y H
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCH 135

Query: 630 QY----SRFRIIHRDLKASNVLL---------------DMDMNP--KISDFGLARMFGGD 668
                 +  R++HRDLK  N+ L               +++  P  KI DFGL++  G  
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG-- 193

Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSGKKNTGVYNADSFN 726
            ++      VGT  Y SPE  L    S   KSD+++ G ++ E  SGK  T  + A++F+
Sbjct: 194 -IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNFS 250

Query: 727 LL 728
            L
Sbjct: 251 QL 252

Length = 1021

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 8/95 (8%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           + +GL Y+H  +   +IHRDLK SN+L++ D   +I DFG+AR       E +      V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 679 GTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 711
            T  Y +PE   +L   ++   D++S G +  E L
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 19/236 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   +L N  +V A+K L+        E   F+ E  ++    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           + +  L     ++    L+++Y     L + L    + RL    AR  +    A+ ++ +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIAI 115

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVGTYGYMSPE 687
               +   +HRD+K  N+L+DM+ + +++DFG   ++     +Q +    VGT  Y+SPE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPE 173

Query: 688 Y--ALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              A++   G +  + D +S G+ M E L G+  T  Y        G + N    F
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 13/146 (8%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCC 578
            L  G    VY       ++  +K   S+      E +  ++ +   +    V K+L   
Sbjct: 5   LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
              G   L++E++  ++LD              + +  I E +A+ L  LHQ     + H
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 639 RDLKASNVLLDMDMNPKISDFGLARM 664
            DL   N+L+D      I D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 37/97 (38%), Positives = 47/97 (48%), Gaps = 10/97 (10%)

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVGTY 681
           + L Y+H  + F   HRDLK  N+L + D   KI DFGLAR  F            V T 
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 682 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSGK 714
            Y +PE  L G F  K     D++S G +  E L+GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)

Query: 557 KNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
           ++E+  +A   H  +VK         + +LI+EY     L+  +    K+ L   +  V 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
           ++    Q +L L +    +++HRDLK++N+ L      K+ DFG ++ +           
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             GT  Y++PE      +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 16/102 (15%)

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM---------FGG----DELQ 671
           L YLH Y    I+HRDLK  N+L+    + K++DFGL+++         + G    D  +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              K++ GT  Y++PE  L   +    D ++ GI++ E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 24/141 (17%)

Query: 586 LILEYMPNKSLDVFL------FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           L++EY P   L   L      FD    +             +A+ +L +H   +   +HR
Sbjct: 78  LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126

Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--ALDG----L 693
           D+K  NVL+D   + K++DFG A     +++  N+K  VGT  Y++PE    ++G     
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 694 FSIKSDVFSFGILMLETLSGK 714
           + ++ D +S G++  E + G+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           L++++ H +L  + G CV   E I++ E++ +  LDV L     +  + W  ++T+ + +
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVL-----LDMDMNP--KISDFGLARMFGGDELQGNT 674
           A  L YL   +   ++H ++ A N+L     L    +P  K+SD G++  F     +   
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181

Query: 675 KRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
           +RI     +++PE    G   S  +D +SFG  +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 37/230 (16%)

Query: 513 ENFSMQCKLGEGGFG-----------PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMM 561
           E++ +   +G G FG            VY  +LL+  E+ +KR  S        F  E  
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF------FWEERD 95

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIE 619
           ++A      +V+L     +     +++EYMP   L   +  +D  +K    W    T   
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT--- 148

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
             A+ +L L        IHRD+K  N+LLD   + K++DFG       + +       VG
Sbjct: 149 --AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVG 205

Query: 680 TYGYMSPEY----ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
           T  Y+SPE       DG +  + D +S G+ + E L G  +T  Y ADS 
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 9e-06
 Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 60/240 (25%)

Query: 521 LGEGGFGPVYKGRL----LNGQEVAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLV 572
           +G G FG V   RL      G   A+K+L      +  Q +   + E  ++A+  +  +V
Sbjct: 9   IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64

Query: 573 KLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLH 629
           KL      Q E    LI+EY+P   +   L    KK      + R  I E I    L + 
Sbjct: 65  KLY--YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI----LAID 115

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGL------------ARMFGGD--------- 668
              +   IHRD+K  N+LLD   + K+SDFGL             R+             
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 669 -------ELQGNTKR--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                        KR         VGT  Y++PE  L   ++ + D +S G++M E L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 8/156 (5%)

Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           E  ++  + H ++++L G         LIL   P    D++ +   K+ +      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + + + YLH+    RIIHRD+KA N+ ++   +  + DFG A  F  D          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT    +PE      +    D++S GI++ E  +  
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 15/149 (10%)

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLL 626
           + N +KL          +LI++Y+     D  LFD  KK   L       II  + + L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            LH++    IIH D+K  NVL D   +   + D+GL ++ G            GT  Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE      + +  D ++ G+L  E L+GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 95/270 (35%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH 568
           E+F     +G+G FG V   RL+     G+  A+K L           K+EM    +L H
Sbjct: 1   EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAH 47

Query: 569 ----RNL---------VKLLGCCVEQGEKILILEYMPNKSL-------DVFLFDPTKKRL 608
               R++         V L     +     LI+E++P   L       D F  D T+   
Sbjct: 48  VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY- 106

Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA------ 662
                       +A+ +L +    +   IHRD+K  N+L+D   + K+SDFGL+      
Sbjct: 107 ------------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154

Query: 663 -------RMFGGDELQ-GNTKR-------------------------------IVGTYGY 683
                  ++  G   +     R                                VGT  Y
Sbjct: 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE  L   +  + D +S G +M E L G
Sbjct: 215 IAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 21/173 (12%)

Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
           +E  L+ +L H  ++ LL   V  G   L+L   P    D++ +   + R LG  A+VT 
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLG-LAQVT- 263

Query: 618 IEGIAQGLL----YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
              +A+ LL    Y+H      IIHRD+K  NVL++   +  + DFG A    G      
Sbjct: 264 --AVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFN 726
              I GT    +PE      ++   D++S G+++ E         V+ A  F+
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE-------AAVHTASLFS 364

Length = 461

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 40/222 (18%)

Query: 517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           +Q ++G G      VY  R    G  V V+   L + + + L+  +NE++L    +H N+
Sbjct: 2   LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61

Query: 572 VKLLGCCVEQGEKILILEYMP----NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           +             +I  +M     N  L  +  +   + L+G      I+ G  +GL Y
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNY 116

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-----QGNTKRIVGTYG 682
           LHQ      IHR++KAS++L        IS  GL  + G   L      G   ++V  + 
Sbjct: 117 LHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165

Query: 683 --------YMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
                   ++SPE     L  +++KSD++S GI   E  +G+
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 55/243 (22%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V     ++   + A+K L  +   +   +   K E  ++A+  +  +VKL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              ++     +++Y+P   +   L      R+  +   +     IA+  L +    +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFY-IAELTLAIESVHKMGF 122

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFG------------------------------ 666
           IHRD+K  N+L+D+D + K++DFGL   F                               
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 667 ---GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              GD L+   +R            +VGT  Y++PE  L   ++   D +S G+++ E L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 712 SGK 714
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 32/167 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E F +   +  G FG VY GR   N +  AVK +         +  N+ M+      R+ 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDA 57

Query: 572 VKL--------LGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTI 617
           + L        L   ++    + L++EY+    +   L     FD         +  V  
Sbjct: 58  LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
           I  +A  L YLH++    IIHRDLK  N+L+  + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 49/241 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEE---FKNEMMLIAK 565
           E+F     +G G FG V   RL+     G   A+K L        E+    + E  ++ +
Sbjct: 1   EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
                +VK+     ++    LI+E++P   +   L    KK  L  +     I   A+ +
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETV 111

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---------------- 669
           L +    +   IHRD+K  N+LLD   + K+SDFGL                        
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 670 -LQG-NTKR---------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             Q  N+KR                VGT  Y++PE  +   ++   D +S G++M E L 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 713 G 713
           G
Sbjct: 232 G 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 44/161 (27%), Positives = 64/161 (39%), Gaps = 39/161 (24%)

Query: 586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
           LI+E++P   +   L    KK  L  +A    I      +  +HQ      IHRD+K  N
Sbjct: 78  LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131

Query: 646 VLLDMDMNPKISDFGLARMFGGDE-----------------LQG-NTKR----------- 676
           +LLD   + K+SDFGL                          Q  N+KR           
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 677 ----IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                VGT  Y++PE  +   ++   D +S G++M E L G
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 44/216 (20%)

Query: 521 LGEGGFGPVYKGRLL-----------NGQEVAV--KRL-SSQSGQGLEEFKNEMMLIAKL 566
           LG G    +Y G L              +E+ V  K L  S     L  F+   M+  ++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMM-RQV 61

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            H+++V L G CV   E I++ E++    LD+F+   +      W+ +V   + +A  L 
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA--KQLASALS 119

Query: 627 YLHQYSRFRIIHRDLKASNVLL-----DMDMNP--KISDFG-----LARMFGGDELQGNT 674
           YL       ++H ++   N+LL     D +  P  K+SD G     L+R       Q   
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECV 169

Query: 675 KRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLE 709
           +RI     +++PE   D    SI +D +SFG  + E
Sbjct: 170 ERI----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 39/227 (17%)

Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLL 575
            LG+G  G V+  RL   G+  A+K L  +      + K    E  ++A L H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
                +    L+++Y P   L   L     K L    AR    E +   L YLH      
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLA-----------RMFGGDELQGNTKRI------- 677
           I++RDLK  N+LL    +  +SDF L+           +       + +   I       
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 678 ---------VGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETLSG 713
                    VGT  Y++PE  + DG   ++  D ++ GIL+ E L G
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 8/78 (10%)

Query: 521 LGEGGFGPVYK------GRLLNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +      G+  N   VAVK L +S      E   +E+ +++ L QH+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 573 KLLGCCVEQGEKILILEY 590
            LLG C   G  ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 55/243 (22%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V   R ++ + + A+K L  +       +   K E  ++A+  +  +V+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              ++     +++Y+P   +   L      R+  +   +     IA+    +    +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122

Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFG------------------------------ 666
           IHRD+K  N+L+D D + K++DFGL   F                               
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 667 ---GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              GD L+   +R            +VGT  Y++PE  L   ++   D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 712 SGK 714
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|185490 PTZ00163, PTZ00163, hypothetical protein; Provisional

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 10/84 (11%)

Query: 111 TNVFSEVKNPVAQLRD-------DGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMG 163
           T++FS  KNP  + R        D   V  DN+  N  E+++  S D P D L   M   
Sbjct: 62  TSIFSGNKNPQKRERKNEEENQKDNTKVDNDNNMENEMENHIDDSIDDPMDDL---MNDK 118

Query: 164 WDLKNRLERYLSSWQSDDDPSPGK 187
           W+  N LE  +  + +  DPS G+
Sbjct: 119 WEHHNSLEDRIKEYYTLTDPSDGE 142

Length = 230

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 55/241 (22%)

Query: 521 LGEGGFGPVYKGRLLNGQEV-AVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +G G FG V   R ++   + A+K L              K E  ++A+  +  +VKL  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 577 CCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
              ++     +++Y+P   +   L      ++ L    AR  I E +   +  +H   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH---KM 120

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMF-----------GG----------DELQGN 673
             IHRD+K  N+L+D D + K++DFGL   F           G           +E    
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 674 TKR--------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            +                     +VGT  Y++PE  L   ++   D +S G+++ E L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 714 K 714
           +
Sbjct: 241 Q 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	744
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.98
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.98
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
PLN00181	793	protein SPA1-RELATED; Provisional	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
PRK10345	210	hypothetical protein; Provisional	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.72
smart00090	237	RIO RIO-like kinase.	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.63
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.5
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.34
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.09
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.01
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.73
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.56
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.51
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.5
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.43
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.35
PRK09902	216	hypothetical protein; Provisional	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.26
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
COG4248	637	Uncharacterized protein with protein kinase and he	98.23
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.07
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.06
PF01636	239	APH: Phosphotransferase enzyme family This family	98.05
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.05
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.88
PRK10593	297	hypothetical protein; Provisional	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.78
PLN02876	822	acyl-CoA dehydrogenase	97.77
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.76
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.55
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.32
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.18
PRK05231	319	homoserine kinase; Provisional	97.06
KOG2270	520	consensus Serine/threonine protein kinase involved	96.85
PLN02236	344	choline kinase	96.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.8
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.68
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.67
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.61
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.61
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.03
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.81
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.78
PLN02756	418	S-methyl-5-thioribose kinase	95.5
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.48

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=388.28  Aligned_cols=231  Identities=47%  Similarity=0.782  Sum_probs=202.4

Q ss_pred             CCCcccHHHHHHHhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEE
Q 004580          499 WLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC  578 (744)
Q Consensus       499 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~  578 (744)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999988999999988765433156699999999999999999999999


Q ss_pred             EEcC-eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          579 VEQG-EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||....++|||||||++|||||++.++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999875544 88999999999999999999999998899999999999999999999999


Q ss_pred             eecCceecCCCccccCcccc-cccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CCccccccccc
Q 004580          658 DFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN-ADSFNLLGYVS  732 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~-~~~~~l~~~~~  732 (744)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .+..++..|++
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999765431  1111112 79999999999999999999999999999999999999888654 44444666653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=359.62  Aligned_cols=203  Identities=30%  Similarity=0.547  Sum_probs=183.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .+|++.+.||+|+|++||+|+++ ++..||||.+...  ..+..+.+..|+++|+.++|||||++++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            67888899999999999999875 4789999998765  66777889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC------CceEEEeecCce
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD------MNPKISDFGLAR  663 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~------~~~kL~DFGla~  663 (744)
                      ||.+|+|..|++   ..+.+++..++.++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999994   4557999999999999999999999998   9999999999999865      358999999999


Q ss_pred             ecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .+.+...   ....+|++-|||||++....|+.|+|+||.|+||||+++|+.||+.....+
T Consensus       164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            9875432   345799999999999999999999999999999999999999999655443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=345.18  Aligned_cols=222  Identities=28%  Similarity=0.384  Sum_probs=193.3

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .++|+++++||+|+||+||.++..+ ++.+|+|++++.   .....+...+|..+|.+++||.||+++..|++++.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999997654 889999999865   334567788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +||+.||.|..+|   ++.+.+++..++.++.+|+.||.|||+.+   ||||||||+|||||++|+++|+|||+++.-..
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999998   56677899999999999999999999998   99999999999999999999999999996433


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccc-cccccccc
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS-LHFYLIFS  743 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~-~~f~~~~~  743 (744)
                      ..  ..+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+...  +.+.+.+.- ...+..+|
T Consensus       178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--~~~~I~~~k~~~~p~~ls  250 (357)
T KOG0598|consen  178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--MYDKILKGKLPLPPGYLS  250 (357)
T ss_pred             CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--HHHHHhcCcCCCCCccCC
Confidence            32  23455899999999999999999999999999999999999999998766444  666666666 33333344

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-40  Score=356.16  Aligned_cols=221  Identities=29%  Similarity=0.421  Sum_probs=197.2

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ..|+..+.||+|+|+.||+++. ..|+.||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5788999999999999999987 67999999998653   4556788999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      |+|++++|..++   +....+++.+++.+..||+.||.|||+++   |||||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999988   46678999999999999999999999998   999999999999999999999999999998755


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      .-  ...+.+|||.|+|||++....++..+||||+|||+|.||+|++||+..+-.+  .+.-|......||..+|
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--ty~~Ik~~~Y~~P~~ls  242 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--TYNKIKLNEYSMPSHLS  242 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--HHHHHHhcCcccccccC
Confidence            32  3345899999999999999999999999999999999999999999876544  66666666666666554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=322.15  Aligned_cols=219  Identities=30%  Similarity=0.417  Sum_probs=200.6

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .++|++++.||.|+||.|.+++.+ +|..+|+|++++..   ..+.+...+|..+|+.+.||.++++.+.+.+.+..++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            368999999999999999999875 48899999998653   34566778999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++|.|.++|   .+.+.+++..++.+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999999   46667999999999999999999999998   99999999999999999999999999998644


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                           .+.+.+|||.|+|||++..+.+..++|.|||||++|||+.|.+||...++  ..+.+.|.....+||.+||
T Consensus       197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhCcccCCcccC
Confidence                 35568999999999999999999999999999999999999999988777  5599999999999999887

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=347.66  Aligned_cols=205  Identities=37%  Similarity=0.623  Sum_probs=178.5

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-eEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-EKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E  589 (744)
                      +++.+.+.||+|+||+||+|.+.....||||++....  ....++|.+|+.+|.+++|||||+++|+|.++. ...+|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            3445566799999999999998544459999997653  222669999999999999999999999999887 7999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~~~~  668 (744)
                      ||++|+|..+|+.. ....+++..+++++.|||+||.|||++.+  ||||||||+|||++.+. ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999764 46789999999999999999999999873  99999999999999997 9999999999876543


Q ss_pred             ccccCcccccccccccCccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      .  .......||+.|||||++.  ...|+.|+|||||||+||||+||+.||.....
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            2  2223368999999999999  56999999999999999999999999988775

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-40  Score=332.65  Aligned_cols=218  Identities=30%  Similarity=0.410  Sum_probs=188.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-eEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-EKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E  589 (744)
                      .+++.++.||+|..|+|||++++ .++.+|+|.+... .+...+++.+|++++++.+||+||.++|+|+... ...++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            45666789999999999999886 4788999999544 5566788999999999999999999999999998 5999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||++|+|+.++.   ..+.+++...-+++.++++||.|||. ++   ||||||||+|||++..|++||+|||.++.+.+.
T Consensus       159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999984   33668999999999999999999996 54   999999999999999999999999999987654


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CCcccccccccc-ccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN---ADSFNLLGYVSN-KSLHFYL  740 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~---~~~~~l~~~~~~-~~~~f~~  740 (744)
                          .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....   .+-.++...|.. ....+|.
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~  304 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE  304 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence                2344789999999999999999999999999999999999999998863   355666666666 4444444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=339.38  Aligned_cols=203  Identities=37%  Similarity=0.568  Sum_probs=180.6

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      +.++..+.||+|.||.|+.|++.....||+|.++.. ....++|.+|+.+|++|+|+|||+++++|..++.++||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            445667899999999999999977779999999765 3445789999999999999999999999999889999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      .|+|.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+.+..+.+..
T Consensus       285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999975 34567889999999999999999999998   9999999999999999999999999999766665543


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .. ...-+..|.|||.+..+.|+.|+|||||||+||||+| |+.|++.+.
T Consensus       361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms  409 (468)
T KOG0197|consen  361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS  409 (468)
T ss_pred             cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence            32 2345779999999999999999999999999999999 888987765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-40  Score=319.80  Aligned_cols=218  Identities=27%  Similarity=0.413  Sum_probs=185.0

Q ss_pred             cCcccccccCccCceEEEccc-ccccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEE-EEEEcCe-EEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLG-CCVEQGE-KILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~-~~~~~~~-~~lV  587 (744)
                      .+|+++++||+|+||.|||+. +.+|..+|.|.+.-.  +....+++..|+.+|++|+|||||++++ -+.+..+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            578999999999999999996 467999999988633  4566778999999999999999999998 4444444 8899


Q ss_pred             EEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR-FRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~-~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      |||+..|+|...+... +..+.+++..+++++.|+++||..+|+.-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999988653 345678999999999999999999998421 13999999999999999999999999999998


Q ss_pred             CCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccc
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNK  734 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~  734 (744)
                      .....  .....+|||.||+||.+.+..|+.|+||||+||++|||..-++||...+-.+  +-..|.+.
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--L~~KI~qg  243 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--LCKKIEQG  243 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH--HHHHHHcC
Confidence            76532  3345799999999999999999999999999999999999999998874332  44445554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=335.34  Aligned_cols=227  Identities=29%  Similarity=0.404  Sum_probs=198.2

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~  584 (744)
                      ....+|...+.||+|+|++|++|+.. .++++|||++.+.   .+.-.+-...|-.+|.+| .||.|++|+..|++...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34478999999999999999999754 5899999998654   233345567888899999 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      |+|+||+++|+|..+|.   +-+.+++...+.++.+|+.||+|||++|   ||||||||+|||||.++++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999994   5577999999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCccc---------cCc--ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccc
Q 004580          665 FGGDELQ---------GNT--KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN  733 (744)
Q Consensus       665 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~  733 (744)
                      +.+....         ...  ...+||..|.+||++.+...++.+|+|+||||||+|+.|++||...++=-  +.+-|..
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--iFqkI~~  301 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--IFQKIQA  301 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--HHHHHHH
Confidence            8653222         111  34799999999999999999999999999999999999999999877655  8888888


Q ss_pred             ccccccccccC
Q 004580          734 KSLHFYLIFSE  744 (744)
Q Consensus       734 ~~~~f~~~~~~  744 (744)
                      .+..||+-|++
T Consensus       302 l~y~fp~~fp~  312 (604)
T KOG0592|consen  302 LDYEFPEGFPE  312 (604)
T ss_pred             hcccCCCCCCH
Confidence            88888887653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-38  Score=353.27  Aligned_cols=219  Identities=32%  Similarity=0.503  Sum_probs=189.2

Q ss_pred             HhcCcccccccCccCceEEEccccc------ccceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      .+.+.+..+.||+|+||+||+|+..      +...||||.+++.... ..++|++|+++++.++|||||+|+|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456677789999999999999753      2457999999987655 78899999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC-------C----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC
Q 004580          584 KILILEYMPNKSLDVFLFDPT-------K----KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM  652 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~  652 (744)
                      .++|+|||..|+|.+||....       .    ..+++..+.+.||.|||.||+||-++.   +|||||.++|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999995321       1    334889999999999999999999987   99999999999999999


Q ss_pred             ceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccccccc
Q 004580          653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYV  731 (744)
Q Consensus       653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~~~~~l~~~~  731 (744)
                      .+||+|||+++.+...++........-+.+|||||.|..+.||+++|||||||+|||+++ |+.|+.....++  .++.+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i  718 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECI  718 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHH
Confidence            999999999998877666554434456789999999999999999999999999999999 888987776555  45554


Q ss_pred             ccc
Q 004580          732 SNK  734 (744)
Q Consensus       732 ~~~  734 (744)
                      .+.
T Consensus       719 ~~g  721 (774)
T KOG1026|consen  719 RAG  721 (774)
T ss_pred             HcC
Confidence            443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=326.49  Aligned_cols=218  Identities=27%  Similarity=0.410  Sum_probs=180.9

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCCCh-------hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSG-------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-------~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      .+.|.+.+.||+|+||.|-+|.. .+|+.||||++++...       .......+|+++|++|+|||||++.+++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            46788889999999999999965 4699999999976421       123346799999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC---CceEEEeec
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFG  660 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~---~~~kL~DFG  660 (744)
                      .|+|||||++|.|-+++.   .++.+.+..-..+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999988873   4556777888899999999999999998   9999999999999766   679999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccc
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLH  737 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~  737 (744)
                      +|+.....   ..+.+.+||+.|.|||++..+.   +..++|+||+||+||-+|+|-+||...-.+ ..+.+-|.+...+
T Consensus       325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLKEQILKGRYA  400 (475)
T ss_pred             hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHHHHHhcCccc
Confidence            99987543   3456689999999999998764   335889999999999999999999764322 2355555555555


Q ss_pred             cc
Q 004580          738 FY  739 (744)
Q Consensus       738 f~  739 (744)
                      |-
T Consensus       401 f~  402 (475)
T KOG0615|consen  401 FG  402 (475)
T ss_pred             cc
Confidence            53

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=335.22  Aligned_cols=224  Identities=25%  Similarity=0.399  Sum_probs=199.1

Q ss_pred             HHHhcCcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCe
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE  583 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~  583 (744)
                      ....++|.++++||+|+||+|+++..+. ++.+|||.+++.   .....+..+.|.+++.... ||.++.++..++..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3455899999999999999999998754 789999999876   3455677888888888775 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      +++||||+.||++..+    ...+.+++..++.++..|+.||.|||+++   |||||||.+|||||.+|++||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999994333    34567899999999999999999999998   9999999999999999999999999999


Q ss_pred             ecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      .-....  ..+.+.+||+.|||||++.+..|+..+|.|||||+|||||.|+.||...++++  +.+.|.+....||..+|
T Consensus       517 e~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--~FdsI~~d~~~yP~~ls  592 (694)
T KOG0694|consen  517 EGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--VFDSIVNDEVRYPRFLS  592 (694)
T ss_pred             ccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHhcCCCCCCCccc
Confidence            754322  35567899999999999999999999999999999999999999999888777  99999999999998876

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.7e-37  Score=322.40  Aligned_cols=208  Identities=27%  Similarity=0.396  Sum_probs=182.3

Q ss_pred             HhcCcccccccCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..++|+++++||+|+||.||+++.++ |..+|+|+|++..   ....+..+.|-.+|....+|.||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            55899999999999999999998654 8999999998763   3455668889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+|||++..+|   .+.+.|++..++.++.+.+-|++.||+.+   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999998   56778999999999999999999999998   9999999999999999999999999986442


Q ss_pred             C----------------------Ccccc-----Cc------------------ccccccccccCcccccCCCCCchhhHH
Q 004580          667 G----------------------DELQG-----NT------------------KRIVGTYGYMSPEYALDGLFSIKSDVF  701 (744)
Q Consensus       667 ~----------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~s~k~Dvw  701 (744)
                      .                      .+...     .+                  ...+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      00110     00                  124799999999999999999999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCCc
Q 004580          702 SFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       702 SlGviL~elltG~~p~~~~~~~~  724 (744)
                      |||||+||||.|-+||...+..+
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~  395 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE  395 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999998877555

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=326.73  Aligned_cols=217  Identities=28%  Similarity=0.426  Sum_probs=186.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|-+.+.||+|+||.||||+-+ +.+.||+|.+.+.  .++..+.+.+|++++++++|||||.+++.|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56788899999999999999754 5789999988654  45667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+.+ +|..+|   .....++++.++.++.++..||.|||+..   |+|||+||+|||++.++.+|++|||+|+.+..+.
T Consensus        82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 999988   45567999999999999999999999987   9999999999999999999999999999876543


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                        .....+.|||-|||||...+.+|+..+|+||+||||||+++|++||-..+-  ..+...|...+.+.|.
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I~~d~v~~p~  221 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSILKDPVKPPS  221 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHHhcCCCCCcc
Confidence              233457899999999999999999999999999999999999999865432  2244444444444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-37  Score=304.56  Aligned_cols=204  Identities=25%  Similarity=0.354  Sum_probs=177.6

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      +.|+.+.++|+|+||+|||++.++ |+.||||++.+..  +.-.+-..+|+++|++++|||+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            568888999999999999999865 9999999997643  3334556899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |++..-|+++-   .....++...+.+++.|+++|+.|+|+++   ||||||||+||||+.++.+||+|||+|+.+....
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99988777654   33445888999999999999999999998   9999999999999999999999999999886321


Q ss_pred             cccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                        ...+..+.|.-|+|||.+.+ ..|+..+||||.||++.||++|++.|...++-+
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD  209 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID  209 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence              22344678999999999987 689999999999999999999999998776533

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=324.50  Aligned_cols=222  Identities=27%  Similarity=0.432  Sum_probs=192.0

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCC----Ch-hhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ----SG-QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~----~~-~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~  583 (744)
                      ..++|.+.+.||+|+||.|+.|+. ..++.||+|++...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            347899999999999999999975 45899999976553    12 33556778999999999 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeecCc
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLA  662 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFGla  662 (744)
                      .++||||+.+|+|.+++..   .+.+.+.++.+++.||+.|++|||+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999843   566888999999999999999999998   9999999999999999 99999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      .....  ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.  .+...+...+.+....||.
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~  244 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPS  244 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCC
Confidence            98741  122345579999999999999877 75 789999999999999999999998  4444477778888888888


Q ss_pred             cc
Q 004580          741 IF  742 (744)
Q Consensus       741 ~~  742 (744)
                      .+
T Consensus       245 ~~  246 (370)
T KOG0583|consen  245 YL  246 (370)
T ss_pred             Cc
Confidence            76

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-36  Score=315.08  Aligned_cols=205  Identities=29%  Similarity=0.416  Sum_probs=174.7

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI  585 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~  585 (744)
                      ..+.|+.+++||+|.||.||+|+. .+|+.||+|+++-..  +....-..+||.+|++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346788899999999999999985 458999999987653  33445567899999999999999999999887  6899


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      ||+|||+.. |.-++.  ...-.+++.++..+++||+.||+|+|+.+   |+|||||..|||||.+|.+||+|||||+.+
T Consensus       195 lVFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            999999864 444442  23345899999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ....... .+..+-|.-|.|||.+.+. .|+.++|+||.||||.||+.|++.|....+
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE  325 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE  325 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence            7655433 3345679999999999875 699999999999999999999999877653

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=321.57  Aligned_cols=212  Identities=30%  Similarity=0.473  Sum_probs=185.7

Q ss_pred             HHHhcCcccccccCccCceEEEcccccccceeEEEeccCCChhh-HHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +...+...+.++||+|-||+|.++....+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            34456777889999999999999998777999999999875544 58999999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +|||++|+|.+||..++... +......+|+.||+.||+||.+..   +|||||.++|+|++.++++||+|||+++.+..
T Consensus       614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999997654333 455666789999999999999987   99999999999999999999999999998877


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYNADS  724 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt--G~~p~~~~~~~~  724 (744)
                      .++.....+.+-+.+|||||.+.-+.+++++|||+||+.+||+++  .++||....++.
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~  748 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ  748 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence            666655556677899999999999999999999999999999765  778887766443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=311.61  Aligned_cols=203  Identities=31%  Similarity=0.475  Sum_probs=172.3

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC--eEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG--EKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E  589 (744)
                      .++...+.||+|+||.||++...+ |+..|||..........+.+.+|+.+|.+++|||||+.+|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456677899999999999998654 8999999886653333778999999999999999999999855444  6899999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCC-
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGG-  667 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~-  667 (744)
                      |+++|+|.+++.....  .+++..++.+..||++||+|||+++   ||||||||+|||++. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999854322  6999999999999999999999998   999999999999999 79999999999998764 


Q ss_pred             CccccCcccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ...........||+.|||||++..+. ...++|||||||++.||+||++||...
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            11112234578999999999999643 345999999999999999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-36  Score=320.53  Aligned_cols=220  Identities=28%  Similarity=0.403  Sum_probs=191.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .-|++.+.||+|+-|.|-.|++. .|+.+|||++.+.   .......+.+|+.+|+.+.||||+++++++.+..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45778899999999999999875 5999999998655   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|-|..++   ..++.+++.++.+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+..++
T Consensus        92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999998888   56778999999999999999999999998   999999999999999999999999999875443


Q ss_pred             ccccCcccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      .   ...+.||++.|.|||++.+.+|. .++||||.|||||.||||+.||+..+-+.  |+..+.+...++|..+|
T Consensus       166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LLlKV~~G~f~MPs~Is  236 (786)
T KOG0588|consen  166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LLLKVQRGVFEMPSNIS  236 (786)
T ss_pred             c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HHHHHHcCcccCCCcCC
Confidence            2   34457999999999999999884 89999999999999999999999555433  66677777777766554

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=317.99  Aligned_cols=205  Identities=33%  Similarity=0.495  Sum_probs=179.1

Q ss_pred             ccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCC
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS  595 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs  595 (744)
                      ..++=||.|+.|.||+|++ .++.||||+.+...       ..+++-|++|+||||+.+.|+|.....++||||||..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3456899999999999998 56899999986432       357888999999999999999999999999999999999


Q ss_pred             hhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcc
Q 004580          596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK  675 (744)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  675 (744)
                      |...|   ...+++.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||-++.....   ....
T Consensus       199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            99999   45567888889999999999999999997   999999999999999999999999999986543   2233


Q ss_pred             cccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccc
Q 004580          676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFY  739 (744)
Q Consensus       676 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~  739 (744)
                      .++||..|||||+|...+.+.|+|||||||||||||||..||...  +.-.++.-+-.++.|++
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV--dssAIIwGVGsNsL~Lp  331 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV--DSSAIIWGVGSNSLHLP  331 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc--chheeEEeccCCccccc
Confidence            479999999999999999999999999999999999999997644  44447777777777665

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=327.53  Aligned_cols=206  Identities=32%  Similarity=0.535  Sum_probs=179.0

Q ss_pred             cCcccccccCccCceEEEcccccc----cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ....|.++||.|.||.|++|+++-    ...||||.|+.. .++...+|..|..+|.++.||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456678999999999999998753    357999999876 567788999999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +|||++|+|+.||....  +.+.+.++..+.++||.||+||.+++   +|||||.++|||++.+..+|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999997544  45889999999999999999999998   99999999999999999999999999998865


Q ss_pred             CccccCcccccc--cccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCC-CCCCCCc
Q 004580          668 DELQGNTKRIVG--TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNT-GVYNADS  724 (744)
Q Consensus       668 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~-~~~~~~~  724 (744)
                      +. .......-|  +.+|.|||.|....++.++|||||||++||.++ |.+|| +..+.|.
T Consensus       784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            54 222222222  579999999999999999999999999999888 99986 5554443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=316.85  Aligned_cols=198  Identities=32%  Similarity=0.494  Sum_probs=179.0

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ..|...++||+|+-|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||+++..|...++++.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4566678999999999999964 458899999997766566677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++|+|.+.+    ....+++.++..|.+++++||+|||.++   |||||||.+|||++.++.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999998886    4445899999999999999999999998   99999999999999999999999999998876654 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                       .....+||+.|||||++....|++|.||||||++++||+-|++||-.
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence             33457999999999999999999999999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=340.02  Aligned_cols=208  Identities=36%  Similarity=0.588  Sum_probs=182.2

Q ss_pred             hcCcccccccCccCceEEEcccccc--cc----eeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++.+..+.||+|.||.||+|...+  +.    .||||.+++. +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4566777899999999999997643  33    4899999875 567788999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          585 ILILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ++++|||++|+|..||.+.+    ....+...+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997642    2456889999999999999999999997   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      +|+.+...++........-+.+|||||.+.++.|+.|+|||||||+|||++| |..||...+.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n  910 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN  910 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence            9997766655544444445679999999999999999999999999999999 8889877653

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=306.54  Aligned_cols=197  Identities=33%  Similarity=0.533  Sum_probs=169.6

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHH--hcCCCeeeEEEEEEEcC----eEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK--LQHRNLVKLLGCCVEQG----EKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~--l~HpnIv~l~~~~~~~~----~~~l  586 (744)
                      +..++.++||+|+||.||||++ +++.||||++.   .+..+.|++|-.+...  ++|+||++++++-....    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            4566778999999999999998 45999999995   4455677777776655  57999999999987665    8999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY------SRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      |+||.+.|+|.++|    +...++|.+..+|+..+++||+|||+.      .+++|+|||||++||||.+++++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    556789999999999999999999963      35789999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCC-CC-----chhhHHHHHHHHHHHHcCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DvwSlGviL~elltG~~p~  717 (744)
                      +|..+............+||.+|||||++.+.. +.     .+.||||+|.|||||++.-.-+
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            999998766666666689999999999997653 22     4689999999999999977644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=315.91  Aligned_cols=211  Identities=33%  Similarity=0.536  Sum_probs=179.2

Q ss_pred             HHHHHHhcCcccccccCccCceEEEcccccccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       506 ~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      .+.....+.+.+.+.||+|+||+||+|++.  ..||||++...  .....+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344445567788899999999999999984  46999999765  45578899999999999999999999999988877


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                       .||+.++++.+|..+||..+  ..++..+.+.|+.||++||.|||.++   |||||||..||+|.+++++||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999998644  56888999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCccccCcccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .-..-.-........|..-|||||+++.   .+|+.++||||||+++|||++|.-||...+.|.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq  600 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ  600 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence            6433211122233457778999999964   579999999999999999999999999555443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-35  Score=284.55  Aligned_cols=202  Identities=30%  Similarity=0.454  Sum_probs=174.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChh--hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|..++.||+|.||.||+|++. .|+.||||+++.....  ......+|++.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999864 5899999999765322  23456899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      ||+ .+|...+.+  +...+...++..++.++++|++|||++.   |+||||||+|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            996 467777754  4557899999999999999999999998   9999999999999999999999999999987654


Q ss_pred             cccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ....  ..+-|.-|.|||.+.+. .|+...|+||.|||+.||+-|.+-|...++
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            2222  23678899999999875 699999999999999999999998876653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=301.48  Aligned_cols=210  Identities=29%  Similarity=0.482  Sum_probs=171.4

Q ss_pred             CCCCCCCCCcccHHHHHHHhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHH--HhcCCC
Q 004580          493 DKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA--KLQHRN  570 (744)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~--~l~Hpn  570 (744)
                      .+++.+.+|.+-..++   ..+..+.+.||+|.||+||+|++ .|+.||||++...++   +.+.+|.++.+  .|+|+|
T Consensus       194 tSGSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHEN  266 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHEN  266 (513)
T ss_pred             cCCCCCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccch
Confidence            3455566776654444   46888999999999999999998 689999999976544   34555555544  569999


Q ss_pred             eeeEEEEEEEcC----eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEecC
Q 004580          571 LVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-----YSRFRIIHRDL  641 (744)
Q Consensus       571 Iv~l~~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~IiHrDL  641 (744)
                      |+.+++.-..+.    +++||++|.+.|+|.+||    ....++....++++..+|.||++||.     +++|.|.||||
T Consensus       267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl  342 (513)
T KOG2052|consen  267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL  342 (513)
T ss_pred             hhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence            999999865543    789999999999999999    44678999999999999999999994     68899999999


Q ss_pred             CCCCEEEeCCCceEEEeecCceecCCC--ccccCcccccccccccCcccccCCC----CC--chhhHHHHHHHHHHHHcC
Q 004580          642 KASNVLLDMDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYALDGL----FS--IKSDVFSFGILMLETLSG  713 (744)
Q Consensus       642 k~~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s--~k~DvwSlGviL~elltG  713 (744)
                      |++|||+..++.+.|+|+|||......  .........+||.+|||||++....    |.  ..+||||||.|+||+...
T Consensus       343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999987654  3333445579999999999986543    22  359999999999998753

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-36  Score=287.12  Aligned_cols=222  Identities=29%  Similarity=0.395  Sum_probs=194.3

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.   ......++.+|+++...|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            378999999999999999999865 4678999998653   233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +||.++|.+...|.+. ....+++.....++.|+|.|+.|+|...   +|||||||+|+|++..+.+||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999998643 3445788888999999999999999987   9999999999999999999999999987643 


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                         .......+||..|.+||...+..++..+|+|++|++.||++.|.+||+....++  .+.-+......||...+
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tYkrI~k~~~~~p~~is  246 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TYKRIRKVDLKFPSTIS  246 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HHHHHHHccccCCcccC
Confidence               233455899999999999999999999999999999999999999999988655  77777788877776554

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.6e-35  Score=318.03  Aligned_cols=203  Identities=26%  Similarity=0.353  Sum_probs=175.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. .++.+|+|+++...   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999764 48899999987532   234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999999765321


Q ss_pred             ccc---------------------------------cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004580          669 ELQ---------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK  715 (744)
Q Consensus       669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~  715 (744)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 004580          716 NTGVYN  721 (744)
Q Consensus       716 p~~~~~  721 (744)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-35  Score=315.00  Aligned_cols=219  Identities=25%  Similarity=0.345  Sum_probs=184.4

Q ss_pred             hcCcccccccCccCceEEEcccccc--cceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .++|++.+.||+|+||.||+|+...  +..||+|++...   .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3679999999999999999997543  368999988643   23345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+++|+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999884   3346889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..  .+...+.+....++..++
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~  252 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQKILEGIIYFPKFLD  252 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCCCCCCCC
Confidence            32     22357899999999999988999999999999999999999999765432  244445555555555443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-35  Score=308.20  Aligned_cols=215  Identities=25%  Similarity=0.314  Sum_probs=181.1

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999865 58899999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999884   3446889999999999999999999988   999999999999999999999999999865432


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+......|+.
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  219 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKILAGKLEFPR  219 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCcCCCc
Confidence                 223578999999999999999999999999999999999999997654322  33333333344443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=300.09  Aligned_cols=223  Identities=28%  Similarity=0.405  Sum_probs=184.3

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCCh--------------hhHHHHHHHHHHHHHhcCCCeeeEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--------------QGLEEFKNEMMLIAKLQHRNLVKLL  575 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------~~~~~f~~Ev~~l~~l~HpnIv~l~  575 (744)
                      ..++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999864 588999999864321              1246889999999999999999999


Q ss_pred             EEEEEc--CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc
Q 004580          576 GCCVEQ--GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN  653 (744)
Q Consensus       576 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~  653 (744)
                      .+..+.  +.+|||+|||..|.+...-   .....+...++++++.++..||+|||.++   ||||||||.|+||+++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence            998765  5899999999999875432   22333899999999999999999999998   999999999999999999


Q ss_pred             eEEEeecCceecCCC---ccccCcccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCccc
Q 004580          654 PKISDFGLARMFGGD---ELQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFN  726 (744)
Q Consensus       654 ~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~  726 (744)
                      +||+|||.+..+...   .........+|||.|||||...++.    .+.+.||||+||.||-|+.|+.||-...  ...
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~  326 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELE  326 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HHH
Confidence            999999999876332   1112233478999999999987733    3578999999999999999999986544  345


Q ss_pred             ccccccccccccccc
Q 004580          727 LLGYVSNKSLHFYLI  741 (744)
Q Consensus       727 l~~~~~~~~~~f~~~  741 (744)
                      +.+.|.+....||..
T Consensus       327 l~~KIvn~pL~fP~~  341 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPEN  341 (576)
T ss_pred             HHHHHhcCcccCCCc
Confidence            888888888888865

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-34  Score=310.50  Aligned_cols=208  Identities=29%  Similarity=0.436  Sum_probs=172.4

Q ss_pred             HhcCcccccccCccCceEEEcccc------cccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcC
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      ..++|++.++||+|+||.||+|..      ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            347899999999999999999963      235689999997543 33456789999999999 8999999999887644


Q ss_pred             -eEEEEEEecCCCChhhhhcCcCC--------------------------------------------------------
Q 004580          583 -EKILILEYMPNKSLDVFLFDPTK--------------------------------------------------------  605 (744)
Q Consensus       583 -~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  605 (744)
                       ..++||||+++|+|..++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             68899999999999988853211                                                        


Q ss_pred             ---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccccccccc
Q 004580          606 ---KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG  682 (744)
Q Consensus       606 ---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  682 (744)
                         ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               234778889999999999999999987   99999999999999999999999999987643322122222355678


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       683 y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-34  Score=312.34  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=175.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++..   .....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67899999999999999999875 4789999998653   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999998884   3446788899999999999999999988   999999999999999999999999999876432


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            2     23578999999999999999999999999999999999999996543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-34  Score=316.87  Aligned_cols=203  Identities=24%  Similarity=0.370  Sum_probs=173.7

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .|++++.||+|+||.||+|+.. +++.+|||+++..   .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999764 4789999998653   23445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++|+|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++++||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999884   3345888899999999999999999987   9999999999999999999999999986432100


Q ss_pred             c---------------------------------------------ccCcccccccccccCcccccCCCCCchhhHHHHH
Q 004580          670 L---------------------------------------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG  704 (744)
Q Consensus       670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG  704 (744)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234799999999999998999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCC
Q 004580          705 ILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       705 viL~elltG~~p~~~~~~  722 (744)
                      |++|||++|+.||...+.
T Consensus       236 ~il~elltG~~Pf~~~~~  253 (381)
T cd05626         236 VILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             hHHHHHHhCCCCCcCCCH
Confidence            999999999999976553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=305.61  Aligned_cols=203  Identities=29%  Similarity=0.390  Sum_probs=176.0

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCCChh-hHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcC-eEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG-EKIL  586 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~-~~~l  586 (744)
                      ..++|.++++||.|.||.||+|+- ..++.||||++++.-.. ..-.=.+|++.|++|+ |||||++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            347899999999999999999974 45889999999865322 2222358999999999 999999999999988 9999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      |||||+. +|.+++.+.  ++.+++..++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+||.+.
T Consensus        88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            9999964 677777553  778999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCccccCcccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ...   ..+..+.|.-|+|||++. ...|+.+.|+|++|||++||.+-++.|...++
T Consensus       162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence            643   334568899999999885 56799999999999999999999999987764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-34  Score=310.22  Aligned_cols=214  Identities=25%  Similarity=0.336  Sum_probs=177.8

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+++.. +++.+|+|+++..   .......+.+|+.++++++||||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999764 5889999998753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCc
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT  674 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  674 (744)
                      +|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            9988884   3456889999999999999999999998   9999999999999999999999999987542221  122


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccccc
Q 004580          675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIF  742 (744)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~  742 (744)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+.  +...+......|+..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~  218 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEIRFPRTL  218 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHHcCCCCCCCCC
Confidence            34578999999999999999999999999999999999999996544322  4444444445555433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-34  Score=306.96  Aligned_cols=196  Identities=26%  Similarity=0.337  Sum_probs=169.6

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+++.. +++.||+|+++..   .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 5889999998753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCc
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT  674 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  674 (744)
                      +|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence            9988874   3446889999999999999999999987   99999999999999999999999999875432221  12


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~  200 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  200 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence            235789999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=294.37  Aligned_cols=210  Identities=27%  Similarity=0.392  Sum_probs=181.4

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ..++|++.+.||.|.-++||+|+. ..++.||||++.-. .....+.+.+|+..|..++||||++.+..|..+..+++||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            347899999999999999999974 45799999999754 3344789999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      .||.+|++.+.++..-.. .+++..+..|.+++++||.|||+++   .||||||+.||||+.+|.+||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999988654433 3899999999999999999999998   999999999999999999999999987766543


Q ss_pred             cccc--CcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          669 ELQG--NTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       669 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      ....  .....+||+.|||||+++.  ..|+.|+||||||+...||.+|..||..+.+-.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk  239 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK  239 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence            2111  1145789999999999654  358999999999999999999999998876544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-33  Score=298.98  Aligned_cols=201  Identities=28%  Similarity=0.391  Sum_probs=173.7

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .|++.+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++.+++|+||+++.+++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999976 468899999886432   2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998777532 2335889999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .   .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            1   123468999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.3e-34  Score=307.98  Aligned_cols=214  Identities=26%  Similarity=0.337  Sum_probs=178.1

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+++.. +++.+|+|+++..   .......+.+|+.+++.++||||+++.+.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 5889999998753   2344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCc
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT  674 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  674 (744)
                      +|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9988874   3446889999999999999999999987   9999999999999999999999999987643221  122


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccccc
Q 004580          675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIF  742 (744)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~  742 (744)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+......|+..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~~p~~~  218 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEDIKFPRTL  218 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHHhccCCccCCCCC
Confidence            33578999999999999999999999999999999999999997654322  4444444555555443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=293.23  Aligned_cols=201  Identities=24%  Similarity=0.453  Sum_probs=182.7

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+++.   ++++.-.+.+|+++|..|+||||+.++.+|...+..+||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            36799999999999999999975 56999999999765   456667789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||..+|.|.+|+   ...+.+++.+.+.++.||..|+.|+|.+.   ++|||||.+|||||.++++||+|||++-++..
T Consensus       132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999   45667999999999999999999999987   99999999999999999999999999988755


Q ss_pred             CccccCcccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..   ..+.++|++-|.+||++.+.+|. +.+|-|||||+||.|+.|.-||+..+
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence            43   34568999999999999999884 89999999999999999999998754

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-34  Score=316.40  Aligned_cols=202  Identities=24%  Similarity=0.371  Sum_probs=172.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .|+++++||+|+||.||+|+.. +++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999864 47889999986532   3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999988843   346788899999999999999999998   9999999999999999999999999975431100


Q ss_pred             ---------------------------------------------cccCcccccccccccCcccccCCCCCchhhHHHHH
Q 004580          670 ---------------------------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG  704 (744)
Q Consensus       670 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG  704 (744)
                                                                   ........+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                         00001224689999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCC
Q 004580          705 ILMLETLSGKKNTGVYN  721 (744)
Q Consensus       705 viL~elltG~~p~~~~~  721 (744)
                      |+||||++|++||...+
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=315.85  Aligned_cols=203  Identities=27%  Similarity=0.352  Sum_probs=173.2

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.||||++...   .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999754 5889999998643   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999884   3456888999999999999999999998   999999999999999999999999999643210


Q ss_pred             cc------------cc---------------------------------CcccccccccccCcccccCCCCCchhhHHHH
Q 004580          669 EL------------QG---------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSF  703 (744)
Q Consensus       669 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSl  703 (744)
                      ..            ..                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00            00                                 0012468999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q 004580          704 GILMLETLSGKKNTGVYN  721 (744)
Q Consensus       704 GviL~elltG~~p~~~~~  721 (744)
                      ||++|||++|+.||...+
T Consensus       235 Gvil~elltG~~Pf~~~~  252 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             chhhhhhhcCCCCCCCCC
Confidence            999999999999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-34  Score=285.13  Aligned_cols=202  Identities=29%  Similarity=0.387  Sum_probs=172.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChh--hHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~lV  587 (744)
                      ++|+.++.|++|.||.||+|+++ +++.||+|+++-..+.  ---.-.+|+.+|.+.+|||||.+..+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            67899999999999999999874 4789999999754322  122347899999999999999999988654  579999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||||+. +|...+..  ..+.+...++..++.|+++|++|||.+.   |+|||||++|+|+...|.+||+|||+|+.+..
T Consensus       156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999975 67777643  3457889999999999999999999998   99999999999999999999999999999876


Q ss_pred             CccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ..  ...+..+-|.-|.|||.+.+. .|++..|+||+|||+.||+++++.|....+
T Consensus       230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE  283 (419)
T KOG0663|consen  230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE  283 (419)
T ss_pred             Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence            42  223446779999999999875 599999999999999999999999987764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=304.69  Aligned_cols=211  Identities=24%  Similarity=0.328  Sum_probs=176.1

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||.||+++.. +++.||+|+++..   .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999865 4788999998643   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      ..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            98884   3446889999999999999999999987   9999999999999999999999999998643322  12234


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccc
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~  741 (744)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..  .+...+.+....|+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYRKILQEPLRFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHHHHHcCCCCCCCc
Confidence            57899999999999999999999999999999999999999754432  2444444444444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-34  Score=313.28  Aligned_cols=203  Identities=27%  Similarity=0.375  Sum_probs=175.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.||||+++..   .......+.+|+.++..++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999864 4889999998653   2334566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999998843   346899999999999999999999998   999999999999999999999999999765321


Q ss_pred             cccc------------------------------------CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004580          669 ELQG------------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS  712 (744)
Q Consensus       669 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt  712 (744)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012468999999999999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 004580          713 GKKNTGVYN  721 (744)
Q Consensus       713 G~~p~~~~~  721 (744)
                      |+.||...+
T Consensus       235 G~~Pf~~~~  243 (364)
T cd05599         235 GYPPFCSDN  243 (364)
T ss_pred             CCCCCCCCC
Confidence            999997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-34  Score=315.34  Aligned_cols=203  Identities=24%  Similarity=0.362  Sum_probs=173.5

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      +|++.+.||+|+||.||+++.. .++.+|||++....   ....+.+.+|+.++.+++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999864 48899999986432   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++|+|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999984   3456788899999999999999999988   9999999999999999999999999985331000


Q ss_pred             -----------------------------------------cccCcccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 004580          670 -----------------------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML  708 (744)
Q Consensus       670 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~  708 (744)
                                                               .........||+.|||||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000011347899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCC
Q 004580          709 ETLSGKKNTGVYNA  722 (744)
Q Consensus       709 elltG~~p~~~~~~  722 (744)
                      ||++|+.||...+.
T Consensus       236 ell~G~~Pf~~~~~  249 (376)
T cd05598         236 EMLVGQPPFLADTP  249 (376)
T ss_pred             ehhhCCCCCCCCCH
Confidence            99999999976653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-33  Score=304.28  Aligned_cols=218  Identities=26%  Similarity=0.355  Sum_probs=178.6

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCC-CeeeEEEEEEEcCeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHR-NLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~  588 (744)
                      +|++.+.||+|+||.||+|+.. .++.||||+++..   .....+.+..|.+++..++|+ +|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999865 4678999998753   234456788899999999765 5888889999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999988874   3445789999999999999999999987   999999999999999999999999998753221


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~  741 (744)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....++..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~~~~~  223 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNVSYPKS  223 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCCCCCCC
Confidence            1  12234578999999999999999999999999999999999999997654332  444444444444443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=307.30  Aligned_cols=198  Identities=26%  Similarity=0.404  Sum_probs=175.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+|+.. .++.||||+++...   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999875 48899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++.   ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999984   3446889999999999999999999998   99999999999999999999999999986543 


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence                2233578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-33  Score=304.55  Aligned_cols=218  Identities=27%  Similarity=0.356  Sum_probs=178.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +|++.+.||+|+||.||+|+.. +++.+|+|+++...   ....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999865 46799999987542   23345567788888777 5889999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988874   3345889999999999999999999987   999999999999999999999999999864322


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~  741 (744)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+.  +...+......++..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i~~~~~~~p~~  223 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHNVAYPKS  223 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCCc
Confidence            2  12234578999999999999999999999999999999999999997655433  444444444444443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=310.22  Aligned_cols=207  Identities=32%  Similarity=0.470  Sum_probs=176.2

Q ss_pred             HHHhcCcccccccCccCceEEEcccccc--c--ce-eEEEeccC---CChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSS---QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE  580 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~l~~---~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~  580 (744)
                      ....++..+.++||+|+||.||+|++..  +  .. ||||..+.   .......+|.+|.++|++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344666777999999999999998643  2  23 89999875   346678899999999999999999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ...+++|||+|+||+|+++|....  ..++..+++.++.+.|+||+|||+.+   +|||||.++|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            999999999999999999995432  25899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      +++.-..  +........-+..|+|||.+....|+.++|||||||++||+++ |..||.....
T Consensus       308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            9886431  1111111235679999999999999999999999999999999 7888877653

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-33  Score=288.15  Aligned_cols=224  Identities=25%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .++|++++.||+|.-|+||++++.+ +..+|+|++.+..   .....+.+.|-+||+.++||.+..|+..+......+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3678889999999999999999865 5789999997653   34456677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||||+||+|...++. +..+.+++..++.++.+++-||+|||..|   ||.|||||+||||-++|++-|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999987754 45667999999999999999999999998   99999999999999999999999998764311


Q ss_pred             C--------------------------------ccc----------------------cCcccccccccccCcccccCCC
Q 004580          668 D--------------------------------ELQ----------------------GNTKRIVGTYGYMSPEYALDGL  693 (744)
Q Consensus       668 ~--------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~  693 (744)
                      .                                ...                      ......+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                000                      0112357999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccc
Q 004580          694 FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       694 ~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~  741 (744)
                      .+.++|.|+|||+||||+.|..||...+.+.  -+-+|...+..||..
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~~~l~Fp~~  357 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVGQPLKFPEE  357 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhcCCCcCCCC
Confidence            9999999999999999999999999888666  556677777777754

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-34  Score=292.93  Aligned_cols=197  Identities=29%  Similarity=0.412  Sum_probs=163.0

Q ss_pred             CcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----eEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKILI  587 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----~~~lV  587 (744)
                      .|+..+++|.|+||.||+|...+ ++.||||+.-.+.+    --.+|+.+|++++|||||+++.+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46667899999999999998754 68999998744322    1246899999999999999999987543     23489


Q ss_pred             EEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeecCceec
Q 004580          588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF  665 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFGla~~~  665 (744)
                      |||||. +|..+++.. ..+..++...+.-+..||.+||+|||+.+   |+||||||+|||+|.+ +.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 455555432 34566888889999999999999999987   9999999999999977 89999999999998


Q ss_pred             CCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...+..   ....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s  230 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS  230 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence            765533   224568899999999875 69999999999999999999999998754

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-33  Score=303.08  Aligned_cols=195  Identities=30%  Similarity=0.411  Sum_probs=168.2

Q ss_pred             cccCccCceEEEcccc----cccceeEEEeccCC----ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.||+|+||.||+++.    ..++.+|+|+++..    .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999974    24788999998653    223345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++.   ....+.+..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999988884   3445788888999999999999999987   9999999999999999999999999987543222 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence             12233578999999999999889999999999999999999999997654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-33  Score=309.79  Aligned_cols=204  Identities=24%  Similarity=0.315  Sum_probs=174.7

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      ...++|++.+.||+|+||.||+++.. +++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999875 4788999998642   2234456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +||||+++|+|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999998842    34788899999999999999999987   999999999999999999999999999876


Q ss_pred             CCCccccCcccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+
T Consensus       193 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         193 DETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             ccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            433211 12345799999999998754    37889999999999999999999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-33  Score=304.51  Aligned_cols=213  Identities=25%  Similarity=0.325  Sum_probs=176.2

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+++.. +++.+|+|+++..   ......++.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999754 5889999998753   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      +|..++.   ....+++.++..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9988874   34468999999999999999999997 55   9999999999999999999999999987643221  11


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccc
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~  741 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+.  +...+......++..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i~~~~~~~p~~  218 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEIRFPRT  218 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHHhcCCCCCCCC
Confidence            223578999999999999999999999999999999999999997654332  444444444444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-33  Score=302.46  Aligned_cols=198  Identities=27%  Similarity=0.413  Sum_probs=168.6

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHH---HHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLI---AKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l---~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      |++.+.||+|+||.||+++.. +++.||||+++..   .....+.+.+|++++   ..++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999764 5889999998753   223345666776655   456799999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|...+.    ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988773    345899999999999999999999987   99999999999999999999999999875432


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..  .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence            21  12234578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-33  Score=300.31  Aligned_cols=196  Identities=29%  Similarity=0.385  Sum_probs=166.0

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+|+.. .++.||+|.++..   .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999864 4778999998753   223344556677666654 799999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99988874   3346889999999999999999999987   9999999999999999999999999998653322  22


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~  201 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE  201 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence            2345789999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-33  Score=309.18  Aligned_cols=204  Identities=26%  Similarity=0.365  Sum_probs=175.2

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. .++.+|+|+++..   .....+.+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999764 4889999998643   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999884   3456889999999999999999999988   999999999999999999999999998755321


Q ss_pred             ccc---------------------------------cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 004580          669 ELQ---------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK  715 (744)
Q Consensus       669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~  715 (744)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113478999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 004580          716 NTGVYNA  722 (744)
Q Consensus       716 p~~~~~~  722 (744)
                      ||.....
T Consensus       235 Pf~~~~~  241 (360)
T cd05627         235 PFCSETP  241 (360)
T ss_pred             CCCCCCH
Confidence            9976553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-33  Score=302.17  Aligned_cols=212  Identities=24%  Similarity=0.377  Sum_probs=175.4

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+|+.. .++.||+|+++..   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 4789999998753   233455677888888876 799999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            99988874   3446889999999999999999999998   99999999999999999999999999986433221  2


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~i~~~~~~~p~  217 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFESILHDDVLYPV  217 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCCCCC
Confidence            233578999999999999999999999999999999999999998665433  44444444444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=283.66  Aligned_cols=224  Identities=27%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..++|+.+++||+|.||.|.+++.+ .++.+|+|++++..   ......-..|-++|+..+||.+..+...++..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3478999999999999999999754 58999999998763   3334445678899999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||..||.|.-+|   ...+.+++...+.+-..|..||.|||+.+   ||.||||.+|+|||.+|++||+|||+++.-.
T Consensus       246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999998887   45667888888889999999999999987   9999999999999999999999999998643


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccccccC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE  744 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~~  744 (744)
                      .  +...+...+|||.|+|||++.+..|+..+|.|.+||++|||++|+.||...+.+.  +..+|..++.+||..+|.
T Consensus       320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLIl~ed~kFPr~ls~  393 (516)
T KOG0690|consen  320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELILMEDLKFPRTLSP  393 (516)
T ss_pred             c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHHHhhhccCCccCCH
Confidence            2  2345667899999999999999999999999999999999999999986655555  999999999999988763

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.8e-33  Score=306.54  Aligned_cols=206  Identities=24%  Similarity=0.308  Sum_probs=175.6

Q ss_pred             HHHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          508 VAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       508 ~~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      .....++|++.+.||+|+||.||+++.. .++.+|+|++...   .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445589999999999999999999875 4788999998642   22334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .++||||+++|+|..++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999998842    34788889999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccCcccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .+...... ......||+.|+|||++...    .++.++|||||||++|||++|+.||...+
T Consensus       191 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         191 KMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             EcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            76543211 12345799999999998754    37899999999999999999999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-33  Score=300.62  Aligned_cols=212  Identities=28%  Similarity=0.400  Sum_probs=174.8

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 4789999998653   233456677888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99988874   3446889999999999999999999987   9999999999999999999999999988643221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i~~~~~~~~~  217 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAILNDEVVYPT  217 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHHhcCCCCCCC
Confidence            233578999999999999999999999999999999999999997655332  44444444444433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.9e-33  Score=295.37  Aligned_cols=205  Identities=31%  Similarity=0.493  Sum_probs=171.0

Q ss_pred             cCcccccccCccCceEEEcccccc-----------------cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKL  574 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l  574 (744)
                      ++|.+.++||+|+||.||++.+.+                 +..||+|.++.. ......+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999996432                 336999998764 33446679999999999999999999


Q ss_pred             EEEEEEcCeEEEEEEecCCCChhhhhcCcC----------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 004580          575 LGCCVEQGEKILILEYMPNKSLDVFLFDPT----------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH  638 (744)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiH  638 (744)
                      ++++.+.+..++||||+++++|..++....                ....+++.++.+++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999998874321                1234788899999999999999999987   999


Q ss_pred             ecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcC--CCC
Q 004580          639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG--KKN  716 (744)
Q Consensus       639 rDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG--~~p  716 (744)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999876443322222234557889999999988999999999999999999974  456


Q ss_pred             CCCC
Q 004580          717 TGVY  720 (744)
Q Consensus       717 ~~~~  720 (744)
                      |...
T Consensus       242 ~~~~  245 (304)
T cd05096         242 YGEL  245 (304)
T ss_pred             CCcC
Confidence            6544

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=275.68  Aligned_cols=218  Identities=26%  Similarity=0.392  Sum_probs=185.2

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .+.|++.+.||+|.|+.|++... ..|+.+|+|++...  ...+.+++.+|+++-+.|+|||||++...+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            47788999999999999999965 45899999987532  4457889999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC---CceEEEeecCceec
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF  665 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~---~~~kL~DFGla~~~  665 (744)
                      |+|+|++|-.-+   ..+...++..+-..+.||+++|.|+|.++   |||||+||+|+||-..   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999986544   23345677788899999999999999998   9999999999999643   34899999999988


Q ss_pred             CCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      .....   .-...|||+|||||++...+|+..+|||+.|||||-|+.|.+||-..+.+.  +++-|.+...+|+.
T Consensus       164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd~~~  233 (355)
T KOG0033|consen  164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYDYPS  233 (355)
T ss_pred             CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccCCCC
Confidence            74332   233689999999999999999999999999999999999999987644443  77777777777765

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-33  Score=306.95  Aligned_cols=203  Identities=25%  Similarity=0.323  Sum_probs=173.7

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..++|++.+.||+|+||.||+++.. +++.+|+|+++..   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999864 4789999998642   22344567899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+++|+|..++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998843    34788889999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccCcccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            43211 12235789999999998653    47899999999999999999999997654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-33  Score=300.04  Aligned_cols=217  Identities=25%  Similarity=0.379  Sum_probs=177.3

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +|+..+.||+|+||.||+++.. +++.||+|+++..   .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677889999999999999764 5889999998753   2234456788888888886 567888999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999988873   3346889999999999999999999987   999999999999999999999999998864332


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+.  +.+.+......++.
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~~p~  222 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNVSYPK  222 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCCCc
Confidence            21  1233568999999999999999999999999999999999999997654332  44444444444443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=295.10  Aligned_cols=202  Identities=27%  Similarity=0.419  Sum_probs=181.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..|+.++.||+|+||.||+|.+. .++.||+|++.-. .+...+++++|+.++..++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45667789999999999999864 4789999999755 445578899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      |.+|++...|   +....+.+..+..++.+++.|+.|||.++   .+|||||+.|||+..++.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999888   44555688888889999999999999998   99999999999999999999999999998876554


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ..  ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+...++
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            33  558999999999999988999999999999999999999999987776

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=311.26  Aligned_cols=205  Identities=19%  Similarity=0.242  Sum_probs=177.9

Q ss_pred             CcccccccCccCceEEEccccc-c-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .|.+.+.||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999643 3 5778888876555555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          592 PNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ++|+|..++... .....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887543 23456889999999999999999999987   99999999999999999999999999997654332


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            222334679999999999999999999999999999999999999997544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-33  Score=282.97  Aligned_cols=205  Identities=28%  Similarity=0.404  Sum_probs=171.6

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCCh--hhHHHHHHHHHHHHHhcCCC-eeeEEEEEEEcC-----
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRN-LVKLLGCCVEQG-----  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~Hpn-Iv~l~~~~~~~~-----  582 (744)
                      ...|+.+++||+|.||+||+|+.. +|+.||+|+++...+  .......+|+.++++++|+| ||++.+++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            356777789999999999999854 588999999876533  23345678999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCChhhhhcCcCCc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          583 -EKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       583 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                       ..++|+||++ .+|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||++.+.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             7889999995 4677777543321 45777889999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      +|+.+.-..  ......++|.-|.|||++.+. .|+...||||+|||+.||+++++-|....+
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            999654221  113345788899999999887 799999999999999999999999987764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-32  Score=296.35  Aligned_cols=201  Identities=26%  Similarity=0.376  Sum_probs=176.1

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.+.||+|+||.||+++.. .+..+|+|.++.. .....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            378999999999999999999865 4788999988754 33445779999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..+....
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999998843   345889999999999999999999854  49999999999999999999999999998654321


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                          .....+++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                223568999999999999999999999999999999999999996543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.7e-33  Score=300.53  Aligned_cols=201  Identities=27%  Similarity=0.386  Sum_probs=171.1

Q ss_pred             CcccccccCccCceEEEcccc----cccceeEEEeccCC----ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~  584 (744)
                      +|++.+.||+|+||.||+++.    ..++.+|+|++++.    .....+.+..|+.++..++ ||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999864    24788999998643    2234566888999999994 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++||||+++|+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999998884   3445889999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  211 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG  211 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence            5433211 22235789999999999865 47899999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=284.47  Aligned_cols=203  Identities=29%  Similarity=0.439  Sum_probs=175.3

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccC--CChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-----cCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-----QGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-----~~~  583 (744)
                      ...|...+.||+|+||.|..+... +|+.||||++..  ......++..+|+++|+.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            355666789999999999999764 589999999873  356677889999999999999999999998865     247


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .|+|+|+| ..+|...+   ..+..++...+..+++||++||.|+|+.+   |+||||||.|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 56788877   34445899999999999999999999998   9999999999999999999999999999


Q ss_pred             ecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...........+..+.|.-|.|||++.. ..|+.+.||||.|||+.||++|++.|...+
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d  232 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD  232 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence            8865433334456788999999998864 579999999999999999999999998876

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.2e-33  Score=292.09  Aligned_cols=202  Identities=25%  Similarity=0.362  Sum_probs=173.8

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|+||.||+++.. +++.+|+|+++..  .....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999875 4788999998754  23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |++++++..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2345889999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      . .......+++.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            1 12223568999999999999899999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.3e-33  Score=300.65  Aligned_cols=203  Identities=24%  Similarity=0.330  Sum_probs=173.5

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 4788999998642   2233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998532  345788999999999999999999987   999999999999999999999999999876543


Q ss_pred             ccccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ... ......||+.|+|||++.+     ..++.++|||||||+||||++|+.||...+
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            221 1223568999999999875     467899999999999999999999996543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=304.73  Aligned_cols=203  Identities=27%  Similarity=0.411  Sum_probs=177.2

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.||||+++...   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999865 58899999987532   234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999853   356889999999999999999999987   999999999999999999999999999876443


Q ss_pred             c---------------------------cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 E---------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223578999999999999999999999999999999999999997655

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-32  Score=292.33  Aligned_cols=201  Identities=28%  Similarity=0.368  Sum_probs=169.6

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.+.||+|+||.||+|+.. +++.+|||+++.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999875 588999999875432 234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |++ ++|..++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 566666532  2345788999999999999999999998   9999999999999999999999999997643322


Q ss_pred             cccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              11223467899999999865 45889999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-32  Score=295.59  Aligned_cols=195  Identities=28%  Similarity=0.390  Sum_probs=166.0

Q ss_pred             cccCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+|+... ++.||||+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998654 7889999987541   23345566777777764 899999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            99998884   3346889999999999999999999987   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence            233578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-32  Score=302.45  Aligned_cols=208  Identities=33%  Similarity=0.462  Sum_probs=172.9

Q ss_pred             hcCcccccccCccCceEEEcccc------cccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~  583 (744)
                      .++|++.+.||+|+||.||+++.      .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            46899999999999999999863      224579999997543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC-----------------------------------------------------------
Q 004580          584 KILILEYMPNKSLDVFLFDPT-----------------------------------------------------------  604 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  604 (744)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998874311                                                           


Q ss_pred             --------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          605 --------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       605 --------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                              ....+++.++.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1134788889999999999999999987   99999999999999999999999999987643321111122


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      ..++..|||||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            345678999999999999999999999999999997 9999876543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-32  Score=297.28  Aligned_cols=194  Identities=24%  Similarity=0.382  Sum_probs=167.8

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.||+|+++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 4789999999753   233456688999999988 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            99988773   3456899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|+.||+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  199 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  199 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence            23357899999999999999999999999999999999999999743

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-32  Score=289.92  Aligned_cols=201  Identities=27%  Similarity=0.384  Sum_probs=170.5

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999764 57899999986542 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 78777743  2345788999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1223467899999998875 568999999999999999999999996544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.6e-33  Score=296.34  Aligned_cols=211  Identities=27%  Similarity=0.372  Sum_probs=172.1

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.||+|.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999865 47899999987532   23345567788777754 899999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            99988874   3346889999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccc
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFY  739 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~  739 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.+  .+...+......++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~~~~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDTPHYP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCC
Confidence            23457899999999999999999999999999999999999999765432  23444443334443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-32  Score=288.17  Aligned_cols=196  Identities=30%  Similarity=0.422  Sum_probs=169.3

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||+||+++.. +++.+|+|++....   ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999764 58899999986532   22346678899999999999999999999999999999999999999


Q ss_pred             hhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcc
Q 004580          597 DVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK  675 (744)
Q Consensus       597 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  675 (744)
                      ..++... .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8877432 23456899999999999999999999987   99999999999999999999999999987654322  123


Q ss_pred             cccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       676 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            3578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=296.93  Aligned_cols=203  Identities=25%  Similarity=0.341  Sum_probs=173.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999864 4889999998642   2234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999998843  2345889999999999999999999998   999999999999999999999999999876443


Q ss_pred             ccccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            211 1122468999999999863     457889999999999999999999996543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.1e-33  Score=297.51  Aligned_cols=195  Identities=27%  Similarity=0.339  Sum_probs=164.7

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHH-HHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||+||+++.. +++.||+|++....   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999864 58899999986432   222344455544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            99988884   3456889999999999999999999988   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            234578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-32  Score=295.49  Aligned_cols=194  Identities=27%  Similarity=0.413  Sum_probs=167.7

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.+|+|+++..   .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999864 4788999999754   233456688999999888 599999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988773   3446899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            23357899999999999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-32  Score=295.77  Aligned_cols=193  Identities=25%  Similarity=0.400  Sum_probs=166.4

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.+|+|+++..   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999864 4788999998753   233455678888888777 799999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99988773   3346889999999999999999999987   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            2335789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-33  Score=309.90  Aligned_cols=211  Identities=27%  Similarity=0.358  Sum_probs=178.6

Q ss_pred             HHHHhcCcccccccCccCceEEEccccccc-ceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEE-EEEEc---
Q 004580          508 VAAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLG-CCVEQ---  581 (744)
Q Consensus       508 ~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~-~~~~~---  581 (744)
                      +.....++++.+.|.+|||+.||.+++..+ .++|+|++-..++...+.+.+|+.+|++|+ |+|||.+++ .....   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            344557788999999999999999998765 999999998888899999999999999998 999999999 33221   


Q ss_pred             ---CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEe
Q 004580          582 ---GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD  658 (744)
Q Consensus       582 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~D  658 (744)
                         -+++|.||||++|.|-+++......+ |++.++++|+.++++|+++||... +||||||||-+||||..+++.||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence               37789999999999999986543333 999999999999999999999974 7899999999999999999999999


Q ss_pred             ecCceecCCCccccC-------cccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          659 FGLARMFGGDELQGN-------TKRIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       659 FGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ||.|...........       .-....|+.|+|||++   .+..+++|+|||+|||+||-|+....||+..
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            999875432221100       0113568999999987   5778999999999999999999999999876

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-33  Score=296.80  Aligned_cols=195  Identities=27%  Similarity=0.339  Sum_probs=164.2

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHH-HHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      ++||+|+||.||+++.. +++.+|+|++....   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999864 57899999986432   222344555554 67889999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|...+.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            99988773   3445788889999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            234578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-33  Score=299.73  Aligned_cols=195  Identities=31%  Similarity=0.382  Sum_probs=169.0

Q ss_pred             cccCccCceEEEcccc----cccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          519 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      +.||+|+||.||+++.    ..++.+|+|+++...  ......+..|++++.+++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    357899999987532  2334567889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|..++.   +...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            999998884   3446899999999999999999999987   9999999999999999999999999998654321  1


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            2233578999999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-32  Score=294.91  Aligned_cols=212  Identities=26%  Similarity=0.358  Sum_probs=174.6

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.+|||+++..   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999875 4788999998753   233456677888888888 699999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99988874   3346899999999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....++.
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~~i~~~~~~~~~  217 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQSILEDEVRYPR  217 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHHHHHcCCCCCCC
Confidence            233568999999999999999999999999999999999999997654322  44444444444443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.8e-33  Score=297.51  Aligned_cols=195  Identities=26%  Similarity=0.339  Sum_probs=165.3

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHH-HHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMM-LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +|+.+|+|++...   ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999764 5889999998653   2233345555554 56778999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99988873   3456889999999999999999999988   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            234578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=288.29  Aligned_cols=201  Identities=29%  Similarity=0.400  Sum_probs=173.7

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      +|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999864 58899999986532   2234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887532 2345899999999999999999999987   9999999999999999999999999998754322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .   .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence            1   123468899999999998899999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.6e-33  Score=300.11  Aligned_cols=200  Identities=26%  Similarity=0.350  Sum_probs=173.0

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhc-C-----CCeeeEEEEEEEcCeEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-H-----RNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-H-----pnIv~l~~~~~~~~~~~l  586 (744)
                      +|++.+.||+|.||+|.+|.+. .++.||||+++... .-..+-..|+++|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999999999764 58999999997653 33455678999999997 4     379999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC--CceEEEeecCcee
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD--MNPKISDFGLARM  664 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~--~~~kL~DFGla~~  664 (744)
                      |+|.++ .+|.++|..... ..++...++.++.||+.||..||+.+   |||+||||+||||.+.  ..+||+|||++..
T Consensus       266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999884 578999876443 45899999999999999999999988   9999999999999764  4799999999997


Q ss_pred             cCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .....+     ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|...++.+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            554332     3567889999999999999999999999999999999999888776533

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-32  Score=299.31  Aligned_cols=207  Identities=31%  Similarity=0.428  Sum_probs=172.7

Q ss_pred             hcCcccccccCccCceEEEcccc------cccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~  583 (744)
                      .++|++.+.||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999853      235689999997542 33456789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC-----------------------------------------------------------
Q 004580          584 KILILEYMPNKSLDVFLFDPT-----------------------------------------------------------  604 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  604 (744)
                      .++||||+++|+|..++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999988885321                                                           


Q ss_pred             -------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          605 -------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       605 -------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                                   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+......
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         1125788899999999999999999987   999999999999999999999999999876543221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~  321 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP  321 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence            11122345678999999999999999999999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-32  Score=296.31  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=172.4

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.++||+|+||.||+++... ++.+|+|++.+.   .....+.+.+|+.++..++|++|+++.+.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478899999999999999998654 678999998642   2233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++|+|..++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998532  345888999999999999999999987   999999999999999999999999999865432


Q ss_pred             ccccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            21 1122357899999999986     3468899999999999999999999997543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-32  Score=288.29  Aligned_cols=193  Identities=22%  Similarity=0.367  Sum_probs=166.5

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCChhh---HHHHHHHHHHHHHhcCCCeeeEEEEEEE----cCeEEEEEEec
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILILEYM  591 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~f~~Ev~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~  591 (744)
                      ..|++|+++.||+|+. +|+.||||+++......   .+.|.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 78999999997643322   5778899999999999999999999877    34788999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++|+|..++..   ...+++.....++.+++.||.|||+..  .++||||||+|||+++++.+||+|||+++.+....  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999853   346889999999999999999999852  28899999999999999999999999998654322  


Q ss_pred             cCcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||...+.
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~  227 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT  227 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence               12467889999999976  6799999999999999999999999986653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=2.7e-32  Score=308.80  Aligned_cols=208  Identities=23%  Similarity=0.317  Sum_probs=177.4

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----  582 (744)
                      ..++|++.+.||+|+||.||+++. .+++.||||++...  .......+.+|+.++..++|+||+++...+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            457999999999999999999975 45899999998653  3455667889999999999999999988765432     


Q ss_pred             ---eEEEEEEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEe
Q 004580          583 ---EKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD  658 (744)
Q Consensus       583 ---~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~D  658 (744)
                         ..++||||+++|+|..++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               367999999999999988643 23456889999999999999999999987   99999999999999999999999


Q ss_pred             ecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            999987654332223344679999999999999999999999999999999999999997544

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=1.4e-32  Score=295.85  Aligned_cols=195  Identities=27%  Similarity=0.346  Sum_probs=163.4

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHH-HHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEM-MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev-~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+++.. +++.+|+|++....   ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999865 46789999986432   12233444444 456778999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            99998884   3445778888899999999999999998   9999999999999999999999999997543221  12


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            334578999999999999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=4.3e-33  Score=296.04  Aligned_cols=206  Identities=27%  Similarity=0.417  Sum_probs=182.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe-EEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE-KILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~-~~lV~  588 (744)
                      ++|+.++++|+|+||.++..+++ ++..+++|++.-.  .+...+...+|+.++++++|||||.+.+.+.+.+. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            67889999999999999999865 4778999987643  34445577899999999999999999999999888 89999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      +|++||++.+.+.... ...++++.+..++.|++.|+.|||+..   |.|||||+.||+++.++.+||.|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999886533 567889999999999999999999776   999999999999999999999999999998776


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      ..  .....+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+-..
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~  213 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE  213 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence            52  3344799999999999999999999999999999999999999998876444

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.98  E-value=6.7e-32  Score=291.56  Aligned_cols=201  Identities=27%  Similarity=0.385  Sum_probs=174.9

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.++||+|+||.||+++.. .+..+|+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            378999999999999999999875 4778999988654 33445679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|.+++.   ....+++..+..++.+++.||.|||+..  +|+||||||+|||++.++.+||+|||++..+....
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            999999999984   3345788999999999999999999753  39999999999999999999999999997653321


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                          .....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence                123468899999999999899999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.98  E-value=7.5e-33  Score=298.71  Aligned_cols=203  Identities=24%  Similarity=0.369  Sum_probs=174.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.. +++.+|+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999764 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988532  246889999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccccCcccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ... ......+|+.|+|||++.      ...++.++|||||||++|||++|+.||....
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            221 122346899999999986      4567899999999999999999999996543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.3e-33  Score=286.40  Aligned_cols=229  Identities=27%  Similarity=0.353  Sum_probs=196.2

Q ss_pred             HHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      ....+.|..-++||+|+||.|+-++.+ .|+.+|.|++.+.   ...+.....+|-.+|.+++.+.||.+-.+|+..+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            334467888899999999999999765 4889999988543   344556678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++|+..|.||+|.-+|.... .+.++++.++.++.+|+.||++||...   ||.|||||+|||||++|+++|+|+|+|..
T Consensus       261 ClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence            99999999999998886543 367999999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc--cccccccccccccccccc
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS--FNLLGYVSNKSLHFYLIF  742 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~--~~l~~~~~~~~~~f~~~~  742 (744)
                      +......   ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....+..  +.+-.-+.+...+|++.|
T Consensus       337 i~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF  413 (591)
T KOG0986|consen  337 IPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF  413 (591)
T ss_pred             cCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence            8665422   22489999999999999999999999999999999999999997765322  346667777778888777


Q ss_pred             cC
Q 004580          743 SE  744 (744)
Q Consensus       743 ~~  744 (744)
                      ||
T Consensus       414 S~  415 (591)
T KOG0986|consen  414 SE  415 (591)
T ss_pred             CH
Confidence            64

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=3.5e-32  Score=294.27  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=167.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----eEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI  585 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----~~~  585 (744)
                      +|++.+.||+|+||.||+|+.. +++.||||+++..  ......++.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999864 5889999998643  2334567889999999999999999999886432     579


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +||||++ ++|..++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 57877773   3445889999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCcc-ccCcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDEL-QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..... ........+|+.|+|||++.+  ..++.++|||||||++|||++|++||...+
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            33211 111233578999999999876  678999999999999999999999996543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-33  Score=301.28  Aligned_cols=201  Identities=31%  Similarity=0.489  Sum_probs=176.5

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------CeEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GEKIL  586 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------~~~~l  586 (744)
                      +...+.||+|+||.||+|+.+ .|+.||||.++.. .....+...+|+++|++++|||||++++.-.+.      ...++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445578999999999999954 5999999999864 345567788999999999999999999986543      36789


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC--CC--ceEEEeecCc
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--DM--NPKISDFGLA  662 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~--~~--~~kL~DFGla  662 (744)
                      |||||.+|+|+..|...++...+++.+.+.+..++..||.|||+++   ||||||||.||++-.  ++  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999999988899999999999999999999999887   999999999999943  23  4699999999


Q ss_pred             eecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +.+..+.   ......||..|++||...+ +.|+..+|.|||||++||..||..||....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9987755   4456899999999999985 889999999999999999999999997654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=3.9e-32  Score=293.06  Aligned_cols=216  Identities=27%  Similarity=0.403  Sum_probs=186.2

Q ss_pred             HhcCcccccccCccCceEEEcccccc-cceeEEEeccCCChh---hHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ---GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~  585 (744)
                      ..+.|++.+.||+|.||.||+++... |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+++.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678899999999999999998765 999999999765432   4568999999999999 999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC----CceEEEeecC
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD----MNPKISDFGL  661 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~----~~~kL~DFGl  661 (744)
                      +|||++.+|.|.+.+...   . +++.++..++.||+.+++|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999998888544   2 899999999999999999999988   9999999999999644    4799999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccc
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF  738 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f  738 (744)
                      +.....   .......+||+.|+|||++....|+.++||||+||++|.|++|.+||....+..  ....+......|
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~~i~~~~~~f  257 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFLAILRGDFDF  257 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHHHHHcCCCCC
Confidence            998766   234556899999999999999999999999999999999999999998877544  222444444433

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.98  E-value=5.9e-32  Score=298.04  Aligned_cols=208  Identities=31%  Similarity=0.429  Sum_probs=173.7

Q ss_pred             HhcCcccccccCccCceEEEccccc------ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcC
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~  582 (744)
                      ..++|.+.++||+|+||.||+|+..      .+..||||+++... ....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3578999999999999999999742      13469999997543 344567999999999996 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCcC----------------------------------------------------------
Q 004580          583 EKILILEYMPNKSLDVFLFDPT----------------------------------------------------------  604 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  604 (744)
                      ..++||||+++|+|..+|+...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875321                                                          


Q ss_pred             -----------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          605 -----------------------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       605 -----------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                                                         ....+++.++..++.||++||+|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                               0124778888999999999999999987   99999999999999


Q ss_pred             CCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999987644322222223456788999999999999999999999999999997 888987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=5.6e-32  Score=297.86  Aligned_cols=193  Identities=22%  Similarity=0.276  Sum_probs=166.1

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..+|++.+.||+|+||.||++... .++.||+|...      .+.+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999864 57899999753      23567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +. ++|..++.   ....+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            96 67777763   3345789999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            112233579999999999999999999999999999999999998753

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.98  E-value=7.2e-32  Score=281.79  Aligned_cols=204  Identities=28%  Similarity=0.419  Sum_probs=172.6

Q ss_pred             hcCcccccccCccCceEEEccccc----ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.|.+|+..+.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            367889999999999999999653    35689999997653 3445679999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+++|+|+.++...  ...+++.+++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998542  346889999999999999999999987   9999999999999999999999999876543


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~  213 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            22111 1112344678999999999999999999999999999875 999987554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=8.7e-32  Score=312.96  Aligned_cols=206  Identities=24%  Similarity=0.343  Sum_probs=174.8

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.++||+|+||.||+|+.. .++.||+|+++..   .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999864 4889999998753   2334567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          589 EYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ||+++++|..++....        ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCcc----------------ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          661 LARMFGGDEL----------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +++.......                ........||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            9987622110                001123568999999999999999999999999999999999999997644

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=9.6e-32  Score=292.86  Aligned_cols=196  Identities=30%  Similarity=0.422  Sum_probs=166.1

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|+..++||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56777889999999999999864 5889999998654 334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|....       ...+..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999985432       3456778899999999999999987   99999999999999999999999999987643221


Q ss_pred             ccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||...
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence              1223578999999998743     23457899999999999999999999743

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=1e-31  Score=284.15  Aligned_cols=201  Identities=27%  Similarity=0.432  Sum_probs=166.2

Q ss_pred             cCcccccccCccCceEEEccccc--ccceeEEEeccCCC--hhhHHHHHHHHHHHHHh---cCCCeeeEEEEEEE-----
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVE-----  580 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~HpnIv~l~~~~~~-----  580 (744)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999753  46789999886532  22334566777777766   69999999998853     


Q ss_pred             cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ....++||||++ ++|..++... ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999997 5788777532 2335789999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +++......   ......+++.|+|||.+.+..++.++|||||||++|||++|++||....
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            998764331   2233568999999999998899999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.98  E-value=8.9e-32  Score=282.89  Aligned_cols=207  Identities=31%  Similarity=0.514  Sum_probs=176.3

Q ss_pred             hcCcccccccCccCceEEEcccccc------cceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++|.+.+.||+|+||.||+|+..+      ++.||||.++..... ..+.|.+|++++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999997533      478999999765443 567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC-----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc
Q 004580          585 ILILEYMPNKSLDVFLFDPT-----------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN  653 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~  653 (744)
                      ++||||+++++|.+++....           ....+++.++..++.||+.|+.|||+.+   |+||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985421           2345788999999999999999999987   999999999999999999


Q ss_pred             eEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999986543322222223345788999999999999999999999999999998 999986544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=1.7e-31  Score=281.36  Aligned_cols=207  Identities=34%  Similarity=0.543  Sum_probs=175.3

Q ss_pred             cCcccccccCccCceEEEcccccc------cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      ++|++.+.||+|+||.||+|....      ...+|+|.++.. .....++|.+|+.++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578889999999999999997532      257999998754 3344567999999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhcCcCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC
Q 004580          586 LILEYMPNKSLDVFLFDPTK-------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM  652 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~  652 (744)
                      ++|||+++++|.+++.....             ...+++.++..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854211             145788999999999999999999987   99999999999999999


Q ss_pred             ceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999987644332222333456788999999998899999999999999999998 9999876543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.2e-31  Score=287.47  Aligned_cols=203  Identities=32%  Similarity=0.510  Sum_probs=170.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccc----eeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .+|++.+.||+|+||.||+|++. +++    .||+|.++.. .....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999753 333    4899998754 344567899999999999999999999998764 5779


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999988542  345788899999999999999999987   9999999999999999999999999999765


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .............+..|+|||.+.+..++.++||||||+++|||++ |+.||+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            4322211222234678999999999999999999999999999998 999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-32  Score=281.21  Aligned_cols=204  Identities=25%  Similarity=0.360  Sum_probs=178.6

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .-|.+.+.||+|.|.+|-++++ -.|..||||++.+.  +......+.+|++.|+.++|||||+++.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577788999999999999976 46999999999765  34445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~~  668 (744)
                      .=.+|+|.+|+..++.  .+.+....+++.||+.|+.|+|+..   +|||||||+||.+-+ -|-+||.|||++-.+.+.
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999976544  4889999999999999999999998   999999999988754 578999999999876554


Q ss_pred             ccccCcccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .   .....+|+..|.|||++.+..|+ +++||||||||||.|++|++||...++.+
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE  226 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE  226 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence            3   33457999999999999998886 68999999999999999999998887655

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=1.8e-31  Score=280.41  Aligned_cols=208  Identities=29%  Similarity=0.460  Sum_probs=173.5

Q ss_pred             HhcCcccccccCccCceEEEccccc------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      ..++|++.+.||+|+||.||+|...      .+..+|+|+++.. ......+|.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998642      2567999998653 23445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          584 KILILEYMPNKSLDVFLFDPTK-------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999998854221       234678889999999999999999987   999999999999999999999


Q ss_pred             EeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~  226 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS  226 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999986644332222222345778999999999999999999999999999999 688886544

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=2.9e-31  Score=280.55  Aligned_cols=207  Identities=31%  Similarity=0.502  Sum_probs=176.2

Q ss_pred             hcCcccccccCccCceEEEccccc------ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.++.......+.+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            367889999999999999999742      24568999998766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcC----------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceE
Q 004580          586 LILEYMPNKSLDVFLFDPT----------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK  655 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~k  655 (744)
                      +||||+++++|.+++....          ....+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999885321          2235899999999999999999999987   99999999999999999999


Q ss_pred             EEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       656 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |+|||+++.+.............++..|+|||++.+..++.++||||||++++||++ |++||....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999986643322111222345778999999998999999999999999999998 898986654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=2.7e-31  Score=279.98  Aligned_cols=205  Identities=33%  Similarity=0.492  Sum_probs=173.2

Q ss_pred             cCcccccccCccCceEEEcccc-----cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ++|++.+.||+|+||.||+|..     ..++.+|+|.++.. ......+|.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5688889999999999999974     24578999998753 33445789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC--------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC
Q 004580          587 ILEYMPNKSLDVFLFDPT--------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM  652 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~  652 (744)
                      ||||+++++|..++....              ....+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999884221              1235788899999999999999999987   99999999999999999


Q ss_pred             ceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004580          653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVY  720 (744)
Q Consensus       653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~  720 (744)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999987644332222233445678999999988889999999999999999999 88888654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=2.5e-31  Score=276.55  Aligned_cols=204  Identities=35%  Similarity=0.499  Sum_probs=175.9

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            36799999999999999999988778889999986533 34578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..+......
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999988543 2345788899999999999999999987   999999999999999999999999999876543221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . .....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  209 (261)
T cd05072         160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS  209 (261)
T ss_pred             c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence            1 122345678999999998889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=1.2e-31  Score=278.99  Aligned_cols=202  Identities=41%  Similarity=0.628  Sum_probs=168.5

Q ss_pred             ccccccCccCceEEEccccc-----ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          516 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++.. .....++|.+|++.+.+++||||++++|++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35679999999999999775     2568999999654 34457899999999999999999999999998888999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++|+|+++|... ....+++.++..++.||++||.|||+.+   |+|+||+++||+++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999999653 2356899999999999999999999987   9999999999999999999999999999873322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .............|+|||.+....++.++||||||+++|||++ |+.|+...+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~  210 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD  210 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2222223456779999999999999999999999999999999 678887664

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=3e-31  Score=275.24  Aligned_cols=202  Identities=31%  Similarity=0.461  Sum_probs=173.4

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      ++|++.+.||+|+||.||+++..++..+|+|.++.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            568888999999999999998877788999988643 3335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988542  235889999999999999999999987   9999999999999999999999999998654332211


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence             112235668999999988889999999999999999999 888986554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=5.4e-32  Score=262.81  Aligned_cols=200  Identities=29%  Similarity=0.408  Sum_probs=173.0

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--------hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCV  579 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~  579 (744)
                      ....+|+..+.||+|..++|-++.++ .|+++|+|++....        ..-.++-..|+.+|+++. ||+|+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34467888899999999999998764 48899999885321        122455678999999985 999999999999


Q ss_pred             EcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEee
Q 004580          580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DF  659 (744)
                      .+...++|+|.|+.|.|.++|   ...-.+++++.++|+.|+.+|+.|||...   ||||||||+|||++++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            999999999999999999998   45557899999999999999999999998   999999999999999999999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                      |.+..+.+..   .....+|||+|+|||.+.-      ..|+...|+|++|||+|.|+.|.+||-
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            9999886643   3455899999999998842      347889999999999999999999983

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=2.7e-31  Score=287.24  Aligned_cols=207  Identities=30%  Similarity=0.467  Sum_probs=171.6

Q ss_pred             hcCcccccccCccCceEEEccccc------ccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc-C
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ-G  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~-~  582 (744)
                      .++|++.+.||+|+||.||+|...      .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            467999999999999999999642      24689999987542 33456788899999999 799999999988654 5


Q ss_pred             eEEEEEEecCCCChhhhhcCcCC---------------------------------------------------------
Q 004580          583 EKILILEYMPNKSLDVFLFDPTK---------------------------------------------------------  605 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  605 (744)
                      ..++++||+++++|..++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999988743211                                                         


Q ss_pred             -cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccccccccccc
Q 004580          606 -KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM  684 (744)
Q Consensus       606 -~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~  684 (744)
                       ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136889999999999999999999987   9999999999999999999999999998764433222222345677899


Q ss_pred             CcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          685 SPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       685 aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |||++.+..++.++|||||||+||||++ |+.||....
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5e-31  Score=274.42  Aligned_cols=204  Identities=33%  Similarity=0.482  Sum_probs=175.3

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46788999999999999999987777889999987543 34577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++.... ...+++.++..++.|++.|+.|||+.+   |+||||||+||+++.++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346889999999999999999999987   999999999999999999999999999887533221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . ......+..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            1 111223457999999999999999999999999999999 998986544

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=2.6e-31  Score=291.61  Aligned_cols=200  Identities=26%  Similarity=0.375  Sum_probs=168.8

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----eEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI  585 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----~~~  585 (744)
                      +|++.++||+|+||.||+++. .+++.||||++...  .....+++.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999986 46889999998653  2344567889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +|+||++ ++|...+.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 46666653   3456899999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            433221 12234678899999998874 57999999999999999999999997654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=5.4e-31  Score=276.96  Aligned_cols=194  Identities=28%  Similarity=0.403  Sum_probs=165.8

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||.||+++.. +|+.+|+|.+....   ......+..|++++.+++||||+++.+.+.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999764 58999999986431   22234566799999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      ..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++..+.....   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            8887542 2334788999999999999999999987   99999999999999999999999999987644321   123


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence            468899999999999889999999999999999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=274.76  Aligned_cols=202  Identities=31%  Similarity=0.459  Sum_probs=173.2

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-----hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ++|++.+.||+|++|.||++... +++.+|+|.+....     ....+.+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999754 58899999876432     2234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      |+||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999998874   3345788999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccC-cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          667 GDELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       667 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence            3221111 12345778999999999999999999999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-33  Score=272.50  Aligned_cols=201  Identities=28%  Similarity=0.480  Sum_probs=180.2

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +-|.++++||+|+||.||++.+++ |+.+|||....  +.+.+++..|+.+|++.+.|++|+++|.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            457888999999999999998765 89999998754  456789999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ..|+..+.+..  ++.++.+.++..++..-++||+|||...   -||||||+.||||+.+|.+||+|||.|..+......
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999998853  4567999999999999999999999986   899999999999999999999999999877554332


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                        ...+.||+-|||||++..-.|..++||||||+...||..|++||...++
T Consensus       186 --RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  186 --RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             --hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence              2347999999999999999999999999999999999999999976653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=280.17  Aligned_cols=222  Identities=27%  Similarity=0.362  Sum_probs=189.0

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCCh---hhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..+|..+.+||+|+||.|.++.-+. .+.+|||+++++.-   .+.+--..|-++|+.. +-|.++.+..+++.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3578888999999999999996543 56899999987632   2233345566666655 46789999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+.+|+|--++   +.-+.+-+..+..+|.+||-||-+||+++   ||.||||.+|||||.+|++||+|||+++.-.
T Consensus       428 VMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999997666   34455677788899999999999999998   9999999999999999999999999998633


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccccccccc
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      -..  ..+...+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++  +.+.|......||+.+|
T Consensus       502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~aI~ehnvsyPKslS  574 (683)
T KOG0696|consen  502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQAIMEHNVSYPKSLS  574 (683)
T ss_pred             cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHccCcCccccc
Confidence            222  34566899999999999999999999999999999999999999999877777  99999999999999886

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=4.2e-31  Score=278.95  Aligned_cols=200  Identities=28%  Similarity=0.388  Sum_probs=172.4

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ....+.+.+|+.++.+++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999764 58899999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999998887542 2346899999999999999999999987   9999999999999999999999999997654321 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence              1123468999999999998999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=5.1e-31  Score=279.12  Aligned_cols=206  Identities=31%  Similarity=0.506  Sum_probs=176.1

Q ss_pred             cCcccccccCccCceEEEccccc------ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.++.......+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999642      345689999877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc
Q 004580          587 ILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN  653 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~  653 (744)
                      ||||+++++|.+++....             ....+++..++.++.||+.|++|||+.+   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985422             2245889999999999999999999988   999999999999999999


Q ss_pred             eEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999986544322222223456788999999999999999999999999999999 999986544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=300.06  Aligned_cols=210  Identities=31%  Similarity=0.456  Sum_probs=180.2

Q ss_pred             ccccccCccCceEEEcccc-cccc----eeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          516 SMQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ...++||.|+||+||+|.+ .+|+    +||+|++... ..+..+++.+|+.+|.+++|||+++|+++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457999999999999965 3343    6899998765 4556789999999999999999999999998765 889999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |||.|.|.++++.  .+..+..+..+.+..|||+||.|||.+.   ++||||.++|||+.+...+||.|||+++.+..+.
T Consensus       778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999865  4456888999999999999999999876   9999999999999999999999999999987765


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCcccccccccc
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYVSN  733 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~~~~~l~~~~~~  733 (744)
                      .........-.+.|||-|.+....|+.++|||||||.+|||+| |..|+.....++  +++++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--I~dlle~  915 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--IPDLLEK  915 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--hhHHHhc
Confidence            4444443445778999999999999999999999999999999 999999888666  5555443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=2.9e-31  Score=296.72  Aligned_cols=200  Identities=22%  Similarity=0.386  Sum_probs=163.1

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--------
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--------  581 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--------  581 (744)
                      ..++|++.+.||+|+||.||+|... .++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3468999999999999999999864 57899999885432    2345799999999999999999887542        


Q ss_pred             CeEEEEEEecCCCChhhhhcC-cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEee
Q 004580          582 GEKILILEYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDF  659 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DF  659 (744)
                      ...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999986 55555432 234456899999999999999999999998   99999999999998665 7999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |+++.+....   ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||....
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9998764322   12234679999999998764 68999999999999999999999997643

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.2e-31  Score=292.73  Aligned_cols=198  Identities=22%  Similarity=0.309  Sum_probs=170.8

Q ss_pred             hcCcccccccCccCceEEEccccc---ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ..+|++.+.||+|+||.||++...   .++.||+|.+...     ..+.+|+.++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            467999999999999999998642   3578999988643     23568999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      |++. ++|..++   .....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 5677776   34456899999999999999999999987   999999999999999999999999999876554


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            33333334678999999999999999999999999999999999999986543

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=3.6e-31  Score=274.92  Aligned_cols=202  Identities=34%  Similarity=0.500  Sum_probs=173.4

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      ++|++.+.||+|+||.||+++..++..+|+|.++... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            5688889999999999999987667779999987543 345779999999999999999999999998889999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|..++...  ...+++.++..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999988542  235889999999999999999999987   9999999999999999999999999998764432211


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence             111235678999999988889999999999999999999 999987654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=6.2e-31  Score=277.70  Aligned_cols=201  Identities=29%  Similarity=0.401  Sum_probs=172.1

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .|++.+.||+|+||.||++... .++.+|||.+....   ....+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677789999999999999764 58899999886432   2234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|..++... ....+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999887432 2235889999999999999999999987   9999999999999999999999999997654322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence               1123468999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=5.2e-31  Score=281.63  Aligned_cols=201  Identities=27%  Similarity=0.399  Sum_probs=169.5

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|.+.+.||+|+||.||+|+.. .++.+|+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67899999999999999999864 47789999987542 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++ +|..++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 67666643  2345788999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1223467889999998865 468999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7e-32  Score=291.14  Aligned_cols=193  Identities=27%  Similarity=0.374  Sum_probs=161.3

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHh---cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      ||+|+||.||+|+.. +++.||||++....   ......+..|..++...   +||||++++..+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999864 48899999986432   22233455566666655   699999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|..++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99988874   3456889999999999999999999998   9999999999999999999999999987643322  12


Q ss_pred             cccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~  201 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED  201 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence            2345789999999998765 48999999999999999999999987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.6e-31  Score=279.38  Aligned_cols=198  Identities=32%  Similarity=0.436  Sum_probs=174.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|++|.||+++.. +++.+|+|.++..   .....+.+.+|++++++++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999864 4889999998643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++..   ...++...+..++.||+.||+|||+.+   |+|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999998843   356889999999999999999999987   999999999999999999999999999876443


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...+
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                 223468899999999988888999999999999999999999987554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=4.2e-31  Score=274.80  Aligned_cols=205  Identities=35%  Similarity=0.550  Sum_probs=179.9

Q ss_pred             HhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ...+|++.++||+|+||.||+|...+++.+|+|.++.......+++.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34678999999999999999999877899999999877665677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++.... ...+++.++..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+.....
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999986532 345789999999999999999999987   99999999999999999999999999987644322


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...  ...++..|+|||.+.+..++.++||||||++++||++ |+.||...+
T Consensus       160 ~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         160 LSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             ccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            111  2345678999999998899999999999999999998 888987654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=5e-31  Score=287.94  Aligned_cols=199  Identities=28%  Similarity=0.341  Sum_probs=167.9

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----  582 (744)
                      ..++|++.+.||+|+||.||+++.. .++.+|||+++..  ......++.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999764 4889999998653  3344567889999999999999999999986543     


Q ss_pred             -eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          583 -EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                       ..++||||++++ |...+.     ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             579999999865 444442     23778889999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            98653322   1223568999999999999999999999999999999999999997554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=8.1e-31  Score=273.71  Aligned_cols=201  Identities=26%  Similarity=0.422  Sum_probs=173.4

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      .++|++.+.||+|+||.||+|+. .+++.+|+|+++.......+.+.+|+.++.+++||||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            36799999999999999999986 45789999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++.   ....+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.....
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999998884   3346789999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                        ......++..|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence              112346788999999884   345788999999999999999999998543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=5.3e-32  Score=291.45  Aligned_cols=192  Identities=31%  Similarity=0.473  Sum_probs=166.2

Q ss_pred             ccccCccCceEEEccccc-ccceeEEEeccC----CChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe--EEEEEEe
Q 004580          518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSS----QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE--KILILEY  590 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~--~~lV~Ey  590 (744)
                      .++||+|+|-+||+|.+. +|.+||--.++.    ..+...++|..|+.+|+.|+||||++++..+.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            458999999999999874 377887543332    255667899999999999999999999999987654  7899999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFGla~~~~~~~  669 (744)
                      |..|+|..|+.   +.+.++...+..+++||++||.|||++. |||||||||-+||+|+.+ |.+||+|+|||..+....
T Consensus       125 ~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999984   4456788899999999999999999985 799999999999999754 899999999999876543


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                      .    ..++|||.|||||+.. ..|...+||||||+.++||+|+.+||.
T Consensus       201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            2    3379999999999766 889999999999999999999999984

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=3.2e-31  Score=279.27  Aligned_cols=206  Identities=35%  Similarity=0.510  Sum_probs=172.7

Q ss_pred             cCcccccccCccCceEEEccccc------ccceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      .+|.+.+.||+|+||.||+|+..      .++.||+|+++.... ...+.|.+|+.++..++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45778899999999999999753      257899999975533 33567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCc-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC
Q 004580          586 LILEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM  652 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~  652 (744)
                      +++||+++++|..++...             .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999887421             12345788899999999999999999987   99999999999999999


Q ss_pred             ceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       653 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999887644332222233455779999999988889999999999999999998 888886544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=9.1e-31  Score=275.51  Aligned_cols=203  Identities=30%  Similarity=0.438  Sum_probs=169.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccc----eeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ++|++.+.||+|+||.||+|+.. +++    .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            57888899999999999999763 344    47888876443 234567888999999999999999999875 456788


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999853  2346889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            4332222233456778999999998899999999999999999998 999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.1e-30  Score=275.05  Aligned_cols=206  Identities=30%  Similarity=0.506  Sum_probs=174.9

Q ss_pred             cCcccccccCccCceEEEccccc------ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .+|...++||+|+||.||+++..      ++..+|+|.++.......+.|.+|+++++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999998532      356799999887777777889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCce
Q 004580          587 ILEYMPNKSLDVFLFDPTK------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP  654 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~  654 (744)
                      +|||+++++|..++.....            ...+++..++.++.||+.|++|||+.+   |+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998854321            135788999999999999999999987   9999999999999999999


Q ss_pred             EEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |++||....
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            9999999986543322111222345678999999999999999999999999999998 888985543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.5e-30  Score=273.73  Aligned_cols=194  Identities=28%  Similarity=0.414  Sum_probs=170.0

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.++||+|+||.||+|+. .+++.+|+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999975 45789999998654 334456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..+.       .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999986552       3678888999999999999999987   9999999999999999999999999998764322 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                         .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence               22357889999999999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=9e-31  Score=275.14  Aligned_cols=208  Identities=32%  Similarity=0.511  Sum_probs=173.4

Q ss_pred             HhcCcccccccCccCceEEEcccccc------cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      ..++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34679999999999999999997643      4678999886543 3445679999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC---ceEE
Q 004580          584 KILILEYMPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NPKI  656 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~---~~kL  656 (744)
                      .++||||+++++|.+++....    ....+++.+++.++.||+.||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999885432    1235889999999999999999999987   99999999999998764   5999


Q ss_pred             EeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999987644332222222234568999999999999999999999999999997 988987544

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-30  Score=272.52  Aligned_cols=204  Identities=33%  Similarity=0.501  Sum_probs=173.2

Q ss_pred             cCcccccccCccCceEEEcccccc----cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.+.||+|+||.||+|+...    ...||||.++.. ......+|.+|+.++.+++||||+++++.+.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999997642    357999998754 334456799999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|..++...  ...+++.++..++.|++.|++|||+.+   |+|+||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  236889999999999999999999987   99999999999999999999999999998752


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~  213 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence            221111222344678999999998999999999999999999998 998885443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=260.45  Aligned_cols=230  Identities=25%  Similarity=0.285  Sum_probs=186.4

Q ss_pred             HHHHhcCcccccccCccCceEEEccc-ccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC----
Q 004580          508 VAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----  582 (744)
Q Consensus       508 ~~~~~~~y~i~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~----  582 (744)
                      +....++|.+.++||+|||+-||.++ ..+++.+|+|++.-...++.+...+|++.-++++||||++++++...+.    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34456899999999999999999997 4568899999998777778888999999999999999999998875433    


Q ss_pred             -eEEEEEEecCCCChhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          583 -EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       583 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                       +.||+++|...|+|.+.+.... ++..+++.+++.++.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence             5899999999999988875543 4457999999999999999999999975 579999999999999999999999999


Q ss_pred             CceecCCCccccC--------cccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccc
Q 004580          661 LARMFGGDELQGN--------TKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG  729 (744)
Q Consensus       661 la~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~  729 (744)
                      .+....-. ....        .....-|..|.|||.+.   +...++++|||||||+||+|+.|..||+.--...-.+.-
T Consensus       175 S~~~a~i~-i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  175 SATQAPIQ-IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             CccccceE-eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            98764221 0000        11234578999999884   456789999999999999999999999876554433433


Q ss_pred             cccccccccc
Q 004580          730 YVSNKSLHFY  739 (744)
Q Consensus       730 ~~~~~~~~f~  739 (744)
                      .+.+.+..||
T Consensus       254 Av~n~q~s~P  263 (302)
T KOG2345|consen  254 AVQNAQISIP  263 (302)
T ss_pred             eeeccccccC
Confidence            3444455444

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=7.6e-31  Score=273.93  Aligned_cols=201  Identities=25%  Similarity=0.440  Sum_probs=174.5

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      .++|++.+.||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888999999999999999764 5889999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++.   ..+.+++.++..++.|++.|+.|||+.+   |+|+||||+||+++.++.+||+|||++..+.... 
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999999874   3446889999999999999999999997   9999999999999999999999999998764322 


Q ss_pred             ccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                       .......++..|+|||++.   ...++.++|+|||||++|||++|+.||...
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence             1223357889999999874   456889999999999999999999997543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=1e-30  Score=277.57  Aligned_cols=200  Identities=28%  Similarity=0.446  Sum_probs=175.8

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .+|++.+.||+|++|.||+|+. .+++.+|+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            6889999999999999999975 458899999987665555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++.    ...+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999873    234788999999999999999999987   99999999999999999999999999886543221 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence             1122467889999999998889999999999999999999999996554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=1.3e-30  Score=269.91  Aligned_cols=202  Identities=30%  Similarity=0.458  Sum_probs=176.5

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+++.. +++.+++|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999864 5889999988643  345567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++... ....+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356889999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  .....+++.|+|||++.+..++.++|+||||++++||++|+.||...+
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            1  223467889999999999999999999999999999999999997655

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.3e-31  Score=271.65  Aligned_cols=202  Identities=34%  Similarity=0.496  Sum_probs=171.9

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      .+|++.+.||+|+||.||+++...+..+|+|.+.... ...++|.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4578889999999999999987777789999986432 234678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|.+++...  ...+++..+..++.||+.|++|||+.+   |+||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999988532  236889999999999999999999988   9999999999999999999999999998764332111


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence             111223457999999999999999999999999999999 788887554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=9.9e-31  Score=276.52  Aligned_cols=208  Identities=27%  Similarity=0.453  Sum_probs=172.8

Q ss_pred             HhcCcccccccCccCceEEEccccc------ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998643      24579999886543 3344568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          584 KILILEYMPNKSLDVFLFDPT-------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                      .++||||+++|+|..++....       .....++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999985421       1234567788999999999999999987   999999999999999999999


Q ss_pred             EeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999986544332222222345678999999999999999999999999999998 778886543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.1e-30  Score=287.73  Aligned_cols=207  Identities=31%  Similarity=0.450  Sum_probs=172.1

Q ss_pred             hcCcccccccCccCceEEEccccc------ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~  583 (744)
                      .++|.+.+.||+|+||.||+|++.      .++.||||+++... ....+.+.+|++++.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457888899999999999999753      24679999997543 333457899999999997 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcC-----------------------------------------------------------
Q 004580          584 KILILEYMPNKSLDVFLFDPT-----------------------------------------------------------  604 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  604 (744)
                      .++||||+++|+|.++++...                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999885321                                                           


Q ss_pred             ------------------------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 004580          605 ------------------------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL  648 (744)
Q Consensus       605 ------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl  648 (744)
                                                          ....+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                1124677888999999999999999887   9999999999999


Q ss_pred             eCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999987543221111222356788999999998889999999999999999998 888986543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.8e-30  Score=277.42  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=172.9

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.++.. .....+++.+|++++.+++||||+++++.+.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999764 4778899988654 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++..   ...+++..+..++.||++||+|||+..  +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            999999999843   356889999999999999999999842  39999999999999999999999999987653321 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence               223467899999999988889999999999999999999999986443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.6e-30  Score=272.04  Aligned_cols=204  Identities=30%  Similarity=0.485  Sum_probs=169.8

Q ss_pred             cccccccCccCceEEEcccccc----cceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe-----
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE-----  583 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~-----  583 (744)
                      |.+.+.||+|+||.||+|....    +..+|+|+++..  .....+++.+|+..++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999997642    367999998754  33446789999999999999999999998876554     


Q ss_pred             -EEEEEEecCCCChhhhhcCcC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEee
Q 004580          584 -KILILEYMPNKSLDVFLFDPT---KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DF  659 (744)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432   2346889999999999999999999987   999999999999999999999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |+++.+..............+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~  220 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE  220 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            99987654332222222334678999999988899999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=8.8e-31  Score=292.21  Aligned_cols=194  Identities=25%  Similarity=0.322  Sum_probs=166.5

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..+|.+.+.||+|+||.||++++.. ++.||||...      ...+.+|++++++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999998754 7889999643      23457899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +. ++|..++..  ....+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 677777643  2346899999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~  717 (744)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22223457899999999999999999999999999999999988654

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=9.3e-31  Score=275.35  Aligned_cols=208  Identities=27%  Similarity=0.418  Sum_probs=176.0

Q ss_pred             HhcCcccccccCccCceEEEcccccc-----cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-cCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-~~~  583 (744)
                      ..++|++.+.||+|+||.||+|...+     +..|++|+++.. .....+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35788999999999999999998755     678999998754 34456778999999999999999999998776 467


Q ss_pred             EEEEEEecCCCChhhhhcCcCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEe
Q 004580          584 KILILEYMPNKSLDVFLFDPTKK-----RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD  658 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~D  658 (744)
                      .++++||+++++|..++......     ..+++.++..++.||+.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998543222     56899999999999999999999987   99999999999999999999999


Q ss_pred             ecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||...+
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  224 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID  224 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence            999987644332222222345678999999998899999999999999999999 999987543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=1.3e-30  Score=272.47  Aligned_cols=200  Identities=27%  Similarity=0.364  Sum_probs=162.1

Q ss_pred             cccCccCceEEEcccccc---cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+|+...   ...+|+|.++... ......|.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999996533   3468888876442 344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCcCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          595 SLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +|..++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  234567788899999999999999987   9999999999999999999999999987643332211


Q ss_pred             CcccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            1222345678999998743       456889999999999999999 777876543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=1.2e-30  Score=272.26  Aligned_cols=204  Identities=27%  Similarity=0.430  Sum_probs=175.1

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+|+.. +++.+|||.++..   .......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999864 5889999987542   3344567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          589 EYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||+++++|..++.... ....++...+..++.||++||+|||+.+   |+|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988875322 3445788999999999999999999987   99999999999999999999999999987654


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...  ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence            321  1122467889999999998889999999999999999999999985443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=2.4e-30  Score=274.14  Aligned_cols=202  Identities=32%  Similarity=0.513  Sum_probs=174.8

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +.|++.++||+|+||.||+|+... ++.+|+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            678999999999999999998754 7899999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++..  ....+++..+..++.|++.+++|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            99999887643  2345889999999999999999999987   9999999999999999999999999987643321  


Q ss_pred             cCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .......++..|+|||++.     ...++.++|||||||++|||++|++||...+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  219 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  219 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence            1122346788999999985     3457889999999999999999999986644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1.8e-30  Score=268.69  Aligned_cols=198  Identities=30%  Similarity=0.451  Sum_probs=166.9

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      +.||+|+||.||+|+.. +++.+|+|.++.. .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999864 5889999988654 344557799999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      ..++..  ....+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            998843  2345789999999999999999999987   99999999999999999999999999886543221111111


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~  201 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS  201 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            223457999999999999999999999999999998 888886544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=2e-30  Score=273.28  Aligned_cols=202  Identities=31%  Similarity=0.436  Sum_probs=170.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++..  .....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999864 5889999998643  223356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ++ ++|..++........+++.++..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            98 578777754444467899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||++.+. .++.++||||||++++||++|++||....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              11223568899999988654 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=1.6e-30  Score=271.10  Aligned_cols=203  Identities=32%  Similarity=0.493  Sum_probs=173.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .+|++.+.||+|++|.||+|... .++.+|+|+++.. ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999864 4788999998754 334577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999988542 2345789999999999999999999987   999999999999999999999999999876543221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . ......+..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  210 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  210 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            1 111234568999999999999999999999999999998 899987644

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=1.6e-30  Score=277.67  Aligned_cols=207  Identities=32%  Similarity=0.499  Sum_probs=172.7

Q ss_pred             hcCcccccccCccCceEEEccccc--------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ  581 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~  581 (744)
                      .++|.+.+.||+|+||.||+++..        ....+|+|.++.. ......++.+|+.++.++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999998642        2346999999754 344566788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 004580          582 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL  648 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl  648 (744)
                      +..++||||+++++|.+++....             ....+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999986432             1235889999999999999999999987   9999999999999


Q ss_pred             eCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999999999999986643222111222234568999999998899999999999999999998 888886544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.5e-30  Score=272.27  Aligned_cols=200  Identities=28%  Similarity=0.372  Sum_probs=164.4

Q ss_pred             cccCccCceEEEcccccc---cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.||+|+||.||+|...+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999997533   4579999887653 334457899999999999999999999999989999999999999


Q ss_pred             ChhhhhcCcC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          595 SLDVFLFDPT--KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       595 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +|..++....  .....++..+..++.|+++|++|||+.+   ++||||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2234567788899999999999999987   9999999999999999999999999997654333222


Q ss_pred             CcccccccccccCcccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  214 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS  214 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            22234567889999988642       35789999999999999996 999997654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.7e-30  Score=276.95  Aligned_cols=207  Identities=31%  Similarity=0.503  Sum_probs=173.9

Q ss_pred             hcCcccccccCccCceEEEccccc--------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ  581 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~  581 (744)
                      .++|.+.+.||+|+||.||+++..        ++..+|+|.++.. .....+++.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999631        2457999998754 344567899999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 004580          582 GEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL  648 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl  648 (744)
                      ...++||||+++++|..++....             ....+++.++..++.||++||.|||+.+   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999986432             1235788899999999999999999987   9999999999999


Q ss_pred             eCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999987754332222222345678999999998899999999999999999998 778876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=2e-30  Score=272.79  Aligned_cols=204  Identities=31%  Similarity=0.472  Sum_probs=170.2

Q ss_pred             hcCcccccccCccCceEEEccccc-ccc----eeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      .++|++.+.||+|+||.||+|+.. +++    .||+|.++.. .....+++.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            367888999999999999999753 344    4899998754 34456788999999999999999999999875 4577


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +++||+++|+|.+++...  ...+++.+++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999988542  345889999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..||+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  216 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP  216 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            54322111112234678999999998899999999999999999998 889987543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.1e-30  Score=270.97  Aligned_cols=198  Identities=35%  Similarity=0.548  Sum_probs=172.6

Q ss_pred             cccccccCccCceEEEcccccc-cceeEEEeccCCChhhHH--HHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLE--EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~--~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      |++.+.||+|+||.||+++... ++.+|+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6778999999999999998654 668999999876443322  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++.   ....+++.++..++.||++||++||+.+   |+|+||||+||++++++.++|+|||.+......  .
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence            9999999885   4566899999999999999999999997   999999999999999999999999999864211  1


Q ss_pred             cCcccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .......++..|+|||++. +..++.++||||+|+++++|++|+.||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2233457789999999998 888999999999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=6.4e-31  Score=296.99  Aligned_cols=200  Identities=24%  Similarity=0.326  Sum_probs=163.7

Q ss_pred             HHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCC------CeeeEEEEEEEc
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR------NLVKLLGCCVEQ  581 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hp------nIv~l~~~~~~~  581 (744)
                      ....++|++.++||+|+||.||+|.+. .++.||||+++... ....++..|+.++++++|.      +++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345688999999999999999999864 47889999986432 2344567788888887654      588888888764


Q ss_pred             -CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEeCCC-------
Q 004580          582 -GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDM-------  652 (744)
Q Consensus       582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~IiHrDLk~~NILl~~~~-------  652 (744)
                       .+.++|||++ +++|..++.   ....+++.++..++.||+.||+|||++ +   ||||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             5788999988 667777763   335689999999999999999999984 6   99999999999998765       


Q ss_pred             ---------ceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          653 ---------NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       653 ---------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..+
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     499999998764221     2234678999999999999999999999999999999999999997654

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=2.5e-30  Score=272.43  Aligned_cols=202  Identities=30%  Similarity=0.482  Sum_probs=173.7

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +.|++.+.||+|+||.||+++... +..+++|.+........+.+.+|+++++.++||||+++++.+...+..++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            346788899999999999998754 6788999987666667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus        85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--  157 (282)
T cd06643          85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  157 (282)
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence            99999887753  2346899999999999999999999987   9999999999999999999999999987653322  


Q ss_pred             cCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .......++..|+|||++.     +..++.++|||||||++|||++|++||...+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            1122346889999999984     3457889999999999999999999987544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=1.4e-30  Score=282.64  Aligned_cols=207  Identities=30%  Similarity=0.459  Sum_probs=169.6

Q ss_pred             hcCcccccccCccCceEEEcccc------cccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc-C
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ-G  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~-~  582 (744)
                      .++|++.+.||+|+||.||+|+.      ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            36799999999999999999963      346789999997543 33456788999999999 689999999988654 4


Q ss_pred             eEEEEEEecCCCChhhhhcCcC----------------------------------------------------------
Q 004580          583 EKILILEYMPNKSLDVFLFDPT----------------------------------------------------------  604 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  604 (744)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999998875321                                                          


Q ss_pred             ------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccccc
Q 004580          605 ------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV  678 (744)
Q Consensus       605 ------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  678 (744)
                            ....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  0124678888999999999999999987   9999999999999999999999999998754322111122234


Q ss_pred             ccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       679 gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            5678999999999999999999999999999997 888886543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-30  Score=276.29  Aligned_cols=206  Identities=29%  Similarity=0.461  Sum_probs=170.7

Q ss_pred             cCcccccccCccCceEEEcccccc---------------cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLG  576 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~  576 (744)
                      .+|++.+.||+|+||.||+++..+               ...||+|.++.. .....+.|.+|++++.+++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999986532               224899998764 3344567999999999999999999999


Q ss_pred             EEEEcCeEEEEEEecCCCChhhhhcCcC---------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 004580          577 CCVEQGEKILILEYMPNKSLDVFLFDPT---------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL  647 (744)
Q Consensus       577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NIL  647 (744)
                      ++...+..++||||+++++|..++....         ....+++..+..++.|++.||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885422         1124688899999999999999999987   999999999999


Q ss_pred             EeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 004580          648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYN  721 (744)
Q Consensus       648 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt--G~~p~~~~~  721 (744)
                      ++.++.+||+|||++................++..|+|||++.+..++.++||||||++++||++  |..||....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99999999999999986543322222222345678999999998889999999999999999998  556776543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2.1e-30  Score=270.12  Aligned_cols=203  Identities=33%  Similarity=0.522  Sum_probs=171.5

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.++||+|+||.||+|+..++..||+|+++... ...++|.+|+.++++++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35799999999999999999987666789999997532 23467899999999999999999999864 45689999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999998542 2345789999999999999999999987   999999999999999999999999999876543321


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            1 122345678999999988899999999999999999999 788886544

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=1.7e-30  Score=278.57  Aligned_cols=198  Identities=25%  Similarity=0.414  Sum_probs=160.0

Q ss_pred             cccCccCceEEEccccc---ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE--cCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~  593 (744)
                      ++||+|+||.||+|+..   +++.+|+|.++...  ....+.+|+.++++++||||+++++++..  ....+++|||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            58999999999999754   45789999986542  23457889999999999999999998864  4568899999875


Q ss_pred             CChhhhhcCc------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----eCCCceEEEeecCce
Q 004580          594 KSLDVFLFDP------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLAR  663 (744)
Q Consensus       594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl----~~~~~~kL~DFGla~  663 (744)
                       +|..++...      .....+++..+..++.||+.||+|||+.+   |+||||||+|||+    +..+.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence             666655321      12235888999999999999999999988   9999999999999    455789999999998


Q ss_pred             ecCCCccc-cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          664 MFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      .+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||.....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~  221 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence            76543211 12234578999999999877 4589999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=306.66  Aligned_cols=210  Identities=26%  Similarity=0.319  Sum_probs=182.3

Q ss_pred             HHHHHHHhcCcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE
Q 004580          505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE  580 (744)
Q Consensus       505 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~  580 (744)
                      ...+....++|+++++||+|+||.|..++++. ++.+|+|++.+.   ......-|..|-.+|..-+.+=|+.+..+|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34455567899999999999999999998765 788999999873   34456778999999988888999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ..++|+|||||+||+|-.++...   ..+++..++.++..|.-||.-||+.|   +|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            99999999999999999988443   36899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .+-.+..+.. ......+|||.|++||++.    + +.|+...|.||+||++|||+.|..||....
T Consensus       221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            9988764432 2234469999999999984    3 579999999999999999999999986544

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=273.59  Aligned_cols=207  Identities=28%  Similarity=0.450  Sum_probs=175.3

Q ss_pred             hcCcccccccCccCceEEEcccccc------cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++|++.+.||+|+||.||+|....      +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999997532      3689999987543 34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC-------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          585 ILILEYMPNKSLDVFLFDPT-------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                      ++||||+++++|..++....       ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999985422       1234788999999999999999999987   9999999999999999999999


Q ss_pred             eecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            9999987654332222233456789999999988889999999999999999998 899987554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.2e-30  Score=285.46  Aligned_cols=198  Identities=27%  Similarity=0.338  Sum_probs=167.6

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------C
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------G  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------~  582 (744)
                      .++|++.+.||+|+||.||++... .++.||||++...  ......++.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999764 4788999998753  334456788999999999999999999987543      3


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++||||+++ +|...+.     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            57999999976 4555542     23778889999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            8754322   1223468999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=2.7e-30  Score=270.40  Aligned_cols=203  Identities=31%  Similarity=0.513  Sum_probs=166.8

Q ss_pred             ccccccCccCceEEEcccccc-cc--eeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------CeE
Q 004580          516 SMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GEK  584 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------~~~  584 (744)
                      .+.+.||+|+||.||+|+..+ ++  .+|+|.++..  .....+.+.+|+.++++++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456899999999999998654 32  5899988654  344567899999999999999999999987542      256


Q ss_pred             EEEEEecCCCChhhhhcCc---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          585 ILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                      +++|||+++|+|..++...   .....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999998887422   22345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  219 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE  219 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            987654322111222345678999999999999999999999999999999 788886543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=2.4e-30  Score=269.92  Aligned_cols=202  Identities=29%  Similarity=0.438  Sum_probs=170.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-----ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~  584 (744)
                      .+|++.+.||+|+||.||++... +++.||+|.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999864 4889999987532     123456788999999999999999999988764  467


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      +++|||+++++|..++..   ...+++.....++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999988842   345788889999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            5432111 1223346788999999998888999999999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=2.6e-30  Score=273.48  Aligned_cols=205  Identities=32%  Similarity=0.497  Sum_probs=171.1

Q ss_pred             CcccccccCccCceEEEccccc------ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      +|++.+.||+|+||.||+|+..      ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999752      23568899887543 3445789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcC---------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 004580          587 ILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN  645 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~N  645 (744)
                      ++||+++++|..++....                     ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998874321                     1235788999999999999999999987   9999999999


Q ss_pred             EEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999986543322111222345678999999988889999999999999999998 998986544

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.1e-30  Score=276.57  Aligned_cols=208  Identities=31%  Similarity=0.500  Sum_probs=174.9

Q ss_pred             HhcCcccccccCccCceEEEccccc------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcC
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      ..++|++.+.||+|+||.||++...      ....+|+|.++.. ......++.+|+.++.++ +||||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3467889999999999999999753      2357999998754 334456789999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCc-------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          583 EKILILEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                      ..+++|||+++++|..++...             .....+++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999988532             22456889999999999999999999987   99999999999999


Q ss_pred             CCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999987654332222222345678999999999999999999999999999998 888886544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.2e-30  Score=284.35  Aligned_cols=199  Identities=28%  Similarity=0.333  Sum_probs=167.9

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------  581 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------  581 (744)
                      ..++|++.+.||+|+||.||++... .++.+|||+++..  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4478999999999999999999764 4789999998754  334456788999999999999999999988643      


Q ss_pred             CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                      ...++||||++++ +...+.     ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            3579999999764 444442     24788889999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++......   ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98654322   1223578999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=2.4e-30  Score=274.92  Aligned_cols=201  Identities=28%  Similarity=0.441  Sum_probs=176.8

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      .++|++.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36899999999999999999985 46899999998766555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++.    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999999873    235788999999999999999999987   99999999999999999999999999987544321


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  122467889999999999889999999999999999999999996654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=2.2e-30  Score=274.73  Aligned_cols=207  Identities=30%  Similarity=0.467  Sum_probs=174.3

Q ss_pred             hcCcccccccCccCceEEEcccccc-----------------cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeee
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVK  573 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~  573 (744)
                      .++|++.+.||+|+||.||+++..+                 +..||+|.+.... ....+++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678999999999999999986532                 2458999987653 345678999999999999999999


Q ss_pred             EEEEEEEcCeEEEEEEecCCCChhhhhcCcC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 004580          574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN  645 (744)
Q Consensus       574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~N  645 (744)
                      +++++...+..++++||+++++|..++....        ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985432        1236899999999999999999999987   9999999999


Q ss_pred             EEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 004580          646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYN  721 (744)
Q Consensus       646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt--G~~p~~~~~  721 (744)
                      |+++.++.++|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++  |..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999987654332222233456778999999998889999999999999999998  566775543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.7e-30  Score=268.76  Aligned_cols=203  Identities=35%  Similarity=0.535  Sum_probs=172.1

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.++||+|+||.||++...++..+|+|.++.... ..++|.+|+.++++++|||++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357889999999999999999877788899999875432 3567999999999999999999999874 45688999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++.++..++.+++.||+|||+.+   |+||||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999988643 2345789999999999999999999987   999999999999999999999999999876543221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            1 112345668999999988889999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=2.5e-30  Score=274.64  Aligned_cols=200  Identities=29%  Similarity=0.463  Sum_probs=176.2

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ++|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            5689999999999999999975 468899999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++.    ...+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            9999999873    235889999999999999999999997   999999999999999999999999998865443211


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              123467889999999999889999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=2.7e-30  Score=274.53  Aligned_cols=203  Identities=32%  Similarity=0.476  Sum_probs=169.2

Q ss_pred             cCcccccccCccCceEEEcccccc-cc--eeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999997643 33  4788888753 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCce
Q 004580          588 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP  654 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~  654 (744)
                      +||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985421             1235889999999999999999999987   9999999999999999999


Q ss_pred             EEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ||+|||++.......   .......+..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999986432111   1111223557999999998899999999999999999998 999986654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=3.8e-30  Score=268.29  Aligned_cols=204  Identities=29%  Similarity=0.443  Sum_probs=176.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|++|.||+|... +++.+|+|.++..   .....+++.+|++++++++|+||+++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999875 6889999988642   2334678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||+++++|..++... .....+++.++..++.++++||+|||+.+   |+||||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888543 23456889999999999999999999987   99999999999999999999999999887644


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence            3211  122467889999999998889999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=2.5e-30  Score=275.43  Aligned_cols=206  Identities=32%  Similarity=0.451  Sum_probs=173.4

Q ss_pred             hcCcccccccCccCceEEEcccc------cccceeEEEeccCCC-hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~  583 (744)
                      .++|.+.+.||+|+||.||++..      ..+..+|||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            36789999999999999999863      124579999987543 34456799999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .++||||+++++|..++.... ...+++.++..++.||+.||+|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999985422 234899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            6643321111122345778999999999999999999999999999998 999986544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=3.9e-30  Score=268.81  Aligned_cols=206  Identities=30%  Similarity=0.451  Sum_probs=172.3

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      +++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            4455555679999999999999864 477899999877666677889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~~  668 (744)
                      |+++++|..++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++..+...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999999864322112277888899999999999999987   999999999999986 679999999999866432


Q ss_pred             ccccCcccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..  ......+++.|+|||++....  ++.++||||||+++|||++|+.||....
T Consensus       163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            21  122245788999999986643  7899999999999999999999986543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=272.75  Aligned_cols=203  Identities=28%  Similarity=0.455  Sum_probs=176.3

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      .++|++.+.||+|+||.||+++.. +++.+|+|.++.......+.|.+|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999864 5789999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++..  ....+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999998843  2345899999999999999999999998   99999999999999999999999999876533211


Q ss_pred             ccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||.+.     ...++.++|+||||+++|||++|+.||...+
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence              122346888999999875     3457889999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=3e-30  Score=269.47  Aligned_cols=203  Identities=30%  Similarity=0.455  Sum_probs=170.9

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-----hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~  584 (744)
                      .+|+..+.||+|+||.||++... .++.+|+|+++...     ....+.+.+|+.++++++||||+++++.+.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888899999999999999764 48899999876431     23456788999999999999999999988753  577


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++++||+++++|..++..   ...+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999988843   345788999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCcc-ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          665 FGGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~  213 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE  213 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence            543211 111223457889999999998889999999999999999999999997553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=2.7e-30  Score=274.33  Aligned_cols=206  Identities=29%  Similarity=0.466  Sum_probs=171.5

Q ss_pred             cCcccccccCccCceEEEccccc-----------------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKL  574 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l  574 (744)
                      ++|++.+.||+|+||.||+++..                 +...+|+|+++.. .....++|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998532                 2346899998754 34456789999999999999999999


Q ss_pred             EEEEEEcCeEEEEEEecCCCChhhhhcCcC--------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 004580          575 LGCCVEQGEKILILEYMPNKSLDVFLFDPT--------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNV  646 (744)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NI  646 (744)
                      ++++...+..++||||+++++|..++....        ....+++.++..++.||+.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            999999999999999999999999885432        1234778899999999999999999997   99999999999


Q ss_pred             EEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 004580          647 LLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--GKKNTGVYN  721 (744)
Q Consensus       647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt--G~~p~~~~~  721 (744)
                      |++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999987644322221222344678999999888899999999999999999998  667776543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=2.5e-30  Score=273.21  Aligned_cols=200  Identities=28%  Similarity=0.432  Sum_probs=164.2

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHh---cCCCeeeEEEEEEE-----cC
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVE-----QG  582 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~HpnIv~l~~~~~~-----~~  582 (744)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++...  ......+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 58899999886532  22233456677777665   69999999998864     24


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++||||+++ +|..++... ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 777776432 2345889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +.+....   ......++..|+|||++.+..++.++|||||||++|||++|++||....
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence            8764322   1223467889999999998899999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=3.4e-30  Score=268.64  Aligned_cols=202  Identities=30%  Similarity=0.470  Sum_probs=173.0

Q ss_pred             CcccccccCccCceEEEcccccccceeEEEeccCCC------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +|++.+.||+|+||.||+|...+++.+|+|.++...      ....+.+.+|+.++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788999999999999987788999999886432      22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +||+++++|..++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   345788999999999999999999987   99999999999999999999999999886532


Q ss_pred             Ccc----ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DEL----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...    ........++..|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence            111    111223467889999999998889999999999999999999999997543

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=3.2e-30  Score=276.19  Aligned_cols=206  Identities=33%  Similarity=0.510  Sum_probs=172.0

Q ss_pred             cCcccccccCccCceEEEccccc--------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      ++|.+.+.||+|+||.||+++..        ....+|+|.++.. .....+++.+|+.++.++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            67888999999999999998642        2457899998754 334567789999999999 5999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          583 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                      ..+++|||+++|+|..++....             ....+++.++..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999985422             1245889999999999999999999987   99999999999999


Q ss_pred             CCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999987644322111222234567999999999999999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.1e-31  Score=281.76  Aligned_cols=204  Identities=26%  Similarity=0.423  Sum_probs=180.7

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ...|.+.+.||+|.|+.|.++++. .+..||+|.+.+.  +....+.+.+|+++|..++|||||+++.+...+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467899999999999999999864 4899999998765  3344556899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||..+|.+.+++.   +.+.+.+..+..++.|+.+|++|||+++   |||||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999994   4455667888999999999999999998   999999999999999999999999999987643


Q ss_pred             ccccCcccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .   .....+|++.|.|||++.+..| ++++|+||+|++||.|+.|..||+..+-.+
T Consensus       209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~  262 (596)
T KOG0586|consen  209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE  262 (596)
T ss_pred             c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence            2   3455799999999999998776 589999999999999999999999876544

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=2.7e-30  Score=270.43  Aligned_cols=204  Identities=30%  Similarity=0.487  Sum_probs=171.4

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc------C
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ------G  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~------~  582 (744)
                      +.+.|++.+.||+|+||.||+|+.. .++.+|+|++.... ....++.+|+.++.++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4577888999999999999999764 47889999986443 3456788999999998 699999999998753      4


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++||||+++++|..++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            688999999999999988542 2346889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCccccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||....
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            8754322  1223357889999999986     3468889999999999999999999986543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2e-30  Score=281.43  Aligned_cols=198  Identities=30%  Similarity=0.396  Sum_probs=167.6

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc-----
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----  581 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~-----  581 (744)
                      ...++|++.+.||+|+||.||++... .++.||||+++...  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999754 57899999986532  23456678999999999999999999887543     


Q ss_pred             -CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          582 -GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                       ...++++|++ +++|..++.    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3578999987 678877662    345899999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +++.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99875432     223468999999999877 56899999999999999999999999654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=267.13  Aligned_cols=202  Identities=27%  Similarity=0.445  Sum_probs=176.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ++|++.+.||+|+||.||+++.. +++.+|+|.+........+.+.+|+.++++++||||+++++.+.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            67899999999999999999864 47789999987765556788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++...  ...+++.++..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++..+..... 
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999987432  246889999999999999999999987   99999999999999999999999999886543211 


Q ss_pred             cCcccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||.+...   .++.++|+||||+++|||++|+.||...+
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence             11234678899999999777   88999999999999999999999986544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=281.34  Aligned_cols=205  Identities=31%  Similarity=0.488  Sum_probs=179.3

Q ss_pred             HhcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ...++.+..+||-|.||.||.|.++. .-.||||.|+.+. ...++|..|..+|+.++|||+|+|+|+|..+..+|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34566777899999999999998754 6689999997654 457899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      ||.+|+|.+||.+.. +..++..-.+.++.||..||+||...+   +|||||..+|+|+.++..+|++|||+++++..+.
T Consensus       344 fM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            999999999997643 345677778899999999999999987   9999999999999999999999999999987765


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      +... ....-+..|.|||-+.-..|+.|+|||+|||+|||+.| |-.||...+
T Consensus       420 YTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  420 YTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             eecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            5432 22344779999999999999999999999999999999 888887654

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.9e-30  Score=302.84  Aligned_cols=208  Identities=25%  Similarity=0.391  Sum_probs=171.7

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI  585 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~  585 (744)
                      ..++|++++.||+|+||.||+++.. .++.+|+|.+...  .......|..|+.++..++|||||++++++.+.  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3478999999999999999999864 4678899988643  344567799999999999999999999988654  5689


Q ss_pred             EEEEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEecCCCCCEEEeCC---------
Q 004580          586 LILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR----FRIIHRDLKASNVLLDMD---------  651 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~IiHrDLk~~NILl~~~---------  651 (744)
                      |||||+++++|..+|... .....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+..         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999988542 223568999999999999999999998542    349999999999999642         


Q ss_pred             --------CceEEEeecCceecCCCccccCcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          652 --------MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       652 --------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                              ..+||+|||++..+.....   .....||+.|+|||++.+  ..++.++||||||||||||++|+.||...+
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    3489999999987643321   223578999999999864  458899999999999999999999996543

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=4.4e-30  Score=267.18  Aligned_cols=203  Identities=35%  Similarity=0.515  Sum_probs=173.5

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++||||+++++++ ..+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence            46789999999999999999998888999999987543 3456899999999999999999999886 456789999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999987543 2346889999999999999999999987   999999999999999999999999999876533221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      . .....++..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus       159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            1 112345678999999998889999999999999999999 999997544

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-30  Score=268.93  Aligned_cols=200  Identities=28%  Similarity=0.418  Sum_probs=175.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++||||+++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999864 58899999986543 44556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999998843    26899999999999999999999987   9999999999999999999999999998875432 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence             12223467889999999998889999999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=7.3e-30  Score=263.67  Aligned_cols=197  Identities=32%  Similarity=0.439  Sum_probs=168.4

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChh
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD  597 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (744)
                      ++||+|+||.||+|...+++.+|+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999988788899999987653 334557899999999999999999999999999999999999999999


Q ss_pred             hhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccc
Q 004580          598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI  677 (744)
Q Consensus       598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  677 (744)
                      .++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            987532  345789999999999999999999987   9999999999999999999999999997654332211 1112


Q ss_pred             cccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       678 ~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .++..|+|||++....++.++||||||+++|||++ |..||....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            34568999999998899999999999999999999 898986554

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3e-30  Score=272.35  Aligned_cols=203  Identities=26%  Similarity=0.419  Sum_probs=172.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|+||.||+++.. .++.+|+|.++.. .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999875 5889999988654 344457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++........+++..+..++.||+.||.|||+..  +|+|+||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999998865433446899999999999999999999742  39999999999999999999999999997653321 


Q ss_pred             ccCcccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         .....++..|+|||.+.+.      .++.++|+|||||++|||++|+.||....
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  211 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET  211 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence               2224578899999998544      35889999999999999999999996543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=3.1e-30  Score=269.14  Aligned_cols=204  Identities=27%  Similarity=0.435  Sum_probs=175.7

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|++|.||+++. .+++.+|||.+...   .....+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 46889999987643   3344568899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||+++++|..++... .....+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999987532 23456899999999999999999999987   99999999999999999999999999887643


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            321  1123467889999999998899999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=285.15  Aligned_cols=195  Identities=32%  Similarity=0.521  Sum_probs=171.9

Q ss_pred             ccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhh
Q 004580          520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV  598 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (744)
                      +||+|.||+||-|++.+ ...+|||.+........+-+.+|+.+.+.++|.|||+++|.+.+.+..-+.||.+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999765 55799999987777777889999999999999999999999999999999999999999999


Q ss_pred             hhcCcCCcccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCCCccccCcc
Q 004580          599 FLFDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTK  675 (744)
Q Consensus       599 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~  675 (744)
                      +|..  +=+++  ++..+-.+.+||++||.|||++.   |||||||-+|||++. .|.+||+|||-++.+..-  .+-+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence            9853  33445  67788899999999999999998   999999999999975 588999999999987553  34556


Q ss_pred             cccccccccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          676 RIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       676 ~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...||..|||||++..++  |+.++|||||||.+.||.||++||-...
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg  782 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG  782 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence            688999999999997654  8899999999999999999999995543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=5.9e-30  Score=269.80  Aligned_cols=201  Identities=27%  Similarity=0.379  Sum_probs=172.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999875 48899999886432  2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|..++.   ....+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999887763   3345899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|++||...+
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            1  1222456788999999876 568899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=285.09  Aligned_cols=197  Identities=34%  Similarity=0.487  Sum_probs=168.5

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +-|+-++.||.|+||.||.+++ .+.+.||||++.-.   +.....++..|++.|.+++|||++.+.|+|..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3466778999999999999986 45788999998643   3445678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      |||-|. -.+++.  ....++.+.++..|..+.+.||+|||+++   .||||||+.||||++.+.+||+|||.|....+.
T Consensus       106 EYClGS-AsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYCLGS-ASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHhcc-HHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            999654 333331  23456888999999999999999999998   999999999999999999999999999876442


Q ss_pred             ccccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                            ..++|||.|||||+|.   .+.|+-|+||||||+...||...++|.-.++
T Consensus       180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN  229 (948)
T KOG0577|consen  180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  229 (948)
T ss_pred             ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence                  3479999999999984   5789999999999999999999999865444

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=3.5e-30  Score=272.23  Aligned_cols=206  Identities=30%  Similarity=0.485  Sum_probs=172.9

Q ss_pred             hcCcccccccCccCceEEEccccc------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++|++.+.||+|+||.||+++..      ++..+|+|+++.. ......+|.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999753      4678999998754 334457799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcC-------------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 004580          585 ILILEYMPNKSLDVFLFDPT-------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASN  645 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~N  645 (744)
                      ++|+||+++++|..++....                   ....+++.+++.++.||+.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788899999999999999999987   9999999999


Q ss_pred             EEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004580          646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVY  720 (744)
Q Consensus       646 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~  720 (744)
                      |+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999986544322222222334667999999998899999999999999999998 87787544

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=5.3e-30  Score=267.46  Aligned_cols=201  Identities=31%  Similarity=0.517  Sum_probs=171.6

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCCh---------hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---------~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999764 478999998864322         123578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .++|+||+++++|..++.   ....+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999884   3346788999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCcccc----CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          664 MFGGDELQG----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       664 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .+.......    ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            775322111    112245788999999999888999999999999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=4.1e-30  Score=273.60  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=169.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            67899999999999999999764 47899999986442 33345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ++ ++|..++..  ....+++..+..++.||++||+|||+.+   |+|+||||+|||++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 578777743  2345788999999999999999999987   99999999999999999999999999976433221


Q ss_pred             ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence              11224568899999988654 57899999999999999999999997544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-30  Score=279.26  Aligned_cols=192  Identities=24%  Similarity=0.321  Sum_probs=163.1

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ....+|++.+.||+|+||.||+|+.. .++.||+|+....      ....|+.++++++||||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            44568999999999999999999865 4678999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+. ++|..++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777643  3446899999999999999999999987   999999999999999999999999999753322


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN  716 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p  716 (744)
                      .   ......||..|+|||++.+..++.++|||||||++|||+++..+
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            1   22235689999999999999999999999999999999986554

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=6.7e-30  Score=269.35  Aligned_cols=199  Identities=35%  Similarity=0.447  Sum_probs=166.5

Q ss_pred             cccccccCccCceEEEccc-----ccccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGR-----LLNGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL  586 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~-----~~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~l  586 (744)
                      |++.+.||+|+||+||++.     ..+++.||+|.++... ....+.|.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3788999999999998754     2357789999987543 34567789999999999999999999988654  36789


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+++++|.+++..    ..+++.++..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998843    34899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCcccc-CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            422111 111224566799999998888999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=4.9e-30  Score=265.91  Aligned_cols=202  Identities=24%  Similarity=0.381  Sum_probs=174.5

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999764 5889999988643 3445678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++... ....++...+..++.||+.||.|||+.+   |+|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998887432 3345788999999999999999999987   99999999999999999999999999987643221 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence             1223568889999999998889999999999999999999999997544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2.6e-30  Score=317.86  Aligned_cols=191  Identities=28%  Similarity=0.485  Sum_probs=162.8

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ..+...+.||+|+||.||+|+. .++..||||+++.....    ...|++.+++++|||||++++++.+++..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4577778999999999999986 46889999998654322    134688899999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++|+|.++++      .++|.++.+++.||++||+|||..+.++|+||||||+||+++.++..++. |+........   
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999984      27899999999999999999997766679999999999999999888876 6665443211   


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                         ....+++.|||||++.+..++.++|||||||++|||+||+.||+..
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence               1236789999999999999999999999999999999999998644

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=5.9e-30  Score=274.29  Aligned_cols=198  Identities=26%  Similarity=0.416  Sum_probs=159.5

Q ss_pred             cccCccCceEEEccccc---ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE--cCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~  593 (744)
                      .+||+|+||.||+|+..   .+..+|+|.++...  ....+.+|+.++++++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999864   35689999986542  23467889999999999999999998854  4578899999986


Q ss_pred             CChhhhhcCc------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----eCCCceEEEeecCce
Q 004580          594 KSLDVFLFDP------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLAR  663 (744)
Q Consensus       594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl----~~~~~~kL~DFGla~  663 (744)
                       +|..++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             555554211      12335788999999999999999999987   9999999999999    456789999999998


Q ss_pred             ecCCCccc-cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          664 MFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      .+...... .......+|+.|+|||++.+ ..++.++|||||||++|||+||++||....+
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~  221 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence            76543211 12233578899999999876 4589999999999999999999999976543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.9e-30  Score=266.12  Aligned_cols=205  Identities=36%  Similarity=0.539  Sum_probs=176.0

Q ss_pred             HhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..++|++.++||+|+||.||++...+++.+|||.++... ...+++.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            347899999999999999999988777889999987543 3457799999999999999999999999988899999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++... ....+++.++..++.+++.|+.|||+.+   |+|+||||+||+++.++.+||+|||++..+.....
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999998643 2345889999999999999999999987   99999999999999999999999999987654221


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .. ......+..|+|||.+.+..++.++|+||||++++||++ |+.||....
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11 112234568999999998889999999999999999999 999986543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=5e-30  Score=268.14  Aligned_cols=204  Identities=31%  Similarity=0.499  Sum_probs=171.1

Q ss_pred             cCcccccccCccCceEEEcccccc-c---ceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ..|++.+.||+|+||.||+|+... +   ..||||.++.. .....++|..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999998643 3   36999998764 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|..++...  .+.+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999988542  345889999999999999999999987   99999999999999999999999999886543


Q ss_pred             CccccCccccc---ccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQGNTKRIV---GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...........   .+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence            32211111111   2457999999999999999999999999999886 999986554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=3e-30  Score=274.95  Aligned_cols=203  Identities=32%  Similarity=0.494  Sum_probs=169.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccc--eeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.+.||+|+||.||+|+.. ++.  .+|+|.++.. .....+++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57889999999999999999864 343  4688877653 344567889999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCce
Q 004580          588 LEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP  654 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~  654 (744)
                      |||+++++|..++....             ....+++.+++.++.||+.|++|||+.+   |+||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999885421             1236789999999999999999999987   9999999999999999999


Q ss_pred             EEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ||+|||+++......   .......+..|+|||++.+..++.++|||||||++|||+| |+.||...+
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            999999986432111   1111234568999999988889999999999999999998 999986544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=284.08  Aligned_cols=203  Identities=27%  Similarity=0.464  Sum_probs=177.5

Q ss_pred             hcCcccccccCccCceEEEccccccc-ceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      .+.++|+..||.|+||.||++..++. -..|-|.+...++...++|.-|+.+|...+||+||+|++.|+..+.+++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            35677888999999999999987653 34567888888888899999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      |.||-++..+..  -.+.+.+.++..+.+|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+......  
T Consensus       111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--  183 (1187)
T ss_pred             cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--
Confidence            999999988753  4567999999999999999999999997   999999999999999999999999987653221  


Q ss_pred             ccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ......++|||+|||||++.     +.+|++++||||||+.|.||.-+.+|-...+
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln  239 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN  239 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence            11234579999999999874     6789999999999999999999999975544

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=5.4e-30  Score=273.25  Aligned_cols=202  Identities=24%  Similarity=0.322  Sum_probs=171.2

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++... ++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368889999999999999998654 7889999886543   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999984   3346889999999999999999999987   999999999999999999999999998742111


Q ss_pred             ccc-------------cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          669 ELQ-------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       669 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ...             .......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            000             0111245788999999999888999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=7.6e-30  Score=268.97  Aligned_cols=201  Identities=30%  Similarity=0.499  Sum_probs=169.3

Q ss_pred             cCcccccccCccCceEEEcccc-----cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI  585 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~  585 (744)
                      ++|++.+.||+|+||.||++..     .+++.||+|+++.......+.|.+|+.++.+++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999863     24788999999877666778899999999999999999999987543  4688


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  345889999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCcccc-CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          666 GGDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       666 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                      ....... ......++..|+|||.+.+..++.++||||||++++||++|..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            4322111 1111223456999999998899999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=9.8e-30  Score=264.31  Aligned_cols=196  Identities=32%  Similarity=0.475  Sum_probs=163.0

Q ss_pred             ccCccCceEEEccccc---ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCC
Q 004580          520 KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS  595 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs  595 (744)
                      .||+|+||.||+|...   .+..||+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999653   34579999987653 344567999999999999999999999875 457899999999999


Q ss_pred             hhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc-Cc
Q 004580          596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-NT  674 (744)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~  674 (744)
                      |.+++..  ....+++.++..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+....... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998853  2346889999999999999999999987   9999999999999999999999999998654332111 11


Q ss_pred             ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       675 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  203 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK  203 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence            11223578999999988889999999999999999996 999987554

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.7e-30  Score=268.30  Aligned_cols=204  Identities=32%  Similarity=0.500  Sum_probs=171.6

Q ss_pred             cCcccccccCccCceEEEcccccc-cc----eeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .+|++.+.||+|+||.||+|...+ ++    .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            678888999999999999997533 32    58999887653 3456789999999999999999999999887 78899


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      |+||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999988542  334889999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      ............++..|+|||.+....++.++|+||||+++|||++ |+.||+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  217 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA  217 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence            4322111111233568999999988899999999999999999998 9999977553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=5e-30  Score=265.84  Aligned_cols=199  Identities=31%  Similarity=0.463  Sum_probs=172.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC-----hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-----GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++||||+++.+++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999865 68899999886432     23557899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   345789999999999999999999987   99999999999999999999999999987644


Q ss_pred             CccccCcccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            32   123356788999999988776 8999999999999999999999986654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=7e-30  Score=264.54  Aligned_cols=200  Identities=29%  Similarity=0.458  Sum_probs=176.1

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ++|++.+.||+|+||.||+++..+ ++.+++|.++....  .+++.+|++++++++||||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678999999999999999998755 78999999865433  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999998843  2456899999999999999999999987   99999999999999999999999999987644321 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||++.+..++.++||||||+++|||++|++||....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~  203 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH  203 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence             1223457889999999999899999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=7.4e-30  Score=264.68  Aligned_cols=200  Identities=39%  Similarity=0.579  Sum_probs=173.3

Q ss_pred             cccCccCceEEEcccccc----cceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||++....    +..+|+|.++..... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998653    778999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          594 KSLDVFLFDPTK------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ++|..++.....      ...+++.++..++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865321      367899999999999999999999987   99999999999999999999999999998765


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  212 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS  212 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence            432222333567889999999988899999999999999999999 688987664

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.1e-29  Score=263.21  Aligned_cols=202  Identities=25%  Similarity=0.393  Sum_probs=175.5

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788899999999999988753 4788999987543  345567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++.... ...+++.++..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999885432 346889999999999999999999987   99999999999999999999999999987644332


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......+++.|+|||.+.+..++.++||||||++++||++|+.||+..+
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence              1223568899999999988889999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=7.2e-30  Score=275.97  Aligned_cols=206  Identities=31%  Similarity=0.496  Sum_probs=172.1

Q ss_pred             cCcccccccCccCceEEEccccc--------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      .+|++.+.||+|+||.||+++..        ....+|+|.++.. .....+++.+|+.++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46889999999999999999642        1236899988754 344567899999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          583 EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                      ..++++||+++|+|..++....             ....+++.++..++.||+.||+|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999885421             2335788999999999999999999987   99999999999999


Q ss_pred             CCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       650 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999987654322222222334567999999999999999999999999999998 888886544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=9.6e-30  Score=264.21  Aligned_cols=195  Identities=33%  Similarity=0.478  Sum_probs=163.8

Q ss_pred             ccCccCceEEEcccc---cccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          520 KLGEGGFGPVYKGRL---LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~---~~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +||+|+||.||+|.+   .+++.+|+|+++...  ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999964   347789999986542  345678999999999999999999999875 45778999999999


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc-C
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-N  673 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~  673 (744)
                      +|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....... .
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999884   3345889999999999999999999987   9999999999999999999999999998764432111 1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .....++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  203 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK  203 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            112234578999999988889999999999999999998 999997654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=8.5e-30  Score=264.32  Aligned_cols=198  Identities=31%  Similarity=0.436  Sum_probs=169.1

Q ss_pred             cccCccCceEEEcccccc--c--ceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|++|.||+|.+.+  +  ..+|+|.++.... ...+++.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999997643  3  3689999987655 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc-c
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-G  672 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~  672 (744)
                      ++|..++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 46899999999999999999999987   999999999999999999999999999876542211 1


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            1112456788999999999999999999999999999999 999986543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.3e-29  Score=262.70  Aligned_cols=202  Identities=28%  Similarity=0.400  Sum_probs=172.6

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-cCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E  589 (744)
                      +|++.+.||+|++|.||+++.. +++.+|+|++...  .....+.+.+|+.++++++|||++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999864 4788999998643  23455678999999999999999999988764 446789999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|.+++... ....+++.++..++.+++.|+++||+.+   |+|+||||+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888542 2345899999999999999999999988   9999999999999999999999999998764322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        .......+++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  206 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD  206 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence              12233567889999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=258.88  Aligned_cols=198  Identities=26%  Similarity=0.363  Sum_probs=170.9

Q ss_pred             cccCccCceEEEccc-ccccceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          519 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      +.||+|+|+.|--+. +.+|.++|||++.+.......+..+|++++...+ |+||+.++.+|.++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999999885 5679999999999888888889999999999986 99999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc---eEEEeecCceecCCC-----
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGD-----  668 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~---~kL~DFGla~~~~~~-----  668 (744)
                      ..++.   +...+++.++.++.++|+.||.+||..+   |.||||||+|||..+...   +||+||.++.-+...     
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99884   5556899999999999999999999998   999999999999976654   799999987654221     


Q ss_pred             ccccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ...+.....+|+..|||||+..     ...|+.+.|.||||||||-||+|-+||-....
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            1122233468888999999863     23588999999999999999999999977653

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.2e-29  Score=264.07  Aligned_cols=202  Identities=34%  Similarity=0.522  Sum_probs=170.7

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      ++|++.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688889999999999999987777789999886543 34567899999999999999999998874 456889999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999988543 2335789999999999999999999987   9999999999999999999999999998764432211


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence             112345678999999998899999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=276.08  Aligned_cols=209  Identities=31%  Similarity=0.470  Sum_probs=178.8

Q ss_pred             HHHhcCcccccccCccCceEEEcccccc---cc--eeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG  582 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~---g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~  582 (744)
                      ....+..+..+.||+|-||.||+|...+   |+  .||||..+.+ .....+.|..|..+|++++||||++++|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3445666777899999999999997532   33  5899998875 45567889999999999999999999999875 5


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++|||.++-|.|+.||..  ++..++......++.||..||+|||+..   +|||||..+|||+....-+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            78999999999999999954  4456888889999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS  724 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~~~  724 (744)
                      +.+..+.+.... ...-+..|||||.+.-.+|+.++|||-|||.+||++. |.+||......+
T Consensus       539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            998876655444 3455789999999999999999999999999999887 889986654433

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=1e-29  Score=264.87  Aligned_cols=206  Identities=29%  Similarity=0.451  Sum_probs=177.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+......++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999754 57889999986542 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++........+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433456899999999999999999999987   99999999999999999999999999887654322


Q ss_pred             cc--CcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QG--NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..  ......++..|+|||++... .++.++|+||||++++||++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            21  12334688899999998877 78999999999999999999999986543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=6.5e-30  Score=269.70  Aligned_cols=210  Identities=27%  Similarity=0.372  Sum_probs=173.9

Q ss_pred             HHHHHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEE----
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCV----  579 (744)
Q Consensus       506 ~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~----  579 (744)
                      .......++|++.+.||+|+||.||+++.. .++.+|+|+++... ...+++.+|+.++.++ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            444556789999999999999999999764 47899999886432 2346688999999999 6999999999884    


Q ss_pred             -EcCeEEEEEEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          580 -EQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       580 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                       .++..++||||+++++|..++... .....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence             345789999999999999887532 23456788999999999999999999987   9999999999999999999999


Q ss_pred             eecCceecCCCccccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |||+++.+......  .....+++.|+|||++..     ..++.++|||||||++|||++|+.||...+
T Consensus       167 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         167 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             cCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99999876443221  223468899999998853     457899999999999999999999986554

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9e-30  Score=265.53  Aligned_cols=202  Identities=30%  Similarity=0.450  Sum_probs=170.8

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-----ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~  584 (744)
                      .+|++.+.||+|+||.||+|+.. +++.+|+|.+...     .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999864 5889999987432     234456889999999999999999999998764  468


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++++||+++++|..++.   ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999998874   2345788999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ....... .......++..|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            5432111 1112346788999999999888999999999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.1e-29  Score=273.58  Aligned_cols=200  Identities=21%  Similarity=0.292  Sum_probs=165.2

Q ss_pred             cccccCcc--CceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          517 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       517 i~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ++++||+|  +|++||+++.. +|+.||+|+++..  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999764 5889999998754  2334456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc-
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-  670 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~-  670 (744)
                      ++++|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++++||+.+........ 
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885422 234789999999999999999999987   99999999999999999999999987554322110 


Q ss_pred             ----ccCcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 ----QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                          ........++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                001122356778999999976  45899999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=275.32  Aligned_cols=196  Identities=29%  Similarity=0.474  Sum_probs=170.8

Q ss_pred             ccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      .++||.|.||+||-|+++ +|+.||||++.+.  ..+....+.+|+.+|++++||.||.+.-.|+..+..+.|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            378999999999999875 5999999998764  4455688999999999999999999999999999999999999665


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC---CceEEEeecCceecCCCccc
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~---~~~kL~DFGla~~~~~~~~~  671 (744)
                      -|...|.  ...+.+++..-..++.||+.||.|||.++   |+|+||||+||||...   -.+||+|||.|+.+......
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            5555553  23445788888889999999999999998   9999999999999654   47999999999999876543


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         ..++||+.|+|||++..+.|...-|+||.|||+|--++|.-||+..+
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence               44799999999999999999999999999999999999998887644

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=1.4e-29  Score=266.08  Aligned_cols=200  Identities=29%  Similarity=0.450  Sum_probs=174.1

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..|+..+.||.|+||.||+|... .++.+|+|.++.. .....+.+.+|+.+++++.||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999864 4789999988654 345567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998742    35788899999999999999999987   99999999999999999999999999987654332


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  .....++..|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus       157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            1  222457889999999998889999999999999999999999987554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=9.3e-30  Score=265.86  Aligned_cols=204  Identities=31%  Similarity=0.488  Sum_probs=171.5

Q ss_pred             cCcccccccCccCceEEEcccccc----cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .+|++.+.||+|+||.||+|+...    +..+|+|.++... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            578889999999999999997532    3369999987542 34457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|..++...  ...+++.++..++.|++.|++|||+.+   |+||||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998532  245789999999999999999999987   99999999999999999999999999987654


Q ss_pred             Ccccc-CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ..... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence            32111 1111223568999999998899999999999999999887 999986554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.3e-29  Score=264.32  Aligned_cols=192  Identities=24%  Similarity=0.366  Sum_probs=161.1

Q ss_pred             cccCccCceEEEcccccc-------------cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          519 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            469999999999997432             2258999887665555678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc-------eEEEe
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN-------PKISD  658 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~-------~kL~D  658 (744)
                      +||||+++++|+.++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988743  2345889999999999999999999987   999999999999987654       89999


Q ss_pred             ecCceecCCCccccCcccccccccccCccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCC
Q 004580          659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETL-SGKKNTGVYN  721 (744)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGviL~ell-tG~~p~~~~~  721 (744)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            9998764322      1235678899999886 467899999999999999998 5777876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=1.1e-29  Score=268.92  Aligned_cols=203  Identities=29%  Similarity=0.365  Sum_probs=168.3

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++++|.+.+.||+|+||.||+|... +++.+|+|+++... ......+.+|+.+++.++|+||+++.+++.++...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999764 58899999986543 223346788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||++ +++..++..  ....+.+.++..++.||+.||+|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 566655532  2245778888999999999999999987   999999999999999999999999998764332


Q ss_pred             ccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..  ......++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            11  11223568899999998764 57899999999999999999999997544

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.1e-29  Score=265.27  Aligned_cols=204  Identities=32%  Similarity=0.514  Sum_probs=171.6

Q ss_pred             cCcccccccCccCceEEEcccccc-c---ceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|.++.. .....+++.+|++++.+++||||+++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            567888999999999999998643 3   36899998755 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|..++..  ....+++.++..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999998853  2346889999999999999999999987   99999999999999999999999999987643


Q ss_pred             CccccCc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQGNT-KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ....... .....+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~  215 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS  215 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            2211111 11223457999999988889999999999999999997 999986544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=4.9e-30  Score=269.52  Aligned_cols=200  Identities=29%  Similarity=0.459  Sum_probs=172.8

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.|+..+.||+|+||.||+|... .++.||+|.++.. .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45677789999999999999764 4788999988744 344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++.    ...+++..+..++.||++|+.|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999998873    345789999999999999999999987   99999999999999999999999999987644321


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH  205 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence              1122457889999999999899999999999999999999999986543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=3.8e-30  Score=272.66  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=172.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +.|.....||+|+||.||++... +++.||||.+........+.+.+|+.++..++||||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34444568999999999999764 57899999987665566678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++.    ...+++.++..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||++..+..... 
T Consensus       102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            9999998873    234789999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  222 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP  222 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1223467889999999988889999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-29  Score=262.58  Aligned_cols=199  Identities=33%  Similarity=0.504  Sum_probs=173.6

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.+.||+|+||.||++.. .++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35788899999999999999986 478999999976544 5678999999999999999999999999899999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999885432 236899999999999999999999987   99999999999999999999999999987633211 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                          ....+..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  204 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence                2234568999999998889999999999999999997 998986654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=7.3e-30  Score=269.25  Aligned_cols=201  Identities=28%  Similarity=0.413  Sum_probs=174.2

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|+||+||+++.. +++.+|+|++... .....+++.+|++++..++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888999999999999999864 5888999987654 344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|..++.   ..+.+++..+..++.+++.||.|||+..  +|+||||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999998874   3346889999999999999999999742  39999999999999999999999999987543221 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                         .....++..|+|||++.+..++.++|+|||||++|||++|+.||.....
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence               2235688999999999888999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-29  Score=271.35  Aligned_cols=205  Identities=26%  Similarity=0.333  Sum_probs=174.9

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCCh---hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|++|.||++...+ ++.+|+|.+.....   ...+.+.+|++++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468889999999999999998754 88999999875432   34567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|.+++... ....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999987532 3356889999999999999999999987   999999999999999999999999998765321


Q ss_pred             ccc---------------------------cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQ---------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            100                           01112467889999999999889999999999999999999999997554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=5.7e-30  Score=270.01  Aligned_cols=200  Identities=26%  Similarity=0.353  Sum_probs=170.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|+||.||+|... +++.+|+|++....  ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999875 47899999886532  2235678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|+.+..   ....+++.++..++.||++||+|||+.+   |+|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999987763   2334889999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence            1  1223457889999999875 45788999999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.1e-29  Score=266.33  Aligned_cols=205  Identities=31%  Similarity=0.448  Sum_probs=173.0

Q ss_pred             cCcccccccCccCceEEEccccc------ccceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      ++|++.+.||+|+||.||+|+..      +.+.+++|.+...... ..+++.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67888999999999999999753      2457999988665433 5678999999999999999999999999889999


Q ss_pred             EEEEecCCCChhhhhcCcCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEee
Q 004580          586 LILEYMPNKSLDVFLFDPTKK------RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DF  659 (744)
                      +||||+++++|.+++......      ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998643321      26899999999999999999999987   999999999999999999999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |+++........ ......++..|+|||.+.+...+.++||||||++++||++ |..||....
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~  223 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS  223 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence            998754332221 1222356778999999988888999999999999999999 777886543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=1.4e-29  Score=263.67  Aligned_cols=202  Identities=28%  Similarity=0.418  Sum_probs=172.4

Q ss_pred             cCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||.|++|.||+++... ++.+|+|++....   ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999998753 8899999986532   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      .+++..   ...++...+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   345889999999999999999999987   9999999999999999999999999998765432   1223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccc
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYV  731 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~  731 (744)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|+.||....++...+...+
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence            4678899999999888899999999999999999999999987664343343333

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=280.85  Aligned_cols=204  Identities=31%  Similarity=0.435  Sum_probs=175.7

Q ss_pred             cCcccccccCccCceEEEcccccc--cc--eeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++..+.|+||+|+||.|++|.+..  |+  .||||.++..... ..++|.+|+.+|.+|+|||+++|+|+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            455667899999999999998753  44  6899999887554 78899999999999999999999999987 778899


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +|.++.|+|.+.|++ ..+..+.......++.|||.||.||.++.   +|||||..+||||-....+||+||||.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 45566778888899999999999999987   99999999999999999999999999998866


Q ss_pred             Cccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++.. .......-+..|.|||.+....|+.++|||+|||.||||+| |+.||..-.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            4322 22222344678999999999999999999999999999999 667886543

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=6.8e-30  Score=271.47  Aligned_cols=198  Identities=29%  Similarity=0.455  Sum_probs=171.0

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      |+....||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            333458999999999999764 5889999998765555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....  .
T Consensus       103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            99988763    245789999999999999999999987   99999999999999999999999999876543221  1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....++..|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            223568899999999998899999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=1.2e-29  Score=267.18  Aligned_cols=202  Identities=28%  Similarity=0.414  Sum_probs=165.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHH-HHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMML-IAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999865 58999999987542 2334455566664 566789999999999999999999999


Q ss_pred             ecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      |++ ++|..++... .....+++..+..++.||+.||+|||++.  +++||||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6777766432 23456899999999999999999999862  3999999999999999999999999999875432


Q ss_pred             ccccCcccccccccccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||...
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence            2   1122457889999998865    45688999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=1.9e-29  Score=262.49  Aligned_cols=203  Identities=33%  Similarity=0.480  Sum_probs=172.8

Q ss_pred             hcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .++|++.++||+|+||.||++...++..+|+|.++.. ....+.+.+|+.++++++|+||+++.+.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4688999999999999999998767788999988654 3345678999999999999999999999877 7789999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++... ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998543 2345788899999999999999999987   999999999999999999999999999876433221


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       ......++..|+|||++....++.++|+||||+++||+++ |+.||...+
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence             1112345678999999998889999999999999999999 888987543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.3e-29  Score=267.43  Aligned_cols=200  Identities=32%  Similarity=0.510  Sum_probs=168.8

Q ss_pred             cCcccccccCccCceEEEcccc-----cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~  584 (744)
                      ..|++.+.||+|+||.||+++.     ..++.||+|.++.. .....+.+.+|+.+++.++||||+++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999863     24778999998754 344557899999999999999999999998775  568


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++||||+++++|..++...  ...+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999988432  235789999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~  717 (744)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            6543211 1122345677899999999888999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-29  Score=259.91  Aligned_cols=198  Identities=34%  Similarity=0.475  Sum_probs=168.6

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChh
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD  597 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (744)
                      ++||+|+||.||++...+++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999876689999999876533 35678999999999999999999999999999999999999999999


Q ss_pred             hhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccc
Q 004580          598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI  677 (744)
Q Consensus       598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  677 (744)
                      .++...  ...+++..+..++.+++.+++|||+.+   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            988532  235788899999999999999999987   999999999999999999999999999865432222111122


Q ss_pred             cccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       678 ~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..||....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            34567999999998899999999999999999999 788886544

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=2.2e-29  Score=263.56  Aligned_cols=197  Identities=32%  Similarity=0.492  Sum_probs=163.6

Q ss_pred             cccCccCceEEEcccccc-cc--eeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+|+..+ +.  .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999998644 33  5788988754 344567899999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCcC-------------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          594 KSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                      ++|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885422             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++.......   .......+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  216 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  216 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence            986422111   1111233567999999988899999999999999999997 999986543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=2.2e-29  Score=261.02  Aligned_cols=202  Identities=31%  Similarity=0.503  Sum_probs=172.6

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      .+|++.+.||+|+||.||++...+++.+|+|.++... ...++|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999987668899999986542 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|.+++..  ....+++..+..++.+++.|++|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999988853  2345789999999999999999999987   9999999999999999999999999998764432211


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       .....++.+|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence             112234678999999998899999999999999999998 899986544

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=1.4e-29  Score=269.86  Aligned_cols=204  Identities=33%  Similarity=0.530  Sum_probs=168.8

Q ss_pred             hcCcccccccCccCceEEEccccc-ccc----eeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      .++|++.+.||+|+||.||+|... +++    .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999753 343    47889886543 33345789999999999999999999998654 567


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +++||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999887532  335788999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~  216 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP  216 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            54332222222345678999999998999999999999999999997 889986543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-29  Score=267.66  Aligned_cols=201  Identities=29%  Similarity=0.388  Sum_probs=168.5

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|++|.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67889999999999999999865 578999999865422 2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++ +|..++...  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 888877532  236789999999999999999999987   99999999999999999999999999875432211


Q ss_pred             ccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence              1112346788999998875 458899999999999999999999986543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=2.1e-29  Score=261.39  Aligned_cols=197  Identities=33%  Similarity=0.508  Sum_probs=168.3

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEE-EcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV-EQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~  591 (744)
                      ++|++.+.||+|+||.||++.. .+..+|+|.++...  ..+.+.+|+.++++++|+|++++++++. +.+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            5788899999999999999976 47889999986543  3467899999999999999999999765 446789999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999988542 2335789999999999999999999987   9999999999999999999999999988653321  


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                         .....+..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~  204 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence               12334568999999998899999999999999999997 998886543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.9e-29  Score=262.52  Aligned_cols=201  Identities=31%  Similarity=0.500  Sum_probs=174.3

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCCh--hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|+||.||++... +++.+|+|.++....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999764 588999999876543  3678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998843   345788999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccC--cccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGN--TKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ...  .....++..|+|||++.+..   ++.++||||||++++||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            111  12346788999999998766   889999999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=1.4e-29  Score=264.21  Aligned_cols=202  Identities=27%  Similarity=0.456  Sum_probs=172.1

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCCC------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      +|+..+.||+|++|.||+++. .+++.+|+|.++...      ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999975 458899999986432      1235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceec
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMF  665 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~  665 (744)
                      |+||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999998843   346889999999999999999999997   99999999999998775 5999999999876


Q ss_pred             CCCccc--cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            543111  11123467889999999988889999999999999999999999986543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=2.2e-29  Score=265.45  Aligned_cols=200  Identities=30%  Similarity=0.436  Sum_probs=171.9

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999864 58899999987543  34457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999998875432  56899999999999999999999987   99999999999999999999999999987654321


Q ss_pred             ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|+++|...
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence             112234688899999998654 4689999999999999999998887543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-31  Score=306.13  Aligned_cols=205  Identities=29%  Similarity=0.452  Sum_probs=174.9

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      -++.-...||.|.||.||-|.. .+|+..|+|.++..  .........+|+.++..++|||+|+.+|+-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            3455567899999999999974 45888999987654  34456678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      ||++|+|.+.+   +..+..++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..+..+.
T Consensus      1315 yC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999988   34444566666778899999999999998   9999999999999999999999999999886642


Q ss_pred             --cccCcccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004580          670 --LQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       670 --~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGviL~elltG~~p~~~~~~~  723 (744)
                        .........||+.|||||++.+..   ..-++||||+|||++||+||++||...+.+
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence              233345578999999999997643   567899999999999999999999877644

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.6e-29  Score=262.36  Aligned_cols=190  Identities=29%  Similarity=0.467  Sum_probs=160.8

Q ss_pred             cccCccCceEEEcccccccc-----------eeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          519 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999875432           4788887654433 6789999999999999999999999988 788999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-------ceEEEeec
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-------NPKISDFG  660 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-------~~kL~DFG  660 (744)
                      |||+++++|+.++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999985422  26889999999999999999999987   99999999999999887       79999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++......      ....++..|+|||++.+.  .++.++||||||+++|||++ |..|+....
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            99875431      123456789999999876  78999999999999999999 566776654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=1.1e-29  Score=265.36  Aligned_cols=200  Identities=38%  Similarity=0.552  Sum_probs=167.3

Q ss_pred             cccCccCceEEEcccccc-------cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999997532       2578999886543 34567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-----ceEEEeecC
Q 004580          591 MPNKSLDVFLFDPT----KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-----NPKISDFGL  661 (744)
Q Consensus       591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-----~~kL~DFGl  661 (744)
                      +++++|.+++....    ....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2245788999999999999999999987   99999999999999877     899999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ++.+..............+..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~  218 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN  218 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence            986644332222222345678999999999999999999999999999998 999986543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=2.4e-29  Score=261.67  Aligned_cols=201  Identities=31%  Similarity=0.417  Sum_probs=177.6

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|++|.||+++... ++.+|||++..... ...+++.+|+..+.+++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368888999999999999998764 88999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      +++++|.+++..   ...+++..+..++.|+++|++|||+ .+   ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   2568999999999999999999999 87   9999999999999999999999999998765433


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...  ....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            221  23467889999999999999999999999999999999999987664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=2e-29  Score=266.70  Aligned_cols=200  Identities=30%  Similarity=0.405  Sum_probs=169.6

Q ss_pred             CcccccccCccCceEEEcccc----cccceeEEEeccCCC----hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~  584 (744)
                      +|++.+.||+|+||.||+++.    .+|+.+|+|+++...    ....+.+.+|+.++.++ +|+||+++.+.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999875    357899999987532    23356788999999999 599999999999998999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++|+||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998843   345788999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccccCcccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +...... ......++..|+|||.+...  .++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  211 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD  211 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence            6443222 12235678899999998753  4678999999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-29  Score=270.58  Aligned_cols=206  Identities=26%  Similarity=0.387  Sum_probs=169.8

Q ss_pred             CcccccccCccCceEEEccccc---ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKI  585 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~  585 (744)
                      +|++.++||+|++|.||+|+..   .++.+|+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999987632   34456778899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhcCc-C-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC----CCceEEEee
Q 004580          586 LILEYMPNKSLDVFLFDP-T-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM----DMNPKISDF  659 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~----~~~~kL~DF  659 (744)
                      +||||+++ +|..++... . ....++...+..++.||+.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 455544322 1 2236889999999999999999999987   999999999999999    899999999


Q ss_pred             cCceecCCCcc-ccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004580          660 GLARMFGGDEL-QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       660 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~~~  723 (744)
                      |++..+..... ........++..|+|||.+.+ ..++.++||||||++++||++|++||.....+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence            99987644322 112233567889999998876 45889999999999999999999999866543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=6e-30  Score=265.70  Aligned_cols=199  Identities=29%  Similarity=0.380  Sum_probs=175.2

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      +|++.+.||.|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999875 48899999986532   2456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|..++..   ...+++.++..++.||++||.|||+.+   |+|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999998843   356889999999999999999999987   9999999999999999999999999988764432


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence               1223467889999999998889999999999999999999999988655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=2.1e-29  Score=263.71  Aligned_cols=200  Identities=29%  Similarity=0.430  Sum_probs=169.3

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC----------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS----------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG  582 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~  582 (744)
                      +|.+.+.||+|+||.||+|... +++.+|+|.++...          ....+.+.+|+.++..++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999754 58899999875321          112356888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++||||+++++|..++..   ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999998843   356889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      +...............++..|+|||.+....  ++.++|+||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            8654322112223346788999999987654  88999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-29  Score=266.16  Aligned_cols=201  Identities=27%  Similarity=0.383  Sum_probs=172.9

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|++|.||+|... +++.||+|+++..  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999875 4789999998653  33445788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |++++.+..++.   ....+++.++..++.||+.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999987776552   3345889999999999999999999987   9999999999999999999999999998765433


Q ss_pred             cccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      . .......++..|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            2 122235678899999999888 8899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=2e-29  Score=264.67  Aligned_cols=191  Identities=26%  Similarity=0.362  Sum_probs=159.1

Q ss_pred             ccCccCceEEEcccccc-------------------------cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeE
Q 004580          520 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL  574 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l  574 (744)
                      +||+|+||.||+|....                         ...||+|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999996421                         13588999876555556678999999999999999999


Q ss_pred             EEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC--
Q 004580          575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM--  652 (744)
Q Consensus       575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~--  652 (744)
                      ++++.+....++||||+++++|+.++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988853  2346789999999999999999999987   99999999999998643  


Q ss_pred             -----ceEEEeecCceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCC
Q 004580          653 -----NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SGKKNTGVYN  721 (744)
Q Consensus       653 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~ell-tG~~p~~~~~  721 (744)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence                 3799999988653221      11346778999998875 56899999999999999985 6888887554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=2.3e-29  Score=263.31  Aligned_cols=202  Identities=29%  Similarity=0.413  Sum_probs=169.9

Q ss_pred             cCcccccccCccCceEEEcccccc----cceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|.+.+.||+|+||.||+|...+    ...+|||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            568888999999999999997543    2468999887654 4556789999999999999999999998865 567899


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|.+++...  ...+++.++..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998532  335899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...... ....++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus       160 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         160 ESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             ccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            322111 12234568999999988889999999999999999996 999986654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2e-29  Score=267.32  Aligned_cols=200  Identities=29%  Similarity=0.460  Sum_probs=175.1

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      ++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            68899999999999999999753 57889999987555555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999998742    34788899999999999999999987   99999999999999999999999999876544322 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1222467889999999988889999999999999999999999997554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=2.1e-29  Score=263.52  Aligned_cols=198  Identities=23%  Similarity=0.359  Sum_probs=159.0

Q ss_pred             ccCccCceEEEcccccccc---eeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCC
Q 004580          520 KLGEGGFGPVYKGRLLNGQ---EVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS  595 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~g~---~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs  595 (744)
                      +||+|+||.||+++..++.   .+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            6999999999999754433   45677765443 3456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCc
Q 004580          596 LDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT  674 (744)
Q Consensus       596 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  674 (744)
                      |..++.... .....+...+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999986432 2234567778899999999999999987   999999999999999999999999998643222211222


Q ss_pred             ccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 004580          675 KRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSG-KKNTGVY  720 (744)
Q Consensus       675 ~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGviL~elltG-~~p~~~~  720 (744)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..||...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            23467889999998753       2457899999999999999974 5677543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=2.9e-29  Score=265.55  Aligned_cols=210  Identities=30%  Similarity=0.395  Sum_probs=173.6

Q ss_pred             HHHHHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc--
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ--  581 (744)
Q Consensus       506 ~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~--  581 (744)
                      .++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ...+++.+|+.++.++ +|||++++++++...  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            444556789999999999999999999864 57899999986532 2346678899999999 799999999998754  


Q ss_pred             ---CeEEEEEEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          582 ---GEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       582 ---~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                         ...++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence               3689999999999999887532 23456889999999999999999999987   9999999999999999999999


Q ss_pred             eecCceecCCCccccCcccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |||++..+......  .....++..|+|||.+...     .++.++|||||||++|||++|+.||...+
T Consensus       171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            99998875432211  1224678899999988643     36899999999999999999999987544

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=2.8e-29  Score=264.44  Aligned_cols=202  Identities=30%  Similarity=0.456  Sum_probs=170.9

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +|++.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788999999999999999875 58899999987543 233466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++ +|..++........+++.++..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 77777754444456899999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11223568899999988664 57899999999999999999999987654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.7e-29  Score=258.95  Aligned_cols=196  Identities=36%  Similarity=0.512  Sum_probs=163.9

Q ss_pred             cccCccCceEEEcccccc----cceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      ++||+|+||.||+|+...    +..+|+|.++.... ...+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999996432    26899999876543 35678999999999999999999999865 5578999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc-
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-  672 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-  672 (744)
                      ++|.+++..   ...+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999853   236889999999999999999999987   9999999999999999999999999998764432111 


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |++||...+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~  203 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK  203 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence            1111223467999999998899999999999999999998 999987654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=1.3e-29  Score=263.95  Aligned_cols=200  Identities=29%  Similarity=0.416  Sum_probs=174.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++|++.+.||+|++|.||++... +++.+|+|++.... ....+++.+|+.++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999875 58899999987653 34567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      +++++|..++....  ..++...+..++.|++.||+|||+ .+   ++|+||||+||+++.++.++|+|||.+..+....
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999885422  568889999999999999999999 76   9999999999999999999999999987653321


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .    ....++..|+|||.+.+..++.++||||||+++++|++|+.||...+
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  203 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN  203 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence            1    11567889999999999999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.7e-29  Score=261.87  Aligned_cols=199  Identities=27%  Similarity=0.490  Sum_probs=172.2

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhc---CCCeeeEEEEEEEcCeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .|++.+.||+|+||.||+|.. .+++.+|+|.++.. .....+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999986 45889999998654 3445677889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|..++..    ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988732    36889999999999999999999987   999999999999999999999999999877544


Q ss_pred             ccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..  ......++..|+|||.+.++ .++.++|+||||+++|||++|+.||....
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            31  12234688899999988754 57899999999999999999999996544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=1.3e-29  Score=267.04  Aligned_cols=197  Identities=26%  Similarity=0.398  Sum_probs=165.3

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|+||.||+++.. +|+.+|+|+++...  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999864 58899999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++ +|..++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 66666543  2345899999999999999999999987   9999999999999999999999999998654322 


Q ss_pred             ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                       .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence             111224568899999998764 47899999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.3e-29  Score=262.85  Aligned_cols=192  Identities=29%  Similarity=0.386  Sum_probs=158.4

Q ss_pred             ccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHH---hcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAK---LQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~---l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      .||+|+||.||+++.. +++.+|+|.+....   ......+.+|..++..   .+||||+.+.+.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 48899999886432   1222334445443333   479999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|..++.   ....+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999998884   3346899999999999999999999988   9999999999999999999999999997654322   


Q ss_pred             CcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence             122468999999998864 568999999999999999999999997544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=3.2e-29  Score=263.36  Aligned_cols=194  Identities=30%  Similarity=0.430  Sum_probs=166.1

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999754 58899999886432   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      ..++.... ...+++.++..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||.+.......   ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            98885432 246889999999999999999999987   9999999999999999999999999987654321   1223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            457789999999988889999999999999999999999996654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=3.8e-29  Score=265.56  Aligned_cols=200  Identities=30%  Similarity=0.395  Sum_probs=169.0

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCCh-----hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-----QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +|++.+.||+|++|.||+|... +++.||||+++....     .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999864 588999999875432     2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+ +++|..++....  ..+++.++..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999885422  36899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...  ......++..|+|||.+.+ ..++.++|||||||+++||++|.++|...+
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence            321  1122345778999998865 467899999999999999999987776433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=4.7e-29  Score=258.57  Aligned_cols=202  Identities=25%  Similarity=0.400  Sum_probs=173.6

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|+||.+|+++.. +++.+|+|++...  .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5788999999999999999764 5889999988643  334456889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++... ....+++.++..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999998887532 2235788999999999999999999987   99999999999999999999999999987644321


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  .....+++.|+|||++.+..++.++|+||||++++||++|+.||...+
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN  205 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence            1  122457889999999998899999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=5.4e-29  Score=257.92  Aligned_cols=202  Identities=38%  Similarity=0.586  Sum_probs=171.7

Q ss_pred             cccccccCccCceEEEcccccc-----cceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +++.+.||+|+||.||+++..+     +..+|+|+++..... ..+.+..|+..+..++|+||+++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998643     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854221 12899999999999999999999987   999999999999999999999999999876554


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      ...... ...+++.|+|||.+.+..++.++||||||++++||++ |+.||...+
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~  209 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS  209 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            222111 1236789999999988889999999999999999998 788887543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=5e-29  Score=260.96  Aligned_cols=204  Identities=30%  Similarity=0.478  Sum_probs=167.3

Q ss_pred             cccccccCccCceEEEccccc----ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC------
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------  582 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~------  582 (744)
                      |++.+.||+|+||.||+|...    .++.+|||+++..  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    3678999998654  3445678899999999999999999999886542      


Q ss_pred             eEEEEEEecCCCChhhhhcCc---CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEee
Q 004580          583 EKILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DF  659 (744)
                      ..++++||+++|+|..++...   .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998876432   12235788999999999999999999987   999999999999999999999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                      |+++.+.............+++.|++||.+....++.++||||||+++|||++ |++||...+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~  220 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE  220 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence            99987644332222222345678999999998899999999999999999999 888886543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=7.9e-29  Score=260.36  Aligned_cols=199  Identities=29%  Similarity=0.452  Sum_probs=172.1

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      -|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            466778999999999999975 35789999987643 2344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++++|..++.    ...+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999998873    235789999999999999999999987   99999999999999999999999999987644321 


Q ss_pred             cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||.+.+..++.++|+|||||++|||++|..||....
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  205 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH  205 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence             1122467889999999988889999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=5.4e-29  Score=259.04  Aligned_cols=196  Identities=31%  Similarity=0.477  Sum_probs=160.0

Q ss_pred             cccCccCceEEEcccccc----cceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-cCeEEEEEEecC
Q 004580          519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKILILEYMP  592 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~  592 (744)
                      +.||+|+||.||+|...+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            469999999999997532    357999998643 34456788999999999999999999998764 556889999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc-
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-  671 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-  671 (744)
                      +++|..++...  ...+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998532  234577888899999999999999987   999999999999999999999999999865432211 


Q ss_pred             -cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004580          672 -GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG-KKNTGV  719 (744)
Q Consensus       672 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG-~~p~~~  719 (744)
                       .......++..|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence             111123456789999999888999999999999999999995 556654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=3.6e-29  Score=263.73  Aligned_cols=201  Identities=29%  Similarity=0.430  Sum_probs=169.0

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+|+.. +++.+|||+++...  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999764 58899999886542  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ++ ++|..++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5787777542 2356889999999999999999999987   99999999999999999999999999886543221


Q ss_pred             ccCcccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              112235678899999887644 6889999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.1e-29  Score=261.87  Aligned_cols=191  Identities=28%  Similarity=0.415  Sum_probs=161.0

Q ss_pred             cccCccCceEEEcccccc--------cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.||+|+||.||+|....        ..++|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999997532        235888888665556667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc--------eEEEeecCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--------PKISDFGLA  662 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~--------~kL~DFGla  662 (744)
                      +++|+|+.++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  235789999999999999999999987   999999999999987765        699999998


Q ss_pred             eecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK-KNTGVY  720 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~-~p~~~~  720 (744)
                      ......      ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~  209 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL  209 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence            754322      22457788999999986 45799999999999999999995 555443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=6.6e-29  Score=261.22  Aligned_cols=191  Identities=29%  Similarity=0.399  Sum_probs=158.4

Q ss_pred             ccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHH---HHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMML---IAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~---l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      .||+|+||.||+++.. .++.||+|.+....   ......+..|..+   +....||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999764 47899999886532   1222234444433   444579999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|..++.   ....+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999988874   3456899999999999999999999987   9999999999999999999999999987654321   


Q ss_pred             CcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence             1234689999999998754 6899999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1e-28  Score=258.16  Aligned_cols=200  Identities=25%  Similarity=0.340  Sum_probs=164.9

Q ss_pred             HHHHhcCccccccc--CccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCe
Q 004580          508 VAAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       508 ~~~~~~~y~i~~~L--G~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~  583 (744)
                      .....++|++.+.+  |+|+||.||+++.. +++.+|+|.+........     |+.....+ +||||+++++.+...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445677777776  99999999999764 578899998864322111     22222222 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCc
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLA  662 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla  662 (744)
                      .++||||+++++|..++..   ...+++.++..++.||++||.|||+.+   |+||||||+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999998843   337899999999999999999999987   99999999999999998 9999999999


Q ss_pred             eecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      +......      ...++..|+|||++.+..++.++||||||+++|||++|+.||.....+.
T Consensus       158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~  213 (267)
T PHA03390        158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE  213 (267)
T ss_pred             eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence            8754321      2357889999999999899999999999999999999999998554443

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=7.3e-29  Score=256.89  Aligned_cols=201  Identities=26%  Similarity=0.416  Sum_probs=172.9

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||++... +++.+|+|.+...  .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999764 5788999988653  334567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~~~~~  669 (744)
                      +++++|.+++... ....+++..+..++.+++++|+|||+++   |+|+||||+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345789999999999999999999987   99999999999998654 68999999998765432


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+..+
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence               1122467889999999998889999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=6.7e-29  Score=259.51  Aligned_cols=203  Identities=27%  Similarity=0.434  Sum_probs=170.6

Q ss_pred             CcccccccCccCceEEEcccccc--cceeEEEeccCC----------ChhhHHHHHHHHHHHHH-hcCCCeeeEEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQ----------SGQGLEEFKNEMMLIAK-LQHRNLVKLLGCCVE  580 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~----------~~~~~~~f~~Ev~~l~~-l~HpnIv~l~~~~~~  580 (744)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998754  678999987532          22334567788888865 789999999999999


Q ss_pred             cCeEEEEEEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEee
Q 004580          581 QGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DF  659 (744)
                      .+..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+..  +|+|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998877432 23456889999999999999999999632  3999999999999999999999999


Q ss_pred             cCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|++||...+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~  217 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN  217 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence            9998765432   2233567889999999999889999999999999999999999986543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=4e-30  Score=254.18  Aligned_cols=208  Identities=26%  Similarity=0.367  Sum_probs=170.2

Q ss_pred             HHhcCcccccccCccCceEEEcccccc-----cceeEEEeccCCCh--hhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-c
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-Q  581 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-~  581 (744)
                      +....|+....||+|.||.||+|.-.+     ...+|+|+++....  .-.....+|+.+++.++||||+.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            344678999999999999999994322     33799999976522  123456789999999999999999999887 7


Q ss_pred             CeEEEEEEecCCCChhhhhc--CcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC----CceE
Q 004580          582 GEKILILEYMPNKSLDVFLF--DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD----MNPK  655 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~----~~~k  655 (744)
                      ...++++||.+.. |...++  ...+.+.++...+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            7899999999875 444443  2334467899999999999999999999987   9999999999999876    8999


Q ss_pred             EEeecCceecCCCcccc-CcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          656 ISDFGLARMFGGDELQG-NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       656 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |+|||+++.+...-.+- ....++-|.-|.|||.+.+. .||.+.|||+.|||+.||+|-++.|...+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999886532211 23446779999999999875 58999999999999999999999887665

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=3.9e-29  Score=263.13  Aligned_cols=203  Identities=31%  Similarity=0.453  Sum_probs=171.6

Q ss_pred             cCcccccccCccCceEEEccccc-----ccceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEE--cCeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~--~~~~  584 (744)
                      ++|++.+.||+|+||.||+++..     .++.+|||.++..... ..++|.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999753     3678999999765443 56789999999999999999999999877  5578


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998542  235889999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +...... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            7532211 1111224456799999998889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=7.5e-29  Score=262.00  Aligned_cols=201  Identities=29%  Similarity=0.402  Sum_probs=171.9

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~lV~  588 (744)
                      ++|+..+.||.|++|.||++... .++.+|+|.+... ......++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999874 4788999998754 234567799999999999999999999998654  4789999


Q ss_pred             EecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||+++++|.+++... .....++...+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876432 23456788999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            22    12245678999999999999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=6.5e-29  Score=257.38  Aligned_cols=196  Identities=33%  Similarity=0.515  Sum_probs=167.5

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      ++|++.+.||+|+||.||++.. .++.+|+|.++...  ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5688999999999999999975 67889999986542  346789999999999999999999998654 5789999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|..++... ....+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            99999998543 2335789999999999999999999987   999999999999999999999999999864321    


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~  721 (744)
                       ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  202 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS  202 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence             111234568999999998899999999999999999998 999986654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=6.3e-29  Score=261.67  Aligned_cols=209  Identities=29%  Similarity=0.466  Sum_probs=172.2

Q ss_pred             HHHHHHhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEE---
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE---  580 (744)
Q Consensus       506 ~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~---  580 (744)
                      .++....+.|++.+.||+|+||.||+|+.. .++.+|+|.+.... ....++..|+.++.++ +||||+++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            334445678999999999999999999864 47889999885433 3446788999999998 69999999999853   


Q ss_pred             ---cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          581 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                         ....+++|||+++++|..++... ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               45789999999999999888542 2345788888999999999999999987   9999999999999999999999


Q ss_pred             eecCceecCCCccccCcccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |||++.......  .......++..|+|||.+.     +..++.++|||||||++|||++|+.||....
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999988653321  1122356888999999886     3467889999999999999999999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=8.5e-29  Score=262.39  Aligned_cols=202  Identities=26%  Similarity=0.342  Sum_probs=166.4

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCe-----
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGE-----  583 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~-----  583 (744)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999864 58899999876542  223467888999999995 6999999999887665     


Q ss_pred             EEEEEEecCCCChhhhhcCcCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeec
Q 004580          584 KILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFG  660 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFG  660 (744)
                      .++||||+++ +|..++.....  ...+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 77777643221  346899999999999999999999987   999999999999998 8899999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9986543211  1122356788999998865 45789999999999999999999998654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.8e-29  Score=257.67  Aligned_cols=191  Identities=27%  Similarity=0.333  Sum_probs=161.0

Q ss_pred             cccCccCceEEEccccc-ccceeEEEeccCCCh---hhHHHHHHHHHHH-HHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---QGLEEFKNEMMLI-AKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~Ev~~l-~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|+||.||+|... +++.||+|.++....   .....+..|..++ ...+|||++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999764 488999999865422   2223344554443 445899999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999884   3346889999999999999999999987   99999999999999999999999999876432      


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  197 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET  197 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            122457889999999988889999999999999999999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=7.9e-29  Score=262.51  Aligned_cols=201  Identities=29%  Similarity=0.391  Sum_probs=169.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~lV  587 (744)
                      ++|++.+.||+|+||.||+|+.. +++.+|+|.++...  ......+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999875 47889999986542  22334577899999999999999999998877  899999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      +||+++ +|..++...  ...+++.++..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999985 887777432  236899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...  ......+++.|+|||.+.+. .++.++|+||||+++|||++|++||....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            321  12224568899999988764 46899999999999999999999987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=9.1e-29  Score=261.10  Aligned_cols=203  Identities=29%  Similarity=0.438  Sum_probs=176.6

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++.|+..+.||+|++|.||++... +++.+++|+++.... ..+.+.+|+++++.++|+|++++++.+......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999875 588999999876544 56778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++++|.+++....  ..+++.++..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999985422  36899999999999999999999987   9999999999999999999999999987654322


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  ......++..|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            1  1122457789999999998889999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.9e-29  Score=260.19  Aligned_cols=204  Identities=29%  Similarity=0.441  Sum_probs=172.1

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcC------
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG------  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~------  582 (744)
                      .+++|++.+.||+|++|.||+|+.. +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4688999999999999999999874 478899999865443 346799999999999 6999999999997644      


Q ss_pred             eEEEEEEecCCCChhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          583 EKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                      ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999998875422 2456889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      +........  ......++..|+|||++..     ..++.++||||||++++||++|+.||...
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            987543221  1223467889999998753     34678999999999999999999999654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.4e-28  Score=253.32  Aligned_cols=199  Identities=34%  Similarity=0.536  Sum_probs=176.4

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      +|++.+.||+|++|.||++... +++.+++|++........+.+.+|+..+++++|||++++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777889999999999999875 588999999977655567889999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|.+++...  ...+++..+..++.|++.||++||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999988542  246899999999999999999999987   99999999999999999999999999987654321  


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                       .....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             23356788999999998888999999999999999999999998765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1e-28  Score=260.77  Aligned_cols=197  Identities=26%  Similarity=0.413  Sum_probs=170.9

Q ss_pred             cccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          515 FSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      |...+.||+|++|.||++.. .+++.+++|+++.......+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44456999999999999975 35789999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      ++|.+++..    ..+++.++..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||.+........  .
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999998843    45789999999999999999999987   99999999999999999999999998876543221  1


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~  218 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE  218 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence            22246888999999999888999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=6.6e-29  Score=281.98  Aligned_cols=202  Identities=24%  Similarity=0.368  Sum_probs=159.1

Q ss_pred             HhcCcccccccCccCceEEEcccccc--cceeEEE------------------eccCCChhhHHHHHHHHHHHHHhcCCC
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSSQSGQGLEEFKNEMMLIAKLQHRN  570 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~--g~~vAVK------------------~l~~~~~~~~~~f~~Ev~~l~~l~Hpn  570 (744)
                      ..++|++.++||+|+||+||++..+.  +...++|                  .++ ........+.+|+.++.+++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34789999999999999999986432  2222222                  111 12234567889999999999999


Q ss_pred             eeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcC--CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 004580          571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL  648 (744)
Q Consensus       571 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl  648 (744)
                      |+++++++.+.+..++|+|++.. +|..++....  ........++..++.||+.||+|||+.+   ||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            99999999999999999999864 5555553321  1222345667889999999999999987   9999999999999


Q ss_pred             eCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCC-CCC
Q 004580          649 DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK-NTG  718 (744)
Q Consensus       649 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~-p~~  718 (744)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+. |+.
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            99999999999999877543221 1223578999999999999999999999999999999999885 443

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=9.7e-29  Score=256.91  Aligned_cols=206  Identities=27%  Similarity=0.419  Sum_probs=173.2

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE--cCeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~--~~~~~lV~  588 (744)
                      +|++.+.||.|+||.||++... +++.+|+|.++..  .....+++.+|+.++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999754 5788999988643  34456778999999999999999999998764  34678999


Q ss_pred             EecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          589 EYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYS--RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      ||+++++|..++... .....+++.++..++.||+.||+|||..+  ..+|+|+||||+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988543 23457899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ......  .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            543321  223468899999999998889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-29  Score=265.61  Aligned_cols=204  Identities=28%  Similarity=0.373  Sum_probs=171.7

Q ss_pred             HHhcCcccccccCccCceEEEcccccccceeEEEeccC--CChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~--~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~l  586 (744)
                      .....|+++++||+||.+.||++...+.+.+|+|+...  .+.+..+-|.+|+..|.+|+ |.+||+|++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34567999999999999999999887778888887643  46777889999999999997 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||= ..+|..+|...  ...++.-.++.+..|++.++.++|+++   |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99974 55777877432  222332377889999999999999998   99999999999994 6799999999999887


Q ss_pred             CCccccCcccccccccccCcccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGL-----------FSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .+...-.....+||+.||+||.+....           ++.++||||||||||+|+.|++||...
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            765544445579999999999985322           568899999999999999999999654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=1.4e-28  Score=262.59  Aligned_cols=197  Identities=32%  Similarity=0.483  Sum_probs=166.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+++.+|+.+++.++||||+++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999864 58899999886432   234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++ ++..++..  ....+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99974 55555432  2345899999999999999999999987   999999999999999999999999998765322


Q ss_pred             ccccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                            ....++..|+|||++.   ...++.++||||||+++|||++|++||...+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence                  2245788999999874   4568899999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2e-29  Score=268.73  Aligned_cols=222  Identities=23%  Similarity=0.329  Sum_probs=187.7

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .-|..++.||-|+||+|.+++..+ ...+|.|.|++.+   .......+.|-.||+....+=||+|+..|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457778899999999999997544 5678999997653   345566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC--
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--  666 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~--  666 (744)
                      ||++||++-.+|.   +-+.+.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||+||||+.-+.  
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999988873   4567888888999999999999999998   9999999999999999999999999986431  


Q ss_pred             --CCcccc------------------------------------CcccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 004580          667 --GDELQG------------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML  708 (744)
Q Consensus       667 --~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~  708 (744)
                        ...+..                                    .....+||+.|+|||++....++...|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence              000000                                    001247999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCccccccccccccccccc
Q 004580          709 ETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       709 elltG~~p~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      ||+.|++||-.....+.++.-.-|+...||+-
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~  894 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPY  894 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhhcccccc
Confidence            99999999988887777777777777777764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=1.6e-28  Score=253.90  Aligned_cols=202  Identities=30%  Similarity=0.449  Sum_probs=176.8

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILIL  588 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~lV~  588 (744)
                      +|.+.+.||+|++|.||+|... +++.+++|++....  ....+.+.+|+.++++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999875 58899999987654  35578899999999999999999999999988  8999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++++|.+++..   ...+++.++..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999998843   237899999999999999999999987   999999999999999999999999999987654


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32111233567889999999988889999999999999999999999997765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.1e-28  Score=268.91  Aligned_cols=199  Identities=29%  Similarity=0.362  Sum_probs=168.1

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------  581 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------  581 (744)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++...  .....+++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3478999999999999999999864 5889999998643  334456788899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                      ...++||||+++ +|...+..     .++..++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999965 66666532     2788899999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            987644321   222457889999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=5.4e-29  Score=258.84  Aligned_cols=195  Identities=29%  Similarity=0.404  Sum_probs=168.2

Q ss_pred             cCccCceEEEcccccc-cceeEEEeccCCCh---hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998764 88999999865433   4567789999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc------
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL------  670 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~------  670 (744)
                      ..++..   ...+++..+..++.||++||+|||+.+   |+|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            998853   236899999999999999999999987   99999999999999999999999999886533211      


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ........++..|+|||.+.+...+.++||||||++++||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            012223467889999999988889999999999999999999999987554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=8.1e-29  Score=267.98  Aligned_cols=201  Identities=27%  Similarity=0.411  Sum_probs=166.9

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc-----CeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~-----~~~  584 (744)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.. ......++.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999754 5889999998643 233456788999999999999999999887654     357


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++|+||+++ +|...+    ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 666655    2345889999999999999999999997   99999999999999999999999999987


Q ss_pred             cCCCccc-cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            6432211 11223567899999998755 56899999999999999999999999653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=2.4e-28  Score=258.92  Aligned_cols=201  Identities=28%  Similarity=0.391  Sum_probs=165.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.+.||+|++|.||+|+.. +++.+|+|+++...  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999865 58899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCCC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD  668 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~~  668 (744)
                      |+++ +|..++... ....+++..+..++.||+.||+|||+.+   |+|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 666665322 2223578888899999999999999987   999999999999985 557999999999865432


Q ss_pred             ccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      .  .......+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  11122356889999998866 45789999999999999999999999654

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.5e-28  Score=260.47  Aligned_cols=194  Identities=26%  Similarity=0.406  Sum_probs=169.4

Q ss_pred             ccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          518 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ..+||+|+||.||++... +++.+|||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            358999999999999764 5889999998665555667799999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      .+++.    ...+++.....++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++..+.....  ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            98763    235789999999999999999999987   99999999999999999999999999876643221  1223


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46788999999998888999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=5e-29  Score=261.60  Aligned_cols=203  Identities=31%  Similarity=0.446  Sum_probs=175.8

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|.+.+.||+|++|.||+++.. +++.+|+|++...   .....+.+.+|+.++.+++ ||||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999865 5889999998653   2334567889999999999 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |||+++++|.+++.   ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999884   3346899999999999999999999987   99999999999999999999999999987654


Q ss_pred             Cccc------------------cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQ------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ....                  .......++..|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            3221                  11223467889999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-28  Score=252.24  Aligned_cols=200  Identities=33%  Similarity=0.467  Sum_probs=175.0

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCCh--hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+++.. +++.+++|.+.....  ...+.+.+|++++.+++|||++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999764 578999999876543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++++|.+++..   ...+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999998843   356899999999999999999999987   99999999999999999999999999987754332


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  .....++..|+|||...+..++.++||||+|++++||++|+.||....
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            1  223467889999999988888999999999999999999999986543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.5e-28  Score=262.61  Aligned_cols=202  Identities=30%  Similarity=0.416  Sum_probs=167.2

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~l  586 (744)
                      .++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            368999999999999999999864 48899999986432  22234567899999999999999999998765  46899


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||||+++ +|..++...  ...+++.++..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++..+.
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 677766432  356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|++||...+
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4321  1122345778999999865 557899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=236.46  Aligned_cols=222  Identities=27%  Similarity=0.356  Sum_probs=178.9

Q ss_pred             HhcCcccccccCccCceEEEcccc-cccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ..+.....+.||+|++|.|-+-++ .+|...|+|+++.. ..+..++..+|+.+..+. ..|.+|.++|...+....++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            345566667999999999998876 46999999999765 445566777888766554 589999999999999999999


Q ss_pred             EEecCCCChhhhhcC-cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          588 LEYMPNKSLDVFLFD-PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ||.|. .+|+.+-.. ..+...+++.-+-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|++|||.+..+.
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99995 566665432 145667888888999999999999999975  59999999999999999999999999998875


Q ss_pred             CCccccCcccccccccccCcccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccccccc
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF  738 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~f  738 (744)
                      +.-...   --.|-..|||||.+..    ..|+.|+||||||+.+.||.+++.||+.....-.++.+-+......+
T Consensus       201 dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L  273 (282)
T KOG0984|consen  201 DSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL  273 (282)
T ss_pred             hhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence            543211   1256678999998853    36899999999999999999999999988777666766665554433

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-28  Score=258.38  Aligned_cols=200  Identities=29%  Similarity=0.423  Sum_probs=167.8

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      |++.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+.++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999764 68999999986542  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      + ++|..++.... ...+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++..+..... 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 68888874322 235899999999999999999999987   99999999999999999999999999976543211 


Q ss_pred             cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||++.+. .++.++||||||+++|||++|++||...+
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11223567899999988664 57899999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=2.1e-28  Score=259.58  Aligned_cols=203  Identities=19%  Similarity=0.244  Sum_probs=152.3

Q ss_pred             hcCcccccccCccCceEEEcccccc----cceeEEEeccCCChhhH-----------HHHHHHHHHHHHhcCCCeeeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGL-----------EEFKNEMMLIAKLQHRNLVKLLG  576 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~-----------~~f~~Ev~~l~~l~HpnIv~l~~  576 (744)
                      .++|++.++||+|+||.||+|+..+    +..+|+|+.........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998644    34566665432221110           11223334455668999999999


Q ss_pred             EEEEcC----eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC
Q 004580          577 CCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM  652 (744)
Q Consensus       577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~  652 (744)
                      ++....    ..++++|++.. ++...+.   .....++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    34677777643 4444442   2223567888999999999999999987   99999999999999999


Q ss_pred             ceEEEeecCceecCCCcc-----ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          653 NPKISDFGLARMFGGDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       653 ~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .++|+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||+++||++|+.||....
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999987643211     111223468999999999999999999999999999999999999998764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=2.9e-28  Score=256.82  Aligned_cols=200  Identities=30%  Similarity=0.451  Sum_probs=168.9

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc--CeEEEEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ--GEKILILE  589 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E  589 (744)
                      |++.+.||+|++|.||+|+.. +++.+|+|+++...  ....+.+.+|+.++++++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999865 47899999997652  33456788999999999999999999999888  89999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++ +|..++...  ...+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 777776432  246899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            11 1222356788999998765 457899999999999999999999987554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=1.6e-28  Score=254.44  Aligned_cols=202  Identities=27%  Similarity=0.440  Sum_probs=172.1

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|+||.||++... ++..+|+|.+...  .....+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999865 4788999998643  223456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~~~~~  669 (744)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2335789999999999999999999987   99999999999999885 46999999998764432


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  ......+++.|+|||++.+..++.++|+||||++++||++|+.||...+
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  206 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN  206 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            1  1122457889999999988889999999999999999999999987543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=1.5e-28  Score=259.60  Aligned_cols=203  Identities=30%  Similarity=0.412  Sum_probs=165.6

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            45667789999999999999864 4789999998654 2344567899999999996 9999999999999999999999


Q ss_pred             ecCCCChhhhhcC--cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          590 YMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      |++. ++..+...  ......+++..+..++.+++.||+|||+..  +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9874 44332211  122356889999999999999999999752  399999999999999999999999999976543


Q ss_pred             CccccCcccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...   .....++..|+|||++.+.   .++.++||||||+++|||++|+.||....
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            221   1223578899999998776   68999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=2.2e-28  Score=264.72  Aligned_cols=201  Identities=30%  Similarity=0.434  Sum_probs=167.5

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc--CeEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ--GEKI  585 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~--~~~~  585 (744)
                      .++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.++.++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            478999999999999999999865 4788999988542  233456678899999999 999999999988653  4689


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 488777632    26788999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCccc---cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          666 GGDELQ---GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       666 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            443221   12233567889999998765 56789999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=244.70  Aligned_cols=202  Identities=25%  Similarity=0.396  Sum_probs=166.3

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccCC-ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++.+.+..||.|..|+|++++.+. |..+|||.+... +.+..+++...+.++.+-+ .|.||+.+|+|.......+.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            455667789999999999998764 789999999765 4555677777887776665 7999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      .|.. .++.+|.  ...+++++.-+-++...+.+||.||....  .|||||+||+|||+|+.|++||+|||++..+-...
T Consensus       172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9853 2344442  23455788888899999999999999865  69999999999999999999999999998876544


Q ss_pred             cccCcccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      ..   ....|-+.|||||.+.-   ..|+.++||||||+.|+||.||+.||+.-+.
T Consensus       247 Ah---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  247 AH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             cc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence            32   23578899999999864   3588999999999999999999999987543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=2.6e-28  Score=260.40  Aligned_cols=204  Identities=27%  Similarity=0.402  Sum_probs=166.0

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC------
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~------  582 (744)
                      .++|++.+.||+|+||.||+++.. +++.||||++....  ......+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            367999999999999999999864 58899999886432  222345678999999999999999999987654      


Q ss_pred             --eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          583 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                        ..++||||+++ +|...+..  ....+++.++..++.||+.||+|||+++   |+|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999975 66666532  2235889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCccc--cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          661 LARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99876443211  111234567889999988764 47899999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=2.5e-28  Score=259.69  Aligned_cols=203  Identities=29%  Similarity=0.425  Sum_probs=167.7

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----  582 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----  582 (744)
                      ..++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578999999999999999999875 47899999986542  233456788999999999999999999987654     


Q ss_pred             -----eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          583 -----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       583 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                           ..++|+||+++ ++...+..  ....+++.++..++.||+.||+|||+.+   |+|+||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999987 55555532  2346899999999999999999999987   9999999999999999999999


Q ss_pred             eecCceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      |||++..+...... ......++..|+|||.+.+ ..++.++|||||||+++||++|++||...
T Consensus       159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999876543211 1122345778999998865 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=228.71  Aligned_cols=203  Identities=27%  Similarity=0.405  Sum_probs=167.2

Q ss_pred             CcccccccCccCceEEEcccccc-cceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|...++||+|.||+||+|+..+ ++.||+|+.+-+  ++.-.....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46667899999999999998755 788999987643  333345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +.. +|..+..  .-++.++.+.++.++.|+++||.++|++.   +.||||||+|+|++.+|++|++|||+++.++-.. 
T Consensus        83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence            954 4444431  34566889999999999999999999998   9999999999999999999999999999875432 


Q ss_pred             ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLS-GKKNTGVYNADS  724 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~ellt-G~~p~~~~~~~~  724 (744)
                      .. ....+-|.-|.+|.++.+. .|++..|+||.|||+.||.. |++.|...+.++
T Consensus       156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd  210 (292)
T KOG0662|consen  156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD  210 (292)
T ss_pred             Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence            11 1223568899999999875 58999999999999999987 666677766443

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=247.44  Aligned_cols=218  Identities=23%  Similarity=0.283  Sum_probs=179.5

Q ss_pred             HhcCcccc-cccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEE----cCe
Q 004580          511 ATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE----QGE  583 (744)
Q Consensus       511 ~~~~y~i~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~----~~~  583 (744)
                      .+++|++. ++||-|-.|.|..+.++ .++.+|+|+|.+.     ....+|+++.-.. .|||||.++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677765 57999999999998764 5889999999643     2345677765444 59999999999864    346


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC---CCceEEEeec
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFG  660 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~---~~~~kL~DFG  660 (744)
                      +.+|||.|+||.|...+.+ .....+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|...   +-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999888754 34456899999999999999999999998   999999999999975   4468999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCccccccccccccccc
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN--ADSFNLLGYVSNKSLHF  738 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~--~~~~~l~~~~~~~~~~f  738 (744)
                      +|+.-..   .......+-|+.|.|||++....|+...|+||+||++|-|++|-+||-..+  .-+..+..-|...+..|
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9997543   233445688999999999999999999999999999999999999998776  44566777788888888


Q ss_pred             cc
Q 004580          739 YL  740 (744)
Q Consensus       739 ~~  740 (744)
                      |.
T Consensus       287 P~  288 (400)
T KOG0604|consen  287 PE  288 (400)
T ss_pred             CC
Confidence            74

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=4.7e-28  Score=254.75  Aligned_cols=197  Identities=26%  Similarity=0.362  Sum_probs=162.5

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCC-hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEc--CeEEEEEE
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ--GEKILILE  589 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E  589 (744)
                      |++.++||+|+||.||+++.. +++.+|+|+++... ........+|+..+.++. ||||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999764 58899999987542 222234457888888885 99999999999987  88999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++ +|.+++..  ....+++.++..++.||+.||+|||+.+   |+||||||+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 66666643  2346899999999999999999999987   999999999999999 999999999998764332


Q ss_pred             cccCcccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .   .....++..|+|||.+. +..++.++|||||||++|||++|++||...+
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            1   12245788999999764 4567899999999999999999999997654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=2.5e-28  Score=257.98  Aligned_cols=199  Identities=30%  Similarity=0.409  Sum_probs=168.4

Q ss_pred             CcccccccCccCceEEEcccc----cccceeEEEeccCCC----hhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~  584 (744)
                      +|++.+.||+|++|.||+++.    .+++.+|||.++...    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999864    246789999986432    23456788999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++||||+++++|..++..   ...+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988743   345889999999999999999999987   99999999999999999999999999887


Q ss_pred             cCCCccccCcccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      +...... ......++..|+|||.+.+..  .+.++||||||++++||++|+.||..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            6443211 112246788999999987665  78899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.96  E-value=6.9e-30  Score=228.35  Aligned_cols=110  Identities=47%  Similarity=0.788  Sum_probs=81.5

Q ss_pred             CCcEEEEecCCCCCCC--CCceEEEeeCCcEEEecCCCceEEEE-eeeccc-CCceEEEccCCCEEEEcCCCCCccccee
Q 004580           70 PDTVVWVANRDRPISD--HNAVLTISNKGNLVLLNQTNGTIWST-NVFSEV-KNPVAQLRDDGNLVIRDNSSGNTTESYL  145 (744)
Q Consensus        70 ~~~~vW~anr~~p~~~--~~~~l~~~~~g~l~l~~~~~~~~W~t-~~~~~~-~~~~~~l~d~gNlvl~~~~~~~~~~~~~  145 (744)
                      ++||||+|||+.|+.+  ...+|.|+.||||+|++..++++|++ ++.+.. .+..|+|+|+|||||++.     .+.+|
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l   75 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL   75 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence            4699999999999954  35899999999999999999999999 443322 578999999999999996     56899


Q ss_pred             ceeccCCccccccCCcccccccCCCceEEEEecCCCCCC
Q 004580          146 WQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPS  184 (744)
Q Consensus       146 wqSFd~PtDtlLpg~~l~~~~~t~~~~~l~S~~s~~dps  184 (744)
                      ||||||||||+||+|+|+.+..++....++||++.+|||
T Consensus        76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            999999999999999999888887777899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.3e-29  Score=246.44  Aligned_cols=224  Identities=24%  Similarity=0.384  Sum_probs=185.9

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..+|.++++||+|+|+.|..+++.. .+.+|+|++++.   ..++.+=.+.|-.++... +||.+|-+..+++.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4688999999999999999998754 778999998764   334444456666666665 69999999999999999999


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      |.||+++|+|--++   +.++.++++.++.+...|.-||.|||+.+   ||.||||.+|||+|.+|++||+|+|+++.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999986555   56778999999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------ccccccccccccccccc
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD------SFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~------~~~l~~~~~~~~~~f~~  740 (744)
                      ...  ..+...+|||.|+|||++.+..|...+|.|+|||+++||+.|+.||+....+      +--+.+-+...++..|-
T Consensus       403 ~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr  480 (593)
T KOG0695|consen  403 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR  480 (593)
T ss_pred             CCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence            221  2455689999999999999999999999999999999999999999765311      11255666666666665


Q ss_pred             ccc
Q 004580          741 IFS  743 (744)
Q Consensus       741 ~~~  743 (744)
                      .+|
T Consensus       481 sls  483 (593)
T KOG0695|consen  481 SLS  483 (593)
T ss_pred             eee
Confidence            443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=267.11  Aligned_cols=203  Identities=25%  Similarity=0.330  Sum_probs=179.8

Q ss_pred             cCcccccccCccCceEEEcccccccc-eeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~-~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .+++++..||-|+||.|-+++..... .+|+|++++.   +....+.+..|-.+|...+.|.||+++..|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            46667778999999999998775433 4899988764   3445667888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      |-|-||.|-..|   ..++.++......++..+.+|++|||+++   ||.|||||+|+||+.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999888   45667888889999999999999999998   999999999999999999999999999998664


Q ss_pred             ccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      .   .+-+.+||+.|.|||++.++..+.++|.||||+++|||++|++||...++-.
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk  626 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK  626 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence            3   4556899999999999999999999999999999999999999999877544

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=7.5e-28  Score=258.24  Aligned_cols=195  Identities=32%  Similarity=0.489  Sum_probs=165.3

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .|+..+.||+|+||.||+++.. +++.+|+|++...   ......++.+|+.++++++|||++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4777889999999999999864 5789999998643   22344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++ +|.+.+..  ....+++.++..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9975 66655532  2345889999999999999999999987   999999999999999999999999998754321 


Q ss_pred             cccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                           ....++..|+|||++.   ...++.++|||||||++|||++|+.||...
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                 2246788999999974   456889999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.95  E-value=1.2e-28  Score=219.92  Aligned_cols=109  Identities=38%  Similarity=0.807  Sum_probs=105.2

Q ss_pred             eecCCCCCceeeeeecc-cccceeEEEeeeCcceEEEEeccCCCeeeEEEEccCCcEEEEEEecCCCceEEEEecCcCcC
Q 004580          210 ACSGQWNGAAFVSAISY-TNFLYEQYLVENQDEISYWYEPFNRPSIMTLKLNPSGLLTRQIWNNNGNDWDLVFSFPDEYC  288 (744)
Q Consensus       210 ~~sg~w~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C  288 (744)
                      ||+|+|||..|.+.|++ ...++.+.|+.+.+|.+|+|...+.+.++|++||++|+++++.|++..++|.++|++|.|+|
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C   80 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC   80 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence            89999999999999999 67889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcCCCCCCCccccccCCccCC
Q 004580          289 GKYGYCGANTICSPDQKPICECLEGFKLKS  318 (744)
Q Consensus       289 ~~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~  318 (744)
                      |+|+.||+||+|+.+..|.|+||+||+|++
T Consensus        81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            999999999999988899999999999975

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=7.9e-28  Score=248.84  Aligned_cols=203  Identities=26%  Similarity=0.428  Sum_probs=177.0

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|+||.||++... +++.+|+|++....  ....+++.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999864 48899999987543  35567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      +++++|..++.... ....+++.++..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885432 2467899999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .  ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            1  1223467889999999998889999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=256.58  Aligned_cols=206  Identities=32%  Similarity=0.460  Sum_probs=172.5

Q ss_pred             hcCcccccccCccCceEEEcccc-cccceeEEEeccCCC-------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEE-EcC
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS-------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCV-EQG  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~-~~~  582 (744)
                      .++|-++.+||+|+|+.||++.+ .+.+.||||+-....       +.-.+...+|.++.+.|.||.||++++++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            36788889999999999999964 457899999864321       122344568999999999999999999985 567


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC---CceEEEee
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDF  659 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~---~~~kL~DF  659 (744)
                      .++-|+||++|.+|+-+|   .....+++.+++.|+.||+.||.||... ++||||-||||.||||...   |.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            889999999999999999   4566799999999999999999999987 4789999999999999654   68999999


Q ss_pred             cCceecCCCcccc-----CcccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          660 GLARMFGGDELQG-----NTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       660 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      |+++.+..+.+..     .+....||.-|++||.+.-+    .++.|+||||.|||+|..+.|++||...-
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            9999997765442     23346789999999987532    47899999999999999999999998654

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=3.2e-28  Score=251.91  Aligned_cols=202  Identities=30%  Similarity=0.449  Sum_probs=175.1

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +|++.+.||+|++|.||+++.. +++.+|+|.+...  ......++.+|++++++++||||+++.+.+.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999754 5789999998653  334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      +++++|..++... .....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999987542 22356889999999999999999999987   9999999999999999999999999998765431


Q ss_pred             cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                          .....++..|+|||.+.+..++.++|+||||++++||++|+.||...+.
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  206 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM  206 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                1224578899999999999999999999999999999999999976553

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=2.2e-28  Score=264.40  Aligned_cols=202  Identities=22%  Similarity=0.356  Sum_probs=168.5

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE----cCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~----~~~~  584 (744)
                      .++|++.+.||+|++|.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999764 58899999987542  2345678889999999999999999987753    3478


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++||||+. ++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 57887773   3445899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCcccc--CcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          665 FGGDELQG--NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            64432111  1123468889999998865 45889999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.6e-28  Score=261.79  Aligned_cols=203  Identities=30%  Similarity=0.402  Sum_probs=169.0

Q ss_pred             HHHHHHhcCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc-
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-  581 (744)
Q Consensus       506 ~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~-  581 (744)
                      .++...+++|++.+.||+|+||.||++.. .+++.||+|+++..  .....+.+.+|+.++.+++||||+++.+++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34556779999999999999999999975 45889999998753  233456788999999999999999999988643 


Q ss_pred             -----CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          582 -----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       582 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                           ...+++++++ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467788876 778877763    235889999999999999999999987   999999999999999999999


Q ss_pred             EeecCceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +|||+++.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  222 (345)
T cd07877         162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  222 (345)
T ss_pred             eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998864322     223467889999998866 568899999999999999999999986543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=4.1e-28  Score=262.62  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=167.3

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc-----Ce
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----GE  583 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~-----~~  583 (744)
                      ..+|.+.+.||+|+||.||+++.. +++.||||.++..  ......++.+|+.++..++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999864 5889999998653  233456678899999999999999999987654     35


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .++|+||+. ++|..++.   ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 67777763   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|++||...
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            764332  11223457889999998865 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.3e-28  Score=248.95  Aligned_cols=193  Identities=32%  Similarity=0.443  Sum_probs=168.2

Q ss_pred             cCccCceEEEccccc-ccceeEEEeccCCC---hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      ||+|+||.||++... +++.+|+|.++...   ....+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999865 48899999987542   23566889999999999999999999999999999999999999999


Q ss_pred             hhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccc
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR  676 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  676 (744)
                      .+++..   ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            998843   335889999999999999999999987   9999999999999999999999999998764432  11233


Q ss_pred             ccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       677 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..++..|+|||.+.+...+.++|+||||+++|||++|+.||...+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            567889999999998889999999999999999999999996654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=9e-28  Score=257.07  Aligned_cols=201  Identities=22%  Similarity=0.231  Sum_probs=165.5

Q ss_pred             ccccccCccCceEEEcccccccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      .+.+.+|.|+++.|++++. +++.+|||+++..  .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3445566666666666655 6899999998754  445667899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc---
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---  670 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~---  670 (744)
                      ++|..++.... ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+||+.+..+.....   
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999886432 235788899999999999999999987   99999999999999999999999999876543211   


Q ss_pred             --ccCcccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 --QGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 --~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        ........++..|+|||++...  .++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence              1112234567789999998763  58899999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=8.5e-28  Score=260.74  Aligned_cols=198  Identities=28%  Similarity=0.403  Sum_probs=167.2

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC----
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----  582 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~----  582 (744)
                      ...++|++.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34578999999999999999999753 5889999998543  2334567889999999999999999999887543    


Q ss_pred             --eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          583 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                        ..++||||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              468999998 678877763    345889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99865432     122456889999999876 45889999999999999999999998754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=6.6e-28  Score=253.66  Aligned_cols=199  Identities=32%  Similarity=0.449  Sum_probs=169.7

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCCh--hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG--QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      |++.+.||+|++|.||+++.. +++.+++|+++....  .....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999864 588999999875432  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      ++ +|..++...  ...+++.++..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            86 777766432  256899999999999999999999987   9999999999999999999999999998775533  


Q ss_pred             cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            111224577889999998876 78999999999999999999999986654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=3.6e-28  Score=259.45  Aligned_cols=204  Identities=29%  Similarity=0.446  Sum_probs=165.4

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC------
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~------  582 (744)
                      .++|++.++||+|+||.||+|+.. +++.+|+|++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999864 57899999885432  222346788999999999999999999875433      


Q ss_pred             --eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeec
Q 004580          583 --EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFG  660 (744)
                        ..++|+||++. ++...+..  ....+++.++..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 45555532  2346899999999999999999999997   9999999999999999999999999


Q ss_pred             CceecCCCcccc---------CcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          661 LARMFGGDELQG---------NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       661 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            998664322111         11224567889999987654 58899999999999999999999986543

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=8.9e-28  Score=259.69  Aligned_cols=202  Identities=28%  Similarity=0.382  Sum_probs=165.8

Q ss_pred             cCccc-ccccCccCceEEEccccc-ccceeEEEeccCCChhh--------------HHHHHHHHHHHHHhcCCCeeeEEE
Q 004580          513 ENFSM-QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG--------------LEEFKNEMMLIAKLQHRNLVKLLG  576 (744)
Q Consensus       513 ~~y~i-~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~Ev~~l~~l~HpnIv~l~~  576 (744)
                      ++|.. .+.||+|+||+||+|+.. .++.||||+++......              ...+.+|++++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 467999999999999864 58899999886532211              125788999999999999999999


Q ss_pred             EEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                      ++...+..++||||++ ++|.+++.   ....+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 57887773   3445889999999999999999999987   999999999999999999999


Q ss_pred             EeecCceecCCCcc------------ccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          657 SDFGLARMFGGDEL------------QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +|||++........            ........++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999987652111            1111123467889999998764 47899999999999999999999997654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=248.98  Aligned_cols=216  Identities=26%  Similarity=0.385  Sum_probs=187.5

Q ss_pred             cHHHHHHHhcCcccccccCccCceEEEccccc------ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEE
Q 004580          504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLG  576 (744)
Q Consensus       504 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~  576 (744)
                      ...++.....+++...++-+|.||.||+|.+.      +.+.|-||.++.. ++.+...+..|...+..+.|||++.+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34556666678888889999999999999543      3567888988765 4556778999999999999999999999


Q ss_pred             EEEEc-CeEEEEEEecCCCChhhhhc-----CcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC
Q 004580          577 CCVEQ-GEKILILEYMPNKSLDVFLF-----DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       577 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~  650 (744)
                      ++.+. ...+.++.++.-|+|..||.     +....+.++..+...++.|++.|++|||.++   +||.||..+|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            98764 56788899999999999997     5555677888899999999999999999998   999999999999999


Q ss_pred             CCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004580          651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNA  722 (744)
Q Consensus       651 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~~~~  722 (744)
                      ..++||+|=.+++.+.+.++.........+..||+||.+....|+.++|||||||+||||+| |+.|+...++
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence            99999999999999988777766666677889999999999999999999999999999999 8888866553

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=6e-28  Score=256.27  Aligned_cols=201  Identities=26%  Similarity=0.402  Sum_probs=164.6

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCC-hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .++|++.+.||+|++|.||+|+... ++.+|||+++... .....++..|+.++.+.. ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678889999999999999998754 8899999987542 234456677887777775 999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+++ ++..++..  ....+++..+..++.||++||+|||+..  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99864 55555432  2336889999999999999999999742  3999999999999999999999999999865432


Q ss_pred             ccccCcccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ..   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||...
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            21   12235678999999987554    789999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=280.45  Aligned_cols=207  Identities=34%  Similarity=0.488  Sum_probs=173.8

Q ss_pred             HHhcCcccccccCccCceEEEccccc----c----cceeEEEeccCC-ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL----N----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCV  579 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~----~----g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~  579 (744)
                      ...++.++.+.||+|.||.|++|...    .    ...||||.++.. .....+.+..|+++|+.+. ||||+.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            34455667779999999999999642    1    347999999865 3356788999999999995 999999999999


Q ss_pred             EcCeEEEEEEecCCCChhhhhcCcC------C-----c--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 004580          580 EQGEKILILEYMPNKSLDVFLFDPT------K-----K--RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNV  646 (744)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NI  646 (744)
                      +.+..++|+||++.|+|..+|+...      .     .  ..++..+.+.++.|||.||+||++..   +|||||.++||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence            9999999999999999999996543      0     0  24889999999999999999999987   99999999999


Q ss_pred             EEeCCCceEEEeecCceecCCCccccCc-ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004580          647 LLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGV  719 (744)
Q Consensus       647 Ll~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt-G~~p~~~  719 (744)
                      |+.++..+||+|||+|+........... ..-.-+..|||||.+....|+.|+|||||||+||||+| |..|+..
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999976554433211 11113567999999999999999999999999999999 7788875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=9.6e-28  Score=258.60  Aligned_cols=199  Identities=29%  Similarity=0.426  Sum_probs=167.4

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-cCeEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-QGEKI  585 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-~~~~~  585 (744)
                      ..+++|++.+.||+|+||.||+++.. +++.+|+|++...  .....+.+.+|+.++..++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45688999999999999999999754 6889999987643  22345678899999999999999999999876 45788


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +|+||+ +++|..++.    ...+++..+..++.|+++||+|||+.+   |+||||+|+||++++++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 457877763    335778888899999999999999987   999999999999999999999999998764


Q ss_pred             CCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            321     122456889999998766 568999999999999999999999996543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=8.6e-28  Score=260.61  Aligned_cols=196  Identities=30%  Similarity=0.439  Sum_probs=164.1

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------C
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------G  582 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------~  582 (744)
                      .++|.+.+.||+|+||.||+|+.. +++.+|||+++..  .......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999854 5889999998653  223345688999999999999999999998654      3


Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++|+||++. +|..++     ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            56899999974 565543     235788999999999999999999987   999999999999999999999999998


Q ss_pred             eecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            864321     123466888999999876 468899999999999999999999997654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=251.51  Aligned_cols=199  Identities=30%  Similarity=0.451  Sum_probs=165.5

Q ss_pred             cccccccCccCceEEEcccccc-cceeEEEeccCCC--hhhHHHHHHHHHHHHHh---cCCCeeeEEEEEEEcCe-----
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQGE-----  583 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l---~HpnIv~l~~~~~~~~~-----  583 (744)
                      |++.+.||+|+||.||+|+... ++.+|+|+++...  ......+.+|+.++.++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999998754 8899999987432  22234566788777666   59999999999988776     


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .+++|||+++ +|..++.... ...+++.++..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7877764322 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .+.....   .....++..|+|||.+.+..++.++|+||||+++|||++|++||....
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            7644321   122356888999999999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6e-28  Score=260.39  Aligned_cols=201  Identities=29%  Similarity=0.406  Sum_probs=171.4

Q ss_pred             CcccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----eEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI  585 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----~~~  585 (744)
                      +|++.+.||+|++|.||+++.. .++.+|+|++....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999865 48899999987643  445578999999999999999999999988775     789


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +||||+++ +|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 7777774   3337899999999999999999999987   999999999999999999999999999976


Q ss_pred             CCCccc-cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQ-GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            543210 112234678899999999887 78999999999999999999999997554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=2.7e-27  Score=253.47  Aligned_cols=195  Identities=33%  Similarity=0.480  Sum_probs=163.8

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      |...+.||+|+||.||+|+.. .++.+++|++...   .....+.+.+|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999864 5789999998643   223446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      +++ ++..++..  ....+++.++..++.||+.|+.|||+.+   |+|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            975 55555532  2345889999999999999999999987   99999999999999999999999999864321   


Q ss_pred             ccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         .....++..|+|||++.   ...++.++||||||+++|||++|++||...+
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~  224 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  224 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence               12346788999999984   4568899999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-30  Score=248.38  Aligned_cols=203  Identities=29%  Similarity=0.387  Sum_probs=165.0

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++.+-+..||.|+||+|+|-.++ .|+..|||+++.. .+....++..|.+...+- +.||||+++|++..++..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            44555679999999999999775 4899999999865 346677888888765544 68999999999999999999999


Q ss_pred             ecCCCChhhhhcC--cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          590 YMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      .|. .+|+.+-..  ..++..+++.-+-.|.....+||.||...-  .|||||+||+||||+..|.+||+|||++..+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            995 455544211  123456788888888889999999999865  599999999999999999999999999987654


Q ss_pred             CccccCcccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ....   +.-.|-..|||||.+..  ..|+.++||||||+.|+|+.||+.|+...+
T Consensus       221 SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  221 SIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             HHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence            3321   22367778999999864  358999999999999999999999987765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=1.9e-28  Score=279.79  Aligned_cols=198  Identities=32%  Similarity=0.478  Sum_probs=158.6

Q ss_pred             HHhcCcccccccCccCceEEEccccc-ccceeEEEeccCC-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE-------
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE-------  580 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~-------  580 (744)
                      ....+|+.++.||+||||.||+++.+ ||+.+|||++... .......+.+|++++++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45578999999999999999999753 7999999998655 34445678899999999999999999852110       


Q ss_pred             -----------------------------------------------------------------------c--------
Q 004580          581 -----------------------------------------------------------------------Q--------  581 (744)
Q Consensus       581 -----------------------------------------------------------------------~--------  581 (744)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHH
Q 004580          582 ---------------------------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL  628 (744)
Q Consensus       582 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL  628 (744)
                                                       ..+||-||||+..+++.++.......  .....++++.+|++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             12467789998888888875432211  4567889999999999999


Q ss_pred             HhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC----C------------CccccCcccccccccccCcccccCC
Q 004580          629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG----G------------DELQGNTKRIVGTYGYMSPEYALDG  692 (744)
Q Consensus       629 H~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~  692 (744)
                      |+++   ||||||||.||+|+++..+||+|||+|....    .            .......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9998   9999999999999999999999999999721    0            0111123446899999999999764


Q ss_pred             ---CCCchhhHHHHHHHHHHHHc
Q 004580          693 ---LFSIKSDVFSFGILMLETLS  712 (744)
Q Consensus       693 ---~~s~k~DvwSlGviL~ellt  712 (744)
                         .|+.|+|+|||||||+||+-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc
Confidence               49999999999999999974

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=1.8e-27  Score=256.95  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=164.3

Q ss_pred             CcccccccCccCceEEEccccc-c--cceeEEEeccCC--ChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEc----Ce
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLL-N--GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ----GE  583 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~-~--g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~----~~  583 (744)
                      +|++.+.||+|+||.||+++.. .  +..+|+|+++..  .....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999864 3  678999998653  223356788899999999 599999999875432    45


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .++++||++ ++|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788889886 57877773   3456889999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccc--cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          664 MFGGDELQ--GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .+......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            76543211  11223578899999998765 468999999999999999999999987543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=1.7e-27  Score=256.79  Aligned_cols=199  Identities=23%  Similarity=0.289  Sum_probs=162.4

Q ss_pred             cccCcc--CceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEG--GFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.||+|  +||+||++++. .++.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  89999999864 5899999998643  233457889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc-
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-  672 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-  672 (744)
                      ++|..++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99998875432 235788999999999999999999987   9999999999999999999999998654332211000 


Q ss_pred             ----CcccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          673 ----NTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       673 ----~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                01112345679999999764  47899999999999999999999997653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=252.07  Aligned_cols=199  Identities=30%  Similarity=0.378  Sum_probs=166.9

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCCh-hhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEEec
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      |++.+.||+|++|.||+|+.. .++.+|||++..... .......+|+..+.+++ ||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999875 478899999865422 23334567999999999 999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                       +++|..++.... ...+++.++..++.|++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888774322 346899999999999999999999987   99999999999999999999999999987644221 


Q ss_pred             cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                        .....++..|+|||++.. ..++.++|+||||++++||++|++||....
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence              122457889999998854 457899999999999999999999986554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=1.6e-27  Score=279.13  Aligned_cols=145  Identities=29%  Similarity=0.417  Sum_probs=130.3

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|.+.++||+|+||.||+|+.. .++.||||+++..   .......+..|+.++..++||||++++..+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67899999999999999999875 5889999998653   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      ||+++++|..++..   ...+++..++.++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998843   345788899999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=8.7e-28  Score=260.57  Aligned_cols=201  Identities=27%  Similarity=0.378  Sum_probs=165.7

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc----------
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ----------  581 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~----------  581 (744)
                      .+|++.+.||+|+||.||+|... .++.||+|++........+.+.+|+.++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67899999999999999999764 4889999998766556667889999999999999999999776543          


Q ss_pred             ----CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEE
Q 004580          582 ----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKI  656 (744)
Q Consensus       582 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL  656 (744)
                          ...++|+||++ ++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||+++. +..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 57877763    335889999999999999999999987   999999999999974 567899


Q ss_pred             EeecCceecCCCccc-cCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       657 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999876432111 11122357889999998754 568899999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=250.04  Aligned_cols=199  Identities=33%  Similarity=0.445  Sum_probs=169.2

Q ss_pred             cccccccCccCceEEEccccc-ccceeEEEeccCCC--hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      |+..+.||+|++|.||+|+.. +++.+|+|++....  ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556789999999999999875 48899999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~  671 (744)
                      + ++|..++....  ..+++..+..++.|+++||+|||+.+   |+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58988885321  46899999999999999999999987   99999999999999999999999999987644221 


Q ss_pred             cCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                       ......++..|+|||.+.+. .++.++||||||++++||++|++||...+
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence             11223456789999998776 78999999999999999999999986643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=3e-27  Score=252.52  Aligned_cols=197  Identities=34%  Similarity=0.498  Sum_probs=165.5

Q ss_pred             cCcccccccCccCceEEEccccc-ccceeEEEeccCC---ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777789999999999999864 4788999988642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~  668 (744)
                      ||+. +++...+..  ....+++.++..++.|++.|+.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 566665532  2345789999999999999999999987   999999999999999999999999998865432


Q ss_pred             ccccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                            ....++..|+|||.+.   ...++.++|||||||++|||++|+.||...+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  218 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence                  2245788999999974   3567889999999999999999999975543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=2.3e-27  Score=246.64  Aligned_cols=201  Identities=29%  Similarity=0.388  Sum_probs=166.1

Q ss_pred             CcccccccCccCceEEEcccccc-cceeEEEeccCC-----ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +|.+.+.||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999997643 445556655431     223345677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          588 LEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      +||+++++|..++... .....+++.++..++.|+++||+|||+.+   ++|+||||+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887542 23456899999999999999999999987   999999999999975 569999999998764


Q ss_pred             CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~  720 (744)
                      ....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~  208 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ  208 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            4321  122345788999999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.4e-27  Score=257.28  Aligned_cols=198  Identities=29%  Similarity=0.423  Sum_probs=167.1

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe----
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE----  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~----  583 (744)
                      ..++|++.+.||+|++|.||+|+.. +++.+|+|++...  .....+.+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999875 4789999998653  23345667889999999999999999988766554    


Q ss_pred             --EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          584 --KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       584 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                        .++|+||+ +++|.+++.    ...+++.++..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 568888773    245899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccCcccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865432     222457888999998865 467899999999999999999999996543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-27  Score=261.80  Aligned_cols=212  Identities=27%  Similarity=0.446  Sum_probs=180.3

Q ss_pred             cHHHHHHHhcCcccccccCccCceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEE-
Q 004580          504 SLASVAAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE-  580 (744)
Q Consensus       504 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~-  580 (744)
                      .+..+...++.|++.+.||.|.+|.||+++. ++++..|+|++.... ...++++.|..+++.. .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444555678899999999999999999975 468899999986543 3346678888888887 49999999999875 


Q ss_pred             ----cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          581 ----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       581 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                          +++++||||||.+|+.-+++.... ...+.|..+..|...+++|+.+||...   ++|||||-.|||++.++.+||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                468999999999999999886544 677999999999999999999999987   999999999999999999999


Q ss_pred             EeecCceecCCCccccCcccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      +|||++..+....  ......+||+.|||||++.-     ..|+.++|+||||++..||--|.+|+-.++.
T Consensus       165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            9999998876543  23344789999999999954     3478899999999999999999999876664

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=7.7e-27  Score=239.52  Aligned_cols=180  Identities=21%  Similarity=0.160  Sum_probs=152.8

Q ss_pred             cCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcC
Q 004580          524 GGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD  602 (744)
Q Consensus       524 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  602 (744)
                      |.+|.||+++.. +++.+|+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999864 57899999987543     234455555666799999999999999999999999999999988843


Q ss_pred             cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccccccccc
Q 004580          603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG  682 (744)
Q Consensus       603 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  682 (744)
                         ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||.+..+....     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               335889999999999999999999987   9999999999999999999999999887654321     12345678


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       683 y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+..
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9999999888899999999999999999999987654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=258.63  Aligned_cols=204  Identities=22%  Similarity=0.309  Sum_probs=153.9

Q ss_pred             HhcCcccccccCccCceEEEcccc-----------------cccceeEEEeccCCChhhHHH--------------HHHH
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSSQSGQGLEE--------------FKNE  559 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~~~--------------f~~E  559 (744)
                      ..++|++.++||+|+||.||+|.+                 ..++.||||+++.......++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999853                 235679999986543332233              3447


Q ss_pred             HHHHHHhcCCCe-----eeEEEEEEE--------cCeEEEEEEecCCCChhhhhcCcC---------------------C
Q 004580          560 MMLIAKLQHRNL-----VKLLGCCVE--------QGEKILILEYMPNKSLDVFLFDPT---------------------K  605 (744)
Q Consensus       560 v~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~  605 (744)
                      +.++.+++|.++     +++++++..        .+..+|||||+++++|.++++...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788877654     667777653        357899999999999999886421                     1


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccccccccccC
Q 004580          606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS  685 (744)
Q Consensus       606 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a  685 (744)
                      ...+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123467788899999999999999987   99999999999999999999999999976543221 11112234789999


Q ss_pred             cccccCCC--------------------C--CchhhHHHHHHHHHHHHcCCC-CCC
Q 004580          686 PEYALDGL--------------------F--SIKSDVFSFGILMLETLSGKK-NTG  718 (744)
Q Consensus       686 PE~~~~~~--------------------~--s~k~DvwSlGviL~elltG~~-p~~  718 (744)
                      ||.+....                    +  ..+.||||+||+++||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            99875432                    1  124799999999999999985 664

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.3e-26  Score=232.71  Aligned_cols=215  Identities=33%  Similarity=0.438  Sum_probs=178.8

Q ss_pred             cccccccCccCceEEEcccccc-cceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999998765 789999999866544 67889999999999999999999999998899999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +++|.+++.....  .+++..+..++.++++++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            9999998853221  1788999999999999999999987   99999999999999999999999999988654321 1


Q ss_pred             CcccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccc
Q 004580          673 NTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS  735 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~  735 (744)
                      ......++..|++||.+ ....++.++|+|+||++++||++|+.||+........+.+.+.+..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            22334677889999998 6677888999999999999999999999663333334555544433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=252.68  Aligned_cols=197  Identities=25%  Similarity=0.352  Sum_probs=166.9

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCC--------hhhHHHHHHHHHHHHHhc---CCCeeeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS--------GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCV  579 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--------~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~  579 (744)
                      -.+|+.++.+|+|+||.|+.+.++. ..+|+||.+.+..        ....-....|+.+|..++   |+||++++.+|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3568999999999999999998754 5678899886531        111223567999999998   999999999999


Q ss_pred             EcCeEEEEEEecCCC-ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEe
Q 004580          580 EQGEKILILEYMPNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISD  658 (744)
Q Consensus       580 ~~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~D  658 (744)
                      +.+.+||+||-...| +|.+++   +.++.+++.++..|++||+-|+++||+++   |||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999987543 555555   45667999999999999999999999998   99999999999999999999999


Q ss_pred             ecCceecCCCccccCcccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 004580          659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGviL~elltG~~p~~  718 (744)
                      ||.|.......    ....+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus       714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998765543    344789999999999999887 566899999999999999888864

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=238.28  Aligned_cols=200  Identities=26%  Similarity=0.380  Sum_probs=164.2

Q ss_pred             CcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcC-----eEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG-----EKI  585 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~-----~~~  585 (744)
                      +.+..+.||-|+||.||...+ ++|+.||+|++..-  .-...+++.+|++++..++|.|++..++...-..     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344557999999999999976 46999999988543  2334577889999999999999999988765432     567


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      .++|.|. .+|...+   .....++...+.-+.+||++||+|||+.+   |.||||||.|+|++.+..+||+|||+|+.-
T Consensus       134 V~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            7888774 4555555   34556788888899999999999999998   999999999999999999999999999987


Q ss_pred             CCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ..++....+. .+-|..|.|||++++. .|+.+.||||.|||+.||+-.+..|...+
T Consensus       207 e~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  207 DQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             chhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence            6655444333 4568899999999875 58999999999999999999988876654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6e-27  Score=253.75  Aligned_cols=197  Identities=25%  Similarity=0.341  Sum_probs=165.0

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .++.|++...+|.|+|+.|-++... .++..+||++.+..    .+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3678899899999999999998764 57899999997652    2234566555554 6999999999999999999999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE-eCCCceEEEeecCceecCC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL-DMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl-~~~~~~kL~DFGla~~~~~  667 (744)
                      |.+.++-+...+.   ...... .++..++.+|+.|+.|||+++   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998766653   222233 677789999999999999988   9999999999999 5889999999999998655


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~  723 (744)
                      .     ....+-|..|.|||++....++.++|+||||++|||||+|+.||.....+
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence            4     22235688999999999999999999999999999999999999876544

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.94  E-value=4.4e-26  Score=205.73  Aligned_cols=115  Identities=43%  Similarity=0.705  Sum_probs=102.5

Q ss_pred             ccccCCCeeeeCCCeEEEEEECCCCCCCeEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeCCcEEEecCCCceEEEE
Q 004580           32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST  111 (744)
Q Consensus        32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t  111 (744)
                      +.|++|++|+|+++.|++|||.+..+...+.+|||.+...++||.|||+.|. ...+.|.|+.||+|+|+|.+|.+||+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S   80 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS   80 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence            5788999999999999999999987656999999987768899999999984 457899999999999999999999999


Q ss_pred             eeecccCCceEEEccCCCEEEEcCCCCCcccceeceeccCC
Q 004580          112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYP  152 (744)
Q Consensus       112 ~~~~~~~~~~~~l~d~gNlvl~~~~~~~~~~~~~wqSFd~P  152 (744)
                      ++.+.....+|+|+|||||||++.     .+.+||||||||
T Consensus        81 ~~~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~P  116 (116)
T cd00028          81 NTTRVNGNYVLVLLDDGNLVLYDS-----DGNFLWQSFDYP  116 (116)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC-----CCCEEEcCCCCC
Confidence            986535667899999999999997     357899999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=5.1e-27  Score=223.06  Aligned_cols=196  Identities=23%  Similarity=0.397  Sum_probs=164.5

Q ss_pred             HhcCcccccccCccCceEEEccc-ccccceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcC--eEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQG--EKIL  586 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~--~~~l  586 (744)
                      ..++|++.+++|+|-++.||.|. ..+.++++||+++.-   ..+.+++|+++|..|. ||||+.+++...++.  ...|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            34789999999999999999997 456789999999743   3467889999999998 999999999988764  5679


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeecCceec
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF  665 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFGla~~~  665 (744)
                      |+||+.+.+....-      +.++..+++.++.++++||.|+|++|   |+|||+||.|+++|.. ..++|+|+|+|...
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998865442      34778889999999999999999998   9999999999999965 57999999999876


Q ss_pred             CCCccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      -+..   ...-.+.+..|.-||.+.+- .|+..-|+|||||+|.+|+..+.||-..+
T Consensus       184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            4432   11223557788999999764 58999999999999999999999985544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.5e-27  Score=229.66  Aligned_cols=203  Identities=28%  Similarity=0.457  Sum_probs=162.7

Q ss_pred             cCcccccccCccCceEEEcccccc-cceeEEEeccC-C-ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE--------c
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSS-Q-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------Q  581 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~-~-~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~--------~  581 (744)
                      ..|+-..+||+|.||.||+|+..+ |+.||+|+.-- . .+.--..-.+|+++|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            456667799999999999998754 77889876432 2 22223345789999999999999999988753        2


Q ss_pred             CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecC
Q 004580          582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGl  661 (744)
                      ...++|+.+++. +|.-.|.+  ....++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999975 45555532  2345888999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCC--ccccCcccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 ARMFGGD--ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++.+...  ......+..+-|.-|++||.+.+. .|+++.|||..|||+.||+||.+-+....
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            9877442  223333445678999999998764 68999999999999999999998876654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=9.2e-27  Score=237.37  Aligned_cols=199  Identities=24%  Similarity=0.292  Sum_probs=166.7

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcC--CC----eeeEEEEEEEcCeE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RN----LVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H--pn----Iv~l~~~~~~~~~~  584 (744)
                      +.+|++...+|+|.||.|-++.+.. +..||||+++.-. .-.+.-+-|+.+++++.+  |+    +|.+.+++...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6889999999999999999997644 6889999997543 334556779999999943  33    77888889999999


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC--------------
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--------------  650 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~--------------  650 (744)
                      ++|+|.| |-++.++|..+ +-.+++...++.|+.|+++++++||+..   ++|.||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999988 55788888543 3456889999999999999999999998   999999999999832              


Q ss_pred             ------CCceEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          651 ------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       651 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                            +..+||+|||.|..-....     ..++.|..|.|||++.+-.++.++||||+||||+||.||...|...+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                  2348999999998744332     34788999999999999999999999999999999999999887655

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=1.1e-25  Score=257.19  Aligned_cols=199  Identities=23%  Similarity=0.275  Sum_probs=140.3

Q ss_pred             HhcCcccccccCccCceEEEcccccc-----cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEE------EE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC------CV  579 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~------~~  579 (744)
                      ..++|++.++||+|+||.||+|++.+     +..||||++......  +....|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999998643     688999988643221  111111  1122222222222211      23


Q ss_pred             EcCeEEEEEEecCCCChhhhhcCcCC-----------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 004580          580 EQGEKILILEYMPNKSLDVFLFDPTK-----------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK  642 (744)
Q Consensus       580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk  642 (744)
                      ...+.++|+||+++++|..++.....                 ........+..++.||+.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            55689999999999999888753211                 011123445679999999999999987   9999999


Q ss_pred             CCCEEEeC-CCceEEEeecCceecCCCccccCcccccccccccCcccccCC----------------------CCCchhh
Q 004580          643 ASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG----------------------LFSIKSD  699 (744)
Q Consensus       643 ~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D  699 (744)
                      |+|||++. ++.+||+|||+|+.+..... .......+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543221 122345789999999966432                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCC
Q 004580          700 VFSFGILMLETLSGKKNT  717 (744)
Q Consensus       700 vwSlGviL~elltG~~p~  717 (744)
                      ||||||+||||+++..++
T Consensus       362 VwSlGviL~el~~~~~~~  379 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRS  379 (566)
T ss_pred             cHHHHHHHHHHHhCcCCC
Confidence            999999999999976554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=4.2e-25  Score=225.68  Aligned_cols=186  Identities=34%  Similarity=0.474  Sum_probs=164.3

Q ss_pred             CceEEEcccccc-cceeEEEeccCCChhh-HHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcC
Q 004580          525 GFGPVYKGRLLN-GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD  602 (744)
Q Consensus       525 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  602 (744)
                      +||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998754 8899999997665444 68899999999999999999999999999999999999999999998853


Q ss_pred             cCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCccccccccc
Q 004580          603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG  682 (744)
Q Consensus       603 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  682 (744)
                      .   ..+++..+..++.++++++.+||+.+   |+|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   22788999999999999999999987   9999999999999999999999999998865432   2233567889


Q ss_pred             ccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       683 y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      |++||.+.+..++.++||||||+++++|++|+.||..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999988899999999999999999999999876

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=3e-26  Score=240.17  Aligned_cols=227  Identities=21%  Similarity=0.248  Sum_probs=187.1

Q ss_pred             ccHHHHHHHhcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhc------CCCeeeEE
Q 004580          503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ------HRNLVKLL  575 (744)
Q Consensus       503 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~------HpnIv~l~  575 (744)
                      +.+..-+.....|.+....|+|-|++|.+|++.. |+.||||+++...-. .+.=+.|+++|++|+      .-|.++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3444445556789999999999999999998754 889999999865322 233467999999996      34799999


Q ss_pred             EEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ce
Q 004580          576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NP  654 (744)
Q Consensus       576 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~  654 (744)
                      ..|...++++||+|-+ ..+|.+.|......-.|....+..++.|+.-||..|...+   |+|.||||+|||+++.. .+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999987 4678999977767777888999999999999999999987   99999999999998764 67


Q ss_pred             EEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccc
Q 004580          655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNK  734 (744)
Q Consensus       655 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~  734 (744)
                      ||||||.|.....++..+    ..-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.......  ++-++...
T Consensus       577 KLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~me~  650 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFMEL  650 (752)
T ss_pred             eeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHHHh
Confidence            999999999876665432    344567999999999999999999999999999999999998776554  66666655


Q ss_pred             cccccc
Q 004580          735 SLHFYL  740 (744)
Q Consensus       735 ~~~f~~  740 (744)
                      --+||+
T Consensus       651 KGk~p~  656 (752)
T KOG0670|consen  651 KGKFPN  656 (752)
T ss_pred             cCCCcH
Confidence            555554

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.92  E-value=1.7e-24  Score=194.76  Aligned_cols=113  Identities=46%  Similarity=0.750  Sum_probs=100.6

Q ss_pred             ccccCCCeeeeCCCeEEEEEECCCCCCCeEEEEEeecCCCcEEEEecCCCCCCCCCceEEEeeCCcEEEecCCCceEEEE
Q 004580           32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST  111 (744)
Q Consensus        32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t  111 (744)
                      +.|..|+.|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|++.+|.+||+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S   79 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS   79 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence            56888999999999999999998765 688999998766789999999999876 5899999999999999999999999


Q ss_pred             eeecccCCceEEEccCCCEEEEcCCCCCcccceeceeccC
Q 004580          112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY  151 (744)
Q Consensus       112 ~~~~~~~~~~~~l~d~gNlvl~~~~~~~~~~~~~wqSFd~  151 (744)
                      ++..+....+++|+|+|||||++.     .+.++||||||
T Consensus        80 ~t~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~  114 (114)
T smart00108       80 NTTGANGNYVLVLLDDGNLVIYDS-----DGNFLWQSFDY  114 (114)
T ss_pred             cccCCCCceEEEEeCCCCEEEECC-----CCCEEeCCCCC
Confidence            986345667899999999999987     34699999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=8.4e-26  Score=249.78  Aligned_cols=206  Identities=30%  Similarity=0.444  Sum_probs=163.5

Q ss_pred             cccccccCccCceE-EEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          515 FSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       515 y~i~~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      |.-.+.+|.|+-|+ ||+|.. +|++||||++-.   ...+-..+|+..++.- +|||||++++.-.++...|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            34456889998865 799987 789999999853   2334557899998887 49999999999999999999999995


Q ss_pred             CCChhhhhcCc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC---C--CceEEEeecCceecC
Q 004580          593 NKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---D--MNPKISDFGLARMFG  666 (744)
Q Consensus       593 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~---~--~~~kL~DFGla~~~~  666 (744)
                       .+|++++... ...........+.+..|+++||++||+.+   ||||||||+||||+.   +  ..++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5788888542 11111111445778899999999999987   999999999999976   2  478999999999987


Q ss_pred             CCccc-cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCccccc
Q 004580          667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG-KKNTGVYNADSFNLL  728 (744)
Q Consensus       667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG-~~p~~~~~~~~~~l~  728 (744)
                      ..... .......||.+|+|||++....-+.++||+|+||++|+.++| ..||...-+.+.|+.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl  726 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL  726 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh
Confidence            65322 224457899999999999999888999999999999999996 779987765544443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-25  Score=223.61  Aligned_cols=216  Identities=27%  Similarity=0.314  Sum_probs=171.6

Q ss_pred             cCcccccccCccCceEEEcccc-cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEc------Ce
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GE  583 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~------~~  583 (744)
                      .+|.-++.+|.|.- .|-.+-+ -.++.||+|++...  .....++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56667788999988 5555543 35889999987543  344567778999999999999999999998643      36


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCce
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~  663 (744)
                      .|+|||+|. .+|...++     -.++-..+.++..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            799999995 45666653     23667788999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCcccccccccccccccccc
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN--ADSFNLLGYVSNKSLHFYLI  741 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~--~~~~~l~~~~~~~~~~f~~~  741 (744)
                      .-+..   -..+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+..|...+  +.-..+.+...+.+.+|.+.
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            75443   13344678999999999999889999999999999999999999888655  22234444455555555443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=211.93  Aligned_cols=217  Identities=20%  Similarity=0.329  Sum_probs=166.7

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEE-EEEcCeEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC-CVEQGEKILIL  588 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~-~~~~~~~~lV~  588 (744)
                      .+.|.|.+.||+|.||.+-+++++. .+.+++|-+.. .....++|.+|..---.| .|.||+.-+++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4779999999999999999998865 56888887754 334567899988654445 48999887665 56667888999


Q ss_pred             EecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe--CCCceEEEeecCceecC
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDMNPKISDFGLARMFG  666 (744)
Q Consensus       589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~--~~~~~kL~DFGla~~~~  666 (744)
                      ||+|.|+|.+-+-    ...+.+....+++.|++.|+.|||+..   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999987762    345778888999999999999999998   99999999999994  33489999999988644


Q ss_pred             CCccccCcccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC---CCccccccccccccccc
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSGKKNTGVYN---ADSFNLLGYVSNKSLHF  738 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGviL~elltG~~p~~~~~---~~~~~l~~~~~~~~~~f  738 (744)
                      .-     .....-+..|.+||.....     ...+.+|+|.||++++..+||+.||....   ....++.+|..+.....
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            32     1223345679999977543     24678999999999999999999997443   33344555555555554


Q ss_pred             ccc
Q 004580          739 YLI  741 (744)
Q Consensus       739 ~~~  741 (744)
                      |+.
T Consensus       250 P~~  252 (378)
T KOG1345|consen  250 PKK  252 (378)
T ss_pred             chh
Confidence            443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-23  Score=218.60  Aligned_cols=133  Identities=29%  Similarity=0.331  Sum_probs=108.2

Q ss_pred             hcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhc-----CC---CeeeEEEEEEE--
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----HR---NLVKLLGCCVE--  580 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-----Hp---nIv~l~~~~~~--  580 (744)
                      ..+|-+.++||.|.|++||++.+. +.+.||+|+.+.. ..-.+.-..|+++|+.++     |+   .||+|+++|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            367889999999999999999764 5778999998643 334556688999999984     33   59999999975  


Q ss_pred             --cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          581 --QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       581 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                        +.++++|+|++- .+|..++.. ..-+.++...+..|++||+.||.|||..+  +|||.||||+|||+.
T Consensus       156 pNG~HVCMVfEvLG-dnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLG-DNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhhh-hHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              459999999994 455555533 23445889999999999999999999988  699999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=2e-22  Score=200.58  Aligned_cols=183  Identities=40%  Similarity=0.644  Sum_probs=158.4

Q ss_pred             cCccCceEEEcccccc-cceeEEEeccCCChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhh
Q 004580          521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV  598 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (744)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 889999998765432 45789999999999999999999999999999999999999999999


Q ss_pred             hhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-CCceEEEeecCceecCCCccccCcccc
Q 004580          599 FLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRI  677 (744)
Q Consensus       599 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~  677 (744)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            884321  45789999999999999999999997   999999999999999 89999999999987654321  12224


Q ss_pred             cccccccCcccccCC-CCCchhhHHHHHHHHHHH
Q 004580          678 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLET  710 (744)
Q Consensus       678 ~gt~~y~aPE~~~~~-~~s~k~DvwSlGviL~el  710 (744)
                      .+...|++||.+... ..+.++|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            567899999999877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=1.7e-23  Score=216.57  Aligned_cols=208  Identities=25%  Similarity=0.403  Sum_probs=170.3

Q ss_pred             HHHHHhcCcccccccCccCceEEEcccccc----cceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEc
Q 004580          507 SVAAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ  581 (744)
Q Consensus       507 ~~~~~~~~y~i~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~  581 (744)
                      ......+.|..+++||+|.|++||++.+.+    .+.||+|.+...+  ...++.+|+++|..+. +.||+++.+++...
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            345556788999999999999999997643    5789999986543  3366899999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeec
Q 004580          582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFG  660 (744)
Q Consensus       582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFG  660 (744)
                      +...+|+||++....+++...      ++..++..++..++.||+++|..+   ||||||||.|+|.+.. +.-.|+|||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            999999999999988887642      567889999999999999999998   9999999999999865 678999999


Q ss_pred             CceecCCCc-------------cc---------------------c--------CcccccccccccCcccccCC-CCCch
Q 004580          661 LARMFGGDE-------------LQ---------------------G--------NTKRIVGTYGYMSPEYALDG-LFSIK  697 (744)
Q Consensus       661 la~~~~~~~-------------~~---------------------~--------~~~~~~gt~~y~aPE~~~~~-~~s~k  697 (744)
                      +|...+...             ..                     .        ......||++|.|||++... .-+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            998321100             00                     0        00124699999999999764 47899


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCCcc
Q 004580          698 SDVFSFGILMLETLSGKKNTGVYNADSF  725 (744)
Q Consensus       698 ~DvwSlGviL~elltG~~p~~~~~~~~~  725 (744)
                      +||||.|||++-+++++.||-...+|-.
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~  286 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDAD  286 (418)
T ss_pred             cceeeccceeehhhccccccccCccccc
Confidence            9999999999999999999866555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-24  Score=232.39  Aligned_cols=200  Identities=26%  Similarity=0.425  Sum_probs=175.7

Q ss_pred             HhcCcccccccCccCceEEEccccc-ccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ..++|+.+..+|.|.||.|||+++. .++..|||+++-.......-+++|+.+++..+||||+.++|-+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3478999999999999999999864 588999999987777777788899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+.+|+|++.-   ...+++++.++....+..++|++|||+++   -+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus        93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999998765   34567889999999999999999999998   8999999999999999999999999988765432


Q ss_pred             cccCcccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004580          670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGviL~elltG~~p~~  718 (744)
                        ...+...||+.|||||+..   .+.|..++|||++|+...||-.-++|..
T Consensus       167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf  216 (829)
T KOG0576|consen  167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF  216 (829)
T ss_pred             --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence              2334579999999999873   5678999999999999999988887743

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.1e-22  Score=215.75  Aligned_cols=166  Identities=20%  Similarity=0.236  Sum_probs=129.5

Q ss_pred             HhcCcccccccCccCceEEEccccc--ccceeEEEeccCC-----ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCe
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQ-----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~-----~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      ..++|.+.+.||+|+||+||+|++.  +++.+|||++...     .....+.|.+|+++|++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4578999999999999999999764  4677899986533     12335679999999999999999864332   256


Q ss_pred             EEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEeCCCceEEEeecCc
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL-KASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDL-k~~NILl~~~~~~kL~DFGla  662 (744)
                      .++||||+++++|....    ..   .   ...++.+++++|.|||+.+   |+|||| ||+|||++.++++||+|||+|
T Consensus        93 ~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            89999999999986321    11   1   1467889999999999987   999999 999999999999999999999


Q ss_pred             eecCCCcccc------CcccccccccccCcccccCC
Q 004580          663 RMFGGDELQG------NTKRIVGTYGYMSPEYALDG  692 (744)
Q Consensus       663 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~  692 (744)
                      +.+.......      ......+++.|+|||.+...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9875532111      11346788899999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=1.4e-19  Score=192.34  Aligned_cols=202  Identities=37%  Similarity=0.525  Sum_probs=170.7

Q ss_pred             cccccccCccCceEEEcccccccceeEEEeccCCChh---hHHHHHHHHHHHHHhcCC-CeeeEEEEEEEcCeEEEEEEe
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ---GLEEFKNEMMLIAKLQHR-NLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~f~~Ev~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      |.+.+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++...+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999875  78899998765332   477899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceecCCCc
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDE  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~~~~~  669 (744)
                      +.++++..++........+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866532211136888999999999999999999998   99999999999999988 79999999998665543


Q ss_pred             ccc----CcccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          670 LQG----NTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ...    ......++..|+|||.+.+   .......|+||+|++++++++|..|+....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            221    2345789999999999987   578899999999999999999999966554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=5.2e-20  Score=197.53  Aligned_cols=203  Identities=25%  Similarity=0.302  Sum_probs=164.1

Q ss_pred             CcccccccCccCceEEEccccccc--ceeEEEeccCCChhhHHHHHHHHHHHHHhcC----CCeeeEEEEE-EEcCeEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH----RNLVKLLGCC-VEQGEKIL  586 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H----pnIv~l~~~~-~~~~~~~l  586 (744)
                      +|++.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++..++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986543  4788888765433333378889999988873    5888888888 46778899


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-----CceEEEeecC
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-----MNPKISDFGL  661 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-----~~~kL~DFGl  661 (744)
                      ||+.+ +.+|.++..... .+.++......++.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99876 778877654333 567899999999999999999999998   9999999999999765     4699999999


Q ss_pred             ce--ecCCCcc----ccC--cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          662 AR--MFGGDEL----QGN--TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      ++  .+.....    ...  .....||..|.+++...+...+.+.|+||++.++.|++.|..||....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            99  4322111    111  223569999999999999999999999999999999999999986554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.82  E-value=6.7e-21  Score=228.65  Aligned_cols=149  Identities=19%  Similarity=0.187  Sum_probs=112.5

Q ss_pred             HhcC-CCeeeEEEEE-------EEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 004580          565 KLQH-RNLVKLLGCC-------VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI  636 (744)
Q Consensus       565 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~I  636 (744)
                      .++| +||+++++.+       .+....++++|++ +++|..+|..  ....+++.+++.++.||++||+|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3445 5777777776       2334677889987 5589999853  2355899999999999999999999988   9


Q ss_pred             EEecCCCCCEEEeCC-------------------CceEEEeecCceecCCCcc--------------ccCcccccccccc
Q 004580          637 IHRDLKASNVLLDMD-------------------MNPKISDFGLARMFGGDEL--------------QGNTKRIVGTYGY  683 (744)
Q Consensus       637 iHrDLk~~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  683 (744)
                      +||||||+||||+..                   +.+|++|||+++.......              ........+|+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4456666666654211000              0000113578889


Q ss_pred             cCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          684 MSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       684 ~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                      ||||++.+..++.++|||||||+||||++|.+|+..
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            999999999999999999999999999999988754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=6.8e-20  Score=180.63  Aligned_cols=139  Identities=18%  Similarity=0.169  Sum_probs=108.0

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChh--h-------HHH-----------------HHHHHHHHHHhcCCCe
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--G-------LEE-----------------FKNEMMLIAKLQHRNL  571 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~-----------------f~~Ev~~l~~l~HpnI  571 (744)
                      .+.||+|++|.||+|...+|+.||||+++.....  .       ...                 ...|++++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999998878999999998754211  1       112                 2349999999988876


Q ss_pred             eeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEecCCCCCEEEeC
Q 004580          572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL-HQYSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~IiHrDLk~~NILl~~  650 (744)
                      .....+..  ...++||||++++++.....   ....++..+...++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332222  23389999999987654431   234678899999999999999999 6777   99999999999998 


Q ss_pred             CCceEEEeecCceec
Q 004580          651 DMNPKISDFGLARMF  665 (744)
Q Consensus       651 ~~~~kL~DFGla~~~  665 (744)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=4.6e-20  Score=184.06  Aligned_cols=171  Identities=14%  Similarity=0.156  Sum_probs=133.2

Q ss_pred             HhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhH---HH------HHHHHHHHHHhcCCCeeeEEEEEEEc
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL---EE------FKNEMMLIAKLQHRNLVKLLGCCVEQ  581 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~---~~------f~~Ev~~l~~l~HpnIv~l~~~~~~~  581 (744)
                      ...+|.+.++||.|+||.||.... +++.+|||.+++......   +.      +.+|+..+.++.||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            357899999999999999999755 577899999976532222   22      68999999999999999998886643


Q ss_pred             --------CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc
Q 004580          582 --------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN  653 (744)
Q Consensus       582 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~  653 (744)
                              +..++||||++|.+|.++..       ++.    ....+++.++..||+.+   ++|||+||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977631       222    24568999999999998   99999999999999988 


Q ss_pred             eEEEeecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 004580          654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL  711 (744)
Q Consensus       654 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ell  711 (744)
                      ++|+|||...........              ..++....+..++|+|+||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988754322110              01344455678999999999887653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3.9e-19  Score=175.72  Aligned_cols=141  Identities=20%  Similarity=0.232  Sum_probs=111.6

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChh--------------------------hHHHHHHHHHHHHHhcCCCe
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--------------------------GLEEFKNEMMLIAKLQHRNL  571 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------------------------~~~~f~~Ev~~l~~l~HpnI  571 (744)
                      .+.||+|++|.||+|+..+|+.||||+++.....                          ....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998754211                          01234678999999999987


Q ss_pred             eeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeC
Q 004580          572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~  650 (744)
                      .....+...  ..++||||++++++.....   ....++..+...++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3489999999886543321   22356788899999999999999999 77   99999999999999 


Q ss_pred             CCceEEEeecCceecCC
Q 004580          651 DMNPKISDFGLARMFGG  667 (744)
Q Consensus       651 ~~~~kL~DFGla~~~~~  667 (744)
                      ++.++|+|||++..+..
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.7e-20  Score=179.13  Aligned_cols=200  Identities=24%  Similarity=0.362  Sum_probs=158.7

Q ss_pred             ccccccCccCceEEEcccccccceeEEEeccCC--ChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCC
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      .+.-+|.+...|+.|+|++ .|..+++|++...  .....++|..|.-.++.+.||||+++++.|..+.+..+|..|||.
T Consensus       193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3345788999999999998 4667777887643  334457899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE--eecCceecCCCccc
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS--DFGLARMFGGDELQ  671 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~--DFGla~~~~~~~~~  671 (744)
                      |+|...|+.. ..-..+..++.+++.+||+|++|||+..+ -|.---|.++.|++|++.+++|.  |--++..       
T Consensus       272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq-------  342 (448)
T KOG0195|consen  272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------  342 (448)
T ss_pred             hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee-------
Confidence            9999999864 33456778999999999999999999862 23344689999999999988875  3222111       


Q ss_pred             cCcccccccccccCcccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCCcccc
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSGKKNTGVYNADSFNL  727 (744)
Q Consensus       672 ~~~~~~~gt~~y~aPE~~~~~~~s---~k~DvwSlGviL~elltG~~p~~~~~~~~~~l  727 (744)
                        .....-.+.||+||.++..+-+   .++|+|||+++||||.|...||.....-+.-+
T Consensus       343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm  399 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM  399 (448)
T ss_pred             --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence              0112346789999999877643   57999999999999999999998877555333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=3.2e-19  Score=171.52  Aligned_cols=202  Identities=23%  Similarity=0.332  Sum_probs=164.1

Q ss_pred             hcCcccccccCccCceEEEccc-ccccceeEEEeccCCChhhHHHHHHHHHHHHHhcC-CCeeeEEEEEEEcCeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ..+|.++++||.|+||.+|.|. ..+|++||||.-+.....  .++..|.++...|+| +.|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4789999999999999999996 467999999987654333  456778888888986 667777777788889999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC---CceEEEeecCceecC
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFG  666 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~---~~~kL~DFGla~~~~  666 (744)
                      .+ +-+|.++..-  -.+.++..+++-++.|++.-++|+|.++   +|||||||+|+|+.-+   ..+.|+|||+|+.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            87 5666665421  2345788899999999999999999998   9999999999999654   468999999999875


Q ss_pred             CCcc-----ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          667 GDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      +...     ........||.+|.+-....+...+.+.|+=|+|.+|..+.-|..||....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            4211     122345689999999887777778889999999999999999999997654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.6e-18  Score=173.92  Aligned_cols=203  Identities=24%  Similarity=0.342  Sum_probs=166.0

Q ss_pred             hcCcccccccCccCceEEEccc-ccccceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .-+|.+.++||+|+||+++.|+ +-+++.||||.-...  ...-++..|.+..+.|. .++|...+.+-.++.+..||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            4589999999999999999996 457999999974332  22345677888888775 6888888888888889999999


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-----CceEEEeecCcee
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-----MNPKISDFGLARM  664 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-----~~~kL~DFGla~~  664 (744)
                      .+ |-+|.++. + --.+.++.+.+.-+|.|++.-++|+|++.   +|.|||||+|+||...     ..+.|+|||+|+.
T Consensus       105 LL-GPSLEDLF-D-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLF-D-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHH-H-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            87 56666543 2 23456889999999999999999999998   9999999999999643     3589999999998


Q ss_pred             cCCCcc-----ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004580          665 FGGDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       665 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~  722 (744)
                      +.....     ....+...||.+||+-....+..-+.+.|+=|||-++...|-|..||.....
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            755321     1223456899999999999999999999999999999999999999976653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=7.1e-18  Score=164.70  Aligned_cols=187  Identities=18%  Similarity=0.133  Sum_probs=138.1

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCChh----hHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEEec
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ----GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~----~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      +...|++|+||+||.+.. .+.+++.+.+.....-    ....|.+|+++|++++ |+++.+++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999997755 6788888877654331    1235889999999996 5788888885    4568999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDL-KASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDL-k~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ++.+|...+.    .      ....++.|++++|.++|+++   |+|||| ||+|||++.++.++|+|||+|........
T Consensus        81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9998864431    0      12357789999999999998   999999 79999999999999999999986543221


Q ss_pred             -----c-cC-----cccccccccccCcccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          671 -----Q-GN-----TKRIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 -----~-~~-----~~~~~gt~~y~aPE~~~~~-~~s-~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                           . ..     ......++.|++|+...-. ..+ ...+.++.|..+|.++|++.+.-...
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                 0 00     0012346778888754322 233 56789999999999999998654433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.75  E-value=2.2e-18  Score=168.06  Aligned_cols=108  Identities=23%  Similarity=0.200  Sum_probs=93.7

Q ss_pred             CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccC
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN  673 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~  673 (744)
                      |+|.+++..  ....+++.+++.++.||++||+|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            678888743  2446899999999999999999999875         999999999999999  99998754321    


Q ss_pred             cccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       674 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                         ..|++.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence               257899999999999999999999999999999999999986544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.5e-18  Score=199.74  Aligned_cols=200  Identities=22%  Similarity=0.245  Sum_probs=161.1

Q ss_pred             HHHhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhc---CCCeeeEEEEEEEcCeEE
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~~~~~~~  585 (744)
                      ....+.|.|.+.||+|+||+||+|...+|+.||+|+=+....-   +|.--.+++.+|+   -+.|..+..++.-.+.-+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3455789999999999999999999888999999987654332   2333334455555   234455555556667788


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-------CCceEEEe
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-------DMNPKISD  658 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-------~~~~kL~D  658 (744)
                      ||+||.+.|+|.+++.   ..+.+++.....++.|+++.++.||..+   |||+||||+|.||..       ..-++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999884   6677999999999999999999999998   999999999999942       33589999


Q ss_pred             ecCceecCCCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004580          659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~  717 (744)
                      ||.+..+..-.........++|-.+-.+|+..+.++++++|.|.++.+++-||.|+.--
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            99988664332223445568899999999999999999999999999999999999743

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.5e-17  Score=163.99  Aligned_cols=136  Identities=20%  Similarity=0.241  Sum_probs=105.2

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHh-----cCCCeeeEEEEEEEcC---e-EEEE
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-----QHRNLVKLLGCCVEQG---E-KILI  587 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-----~HpnIv~l~~~~~~~~---~-~~lV  587 (744)
                      -.+.||+|+||.||.  +++....+||++........+++.+|+.++..+     .||||+++++++.+..   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            346899999999996  433333479988765445567899999999999     5799999999998863   3 3378


Q ss_pred             EEe--cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEecCCCCCEEEeCC----CceEEEeec
Q 004580          588 LEY--MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL-LYLHQYSRFRIIHRDLKASNVLLDMD----MNPKISDFG  660 (744)
Q Consensus       588 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~IiHrDLk~~NILl~~~----~~~kL~DFG  660 (744)
                      +||  +++++|.+++..    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++..    ..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  668999999943    224444  35577788777 9999998   9999999999999743    379999944


Q ss_pred             Cce
Q 004580          661 LAR  663 (744)
Q Consensus       661 la~  663 (744)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.7e-19  Score=191.51  Aligned_cols=186  Identities=30%  Similarity=0.391  Sum_probs=155.7

Q ss_pred             ccCccCceEEEcccc----cccceeEEEeccCCChh--hHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          520 KLGEGGFGPVYKGRL----LNGQEVAVKRLSSQSGQ--GLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~~--~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      .+|+|.||.|+.++.    +.|..+|+|.+++....  .......|..++...+ ||.+|++..+++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998753    34778899988764221  1124566778888887 9999999999999999999999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcccc
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~  672 (744)
                      +|.|...+   .....+.......+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99987776   34445667777778888999999999998   99999999999999999999999999987544322  


Q ss_pred             CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       673 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~  719 (744)
                          .+||..|||||++.  .....+|.||||++.+||+||-.||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                28999999999988  667889999999999999999999987

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.3e-18  Score=198.57  Aligned_cols=201  Identities=24%  Similarity=0.325  Sum_probs=158.0

Q ss_pred             cccccCccCceEEEccccc-ccceeEEEecc----C-CChh-hHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEE
Q 004580          517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----S-QSGQ-GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~----~-~~~~-~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ..+.+|.|++|.|+..... ..+..+.|..+    . ..+. ....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3468999999977766432 23334444332    1 1111 12226677878888999999888877777766666799


Q ss_pred             ecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~  669 (744)
                      |+++ +|..++.   ....+...++..+++|+++|++|||+.+   |.|||||++|++++.++.+||+|||.+..+....
T Consensus       402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 9888873   3346788899999999999999999998   9999999999999999999999999998775443


Q ss_pred             cc--cCcccccccccccCcccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004580          670 LQ--GNTKRIVGTYGYMSPEYALDGLFSI-KSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       670 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~-k~DvwSlGviL~elltG~~p~~~~~~~~  724 (744)
                      ..  ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||.....++
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~  532 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD  532 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence            22  3445578999999999999999875 5899999999999999999998877554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.72  E-value=9e-19  Score=198.93  Aligned_cols=198  Identities=21%  Similarity=0.220  Sum_probs=151.7

Q ss_pred             CcccccccCccCceEEEcccccccceeEEEeccCCC-hhhHHHHHHHHHHH--HHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-GQGLEEFKNEMMLI--AKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~f~~Ev~~l--~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ++...+.||.+.|=+|.+|++++|. |+||++-+.. ....+.|+++++-+  ..++|||.+++...-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666789999999999999998887 8999886553 44556666555444  445899999998876666667788888


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc-
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~-  669 (744)
                      +.+ +|.+.|   ..++.+...+...|+.|++.||..+|..+   |+|+|||.+||||+.-.-+.|+||..-+...-.+ 
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            755 444444   45566778888999999999999999998   9999999999999999999999999876542211 


Q ss_pred             cccC----cccccccccccCcccccC----------CC-CCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004580          670 LQGN----TKRIVGTYGYMSPEYALD----------GL-FSIKSDVFSFGILMLETLS-GKKNTGV  719 (744)
Q Consensus       670 ~~~~----~~~~~gt~~y~aPE~~~~----------~~-~s~k~DvwSlGviL~ellt-G~~p~~~  719 (744)
                      .+..    ..+...-..|+|||-+..          .. .+++.||||+||++.||++ |+++|+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            1111    112233457999998743          12 6789999999999999998 7888864

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.2e-16  Score=162.86  Aligned_cols=150  Identities=17%  Similarity=0.152  Sum_probs=114.3

Q ss_pred             HHHHhcCcccccccCccCceEEEccc--ccccceeEEEeccCCChh------------------------hHHHHHHHHH
Q 004580          508 VAAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQ------------------------GLEEFKNEMM  561 (744)
Q Consensus       508 ~~~~~~~y~i~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~Ev~  561 (744)
                      +......|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|+.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33344468889999999999999998  567999999998643210                        1123678999


Q ss_pred             HHHHhcCCC--eeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 004580          562 LIAKLQHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR  639 (744)
Q Consensus       562 ~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHr  639 (744)
                      ++.++.+..  +.+++..    ...++||||+++.+|.....   ....+...+...++.||+.++.+||+.+  +|+||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            999998633  3334432    23589999999988766542   2234556667899999999999999986  49999


Q ss_pred             cCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          640 DLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       640 DLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||||+||+++ +++++|+|||.+.....
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            9999999999 88999999999886443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.2e-16  Score=158.88  Aligned_cols=134  Identities=22%  Similarity=0.311  Sum_probs=113.5

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCCh--------hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.||+|++|.||+|+. .+..+++|+......        .....+.+|+.++..++|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899998654321        1234678899999999999988877777778888999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      +++++|..++...      .. .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887321      12 77899999999999999988   99999999999999 78999999999875

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.68  E-value=2.7e-17  Score=131.65  Aligned_cols=66  Identities=47%  Similarity=1.097  Sum_probs=58.8

Q ss_pred             cCCCCceEEecccCCCCcceeccccccCHHHHHHHHhccCCeeeccccccCCCcceEEEccccccc
Q 004580          336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDA  401 (744)
Q Consensus       336 C~~~~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~C~~w~~~l~~~  401 (744)
                      |+.+|+|+++++|++|++....++.++++++|++.||+||||+||+|.+..++++|++|+++|+|+
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence            555699999999999999877776779999999999999999999997666778999999999984

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=5.2e-16  Score=154.58  Aligned_cols=143  Identities=19%  Similarity=0.177  Sum_probs=111.1

Q ss_pred             HHHhcCcccccccCccCceEEEcccccccceeEEEeccCCCh----------------------hhHHHHHHHHHHHHHh
Q 004580          509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG----------------------QGLEEFKNEMMLIAKL  566 (744)
Q Consensus       509 ~~~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----------------------~~~~~f~~Ev~~l~~l  566 (744)
                      ......|.+.+.||+|+||.||++...+|+.||||+++....                      .....+..|..++..+
T Consensus        11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            333344778899999999999999887899999998654220                      0112367889999999


Q ss_pred             cCCC--eeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q 004580          567 QHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKAS  644 (744)
Q Consensus       567 ~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~  644 (744)
                      .|++  +...++    ....++||||+++++|.....         ......++.+++.++.++|+.+   |+||||||+
T Consensus        91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~  154 (198)
T cd05144          91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEF  154 (198)
T ss_pred             HHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence            8874  444433    345689999999999876531         0234578899999999999987   999999999


Q ss_pred             CEEEeCCCceEEEeecCceecCC
Q 004580          645 NVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       645 NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      ||++++++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=5.6e-16  Score=154.41  Aligned_cols=131  Identities=23%  Similarity=0.354  Sum_probs=107.4

Q ss_pred             ccCccCceEEEcccccccceeEEEeccCCCh--------hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEec
Q 004580          520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG--------QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .||+|++|.||+|.. ++..+++|.......        ...+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998654211        12356788999999999988665555666677789999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      ++++|.+.+....          ..++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||+++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988763211          078999999999999988   99999999999999 889999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=6.7e-16  Score=177.00  Aligned_cols=137  Identities=22%  Similarity=0.324  Sum_probs=111.5

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEec-cCC-C------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL-SSQ-S------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l-~~~-~------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      ..|...+.||+|+||.||+|.... +.+++|+. .+. .      ....+++.+|++++..++|++++....++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            444567899999999999998744 34444432 211 1      12245788999999999999999888887777788


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ++||||+++++|.+++.           ....++.+++++|.+||+.+   |+||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999988773           35678999999999999988   9999999999999 578999999999986


Q ss_pred             c
Q 004580          665 F  665 (744)
Q Consensus       665 ~  665 (744)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.63  E-value=3.7e-16  Score=160.70  Aligned_cols=200  Identities=23%  Similarity=0.345  Sum_probs=132.0

Q ss_pred             CcccccccCccCceEEEcccccc-cceeEEEeccCC---ChhhHHHHHHHHHHHHHhc----------CCCeeeEEEEEE
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQ----------HRNLVKLLGCCV  579 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~---~~~~~~~f~~Ev~~l~~l~----------HpnIv~l~~~~~  579 (744)
                      .+...+.||.|+++.||.+++.+ ++++|||++...   .....+++++|......+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44556799999999999998765 899999987533   2345677777776555432          222222222221


Q ss_pred             --------EcC---------eEEEEEEecCCCChhhhhc---Cc-CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 004580          580 --------EQG---------EKILILEYMPNKSLDVFLF---DP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH  638 (744)
Q Consensus       580 --------~~~---------~~~lV~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiH  638 (744)
                              ...         ..+++|+-+ .++|..++.   .. .....+....++.+..|+++.+++||+.+   |+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    111         235667766 566766642   11 11233445667788899999999999998   999


Q ss_pred             ecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccC--------CCCCchhhHHHHHHHHHHH
Q 004580          639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLET  710 (744)
Q Consensus       639 rDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwSlGviL~el  710 (744)
                      +||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999988775442211     234578999997643        2478999999999999999


Q ss_pred             HcCCCCCCCCCC
Q 004580          711 LSGKKNTGVYNA  722 (744)
Q Consensus       711 ltG~~p~~~~~~  722 (744)
                      ++|+.||+....
T Consensus       244 WC~~lPf~~~~~  255 (288)
T PF14531_consen  244 WCGRLPFGLSSP  255 (288)
T ss_dssp             HHSS-STCCCGG
T ss_pred             HHccCCCCCCCc
Confidence            999999987653

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=1.9e-15  Score=155.16  Aligned_cols=147  Identities=22%  Similarity=0.337  Sum_probs=108.1

Q ss_pred             cCCCeeeEEEEEEEc---------------------------CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHH
Q 004580          567 QHRNLVKLLGCCVEQ---------------------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE  619 (744)
Q Consensus       567 ~HpnIv~l~~~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  619 (744)
                      +|||||++.++|.+.                           ...|+||.-.+ .+|++++.    .+..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence            599999999887641                           25678887664 46777763    22345666778899


Q ss_pred             HHHHHHHHHHhcCCCCeEEecCCCCCEEEe--CCC--ceEEEeecCceecCCC----ccccCcccccccccccCcccccC
Q 004580          620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDM--NPKISDFGLARMFGGD----ELQGNTKRIVGTYGYMSPEYALD  691 (744)
Q Consensus       620 ~ia~gl~yLH~~~~~~IiHrDLk~~NILl~--~~~--~~kL~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  691 (744)
                      |+++|+.|||.++   |.|||+|++|||+.  ++.  .+.|+|||.+-.-...    .+....-...|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   99999999999994  333  4789999987543221    11111122456778899998854


Q ss_pred             CC------CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004580          692 GL------FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       692 ~~------~s~k~DvwSlGviL~elltG~~p~~~~~  721 (744)
                      .+      .-.|+|.|+.|.+.||++....||....
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG  461 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG  461 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence            32      2368999999999999999999987643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1.5e-14  Score=136.42  Aligned_cols=135  Identities=23%  Similarity=0.240  Sum_probs=114.6

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcC--CCeeeEEEEEEEcCeEEEEEEecCCC
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQGEKILILEYMPNK  594 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~g  594 (744)
                      +.+.||+|.++.||+++.. +..+++|..+....  ...+.+|+.++..++|  +++.+++......+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4578999999999999874 47899999865433  5678999999999987  58899988888778899999999988


Q ss_pred             ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          595 SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      .+..+          +......++.++++++++||.....+++|+|++|+||++++.+.++++||+.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543          4566778899999999999987545699999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.1e-15  Score=174.25  Aligned_cols=185  Identities=25%  Similarity=0.333  Sum_probs=132.1

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..+|+.++.|..|+||.||..+++. .+.+|+|+-+.. -.    +++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hh----hhc---cccccCCccee------------------
Confidence            3688999999999999999998865 567888543211 00    000   22222333333                  


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCc-
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE-  669 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~-  669 (744)
                         |+-...+.   .-+.++..        .+.+++|||+.+   |+|||+||+|++|+.-|++|+.|||+.+...... 
T Consensus       136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               33333332   22223322        267899999998   9999999999999999999999999988542211 


Q ss_pred             -------cc-----cCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCcccccccccccccc
Q 004580          670 -------LQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLH  737 (744)
Q Consensus       670 -------~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~~~~  737 (744)
                             +.     -..+.++||+.|+|||++....|...+|.|++|+|+||.+.|..||.....++  |++-+.+....
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg~visd~i~  276 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVISDDIE  276 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHhhhhhhhcc
Confidence                   00     11234689999999999999999999999999999999999999998765555  66666666666


Q ss_pred             cccc
Q 004580          738 FYLI  741 (744)
Q Consensus       738 f~~~  741 (744)
                      |++.
T Consensus       277 wpE~  280 (1205)
T KOG0606|consen  277 WPEE  280 (1205)
T ss_pred             cccc
Confidence            6553

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.1e-14  Score=143.54  Aligned_cols=137  Identities=20%  Similarity=0.250  Sum_probs=98.9

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChh--hHHH----------------------HHHHHHHHHHhcCCC--e
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ--GLEE----------------------FKNEMMLIAKLQHRN--L  571 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~----------------------f~~Ev~~l~~l~Hpn--I  571 (744)
                      .+.||+|+||.||+|...+++.||||+++.....  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999998878999999988653211  1111                      135666666665443  3


Q ss_pred             eeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEeC
Q 004580          572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~IiHrDLk~~NILl~~  650 (744)
                      .+.++.    ...++||||++++.+.........   . ..+...++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444433    346899999999654322111000   1 15678899999999999999 76   99999999999999 


Q ss_pred             CCceEEEeecCceecC
Q 004580          651 DMNPKISDFGLARMFG  666 (744)
Q Consensus       651 ~~~~kL~DFGla~~~~  666 (744)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=9.7e-14  Score=141.89  Aligned_cols=135  Identities=21%  Similarity=0.263  Sum_probs=102.8

Q ss_pred             cccC-ccCceEEEcccccccceeEEEeccCCC-------------hhhHHHHHHHHHHHHHhcCCCe--eeEEEEEEEcC
Q 004580          519 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSSQS-------------GQGLEEFKNEMMLIAKLQHRNL--VKLLGCCVEQG  582 (744)
Q Consensus       519 ~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~f~~Ev~~l~~l~HpnI--v~l~~~~~~~~  582 (744)
                      ..|| .|+.|+||++.. ++..++||.+....             ......+.+|+.++.+++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            3676 788888888876 47789998875321             1233567889999999998875  66676644322


Q ss_pred             ----eEEEEEEecCC-CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEE
Q 004580          583 ----EKILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~  657 (744)
                          ..++|||++++ .+|..++..    ..++..    .+.+|+.++.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688887732    234433    3568999999999998   9999999999999998999999


Q ss_pred             eecCceec
Q 004580          658 DFGLARMF  665 (744)
Q Consensus       658 DFGla~~~  665 (744)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998763

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.50  E-value=3.7e-15  Score=159.64  Aligned_cols=124  Identities=30%  Similarity=0.427  Sum_probs=109.0

Q ss_pred             eEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      ..++.|++++..+|.++|.........++...+.++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766666677888899999999999999   55   999999999999999999999999998


Q ss_pred             eecCCCc----cccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004580          663 RMFGGDE----LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS  712 (744)
Q Consensus       663 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt  712 (744)
                      .......    .........||.-||+||.+.+..|+.|+||||||+||+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8775544    2223345689999999999999999999999999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.49  E-value=3.4e-14  Score=155.32  Aligned_cols=166  Identities=31%  Similarity=0.424  Sum_probs=131.2

Q ss_pred             HHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 004580          564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA  643 (744)
Q Consensus       564 ~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~  643 (744)
                      +.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....+++.-...++++|++||+|||.-.  --.|+.+++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            567899999999999999999999999999999999865  3445888889999999999999999864  239999999


Q ss_pred             CCEEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCC-------CCchhhHHHHHHHHHHHHcCCCC
Q 004580          644 SNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSGKKN  716 (744)
Q Consensus       644 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~k~DvwSlGviL~elltG~~p  716 (744)
                      .|.+++....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999988764311111111122345699999987641       46779999999999999999999


Q ss_pred             CCCCC--CCcccccccccc
Q 004580          717 TGVYN--ADSFNLLGYVSN  733 (744)
Q Consensus       717 ~~~~~--~~~~~l~~~~~~  733 (744)
                      |+...  .+..++...+.+
T Consensus       158 ~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             cccccccCChHHHHHHHHh
Confidence            98754  222234444444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.7e-14  Score=165.04  Aligned_cols=218  Identities=25%  Similarity=0.312  Sum_probs=172.2

Q ss_pred             cCcccccccCccCceEEEcccccc--cceeEEEeccCCC--hhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEE
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999998886533  4456777665442  333445556777777787 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCEEEeCCC-ceEEEeecCceec
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-QYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMF  665 (744)
Q Consensus       588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~IiHrDLk~~NILl~~~~-~~kL~DFGla~~~  665 (744)
                      .||..++++...+.. ......+......+..|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999998776631 12213555667788999999999999 766   99999999999999999 9999999999988


Q ss_pred             CC-CccccCcccccc-cccccCcccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccccccccccc
Q 004580          666 GG-DELQGNTKRIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNK  734 (744)
Q Consensus       666 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DvwSlGviL~elltG~~p~~~~~~~~~~l~~~~~~~  734 (744)
                      .. ..........+| ++.|+|||...+. ......|+||.|+++..+++|..|+............+..+.
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence            76 444444555678 9999999999884 456789999999999999999999988876554445444443

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.43  E-value=1.4e-13  Score=113.67  Aligned_cols=71  Identities=15%  Similarity=0.302  Sum_probs=60.4

Q ss_pred             cCCCCceEEecccCCCCcceeccccccCHHHHHHHHhc---cCCeeeccccccCCCcceEEEcccc-cccCCCCCccCCc
Q 004580          336 CIGGHQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK---NCTCRAYANSNVTEGSGCLMWFGDL-LDANRPTRNFTGQ  411 (744)
Q Consensus       336 C~~~~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~g~~C~~w~~~l-~~~~~~~~~~~~~  411 (744)
                      |.....|+++.++++||+..      ++++||++.|++   ||||+||+|.+.  +.||++|+++| +++++..+  .+.
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~--~g~   74 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFS--HGF   74 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccC--CCc
Confidence            34457899999999999743      689999999999   999999999653  46899999999 99988765  588


Q ss_pred             eeeee
Q 004580          412 SVYIR  416 (744)
Q Consensus       412 ~lylr  416 (744)
                      ++|+|
T Consensus        75 ~Ly~r   79 (80)
T cd00129          75 DLYEN   79 (80)
T ss_pred             eeEeE
Confidence            99987

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=5.1e-13  Score=148.32  Aligned_cols=141  Identities=22%  Similarity=0.266  Sum_probs=102.0

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCChhhH----------------------------------------HHHHH
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL----------------------------------------EEFKN  558 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------------------------------------~~f~~  558 (744)
                      +.||.|++|+||+|++++|+.||||+.+.......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            68999999999999999999999999865421110                                        12555


Q ss_pred             HHHHHHHhc----CCCeeeEEEEEE-EcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHH-HHHHHHhcC
Q 004580          559 EMMLIAKLQ----HRNLVKLLGCCV-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ-GLLYLHQYS  632 (744)
Q Consensus       559 Ev~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~~  632 (744)
                      |...+.+++    |.+-+.+-.++. ..+..+|||||++|++|.+++.....  ..   .+..++..+++ .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            666666653    333334333332 24567999999999999877532111  11   23456666666 467888887


Q ss_pred             CCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       633 ~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                         ++|+|++|.||+++.+++++++|||++..+..
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               99999999999999999999999999988754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.34  E-value=1.6e-12  Score=110.26  Aligned_cols=80  Identities=34%  Similarity=0.802  Sum_probs=64.5

Q ss_pred             CCCcCCC---CceEEecccCCCCcceeccccccCHHHHHHHHhccCCeeeccccccCCCcceEEEcccccccCCCCCccC
Q 004580          333 SSECIGG---HQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGDLLDANRPTRNFT  409 (744)
Q Consensus       333 ~l~C~~~---~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~C~~w~~~l~~~~~~~~~~~  409 (744)
                      +++|..+   +.|+++.++++|++....  ..+++++|++.|++||+|.||+|.+  ++++|.+|.+.+.+.+....  .
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~~--~   75 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLSS--G   75 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeecC--C
Confidence            3456544   789999999999885543  6789999999999999999999964  35789999999998766443  3


Q ss_pred             CceeeeecC
Q 004580          410 GQSVYIRVP  418 (744)
Q Consensus       410 ~~~lylrlp  418 (744)
                      +..+|||+|
T Consensus        76 ~~~~yiKv~   84 (84)
T cd01098          76 GGTLYLRLA   84 (84)
T ss_pred             CcEEEEEeC
Confidence            578999986

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1e-11  Score=120.16  Aligned_cols=132  Identities=22%  Similarity=0.154  Sum_probs=98.4

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChh
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD  597 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (744)
                      .+.|+.|..+.||+++. .++.+++|....... ....+..|++++..+.+.++++-+-.+ .....++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCccc
Confidence            35789999999999986 478899999765432 223567899999999766655433222 334458999999998875


Q ss_pred             hhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          598 VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS--RFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ...           .....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            320           111345678999999999876  23469999999999999 67899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=1.9e-11  Score=137.28  Aligned_cols=145  Identities=17%  Similarity=0.235  Sum_probs=97.5

Q ss_pred             hcCcccccccCccCceEEEcccccc-cceeEEEeccCCChhh----------------------------------H---
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQG----------------------------------L---  553 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~----------------------------------~---  553 (744)
                      -..|+. +.||.|++|+||+|++++ |+.||||+.++.....                                  .   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 799999999999999877 9999999987542110                                  0   


Q ss_pred             ---HHHHHHHHHHHHhc----CCCeeeEEEEEEE-cCeEEEEEEecCCCChhhhhcCcCCc---ccCCHHHHHHHHHHHH
Q 004580          554 ---EEFKNEMMLIAKLQ----HRNLVKLLGCCVE-QGEKILILEYMPNKSLDVFLFDPTKK---RLLGWQARVTIIEGIA  622 (744)
Q Consensus       554 ---~~f~~Ev~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia  622 (744)
                         -+|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++......+   ..+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence               12445555555553    4445555555543 45788999999999987642111111   112222222333333 


Q ss_pred             HHHHHHHhcCCCCeEEecCCCCCEEEeCCC----ceEEEeecCceecCC
Q 004580          623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFGLARMFGG  667 (744)
Q Consensus       623 ~gl~yLH~~~~~~IiHrDLk~~NILl~~~~----~~kL~DFGla~~~~~  667 (744)
                            +..+   ++|+|+||.||+++.++    +++++|||++..+..
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3455   99999999999999888    999999999998754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=7.8e-10  Score=108.34  Aligned_cols=137  Identities=14%  Similarity=0.115  Sum_probs=98.1

Q ss_pred             cccCccCceEEEcccccc-------cceeEEEeccCCC----------------------hhhHHHHH----HHHHHHHH
Q 004580          519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQS----------------------GQGLEEFK----NEMMLIAK  565 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~----------------------~~~~~~f~----~Ev~~l~~  565 (744)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ......+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       4789999874210                      01122333    79999999


Q ss_pred             hcC--CCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEecCC
Q 004580          566 LQH--RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL-HQYSRFRIIHRDLK  642 (744)
Q Consensus       566 l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~IiHrDLk  642 (744)
                      +..  .++...+.+    ...++||||+.+..+.....   +...++..+...+..+++.+|..| |..+   |||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            864  455555543    46689999998754422111   112344556677889999999999 7776   9999999


Q ss_pred             CCCEEEeCCCceEEEeecCceecC
Q 004580          643 ASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       643 ~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      +.|||++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.09  E-value=7.1e-10  Score=122.67  Aligned_cols=166  Identities=20%  Similarity=0.254  Sum_probs=126.6

Q ss_pred             ccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHH
Q 004580          534 LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA  613 (744)
Q Consensus       534 ~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~  613 (744)
                      ..++.+|.|...+.......+...+-++.|+.++||||++++......+..|||+|-+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688899988876655445567788899999999999999999999999999999874  44444422      23566


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCccccCcccccccccccCcccccCCC
Q 004580          614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL  693 (744)
Q Consensus       614 ~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  693 (744)
                      ....+.||+.||.+||..+  .++|++|...-|++++.|+.||++|-++........  .......-..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6778899999999999877  599999999999999999999999998865433221  111112223566676543322


Q ss_pred             CCchhhHHHHHHHHHHHHcC
Q 004580          694 FSIKSDVFSFGILMLETLSG  713 (744)
Q Consensus       694 ~s~k~DvwSlGviL~elltG  713 (744)
                        -..|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              356999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=8.5e-10  Score=111.52  Aligned_cols=142  Identities=20%  Similarity=0.286  Sum_probs=109.2

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCCh-hhHHHHHHHHHHHHHhcCC--CeeeEEEEEEEc---CeEEEEEEecC
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHR--NLVKLLGCCVEQ---GEKILILEYMP  592 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~Ev~~l~~l~Hp--nIv~l~~~~~~~---~~~~lV~Ey~~  592 (744)
                      +.|+.|..+.||+++..+|+.+++|....... ....++..|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999876678999999765432 2456789999999999763  456677665543   25689999999


Q ss_pred             CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS----------------------------------------  632 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~----------------------------------------  632 (744)
                      +.++...+..    ..++..++..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765421    34667777888888888888888521                                        


Q ss_pred             -------------CCCeEEecCCCCCEEEeC--CCceEEEeecCcee
Q 004580          633 -------------RFRIIHRDLKASNVLLDM--DMNPKISDFGLARM  664 (744)
Q Consensus       633 -------------~~~IiHrDLk~~NILl~~--~~~~kL~DFGla~~  664 (744)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=3.7e-09  Score=100.06  Aligned_cols=131  Identities=21%  Similarity=0.316  Sum_probs=101.5

Q ss_pred             cccCccCceEEEcccccccceeEEEe-ccCC--Ch-----hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSSQ--SG-----QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~-l~~~--~~-----~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey  590 (744)
                      ..+.+|+-+.++.+.+ -|..+++|. +++.  .+     -..++-.+|.+++.+++--.|-...-+..++....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4688999999999865 344566663 3322  11     1234577899999999877766666667788889999999


Q ss_pred             cCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      +++..|.+.+...          ...++..+-+.+.-||..+   |||+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998887432          2567777888899999998   99999999999997665 99999999975

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=3.7e-10  Score=123.92  Aligned_cols=198  Identities=26%  Similarity=0.356  Sum_probs=152.9

Q ss_pred             cCcccccccCc--cCceEEEcccc---cccceeEEEeccCC--ChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeE
Q 004580          513 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       513 ~~y~i~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~~--~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~  584 (744)
                      ..|.+.+.+|.  |.+|.||.++.   .++..+|+|+-+..  .+....+=.+|+....+++ |+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34566788999  99999999976   34778999874332  2233333345666666664 99999988888888899


Q ss_pred             EEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEee
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDF  659 (744)
Q Consensus       585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DF  659 (744)
                      ++-+|++. .+|..+.+.  ....++...+.....+...    |+..+|+..   |+|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999875 677776643  3344677778888888888    999999987   9999999999999999 88999999


Q ss_pred             cCceecCCCccccCc---ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004580          660 GLARMFGGDELQGNT---KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       660 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~  717 (744)
                      |+...+.........   ....+...|++||. ..+.++...|+|++|.+..|..++....
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccc
Confidence            999988765432221   22357788999995 4566788999999999999999988644

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=5.5e-09  Score=98.23  Aligned_cols=143  Identities=22%  Similarity=0.309  Sum_probs=106.9

Q ss_pred             cccccCccCceEEEcccccccceeEEE-eccCCC-------hhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEE
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSSQS-------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK-~l~~~~-------~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      .+..|-+|+-+.|+++.. .|+...|| ++.+..       .-...+.++|.+++.++.--.|....-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456899999999999987 56666666 343321       123567889999999998777766666677777888999


Q ss_pred             EecCC-CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCC---ceEEEeecCcee
Q 004580          589 EYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM---NPKISDFGLARM  664 (744)
Q Consensus       589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~---~~kL~DFGla~~  664 (744)
                      ||+++ .++..++....... ...+....++..|-+.+.-||..+   |||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 36677764332222 222333678889999999999998   99999999999997665   358999999864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=5.5e-10  Score=113.05  Aligned_cols=154  Identities=24%  Similarity=0.276  Sum_probs=116.2

Q ss_pred             HHHHHhcCCCeeeEEEEEEEc-----CeEEEEEEecCCCChhhhhcCcC-CcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 004580          561 MLIAKLQHRNLVKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLYLHQYSRF  634 (744)
Q Consensus       561 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~  634 (744)
                      ..+-.+.|.|||++..++.+.     ....+++|||+.|++..+|.... .+..+......++..||+.||.|||+. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            344556799999999988654     35789999999999999997543 344577778889999999999999996 57


Q ss_pred             CeEEecCCCCCEEEeCCCceEEEeecCceecC--CCccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHc
Q 004580          635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS  712 (744)
Q Consensus       635 ~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~ellt  712 (744)
                      +|+|+++..+-|++..++-+|+.--.-.....  ............+-++|.|||.=.....+..+|||+||+..+||--
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            89999999999999988888875211110000  0000111122346789999998777777889999999999999988


Q ss_pred             CCC
Q 004580          713 GKK  715 (744)
Q Consensus       713 G~~  715 (744)
                      +..
T Consensus       278 lEi  280 (458)
T KOG1266|consen  278 LEI  280 (458)
T ss_pred             hee
Confidence            875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.93  E-value=2.2e-10  Score=131.68  Aligned_cols=223  Identities=19%  Similarity=0.252  Sum_probs=157.7

Q ss_pred             HHhcCcccccccCccCceEEEcccccc-cceeEEEeccCCCh---hhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       510 ~~~~~y~i~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~---~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      ...+.+.+.+.+-+|.++.++.++-.. |...+.|.......   ...+....+-.++-..+||-+++...-+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            345788888899999999999886533 43344444332211   11222222222222234555665544444567889


Q ss_pred             EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      |+++|+.+++|...|+.   .+..+....+.....+..+++|||...   +.|+|++|.|+|...++..++.||+.....
T Consensus       881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999888854   234555556667777889999999876   899999999999999999999999843322


Q ss_pred             CCC-------------------------cccc----CcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004580          666 GGD-------------------------ELQG----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN  716 (744)
Q Consensus       666 ~~~-------------------------~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p  716 (744)
                      ..-                         ....    ......+|+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                         0000    11235789999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccccccccc
Q 004580          717 TGVYNADSFNLLGYVSNKSLHFYL  740 (744)
Q Consensus       717 ~~~~~~~~~~l~~~~~~~~~~f~~  740 (744)
                      |+......  +.+.+.+.+..+|.
T Consensus      1035 ~na~tpq~--~f~ni~~~~~~~p~ 1056 (1205)
T KOG0606|consen 1035 FNAETPQQ--IFENILNRDIPWPE 1056 (1205)
T ss_pred             CCCcchhh--hhhccccCCCCCCC
Confidence            98766554  77888887777653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=4.4e-08  Score=95.67  Aligned_cols=126  Identities=26%  Similarity=0.295  Sum_probs=81.2

Q ss_pred             EEEcccccccceeEEEeccCCC--------------------------hhhHHHHHHHHHHHHHhcCCC--eeeEEEEEE
Q 004580          528 PVYKGRLLNGQEVAVKRLSSQS--------------------------GQGLEEFKNEMMLIAKLQHRN--LVKLLGCCV  579 (744)
Q Consensus       528 ~Vy~~~~~~g~~vAVK~l~~~~--------------------------~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~~~  579 (744)
                      .||.|...+|..+|||+.+...                          .......++|.+.|.++..-+  +.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3888887788899999864210                          011345678999999998664  4555543  


Q ss_pred             EcCeEEEEEEecC--CCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEecCCCCCEEEeCCCceEE
Q 004580          580 EQGEKILILEYMP--NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY-LHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       580 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~IiHrDLk~~NILl~~~~~~kL  656 (744)
                        ...++||||++  +..+..+... .    ++..+...++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              23479999999  5555443211 1    1123455677778885555 56776   9999999999999988 9999


Q ss_pred             EeecCceecC
Q 004580          657 SDFGLARMFG  666 (744)
Q Consensus       657 ~DFGla~~~~  666 (744)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.75  E-value=3.3e-09  Score=116.53  Aligned_cols=194  Identities=22%  Similarity=0.245  Sum_probs=147.0

Q ss_pred             hcCcccccccCccCceEEEccccc--ccceeEEEeccCCChhhHHHH--HHHHHHHHHh-cCCCeeeEEEEEEEcCeEEE
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSGQGLEEF--KNEMMLIAKL-QHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~i~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~f--~~Ev~~l~~l-~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ..+|..+..||.|.|+.|++...+  ++..+++|.+.+......++.  ..|+.+...+ .|.++++....+..-.+.++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            467888899999999999987643  467889998876533322222  3455555555 48999988888877788889


Q ss_pred             EEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCC-CceEEEeecCceec
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMF  665 (744)
Q Consensus       587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~-~~~kL~DFGla~~~  665 (744)
                      --||++++++....   .....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.||+.+..+
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            99999999887665   33445777888999999999999999887   9999999999999886 78899999998743


Q ss_pred             CCCccccCccccccccccc--CcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004580          666 GGDELQGNTKRIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSGKKN  716 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DvwSlGviL~elltG~~p  716 (744)
                      .-..    .. ....-+++  +|+......+-.++|++|||.-+.|.+++.+.
T Consensus       418 ~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  418 AFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             ceec----cc-ccccccccccchhhccccccccccccccccccccccccCccc
Confidence            2111    01 12223344  55555667788999999999999999999863

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.73  E-value=1.5e-07  Score=97.51  Aligned_cols=131  Identities=18%  Similarity=0.165  Sum_probs=94.6

Q ss_pred             EEcccccccceeEEEeccCCChh-----------hHHHHHHHHHHHHHhcCCC--eeeEEEEEEE-----cCeEEEEEEe
Q 004580          529 VYKGRLLNGQEVAVKRLSSQSGQ-----------GLEEFKNEMMLIAKLQHRN--LVKLLGCCVE-----QGEKILILEY  590 (744)
Q Consensus       529 Vy~~~~~~g~~vAVK~l~~~~~~-----------~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~~~~-----~~~~~lV~Ey  590 (744)
                      |.+... +|+.+.||+.......           ....+.+|...+.++...+  ..+.+++...     ...-+||+|+
T Consensus        38 vvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~  116 (268)
T PRK15123         38 TLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED  116 (268)
T ss_pred             EEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence            556554 6778999976433211           1124788999999886443  3344555443     2357899999


Q ss_pred             cCCC-ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC-------CCceEEEeecCc
Q 004580          591 MPNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-------DMNPKISDFGLA  662 (744)
Q Consensus       591 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~-------~~~~kL~DFGla  662 (744)
                      +++. +|.+++.... ....+...+..++.+++..+.-||..+   |+|+|+++.|||++.       +..+.|+||+.+
T Consensus       117 l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        117 LAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             CCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            9986 7888763211 233456677889999999999999998   999999999999985       467999999988


Q ss_pred             ee
Q 004580          663 RM  664 (744)
Q Consensus       663 ~~  664 (744)
                      +.
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            64

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.56  E-value=7.1e-07  Score=96.27  Aligned_cols=169  Identities=20%  Similarity=0.295  Sum_probs=126.6

Q ss_pred             ceEEEcccc-cccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEE----cCeEEEEEEecCCC-Chhhh
Q 004580          526 FGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILILEYMPNK-SLDVF  599 (744)
Q Consensus       526 fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~~g-sL~~~  599 (744)
                      -.+.||+.. .+|..+++|+++............-++.++++.|+|||++..++..    ...+++||+|.|+. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            356788853 4799999999954433333333456778999999999999998873    35789999999864 56554


Q ss_pred             hcCc------------CCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          600 LFDP------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       600 l~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      -+..            ......++..++.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|..-|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            3322            12345678899999999999999999998   88899999999999888999988777766544


Q ss_pred             CccccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN  716 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p  716 (744)
                      +..                |-+..   -.+-|.=.||.+++.|-||...
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            330                00111   1367999999999999999654

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.51  E-value=2.9e-07  Score=82.72  Aligned_cols=87  Identities=23%  Similarity=0.278  Sum_probs=62.6

Q ss_pred             eEEEeeCCcEEEecCC-CceEEEEeeecc-cCCceEEEccCCCEEEEcCCCCCcccceeceeccCCccccccCCcccccc
Q 004580           89 VLTISNKGNLVLLNQT-NGTIWSTNVFSE-VKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL  166 (744)
Q Consensus        89 ~l~~~~~g~l~l~~~~-~~~~W~t~~~~~-~~~~~~~l~d~gNlvl~~~~~~~~~~~~~wqSFd~PtDtlLpg~~l~~~~  166 (744)
                      .+.++.||+||+++.. +.+||++++... ..+..+.|+++|||||++.+     +.++|+|   .|             
T Consensus        23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S---~t-------------   81 (114)
T smart00108       23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS---NT-------------   81 (114)
T ss_pred             ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe---cc-------------
Confidence            4567789999999765 589999997532 23368899999999999873     4678987   11             


Q ss_pred             cCCCceEEEEecCCCCCCCCceeeeeeccCCceEEEEeCCeeeeec
Q 004580          167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACS  212 (744)
Q Consensus       167 ~t~~~~~l~S~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~s  212 (744)
                                     ....|.+.+.|+.+|+.+++-.+ ..+.|.|
T Consensus        82 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~S  111 (114)
T smart00108       82 ---------------TGANGNYVLVLLDDGNLVIYDSD-GNFLWQS  111 (114)
T ss_pred             ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEeCC
Confidence                           01246788999999998764332 3466754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.50  E-value=7.9e-07  Score=89.36  Aligned_cols=135  Identities=21%  Similarity=0.211  Sum_probs=96.1

Q ss_pred             cccccccCccCceEEEcccccccceeEEEeccCCC----------------------hhhHHHHHHHHHHHHHhcCC--C
Q 004580          515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----------------------GQGLEEFKNEMMLIAKLQHR--N  570 (744)
Q Consensus       515 y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------------~~~~~~f~~Ev~~l~~l~Hp--n  570 (744)
                      ..+..+||.|--+.||.|...+|.++|||.-+...                      .......++|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44567999999999999999899999999653210                      01233467899999998755  5


Q ss_pred             eeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC
Q 004580          571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       571 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~  650 (744)
                      |.+.++.    +.-.+||||+++-.|...-        +.......++..|++-+.-+-..+   |||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            5555543    4557899999987764432        122233344444555444444555   999999999999999


Q ss_pred             CCceEEEeecCcee
Q 004580          651 DMNPKISDFGLARM  664 (744)
Q Consensus       651 ~~~~kL~DFGla~~  664 (744)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.5e-06  Score=86.88  Aligned_cols=107  Identities=23%  Similarity=0.243  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHHHHhcCC--CeeeEEEEEEEcC----eEEEEEEecCCC-ChhhhhcCcCCcccCCHHHHHHHHHHHHHHH
Q 004580          553 LEEFKNEMMLIAKLQHR--NLVKLLGCCVEQG----EKILILEYMPNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGL  625 (744)
Q Consensus       553 ~~~f~~Ev~~l~~l~Hp--nIv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl  625 (744)
                      .....+|...+..+...  ...+.+++.....    ..+||+|++++. +|.+++....   ..+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence            44678888888888643  3455566655432    458999999984 7888874321   255667789999999999


Q ss_pred             HHHHhcCCCCeEEecCCCCCEEEeCCC---ceEEEeecCceec
Q 004580          626 LYLHQYSRFRIIHRDLKASNVLLDMDM---NPKISDFGLARMF  665 (744)
Q Consensus       626 ~yLH~~~~~~IiHrDLk~~NILl~~~~---~~kL~DFGla~~~  665 (744)
                      +-||..+   |+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999998   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=7.1e-07  Score=100.02  Aligned_cols=146  Identities=16%  Similarity=0.214  Sum_probs=96.9

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhh------------------------------HH--------
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG------------------------------LE--------  554 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~------------------------------~~--------  554 (744)
                      ..|+. +.|+.++-|+||+|++++|+.||||+.+..-...                              .+        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34442 6899999999999999999999999986442110                              11        


Q ss_pred             --HHHHHHHHHHHhc----CCCeeeEEEEEE-EcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHH-H
Q 004580          555 --EFKNEMMLIAKLQ----HRNLVKLLGCCV-EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL-L  626 (744)
Q Consensus       555 --~f~~Ev~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~  626 (744)
                        ++.+|...+.+++    +..-+++-.++. -.+..+|+|||++|-.+.+......  ...+.   ..++..++++. .
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~  279 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLR  279 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHH
Confidence              2344555555553    222333334443 3568899999999999887743222  22332   33344344332 2


Q ss_pred             HHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCC
Q 004580          627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       627 yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~  667 (744)
                      .+-..+   ++|.|..|.||+++.++++.+.|||+...+.+
T Consensus       280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222234   99999999999999999999999999987754

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.43  E-value=5.1e-07  Score=81.37  Aligned_cols=88  Identities=23%  Similarity=0.224  Sum_probs=63.7

Q ss_pred             EEEee-CCcEEEecCC-CceEEEEeeec-ccCCceEEEccCCCEEEEcCCCCCcccceeceeccCCccccccCCcccccc
Q 004580           90 LTISN-KGNLVLLNQT-NGTIWSTNVFS-EVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL  166 (744)
Q Consensus        90 l~~~~-~g~l~l~~~~-~~~~W~t~~~~-~~~~~~~~l~d~gNlvl~~~~~~~~~~~~~wqSFd~PtDtlLpg~~l~~~~  166 (744)
                      +.++. ||+||+++.. +.+||++|+.. ......+.|+++|||||++.+     +.++|+|=-.               
T Consensus        24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~~---------------   83 (116)
T cd00028          24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNTT---------------   83 (116)
T ss_pred             CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEeccc---------------
Confidence            55666 9999999764 58999999753 235567899999999999873     4678986211               


Q ss_pred             cCCCceEEEEecCCCCCCCCceeeeeeccCCceEEEEeCCeeeeecCC
Q 004580          167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ  214 (744)
Q Consensus       167 ~t~~~~~l~S~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  214 (744)
                                      .+.+.+.+.|+.+|+..++-.+ ..+.|.|..
T Consensus        84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~  114 (116)
T cd00028          84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD  114 (116)
T ss_pred             ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence                            1246788999999988865433 355776543

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.35  E-value=1.1e-06  Score=72.85  Aligned_cols=60  Identities=37%  Similarity=0.873  Sum_probs=48.8

Q ss_pred             CceEEecccCCCCcceeccccccCHHHHHHHHhc-cCCeeeccccccCCCcceEEEc-ccccccC
Q 004580          340 HQFIKLDNIRAPDFIEVFLNKSMNLQQCAAECLK-NCTCRAYANSNVTEGSGCLMWF-GDLLDAN  402 (744)
Q Consensus       340 ~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~g~~C~~w~-~~l~~~~  402 (744)
                      ..|++++++.+++..... ....++++|++.|++ +|+|.||+|..  .+.+|.+|. +.+.+..
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~   65 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDAR   65 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccce
Confidence            569999999999665433 346799999999999 99999999964  456899999 6776665

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PRK09902 hypothetical protein; Provisional

Probab=98.27  E-value=9.9e-06  Score=79.75  Aligned_cols=139  Identities=16%  Similarity=0.177  Sum_probs=101.2

Q ss_pred             cCccCceEEEcccccccceeEEEeccCC------ChhhHHHHHHHHHHHHHhcCCC--eeeEEEEEEEc----CeEEEEE
Q 004580          521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQ------SGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQ----GEKILIL  588 (744)
Q Consensus       521 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~------~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~~~~~----~~~~lV~  588 (744)
                      -|+||-+-|++-.+ +|+.+-+|+-...      .+.....|.+|...+.++...+  +.+.+......    -.-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            35688888888765 4557888876421      1446788999999999996433  44444221111    1467999


Q ss_pred             EecCC-CChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc--eEEEeecCcee
Q 004580          589 EYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN--PKISDFGLARM  664 (744)
Q Consensus       589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~--~kL~DFGla~~  664 (744)
                      |-+++ .+|..++.+. .....+...+..+..++++.++-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98764 4777776432 1224567778899999999999999998   999999999999986666  99999987764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.26  E-value=1.7e-05  Score=80.44  Aligned_cols=139  Identities=17%  Similarity=0.170  Sum_probs=85.6

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC--eeeEEEEEEEcCeEEEEEEecCCCC-
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEYMPNKS-  595 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gs-  595 (744)
                      .+||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+.+..+.+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47999999999984   35567888876533  3355688999999987544  3556666666777889999999973 


Q ss_pred             hhhhh---------------------cCcCCcccCCHHHH-HHHHH----------HHHH-HHHHHHhc-CCCCeEEecC
Q 004580          596 LDVFL---------------------FDPTKKRLLGWQAR-VTIIE----------GIAQ-GLLYLHQY-SRFRIIHRDL  641 (744)
Q Consensus       596 L~~~l---------------------~~~~~~~~l~~~~~-~~i~~----------~ia~-gl~yLH~~-~~~~IiHrDL  641 (744)
                      +...+                     |..... ....... ..+..          .+.+ ...+|... ..+.++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     110000 0011000 00000          0111 12222211 2345789999


Q ss_pred             CCCCEEEeCCCceEEEeecCcee
Q 004580          642 KASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       642 k~~NILl~~~~~~kL~DFGla~~  664 (744)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=98.25  E-value=7.6e-06  Score=73.26  Aligned_cols=99  Identities=24%  Similarity=0.405  Sum_probs=68.3

Q ss_pred             CeeeeCCCeEEEEEECCCCCCCeEEEEEeecCCCcEEEEe-cCCCCCCCCCceEEEeeCCcEEEecCCCceEEEEeeecc
Q 004580           38 EKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVA-NRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSE  116 (744)
Q Consensus        38 ~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~  116 (744)
                      +.+.+.+|.+.|-|...|+     |-|.-  -..+++|.+ +...... ..+.+.|+.||||||+|..+.++|+|.  ..
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVLYD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF--DY   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEEEE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred             cccccccccccceECCCCe-----EEEEc--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence            4565655889998988776     45542  235679999 4343332 478999999999999999999999994  44


Q ss_pred             cCCceEEEcc--CCCEEEEcCCCCCcccceeceeccCC
Q 004580          117 VKNPVAQLRD--DGNLVIRDNSSGNTTESYLWQSFDYP  152 (744)
Q Consensus       117 ~~~~~~~l~d--~gNlvl~~~~~~~~~~~~~wqSFd~P  152 (744)
                      .....+..++  +||++ +..     ...+.|.|=+.|
T Consensus        82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dp  113 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDP  113 (114)
T ss_dssp             SS-EEEEEET--TSEEE-EES-----TSSEEEESS---
T ss_pred             CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCC
Confidence            4667788888  99999 644     235788876665

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=1.1e-05  Score=79.76  Aligned_cols=138  Identities=16%  Similarity=0.188  Sum_probs=92.4

Q ss_pred             HhcCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHH---------HHHHHHHHHhcCCC---eeeEEEEE
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEF---------KNEMMLIAKLQHRN---LVKLLGCC  578 (744)
Q Consensus       511 ~~~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f---------~~Ev~~l~~l~Hpn---Iv~l~~~~  578 (744)
                      ...+|++.+++-......|.+-.. +|+.+++|..+.......+.|         .+++..+.+++...   ...++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777777887777777776655 678999999876543333322         33444444553322   22222222


Q ss_pred             EE-----cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCc
Q 004580          579 VE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN  653 (744)
Q Consensus       579 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~  653 (744)
                      ..     ....+++|||++|..|.++..       ++.    .++..|.+++.-||+.|   +.|+|..|.|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            22     235678999999988755431       222    24566788899999998   9999999999999855 4


Q ss_pred             eEEEeecCcee
Q 004580          654 PKISDFGLARM  664 (744)
Q Consensus       654 ~kL~DFGla~~  664 (744)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.23  E-value=1.1e-05  Score=84.98  Aligned_cols=193  Identities=15%  Similarity=0.157  Sum_probs=123.3

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHh-cCCCeeeEEEE----E--EEcC-eEEEEE
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC----C--VEQG-EKILIL  588 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l-~HpnIv~l~~~----~--~~~~-~~~lV~  588 (744)
                      ..+.||+|+-+.+|-.-  +-+..+-|+..........+...|   |.+. .||-+-.-+..    .  -+++ ..-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34689999999998642  112234566655443333332222   2222 35543221110    0  1112 244666


Q ss_pred             EecCCCC-hhhhhc---CcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          589 EYMPNKS-LDVFLF---DPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       589 Ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ..+++.- ...+..   ..+......|.-.++.+..++.+.+.||..+   .+-+|++++|+|+.+++.+.|+|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            6665542 222221   1223445789999999999999999999998   88899999999999999999998544333


Q ss_pred             cCCCccccCcccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSG-KKNTGVY  720 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGviL~elltG-~~p~~~~  720 (744)
                      ....   ......+|...|.+||...-.     .-+...|.|.|||++++|+.| +.||...
T Consensus       167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            2111   122335788899999976522     235779999999999999997 7788654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.16  E-value=2.6e-05  Score=77.90  Aligned_cols=151  Identities=19%  Similarity=0.237  Sum_probs=99.6

Q ss_pred             HHHHHHHhcCccccc---ccCccCceEEEcccccccceeEEEeccCCChh-------------------hHHH-----HH
Q 004580          505 LASVAAATENFSMQC---KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQ-------------------GLEE-----FK  557 (744)
Q Consensus       505 ~~~~~~~~~~y~i~~---~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-------------------~~~~-----f~  557 (744)
                      ...+........+.+   .|+.|--+.||+|.-.++..+|||+++.....                   ...+     ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            333444444444433   56778888999998778999999998643110                   1111     23


Q ss_pred             HHHHHHHHhc--CCCeeeEEEEEEEcCeEEEEEEecCCCChh-hhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 004580          558 NEMMLIAKLQ--HRNLVKLLGCCVEQGEKILILEYMPNKSLD-VFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF  634 (744)
Q Consensus       558 ~Ev~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~  634 (744)
                      .|...|.++.  +-.+.+-+.+.    +.+|||||+...... -.|    +.-.+...+...+..++++.+.-|-...  
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--  186 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--  186 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence            5777777764  44444445443    457999999755221 111    1112333366777888888888887733  


Q ss_pred             CeEEecCCCCCEEEeCCCceEEEeecCceecC
Q 004580          635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       635 ~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~  666 (744)
                      ++||+||..-|||+. ++.+.|+||+.|....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            499999999999999 8899999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.07  E-value=4.4e-05  Score=78.49  Aligned_cols=141  Identities=14%  Similarity=0.131  Sum_probs=85.4

Q ss_pred             ccCccCc-eEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhc-CCCeeeEEEEEEEcCeEEEEEEecCCCChh
Q 004580          520 KLGEGGF-GPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLD  597 (744)
Q Consensus       520 ~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  597 (744)
                      .|..|.. ..||+.... +..+.||+.....   ..++.+|++++..+. +.-+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555555 788998653 4678888875432   345678898888885 444556677666666788999999998876


Q ss_pred             hhh-------------------cCcCC-cccCCH--HHHHHH-HH-------------------HHHHHHHHHHh----c
Q 004580          598 VFL-------------------FDPTK-KRLLGW--QARVTI-IE-------------------GIAQGLLYLHQ----Y  631 (744)
Q Consensus       598 ~~l-------------------~~~~~-~~~l~~--~~~~~i-~~-------------------~ia~gl~yLH~----~  631 (744)
                      ...                   |.... ......  ...... ..                   .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11000 001100  000000 00                   01111222211    1


Q ss_pred             CCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       632 ~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ..+.++|+|+.|.|||++++....|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234589999999999999987789999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=1.6e-05  Score=88.96  Aligned_cols=142  Identities=20%  Similarity=0.253  Sum_probs=92.6

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCChhh-------------------------------------HHHHHHHHH
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-------------------------------------LEEFKNEMM  561 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f~~Ev~  561 (744)
                      +.|+.-+.|+||+|++++|+.||||+-+..-+..                                     +-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6899999999999999999999999876432110                                     112455555


Q ss_pred             HHHHh----cCCC---eeeEEEEEEE-cCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004580          562 LIAKL----QHRN---LVKLLGCCVE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR  633 (744)
Q Consensus       562 ~l~~l----~Hpn---Iv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  633 (744)
                      ...+.    +|-+   -|.+-.++.+ ...++|+||||+|..+.+....  ....++...   ++..+.++.  ++..-.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~--~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAY--LEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHH--HHHHHh
Confidence            54444    3555   2333344433 3578999999999988766422  222244443   333333332  222112


Q ss_pred             CCeEEecCCCCCEEEeC----CCceEEEeecCceecCC
Q 004580          634 FRIIHRDLKASNVLLDM----DMNPKISDFGLARMFGG  667 (744)
Q Consensus       634 ~~IiHrDLk~~NILl~~----~~~~kL~DFGla~~~~~  667 (744)
                      .+++|+|-.|.||++..    +..+.+.|||+...+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            24999999999999984    56899999999887644

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.05  E-value=3.6e-05  Score=78.06  Aligned_cols=144  Identities=22%  Similarity=0.238  Sum_probs=85.4

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC--eeeEEEEEEE---cCeEEEEEEecC
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVE---QGEKILILEYMP  592 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~~~~---~~~~~lV~Ey~~  592 (744)
                      ++.|+.|..+.||+....+ +.+++|.....  .....+..|..++..+....  +.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999998766 68999997544  45677888999998886443  4455554322   335789999999


Q ss_pred             CCChhh----------------hh---cCc-CCcccCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 004580          593 NKSLDV----------------FL---FDP-TKKRLLGWQA---------RVTI------------IEGIAQ-GLLYLHQ  630 (744)
Q Consensus       593 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~yLH~  630 (744)
                      +..+..                .+   +.. ..........         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                11   111 0000011100         0000            111222 3333332


Q ss_pred             ----cCCCCeEEecCCCCCEEEe-CCCceEEEeecCcee
Q 004580          631 ----YSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARM  664 (744)
Q Consensus       631 ----~~~~~IiHrDLk~~NILl~-~~~~~kL~DFGla~~  664 (744)
                          .....++|+|+.++|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                1345699999999999999 566668999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.05  E-value=6.1e-07  Score=98.99  Aligned_cols=187  Identities=16%  Similarity=0.111  Sum_probs=133.3

Q ss_pred             cCcccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC-eeeEEEEEEEcCeEEEEEEec
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN-LVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~  591 (744)
                      .-+...+.+++++++.++|.+....+...++.+...     ....-++++|.+++||| .++.++-+..+....++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            344445678999999999988655555555554322     34456788999999999 777777777777888999999


Q ss_pred             CCC-ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCCcc
Q 004580          592 PNK-SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       592 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~~~  670 (744)
                      ..+ +...-.  ....-.+...+...+...-++++++||+..   =+|+|    ||+..+ +..|..||+....+.... 
T Consensus       317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence            877 211111  011112333344455566678899999864   48888    777754 778999999988775543 


Q ss_pred             ccCcccccccccccCcccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT  717 (744)
Q Consensus       671 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGviL~elltG~~p~  717 (744)
                        ......+++.++|||++....+..+.|+|++|+=-.++--|-+|-
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence              234468899999999999999999999999998777776676654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.89  E-value=6.8e-05  Score=73.58  Aligned_cols=105  Identities=23%  Similarity=0.204  Sum_probs=82.7

Q ss_pred             HHHHHHHHHhcC-CCeeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004580          557 KNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR  635 (744)
Q Consensus       557 ~~Ev~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~  635 (744)
                      ..|..++..+++ +++.+++|+|-    .+++.||.+.+++...-..-..-...+|..+.+||.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888986 69999999993    4679999997765321000011123689999999999999999999865556


Q ss_pred             eEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          636 IIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       636 IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                      +.-+|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.88  E-value=2.5e-06  Score=95.42  Aligned_cols=101  Identities=23%  Similarity=0.456  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCceecCCC-ccccC------cccccccccccCccccc
Q 004580          618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGN------TKRIVGTYGYMSPEYAL  690 (744)
Q Consensus       618 ~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~~~~-~~~~~------~~~~~gt~~y~aPE~~~  690 (744)
                      +.+++.|+.|+|...  .+||++|.|++|.++.++..||+.|+.+....+. ++...      ..-......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            344569999999865  5999999999999999999999999988765441 11110      11123456899999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004580          691 DGLFSIKSDVFSFGILMLETLS-GKKNTGVY  720 (744)
Q Consensus       691 ~~~~s~k~DvwSlGviL~ellt-G~~p~~~~  720 (744)
                      +...+.++|+||+|+++|.+.. |+.-++..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhcc
Confidence            9899999999999999999994 55545444

>PRK10593 hypothetical protein; Provisional

Probab=97.79  E-value=0.0003  Score=74.57  Aligned_cols=77  Identities=14%  Similarity=0.129  Sum_probs=56.6

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcC---CCeeeEEEEEEEc---CeEEEEEEe
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---RNLVKLLGCCVEQ---GEKILILEY  590 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~H---pnIv~l~~~~~~~---~~~~lV~Ey  590 (744)
                      -.+.||.|..+.||+....++ .+++|..+..  .....|..|...++.+..   ..+.++++.+..+   +..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            346899999999999865444 4667775431  133578899999998853   4677788777543   568999999


Q ss_pred             cCCCCh
Q 004580          591 MPNKSL  596 (744)
Q Consensus       591 ~~~gsL  596 (744)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.78  E-value=0.00032  Score=69.20  Aligned_cols=128  Identities=16%  Similarity=0.228  Sum_probs=90.0

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCC----------------hhhHHHHHHHHHHHHHhc------CCCeeeEE
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----------------GQGLEEFKNEMMLIAKLQ------HRNLVKLL  575 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~f~~Ev~~l~~l~------HpnIv~l~  575 (744)
                      ...||+|+.-.||.  +++....+||+++...                ....+++.+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35899999999997  4456677888886554                223566777777666666      78899999


Q ss_pred             EEEEEcCeEEEEEEecCC--C----ChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          576 GCCVEQGEKILILEYMPN--K----SLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       576 ~~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                      |........-+|+|.+.+  |    +|.+++    ....++. +....   +-+-..||-++.   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999888999998753  3    245555    2333444 33333   334455666665   99999999999996


Q ss_pred             CCC----ceEEEe
Q 004580          650 MDM----NPKISD  658 (744)
Q Consensus       650 ~~~----~~kL~D  658 (744)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.77  E-value=0.0003  Score=85.19  Aligned_cols=79  Identities=19%  Similarity=0.404  Sum_probs=56.9

Q ss_pred             ccccCccCceEEEccccccc---ceeEEEeccCCC-hhhHHHHHHHHHHHHHhc-CCCe--eeEEEEEEEc---CeEEEE
Q 004580          518 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQ-HRNL--VKLLGCCVEQ---GEKILI  587 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~f~~Ev~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV  587 (744)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |+++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999998866443   367777754322 223457889999999996 6664  7777777654   467899


Q ss_pred             EEecCCCCh
Q 004580          588 LEYMPNKSL  596 (744)
Q Consensus       588 ~Ey~~~gsL  596 (744)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998753

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.76  E-value=0.00015  Score=68.57  Aligned_cols=130  Identities=22%  Similarity=0.278  Sum_probs=90.1

Q ss_pred             ccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCC
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKS  595 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs  595 (744)
                      ...+.|++|.+|.||++.+ .|.++|+|+-+.++  ....+..|.+++..++-.++.+=+-.+   +.-.+.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence            3457899999999999988 45689999876544  347789999999999887776544333   23345599999988


Q ss_pred             hhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC-CCCEEEeCCCceEEEeecCcee
Q 004580          596 LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk-~~NILl~~~~~~kL~DFGla~~  664 (744)
                      |...-...      +.    +....+++.---|...+   |-|+.|. |..++|-.+..+.|+||..|..
T Consensus        99 L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            76653111      12    22333445544455555   8888886 5555555666999999999884

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.73  E-value=0.00024  Score=72.69  Aligned_cols=73  Identities=12%  Similarity=0.186  Sum_probs=45.5

Q ss_pred             cccCccCce-EEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCC---CeeeEEEEEEEc---CeEEEEEEec
Q 004580          519 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHR---NLVKLLGCCVEQ---GEKILILEYM  591 (744)
Q Consensus       519 ~~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~Ey~  591 (744)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|.+++..+...   .+.+.+......   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777666 48875    235777876542  2345788999999888632   233333332221   2347899999


Q ss_pred             CCCChh
Q 004580          592 PNKSLD  597 (744)
Q Consensus       592 ~~gsL~  597 (744)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.00052  Score=70.01  Aligned_cols=142  Identities=18%  Similarity=0.206  Sum_probs=81.9

Q ss_pred             cccCccCceEEEcccccc--cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEEEEEEecCCCCh
Q 004580          519 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  596 (744)
                      +.|..|-...+|+....+  ++.+++|+........ .+..+|+.++..+...++++-+-...+   ..++|||+++.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEeeCCCcC
Confidence            567788888999987653  5788899876432221 233578888888865444433322222   2479999998776


Q ss_pred             hhh-----------------hcCcCCc--------ccCC-HHHHHHHHH----------------------HHHHHHHHH
Q 004580          597 DVF-----------------LFDPTKK--------RLLG-WQARVTIIE----------------------GIAQGLLYL  628 (744)
Q Consensus       597 ~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~gl~yL  628 (744)
                      ...                 +|.....        .... +..+..+..                      .+...+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            321                 1111110        0111 112111111                      111111111


Q ss_pred             ----Hhc-CCCCeEEecCCCCCEEEeC-CCceEEEeecCcee
Q 004580          629 ----HQY-SRFRIIHRDLKASNVLLDM-DMNPKISDFGLARM  664 (744)
Q Consensus       629 ----H~~-~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~  664 (744)
                          ... ....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence                111 2346999999999999998 57899999988764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.67  E-value=0.00036  Score=68.30  Aligned_cols=125  Identities=24%  Similarity=0.366  Sum_probs=90.8

Q ss_pred             cCcccccccCccCc-eEEEcccccccceeEEEeccCC---C-----------h-------hhHHHHHHHHHHHHHhc---
Q 004580          513 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSSQ---S-----------G-------QGLEEFKNEMMLIAKLQ---  567 (744)
Q Consensus       513 ~~y~i~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~---~-----------~-------~~~~~f~~Ev~~l~~l~---  567 (744)
                      .+++.++.||.|.- |.||+++. +|+.+|+|.++.-   .           +       ...+-|..|.+..++|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 99999998 6889999994320   0           0       12345889999999886   


Q ss_pred             CCCe--eeEEEEEEEc------------------CeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHH
Q 004580          568 HRNL--VKLLGCCVEQ------------------GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY  627 (744)
Q Consensus       568 HpnI--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y  627 (744)
                      +.++  |+.+|+..-.                  ..+.||.||++...            .+..    .-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            3455  8888887322                  12356777765432            1222    334567777888


Q ss_pred             HHhcCCCCeEEecCCCCCEEEeCCCceEEEeecCc
Q 004580          628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       628 LH~~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla  662 (744)
                      +|..+   |+-+|++++|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999987     4689999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.55  E-value=0.00054  Score=71.02  Aligned_cols=139  Identities=14%  Similarity=0.093  Sum_probs=79.7

Q ss_pred             ccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCeee-EEEEEEEcCeEEEEEEecCCCChhh
Q 004580          520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK-LLGCCVEQGEKILILEYMPNKSLDV  598 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey~~~gsL~~  598 (744)
                      .+..|-...+|+... +++.+++|...........+..+|..+++.+....+++ ++...  .  -.+|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            455677788888763 56788888765432221123578888998887544433 33322  2  368999999877642


Q ss_pred             h-----------------hcCcC-CcccCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEEecCCCCC
Q 004580          599 F-----------------LFDPT-KKRLLGWQAR-VTIIEG---------IAQGLLYLHQY-----SRFRIIHRDLKASN  645 (744)
Q Consensus       599 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gl~yLH~~-----~~~~IiHrDLk~~N  645 (744)
                      -                 ||... ....++.... ..+..+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 1111222211 111111         11122222211     12358999999999


Q ss_pred             EEEeCCCceEEEeecCcee
Q 004580          646 VLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       646 ILl~~~~~~kL~DFGla~~  664 (744)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.38  E-value=0.0016  Score=71.17  Aligned_cols=75  Identities=15%  Similarity=0.217  Sum_probs=53.7

Q ss_pred             cccCccCceEEEccccccc-ceeEEEeccCC-----C--hhhHHHHHHHHHHHHHhc---CCCeeeEEEEEEEcCeEEEE
Q 004580          519 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQ-----S--GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~-----~--~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~~~~~~~lV  587 (744)
                      +.||.|.+..||+....+| +.++||.-...     .  +...+++..|.+.|..+.   ...+.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5899999999999988776 58999984321     1  234567778888888763   2345556555  45667899


Q ss_pred             EEecCCCC
Q 004580          588 LEYMPNKS  595 (744)
Q Consensus       588 ~Ey~~~gs  595 (744)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.32  E-value=0.002  Score=68.33  Aligned_cols=143  Identities=20%  Similarity=0.170  Sum_probs=86.7

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC--eeeEEEE------EEEcCeEEEEEE
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGC------CVEQGEKILILE  589 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E  589 (744)
                      .+.|..|....+|+... ++..+++|+...   ...++...|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45778888788998865 345788898764   23456677888888885433  3444331      123456689999


Q ss_pred             ecCCCChhhh--------------hcCc----CC----cccCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 004580          590 YMPNKSLDVF--------------LFDP----TK----KRLLGWQARV----------TIIEGIAQGLLYLHQ----YSR  633 (744)
Q Consensus       590 y~~~gsL~~~--------------l~~~----~~----~~~l~~~~~~----------~i~~~ia~gl~yLH~----~~~  633 (744)
                      |++|..+...              +|..    ..    .....|....          .....+..++.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998876420              1110    00    0111221110          011123344455443    123


Q ss_pred             CCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          634 FRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       634 ~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ..++|+|+.|.|||++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999887779999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.18  E-value=0.0025  Score=67.82  Aligned_cols=142  Identities=27%  Similarity=0.315  Sum_probs=83.1

Q ss_pred             cccCccCceEEEcccccc-------cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCee-eEEEEEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey  590 (744)
                      +.|..|--..+|+....+       ++.+++|+...... ...+..+|.+++..+....+. ++++.+. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            455566667888876544       47889999765432 234557888888888644443 3344332 2   358999


Q ss_pred             cCCCChhhh-----------------hcCcCCcc------cCC--HHHHHH--------------------------HHH
Q 004580          591 MPNKSLDVF-----------------LFDPTKKR------LLG--WQARVT--------------------------IIE  619 (744)
Q Consensus       591 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~  619 (744)
                      ++|..+...                 +|......      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998876431                 11111100      010  111100                          111


Q ss_pred             HHHHHHHHHHh------cCCCCeEEecCCCCCEEEeCC----CceEEEeecCceec
Q 004580          620 GIAQGLLYLHQ------YSRFRIIHRDLKASNVLLDMD----MNPKISDFGLARMF  665 (744)
Q Consensus       620 ~ia~gl~yLH~------~~~~~IiHrDLk~~NILl~~~----~~~kL~DFGla~~~  665 (744)
                      .+.+.+..|..      ..+..++|+|+.+.|||++++    +.++++||..|..-
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            22223334432      234578999999999999975    88999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.06  E-value=0.013  Score=62.76  Aligned_cols=142  Identities=20%  Similarity=0.209  Sum_probs=77.6

Q ss_pred             cccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC--eeeEEE------EEEEcCeEEEEEEe
Q 004580          519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLG------CCVEQGEKILILEY  590 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~------~~~~~~~~~lV~Ey  590 (744)
                      +.|..|....+|+....+| .+++|++...   ..+....|+.++..|...+  +.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            5677787788999875444 6888987521   2233444556666654222  223332      11234567899999


Q ss_pred             cCCCChhh-----------h---hcCcC--------CcccCCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 004580          591 MPNKSLDV-----------F---LFDPT--------KKRLLGW-QARVT------------II-EGIAQGLLYLHQY---  631 (744)
Q Consensus       591 ~~~gsL~~-----------~---l~~~~--------~~~~l~~-~~~~~------------i~-~~ia~gl~yLH~~---  631 (744)
                      ++|..+..           .   +|...        ....+.| .+...            .. ..+...++.+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99885421           1   11110        0011111 11111            11 1122222333211   


Q ss_pred             -CCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          632 -SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       632 -~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                       -+..+||+|+.+.|||++.+...-|+||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             234699999999999999665568999998864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.85  E-value=0.0076  Score=63.58  Aligned_cols=142  Identities=18%  Similarity=0.176  Sum_probs=98.1

Q ss_pred             cccccCccCceEEEcccccccceeEEEeccCCC-------h---------------hhHHH----HHHHHHHHHHhcCCC
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS-------G---------------QGLEE----FKNEMMLIAKLQHRN  570 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------~---------------~~~~~----f~~Ev~~l~~l~Hpn  570 (744)
                      +...|..|--+.||-+.-.+|..+|||+++...       .               ...+.    ...|++.|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345788899999999998899999999875220       0               01111    245788888887555


Q ss_pred             eeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEeC
Q 004580          571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM  650 (744)
Q Consensus       571 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~~  650 (744)
                      |...--...  ...+|||+|+.......-.   .+.-.++...+..+-.++++-|.-|-+.+  ++||.||.--|+|+ .
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence            432211111  2346899999643322111   23345667778888899999999998888  69999999999998 5


Q ss_pred             CCceEEEeecCceecC
Q 004580          651 DMNPKISDFGLARMFG  666 (744)
Q Consensus       651 ~~~~kL~DFGla~~~~  666 (744)
                      +|.+.|+|-+-+....
T Consensus       300 dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             CCEEEEEEccccccCC
Confidence            7789999988776543

>PLN02236 choline kinase

Probab=96.84  E-value=0.01  Score=64.25  Aligned_cols=141  Identities=16%  Similarity=0.250  Sum_probs=81.9

Q ss_pred             ccCccCceEEEcccccc-----cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCee-eEEEEEEEcCeEEEEEEecCC
Q 004580          520 KLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      .|-.|---.+|+....+     ++.+++|+.........++ .+|..++..+...++. ++++.+. .+   .|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeCC
Confidence            45456667788875422     3678899886654433333 7788999888765554 3444442 22   58999988


Q ss_pred             CChhhh-----------------hcCcC-C-cc-cCCHHHHHHHHHH-----------------HHHHHHHH----Hh-c
Q 004580          594 KSLDVF-----------------LFDPT-K-KR-LLGWQARVTIIEG-----------------IAQGLLYL----HQ-Y  631 (744)
Q Consensus       594 gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~-----------------ia~gl~yL----H~-~  631 (744)
                      .++...                 +|... . .. ...+.++.++..+                 +...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 11111 0 00 1112222222211                 11112222    21 2


Q ss_pred             CCCCeEEecCCCCCEEEeC-CCceEEEeecCceec
Q 004580          632 SRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMF  665 (744)
Q Consensus       632 ~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~  665 (744)
                      .+..++|+|+++.|||+++ ++.++++||..+..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2346899999999999986 468999999988754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.80  E-value=0.017  Score=61.59  Aligned_cols=144  Identities=21%  Similarity=0.197  Sum_probs=82.7

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhcCCC--eeeEEEE------EEEcCeEEEEEE
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGC------CVEQGEKILILE  589 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E  589 (744)
                      .+.++.|....+|+.... +..+++|+.+...  ..++...|+.++..|....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            456777877889988654 4467788765422  2344556677777774322  3333331      122456789999


Q ss_pred             ecCCCChhhh--------------hcCcCC----c-----ccCCHHHHH------------HHHHHHHHHHHHHHh----
Q 004580          590 YMPNKSLDVF--------------LFDPTK----K-----RLLGWQARV------------TIIEGIAQGLLYLHQ----  630 (744)
Q Consensus       590 y~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~------------~i~~~ia~gl~yLH~----  630 (744)
                      |++|..+...              +|....    .     ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              111000    0     001111100            011223344555543    


Q ss_pred             cCCCCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       631 ~~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ..+..++|+|+.+.||+++.++...|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2235699999999999999887778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.77  E-value=0.0072  Score=63.40  Aligned_cols=75  Identities=19%  Similarity=0.234  Sum_probs=48.6

Q ss_pred             ccccccCccCceEEEcccccccceeEEEeccCCChhhHHHHHHHHHHHHHhc---CCCeeeEEEEEEEcCeEEEEEEecC
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       516 ~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~  592 (744)
                      +-.+.|+-|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   -..+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            344678989999999987 467889999875   333467888998888884   3457778887777777799999998


Q ss_pred             CC
Q 004580          593 NK  594 (744)
Q Consensus       593 ~g  594 (744)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.68  E-value=0.019  Score=60.72  Aligned_cols=140  Identities=19%  Similarity=0.254  Sum_probs=82.7

Q ss_pred             cccccCccCceEEEcccccccceeEEEecc-CCChhhHHHHHHHHHHHHHhcC--CCeeeEEEEEEEcC--eEEEEEEec
Q 004580          517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQG--EKILILEYM  591 (744)
Q Consensus       517 i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~-~~~~~~~~~f~~Ev~~l~~l~H--pnIv~l~~~~~~~~--~~~lV~Ey~  591 (744)
                      +.+.+..|---.+|..... ++++++++-. ...........+|..+|+.+.-  .-+-+.++.|.++.  ..+.||+|+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            3444544433334444332 6778888321 1223344556788888887753  23344566665554  668999999


Q ss_pred             CCCChhhhhcCcCCcccCCHHHHHHHH-HHHHHHHHHHHh----------------------------------------
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTII-EGIAQGLLYLHQ----------------------------------------  630 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~gl~yLH~----------------------------------------  630 (744)
                      ++..+...+....    ..    ..++ ..+++.|+-||+                                        
T Consensus       108 eGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            9865433321110    00    1111 234444444442                                        


Q ss_pred             ----------c-----CCCCeEEecCCCCCEEEeCCCceEEEeecCceec
Q 004580          631 ----------Y-----SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       631 ----------~-----~~~~IiHrDLk~~NILl~~~~~~kL~DFGla~~~  665 (744)
                                +     +++.++|+|+.+.||+++.++-+-|.||+++..-
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                      2     2356999999999999999988999999998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.67  E-value=0.0027  Score=65.81  Aligned_cols=135  Identities=16%  Similarity=0.155  Sum_probs=91.9

Q ss_pred             CcccccccCccCceEEEcccccccceeEEEeccCC--------------------Ch--hhHHHHHHHHHHHHHhcCC--
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--------------------SG--QGLEEFKNEMMLIAKLQHR--  569 (744)
Q Consensus       514 ~y~i~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--------------------~~--~~~~~f~~Ev~~l~~l~Hp--  569 (744)
                      -+.+.++||-|--+-+|.+-..+|++.++|.-+-.                    +.  ...-...+|...|+.|...  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            45677899999999999999888999998854211                    00  0122345688888888532  


Q ss_pred             CeeeEEEEEEEcCeEEEEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEe
Q 004580          570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD  649 (744)
Q Consensus       570 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~IiHrDLk~~NILl~  649 (744)
                      -+.+.++    .+.-++|||++.+-.|...-+      ..+..+   +...+..-+.-|..+|   +||+|..--||+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            2333333    345678999998888755421      122222   3333444455566666   99999999999999


Q ss_pred             CCCceEEEeecCcee
Q 004580          650 MDMNPKISDFGLARM  664 (744)
Q Consensus       650 ~~~~~kL~DFGla~~  664 (744)
                      +++.++++||--...
T Consensus       237 dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVS  251 (465)
T ss_pred             cCCCEEEeechHhhc
Confidence            999999999975543

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.61  E-value=0.0019  Score=52.71  Aligned_cols=51  Identities=16%  Similarity=0.270  Sum_probs=36.2

Q ss_pred             EecccCCCCcceeccccccCHHHHHHHHhccCCeeeccccccCCCcceEEEccc
Q 004580          344 KLDNIRAPDFIEVFLNKSMNLQQCAAECLKNCTCRAYANSNVTEGSGCLMWFGD  397 (744)
Q Consensus       344 ~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~g~~C~~w~~~  397 (744)
                      .+.++.++.+..... ...+.++|++.|+.+|+|.||.|..  +...|+++.+.
T Consensus         8 ~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~--~~~~C~lk~~~   58 (73)
T cd01100           8 QGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT--KSKKCFLKSSE   58 (73)
T ss_pred             ccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC--CCCeEEcccCC
Confidence            334566665433322 2568999999999999999999963  34569998664

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.61  E-value=0.02  Score=59.92  Aligned_cols=31  Identities=26%  Similarity=0.494  Sum_probs=26.1

Q ss_pred             CCeEEecCCCCCEEEeCCCc-eEEEeecCcee
Q 004580          634 FRIIHRDLKASNVLLDMDMN-PKISDFGLARM  664 (744)
Q Consensus       634 ~~IiHrDLk~~NILl~~~~~-~kL~DFGla~~  664 (744)
                      +.++|+|+++.|||++++++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.03  E-value=0.036  Score=59.55  Aligned_cols=80  Identities=15%  Similarity=0.162  Sum_probs=51.1

Q ss_pred             ccCccCceEEEccccccc-ceeEEEeccC-------CChhhHHHHHHHHHHHHHhc--CCCeeeEEEEEEEcCeEEEEEE
Q 004580          520 KLGEGGFGPVYKGRLLNG-QEVAVKRLSS-------QSGQGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       520 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~-------~~~~~~~~f~~Ev~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .||.|....||++...+| +.|+||.-..       .-+...++..-|...|....  -|..|+-+- +.+++...+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence            589999999999987654 5899996421       11344556666777776653  354444332 235666779999


Q ss_pred             ecCCCC-hhhhh
Q 004580          590 YMPNKS-LDVFL  600 (744)
Q Consensus       590 y~~~gs-L~~~l  600 (744)
                      +++... |+..|
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            996543 43433

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.96  E-value=0.015  Score=58.32  Aligned_cols=30  Identities=33%  Similarity=0.506  Sum_probs=21.7

Q ss_pred             CeEEecCCCCCEEE-eCCCceEEEeecCcee
Q 004580          635 RIIHRDLKASNVLL-DMDMNPKISDFGLARM  664 (744)
Q Consensus       635 ~IiHrDLk~~NILl-~~~~~~kL~DFGla~~  664 (744)
                      .++|+|+.+.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.81  E-value=0.03  Score=67.10  Aligned_cols=157  Identities=20%  Similarity=0.203  Sum_probs=110.1

Q ss_pred             HHHHHHHHHHHHHhcCCCeeeEEEEEEEcCeEE----EEEEecCCCChhhhhcCcCCcccCCHHHHHHHHHHHHHHHHHH
Q 004580          553 LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL  628 (744)
Q Consensus       553 ~~~f~~Ev~~l~~l~HpnIv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL  628 (744)
                      ......|...+.++.|+|++.++.+-.+....-    +..|++..-++...+   ..-...+....+.+..++..|++|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence            444566788888999999999999876554332    335566666665555   3445677888889999999999999


Q ss_pred             HhcCCCCeEEecCCCC---CEEEeCCCceEEE--eecCceecCCCccccCcccccccccccCcccccCCCCCc--hhhHH
Q 004580          629 HQYSRFRIIHRDLKAS---NVLLDMDMNPKIS--DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI--KSDVF  701 (744)
Q Consensus       629 H~~~~~~IiHrDLk~~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~Dvw  701 (744)
                      |+..   ..|.-+..+   +-..+.++...+.  ||+..+.+......   .....+..+.|||.........  ..|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence            9985   555555544   4444556666666  88888776543321   1123456788888777665544  47999


Q ss_pred             HHHHHHHHHHcCCCCCC
Q 004580          702 SFGILMLETLSGKKNTG  718 (744)
Q Consensus       702 SlGviL~elltG~~p~~  718 (744)
                      .+|..+..+..|..+-.
T Consensus       377 ~lgll~~~~~~~~~i~~  393 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISE  393 (1351)
T ss_pred             HHHHHHhhhhhcCcccc
Confidence            99999999999987543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.78  E-value=0.071  Score=57.40  Aligned_cols=142  Identities=18%  Similarity=0.247  Sum_probs=79.9

Q ss_pred             cccCccCceEEEcccccc----cceeEEEeccCCChhhHHHHHHHHHHHHHhcCCCee-eEEEEEEEcCeEEEEEEecCC
Q 004580          519 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~f~~Ev~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~  593 (744)
                      +.|..|=--.+|+....+    +..+++|+......... +-.+|..+++.+..-++- ++++++ ..+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence            345446666778775432    23788998765543322 236788899888766664 344444 222   58999987


Q ss_pred             CChhhh-----------------hcCcCC--cc-cCCHHHHHHHHHH----------------------HHHHHHHHH--
Q 004580          594 KSLDVF-----------------LFDPTK--KR-LLGWQARVTIIEG----------------------IAQGLLYLH--  629 (744)
Q Consensus       594 gsL~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~----------------------ia~gl~yLH--  629 (744)
                      ..+..-                 +|....  .. .--+..+.++..+                      +.+-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321                 121110  01 1112222222211                      111122221  


Q ss_pred             --h-cCCCCeEEecCCCCCEEEeC-CCceEEEeecCceec
Q 004580          630 --Q-YSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMF  665 (744)
Q Consensus       630 --~-~~~~~IiHrDLk~~NILl~~-~~~~kL~DFGla~~~  665 (744)
                        . ..+..++|.|+.+.|||+++ ++.++++||..|..-
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence              1 12234799999999999975 578999999988754

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.50  E-value=0.16  Score=55.67  Aligned_cols=73  Identities=11%  Similarity=0.079  Sum_probs=48.8

Q ss_pred             ccccCccCceEEEcccccccceeEEEeccCC-----C--hhhHHHHHHHHHHHHHhc---CCCeeeEEEEEEEcCeEEEE
Q 004580          518 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ-----S--GQGLEEFKNEMMLIAKLQ---HRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       518 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-----~--~~~~~~f~~Ev~~l~~l~---HpnIv~l~~~~~~~~~~~lV  587 (744)
                      .+.||.|....||+... .++.++||+-...     .  +...++-..|...|+.+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            46899999999999876 4567999975421     1  123344445566666553   246667777665  556789


Q ss_pred             EEecCC
Q 004580          588 LEYMPN  593 (744)
Q Consensus       588 ~Ey~~~  593 (744)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.48  E-value=0.11  Score=55.19  Aligned_cols=30  Identities=23%  Similarity=0.315  Sum_probs=25.9

Q ss_pred             CCeEEecCCCCCEEEeCCCceEEEeecCcee
Q 004580          634 FRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       634 ~~IiHrDLk~~NILl~~~~~~kL~DFGla~~  664 (744)
                      ..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            46999999999999987 6789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	744
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-22
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-12
3soa_A	444	Full-Length Human Camkii Length = 444		3e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/238 (40%), Positives = 142/238 (59%), Gaps = 6/238 (2%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE-EFKN 558
           L  FSL  +  A++NFS +  LG GGFG VYKGRL +G  VAVKRL  +  QG E +F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-PTKKRLLGWQARVTI 617
           E+ +I+   HRNL++L G C+   E++L+  YM N S+   L + P  +  L W  R  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
             G A+GL YLH +   +IIHRD+KA+N+LLD +    + DFGLA++    +       +
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN---TGVYNADSFNLLGYVS 732
            GT G+++PEY   G  S K+DVF +G+++LE ++G++      + N D   LL +V 
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  161 bits (407), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/238 (39%), Positives = 140/238 (58%), Gaps = 6/238 (2%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE-EFKN 558
           L  FSL  +  A++NF  +  LG GGFG VYKGRL +G  VAVKRL  +  QG E +F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-PTKKRLLGWQARVTI 617
           E+ +I+   HRNL++L G C+   E++L+  YM N S+   L + P  +  L W  R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
             G A+GL YLH +   +IIHRD+KA+N+LLD +    + DFGLA++    +       +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN---TGVYNADSFNLLGYVS 732
            G  G+++PEY   G  S K+DVF +G+++LE ++G++      + N D   LL +V 
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/215 (42%), Positives = 135/215 (62%), Gaps = 12/215 (5%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG+EEF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD---PTKKRLLGWQARVTIIEGI 621
             +H +LV L+G C E+ E ILI +YM N +L   L+    PT    + W+ R+ I  G 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--MSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-QGNTKRIV-G 679
           A+GL YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++   G EL Q +   +V G
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKG 203
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T GY+ PEY + G  + KSDV+SFG+++ E L  +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/215 (42%), Positives = 135/215 (62%), Gaps = 12/215 (5%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG+EEF+ E+  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD---PTKKRLLGWQARVTIIEGI 621
             +H +LV L+G C E+ E ILI +YM N +L   L+    PT    + W+ R+ I  G 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--MSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-QGNTKRIV-G 679
           A+GL YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++   G EL Q +   +V G
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKG 203
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T GY+ PEY + G  + KSDV+SFG+++ E L  +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/229 (41%), Positives = 127/229 (55%), Gaps = 19/229 (8%)
Query: 497 DSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 551 QGLEE----FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPT 604
              EE    F  E+ ++AK QH NLV+LLG   +  +  L+  YMPN SL   +   D T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
               L W  R  I +G A G+ +LH+      IHRD+K++N+LLD     KISDFGLAR 
Sbjct: 128 PP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                      RIVGT  YM+PE AL G  + KSD++SFG+++LE ++G
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/229 (41%), Positives = 127/229 (55%), Gaps = 19/229 (8%)
Query: 497 DSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 67
Query: 551 QGLEE----FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPT 604
              EE    F  E+ ++AK QH NLV+LLG   +  +  L+  YMPN SL   +   D T
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
               L W  R  I +G A G+ +LH+      IHRD+K++N+LLD     KISDFGLAR 
Sbjct: 128 PP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                      RIVGT  YM+PE AL G  + KSD++SFG+++LE ++G
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 94/229 (41%), Positives = 127/229 (55%), Gaps = 19/229 (8%)
Query: 497 DSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG 550
           D+    FS   +   T NF  +       K+GEGGFG VYKG  +N   VAVK+L++   
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 61
Query: 551 QGLEE----FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPT 604
              EE    F  E+ ++AK QH NLV+LLG   +  +  L+  YMPN SL   +   D T
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
               L W  R  I +G A G+ +LH+      IHRD+K++N+LLD     KISDFGLAR 
Sbjct: 122 PP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                      RIVGT  YM+PE AL G  + KSD++SFG+++LE ++G
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  136 bits (342), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/223 (40%), Positives = 121/223 (54%), Gaps = 19/223 (8%)
Query: 503 FSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEE- 555
           FS   +   T NF  +       K GEGGFG VYKG  +N   VAVK+L++      EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 556 ---FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPTKKRLLG 610
              F  E+ + AK QH NLV+LLG   +  +  L+  Y PN SL   +   D T    L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LS 122
Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
           W  R  I +G A G+ +LH+      IHRD+K++N+LLD     KISDFGLAR       
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                RIVGT  Y +PE AL G  + KSD++SFG+++LE ++G
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 6/210 (2%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNL 571
           + +++ K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V  +G   +     ++ EY+   SL   L     +  L  + R+++   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
           +   I+HRDLK+ N+L+D     K+ DFGL+R+     L   +K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRD 213
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYN 721
              + KSDV+SFG+++ E  + ++  G  N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 116/210 (55%), Gaps = 6/210 (2%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNL 571
           + +++ K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V  +G   +     ++ EY+   SL   L     +  L  + R+++   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
           +   I+HR+LK+ N+L+D     K+ DFGL+R+     L  ++K   GT  +M+PE   D
Sbjct: 157 NP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRD 213
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYN 721
              + KSDV+SFG+++ E  + ++  G  N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLN 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 325
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   T K L   Q  V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 380
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    T R    +   + +PE AL
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 437
Query: 691 DGLFSIKSDVFSFGILMLE 709
            G F+IKSDV+SFGIL+ E
Sbjct: 438 YGRFTIKSDVWSFGILLTE 456

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   T K L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I     + +PE A
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI----KWTAPEAA 353
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 354 LYGRFTIKSDVWSFGILLTE 373

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   T K L   Q  V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 297
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 353
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 354 LYGRFTIKSDVWSFGILLTE 373

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 113/218 (51%), Gaps = 33/218 (15%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRN 570
            +++  +G GGFG VY+   + G EVAVK           Q +E  + E  L A L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR-----LLGWQARVTIIEGIAQGL 625
           ++ L G C+++    L++E+     L+  L   + KR     L+ W  +      IA+G+
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQ------IARGM 118
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNP--------KISDFGLARMFGGDELQGNTK-R 676
            YLH  +   IIHRDLK+SN+L+   +          KI+DFGLAR     E    TK  
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMS 173
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             G Y +M+PE     +FS  SDV+S+G+L+ E L+G+
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/201 (39%), Positives = 109/201 (54%), Gaps = 15/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 242
Query: 573 KLLGCCVEQGEKILIL-EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L     E  E I I+ EYM   SL  FL   T K L   Q  V +   IA G+ Y+   
Sbjct: 243 QLYAVVSE--EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE-- 297
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
            R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE 
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 352
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
           AL G F+IKSDV+SFGIL+ E
Sbjct: 353 ALYGRFTIKSDVWSFGILLTE 373

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 66
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   T K L   Q  V +   IA G+ Y+    
Sbjct: 67  QLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVE--- 121
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT----APEAA 177
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 178 LYGRFTIKSDVWSFGILLTE 197

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 2   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 51
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I + EYM   SL  FL   T K L   Q  
Sbjct: 52  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL- 109
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 110 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 166
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 167 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 200

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 111/216 (51%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++ G   EEF++E ML A+LQH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIE 619
            LLG   +     +I  Y  +  L  FL              D T K  L     V ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTKR 676
            IA G+ YL   S   ++H+DL   NVL+   +N KISD GL R ++  D  +L GN+  
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +    +M+PE  + G FSI SD++S+G+++ E  S
Sbjct: 193 PI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 111/216 (51%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLV 572
           +LGE  FG VYKG L         Q VA+K L  ++ G   EEF++E ML A+LQH N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQARVTIIE 619
            LLG   +     +I  Y  +  L  FL              D T K  L     V ++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTKR 676
            IA G+ YL   S   ++H+DL   NVL+   +N KISD GL R ++  D  +L GN+  
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS-- 207
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +    +M+PE  + G FSI SD++S+G+++ E  S
Sbjct: 208 -LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL + S   +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 184 KSDVWSFGVLMWEVFSEGK 202

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I+I EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 174 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 73
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL   T K L   Q  V +   IA G+ Y+    
Sbjct: 74  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQIASGMAYVE--- 128
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT----APEAA 184
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 185 LYGRFTIKSDVWSFGILLTE 204

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I+I EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 173
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 174 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 6   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 55
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I + EYM   SL  FL   T K L   Q  
Sbjct: 56  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQL- 113
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 114 VDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 170
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 171 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 204

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 65
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 66  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 120
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 176
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 177 LYGRFTIKSDVWSFGILLTE 196

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 67
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 122
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 123 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 178
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 179 LYGRFTIKSDVWSFGILLTE 198

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 187
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 188 LYGRFTIKSDVWSFGILLTE 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV+L G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 186
Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 187 KSDVWSFGVLMWEVFSEGK 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/218 (36%), Positives = 111/218 (50%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I + EYM   SL  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VCEYMSKGSLLDFLKGEMGKYLRLPQL- 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 174 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 183
Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 184 KSDVWSFGVLMWEVFSEGK 202

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L        E F  E  ++ KL+H  LV
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 244 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 298
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGL R+   +E    QG    I  T    +PE A
Sbjct: 299 RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWT----APEAA 354
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 355 LYGRFTIKSDVWSFGILLTE 374

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV+L G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 181
Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 182 KSDVWSFGVLMWEVFSEGK 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV+L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL +     +IHR
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L+  +   K+SDFG+ R    D+   +T    GT     + SPE      +S 
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSS 184
Query: 697 KSDVFSFGILMLETLSGKK 715
           KSDV+SFG+LM E  S  K
Sbjct: 185 KSDVWSFGVLMWEVFSEGK 203

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 112/221 (50%), Gaps = 14/221 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  +  +LG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L      +    +I EYM   SL  FL  D   K LL     +     IA+G+ Y+   
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 127
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYA 689
            R   IHRDL+A+NVL+   +  KI+DFGLAR+   +E    T R    +   + +PE  
Sbjct: 128 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 183
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLL 728
             G F+IKSDV+SFGIL+ E ++  K    G  NAD    L
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/200 (37%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLV 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 187
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 188 LYGRFTIKSDVWSFGILLTE 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/218 (35%), Positives = 111/218 (50%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I ++EYM    L  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VMEYMSKGCLLDFLKGEMGKYLRLPQL- 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 174 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL     K L   Q  V +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   +HRDL A+N+L+  ++  K++DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 132 RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 187
Query: 690 LDGLFSIKSDVFSFGILMLE 709
           L G F+IKSDV+SFGIL+ E
Sbjct: 188 LYGRFTIKSDVWSFGILLTE 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 73  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 130
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 131 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 184
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 73
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 74  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 132 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 185
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 189
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVT 211

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 118/216 (54%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L+  +G +   EF +E +++A + H +LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + L+ + MP+  L  ++ +   K  +G Q  +     IA+G++YL +    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLAR+  GDE + N         +M+ E      F
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T  GK   G+   +  +LL
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 79
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 80  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 137
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 138 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 191
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 80
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 81  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 138
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 139 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 192
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVT 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 78  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 135
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 136 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 189
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVT 211

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 117/216 (54%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L+  +G     EF +E +++A + H +LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + L+ + MP+  L  ++ +   K  +G Q  +     IA+G++YL +    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLAR+  GDE + N         +M+ E      F
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T  GK   G+   +  +LL
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 77  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 134
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 135 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 188
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVT 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 81
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 82  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 139
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +PE   
Sbjct: 140 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 193
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVT 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE 559
           +P  SL  V   +E   +Q ++G G FG V+ G  LN  +VA+K +   S    ++F  E
Sbjct: 15  VPRGSLHMVIDPSELTFVQ-EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEE 72
Query: 560 MMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
             ++ KL H  LV+L G C+EQ    L+ E+M +  L  +L   T++ L   +  + +  
Sbjct: 73  AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCL 130
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            + +G+ YL +     +IHRDL A N L+  +   K+SDFG+ R    D+   +T    G
Sbjct: 131 DVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----G 183
Query: 680 T---YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           T     + SPE      +S KSDV+SFG+LM E  S  K
Sbjct: 184 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/218 (35%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLE 554
            KD+W             E+  ++ KLG+G FG V+ G       VA+K L   +    E
Sbjct: 9   AKDAW---------EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
            F  E  ++ KL+H  LV+L     E+   I + EYM    L  FL     K L   Q  
Sbjct: 59  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGCLLDFLKGEMGKYLRLPQL- 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---Q 671
           V +   IA G+ Y+    R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E    Q
Sbjct: 117 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
           G    I  T    +PE AL G F+IKSDV+SFGIL+ E
Sbjct: 174 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTE 207

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 66
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLY 627
           +L    V Q    +I EYM N SL  FL  P     T  +LL   A+      IA+G+ +
Sbjct: 67  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAF 119
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMS 685
           + + +    IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +
Sbjct: 120 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTA 173
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE    G F+IKSDV+SFGIL+ E ++
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/203 (36%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  +  +LG G FG V+ G      +VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLV 67
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL D  + R L     V +   +A G+ Y+    
Sbjct: 68  QLYAVVSEEPIYI-VTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE--- 122
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEYA 689
           R   IHRDL+++N+L+   +  KI+DFGLAR+   +E    QG    I  T    +PE A
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT----APEAA 178
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
           L G F+IKSDV+SFGIL+ E ++
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVT 201

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 114/221 (51%), Gaps = 14/221 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  +  KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LV
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 70
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L     ++    +I E+M   SL  FL  D   K LL     +     IA+G+ Y+   
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE-- 126
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYA 689
            R   IHRDL+A+NVL+   +  KI+DFGLAR+   +E    T R    +   + +PE  
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 182
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLL 728
             G F+IKS+V+SFGIL+ E ++  K    G  NAD  + L
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/207 (36%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDP-----TKKRLLGWQARVTIIEGIAQGLLY 627
           +L    V Q    +I EYM N SL  FL  P     T  +LL   A+      IA+G+ +
Sbjct: 68  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAF 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMS 685
           + + +    IHR+L+A+N+L+   ++ KI+DFGLAR+   +E    T R    +   + +
Sbjct: 121 IEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTA 174
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE    G F+IKSDV+SFGIL+ E ++
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G  G V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L    V Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+    E    T R    +   + +PE   
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LGEG FG V   R        G++VAVK L  +SG   + + K E+ ++  L H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQ 630
            G C E G     LI+E++P+ SL  +L  P  K  +  + ++     I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK--RIVGTYGYMSPEY 688
           Y     +HRDL A NVL++ +   KI DFGL +    D+     K  R    + Y +PE 
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
            +   F I SDV+SFG+ + E L+
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKL 574
           LGEG FG V   R        G++VAVK L  +SG   + + K E+ ++  L H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL--HQ 630
            G C E G     LI+E++P+ SL  +L  P  K  +  + ++     I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK--RIVGTYGYMSPEY 688
           Y     +HRDL A NVL++ +   KI DFGL +    D+     K  R    + Y +PE 
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
            +   F I SDV+SFG+ + E L+
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+      LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 78
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARV 615
           H+++V+  G C E    +++ EYM +  L+ FL    P  K L          LG    +
Sbjct: 79  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   +A G++YL   +    +HRDL   N L+   +  KI DFG++R     +      
Sbjct: 139 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           R +    +M PE  L   F+ +SDV+SFG+++ E  +  K 
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+      LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 72
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARV 615
           H+++V+  G C E    +++ EYM +  L+ FL    P  K L          LG    +
Sbjct: 73  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   +A G++YL   +    +HRDL   N L+   +  KI DFG++R     +      
Sbjct: 133 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           R +    +M PE  L   F+ +SDV+SFG+++ E  +  K 
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    ++ EYMP  +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYLEKKN 150
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 207 TFSIKSDVWAFGVLLWE 223

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+      LL  Q+   VAVK L   S    ++F+ E  L+  LQ
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 101
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRL----------LGWQARV 615
           H+++V+  G C E    +++ EYM +  L+ FL    P  K L          LG    +
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   +A G++YL   +    +HRDL   N L+   +  KI DFG++R     +      
Sbjct: 162 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           R +    +M PE  L   F+ +SDV+SFG+++ E  +  K 
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           F+P+   +  L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 228

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 232

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 161
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 162 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 131 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 233

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 128
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 129 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 227

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 232

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 135
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 136 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 234

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 236

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 131 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 136
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 137 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 235

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 149 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKK----RLLGWQARVTIIEGIAQGLLYL 628
            G C   G +   LI+EY+P  SL  +L    ++    +LL + ++      I +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPE 687
                 R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE
Sbjct: 149 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 247

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 115/228 (50%), Gaps = 25/228 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHRN 570
           FS   ++G G FG VY  R + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
            ++  GC + +    L++EY    + D+       K+ L       +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM--FGGDELQGNTKRIVGTYGYMSPEY 688
           ++   +IHRD+KA N+LL        S+ GL ++  FG   +       VGT  +M+PE 
Sbjct: 134 HN---MIHRDVKAGNILL--------SEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEV 182
Query: 689 AL---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN 733
            L   +G +  K DV+S GI  +E    ++   ++N ++ + L +++ 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQ 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 254

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 258

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           KL    V +    +I E+M   SL  FL  D   K+ L     +     IA+G+ ++ Q 
Sbjct: 247 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYA 689
           +    IHRDL+A+N+L+   +  KI+DFGLAR+   +E    T R    +   + +PE  
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 357
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
             G F+IKSDV+SFGIL++E ++
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVT 380

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 21/226 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQHRN 570
           FS   ++G G FG VY  R + N + VA+K++S    QS +  ++   E+  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
            ++  GC + +    L++EY    + D+       K+ L       +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           ++   +IHRD+KA N+LL      K+ DFG A       +       VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 223
Query: 691 ---DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN 733
              +G +  K DV+S GI  +E    ++   ++N ++ + L +++ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQ 267

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           KL     ++   I I E+M   SL  FL  D   K+ L     +     IA+G+ ++ Q 
Sbjct: 74  KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 130
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYA 689
           +    IHRDL+A+N+L+   +  KI+DFGLAR+   +E    T R    +   + +PE  
Sbjct: 131 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAI 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
             G F+IKSDV+SFGIL++E ++
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVT 207

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 257

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 113/205 (55%), Gaps = 17/205 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E + +  +LG+G FG VYK +    G   A K + ++S + LE++  E+ ++A   H  +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           VKLLG     G+  +++E+ P  ++D  + +   + L   Q +V +   + + L +LH  
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK 136
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYA 689
              RIIHRDLKA NVL+ ++ + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 690 L-----DGLFSIKSDVFSFGILMLE 709
           +     D  +  K+D++S GI ++E
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIE 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+E++P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 232

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 113/205 (55%), Gaps = 17/205 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E + +  +LG+G FG VYK +    G   A K + ++S + LE++  E+ ++A   H  +
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           VKLLG     G+  +++E+ P  ++D  + +   + L   Q +V +   + + L +LH  
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-VCRQMLEALNFLHSK 128
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYA 689
              RIIHRDLKA NVL+ ++ + +++DFG++       L+   KR   +GT  +M+PE  
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 690 L-----DGLFSIKSDVFSFGILMLE 709
           +     D  +  K+D++S GI ++E
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIE 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 521 LGEGGFG--------PVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNL 571
           LGEG FG        P   G    G+ VAVK L +  G Q    +K E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 572 VKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           +K  GCC +QGEK L  ++EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEY 688
                  IHR+L A NVLLD D   KI DFGLA+    G E     +       + +PE 
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +  F   SDV+SFG+ + E L+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I+E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 136
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 193 KFSIKSDVWAFGVLLWE 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I+E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 521 LGEGGFG--------PVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNL 571
           LGEG FG        P   G    G+ VAVK L +  G Q    +K E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 572 VKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           +K  GCC +QGEK L  ++EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEY 688
                  IHR+L A NVLLD D   KI DFGLA+    G E     +       + +PE 
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +  F   SDV+SFG+ + E L+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I+E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +     +VAVK L S + +  L +  +EM ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L           ++P+   +  L  +  V+ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR     +    T   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV   + F LL
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I+E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 186 KFSIKSDVWAFGVLLWE 202

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 117/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
              NT        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHRDL   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGLAR+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G FG VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 186 KFSIKSDVWAFGVLLWE 202

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I+E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 132
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 189 KFSIKSDVWAFGVLLWE 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 136
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 193 KFSIKSDVWAFGVLLWE 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 521 LGEGGFG--------PVYKGRLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNL 571
           LGEG FG        P   G    G+ VAVK L    G  L   ++ E+ ++  L H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 572 VKLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           VK  GCC +QGEK   L++EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEY 688
                  IHR L A NVLLD D   KI DFGLA+    G E     +       + +PE 
Sbjct: 130 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +  F   SDV+SFG+ + E L+
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 136
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 193 KFSIKSDVWAFGVLLWE 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 521 LGEGGFG--------PVYKGRLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNL 571
           LGEG FG        P   G    G+ VAVK L    G  L   ++ E+ ++  L H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 572 VKLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           VK  GCC +QGEK   L++EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEY 688
                  IHR L A NVLLD D   KI DFGLA+    G E     +       + +PE 
Sbjct: 129 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +  F   SDV+SFG+ + E L+
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 129
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 186 KFSIKSDVWAFGVLLWE 202

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 77  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 129
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 132
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 102 KP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIH 154
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 215 FQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 80  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 132
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 135
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 192 KFSIKSDVWAFGVLLWE 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 131
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 188 KFSIKSDVWAFGVLLWE 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIH 155
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 108/199 (54%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 127
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 136
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 193 KFSIKSDVWAFGVLLWE 209

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQG 624
            N+++L G   +    +++ EYM N SLD FL       T  +L+G      ++ GIA G
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG------MLRGIASG 130
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGY 683
           + YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R       +
Sbjct: 131 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
            SPE      F+  SDV+S+GI++ E +S
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 521 LGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L QH N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTIIEGIAQGL 625
            LLG C   G  ++I EY     L  FL        D    R L  +  +     +AQG+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKRIVGTYG 682
            +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN +  V    
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---K 219
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 13/218 (5%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQH N+VK 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALD 691
             R IHR+L   N+L++ +   KI DFGL ++   D+     K        + +PE   +
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 692 GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
             FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 230

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 144
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 145 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 201 KFSIKSDVWAFGVLLWE 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 95  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIH 147
Query: 639 RDLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL---D 691
           RDLK++N+ L  D+  KI DFGLA    R  G  + +    ++ G+  +M+PE       
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 203
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +S +SDV++FGI++ E ++G+
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL---------------------FDPT 604
           + H +++KL G C + G  +LI+EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
            +R L     ++    I+QG+ YL + S   ++HRDL A N+L+      KISDFGL+R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FGGDELQGNTKRIVG--TYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFG+L+ E  TL G    G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 NADSFNLL 728
               FNLL
Sbjct: 258 PERLFNLL 265

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 133
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 190 KFSIKSDVWAFGVLLWE 206

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 155
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 133
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 190 KFSIKSDVWAFGVLLWE 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 567 -QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTII 618
            QH N+V LLG C   G  ++I EY     L  FL        D    R L  +  +   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTK 675
             +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN +
Sbjct: 167 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             V    +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 224 LPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 75  KP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 127
Query: 639 RDLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL---D 691
           RDLK++N+ L  D+  KI DFGLA    R  G  + +    ++ G+  +M+PE       
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 183
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +S +SDV++FGI++ E ++G+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
              +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 75  AP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---IIH 127
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFS 695
           RDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 696 IKSDVFSFGILMLETLSGK 714
            +SDV++FGI++ E ++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 580 EQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +  +  ++ ++    SL   L    TK  ++     + I    AQG+ YLH  S   IIH
Sbjct: 103 KP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIH 155
Query: 639 RDLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL---D 691
           RDLK++N+ L  D+  KI DFGLA    R  G  + +    ++ G+  +M+PE       
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 211
Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +S +SDV++FGI++ E ++G+
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL---------------------FDPT 604
           + H +++KL G C + G  +LI+EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
            +R L     ++    I+QG+ YL   +  +++HRDL A N+L+      KISDFGL+R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FGGDELQGNTKRIVG--TYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFG+L+ E  TL G    G+ 
Sbjct: 200 VY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 NADSFNLL 728
               FNLL
Sbjct: 258 PERLFNLL 265

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQG 624
            N+++L G   +    +++ EYM N SLD FL       T  +L+G      ++ GIA G
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG------MLRGIASG 147
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGY 683
           + YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R       +
Sbjct: 148 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 204
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
            SPE      F+  SDV+S+GI++ E +S
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 136
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 193 KFSIKSDVWAFGVLLWE 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +  +  ++ ++    SL   L     K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 79  KP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFSI 696
           DLK++N+ L  D   KI DFGLA +          +++ G+  +M+PE         +S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 697 KSDVFSFGILMLETLSGK 714
           +SDV++FGI++ E ++G+
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V   R  + G++VAVK +  +  Q  E   NE++++   QH N+V++   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L     D   +  L  +   T+ E + Q L YLH      +I
Sbjct: 111 YLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL +D   K+SDFG       D      K +VGT  +M+PE     L++ +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 222 VDIWSLGIMVIEMVDGE 238

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN 338
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHR+L A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 394
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 395 KFSIKSDVWAFGVLLWE 411

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ EYM N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--LNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N  +   LGEG FG V K     L G+     VAVK L  + S   L +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL---------------------FDPT 604
           + H +++KL G C + G  +LI+EY    SL  FL                      D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
            +R L     ++    I+QG+ YL   +  +++HRDL A N+L+      KISDFGL+R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 665 FGGDELQGNTKRIVG--TYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVY 720
               E     KR  G     +M+ E   D +++ +SDV+SFG+L+ E  TL G    G+ 
Sbjct: 200 VY--EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 721 NADSFNLL 728
               FNLL
Sbjct: 258 PERLFNLL 265

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           KL     ++   I I E+M   SL  FL  D   K+ L     +     IA+G+ ++ Q 
Sbjct: 241 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 297
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
           +    IHRDL+A+N+L+   +  KI+DFGLAR+     ++           + +PE    
Sbjct: 298 N---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINF 343
Query: 692 GLFSIKSDVFSFGILMLETLS 712
           G F+IKSDV+SFGIL++E ++
Sbjct: 344 GSFTIKSDVWSFGILLMEIVT 364

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 33/227 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSSQSGQGLEEFKNEMMLIAKL 566
            N  ++ +LGEG FG V+     N    Q+   VAVK L   S    ++F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLLGWQA 613
           QH ++VK  G CVE    I++ EYM +  L+ FL               PT+   L    
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE---LTQSQ 129
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
            + I + IA G++YL   +    +HRDL   N L+  ++  KI DFG++R    D    +
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTD 182
Query: 674 TKRIVG----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
             R+ G       +M PE  +   F+ +SDV+S G+++ E  +  K 
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 112/208 (53%), Gaps = 29/208 (13%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--Y 688
            +  + +HRDL A N +LD     K++DFGLAR    D L      +    G   P    
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMLDKEFDSVHNKTGAKLPVKWM 205
Query: 689 ALDGL----FSIKSDVFSFGILMLETLS 712
           AL+ L    F+ KSDV+SFG+L+ E ++
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNTKRIVG-TYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR M+  +    + K        +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +  +  ++ ++    SL   L     K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  KP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 640 DLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
           DLK++N+ L  D   KI DFGLA    R  G  + +    ++ G+  +M+PE        
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDSN 200
Query: 693 LFSIKSDVFSFGILMLETLSGK 714
            +S +SDV++FGI++ E ++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 133
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD              + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 189
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 190 KFSIKSDVWAFGVLLWE 206

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 132
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL A N L+  +   K++DFGL+R+  GD              + +PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 188
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 189 KFSIKSDVWAFGVLLWE 205

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 12/216 (5%)
Query: 504 SLAS-VAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQS---GQGLEEFKN 558
           SLA+ +    E+F +   LG+G F  VY+   ++ G EVA+K +  ++      ++  +N
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           E+ +  +L+H ++++L     +     L+LE   N  ++ +L +  K      +AR   +
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEAR-HFM 118
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             I  G+LYLH +    I+HRDL  SN+LL  +MN KI+DFGLA        +  T  + 
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y+SPE A      ++SDV+S G +    L G+
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++  +G   
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
              +  ++ ++    SL   L     K     +  + I    A+G+ YLH  S   IIHR
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 640 DLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
           DLK++N+ L  D   KI DFGLA    R  G  + +    ++ G+  +M+PE        
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDSN 200
Query: 693 LFSIKSDVFSFGILMLETLSGK 714
            +S +SDV++FGI++ E ++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN--GQEV--AVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG VY G LL+  G+++  AVK L+  +  G + +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G C+  +G  +++L YM +  L  F+     +PT K L+G+  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEY 688
            +  + +HRDL A N +LD     K++DFGLAR     E     N         +M+ E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+ KSDV+SFG+L+ E ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 518 QCKLGEGGFGPVYKGRLLNGQ-----EVAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNL 571
           Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++L G   +    ++I EYM N +LD FL +  K         V ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYAL 690
           +    +HRDL A N+L++ ++  K+SDFGL+R+   D E    T        + +PE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              F+  SDV+SFGI+M E ++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +LLG C  +    +I E+M   +L  +L +  ++ +      + +   I+  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQISSAMEYLEKKN 377
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHR+L A N L+  +   K++DFGL+R+  GD    +         + +PE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 433
Query: 693 LFSIKSDVFSFGILMLE 709
            FSIKSDV++FG+L+ E
Sbjct: 434 KFSIKSDVWAFGVLLWE 450

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       +  Q     +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSEMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 260
Query: 728 L 728
           L
Sbjct: 261 L 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 728 L 728
           L
Sbjct: 318 L 318

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 263
Query: 728 L 728
           L
Sbjct: 264 L 264

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   +I+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       ++ + +T  +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 113/233 (48%), Gaps = 28/233 (12%)
Query: 521 LGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKL-QHRN 570
           LGEG FG V         K +      VAVK L   + +  L +  +EM ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQARVTI 617
           ++ LLG C + G   +I+EY    +L  +L              +   +  + ++  V+ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +    T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F LL
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 259

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 123/241 (51%), Gaps = 25/241 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQG-------LEEFKNEMML 562
           A      + ++G+GGFG V+KGRL+  +  VA+K L     +G        +EF+ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           ++ L H N+VKL G         +++E++P   L   L D  K   + W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLD-MDMN----PKISDFGLARMFGGDELQGNTKRI 677
            G+ Y+ Q     I+HRDL++ N+ L  +D N     K++DFGL++     +   +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 678 VGTYGYMSPEY--ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS 735
           +G + +M+PE   A +  ++ K+D +SF +++   L+G+     Y+      +  +  + 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 736 L 736
           L
Sbjct: 247 L 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQH 568
            E +++ C LG+G FG V K +  +  QE AVK ++  S +  +      E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLY 627
            N++KL     +     ++ E      L    FD   K++         II+ +  G+ Y
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 628 LHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYG 682
           +H+++   I+HRDLK  N+LL   + D + KI DFGL+  F     Q NTK    +GT  
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAY 188
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL 740
           Y++PE  L G +  K DV+S G+++   LSG      Y  + +++L  V      F L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDL 243

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G +G VY GR L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLDVFL---FDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           E G   + +E +P  SL   L   + P K  ++ +G+  +      I +GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN--- 141
Query: 635 RIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           +I+HRD+K  NVL++      KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 694 --FSIKSDVFSFGILMLETLSGK 714
             +   +D++S G  ++E  +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQH 568
            E +++ C LG+G FG V K +  +  QE AVK ++  S +  +      E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLY 627
            N++KL     +     ++ E      L    FD   K++         II+ +  G+ Y
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 628 LHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYG 682
           +H+++   I+HRDLK  N+LL   + D + KI DFGL+  F     Q NTK    +GT  
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAY 188
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL 740
           Y++PE  L G +  K DV+S G+++   LSG      Y  + +++L  V      F L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDL 243

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       +  Q     +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEM 560
           L S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +++ + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
             Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       +  Q     +VGT
Sbjct: 126 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGT 180
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE      +  K D++S GI+ +E + G+
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V  GRL + GQ    VA+K L +  + +   +F +E  ++ +  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G        +++ EYM N SLD FL   T          V ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPEYA 689
            +HRDL A NVL+D ++  K+SDFGL+R+   D     T     T G      + +PE  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT-----TTGGKIPIRWTAPEAI 226
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FS  SDV+SFG++M E L+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
           L H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
           L H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQ-EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G +G VY GR L+ Q  +A+K +  +  +  +    E+ L   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 580 EQGEKILILEYMPNKSLDVFL---FDPTK--KRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           E G   + +E +P  SL   L   + P K  ++ +G+  +      I +GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLHDN--- 127
Query: 635 RIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           +I+HRD+K  NVL++      KISDFG ++   G  +   T+   GT  YM+PE    G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 694 --FSIKSDVFSFGILMLETLSGK 714
             +   +D++S G  ++E  +GK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 16/225 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V L+     +    L+ E+M  K L   L D  K  L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +   RI+HRDLK  N+L++ D   K++DFGLAR F G  ++  T  +V T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKK-NTGVYNADS----FNLLG 729
               +S   D++S G +  E ++GK    GV + D     F++LG
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 521 LGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG------------ 620
            LLG C   G  ++I EY     L  FL    K R+L       I               
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 621 -IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKR 676
            +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN + 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            V    +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 229 PV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 12/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E F +  KLGEG +G VYK      GQ VA+K++  +S   L+E   E+ ++ +    ++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHV 86
Query: 572 VKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           VK  G   +  +  +++EY    S+ D+      + + L      TI++   +GL YLH 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH- 142
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R IHRD+KA N+LL+ + + K++DFG+A        + N   ++GT  +M+PE   
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQ 198
Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
           +  ++  +D++S GI  +E   GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V  GRL + GQ    VA+K L +  + +   +F +E  ++ +  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G        +++ EYM N SLD FL   T          V ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPEYA 689
            +HRDL A NVL+D ++  K+SDFGL+R+   D     T     T G      + +PE  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAI 226
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FS  SDV+SFG++M E L+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQG 624
            N+++L G   +    +++ E M N SLD FL       T  +L+G      ++ GIA G
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG------MLRGIASG 130
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGY 683
           + YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R       +
Sbjct: 131 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
            SPE      F+  SDV+S+GI++ E +S
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 521 LGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG------------ 620
            LLG C   G  ++I EY     L  FL    K R+L       I               
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 621 -IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKR 676
            +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN + 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            V    +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 229 PV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ E M N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 521 LGEGGFG--------PVYKGRLLNGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNL 571
           LGEG FG        P   G    G+ VAVK L + +G Q    +K E+ ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 572 VKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           +K  GCC + G   L  ++EY+P  SL  +L     +  +G    +   + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEY 688
                  IHRDL A NVLLD D   KI DFGLA+    G E     +       + +PE 
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
             +  F   SDV+SFG+ + E L+
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE--FKNEMMLIAKLQH 568
            E +++ C LG+G FG V K +  +  QE AVK ++  S +  +      E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT-KKRLLGWQARVTIIEGIAQGLLY 627
            N++KL     +     ++ E      L    FD   K++         II+ +  G+ Y
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 628 LHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI--VGTYG 682
           +H+++   I+HRDLK  N+LL   + D + KI DFGL+  F     Q NTK    +GT  
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAY 188
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYL 740
           Y++PE  L G +  K DV+S G+++   LSG      Y  + +++L  V      F L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDL 243

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 16/225 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+ VA+KR+      +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V L+     +    L+ E+M  K L   L D  K  L   Q ++ + + + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +   RI+HRDLK  N+L++ D   K++DFGLAR F G  ++  T  +V T  Y +P+  +
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADS----FNLLG 729
               +S   D++S G +  E ++GK    GV + D     F++LG
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQH 568
           N S+   +G G FG V  GRL   + +E++V   + + G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE------GIA 622
            N+++L G   +    +++ E M N SLD FL    +K      A+ T+I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKH----DAQFTVIQLVGMLRGIA 157
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-Y 681
            G+ YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            + SPE      F+  SDV+S+GI++ E +S
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   +    ++I EYM N SLD FL      R    Q  V ++ GI  G+ YL   S   
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQL-VGMLRGIGSGMKYLSDMS--- 151
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYALDGLF 694
            +HRDL A N+L++ ++  K+SDFG++R+   D     T R       + +PE      F
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 695 SIKSDVFSFGILMLETLS 712
           +  SDV+S+GI+M E +S
Sbjct: 212 TSASDVWSYGIVMWEVMS 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+ Y    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +  ++G G FG VYKG+      V + ++   + +  + F+NE+ ++ K +H N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 577 CCVEQGEKILILEYMPNKSLDVFL-FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
              +    I + ++    SL   L    TK ++      + I    AQG+ YLH  +   
Sbjct: 100 YMTKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQGMDYLHAKN--- 152
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLA----RMFGGDELQGNTKRIVGTYGYMSPEYAL- 690
           IIHRD+K++N+ L   +  KI DFGLA    R  G  +++  T    G+  +M+PE    
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSVLWMAPEVIRM 208
Query: 691 --DGLFSIKSDVFSFGILMLETLSGK 714
             +  FS +SDV+S+GI++ E ++G+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 521 LGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTK--KRLLGWQARVTIIE 619
            LLG C   G  ++I EY     L  FL           ++P+   +  L  +  +    
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNTKR 676
            +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR    D    ++GN + 
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            V    +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 231 PV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   +    ++I EYM N SLD FL      R    Q  V ++ GI  G+ YL   S   
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQL-VGMLRGIGSGMKYLSDMS--- 130
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYALDGLF 694
            +HRDL A N+L++ ++  K+SDFG++R+   D     T R       + +PE      F
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 695 SIKSDVFSFGILMLETLS 712
           +  SDV+S+GI+M E +S
Sbjct: 191 TSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  GRL + G+    VA+K L +  + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   +    ++I EYM N SLD FL      R    Q  V ++ GI  G+ YL   S   
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQL-VGMLRGIGSGMKYLSDMS--- 136
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYALDGLF 694
            +HRDL A N+L++ ++  K+SDFG++R+   D     T R       + +PE      F
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 695 SIKSDVFSFGILMLETLS 712
           +  SDV+S+GI+M E +S
Sbjct: 197 TSASDVWSYGIVMWEVMS 214

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 174
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 690 L-DGLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 690 L-DGLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +  ++ +LGEG FG V+     N         VAVK L   +    ++F+ E  L+  LQ
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLGWQAR----------- 614
           H ++VK  G C +    I++ EYM +  L+ FL    P    L+  Q R           
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
           + I   IA G++YL   +    +HRDL   N L+  ++  KI DFG++R    D    + 
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDY 188
Query: 675 KRIVG----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
            R+ G       +M PE  +   F+ +SDV+SFG+++ E  +  K 
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGRL-LNGQE---VAVKRLS-SQSGQGLEEFKNEMMLIAKLQHR 569
            +++  +G G FG V  GRL L G+    VA+K L    + +   +F  E  ++ +  H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGL 625
           N++ L G   +    +++ EYM N SLD FL       T  +L+G      ++ GI+ G+
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVG------MLRGISAGM 137
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYM 684
            YL   S    +HRDL A N+L++ ++  K+SDFGL+R+   D     T R       + 
Sbjct: 138 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
           +PE      F+  SDV+S+GI+M E +S
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 25/241 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQG-------LEEFKNEMML 562
           A      + ++G+GGFG V+KGRL+  +  VA+K L     +G        +EF+ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           ++ L H N+VKL G         +++E++P   L   L D  K   + W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLD-MDMN----PKISDFGLARMFGGDELQGNTKRI 677
            G+ Y+ Q     I+HRDL++ N+ L  +D N     K++DFG ++     +   +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 678 VGTYGYMSPEY--ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS 735
           +G + +M+PE   A +  ++ K+D +SF +++   L+G+     Y+      +  +  + 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 736 L 736
           L
Sbjct: 247 L 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSS-QSGQGLEEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L    S Q   +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVK 573
           F +   +G G +G VYKGR +   ++A  ++   +G   EE K E+ ++ K   HRN+  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 574 LLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
             G  +++       +  L++E+    S+   L   TK   L  +    I   I +GL +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LHQ+   ++IHRD+K  NVLL  +   K+ DFG++     D   G     +GT  +M+PE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 199
Query: 688 YAL-----DGLFSIKSDVFSFGILMLETLSG 713
                   D  +  KSD++S GI  +E   G
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 28/241 (11%)
Query: 513 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLI 563
           +  ++   LGEG FG V         K +      VAVK L   + +  L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+ Y    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
               T        +M+PE   D +++ +SDV+SFG+LM E  TL G    G+   + F L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 728 L 728
           L
Sbjct: 272 L 272

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 209
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 194
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G G FG V K +    ++VA+K++ S+S +  + F  E+  ++++ H N+VKL G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 581 QGEKILILEYMPNKSLDVFLF--DP----TKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                L++EY    SL   L   +P    T    + W  + +      QG+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLHSMQPK 125
Query: 635 RIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
            +IHRDLK  N+LL       KI DFG A      ++Q +     G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 694 FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN 733
           +S K DVFS+GI++ E ++ +K        +F ++  V N
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 122/248 (49%), Gaps = 32/248 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSS-QSGQGLEEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARV 615
            N++ LLG C  +G   L +EY P+ +L  FL        DP      +    L  Q  +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                +A+G+ YL   S+ + IHRDL A N+L+  +   KI+DFGL+R   G E+    K
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 187
Query: 676 RIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--G 729
           + +G     +M+ E     +++  SDV+S+G+L+ E  +L G    G+  A+ +  L  G
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 247
Query: 730 YVSNKSLH 737
           Y   K L+
Sbjct: 248 YRLEKPLN 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF--GGDELQGNTKR 676
           A G  YL +      IHRD+ A N LL         KI DFG+AR     G   +G    
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +     +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 248 L--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E  ++  +LG G FG V  G+     +VAVK +   S    +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           K  G C ++    ++ EY+ N  L  +L    K   L     + +   + +G+ +L  + 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH- 123
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYA 689
             + IHRDL A N L+D D+  K+SDFG+ R    D+   +    VGT     + +PE  
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF 177
Query: 690 LDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN 721
               +S KSDV++FGILM E  S GK    +Y 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 25/241 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQG-------LEEFKNEMML 562
           A      + ++G+GGFG V+KGRL+  +  VA+K L     +G        +EF+ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           ++ L H N+VKL G         +++E++P   L   L D  K   + W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLD-MDMN----PKISDFGLARMFGGDELQGNTKRI 677
            G+ Y+ Q     I+HRDL++ N+ L  +D N     K++DF L++     +   +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 678 VGTYGYMSPEY--ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS 735
           +G + +M+PE   A +  ++ K+D +SF +++   L+G+     Y+      +  +  + 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 736 L 736
           L
Sbjct: 247 L 247

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G G FG V K +    ++VA+K++ S+S +  + F  E+  ++++ H N+VKL G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 581 QGEKILILEYMPNKSLDVFLF--DP----TKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                L++EY    SL   L   +P    T    + W  + +      QG+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLHSMQPK 124
Query: 635 RIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
            +IHRDLK  N+LL       KI DFG A      ++Q +     G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 694 FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN 733
           +S K DVFS+GI++ E ++ +K        +F ++  V N
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMF--GGDELQGNTKR 676
           A G  YL +      IHRD+ A N LL         KI DFG+AR     G   +G    
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +     +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 225 L--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 521 LGEGGFGPVYKGR---LLNGQE---VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVK 573
           +GEG FG V++ R   LL  +    VAVK L  ++   ++ +F+ E  L+A+  + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVT---------- 616
           LLG C       L+ EYM    L+ FL   +   +       L  +ARV+          
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 617 ----IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQ 671
               I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFGL+R ++  D  +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +    +    +M PE      ++ +SDV+++G+++ E  S
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 116/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 140
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 200
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 201 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 120/246 (48%), Gaps = 30/246 (12%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQ--SGQGLEEFKN 558
           L  V    + F++   LG+G FG V + +L        +VAVK L +   +   +EEF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRL---- 608
           E   + +  H ++ KL+G  +    K      ++IL +M +  L  FL      R+    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENP 131
Query: 609 --LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MF 665
             L  Q  V  +  IA G+ YL   S    IHRDL A N +L  DM   ++DFGL+R ++
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 666 GGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN--TGVYNA 722
            GD   QG   ++     +++ E   D L+++ SDV++FG+ M E ++  +    G+ NA
Sbjct: 189 SGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 723 DSFNLL 728
           + +N L
Sbjct: 247 EIYNYL 252

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 121/248 (48%), Gaps = 32/248 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSS-QSGQGLEEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARV 615
            N++ LLG C  +G   L +EY P+ +L  FL        DP      +    L  Q  +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                +A+G+ YL Q    + IHRDL A N+L+  +   KI+DFGL+R   G E+    K
Sbjct: 146 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 197
Query: 676 RIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--G 729
           + +G     +M+ E     +++  SDV+S+G+L+ E  +L G    G+  A+ +  L  G
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
Query: 730 YVSNKSLH 737
           Y   K L+
Sbjct: 258 YRLEKPLN 265

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 219
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 116/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 137
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 198 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 229
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 116/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 199 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + +++E M    L  FL +    P++   L     + +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 137
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 198 THQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + +++E M    L  FL +    P++   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+AR    D  + +  R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +LG+G FG VYK +  N +     A K + ++S + LE++  E+ ++A   H N+VKLL 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    +++E+    ++D  + +  ++ L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL 690
           IHRDLKA N+L  +D + K++DFG++          NT+ I      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
                D  +  K+DV+S GI ++E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +LG+G FG VYK +  N +     A K + ++S + LE++  E+ ++A   H N+VKLL 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    +++E+    ++D  + +  ++ L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL 690
           IHRDLKA N+L  +D + K++DFG++          NT+ I      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
                D  +  K+DV+S GI ++E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 29/204 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQE---VAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           +LG+G FG VYK +  N +     A K + ++S + LE++  E+ ++A   H N+VKLL 
Sbjct: 44  ELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    +++E+    ++D  + +  ++ L   Q +V + +     L YLH     +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQV-VCKQTLDALNYLHDN---KI 156
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL 690
           IHRDLKA N+L  +D + K++DFG++          NT+ I      +GT  +M+PE  +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
                D  +  K+DV+S GI ++E
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIE 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLN-GQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
           N      LG G FG V +      G+E     VAVK L S+      E   +E+ +++ L
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 567 -QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--------------------FDPTK 605
            QH N+V LLG C   G  ++I EY     L  FL                     D   
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 606 KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF 665
            R L  +  +     +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 666 GGDE---LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             D    ++GN +  V    +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 209 MNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  G L L G+    VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           G   +    ++I E+M N SLD FL       T  +L+G      ++ GIA G+ YL   
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 151
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSPEY 688
           +    +HRDL A N+L++ ++  K+SDFGL+R    D         +G      + +PE 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+  SDV+S+GI+M E +S
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 115/226 (50%), Gaps = 23/226 (10%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LGEG FG V +G L        +VAVK  +L + S + +EEF +E   +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 575 LGCCVEQGEK-----ILILEYMPNKSLDVFLFDP---TKKRLLGWQARVTIIEGIAQGLL 626
           LG C+E   +     ++IL +M    L  +L      T  + +  Q  +  +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDEL-QGNTKRIVGTYGYM 684
           YL   S    +HRDL A N +L  DM   ++DFGL+ +++ GD   QG   ++     ++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWI 216
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + E   D +++ KSDV++FG+ M E  T       GV N + ++ L
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 513 ENFSMQCKLGEGGFGPVY--KGRLLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQ 567
           E + +  KLG GG   VY  +  +LN + VA+K +     +  + L+ F+ E+   ++L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H+N+V ++    E     L++EY+   +L  ++        L     +     I  G+ +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H     RI+HRD+K  N+L+D +   KI DFG+A+      L   T  ++GT  Y SPE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPE 182
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
            A        +D++S GI++ E L G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ---GLEEFK 557
           +F   S A  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +     E   
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARV 615
            E+ L+ +L H N++KL     ++G   L+ E      L    FD   ++KR     A  
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-A 135
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQG 672
            II  +  G+ Y+H   + +I+HRDLK  N+LL+    D N +I DFGL+  F   E   
Sbjct: 136 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 189
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             K  +GT  Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 190 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+   RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++  T  +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L++     K+SDFGL+R    DE   +    VG+     +  PE  +   FS 
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 184
Query: 697 KSDVFSFGILMLETLS 712
           KSD+++FG+LM E  S
Sbjct: 185 KSDIWAFGVLMWEIYS 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 177
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
           +N ++   LG G FG VY+G++       +  +VAVK L     +  E +F  E ++I+K
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD----PTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL +    P++   L     + +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIV 678
           A G  YL +      IHRD+ A N LL         KI DFG+A+    D  + +  R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKG 203
Query: 679 G----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G       +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 130
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 191 THQSDVWSYGVTVWELMT 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
            +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 690 LD-GLFSIKSDVFSFGILMLETLSGK 714
           L    +S   D++S G +  E ++ +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-DPTKKRLLGWQARVTIIEGIAQGLL 626
           H N+VKLL     + +  L+ E++   S+D+  F D +    +      + +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           + H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSIKSDVFSFGILMLETLSGK 714
           E  L    +S   D++S G +  E ++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L++     K+SDFGL+R    DE   +    VG+     +  PE  +   FS 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 200
Query: 697 KSDVFSFGILMLETLS 712
           KSD+++FG+LM E  S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAEGMNYLEDR--- 133
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 194 THQSDVWSYGVTVWELMT 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-DPTKKRLLGWQARVTIIEGIAQGLL 626
           H N+VKLL     + +  L+ E++   S+D+  F D +    +      + +  + QGL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           + H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 173
Query: 687 EYALD-GLFSIKSDVFSFGILMLETLSGK 714
           E  L    +S   D++S G +  E ++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 161
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 221
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 222 THQSDVWSYGVTVWELMT 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 146
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 206
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 207 THQSDVWSYGVTVWELMT 224

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V +GRL   G++   VA+K L    + +   EF +E  ++ + +H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT----IIEGIAQGLLYLHQY 631
           G        +++ E+M N +LD FL      RL   Q  V     ++ GIA G+ YL + 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL------RLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSPEY 688
           S    +HRDL A N+L++ ++  K+SDFGL+R    +         +G      + +PE 
Sbjct: 138 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+  SD +S+GI+M E +S
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 139
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 200 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L++     K+SDFGL+R    DE   +    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 180
Query: 697 KSDVFSFGILMLETLS 712
           KSD+++FG+LM E  S
Sbjct: 181 KSDIWAFGVLMWEIYS 196

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 142
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 202
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 203 THQSDVWSYGVTVWELMT 220

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V +GRL   G++   VA+K L    + +   EF +E  ++ + +H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT----IIEGIAQGLLYLHQY 631
           G        +++ E+M N +LD FL      RL   Q  V     ++ GIA G+ YL + 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL------RLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSPEY 688
           S    +HRDL A N+L++ ++  K+SDFGL+R    +         +G      + +PE 
Sbjct: 136 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+  SD +S+GI+M E +S
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L++     K+SDFGL+R    DE   +    VG+     +  PE  +   FS 
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 185
Query: 697 KSDVFSFGILMLETLS 712
           KSD+++FG+LM E  S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ---GLEEFK 557
           +F   S A  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +     E   
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARV 615
            E+ L+ +L H N++KL     ++G   L+ E      L    FD   ++KR     A  
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-A 129
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQG 672
            II  +  G+ Y+H   + +I+HRDLK  N+LL+    D N +I DFGL+  F   E   
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 183
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             K  +GT  Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 184 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 109/211 (51%), Gaps = 10/211 (4%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLI 563
           + SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE++++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
            + ++ N+V  L   +   E  +++EY+   SL     D   +  +       +     Q
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 128
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L +LH     ++IHR++K+ N+LL MD + K++DFG       ++ + +T  +VGT  +
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 183
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           M+PE      +  K D++S GI+ +E + G+
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
           DL A N L++     K+SDFGL+R    DE   +    VG+     +  PE  +   FS 
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSS 191
Query: 697 KSDVFSFGILMLETLS 712
           KSD+++FG+LM E  S
Sbjct: 192 KSDIWAFGVLMWEIYS 207

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ---GLEEFK 557
           +F   S A  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +     E   
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARV 615
            E+ L+ +L H N++KL     ++G   L+ E      L    FD   ++KR     A  
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-A 153
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQG 672
            II  +  G+ Y+H   + +I+HRDLK  N+LL+    D N +I DFGL+  F   E   
Sbjct: 154 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 207
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             K  +GT  Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 208 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-DPTKKRLLGWQARVTIIEGIAQGLL 626
           H N+VKLL     + +  L+ E++   S+D+  F D +    +      + +  + QGL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           + H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 687 EYALD-GLFSIKSDVFSFGILMLETLSGK 714
           E  L    +S   D++S G +  E ++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 121/248 (48%), Gaps = 32/248 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSS-QSGQGLEEFKNEMMLIAKL-QH 568
           +   Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDP------TKKRLLGWQARV 615
            N++ LLG C  +G   L +EY P+ +L  FL        DP      +    L  Q  +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                +A+G+ YL Q    + IHR+L A N+L+  +   KI+DFGL+R   G E+    K
Sbjct: 143 HFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR---GQEVY--VK 194
Query: 676 RIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL--G 729
           + +G     +M+ E     +++  SDV+S+G+L+ E  +L G    G+  A+ +  L  G
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 254
Query: 730 YVSNKSLH 737
           Y   K L+
Sbjct: 255 YRLEKPLN 262

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+VKLL     + +  L+ E++ ++ L  F+ D +    +      + +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             L    +S   D++S G +  E ++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 567
           + ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-DPTKKRLLGWQARVTIIEGIAQGLL 626
           H N+VKLL     + +  L+ E++   S+D+  F D +    +      + +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           + H +   R++HRDLK  N+L++ +   K++DFGLAR FG   ++     +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 687 EYALD-GLFSIKSDVFSFGILMLETLSGK 714
           E  L    +S   D++S G +  E ++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ---GLEEFK 557
           +F   S A  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +     E   
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARV 615
            E+ L+ +L H N++KL     ++G   L+ E      L    FD   ++KR     A  
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-A 152
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQG 672
            II  +  G+ Y+H   + +I+HRDLK  N+LL+    D N +I DFGL+  F   E   
Sbjct: 153 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 206
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             K  +GT  Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 207 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 31/223 (13%)
Query: 507 SVAAATE------NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFK 557
           S+ +AT+      N+ +Q  +G+G F  V   R +L G+EVAVK +  +  +   L++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
            E+ ++  L H N+VKL      +    L++EY      +VF +     R+   +AR   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKF 120
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKR 676
            + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F  G++L      
Sbjct: 121 RQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---- 172
Query: 677 IVGTYGYMSPEYALDGLFSIKS------DVFSFGILMLETLSG 713
             G     SP YA   LF  K       DV+S G+++   +SG
Sbjct: 173 FCG-----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/232 (32%), Positives = 115/232 (49%), Gaps = 33/232 (14%)
Query: 506 ASVAAATENF---SMQCKLGE----GGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN 558
           + V   TEN    SM  +L E    G FG V+K +LLN + VAVK    Q  Q  +  + 
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EY 67
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKI-----LILEYMPNKSLDVFLFDPTKKRLLGWQA 613
           E+  +  ++H N+++ +G   ++G  +     LI  +    SL  FL    K  ++ W  
Sbjct: 68  EVYSLPGMKHENILQFIGA-EKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNE 122
Query: 614 RVTIIEGIAQGLLYLHQY-------SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
              I E +A+GL YLH+         +  I HRD+K+ NVLL  ++   I+DFGLA  F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVF------SFGILMLETLS 712
             +  G+T   VGT  YM+PE  L+G  + + D F      + G+++ E  S
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHR 569
           NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK-KRLLG----WQARVTIIEGIAQG 624
           N++K     +E  E  ++LE      L   +    K KRL+     W+  V +   +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
               H +SR R++HRD+K +NV +      K+ D GL R F       ++  +VGT  YM
Sbjct: 151 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
           SPE   +  ++ KSD++S G L+ E
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYE 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG--YMSPEYALDGLFSIK 697
           DL A N L++     K+SDFGL+R    DE    T  +   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 698 SDVFSFGILMLETLS 712
           SD+++FG+LM E  S
Sbjct: 202 SDIWAFGVLMWEIYS 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DL A N L++     K+SDFGL+R    DE   +         +  PE  +   FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 700 VFSFGILMLETLS 712
           +++FG+LM E  S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    LI+EY      +VF +     R+   +AR +    I   + Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ 129
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               RI+HRDLKA N+LLD DMN KI+DFG +  F    + G      G     SP YA 
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDTFCG-----SPPYAA 178
Query: 691 DGLFSIKS------DVFSFGILMLETLSG 713
             LF  K       DV+S G+++   +SG
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVA+K +  +  +   L++   E+ ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    LI+EY      +VF +     R+   +AR +    I   + Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGG--EVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ 132
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               RI+HRDLKA N+LLD DMN KI+DFG +  F    + G      G   Y +PE   
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPE--- 183
Query: 691 DGLFSIKS------DVFSFGILMLETLSG 713
             LF  K       DV+S G+++   +SG
Sbjct: 184 --LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 140
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 200
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 201 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ---GLEEFKN 558
           F   S A  ++ +  Q  LG+G FG V   +  + GQE AVK +S +  +     E    
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP--TKKRLLGWQARVT 616
           E+ L+ +L H N+ KL     ++G   L+ E      L    FD   ++KR     A   
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-AR 130
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQGN 673
           II  +  G+ Y H   + +I+HRDLK  N+LL+    D N +I DFGL+  F   E    
Sbjct: 131 IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            K  +GT  Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 199 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 108/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           L  G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI++ MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 19/218 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           K ++    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + +    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 190
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + +    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  G L L G+    VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           G   +    ++I E+M N SLD FL       T  +L+G      ++ GIA G+ YL   
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 125
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSPEY 688
           +    +HR L A N+L++ ++  K+SDFGL+R    D         +G      + +PE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                F+  SDV+S+GI+M E +S
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      
Sbjct: 131 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG 187
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + +    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 188 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 581 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           + G   ++ EYM   SL  +L     + +LG    +     + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DL A NVL+  D   K+SDFGL +     +  G          + +PE   +  FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTKSD 187
Query: 700 VFSFGILMLETLS 712
           V+SFGIL+ E  S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 29/207 (14%)
Query: 521 LGEGGFGPVYKGRL-LNGQE---VAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G FG V  GRL L G+    VA+K L    + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           G        ++++E+M N +LD FL       T  +L+G      ++ GIA G+ YL   
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVG------MLRGIAAGMRYL--- 161
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
           +    +HRDL A N+L++ ++  K+SDFGL+R+     ++ + + +  T G      + +
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTA 216
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE      F+  SDV+S+GI+M E +S
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L++EY      +VF +     R+   +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
             +F I+HRDLKA N+LLD DMN KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 690 LDGLFSIKS------DVFSFGILMLETLSG 713
              LF  K       DV+S G+++   +SG
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L++EY      +VF +     R+   +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
             +F I+HRDLKA N+LLD DMN KI+DFG +  F  G++L        G     SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG-----SPPYA 179
Query: 690 LDGLFSIKS------DVFSFGILMLETLSG 713
              LF  K       DV+S G+++   +SG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           L  G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 581 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           + G   ++ EYM   SL  +L     + +LG    +     + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DL A NVL+  D   K+SDFGL +     +  G          + +PE   +  FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 368
Query: 700 VFSFGILMLETLS 712
           V+SFGIL+ E  S
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 19/218 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 133 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           K ++    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 190 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 199 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L++EY      +VF +     R+   +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
             +F I+HRDLKA N+LLD DMN KI+DFG +  F  G++L        G     SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG-----SPPYA 179
Query: 690 LDGLFSIKS------DVFSFGILMLETLSG 713
              LF  K       DV+S G+++   +SG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 136
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           L  G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 695 SIKSDVFSFGILMLETLS 712
           + +SDV+S+G+ + E ++
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 143
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFG A++ G +E + + +       +M+ E  L  ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 204 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 199 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L++EY      +VF +     R+   +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGG--DELQGNTKRIVGTYGYMSP 686
             +F I+HRDLKA N+LLD DMN KI+DFG +    FG   DE  G            SP
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG------------SP 176
Query: 687 EYALDGLFSIKS------DVFSFGILMLETLSG 713
            YA   LF  K       DV+S G+++   +SG
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 190 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 237

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 118/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P      +L   +   +I
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 199 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 118/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P      +L   +   +I
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 189 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 236

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 192 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 193 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 192 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 186 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 233

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G FG   K      G+ + +K L     +    F  E+ ++  L+H N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           +      I EY+   +L   +   +      W  RV+  + IA G+ YLH  +   IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHR 132
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR------------IVGTYGYMSPE 687
           DL + N L+  + N  ++DFGLAR+   ++ Q    R            +VG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
                 +  K DVFSFGI++ E +      G  NAD
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII------GRVNAD 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 19/228 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           + +    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 240

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 581 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           + G   ++ EYM   SL  +L     + +LG    +     + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DL A NVL+  D   K+SDFGL +     +  G          + +PE   +  FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 196
Query: 700 VFSFGILMLETLS 712
           V+SFGIL+ E  S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 221 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 268

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 98/193 (50%), Gaps = 13/193 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 581 Q-GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           + G   ++ EYM   SL  +L     + +LG    +     + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 640 DLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
           DL A NVL+  D   K+SDFGL +     +  G          + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181
Query: 700 VFSFGILMLETLS 712
           V+SFGIL+ E  S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAV+ +  +  +   L++   E+ ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L++EY      +VF +     R+   +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
             +F I+HRDLKA N+LLD DMN KI+DFG +  F  G++L        G     SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT----FCG-----SPPYA 179
Query: 690 LDGLFSIKS------DVFSFGILMLETLSG 713
              LF  K       DV+S G+++   +SG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+  L  + S +  +E  +E  ++A + + ++ +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           LG C+    + LI + MP   L  ++ +   K  +G Q  +     IA+G+ YL      
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR--- 170
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ E  L  ++
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 230
Query: 695 SIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
           + +SDV+S+G+ + E  T   K   G+  ++  ++L
Sbjct: 231 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 104/231 (45%), Gaps = 37/231 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
           EN      LG G FG V               +VAVK L  ++     E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK------------------ 606
           L  H N+V LLG C   G   LI EY     L  +L    +K                  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 607 --RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
              +L ++  +     +A+G+ +L   S    +HRDL A NVL+      KI DFGLAR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 665 FGGDE---LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              D    ++GN +  V    +M+PE   +G+++IKSDV+S+GIL+ E  S
Sbjct: 222 IMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 19/218 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
            +   IA G+ YL+     + +HR+L A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 135 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           K ++    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 192 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 19/218 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
            +   IA G+ YL+     + +HR+L A N ++  D   KI DFG+ R ++  D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           K ++    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 191 KGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V  G+  L G +VAVK L+ Q  + L+   + + E+  +   +H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                 +  +++EY+    L  F +     RL   ++R  + + I  G+ Y H   R  +
Sbjct: 84  VISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESR-RLFQQILSGVDYCH---RHMV 137
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS- 695
           +HRDLK  NVLLD  MN KI+DFGL+ M    E     +   G+  Y +PE     L++ 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPEVISGRLYAG 194
Query: 696 IKSDVFSFGILMLETLSG 713
            + D++S G+++   L G
Sbjct: 195 PEVDIWSSGVILYALLCG 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           E F+   ++G+G FG VYKG   + +EV A+K +   ++   +E+ + E+ ++++     
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + +  G  ++  +  +I+EY+   S LD+    P ++  +      TI+  I +GL YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 133
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                R IHRD+KA+NVLL    + K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVI 188
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGE 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 19/228 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
           +    IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           + +    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLS-SQSGQGLEEFKNEMML 562
            + E  ++  +LG+G FG VY+G    ++ G+    VAVK ++ S S +   EF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKRLLG-----WQARV 615
           +      ++V+LLG   +    ++++E M +  L  +L    P  +   G      Q  +
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
            +   IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R            
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGG 190
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + +    +M+PE   DG+F+  SD++SFG+++ E  S
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQ---GLEEFKNEMML--I 563
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
              +H N+V+L   C       + +  L+ E++ ++ L  +L D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + +GL +LH +   R++HRDLK  N+L+      K++DFGLAR++     Q     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 23/223 (10%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G  VAVK+L         +F+ E+ ++  L    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 575 LGCCVEQG--EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQY 631
            G     G  E  L++EY+P+  L  FL    + R     +R+ +    I +G+ YL   
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YMSP 686
           SR R +HRDL A N+L++ + + KI+DFGLA++   D+       +V   G     + +P
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DXXVVREPGQSPIFWYAP 183
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
           E   D +FS +SDV+SFG+++ E  +    +   +A+   ++G
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 118/229 (51%), Gaps = 21/229 (9%)
Query: 510 AATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLS-SQSGQGLEEFKNEMML 562
            A E  +M  +LG+G FG VY    KG + +  E  VA+K ++ + S +   EF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL--FDPTKKR--LLGWQARVTII 618
           + +    ++V+LLG   +    ++I+E M    L  +L    P  +   +L   +   +I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 619 E---GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDELQGNT 674
           +    IA G+ YL+     + +HRDL A N  +  D   KI DFG+ R ++  D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
           K ++    +MSPE   DG+F+  SDV+SFG+++ E  TL+ +   G+ N
Sbjct: 186 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 233

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQ---GLEEFKNEMML--I 563
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
              +H N+V+L   C       + +  L+ E++ ++ L  +L D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + +GL +LH +   R++HRDLK  N+L+      K++DFGLAR++     Q     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQ---GLEEFKNEMML--I 563
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+    L   +   +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 564 AKLQHRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
              +H N+V+L   C       + +  L+ E++ ++ L  +L D   +  +  +    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + +GL +LH +   R++HRDLK  N+L+      K++DFGLAR++     Q     +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 180
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKL 566
           A   E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEG 620
            H N+VK  G   E   + L LEY     L      D+ + +P  +R             
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQ 111
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +  G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT
Sbjct: 112 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 681 YGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
             Y++PE      F  +  DV+S GI++   L+G+
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 23/223 (10%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G  VAVK+L         +F+ E+ ++  L    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQY 631
            G     G + L  ++EY+P+  L  FL    + R     +R+ +    I +G+ YL   
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLG-- 131
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YMSP 686
           SR R +HRDL A N+L++ + + KI+DFGLA++   D+       +V   G     + +P
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
           E   D +FS +SDV+SFG+++ E  +    +   +A+   ++G
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 229

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 23/223 (10%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G  VAVK+L         +F+ E+ ++  L    +VK 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQY 631
            G     G + L  ++EY+P+  L  FL    + R     +R+ +    I +G+ YL   
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YMSP 686
           SR R +HRDL A N+L++ + + KI+DFGLA++   D+       +V   G     + +P
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 199
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
           E   D +FS +SDV+SFG+++ E  +    +   +A+   ++G
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 520 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG+G FG V   R        G  VAVK+L         +F+ E+ ++  L    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG-IAQGLLYLHQY 631
            G     G + L  ++EY+P+  L  FL    + R     +R+ +    I +G+ YL   
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YMSP 686
              R +HRDL A N+L++ + + KI+DFGLA++   D+       +V   G     + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
           E   D +FS +SDV+SFG+++ E  +    +   +A+   ++G
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 13/211 (6%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIA 564
           ++A   E F+   ++G+G FG V+KG     Q+V A+K +   ++   +E+ + E+ +++
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           +     + K  G  ++  +  +I+EY+   S LD+    P  +  +      T+++ I +
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILK 131
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           GL YLH   +   IHRD+KA+NVLL    + K++DFG+A      +++ NT   VGT  +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFW 186
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           M+PE      +  K+D++S GI  +E   G+
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 117/235 (49%), Gaps = 21/235 (8%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKN 558
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 24  LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKR--LLGWQARV 615
            M+ I  L H ++V+LLG C   G  + L+ +Y+P  SL     D  ++    LG Q  +
Sbjct: 83  HMLAIGSLDHAHIVRLLGLC--PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLL 136
Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                IA+G+ YL ++    ++HR+L A NVLL      +++DFG+A +   D+ Q    
Sbjct: 137 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 193
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                  +M+ E    G ++ +SDV+S+G+ + E  T   +   G+  A+  +LL
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 248

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 19/234 (8%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKN 558
           LA +   TE   ++  LG G FG V+KG  +   E     V +K +  +SG Q  +   +
Sbjct: 6   LARIFKETELRKLKV-LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKR--LLGWQARVT 616
            M+ I  L H ++V+LLG C     + L+ +Y+P  SL     D  ++    LG Q  + 
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLN 119
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               IA+G+ YL ++    ++HR+L A NVLL      +++DFG+A +   D+ Q     
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
                 +M+ E    G ++ +SDV+S+G+ + E  T   +   G+  A+  +LL
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 116/231 (50%), Gaps = 34/231 (14%)
Query: 521 LGEGGFGPVYKGRLL----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G+G FG VY G  +    N  + A+K LS  +  Q +E F  E +L+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 576 GCCVE-QGEKILILEYMPNKSLDVFLF----DPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           G  +  +G   ++L YM +  L  F+     +PT K L+ +  +V      A+G+ YL  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV------ARGMEYL-- 140
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL----QGNTKRIVGTYGYMSP 686
            +  + +HRDL A N +LD     K++DFGLAR     E     Q    R+   +     
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT---- 195
Query: 687 EYALDGL----FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSN 733
             AL+ L    F+ KSDV+SFG+L+ E L+ +      + D F+L  +++ 
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLT-RGAPPYRHIDPFDLTHFLAQ 243

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 116
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG +G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAVK +  +  +   L++   E+ ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLL 626
           +VKL      +    L++EY     +  +L         GW    +AR    + I   + 
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH------GWMKEKEARAKFRQ-IVSAVQ 120
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMS 685
           Y HQ  +F I+HRDLKA N+LLD DMN KI+DFG +  F  G++L              S
Sbjct: 121 YCHQ--KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------S 168
Query: 686 PEYALDGLFSIKS------DVFSFGILMLETLSG 713
           P YA   LF  K       DV+S G+++   +SG
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL  C  +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 148
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ GRL  +   VAVK         L+ +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V+L+G C ++    +++E +  +  D   F  T+   L  +  + ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEY 688
                 IHRDL A N L+      KISDFG++R    G     G  +++     + +PE 
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
              G +S +SDV+SFGIL+ ET S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 17/238 (7%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL 566
           + ++F +   LG G FG V+  R   NG+  A+K L  +     + +E   +E ++++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            H  ++++ G   +  +  +I++Y+    L  F      +R     A+    E +   L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALE 120
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           YLH      II+RDLK  N+LLD + + KI+DFG A+      +   T  + GT  Y++P
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAP 172
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFSE 744
           E      ++   D +SFGIL+ E L+G   T  Y++++      + N  L F   F+E
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTMKTYEKILNAELRFPPFFNE 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +E+ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + K  G  ++  +  +I+EY+   S LD+    P  +  +      TI+  I +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 121
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   IHRD+KA+NVLL      K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 122 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 176
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGE 201

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRN 570
           N+ +   +G+G F  V   R +L G+EVAVK +  +  +   L++   E+ +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +    L+ EY      +VF +     R    +AR    + I   + Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGG--EVFDYLVAHGRXKEKEARAKFRQ-IVSAVQYCHQ 131
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
             +F I+HRDLKA N+LLD D N KI+DFG +  F  G++L        G   Y +PE  
Sbjct: 132 --KF-IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPE-- 182
Query: 690 LDGLFSIKS------DVFSFGILMLETLSG 713
              LF  K       DV+S G+++   +SG
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ GRL  +   VAVK         L+ +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V+L+G C ++    +++E +  +  D   F  T+   L  +  + ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEY 688
                 IHRDL A N L+      KISDFG++R    G     G  +++     + +PE 
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
              G +S +SDV+SFGIL+ ET S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V  G   L G +VAVK L+ Q  + L+   + K E+  +   +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                 +  +++EY+    L  F +     R+   +AR  + + I   + Y H   R  +
Sbjct: 79  VISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS- 695
           +HRDLK  NVLLD  MN KI+DFGL+ M    E   ++    G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLYAG 189
Query: 696 IKSDVFSFGILMLETLSG 713
            + D++S G+++   L G
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +E+ + E+ ++++     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + K  G  ++  +  +I+EY+   S LD+    P  +  +      TI+  I +GL YLH
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 141
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   IHRD+KA+NVLL      K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 142 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 196
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 197 KQSAYDSKADIWSLGITAIELARGE 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            E++ +   LGEG  G V      +  + VAVK +  +      E  K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N+VK  G   E   + L LEY     L      D+ + +P  +R             +  
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQLMA 115
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G++YLH      I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y
Sbjct: 116 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           ++PE      F  +  DV+S GI++   L+G+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R  N + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     ++IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSSQSGQGLE 554
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 2   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 58
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
             + E+  +  L+H +++KL      + E I+++EY  N+  D  +    + ++   +AR
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 115
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN- 673
               + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFGL+ +       GN 
Sbjct: 116 -RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 167
Query: 674 TKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETL 711
            K   G+  Y +PE     L++  + DV+S G+++   L
Sbjct: 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGY 683
           Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   + GT  Y
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + PE     +   K D++S G+L  E L GK
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +LG G FG V +G  R+   Q +VA+K L   + +   EE   E  ++ +L +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           G C  Q E + L++E      L  FL    K+  +       ++  ++ G+ YL + +  
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYALDG 692
             +HRDL A NVLL      KISDFGL++  G D+    T R  G +   + +PE     
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 188
Query: 693 LFSIKSDVFSFGILMLETLS 712
            FS +SDV+S+G+ M E LS
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V  G   L G +VAVK L+ Q  + L+   + K E+  +   +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                 +  +++EY+    L  F +     R+   +AR  + + I   + Y H   R  +
Sbjct: 79  VISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS- 695
           +HRDLK  NVLLD  MN KI+DFGL+ M    E    +    G+  Y +PE     L++ 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLYAG 189
Query: 696 IKSDVFSFGILMLETLSG 713
            + D++S G+++   L G
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSSQSGQGLE 554
           P  SLA   A   N+ +   LGEG FG V        GQ+VA+K      L+    QG  
Sbjct: 3   PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 59
Query: 555 EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
             + E+  +  L+H +++KL      + E I+++EY  N+  D  +    + ++   +AR
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR 116
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN- 673
               + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFGL+ +       GN 
Sbjct: 117 -RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNF 168
Query: 674 TKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETL 711
            K   G+  Y +PE     L++  + DV+S G+++   L
Sbjct: 169 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 207

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNE 559
           ++ S   A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 560 MMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           + + + L+H N+++L G   +     LILEY P   L     +  K      Q   T I 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 118
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            +A  L Y H     R+IHRD+K  N+LL      KI+DFG    +           + G
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCG 171
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T  Y+ PE     +   K D++S G+L  E L GK
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A +    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYS 632
           LG C+    + L+ + MP   L     D  ++    LG Q  +     IA+G+ YL    
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCL----LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
             R++HRDL A NVL+    + KI+DFGLAR+   DE + +         +M+ E  L  
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 693 LFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNLL 728
            F+ +SDV+S+G+ + E  T   K   G+   +  +LL
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 521 LGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG G FG V+K      G ++A K + ++  +  EE KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
            + + +L++EY+    L   + D +    L     +  ++ I +G+ ++HQ     I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 640 DLKASNVL-LDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           DLK  N+L ++ D    KI DFGLAR +   E     K   GT  +++PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 698 SDVFSFGILMLETLSG 713
           +D++S G++    LSG
Sbjct: 269 TDMWSVGVIAYMLLSG 284

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V        +E VA+KR++ +  Q  ++E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKR----LLGWQARVTIIEGIAQGL 625
           +V      V + E  L+++ +   S LD+      K      +L      TI+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKR-IVGTYG 682
            YLH+  +   IHRD+KA N+LL  D + +I+DFG++     GGD  +   ++  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 683 YMSPEY--ALDGLFSIKSDVFSFGILMLETLSG 713
           +M+PE    + G +  K+D++SFGI  +E  +G
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELATG 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 522 GEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE- 580
             G FG V+K +L+N   VAVK    Q  Q  +  + E+     ++H NL++ +      
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 581 ---QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY------ 631
              + E  LI  +    SL  +L    K  ++ W     + E +++GL YLH+       
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 632 --SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +  I HRD K+ NVLL  D+   ++DFGLA  F   +  G+T   VGT  YM+PE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-V 196
Query: 690 LDGLFSIKSDVF------SFGILMLETLS 712
           L+G  + + D F      + G+++ E +S
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK---KRLLGWQARVTIIEG 620
           +V LLG C + G  ++ I+E+    +L  +L      F P K   K  L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V        +E VA+KR++ +  Q  ++E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKR----LLGWQARVTIIEGIAQGL 625
           +V      V + E  L+++ +   S LD+      K      +L      TI+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKR-IVGTYG 682
            YLH+  +   IHRD+KA N+LL  D + +I+DFG++     GGD  +   ++  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 683 YMSPEYA--LDGLFSIKSDVFSFGILMLETLSG 713
           +M+PE    + G +  K+D++SFGI  +E  +G
Sbjct: 187 WMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGY 683
           Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   + GT  Y
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + PE     +   K D++S G+L  E L GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 93
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK------KRLLGWQARVTI 617
           +V LLG C + G  ++ I+E+    +L  +L      F P K      K  L  +  +  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D         
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 571 LVKLLGCCVEQGEKILIL------------------EYMPNKSLDVFLFDPTKKRLLGWQ 612
           +V LLG C + G  ++++                  E++P K  D++      K  L  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY------KDFLTLE 148
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
             +     +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D    
Sbjct: 149 HLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                     +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 13/209 (6%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIAKL 566
           A   E F+   K+G+G FG V+KG     Q+V A+K +   ++   +E+ + E+ ++++ 
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
               + K  G  ++  +  +I+EY+   S LD+    P  +  +      TI+  I +GL
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGL 132
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            YLH   +   IHRD+KA+NVLL      K++DFG+A      +++ N    VGT  +M+
Sbjct: 133 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMA 187
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE      +  K+D++S GI  +E   G+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEM 560
           L S   A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
            + + L+H N+++L G   +     LILEY P   L     +  K      Q   T I  
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITE 119
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---I 677
           +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDL 169
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            GT  Y+ PE     +   K D++S G+L  E L GK
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGY 683
           Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   + GT  Y
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 177
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + PE     +   K D++S G+L  E L GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK---KRLLGWQARVTIIEG 620
           +V LLG C + G  ++ I+E+    +L  +L      F P K   K  L  +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   +   L   +K      Q   T I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   +   L   +K      Q   T I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 16/231 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +   +L+ E++ ++ L   L D  +  L    A+  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFGLAR F G  ++  T  IV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADS----FNLLGYVSNKS 735
               +S   D++S G +  E ++G     GV  AD     F +LG  ++K+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +   S  SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGY 683
           Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   + GT  Y
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + PE     +   K D++S G+L  E L GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 508 VAAATENFSMQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEMM 561
           + +  E++ +   +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVN 57
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARVTII 618
           L+ +L+H N+V+     +++    L  ++EY     L   +   TK+R  L  +  + ++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 619 EGIAQGLLYLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
             +   L   H+ S     ++HRDLK +NV LD   N K+ DFGLAR+   DE     K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKE 175
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            VGT  YMSPE      ++ KSD++S G L+ E
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGY 683
           Y H     R+IHRD+K  N+LL      KI+DFG +       +   + R   + GT  Y
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + PE     +   K D++S G+L  E L GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           E F+   K+G+G FG V+KG     Q+V A+K +   ++   +E+ + E+ ++++     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 571 LVKLLGCCVEQGEKILILEYMPNKS-LDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           + K  G  ++  +  +I+EY+   S LD+    P  +  +      TI+  I +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 121
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              +   IHRD+KA+NVLL      K++DFG+A      +++ N    VGT  +M+PE  
Sbjct: 122 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVI 176
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGE 201

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLI 563
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
             L+H +++KL      + E I+++EY  N+  D  +    + ++   +AR    + I  
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 114
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIVGTYG 682
            + Y H   R +I+HRDLK  N+LLD  +N KI+DFGL+ +       GN  K   G+  
Sbjct: 115 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 167
Query: 683 YMSPEYALDGLFS-IKSDVFSFGILMLETL 711
           Y +PE     L++  + DV+S G+++   L
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVML 197

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVKLLGCCVEQGEKILIL-EYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++++ E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 121/231 (52%), Gaps = 16/231 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +   +L+ E++ ++ L   L D  +  L    A+  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFGLAR F G  ++  T  +V T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADS----FNLLGYVSNKS 735
               +S   D++S G +  E ++G     GV  AD     F +LG  ++K+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKN 224

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 121/231 (52%), Gaps = 16/231 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K++   +  +G+      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +   +L+ E++ ++ L   L D  +  L    A+  +++ +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQ-LLNGIAYCHD 118
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFGLAR F G  ++  T  +V T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSGKKN-TGVYNADS----FNLLGYVSNKS 735
               +S   D++S G +  E ++G     GV  AD     F +LG  ++K+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLI 563
           A   N+ +   LGEG FG V        GQ+VA+K      L+    QG    + E+  +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
             L+H +++KL      + E I+++EY  N+  D  +    + ++   +AR    + I  
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV---QRDKMSEQEAR-RFFQQIIS 118
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIVGTYG 682
            + Y H   R +I+HRDLK  N+LLD  +N KI+DFGL+ +       GN  K   G+  
Sbjct: 119 AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT----DGNFLKTSCGSPN 171
Query: 683 YMSPEYALDGLFS-IKSDVFSFGILMLETL 711
           Y +PE     L++  + DV+S G+++   L
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVML 201

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E         K D++S G+L  E L GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 38/232 (16%)
Query: 509 AAATE------NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
           AAA+E      N  +   +G G +G VYKG L + + VAVK  S  + Q     KN +  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYR 60
Query: 563 IAKLQHRNLVKLLG-----CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
           +  ++H N+ + +          + E +L++EY PN SL  +L   T      W +   +
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRL 116
Query: 618 IEGIAQGLLYLH------QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL- 670
              + +GL YLH       + +  I HRDL + NVL+  D    ISDFGL+    G+ L 
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 671 ---QGNTKRI--VGTYGYMSPEYALDGLFSIKS--------DVFSFGILMLE 709
              + +   I  VGT  YM+PE  L+G  +++         D+++ G++  E
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 517 MQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKL 574
           +QC LG GGFG V++ +  ++    A+KR+   + +   E+   E+  +AKL+H  +V+ 
Sbjct: 10  IQC-LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ-ARVTIIE-----------GIA 622
               +E+     +    P   L + +    K+ L  W   R TI E            IA
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ----------G 672
           + + +LH      ++HRDLK SN+   MD   K+ DFGL      DE +           
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
                VGT  YMSPE      +S K D+FS G+++ E L
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNT 674
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR      D ++   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            R+     +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 210 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKLL 575
           +LG G FG V +G  R+   Q +VA+K L   + +   EE   E  ++ +L +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           G C  Q E + L++E      L  FL    K+  +       ++  ++ G+ YL + +  
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYALDG 692
             +HR+L A NVLL      KISDFGL++  G D+    T R  G +   + +PE     
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 514
Query: 693 LFSIKSDVFSFGILMLETLS 712
            FS +SDV+S+G+ M E LS
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 121
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 118
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 28/219 (12%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQ 567
           +++  F    KLG G +  VYKG     G  VA+K +   S +G       E+ L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPN---KSLDVFLFDPTKKRL-------LGWQARVTI 617
           H N+V+L      + +  L+ E+M N   K +D      T + L         WQ     
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ----- 116
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KR 676
              + QGL + H+    +I+HRDLK  N+L++     K+ DFGLAR FG   +  NT   
Sbjct: 117 ---LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSS 167
Query: 677 IVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
            V T  Y +P+  +    +S   D++S G ++ E ++GK
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVKLLGCCVEQGEKILIL-EYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++++ E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 120
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 119
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 94
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 83
Query: 571 LVKLLGCCVEQGEKILIL-EYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++++ E+    +L  +L      F P K       K  L  +  + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 141
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 506 ASVAAATENFSMQC--------KLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQ 551
           + V   TEN   Q         K+GEG FG          GR    +E+ + R+SS+   
Sbjct: 9   SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER- 67
Query: 552 GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW 611
             EE + E+ ++A ++H N+V+      E G   ++++Y      D+F     +K +L  
Sbjct: 68  --EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG--DLFKRINAQKGVLFQ 123
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-EL 670
           + +  I++   Q  L L      +I+HRD+K+ N+ L  D   ++ DFG+AR+     EL
Sbjct: 124 EDQ--ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
               +  +GT  Y+SPE   +  ++ KSD+++ G ++ E
Sbjct: 182 ---ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI++FG    +           + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 141
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V     + +G ++AVK+LS   QS    +    E+ L+  ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 570 NLVKLL-----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 166
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 167 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 218
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + +++  D++S G +M E L+G+
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 125
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 144
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 140
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 141
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 144
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 146
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 143
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 140
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---- 568
           +F     LG+G FG V K R  L+ +  A+K++   + + L    +E+ML+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 569 ---------RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTI 617
                    RN VK +    ++    + +EY  N++L   +      ++R   W+    I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR---------MFGGD 668
           +E ++    Y+H      IIHRDLK  N+ +D   N KI DFGLA+              
Sbjct: 126 LEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 669 ELQGNTKRI---VGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETL 711
            L G++  +   +GT  Y++ E  LDG   ++ K D++S GI+  E +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
           A E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H     R+IHRD+K  N+LL      KI++FG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E     +   K D++S G+L  E L GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 521 LGEGGFGPVYKG------RLLNGQEVAVKRLSSQSGQGLEEFKNEM----MLIAKLQHRN 570
           LG G FG V +       +    + VAVK L  + G    E +  M    +LI    H N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHHLN 129
Query: 571 LVKLLGCCVEQGEKIL-ILEYMPNKSLDVFL------FDPTK-------KRLLGWQARVT 616
           +V LLG C + G  ++ I+E+    +L  +L      F P K       K  L  +  + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
               +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D        
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 508 VAAATENFSMQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEMM 561
           + +  E++ +   +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVN 57
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARVTII 618
           L+ +L+H N+V+     +++    L  ++EY     L   +   TK+R  L  +  + ++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 619 EGIAQGLLYLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
             +   L   H+ S     ++HRDLK +NV LD   N K+ DFGLAR+   D      K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKT 175
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            VGT  YMSPE      ++ KSD++S G L+ E
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 508 VAAATENFSMQCKLGEGGFGPVYK------GRLLNGQEVAVKRLSSQSGQGLEEFKNEMM 561
           + +  E++ +   +G G +G   K      G++L  +E+    ++    Q L    +E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVN 57
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARVTII 618
           L+ +L+H N+V+     +++    L  ++EY     L   +   TK+R  L  +  + ++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 619 EGIAQGLLYLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
             +   L   H+ S     ++HRDLK +NV LD   N K+ DFGLAR+   D      K 
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKA 175
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            VGT  YMSPE      ++ KSD++S G L+ E
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLS----SQSGQGLEEFK-NEMMLIAKLQHRNLVKL 574
           LGEG F  VYK R  N  Q VA+K++     S++  G+      E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           L     +    L+ ++M    L+V + D     L     +  ++  + QGL YLHQ+   
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKD-NSLVLTPSHIKAYMLMTL-QGLEYLHQHW-- 132
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-L 693
            I+HRDLK +N+LLD +   K++DFGLA+ FG    +    ++V T  Y +PE      +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQVV-TRWYRAPELLFGARM 189
Query: 694 FSIKSDVFSFGILMLETL 711
           + +  D+++ G ++ E L
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKLQH 568
           E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H     R+IHRD+K  N+LL  +   KI+DFG    +           + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
               +   K D++S G+L  E L G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKLQH 568
           E+F +   LG+G FG VY  R    + + A+K L  +     G+E + + E+ + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N+++L G   +     LILEY P   L     +  K      Q   T I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H     R+IHRD+K  N+LL  +   KI+DFG    +           + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
               +   K D++S G+L  E L G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 520 KLGEGGFGPV-YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+GEG  G V        G++VAVK++  +  Q  E   NE++++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +   E  +++E++   +L     D      +  +   T+   + + L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
           RD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  + 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 699 DVFSFGILMLETLSGK 714
           D++S GI+++E + G+
Sbjct: 223 DIWSLGIMVIEMIDGE 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQSGQGLEEFKNEMM 561
            S  A   +F +   LG+G FG V+  R +    +G   A+K L   + +  +  + +M 
Sbjct: 21  GSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKME 80
Query: 562 --LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-I 618
             ++A + H  +VKL      +G+  LIL+++    L    F    K ++  +  V   +
Sbjct: 81  RDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYL 136
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             +A GL +LH      II+RDLK  N+LLD + + K++DFGL++     E +  +    
Sbjct: 137 AELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FC 191
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           GT  YM+PE       S  +D +S+G+LM E L+G
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F      R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQ 623
              VKL     +  +    L Y  N  L  ++     FD T  R    +        I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVS 141
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE   +      SD+++ G ++ + ++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                   +E   ++    Y+    +   L +  K + L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                IIHRDLK SNV ++ D   +I DFGLAR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 691 DGL-FSIKSDVFSFGILMLETLSGK 714
           + + ++   D++S G +M E L GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 521 LGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +              VAVK L  S      E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 573 KLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
            LLG C   G  ++I EY           +  D F+   T   ++        +E     
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 621 ---IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNT 674
              +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN 
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +  V    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 231 RLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVKLLGCCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           H  +V +      +        +++EY+   +L   +   T+  +   +A + +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQ 127
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRIVGTY 681
            L + HQ     IIHRD+K +N+++      K+ DFG+AR     G+ +   T  ++GT 
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVIGTA 183
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGY 730
            Y+SPE A       +SDV+S G ++ E L+G+     +  DS + + Y
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPDSVAY 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVKLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           H  +V +     + GE          +++EY+   +L   +   T+  +   +A + +I 
Sbjct: 71  HPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIA 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRI 677
              Q L + HQ     IIHRD+K +N+L+      K+ DFG+AR     G+ +   T  +
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX-QTAAV 179
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +GT  Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 45/223 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSL----DVFLFDPTKKRLLGWQ-------ARVT-- 616
           N++ LL              + P +SL    DV+L       L+G         A++T  
Sbjct: 78  NVIGLLDV------------FTPARSLEEFNDVYLV----THLMGADLNNIVKCAKLTDD 121
Query: 617 ----IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
               +I  I +GL Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 177
Query: 673 NTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 178 ----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                   +E   ++    Y+    +   L +  K + L  +    ++  + +GL Y+H 
Sbjct: 86  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                IIHRDLK SNV ++ D   +I DFGLAR    +E+ G     V T  Y +PE  L
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 193
Query: 691 DGL-FSIKSDVFSFGILMLETLSGK 714
           + + ++   D++S G +M E L GK
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRL--SSQSGQGLE-EFKNEMMLIAKLQH 568
           ++F +   LG+G FG VY  R       VA+K L  S    +G+E + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N+++L     ++    LILEY P   L   L    K      Q   TI+E +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H     ++IHRD+K  N+LL +    KI+DFG +       L+  T  + GT  Y+ PE 
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDYLPPEM 192
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
               + + K D++  G+L  E L G
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 17/228 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 139
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 193
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK--NTGVYNADSFNLLGYVSNK 734
                +S++SD++S G+ ++E   G+    +G  +   F LL Y+ N+
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNE 241

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L   +   T  R+   Q     +  + Q L  LH      +I
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCL-AVLQALSVLHAQG---VI 269
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 328 VDIWSLGIMVIEMVDGE 344

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLLG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  + ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII--EGIAQGLLYLHQYSRF 634
               + +  L++  M    +   +++  +    G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  NVLLD D N +ISD GLA        Q  TK   GT G+M+PE  L   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEY 366
Query: 695 SIKSDVFSFGILMLETLSGK 714
               D F+ G+ + E ++ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK-----RLSS-QSGQGLEEFKNEMMLIAK 565
           +++ M  +LG G F  V K R    G+E A K     RLSS + G   EE + E+ ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           ++H N++ L      + + +LILE +    L  FL    +K  L        ++ I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 128
Query: 626 LYLHQYSRFRIIHRDLKASNV-LLDMDM-NPKIS--DFGLA-RMFGGDELQGNTKRIVGT 680
            YLH     RI H DLK  N+ LLD ++ NP+I   DFG+A ++  G+E     K I GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGT 181
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             +++PE        +++D++S G++    LSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR  + + I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 162
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+++ GT  Y++PE       S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLLG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  + ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII--EGIAQGLLYLHQYSRF 634
               + +  L++  M    +   +++  +    G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  NVLLD D N +ISD GLA        Q  TK   GT G+M+PE  L   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEY 366
Query: 695 SIKSDVFSFGILMLETLSGK 714
               D F+ G+ + E ++ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---- 568
           +F     LG+G FG V K R  L+ +  A+K++   + + L    +E+ML+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 569 ---------RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTI 617
                    RN VK +    ++    + +EY  N +L   +      ++R   W+    I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR---------MFGGD 668
           +E ++    Y+H      IIHRDLK  N+ +D   N KI DFGLA+              
Sbjct: 126 LEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 669 ELQGNTKRI---VGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETL 711
            L G++  +   +GT  Y++ E  LDG   ++ K D++S GI+  E +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR   +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+++ GT  Y++PE       S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 218 FEVDVWSIGCIMYTLLVGK 236

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLLG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  + ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII--EGIAQGLLYLHQYSRF 634
               + +  L++  M    +   +++  +    G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  NVLLD D N +ISD GLA        Q  TK   GT G+M+PE  L   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEY 366
Query: 695 SIKSDVFSFGILMLETLSGK 714
               D F+ G+ + E ++ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR  +   I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLH---RNRV 136
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+++ GT  Y++PE       S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK-----RLSS-QSGQGLEEFKNEMM 561
           +   +++ M  +LG G F  V K R    G+E A K     RLSS + G   EE + E+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           ++ +++H N++ L      + + +LILE +    L  FL    +K  L        ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 117
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNV-LLDMDM-NPKIS--DFGLA-RMFGGDELQGNTKR 676
             G+ YLH     RI H DLK  N+ LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 170
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           I GT  +++PE        +++D++S G++    LSG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMM---LIAKLQHRNLVKLLG 576
           LG GGFG V+  ++   G+  A K+L+ +  +  + ++  M+   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII--EGIAQGLLYLHQYSRF 634
               + +  L++  M    +   +++  +    G+Q    I     I  GL +LHQ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            II+RDLK  NVLLD D N +ISD GLA        Q  TK   GT G+M+PE  L   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEY 366
Query: 695 SIKSDVFSFGILMLETLSGK 714
               D F+ G+ + E ++ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 520 KLGEGGFGPVYKGRLLNGQ-EVAVKRLS-SQSGQGL------------EEFKNEMMLIAK 565
           KLG G +G V   +  NG  E A+K +  SQ  +G             EE  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L H N++KL     ++    L+ E+     L   + +  K           I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMD---MNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
            YLH+++   I+HRD+K  N+LL+     +N KI DFGL+  F  D      +  +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAY 213
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           Y++PE  L   ++ K DV+S G++M   L G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 521 LGEGGFGPV-----YKGRLLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQHRNLV 572
           LGEG FG V     YK +    Q+VA+K +S Q  +  +     + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           KL        + ++++EY   +  D  +    KKR+   + R    + I   + Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIV---EKKRMTEDEGR-RFFQQIICAIEYCH--- 125
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN-TKRIVGTYGYMSPEYALD 691
           R +I+HRDLK  N+LLD ++N KI+DFGL+ +       GN  K   G+  Y +PE    
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT----DGNFLKTSCGSPNYAAPEVING 181
Query: 692 GLFS-IKSDVFSFGILMLETLSGK 714
            L++  + DV+S GI++   L G+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK-----RL-SSQSGQGLEEFKNEMM 561
           +   +++ M  +LG G F  V K R    G+E A K     RL SS+ G   EE + E+ 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           ++ +++H N++ L      + + +LILE +    L  FL    +K  L        ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 138
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNV-LLDMDM-NPKIS--DFGLA-RMFGGDELQGNTKR 676
             G+ YLH     RI H DLK  N+ LLD ++ NP+I   DFG+A ++  G+E     K 
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KN 191
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           I GT  +++PE        +++D++S G++    LSG
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FVATRWYR 185
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 521 LGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +              VAVK L  S      E   +E+ +++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 573 KLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
            LLG C   G  ++I EY           +  D F+   T   ++        +E     
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 621 ---IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNT 674
              +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN 
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +  V    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 226 RLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 26  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L     D      +  +    +   + Q L  LH      +I
Sbjct: 86  YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 138
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 521 LGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +              VAVK L  S      E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 573 KLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
            LLG C   G  ++I EY           +  D F+   T   ++        +E     
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 621 ---IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNT 674
              +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN 
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +  V    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 231 RLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 35  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L   +   T  R+   Q     +  + Q L  LH      +I
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCL-AVLQALSVLHAQG---VI 147
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 206 VDIWSLGIMVIEMVDGE 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 521 LGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +              VAVK L  S      E   +E+ +++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 573 KLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
            LLG C   G  ++I EY           +  D F+   T   ++        +E     
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 621 ---IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNT 674
              +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN 
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +  V    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 208 RLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L + ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVKLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           H  +V +     + GE          +++EY+   +L   +   T+  +   +A + +I 
Sbjct: 71  HPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIA 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRI 677
              Q L + HQ     IIHRD+K +N+++      K+ DFG+AR     G+ +   T  +
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAV 179
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +GT  Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 37  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L   +   T  R+   Q     +  + Q L  LH      +I
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCL-AVLQALSVLHAQG---VI 149
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 208 VDIWSLGIMVIEMVDGE 224

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLE-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK R   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
              H N+V+L+  C       + +  L+ E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
              +GL +LH      I+HRDLK  N+L+      K++DFGLAR++     Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVV 173
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   Y+   ++ +EV   ++  +S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ DM+ KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 696 IKSDVFSFGILMLETLSGK 714
            + D++S G ++   L GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 521 LGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-QHRNLV 572
           LG G FG V +              VAVK L  S      E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 573 KLLGCCVEQGEKILILEY--------MPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
            LLG C   G  ++I EY           +  D F+   T   ++        +E     
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 621 ---IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE---LQGNT 674
              +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D    ++GN 
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +  V    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 224 RLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   Y+   ++ +EV   ++  +S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K +   +AR  + + I QG+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ DM+ KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 696 IKSDVFSFGILMLETLSGK 714
            + D++S G ++   L GK
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 185
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G +G V   Y  RL   Q+VAVK+LS   QS         E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                   +E   ++    Y+    +   L +  K + L  +    ++  + +GL Y+H 
Sbjct: 94  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                IIHRDLK SNV ++ D   +I DFGLAR    +E+ G     V T  Y +PE  L
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEIML 201
Query: 691 DGL-FSIKSDVFSFGILMLETLSGK 714
           + + ++   D++S G +M E L GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLE-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK R   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
              H N+V+L+  C       + +  L+ E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
              +GL +LH      I+HRDLK  N+L+      K++DFGLAR++     Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   Y+   ++ +EV   ++  +S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ DM+ KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 696 IKSDVFSFGILMLETLSGK 714
            + D++S G ++   L GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 147
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 199
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 30  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L     D      +  +    +   + Q L  LH      +I
Sbjct: 90  YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 142
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 201 VDIWSLGIMVIEMVDGE 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   Y+   ++ +EV   ++  +S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K +   +AR  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ DM+ KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 696 IKSDVFSFGILMLETLSGK 714
            + D++S G ++   L GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGL---EEFKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N  G+++ V   + +    L   E+F +E +++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L H ++VKL+G  +E+    +I+E  P   L  +L     K  L     V     I + +
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 122
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYM 684
            YL        +HRD+   N+L+      K+ DFGL+R     D  + +  R+     +M
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 177
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           SPE      F+  SDV+ F + M E LS  K 
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 209

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 195
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGL---EEFKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N  G+++ V   + +    L   E+F +E +++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L H ++VKL+G  +E+    +I+E  P   L  +L     K  L     V     I + +
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 126
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYM 684
            YL        +HRD+   N+L+      K+ DFGL+R     D  + +  R+     +M
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           SPE      F+  SDV+ F + M E LS  K 
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            K+GEG  G V    + + G+ VAVK++  +  Q  E   NE++++   QH N+V++   
Sbjct: 80  IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            +   E  +++E++   +L   +   T  R+   Q     +  + Q L  LH      +I
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCL-AVLQALSVLHAQG---VI 192
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           HRD+K+ ++LL  D   K+SDFG       +      K +VGT  +M+PE      +  +
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 698 SDVFSFGILMLETLSGK 714
            D++S GI+++E + G+
Sbjct: 251 VDIWSLGIMVIEMVDGE 267

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR   +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN 558
           +F  +     +E +    KLG G +G V   R  +   E A+K  R +S S     +   
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARVTI 617
           E+ ++  L H N++KL     ++    L++E      L    FD    R+         I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVI 141
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNT 674
           I+ +  G+ YLH+++   I+HRDLK  N+LL   + D   KI DFGL+ +F   E Q   
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKM 195
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           K  +GT  Y++PE  L   +  K DV+S G+++   L+G
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSSQSGQGL---EEFKNEMMLIAK 565
           A E+  +   LGEG FG VY+G   N  G+++ V   + +    L   E+F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L H ++VKL+G  +E+    +I+E  P   L  +L     K  L     V     I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAM 138
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYM 684
            YL        +HRD+   N+L+      K+ DFGL+R     D  + +  R+     +M
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 193
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           SPE      F+  SDV+ F + M E LS  K 
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAV-----KRLSSQSGQGLEEFKNEMMLIAK 565
           TE + +  +LG+G F  V +  ++L GQE A      K+LS++  Q LE    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQG 624
           L+H N+V+L     E+G   LI + +    L    F+    R    +A  +  I+ I + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 122
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTKRIVGTY 681
           +L+ HQ     ++HR+LK  N+LL   +     K++DFGLA    G+  Q       GT 
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTP 177
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           GY+SPE      +    D+++ G+++   L G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 157
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXGX----VATRWYR 209
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC- 578
           +G GGFG V+K +  ++G+   +KR+   +    E+ + E+  +AKL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 579 -----VEQGEK----------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
                 E   K           + +E+    +L+ ++     ++L    A + + E I +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-LELFEQITK 133
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G+ Y+H     ++I+RDLK SN+ L      KI DFGL      D   G   R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRY 187
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETL 711
           MSPE      +  + D+++ G+++ E L
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 113/234 (48%), Gaps = 23/234 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS--------FNLLGYVSNK 734
                +S++SD++S G+ ++E   G+      +A          F LL Y+ N+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE 228

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQS----GQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++    + +EV   ++  +S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
              +     ++LE    +SL        +K L   +AR   +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYALDGLFS 695
           IHRDLK  N+ L+ D+  KI DFGLA      E  G  K+ + GT  Y++PE       S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 696 IKSDVFSFGILMLETLSGK 714
            + DV+S G +M   L GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVKLLGCCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           H  +V +      +        +++EY+   +L   +   T+  +   +A + +I    Q
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIADACQ 127
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRIVGTY 681
            L + HQ     IIHRD+K +N+++      K+ DFG+AR     G+ +   T  ++GT 
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAVIGTA 183
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 156
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 208
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 157
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 209
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 142
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YVATRWYR 194
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 144
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YVATRWYR 196
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 253

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 97  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 150
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 254

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 88  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 141
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 245

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 246

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 144
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YVATRWYR 196
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 53/227 (23%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           +G GGFG V+K +  ++G+   ++R+   +    E+ + E+  +AKL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW- 74
Query: 580 EQGEKILILEYMP---NKSLDVFLFDPT---------------------KKRLLGWQAR- 614
             G      +Y P   + SL+   +DP                      K  L  W  + 
Sbjct: 75  -DG-----FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 615 ----------VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
                     + + E I +G+ Y+H     ++IHRDLK SN+ L      KI DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              D   G   R  GT  YMSPE      +  + D+++ G+++ E L
Sbjct: 186 LKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLE-EFKNEMMLIAKLQ 567
           AT  +    ++G G +G VYK R   +G  VA+K +   +G+ GL      E+ L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 568 ---HRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
              H N+V+L+  C       + +  L+ E++ ++ L  +L D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
              +GL +LH      I+HRDLK  N+L+      K++DFGLAR++     Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVV 173
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            K+G+G FG V+K R    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI----------IEGIAQG 624
           +  C  +        Y   K+    +FD  +  L G  + V +          ++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGN--TKRIVGTY 681
           L Y+H   R +I+HRD+KA+NVL+  D   K++DFGLAR F      Q N    R+V T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            Y  PE  L +  +    D++  G +M E
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAE 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 142
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YVATRWYR 194
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 144
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YVATRWYR 196
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGX----VATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 185
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 515 FSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLV 572
           + M+ +LG GGFG V +      G++VA+K+   + S +  E +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 573 KL------LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
                   L         +L +EY     L  +L        L      T++  I+  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 627 YLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           YLH+    RIIHRDLK  N++L      +  KI D G A+     EL       VGT  Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE      +++  D +SFG L  E ++G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 182
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 236
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 276

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            K+G+G FG V+K R    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV----------TIIEGIAQG 624
           +  C  +        Y   K     +FD  +  L G  + V           +++ +  G
Sbjct: 83  IEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGN--TKRIVGTY 681
           L Y+H   R +I+HRD+KA+NVL+  D   K++DFGLAR F      Q N    R+V T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            Y  PE  L +  +    D++  G +M E
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAE 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 134
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 186
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 515 FSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLV 572
           + M+ +LG GGFG V +      G++VA+K+   + S +  E +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 573 KL------LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
                   L         +L +EY     L  +L        L      T++  I+  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 627 YLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           YLH+    RIIHRDLK  N++L      +  KI D G A+     EL       VGT  Y
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQY 190
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE      +++  D +SFG L  E ++G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR--LLNGQ--EVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G     +G+   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G  +    K ++ E  P  SL   L       LLG  +R  +   +A+G+ YL    
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             R IHRDL A N+LL      KI DFGL R      D       R V  + + +PE   
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS  SD + FG+ + E  +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 134
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 186
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 135
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 136 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 187
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR--LLNGQ--EVAVKRLSSQ---SGQGL 553
           PL SL  +    ++  +  KLG+G FG V +G     +G+   VAVK L        + +
Sbjct: 7   PLQSLTCLIG-EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA 613
           ++F  E+  +  L HRNL++L G  +    K ++ E  P  SL   L       LLG  +
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS 124
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQ 671
           R  +   +A+G+ YL      R IHRDL A N+LL      KI DFGL R      D   
Sbjct: 125 RYAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV 179
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               R V  + + +PE      FS  SD + FG+ + E  +
Sbjct: 180 MQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLV 572
           F  +  LG G F  V        G+  AVK +  ++ +G E   +NE+ ++ K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQY 631
            L           L+++ +    L    FD   +K     +   T+I  +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH-- 137
Query: 632 SRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            R  I+HRDLK  N+L    D +    ISDFGL++M G  ++        GT GY++PE 
Sbjct: 138 -RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA---CGTPGYVAPEV 193
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
                +S   D +S G++    L G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L   ++VAVK L +   +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 568 HRNLVKLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           H  +V       + GE          +++EY+   +L   +   T+  +   +A + +I 
Sbjct: 71  HPAIV----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIA 123
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRI 677
              Q L + HQ     IIHRD+K +N+++      K+ DFG+AR     G+ +   T  +
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAV 179
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +GT  Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 694 FSIKS-DVFSFGILMLETLSGK 714
              KS D++S G ++ E LS +
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR--LLNGQ--EVAVKRLSS---QSGQGL 553
           PL SL  +    ++  +  KLG+G FG V +G     +G+   VAVK L        + +
Sbjct: 7   PLQSLTCLIG-EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA 613
           ++F  E+  +  L HRNL++L G  +    K ++ E  P  SL   L       LLG  +
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS 124
Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQ 671
           R  +   +A+G+ YL      R IHRDL A N+LL      KI DFGL R      D   
Sbjct: 125 RYAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               R V  + + +PE      FS  SD + FG+ + E  +
Sbjct: 180 MQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 27/233 (11%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS-SQSGQGLEEFK-NEM 560
           S A  A + + +    KLGEG +G VYK    +  + VA+KR+      +G+      E+
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVFLFDPTKKRLLGWQARVTI 617
            L+ +LQHRN+++L           LI EY  N   K +D       K   +  +   + 
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSF 137
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNP--KISDFGLARMFGGDELQG 672
           +  +  G+ + H  SR R +HRDLK  N+LL   D    P  KI DFGLAR F G  ++ 
Sbjct: 138 LYQLINGVNFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 673 NTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADS 724
            T  I+ T  Y  PE  L    +S   D++S   +  E L     T ++  DS
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML---MKTPLFPGDS 242

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 142
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 194
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 139
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 191
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 144
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 196
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 195
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 139
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 191
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 139
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 191
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 506 ASVAAATENFSMQC------KLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEF 556
           + V   TEN   Q       +LG+G F  V +  ++L GQE A K ++++  S +  ++ 
Sbjct: 9   SGVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 557 KNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
           + E  +   L+H N+V+L     E+G   LI + +    L    F+    R    +A  +
Sbjct: 69  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS 124
Query: 617 -IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQG 672
             I+ I + +L+ HQ     ++HRDLK  N+LL   +     K++DFGLA    G+  Q 
Sbjct: 125 HCIQQILEAVLHCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQ 179
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 GT GY+SPE      +    D+++ G+++   L G
Sbjct: 180 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 17/226 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 123
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSPER 177
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNK 734
                +S++SD++S G+ ++E   G+          F LL Y+ N+
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAI--FELLDYIVNE 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 142
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 194
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 136
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 188
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 148
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YVATRWYR 200
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 515 FSMQCKLGEGGFGPVY-KGRLLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLV 572
           F  + KLG G FG V+      +G E  +K ++    Q  +E+ + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR---------VTIIEGIAQ 623
           K+     +     +++E      L         +R++  QAR           +++ +  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGEL--------LERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVG 679
            L Y H      ++H+DLK  N+L   D +P    KI DFGLA +F  DE   N     G
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHSTNA---AG 188
Query: 680 TYGYMSPE-YALDGLFSIKSDVFSFGILMLETLSG 713
           T  YM+PE +  D  F  K D++S G++M   L+G
Sbjct: 189 TALYMAPEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 160
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG----YVATRWYR 212
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 149
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 201
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      LN   VA++++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 139
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG----YVATRWYR 191
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 149
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 201
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 230
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 231 ATDYTSSI--DVWSAGCVLAELLLGQ 254

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 149
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 201
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 195
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPAFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR--LLNGQ--EVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G     +G+   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G  +    K ++ E  P  SL   L       LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             R IHRDL A N+LL      KI DFGL R      D       R V  + + +PE   
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESLK 187
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS  SD + FG+ + E  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGLEEFKNEMM--LI 563
           A    F +   LG+G FG V+  + ++G    Q  A+K L   + +  +  + +M   ++
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-IEGIA 622
            ++ H  +VKL      +G+  LIL+++    L    F    K ++  +  V   +  +A
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELA 136
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
             L +LH      II+RDLK  N+LLD + + K++DFGL++     E +  +    GT  
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           YM+PE       +  +D +SFG+LM E L+G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR--LLNGQ--EVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G     +G+   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G  +    K ++ E  P  SL   L       LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             R IHRDL A N+LL      KI DFGL R      D       R V  + + +PE   
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 187
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS  SD + FG+ + E  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 156
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 208
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 120
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 143
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG----YVATRWYR 195
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            K+G+G FG V+K R    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 81
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI----------IEGIAQG 624
           +  C  +        Y   K     +FD  +  L G  + V +          ++ +  G
Sbjct: 82  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGN--TKRIVGTY 681
           L Y+H   R +I+HRD+KA+NVL+  D   K++DFGLAR F      Q N    R+V T 
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 192
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            Y  PE  L +  +    D++  G +M E
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAE 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 230
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 231 ATDYTSSI--DVWSAGCVLAELLLGQ 254

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 157
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 209
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLE---EFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L   ++VAVK L +   +       F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 568 HRNLVKLLGCCVEQGEK--------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIE 619
           H  +V +     + GE          +++EY+   +L   +   T+  +   +A + +I 
Sbjct: 88  HPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRA-IEVIA 140
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--GDELQGNTKRI 677
              Q L + HQ     IIHRD+K +N+++      K+ DFG+AR     G+ +   T  +
Sbjct: 141 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT-QTAAV 196
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +GT  Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 148
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 200
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 168
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 169 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 224
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 225 ATDYTSSI--DVWSAGCVLAELLLGQ 248

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 519 CKLGEGGFGPVYKGRLL-NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            K+G+G FG V+K R    GQ+VA+K++   + + G  +   + E+ ++  L+H N+V L
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 82
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI----------IEGIAQG 624
           +  C  +        Y   K     +FD  +  L G  + V +          ++ +  G
Sbjct: 83  IEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGN--TKRIVGTY 681
           L Y+H   R +I+HRD+KA+NVL+  D   K++DFGLAR F      Q N    R+V T 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            Y  PE  L +  +    D++  G +M E
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAE 222

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 176
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 177 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 232
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 233 ATDYTSSI--DVWSAGCVLAELLLGQ 256

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 22/222 (9%)
Query: 506 ASVAAATENFSMQCK--------LGEGGFGPVYKGRLLN-GQEVAVKR-LSSQSGQGLEE 555
           + V   TEN   Q          +GEG +G V K R  + G+ VA+K+ L S   + +++
Sbjct: 10  SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 556 FK-NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
               E+ L+ +L+H NLV LL  C ++    L+ E++ +  LD     P     L +Q  
Sbjct: 70  IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVV 126
Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGN 673
              +  I  G+ + H ++   IIHRD+K  N+L+      K+ DFG AR      E+  +
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 674 TKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
               V T  Y +PE  + D  +    DV++ G L+ E   G+
Sbjct: 184 E---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 178
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 179 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 234
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 235 ATDYTSSI--DVWSAGCVLAELLLGQ 258

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 159
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 160 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 215
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR--LLNGQ--EVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G     +G+   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G  +    K ++ E  P  SL   L       LLG  +R  +   +A+G+ YL    
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             R IHRDL A N+LL      KI DFGL R      D       R V  + + +PE   
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 187
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS  SD + FG+ + E  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR--LLNGQ--EVAVKRLSS---QSGQGLEEFKNEMMLIAKLQHRNLV 572
           KLG+G FG V +G     +G+   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G  +    K ++ E  P  SL   L       LLG  +R  +   +A+G+ YL    
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             R IHRDL A N+LL      KI DFGL R      D       R V  + + +PE   
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS  SD + FG+ + E  +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 99  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 256

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 248

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 148
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 149 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 204
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 208
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 208
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 160
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G     V T  Y 
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 212
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 145
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 146 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 201
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++     QG + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRN 570
           ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVTIIEGIAQGLLYL 628
           +V   G     GE  + +E+M   SLD  L    +  +++LG   +V+I   + +GL YL
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 147
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
            +  + +I+HRD+K SN+L++     K+ DFG++    G  +       VGT  YMSPE 
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 201
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLL 728
                +S++SD++S G+ ++E   G+      +A    L+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DFGL R    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 219
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 220 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 275
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
           A D   SI  DV+S G ++ E L G+
Sbjct: 276 ATDYTSSI--DVWSAGCVLAELLLGQ 299

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 153
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 154 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 209
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++     QG + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 132 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 185
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 141
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 142 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 197
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++     QG + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 132 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 185
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 144
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 145 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAPELIFG 200
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLGCC 578
           +G G FG VY+ +L + G+ VA+K++        + FKN E+ ++ KL H N+V+L    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 579 VEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              GEK       L+L+Y+P     V       K+ L        +  + + L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 633 RFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            F I HRD+K  N+LLD D    K+ DFG A+     E   N   I   Y Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAPELIFG 196
Query: 692 GL-FSIKSDVFSFGILMLETLSGK 714
              ++   DV+S G ++ E L G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGLEEFKNEMM--LI 563
           A    F +   LG+G FG V+  + ++G    Q  A+K L   + +  +  + +M   ++
Sbjct: 21  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-IEGIA 622
            ++ H  +VKL      +G+  LIL+++    L    F    K ++  +  V   +  +A
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELA 136
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
             L +LH      II+RDLK  N+LLD + + K++DFGL++     E +  +    GT  
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           YM+PE       +  +D +SFG+LM E L+G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI D+GLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQSGQGLEEFKNEMM--LI 563
           A    F +   LG+G FG V+  + ++G    Q  A+K L   + +  +  + +M   ++
Sbjct: 22  ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 81
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI-IEGIA 622
            ++ H  +VKL      +G+  LIL+++    L    F    K ++  +  V   +  +A
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELA 137
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
             L +LH      II+RDLK  N+LLD + + K++DFGL++     E +  +    GT  
Sbjct: 138 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 192
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           YM+PE       +  +D +SFG+LM E L+G
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 149 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 148
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 149 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 553 LEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQ 612
           +E+   E+ ++ KL H N+VKL+    +  E  L + +       V    PT K L   Q
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQ 138
Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-GGDELQ 671
           AR    + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D L 
Sbjct: 139 ARFYF-QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 672 GNTKRIVGTYGYMSPEYALD--GLFSIKS-DVFSFGILM 707
            NT   VGT  +M+PE   +   +FS K+ DV++ G+ +
Sbjct: 195 SNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLIAK 565
           T+ + +   +G+G F  V +  +L  G E A K     +LS++  Q LE    E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQG 624
           L+H N+V+L     E+G   L+ + +    L    F+    R    +A  +  I+ I + 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 115
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTKRIVGTY 681
           +L+ HQ     ++HRDLK  N+LL         K++DFGLA    GD  Q       GT 
Sbjct: 116 VLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD--QQAWFGFAGTP 170
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           GY+SPE      +    D+++ G+++   L G
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 146
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 147 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 201
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSS----QSGQGLEEFKNEMMLIA 564
           ENF +   LG G +G V+  R ++G +     A+K L      Q  +  E  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 565 KLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
            ++    +  L    +   K+ LIL+Y+    L  F     ++R    + ++ + E I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L +LH   +  II+RD+K  N+LLD + +  ++DFGL++ F  DE +       GT  Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 226
Query: 684 MSPEYAL--DGLFSIKSDVFSFGILMLETLSG 713
           M+P+     D       D +S G+LM E L+G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 128
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 129 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH---- 568
           +F     LG+G FG V K R  L+ +  A+K++   + + L    +E+ L+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 569 ---------RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTI 617
                    RN VK      ++    +  EY  N++L   +      ++R   W+    I
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR---------MFGGD 668
           +E ++    Y+H      IIHR+LK  N+ +D   N KI DFGLA+              
Sbjct: 126 LEALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 669 ELQGNTKRI---VGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETL 711
            L G++  +   +GT  Y++ E  LDG   ++ K D +S GI+  E +
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + I++ +    ++  L+   K + L        +  I +GL Y+H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDL----METDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 250

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI DF LAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 521 LGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKL---- 574
           +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
               +EQ + + ++ ++    +   L+   K + L        +  I +GL Y+H  +  
Sbjct: 111 RAPTIEQMKDVYLVTHL----MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGL 693
            ++HRDLK SN+LL+   + KI DFGLAR+   D +  G     V T  Y +PE  L+  
Sbjct: 165 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 694 FSIKS-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
              KS D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 132
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 187
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILILE +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 132
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY---APECIN 187
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 126
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 127 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 181
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 40/229 (17%)
Query: 515 FSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQ-HRN 570
           + +  KLG+G +G V+K      G+ VAVK++  + Q+    +    E+M++ +L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 571 LVKLLGCCVEQGEK--ILILEYMPNKSLDVF---LFDPTKKRLLGWQARVTIIEGIAQGL 625
           +V LL       ++   L+ +YM      V    + +P  K+ + +Q        + + +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--------LIKVI 122
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG------------------ 667
            YLH      ++HRD+K SN+LL+ + + K++DFGL+R F                    
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 668 -DELQGNTKRIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
            D+ Q      V T  Y +PE  L      K  D++S G ++ E L GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 138
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 521 LGEGGFGPVYKGRLLN---GQEVAVK-----RLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +G+G F  V   R +N   GQ+ AVK     + +S  G   E+ K E  +   L+H ++V
Sbjct: 32  IGKGAFSVVR--RCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI----IEGIAQGLLYL 628
           +LL      G   ++ E+M    L    F+  K+   G+     +    +  I + L Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           H  +   IIHRD+K  NVLL    N    K+ DFG+A   G   L    +  VGT  +M+
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMA 201
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE      +    DV+  G+++   LSG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 24/246 (9%)
Query: 502 LFSLASVAAATENFSMQCK-------LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSG 550
           L+   ++ ++T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + + 
Sbjct: 20  LYFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 79
Query: 551 QGL-EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLL 609
             + E+F  E + + +  H ++VKL+G   E    I I+E      L  FL    +K  L
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSL 136
Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
              + +     ++  L YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D 
Sbjct: 137 DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDS 192
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG--KKNTGVYNADSFNL 727
                 +      +M+PE      F+  SDV+ FG+ M E L    K   GV N D   +
Sbjct: 193 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V 249
Query: 728 LGYVSN 733
           +G + N
Sbjct: 250 IGRIEN 255

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 490
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 491 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 545
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG-----RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG     +++    V + +  +      +E   E  ++ +L +  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL + S F
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE-SNF 491
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYAL 690
             +HRDL A NVLL      KISDFGL++    DE     Q + K  V  Y   +PE   
Sbjct: 492 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 546
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSDV+SFG+LM E  S
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 24/238 (10%)
Query: 510 AATENFSMQCK-------LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFK 557
           A+T ++ +Q +       +GEG FG V++G  ++ +     VA+K   + +   + E+F 
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 61
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI 617
            E + + +  H ++VKL+G   E    I I+E      L  FL    +K  L   + +  
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILY 118
Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI 677
              ++  L YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D       + 
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 174
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
                +M+PE      F+  SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG--------QEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           E F +   LG+GG+G V++ R + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           +++H  +V L+      G+  LILEY+    L + L    ++ +         +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L +LHQ     II+RDLK  N++L+   + K++DFGL +    D    +T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +PE  +    +   D +S G LM + L+G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++       VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL-----DVFLFDPTKKRL 608
           ++FKNE+ +I  +++   +   G      E  +I EYM N S+       F+ D      
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
           +  Q    II+ +     Y+H      I HRD+K SN+L+D +   K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 669 ELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILM 707
           +++G+     GTY +M PE+  +       K D++S GI +
Sbjct: 206 KIKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL-------SSQSGQGLEEFKNEMMLIAKLQHRNL 571
           KLG G +G V   +  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 66
Query: 572 VKLLGCCVEQGEKILILE-YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +KL     ++    L++E Y   +  D  +    +++     A V I++ +  G  YLH+
Sbjct: 67  MKLYEFFEDKRNYYLVMEVYRGGELFDEIIL---RQKFSEVDAAV-IMKQVLSGTTYLHK 122
Query: 631 YSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           ++   I+HRDLK  N+LL+    D   KI DFGL+  F   E+ G  K  +GT  Y++PE
Sbjct: 123 HN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPE 176
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             L   +  K DV+S G+++   L G
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 75  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 224

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKR-LSSQSGQGLEEFK-NEMMLIAKLQHR 569
           E +    K+GEG +G V+K R  + GQ VA+K+ L S+    +++    E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           NLV LL     +    L+ EY  +  L         +R +      +I     Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +++    IHRD+K  N+L+      K+ DFG AR+  G     + +  V T  Y SPE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 690 L-DGLFSIKSDVFSFGILMLETLSG 713
           + D  +    DV++ G +  E LSG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 81  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRL-------SSQSGQGLEEFKNEMMLIAKLQHRNL 571
           KLG G +G V   +  L G E A+K +       +S SG  L    +E+ ++ +L H N+
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVLKQLDHPNI 83
Query: 572 VKLLGCCVEQGEKILILE-YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +KL     ++    L++E Y   +  D  +    +++     A V I++ +  G  YLH+
Sbjct: 84  MKLYEFFEDKRNYYLVMEVYRGGELFDEIIL---RQKFSEVDAAV-IMKQVLSGTTYLHK 139
Query: 631 YSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           ++   I+HRDLK  N+LL+    D   KI DFGL+  F   E+ G  K  +GT  Y++PE
Sbjct: 140 HN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPE 193
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             L   +  K DV+S G+++   L G
Sbjct: 194 -VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 502 LFSLASVAAATENFSMQC-------KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGL 553
           L S A ++   +NF ++        +LG G +G V K R + +GQ +AVKR+ +      
Sbjct: 33  LDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--- 89
Query: 554 EEFKNEMMLIAKLQHRNL-----VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-R 607
            + +  +++   +  R +     V   G    +G+  + +E M + SLD F      K +
Sbjct: 90  SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ 148
Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
            +       I   I + L +LH  S+  +IHRD+K SNVL++     K+ DFG++    G
Sbjct: 149 TIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----G 202
Query: 668 DELQGNTKRI-VGTYGYMSPEYALDGL----FSIKSDVFSFGILMLE 709
             +    K I  G   YM+PE     L    +S+KSD++S GI M+E
Sbjct: 203 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI D GLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 83  GVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+  +   K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+    +  K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI  FGLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG--------QEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           E F +   LG+GG+G V++ R + G         +V  K +  ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           +++H  +V L+      G+  LILEY+    L + L    ++ +         +  I+  
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L +LHQ     II+RDLK  N++L+   + K++DFGL +    D     T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGTIEYM 188
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +PE  +    +   D +S G LM + L+G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI D GLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 17/285 (5%)
Query: 456 EKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENF 515
           +KE E        LA +   G+ + T    E +   +   ++    + S        E  
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 516 SMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRN 570
            +   +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL+G   E    I I+E      L  FL    +K  L   + +     ++  L YL  
Sbjct: 453 IVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R +HRD+ A NVL+  +   K+ DFGL+R          +K  +    +M+PE   
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-KWMAPESIN 565
Query: 691 DGLFSIKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
              F+  SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 607

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 17/285 (5%)
Query: 456 EKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENF 515
           +KE E        LA +   G+ + T    E +   +   ++    + S        E  
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 516 SMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRN 570
            +   +GEG FG V++G  ++ +     VA+K   + +   + E+F  E + + +  H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL+G   E    I I+E      L  FL    +K  L   + +     ++  L YL  
Sbjct: 453 IVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R +HRD+ A NVL+      K+ DFGL+R +  D       +      +M+PE   
Sbjct: 510 K---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 691 DGLFSIKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
              F+  SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 607

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 521 LGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLL 575
           +GEG FG V++G  ++       VA+K   + +   + E+F  E + + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G   E    I I+E      L  FL    +K  L   + +     ++  L YL      R
Sbjct: 78  GVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
            +HRD+ A NVL+      K+ DFGL+R +  D       +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 696 IKSDVFSFGILMLETLSG--KKNTGVYNADSFNLLGYVSN 733
             SDV+ FG+ M E L    K   GV N D   ++G + N
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 570 NLVKLLGC-----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           N++ LL        +E+   + ++ ++    L+  +    K + L       +I  I +G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRG 137
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L Y+H      IIHRDLK SN+ ++ D   KI D GLAR    DE+ G     V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG----YVATRWYR 189
Query: 685 SPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEF-----KNEMMLIA 564
           AT  +    ++G G +G VYK R   +G  VA+K +   +G G           E+ L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 565 KLQ---HRNLVKLLGCCV-----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT 616
           +L+   H N+V+L+  C       + +  L+ E++ ++ L  +L D      L  +    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
           ++    +GL +LH      I+HRDLK  N+L+      K++DFGLAR++     Q     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTP 178
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +V T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTK--KRLLGWQARVT 616
           E+ ++ +     +V   G     GE  + +E+M   SLD  L +  +  + +LG   +V+
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVS 120
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
           I   + +GL YL +  + +I+HRD+K SN+L++     K+ DFG++    G  +      
Sbjct: 121 I--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 172
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            VGT  YM+PE      +S++SD++S G+ ++E   G+
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV- 579
           +G+G +G V++G L +G+ VAVK  SS+  Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 580 ---EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-----QY 631
                 +  LI  Y  + SL  FL   T +  L  +  V+     A GL +LH       
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSA----ACGLAHLHVEIFGTQ 129
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQ-GNTKRIVGTYGYMSPEY 688
            +  I HRD K+ NVL+  ++   I+D GLA M   G D L  GN  R VGT  YM+PE 
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMAPEV 188
Query: 689 -----ALDGLFSIK-SDVFSFGILMLE 709
                  D   S K +D+++FG+++ E
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWE 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 28/243 (11%)
Query: 495 GKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL- 553
           G  S LP     +VA       ++C +G+G +G V++G    G+ VAVK  SS+  +   
Sbjct: 22  GSGSGLPFLVQRTVARQIT--LLEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWF 77
Query: 554 --EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW 611
              E  N +ML    +H N++  +   +        L  + +      L+D  +   L  
Sbjct: 78  RETELYNTVML----RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT 133
Query: 612 QARVTIIEGIAQGLLYLH-----QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
            + + I+  IA GL +LH        +  I HRDLK+ N+L+  +    I+D GLA M  
Sbjct: 134 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 193
Query: 667 GDELQ---GNTKRIVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSGKKN 716
               Q   GN  R VGT  YM+PE  LD    +       + D+++FG+++ E      +
Sbjct: 194 QSTNQLDVGNNPR-VGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 251
Query: 717 TGV 719
            G+
Sbjct: 252 NGI 254

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLY 627
            N+V+L     E+    L+ + +    L    F+    R    +A  +  I+ I + + Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 119
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            H      I+HR+LK  N+LL         K++DFGLA      E         GT GY+
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           SPE      +S   D+++ G+++   L G
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 30/239 (12%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
           D    G  S LPL    ++A       +Q  +G+G FG V++G+   G+EVAVK  SS+ 
Sbjct: 9   DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE 64
Query: 550 GQGLEEFKN-EMMLIAKLQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPT 604
            +    F+  E+     L+H N++  +    +      +  L+ +Y  + SL    FD  
Sbjct: 65  ERSW--FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYL 118
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQ-----YSRFRIIHRDLKASNVLLDMDMNPKISDF 659
            +  +  +  + +    A GL +LH        +  I HRDLK+ N+L+  +    I+D 
Sbjct: 119 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 178
Query: 660 GLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFSIK-------SDVFSFGILMLE 709
           GLA       D +       VGT  YM+PE  LD   ++K       +D+++ G++  E
Sbjct: 179 GLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 236

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 11/219 (5%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKL 566
             +NF     LG+G FG V   R+   G   AVK L          +E    E  +++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           ++   +  L CC +  +++  +    N   D+       +R    +AR    E I   L+
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGG-DLMFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           +LH      II+RDLK  NVLLD + + K++DFG+ +   G      T    GT  Y++P
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSF 725
           E   + L+    D ++ G+L+ E L G       N D  
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLY 627
            N+V+L     E+    L+ + +    L    F+    R    +A  +  I+ I + + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            H      I+HR+LK  N+LL         K++DFGLA      E         GT GY+
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           SPE      +S   D+++ G+++   L G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 30/239 (12%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
           D    G  S LPL    ++A       +Q  +G+G FG V++G+   G+EVAVK  SS+ 
Sbjct: 22  DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE 77
Query: 550 GQGLEEFKN-EMMLIAKLQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPT 604
            +    F+  E+     L+H N++  +    +      +  L+ +Y  + SL    FD  
Sbjct: 78  ERSW--FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYL 131
Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQ-----YSRFRIIHRDLKASNVLLDMDMNPKISDF 659
            +  +  +  + +    A GL +LH        +  I HRDLK+ N+L+  +    I+D 
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 660 GLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFSIK-------SDVFSFGILMLE 709
           GLA       D +       VGT  YM+PE  LD   ++K       +D+++ G++  E
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 41/213 (19%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G +G V     GR   G +VA+K+L    QS    +    E+ L+  ++H N++ LL
Sbjct: 33  VGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 576 GCCVEQGEKILILEYMPNKSLDVF----LFDP---------TKKRLLGWQARVTIIEGIA 622
                         + P+++LD F    L  P          K   LG      ++  + 
Sbjct: 91  DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           +GL Y+H      IIHRDLK  N+ ++ D   KI DFGLAR     E+ G     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMXGX----VVTRW 190
Query: 683 YMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           Y +PE  L+ + ++   D++S G +M E ++GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 33/245 (13%)
Query: 519 CKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVKLLGC 577
           CK+G G +G VYK +  +G++     L    G G+      E+ L+ +L+H N++ L   
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 578 CVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY-----LHQ 630
            +   ++   L+ +Y  +    +  F    K     +  V +  G+ + LLY     +H 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGD-ELQGNTKRIVGTYGYM 684
                ++HRDLK +N+L+ M   P     KI+D G AR+F    +   +   +V T+ Y 
Sbjct: 144 LHANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK----------KNTGVYNADS----FNLLG 729
           +PE  L      K+ D+++ G +  E L+ +          K +  Y+ D     FN++G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 730 YVSNK 734
           + ++K
Sbjct: 263 FPADK 267

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLY 627
            N+V+L     E+    L+ + +    L    F+    R    +A  +  I+ I + + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            H      I+HR+LK  N+LL         K++DFGLA      E         GT GY+
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           SPE      +S   D+++ G+++   L G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL-SSQSGQGLEEFKN 558
           LPL    ++A   +   M  ++G+G +G V+ G+   G++VAVK   +++      E   
Sbjct: 27  LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--T 80
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQAR 614
           E+     ++H N++  +   ++      +  LI +Y  N SL    +D  K   L  ++ 
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSM 136
Query: 615 VTIIEGIAQGLLYLHQ-----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD- 668
           + +      GL +LH        +  I HRDLK+ N+L+  +    I+D GLA  F  D 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 669 ---ELQGNTKRIVGTYGYMSPEYALDGLFS------IKSDVFSFGILMLET 710
              ++  NT+  VGT  YM PE   + L        I +D++SFG+++ E 
Sbjct: 197 NEVDIPPNTR--VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKL 566
             ++F +   LG+G FG VY  R    + + A+K L  S    +G+E + + E+ + + L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N++++     ++    L+LE+ P   L   L    K      Q   T +E +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 128
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           Y H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPP 181
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E         K D++  G+L  E L G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G + A K +      SS+ G   E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + ILI E +    L  FL    +K  L  +     ++ I  G+ YLH   
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 633 RFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFG-GDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      KI DFGLA     G+E     K I GT  +++P
Sbjct: 133 -LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAP 186
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL--SSQSGQGLE-EFKNEMMLIAKLQH 568
           ++F +   LG+G FG VY  R    + + A+K L  S    +G+E + + E+ + + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N++++     ++    L+LE+ P   L   L    K      Q   T +E +A  L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 131
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H+    ++IHRD+K  N+L+      KI+DFG +       L+   + + GT  Y+ PE 
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR--RRXMCGTLDYLPPEM 184
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
                   K D++  G+L  E L G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           +G G +G V       +G++VA+K+LS   QS    +    E++L+  +QH N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 578 CVEQGEKILILEYMPNKSL----DVFLFDP----TKKRLLGWQARVTIIEGIA----QGL 625
                       + P  SL    D +L  P      ++++G +     I+ +     +GL
Sbjct: 92  ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            Y+H      ++HRDLK  N+ ++ D   KI DFGLAR     E+ G     V T  Y +
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 191
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           PE  L  + ++   D++S G +M E L+GK
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                 +    L+L  M    L   ++   +      +A     E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           RI++RDLK  N+LLD   + +ISD GLA  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 694 FSIKSDVFSFGILMLETLSGK 714
           ++   D ++ G L+ E ++G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 521 LGEGGFGPVY--KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G F  V+  K RL  G+  A+K +           +NE+ ++ K++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLYLHQYSRFRII 637
                  L+++ +    L    FD   +R +  +   + +I+ +   + YLH+     I+
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 638 HRDLKASNVL-LDMDMNPKI--SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
           HRDLK  N+L L  + N KI  +DFGL++M    E  G      GT GY++PE      +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 695 SIKSDVFSFGILMLETLSG 713
           S   D +S G++    L G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           +G G +G V       +G++VA+K+LS   QS    +    E++L+  +QH N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 578 CVEQGEKILILEYMPNKSL----DVFLFDPTKK----RLLGWQARVTIIEGIA----QGL 625
                       + P  SL    D +L  P  +    +++G +     I+ +     +GL
Sbjct: 110 ------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL 157
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            Y+H      ++HRDLK  N+ ++ D   KI DFGLAR     E+ G     V T  Y +
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRA 209
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           PE  L  + ++   D++S G +M E L+GK
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL---EEFKNEMMLIAKLQHRNLVK 573
           ++C +G+G +G V++G    G+ VAVK  SS+  +      E  N +ML    +H N++ 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILG 66
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH---- 629
            +   +        L  + +      L+D  +   L   + + I+  IA GL +LH    
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 630 -QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ---GNTKRIVGTYGYMS 685
               +  I HRDLK+ N+L+  +    I+D GLA M      Q   GN  R VGT  YM+
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMA 185
Query: 686 PEYALDGLFSI-------KSDVFSFGILMLETLSGKKNTGV 719
           PE  LD    +       + D+++FG+++ E      + G+
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN---LVKLL 575
           ++G G  G V+K R    G  +AVK++  +SG   E  +  M L   L+  +   +V+  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 576 GCCVEQGEKILILEYMPN--KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           G  +   +  + +E M    + L   +  P  +R+LG   ++T+   I + L YL +  +
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG---KMTV--AIVKALYYLKE--K 143
Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY----- 688
             +IHRD+K SN+LLD     K+ DFG++     D+ +    R  G   YM+PE      
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPD 200
Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                + I++DV+S GI ++E  +G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           LG+GGFG V        G++   +++  KR+  + G+ +    NE  ++ K+  R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                 +    L+L  M    L   ++   +      +A     E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
           RI++RDLK  N+LLD   + +ISD GLA  +  G  ++G     VGT GYM+PE   +  
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 361
Query: 694 FSIKSDVFSFGILMLETLSGK 714
           ++   D ++ G L+ E ++G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 38/227 (16%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPV-----------YKGRLLNGQEVAVKRLSSQSGQGL 553
           +A+    T+++ +  +LG+G F  V           Y  +++N      K+LS++  Q L
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIIN-----TKKLSARDHQKL 77
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQA 613
           E    E  +   L+H N+V+L     E+G   L+ + +    L    F+    R    +A
Sbjct: 78  E---REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEA 130
Query: 614 RVT-IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDE 669
             +  I  I + + ++HQ+    I+HRDLK  N+LL         K++DFGLA      E
Sbjct: 131 DASHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA-----IE 182
Query: 670 LQGNTKR---IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +QG  +      GT GY+SPE      +    D+++ G+++   L G
Sbjct: 183 VQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     +G G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           ++  +    LVKL     +     +++EYMP    D+F       R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                YLH      +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 151 VLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE 580
           +G+G FG VY GR      + +  +   +   L+ FK E+M   + +H N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRD 640
                +I      ++L   + D   K +L       I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 641 LKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY-----------MSPEYA 689
           LK+ NV  D +    I+DFGL  + G  +      ++    G+           +SP+  
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 690 LDGL-FSIKSDVFSFGILMLE 709
            D L FS  SDVF+ G +  E
Sbjct: 215 EDKLPFSKHSDVFALGTIWYE 235

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     +G G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           ++  +    LVKL     +     +++EYMP    D+F       R     AR    + I
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-I 150
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                YLH      +I+RDLK  N+L+D     K++DFG A+      ++G T  + GT 
Sbjct: 151 VLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTP 202
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G F  V        Q+ VA+K ++ ++ +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
              G   LI++ +    L    FD   +K     +    +I  +   + YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IV 138
Query: 638 HRDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL 693
           HRDLK  N+L   LD D    ISDFGL++M    E  G+      GT GY++PE      
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 694 FSIKSDVFSFGILMLETLSG 713
           +S   D +S G++    L G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGL---EEFKNEMMLIAKLQHRNLVK 573
           ++C +G+G +G V++G    G+ VAVK  SS+  +      E  N +ML    +H N++ 
Sbjct: 13  LEC-VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILG 66
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH---- 629
            +   +        L  + +      L+D  +   L   + + I+  IA GL +LH    
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 630 -QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ---GNTKRIVGTYGYMS 685
               +  I HRDLK+ N+L+  +    I+D GLA M      Q   GN  R VGT  YM+
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMA 185
Query: 686 PEYALDGLFSI-------KSDVFSFGILMLETLSGKKNTGV 719
           PE  LD    +       + D+++FG+++ E      + G+
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 9/221 (4%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQHRNLVKLLGCC 578
           +GEG +G V      +    VA+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
                + +   Y+    ++  L+   K + L        +  I +GL Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
           RDLK SN+L++   + KI DFGLAR+   + +  G     V T  Y +PE  L+     K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 698 S-DVFSFGILMLETLSGKKN-TGVYNADSFN-LLGYVSNKS 735
           S D++S G ++ E LS +    G +  D  N +LG + + S
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLEEFKNEMMLIAKLQH 568
           A ++ F ++ +LG G    VY+ +    Q+  A+K L     + +   + E+ ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSH 107
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLY 627
            N++KL        E  L+LE +    L    FD   +K     +     ++ I + + Y
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 628 LHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           LH+     I+HRDLK  N+L      D   KI+DFGL+++    E Q   K + GT GY 
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYC 217
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +PE      +  + D++S GI+    L G
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 514 NFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +FS+   +G GGFG VY       G++   + +  KR+  + G+ L   +  M+ +    
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGI 621
               +  +       +K+  IL+ M    L   L     F     R    +    II G+
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE----IILGL 304
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                  H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+
Sbjct: 305 E------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 353
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           GYM+PE    G+ +   +D FS G ++ + L G
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L+E +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     K++DFGLA+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G F  V        Q+ VA+K ++ ++ +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
              G   LI++ +    L    FD   +K     +    +I  +   + YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IV 138
Query: 638 HRDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL 693
           HRDLK  N+L   LD D    ISDFGL++M    E  G+      GT GY++PE      
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 694 FSIKSDVFSFGILMLETLSG 713
           +S   D +S G++    L G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 17/218 (7%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNE 559
           F + +    ++N+ ++ +LG+G F  V +      G E A K ++++  S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 560 MMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-II 618
             +  KLQH N+V+L     E+    L+ + +    L    F+    R    +A  +  I
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCI 134
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMN---PKISDFGLARMFGGDELQGNTK 675
           + I + + Y H      I+HR+LK  N+LL         K++DFGLA      E      
Sbjct: 135 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-- 189
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              GT GY+SPE      +S   D+++ G+++   L G
Sbjct: 190 -FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 514 NFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +FS+   +G GGFG VY       G++   + +  KR+  + G+ L   +  M+ +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGI 621
               +  +       +K+  IL+ M    L   L     F     R    +    II G+
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE----IILGL 305
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                  H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+
Sbjct: 306 E------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 354
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           GYM+PE    G+ +   +D FS G ++ + L G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 514 NFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +FS+   +G GGFG VY       G++   + +  KR+  + G+ L   +  M+ +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGI 621
               +  +       +K+  IL+ M    L   L     F     R    +    II G+
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE----IILGL 305
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                  H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+
Sbjct: 306 E------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 354
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           GYM+PE    G+ +   +D FS G ++ + L G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 514 NFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
           +FS+   +G GGFG VY       G++   + +  KR+  + G+ L   +  M+ +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGI 621
               +  +       +K+  IL+ M    L   L     F     R    +    II G+
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE----IILGL 305
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
                  H ++RF +++RDLK +N+LLD   + +ISD GLA  F   +   +    VGT+
Sbjct: 306 E------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 354
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           GYM+PE    G+ +   +D FS G ++ + L G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMM---- 561
            +    E+F +   LG+G FG V+        Q  A+K L        ++ +  M+    
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           L    +H  L  +  C  +  E +  ++EY+    L   +    K  L    +R T    
Sbjct: 72  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAA 126
Query: 621 -IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRI 677
            I  GL +LH      I++RDLK  N+LLD D + KI+DFG+ +  M G       T   
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEF 179
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            GT  Y++PE  L   ++   D +SFG+L+ E L G+
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G F  V        Q+ VA+K ++ ++ +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
              G   LI++ +    L    FD   +K     +    +I  +   + YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 638 HRDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL 693
           HRDLK  N+L   LD D    ISDFGL++M    E  G+      GT GY++PE      
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 694 FSIKSDVFSFGILMLETLSG 713
           +S   D +S G++    L G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 521 LGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCC 578
           LG G F  V        Q+ VA+K ++ ++ +G E   +NE+ ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
              G   LI++ +    L    FD   +K     +    +I  +   + YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IV 138
Query: 638 HRDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL 693
           HRDLK  N+L   LD D    ISDFGL++M    E  G+      GT GY++PE      
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 694 FSIKSDVFSFGILMLETLSG 713
           +S   D +S G++    L G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAK 565
           S+    ++     +LG G +G V K R + +GQ +AVKR+ +       + +  +++   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLD 57
Query: 566 LQHRNL-----VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVTIIE 619
           +  R +     V   G    +G+  + +E M + SLD F      K + +       I  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I + L +LH  S+  +IHRD+K SNVL++     K+ DFG++     D  +       G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AG 171
Query: 680 TYGYMSPEYALDGL----FSIKSDVFSFGILMLE 709
              YM+PE     L    +S+KSD++S GI M+E
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K +      +S+ G   EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      K+ DFGLA  +  G E     K I GT  +++P
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K +      +S+ G   EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      K+ DFGLA  +  G E     K I GT  +++P
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVK----RLSSQSGQGL--EEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K    R S  S +G+  EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      K+ DFGLA  +  G E     K I GT  +++P
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 519 CK-LGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLLG 576
           CK +G G FG V++ +L+   EVA+K++        + FKN E+ ++  ++H N+V L  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 577 CCVEQGEKI------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
                G+K       L+LEY+P             K+ +        +  + + L Y+H 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 631 YSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                I HRD+K  N+LLD      K+ DFG A++    E   N   I   Y Y +PE  
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-YRAPELI 213
Query: 690 LDGL-FSIKSDVFSFGILMLETLSGK 714
                ++   D++S G +M E + G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K +      +S+ G   EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      K+ DFGLA  +  G E     K I GT  +++P
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K +      +S+ G   EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSP 686
             +I H DLK  N++L +D N      K+ DFGLA  +  G E     K I GT  +++P
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAP 187
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E        +++D++S G++    LSG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQSGQGLEEFKNEMM 561
           AS +   ++F +   +G G +  V   RL     +     VK+      + ++  + E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 562 LIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +  +   H  LV L  C   +     ++EY+    L   +F   ++R L  +        
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE 129
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           I+  L YLH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSXFC 182
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      +    D ++ G+LM E ++G+
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           ++++  +G G +G V K  +  G  +  A K++     + ++ FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     +  +  L++E      L         KR+        I++ +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 633 RFRIIHRDLKASNVLLDMDM--NP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +  + HRDLK  N L   D   +P K+ DFGLA  F   ++   TK  VGT  Y+SP+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTK--VGTPYYVSPQ-V 179
Query: 690 LDGLFSIKSDVFSFGILMLETLSG 713
           L+GL+  + D +S G++M   L G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           KLGEG +  VYKG+  L    VA+K  RL  + G      + E+ L+  L+H N+V L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
               +    L+ EY+ +K L  +L D     ++        +  + +GL Y H   R ++
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS 695
           +HRDLK  N+L++     K++DFGLAR         + +  V T  Y  P+  L    +S
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVTLWYRPPDILLGSTDYS 179
Query: 696 IKSDVFSFGILMLETLSGK 714
            + D++  G +  E  +G+
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM---- 561
            +    E+F +   LG+G FG V+        Q  A+K L        ++ +  M+    
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKIL-ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           L    +H  L  +  C  +  E +  ++EY+    L   +    K  L    +R T    
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAA 125
Query: 621 -IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRI 677
            I  GL +LH      I++RDLK  N+LLD D + KI+DFG+ +  M G       T   
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNXF 178
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            GT  Y++PE  L   ++   D +SFG+L+ E L G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           ++++  +G G +G V K  +  G  +  A K++     + ++ FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     +  +  L++E      L         KR+        I++ +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 633 RFRIIHRDLKASNVLLDMDM--NP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +  + HRDLK  N L   D   +P K+ DFGLA  F   ++   TK  VGT  Y+SP+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTK--VGTPYYVSPQ-V 196
Query: 690 LDGLFSIKSDVFSFGILMLETLSG 713
           L+GL+  + D +S G++M   L G
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRL------SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +LG G F  V K R  + G E A K +      +S+ G   EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L      + + +LILE +    L  FL    +K  L  +   + I+ I  G+ YLH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 633 RFRIIHRDLKASNVLLDMDMN-----PKISDFGLARMFGGDELQGNT--KRIVGTYGYMS 685
             +I H DLK  N++L +D N      K+ DFGLA      E++     K I GT  +++
Sbjct: 135 --KIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAH-----EIEDGVEFKNIFGTPEFVA 186
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE        +++D++S G++    LSG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 24/184 (13%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
                 V   +   +R+  L +Q  V        G+ +LH      IIHRDLK SN+++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G++M E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 710 TLSG 713
            + G
Sbjct: 218 MIKG 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQSGQGLEEFKNEMM 561
           AS +   ++F +   +G G +  V   RL     +     VK+      + ++  + E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 562 LIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG 620
           +  +   H  LV L  C   +     ++EY+    L   +F   ++R L  +        
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE 161
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
           I+  L YLH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFC 214
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           GT  Y++PE      +    D ++ G+LM E ++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L+E +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     +++DFGLA+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 33/213 (15%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN-----LVK 573
           ++G G +G V K     +GQ +AVKR+ S      E+ + ++++   +  R+     +V+
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVF-------LFDPTKKRLLGWQARVTIIEGIAQGLL 626
             G    +G+  + +E M + S D F       L D   + +LG   ++T+     + L 
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG---KITL--ATVKALN 139
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMS 685
           +L +    +IIHRD+K SN+LLD   N K+ DFG++    G  +    K R  G   YM+
Sbjct: 140 HLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMA 193
Query: 686 PEY----ALDGLFSIKSDVFSFGILMLETLSGK 714
           PE     A    + ++SDV+S GI + E  +G+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 24/184 (13%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
                 V   +   +R+  L +Q  V        G+ +LH      IIHRDLK SN+++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G++M E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 710 TLSG 713
            + G
Sbjct: 218 MIKG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 11/214 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++      G   A K + +      E  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V L     +  E ++I E+M    L   + D   K  +     V  +  + +GL ++H+ 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +    +H DLK  N++     +   K+ DFGL       + + + K   GT  + +PE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
                   +D++S G+L    LSG    G  N D
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 11/214 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++      G   A K + +      E  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V L     +  E ++I E+M    L   + D   K  +     V  +  + +GL ++H+ 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 168
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
           +    +H DLK  N++     +   K+ DFGL       + + + K   GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 690 LDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
                   +D++S G+L    LSG    G  N D
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 256

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     +G G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     K++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 XTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 712 SGK 714
             K
Sbjct: 220 RHK 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 155 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWT 198
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 20  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 79
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 139
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 140 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWT 183
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 184 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIE 619
           ++  +    LVKL     +     +++EY+P   +    F   ++  R     AR    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 150 -IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 155 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 198
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     K++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIE 619
           ++  +    LVKL     +     +++EY+P   +    F   ++  R     AR    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 150 -IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIE 619
           ++  +    LVKL     +     +++EY P   +    F   ++  R     AR    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I     YLH      +I+RDLK  N+++D     K++DFG A+      ++G T  + G
Sbjct: 150 -IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 200
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 507 SVAAATENFSM-----QCK-LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFK 557
           SV  A   F++     Q K +G G  G V      + G  VAVK+LS   Q+    +   
Sbjct: 12  SVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 71
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGW 611
            E++L+  + H+N++ LL     Q       +  L++E M      V   +   +R+   
Sbjct: 72  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM--- 128
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
                ++  +  G+ +LH      IIHRDLK SN+++  D   KI DFGLAR    + + 
Sbjct: 129 ---SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 182
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             T  +V  Y Y +PE  L   ++   D++S G +M E + G
Sbjct: 183 --TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIE 619
           ++  +    LVKL     +     +++EY+P   +    F   ++  R     AR    +
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ 150
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  + G
Sbjct: 151 -IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 516 SMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVK 573
           + Q +LG G FG V++      G + AVK++       LE F+  E+M  A L    +V 
Sbjct: 77  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 130
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA-QGLLYLHQYS 632
           L G   E     + +E +   SL   +    K++    + R     G A +GL YLH  S
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQALEGLEYLH--S 184
Query: 633 RFRIIHRDLKASNVLLDMD-MNPKISDFGLARM-----FGGDELQGNTKRIVGTYGYMSP 686
           R RI+H D+KA NVLL  D  +  + DFG A        G D L G+   I GT  +M+P
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY--IPGTETHMAP 241
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E  L      K DV+S   +ML  L+G
Sbjct: 242 EVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM------SYLLYQMLCGIKHLH 143
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLL 575
           +Q  +G+G FG V++G+   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 64
Query: 576 GCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD   +  +  +  + +    A GL +LH  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 631 ----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYM 684
                 +  I HRDLK+ N+L+  +    I+D GLA       D +       VGT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 685 SPEYALDGLFSIK-------SDVFSFGILMLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 181 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 211

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 14  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 73
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +    F   ++  
Sbjct: 74  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG 129
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 130 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 182
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 183 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 143
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMML 562
           ++ S  A T    +Q  +G+G FG V++G+   G+EVAVK  SS+  +    F+  E+  
Sbjct: 2   AMGSTIART--IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQ 56
Query: 563 IAKLQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
              L+H N++  +    +      +  L+ +Y  + SL    FD   +  +  +  + + 
Sbjct: 57  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 112
Query: 619 EGIAQGLLYLHQ-----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQ 671
              A GL +LH        +  I HRDLK+ N+L+  +    I+D GLA       D + 
Sbjct: 113 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 172
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIK-------SDVFSFGILMLE 709
                 VGT  YM+PE  LD   ++K       +D+++ G++  E
Sbjct: 173 IAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 14  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 73
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +   L     F  
Sbjct: 74  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 133
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 134 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 182
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 183 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 XTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 712 SGK 714
             K
Sbjct: 220 RHK 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLL 575
           +Q  +G+G FG V++G+   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 63
Query: 576 GCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD   +  +  +  + +    A GL +LH  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 631 ----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYM 684
                 +  I HRDLK+ N+L+  +    I+D GLA       D +       VGT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 685 SPEYALDGLFSIK-------SDVFSFGILMLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 180 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 210

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 500 LPLFSLASVAAATENFSMQCK-LGEGGFGPVYKGRLLN---GQEVAVK-----RLSSQSG 550
           +P  S+A      E+    C+ +G+G F  V   R +N   GQ+ AVK     + +S  G
Sbjct: 12  VPRGSMADDDVLFEDVYELCEVIGKGPFSVVR--RCINRETGQQFAVKIVDVAKFTSSPG 69
Query: 551 QGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLG 610
              E+ K E  +   L+H ++V+LL      G   ++ E+M    L    F+  K+   G
Sbjct: 70  LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAG 126
Query: 611 WQARVTI----IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP---KISDFGLAR 663
           +     +    +  I + L Y H  +   IIHRD+K   VLL    N    K+  FG+A 
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 183
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             G   L    +  VGT  +M+PE      +    DV+  G+++   LSG
Sbjct: 184 QLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 105 DANLXQVIQMELDHERM------SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSD 155
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 156 XTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 712 SGK 714
             K
Sbjct: 213 RHK 215

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 520 KLGEGGFGPVYK-GRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           +LG G FG V++      G+    K +++         KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI------AQGLLYLHQYS 632
            ++ E +LILE++        LFD    R+     +++  E I       +GL ++H++S
Sbjct: 118 EDKYEMVLILEFLSGGE----LFD----RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 633 RFRIIHRDLKASNVLLDMDM--NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
              I+H D+K  N++ +     + KI DFGLA     DE+    K    T  + +PE   
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVD 223
Query: 691 DGLFSIKSDVFSFGILMLETLSG 713
                  +D+++ G+L    LSG
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRL--LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD 649
                 V   +   +R+  L +Q  V        G+ +LH      IIHRDLK SN+++ 
Sbjct: 112 DANLSQVIQMELDHERMSYLLYQMLV--------GIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 650 MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
            D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E
Sbjct: 161 SDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 710 TLSG 713
            + G
Sbjct: 218 MIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 181
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 235
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           T+ + +  +LG+G F  V +  ++  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLY 627
            N+V+L     E+G   L+ + +    L    F+    R    +A  +  I+ I + + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 628 LHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            H      I+HRDLK  N+LL         K++DFGLA    GD  Q       GT GY+
Sbjct: 119 CHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPGYL 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           SPE      +    D+++ G+++   L G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +   L     F  
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 517 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRNLVKLL 575
           +Q  +G+G FG V++G+   G+EVAVK  SS+  +    F+  E+     L+H N++  +
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 66
Query: 576 GCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ- 630
               +      +  L+ +Y  + SL    FD   +  +  +  + +    A GL +LH  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 631 ----YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYM 684
                 +  I HRDLK+ N+L+  +    I+D GLA       D +       VGT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 685 SPEYALDGLFSIK-------SDVFSFGILMLE 709
           +PE  LD   ++K       +D+++ G++  E
Sbjct: 183 APE-VLDDSINMKHFESFKRADIYAMGLVFWE 213

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQSGQGLEEFKNEMMLIAKLQ- 567
           ++F +   +G G +  V   RL     +     VK+      + ++  + E  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H  LV L  C   +     ++EY+    L   +F   ++R L  +        I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
           LH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y++
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSXFCGTPNYIA 178
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE      +    D ++ G+LM E ++G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQSGQGLEEFKNEMMLIAKLQ- 567
           ++F +   +G G +  V   RL     +     VK+      + ++  + E  +  +   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H  LV L  C   +     ++EY+    L   +F   ++R L  +        I+  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
           LH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y++
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSXFCGTPNYIA 174
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE      +    D ++ G+LM E ++G+
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQH 568
           T+ + +  +LG+G F  V +  ++  GQE A K ++++  S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLY 627
            N+V+L     E+G   L+ + +    L    F+    R    +A  +  I+ I + + +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 628 LHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            H      I+HRDLK  N+LL         K++DFGLA    GD  Q       GT GY+
Sbjct: 119 CHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPGYL 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           SPE      +    D+++ G+++   L G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +   L     F  
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY P   +   L     F  
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+++D     K++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +   L     F  
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 521 LGEGGFGPVYKGRLLN---GQEVAVK-----RLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +G+G F  V   R +N   GQ+ AVK     + +S  G   E+ K E  +   L+H ++V
Sbjct: 32  IGKGPFSVVR--RCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI----IEGIAQGLLYL 628
           +LL      G   ++ E+M    L    F+  K+   G+     +    +  I + L Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           H  +   IIHRD+K   VLL    N    K+  FG+A   G   L    +  VGT  +M+
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMA 201
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE      +    DV+  G+++   LSG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
           +A+G+ +L   S  + IHRDL A N+LL  +   KI DFGLAR      D ++    R+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSF 725
               +M+PE   D ++S KSDV+S+G+L+ E  +L G    GV   + F
Sbjct: 264 -PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 CTLKILDFGLARTAGTSFMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 712 SG 713
            G
Sbjct: 220 KG 221

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   +    G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   +    G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   +    G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+P   +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 150 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 200
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 201 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 712 SGK 714
             K
Sbjct: 258 RHK 260

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
           K+GEG +G V+K +     E VA+KR+      +G+      E+ L+ +L+H+N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                 +  L+ E+  ++ L  + FD     L     +  + + + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRN---V 122
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFS 695
           +HRDLK  N+L++ +   K++DFGLAR FG   ++  +  +V T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 696 IKSDVFSFGILMLETLSGKK 715
              D++S G +  E  +  +
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  +   +    LVKL     +     ++LEY P   +   L     F  
Sbjct: 82  KLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     K++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLF-SLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  + S A   A  + F     LG G FG V   +    G   A+K L  Q   
Sbjct: 42  KAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVV 101
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+P   +   L     F  
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 161
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 162 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 210
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 211 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 507 SVAAATENFSM-----QCK-LGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFK 557
           SV  A   F++     Q K +G G  G V      + G  VAVK+LS   Q+    +   
Sbjct: 10  SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 69
Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGW 611
            E++L+  + H+N++ LL     Q       +  L++E M      V   +   +R+   
Sbjct: 70  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM--- 126
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
                ++  +  G+ +LH      IIHRDLK SN+++  D   KI DFGLAR    + + 
Sbjct: 127 ---SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM 180
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             T  +V  Y Y +PE  L   +    D++S G +M E + G
Sbjct: 181 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    L KL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     K++DFG A+      ++G T  
Sbjct: 155 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWX 198
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    L KL     +     +++EY P   +   L     F     R    Q  +T
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+++D     K++DFG A+      ++G T  
Sbjct: 155 --------FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWX 198
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 142
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 143 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 196
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 143
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
           VA+K+LS   Q+    +    E++L+  + H+N++ LL              + P KSL+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 VF--------LFDPTKKRLLGWQ---ARVT-IIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
            F        L D    +++  +    R++ ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
           +++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LMLETLSG 713
           +M E + G
Sbjct: 214 IMGEMIKG 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 35  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIE 619
           ++  +    L KL     +     +++EY P   +    F   ++  R     AR    +
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ 150
Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            I     YLH      +I+RDLK  N+++D     K++DFG A+      ++G T  + G
Sbjct: 151 -IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 201
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 516 SMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLVK 573
           + Q +LG G FG V++      G + AVK++       LE F+  E+M  A L    +V 
Sbjct: 96  THQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVP 149
Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA-QGLLYLHQYS 632
           L G   E     + +E +   SL   +    K++    + R     G A +GL YLH  S
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQALEGLEYLH--S 203
Query: 633 RFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNT---KRIVGTYGYMSPEY 688
           R RI+H D+KA NVLL  D  +  + DFG A     D L  +      I GT  +M+PE 
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
            L      K DV+S   +ML  L+G
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 144
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 198
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 143
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 105/264 (39%), Gaps = 73/264 (27%)
Query: 517 MQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQ-GLEEFKNEMMLIAKLQHRNLVKL 574
           +QC +G GGFG V++ +  ++    A+KR+   + +   E+   E+  +AKL+H  +V+ 
Sbjct: 11  IQC-MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 575 LGCCVE--------QGEKILILEY-----------MPNKSLDVFLFDP------------ 603
               +E        + ++I + +            M   S+ +   DP            
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 604 --------------TKKRLLGWQARVTIIEG------------IAQGLLYLHQYSRFRII 637
                          K+ L  W  R   +E             IA+ + +LH      ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LM 186
Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ----------GNTKRIVGTYGYMSPE 687
           HRDLK SN+   MD   K+ DFGL      DE +                VGT  YMSPE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
                 +S K D+FS G+++ E L
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 105 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 155
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 156 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 712 SGK 714
             K
Sbjct: 213 RHK 215

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 113 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 163
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 164 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 220
Query: 712 SGK 714
             K
Sbjct: 221 RHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  L++E M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 106 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 156
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 157 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 213
Query: 712 SGK 714
             K
Sbjct: 214 RHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 521 LGEGGFGPV---YKGRLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           +G G  G V   Y   L   + VA+K+LS   Q+    +    E++L+  + H+N++ LL
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 576 GCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                Q       +  L++E M      V   +   +R+        ++  +  G+ +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLH 137
Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 IIHRDLK SN+++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVI 191
Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
           L   +    D++S G +M E +  K
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 712 SG 713
            G
Sbjct: 220 KG 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSSQSGQGLEE-FKNEMMLIAKL 566
           ++ + +   +G G FG     RL+  ++    VAVK +  + G+ ++E  K E++    L
Sbjct: 18  SDRYELVKDIGAGNFG---VARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+V+     +      +++EY     L  F       R    +AR    + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVS 129
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           Y H     ++ HRDLK  N LLD    P  KI+DFG ++      L    K  VGT  Y+
Sbjct: 130 YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYI 183
Query: 685 SPEYALDGLFSIK-SDVFSFGILMLETLSG 713
           +PE  L   +  K +DV+S G+ +   L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 113 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 163
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 164 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 712 SG 713
            G
Sbjct: 221 KG 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
           VA+K+LS   Q+    +    E++L+  + H+N++ LL              + P KSL+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 VF--------LFDPTKKRLLGWQ---ARVT-IIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
            F        L D    +++  +    R++ ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
           +++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LMLETLSG 713
           +M E + G
Sbjct: 214 IMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 712 SG 713
            G
Sbjct: 220 KG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD 597
           VA+K+LS   Q+    +    E++L+  + H+N++ LL              + P KSL+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLE 99
Query: 598 VF--------LFDPTKKRLLGWQ---ARVT-IIEGIAQGLLYLHQYSRFRIIHRDLKASN 645
            F        L D    +++  +    R++ ++  +  G+ +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 646 VLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
           +++  D   KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 706 LMLETLSG 713
           +M E + G
Sbjct: 214 IMGEMIKG 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSSQSGQGLEE-FKNEMMLIAKL 566
           ++ + +   +G G FG     RL+  ++    VAVK +  + G+ ++E  K E++    L
Sbjct: 17  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 71
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+V+     +      +++EY     L  F       R    +AR    + +  G+ 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVS 128
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           Y H     ++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y+
Sbjct: 129 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 182
Query: 685 SPEYALDGLFSIK-SDVFSFGILMLETLSG 713
           +PE  L   +  K +DV+S G+ +   L G
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFK---NEMM 561
           A   A  + F     LG G FG V   + +  G   A+K L  Q    L++ +   NE  
Sbjct: 34  AQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVT 616
           ++  +    LVKL     +     +++EY+    +   L     F     R    Q  +T
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
                     YLH      +I+RDLK  N+L+D     +++DFG A+      ++G T  
Sbjct: 154 --------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWX 197
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
            E+    L+ E M   S+   L    K+R         +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 639 RDLKASNVLLDM--DMNP-KISDFGLARMFGGDELQGNTKRI--------VGTYGYMSPE 687
           RDLK  N+L +    ++P KI DFGL     G +L G+   I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 688 YA-----LDGLFSIKSDVFSFGILMLETLSG 713
                     ++  + D++S G+++   LSG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 21/227 (9%)
Query: 496 KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQ 551
           +D   P  +L  V     NF M   LG+G FG V        +E+ A+K L         
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMV--LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDD 61
Query: 552 GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTK---KR 607
            +E    E  ++A L     +  L  C +  +++  ++EY+    L   +    K    +
Sbjct: 62  DVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ 121
Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
            + + A ++I      GL +LH+     II+RDLK  NV+LD + + KI+DFG+ +    
Sbjct: 122 AVFYAAEISI------GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM 172
Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           D +   T+   GT  Y++PE      +    D +++G+L+ E L+G+
Sbjct: 173 DGV--TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 96/184 (52%), Gaps = 19/184 (10%)
Query: 539 EVAVKRLSSQSGQGLEEF-KNEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSL 596
           EV  +RLS +  + + E  + E  ++ ++  H +++ L+          L+ + M    L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
             +L   T+K  L  +   +I+  + + + +LH  +   I+HRDLK  N+LLD +M  ++
Sbjct: 188 FDYL---TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 657 SDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEY---ALDGL---FSIKSDVFSFGILMLE 709
           SDFG +  +  G++L    + + GT GY++PE    ++D     +  + D+++ G+++  
Sbjct: 242 SDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 710 TLSG 713
            L+G
Sbjct: 298 LLAG 301

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 520 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-SQSGQGLEEFK-NEMMLIAKLQHRNLVKLLG 576
           K+GEG +G V+K +     E VA+KR+      +G+      E+ L+ +L+H+N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                 +  L+ E+  ++ L  + FD     L     +  + + + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGLGFCHSRN---V 122
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFS 695
           +HRDLK  N+L++ +   K+++FGLAR FG   ++  +  +V T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 696 IKSDVFSFGILMLE 709
              D++S G +  E
Sbjct: 181 TSIDMWSAGCIFAE 194

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 14/237 (5%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMM 561
           A       +F     LG+G FG V   R    G+  A+K L  +     +E  +   E  
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           ++   +H  L  L            ++EY     L    F  +++R+   +        I
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 117
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
              L YLH      +++RD+K  N++LD D + KI+DFGL +    D      K   GT 
Sbjct: 118 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTP 172
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
            Y++PE   D  +    D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 227

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 521 LGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKL----- 574
           LG GG G V+     +  + VA+K++     Q ++    E+ +I +L H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 575 ---------LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
                    +G   E     ++ EYM     +V    P    LL   AR+ + + + +GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFMYQ-LLRGL 133
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGY 683
            Y+H  +   ++HRDLK +N+ ++  D+  KI DFGLAR+       +G+    + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 684 MSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
            SP   L    ++   D+++ G +  E L+GK
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL 608
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L      R 
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL------RR 134
Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
           +G  A        AQ +L         +I+RDLK  N+L+D     +++DFG A+     
Sbjct: 135 IGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   +    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRFR 635
                     ++EY     L    F  +++R+    +AR    E I   L YLH  S   
Sbjct: 216 SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKN 269
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +++RDLK  N++LD D + KI+DFGL +   G +     K   GT  Y++PE   D  + 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 696 IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 328 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 368

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   +    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRFR 635
                     ++EY     L    F  +++R+    +AR    E I   L YLH  S   
Sbjct: 219 SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKN 272
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +++RDLK  N++LD D + KI+DFGL +   G +     K   GT  Y++PE   D  + 
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 696 IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 331 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 371

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 114 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 164
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +       V T  Y +PE  L   +    D++S G +M E +
Sbjct: 165 CTLKILDFGLARTAGTSFMMVP---FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221
Query: 712 SG 713
            G
Sbjct: 222 KG 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 78  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 131
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDNDYGR 189
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 190 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 229

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 73  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 126
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 224

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 482 NEFGEVNGDGKDKGKDSWLPLFSLASVAAAT----------------ENFSMQCKLGEGG 525
            E GE +G  +  G     P  + ASVAA                  + + +   +G G 
Sbjct: 9   EEDGE-DGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGA 67
Query: 526 FGPVYKGRL-LNGQEVAVKRLS------SQSGQGLEEFKNEMMLIAKLQHRNLVKL---L 575
           +G V   R  L GQ+VA+K++       + + + L E K    ++   +H N++ +   L
Sbjct: 68  YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDIL 123
Query: 576 GCCVEQGE---KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              V  GE     ++L+ M +   D+     + + L     R  + + + +GL Y+H   
Sbjct: 124 RPTVPYGEFKSVYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMHSA- 178
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             ++IHRDLK SN+L++ +   KI DFG+AR       E Q      V T  Y +PE  L
Sbjct: 179 --QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 691 D-GLFSIKSDVFSFGILMLETLSGKK 715
               ++   D++S G +  E L+ ++
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 117 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 167
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 168 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 224
Query: 712 SGK 714
             K
Sbjct: 225 CHK 227

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 73  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 126
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 224

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 511 ATENFSMQC-------KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMML 562
           A ENF ++        +LG G +G V K R + +GQ  AVKR+ +       + +  ++ 
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS---QEQKRLLX 81
Query: 563 IAKLQHRNL-----VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-RLLGWQARVT 616
              +  R +     V   G    +G+ + I   + + SLD F      K + +       
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREGD-VWICXELXDTSLDKFYKQVIDKGQTIPEDILGK 140
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR 676
           I   I + L +LH  S+  +IHRD+K SNVL++     K  DFG++     D  +     
Sbjct: 141 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 677 IVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLE 709
             G   Y +PE     L    +S+KSD++S GI  +E
Sbjct: 197 -AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIE 232

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 482 NEFGEVNGDGKDKGKDSWLPLFSLASVAAAT----------------ENFSMQCKLGEGG 525
            E GE +G  +  G     P  + ASVAA                  + + +   +G G 
Sbjct: 8   EEDGE-DGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGA 66
Query: 526 FGPVYKGRL-LNGQEVAVKRLS------SQSGQGLEEFKNEMMLIAKLQHRNLVKL---L 575
           +G V   R  L GQ+VA+K++       + + + L E K    ++   +H N++ +   L
Sbjct: 67  YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDIL 122
Query: 576 GCCVEQGE---KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
              V  GE     ++L+ M +   D+     + + L     R  + + + +GL Y+H   
Sbjct: 123 RPTVPYGEFKSVYVVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQ-LLRGLKYMHSA- 177
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYAL 690
             ++IHRDLK SN+L++ +   KI DFG+AR       E Q      V T  Y +PE  L
Sbjct: 178 --QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 691 D-GLFSIKSDVFSFGILMLETLSGKK 715
               ++   D++S G +  E L+ ++
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 106 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 156
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +   T  +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 157 CTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMV 213
Query: 712 SGK 714
             K
Sbjct: 214 CHK 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 73  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 126
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   +    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRFR 635
                     ++EY     L    F  +++R+    +AR    E I   L YLH  S   
Sbjct: 78  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKN 131
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +++RDLK  N++LD D + KI+DFGL +   G +     K   GT  Y++PE   D  + 
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 189
Query: 696 IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 190 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 73  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 126
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   R    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
                     ++EY     L    F  +++R+   +        I   L YLH      +
Sbjct: 73  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 126
Query: 637 IHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           ++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE   D  +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 697 KSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRF 224

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   +    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRFR 635
                     ++EY     L    F  +++R+    +AR    E I   L YLH  S   
Sbjct: 77  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKN 130
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +++RDLK  N++LD D + KI+DFGL +   G +     K   GT  Y++PE   D  + 
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 696 IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 189 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 15/223 (6%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---EMMLIAKLQHRNLVKLLG 576
           LG+G FG V   +    G+  A+K L  +     +E  +   E  ++   +H  L  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 577 CCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW-QARVTIIEGIAQGLLYLHQYSRFR 635
                     ++EY     L    F  +++R+    +AR    E I   L YLH  S   
Sbjct: 76  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKN 129
Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           +++RDLK  N++LD D + KI+DFGL +   G +     K   GT  Y++PE   D  + 
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 696 IKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              D +  G++M E + G+     YN D   L   +  + + F
Sbjct: 188 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRF 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVKLLGCC 578
           +G G FG     R  L  + VAVK +  + G  ++E  + E++    L+H N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
           +      +I+EY     L   + +    R    +AR    + +  G+ Y H     +I H
Sbjct: 86  LTPTHLAIIMEYASGGELYERICN--AGRFSEDEARF-FFQQLLSGVSYCHS---MQICH 139
Query: 639 RDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
           RDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  L   +  
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 697 K-SDVFSFGILMLETLSG 713
           K +DV+S G+ +   L G
Sbjct: 197 KIADVWSCGVTLYVMLVG 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+    +    F   ++  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIG 136
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 137 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 545 LSSQSGQGLEEFK-NEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
            S++  Q L E    E+ ++ K+  H N+++L           L+ + M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
            T+K  L  +    I+  + + +  LH   +  I+HRDLK  N+LLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 663 -RMFGGDELQGNTKRIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSG 713
            ++  G++L    + + GT  Y++PE     +      +  + D++S G++M   L+G
Sbjct: 172 CQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 545 LSSQSGQGLEEFK-NEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
            S++  Q L E    E+ ++ K+  H N+++L           L+ + M    L  +L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 102
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
            T+K  L  +    I+  + + +  LH   +  I+HRDLK  N+LLD DMN K++DFG +
Sbjct: 103 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 663 -RMFGGDELQGNTKRIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSG 713
            ++  G++L    + + GT  Y++PE     +      +  + D++S G++M   L+G
Sbjct: 159 CQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 22  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 81
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 141
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 142 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+    +    F   ++  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIG 136
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 137 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +      +V  Y Y +PE  L   +    D++S G +M E +
Sbjct: 163 CTLKILDFGLARTAGTSFMM--EPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 219
Query: 712 SGK 714
             K
Sbjct: 220 CHK 222

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+    +    F   ++  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIG 136
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 137 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 16  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 75
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+    +    F   ++  
Sbjct: 76  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIG 131
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 132 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 184
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 185 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 545 LSSQSGQGLEEFK-NEMMLIAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
            S++  Q L E    E+ ++ K+  H N+++L           L+ + M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
            T+K  L  +    I+  + + +  LH   +  I+HRDLK  N+LLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 663 -RMFGGDELQGNTKRIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSG 713
            ++  G++L    + + GT  Y++PE     +      +  + D++S G++M   L+G
Sbjct: 172 CQLDPGEKL----RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGRLLNGQEV--AVKRLSSQSGQGLEEFKNEM----MLI 563
           A   +F     +G+G FG V   R    +EV  AVK L  ++    +E K+ M    +L+
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
             ++H  LV L        +   +L+Y+    L  F     ++  L  +AR    E IA 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IAS 150
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            L YLH      I++RDLK  N+LLD   +  ++DFGL +     E    T    GT  Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEY 205
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE      +    D +  G ++ E L G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           IA GL +L       II+RDLK  NV+LD + + KI+DFG+ +    D +   TK   GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             Y++PE      +    D ++FG+L+ E L+G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 8   KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 67
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 68  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 127
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 128 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAK 176
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 177 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 520 KLGEGGFGPVYKGRLLNGQ--------EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           ++G G F  VYKG  L+ +        E+  ++L+    Q    FK E   +  LQH N+
Sbjct: 33  EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNI 87
Query: 572 VKLLGC--CVEQGEK--ILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGL 625
           V+         +G+K  +L+ E   + +L  +L  F   K ++L    R      I +GL
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR-----QILKGL 142
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            +LH  +   IIHRDLK  N+ +     + KI D GLA +    +     K ++GT  + 
Sbjct: 143 QFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE   +  +    DV++FG   LE  + +
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 42  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 101
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-- 606
            L++ +   NE  ++  +    LVKL     +     +++EY+    +    F   ++  
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIG 157
Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           R     AR    + I     YLH      +I+RDLK  N+L+D     +++DFG A+   
Sbjct: 158 RFXEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 210
Query: 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
              ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 211 --RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 42  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 101
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 161
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 162 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 210
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 211 -----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 540 VAVKRLSS--QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------EKILILEYM 591
           VA+K+LS   Q+    +    E++L+  + H+N++ LL     Q       +  +++E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD 651
                 V   +   +R+        ++  +  G+ +LH      IIHRDLK SN+++  D
Sbjct: 112 DANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
              KI DFGLAR  G   +       V T  Y +PE  L   +    D++S G +M E +
Sbjct: 163 CTLKILDFGLARTAGTSFMMEPE---VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219
Query: 712 SGK 714
             K
Sbjct: 220 CHK 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
            E+    L+ E M   S+   L    K+R         +++ +A  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 639 RDLKASNVLLDM--DMNP-KISDFGLARMFGGDELQGNTKRI--------VGTYGYMSPE 687
           RDLK  N+L +    ++P KI DF L     G +L G+   I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 688 YA-----LDGLFSIKSDVFSFGILMLETLSG 713
                     ++  + D++S G+++   LSG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQ 567
            E++ +   +G G FG V   R    Q+V   +L S+           F  E  ++A   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 568 HRNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQ 623
              +V+L   C  Q +K L  ++EYMP   L   +  +D  +K    W    T     A+
Sbjct: 134 SPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AE 182
Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            +L L       +IHRD+K  N+LLD   + K++DFG   M   +    +    VGT  Y
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPDY 241
Query: 684 MSPEY----ALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE       DG +  + D +S G+ + E L G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSSQSGQGLEE-FKNEMMLIAKL 566
           ++ + +   +G G FG     RL+  ++    VAVK +  + G+ ++E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+V+     +      +++EY     L  F       R    +AR    + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVS 129
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           Y H     ++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYI 183
Query: 685 SPEYALDGLFSIK-SDVFSFGILMLETLSG 713
           +PE  L   +  K +DV+S G+ +   L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  L   ++   D ++ G+L+ +  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E + +   LG G FG V++    + ++  + +     G      K E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
            L        E ++I E++    LD+F    T    L  +  V+ +  + + L +LH ++
Sbjct: 65  HLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 633 RFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFG-GDELQGNTKRIVGTYGYMSPEYA 689
              I H D++  N++     +   KI +FG AR    GD    N + +     Y +PE  
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSIKSDVFSFGILMLETLSG 713
              + S  +D++S G L+   LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LG+G    V++GR    G   A+K  ++ S  + ++    E  ++ KL H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 579 VEQG--EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
            E     K+LI+E+ P  SL   L +P+    L     + ++  +  G+ +L +     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 637 IHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           +HR++K  N++     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLYGTEEYLHPD 185

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 12/205 (5%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           ++ + +   +G G FG     R     E+   +   +  +     K E++    L+H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V+     +      +++EY     L  F       R    +AR    + +  G+ Y H  
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVSYCHA- 133
Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              ++ HRDLK  N LLD    P  KI DFG ++      L    K  VGT  Y++PE  
Sbjct: 134 --MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 690 LDGLFSIK-SDVFSFGILMLETLSG 713
           L   +  K +DV+S G+ +   L G
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 520 KLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS-GQGLE-EFKNEMMLI--AKLQHRNLVKL 574
           +LG G F  V +      GQE A K L  +  GQ    E  +E+ ++  AK   R ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 575 LGCCVEQGEKILILEYMPNKSLDVF-LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
                   E ILILEY      ++F L  P    ++     + +I+ I +G+ YLHQ + 
Sbjct: 95  HEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 634 FRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
             I+H DLK  N+LL   + P    KI DFG++R  G        + I+GT  Y++PE  
Sbjct: 152 --IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEIL 205
Query: 690 LDGLFSIKSDVFSFGIL 706
                +  +D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGII 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLV 572
            + Q +LG G FG V++ +    G + AVK++       LE F+  E++  A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA-QGLLYLHQY 631
            L G   E     + +E +   SL   +    K+     + R     G A +GL YLH  
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR 183
Query: 632 SRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNT---KRIVGTYGYMSPE 687
              RI+H D+KA NVLL  D     + DFG A     D L  +      I GT  +M+PE
Sbjct: 184 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             +      K D++S   +ML  L+G
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 521 LGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LG+G    V++GR    G   A+K  ++ S  + ++    E  ++ KL H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 579 VEQG--EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRI 636
            E     K+LI+E+ P  SL   L +P+    L     + ++  +  G+ +L +     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 637 IHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           +HR++K  N++     D     K++DFG AR    DE       + GT  Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+++D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++PE  +   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQH 568
           ++F +   +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             LV L     ++ +  ++++ +    L   L    ++ +   +  V +   I + ++ L
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLF--ICELVMAL 128
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                 RIIHRD+K  N+LLD   +  I+DF +A M    E Q  T  + GT  YM+PE 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITT--MAGTKPYMAPEM 185
Query: 689 --ALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYNADS 724
             +  G  +S   D +S G+   E L G++   + ++ S
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSSQSGQGLEE-FKNEMMLIAKL 566
           ++ + +   +G G FG     RL+  ++    VAVK +  + G+ ++E  K E++    L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSL 72
Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +H N+V+     +      +++EY     L  F       R    +AR    + +  G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-FFQQLISGVS 129
Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           Y H     ++ HRDLK  N LLD    P  KI  FG ++      L    K  VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYI 183
Query: 685 SPEYALDGLFSIK-SDVFSFGILMLETLSG 713
           +PE  L   +  K +DV+S G+ +   L G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   +L N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           + +  L     +     L+++Y     L + L    + RL    AR  +    A+ ++ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAI 188
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFG-LARMFGGDELQGNTKRIVGTYGYMSPE 687
               +   +HRD+K  N+L+DM+ + +++DFG   ++     +Q +    VGT  Y+SPE
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPE 246
Query: 688 Y--ALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
              A++   G +  + D +S G+ M E L G+  T  Y        G + N    F
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHKERF 300

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           IA GL +L       II+RDLK  NV+LD + + KI+DFG+ +    D +   TK   GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             Y++PE      +    D ++FG+L+ E L+G+
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLV 572
            + Q ++G G FG V++ +    G + AVK++       LE F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA-QGLLYLHQY 631
            L G   E     + +E +   SL   +    K+     + R     G A +GL YLH  
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 632 SRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNT---KRIVGTYGYMSPE 687
              RI+H D+KA NVLL  D     + DFG A     D L  +      I GT  +M+PE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             +      K D++S   +ML  L+G
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT  Y++P   L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFK-NEMMLIAKLQHRNLV 572
            + Q ++G G FG V++ +    G + AVK++       LE F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA-QGLLYLHQY 631
            L G   E     + +E +   SL   +    K+     + R     G A +GL YLH  
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 632 SRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNT---KRIVGTYGYMSPE 687
              RI+H D+KA NVLL  D     + DFG A     D L  +      I GT  +M+PE
Sbjct: 186 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             +      K D++S   +ML  L+G
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLE--EFKNEMMLIAK 565
               +N+ ++  +G G +G VY     N  + VA+K+++      ++      E+ ++ +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 566 LQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           L+   +++L    + +     +++ I+  + +  L      P     L  Q   TI+  +
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNL 140
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             G  ++H+     IIHRDLK +N LL+ D + KI DFGLAR    D+
Sbjct: 141 LLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 111/253 (43%), Gaps = 25/253 (9%)
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLAS--VAAATENFSMQCKLGEGGFGPVYKGRLLN 536
           T   +F   + D  D G D      S A+  ++     +S+  ++G GG   V++     
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 537 GQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEYMP 592
            Q  A+K   L     Q L+ ++NE+  + KLQ  +  +++L    +      +++E   
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-- 137
Query: 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
             ++D+  +   KK +  W+ R +  + + + +  +HQ+    I+H DLK +N L+ +D 
Sbjct: 138 -GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDG 191
Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS-----------DVF 701
             K+ DFG+A     D         VGT  YM PE   D   S ++           DV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 702 SFGILMLETLSGK 714
           S G ++     GK
Sbjct: 252 SLGCILYYMTYGK 264

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 494 KGKDSWLPLFSLASV-AAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ 551
           K K+ +L  +   S   A  + F     LG G FG V   +   +G   A+K L  Q   
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 552 GLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDP 603
            L++ +   NE  ++  +    LVKL     +     +++EY+    +   L     F  
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
              R    Q  +T          YLH      +I+RDLK  N+L+D     +++DFG A+
Sbjct: 141 PHARFYAAQIVLT--------FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
                 ++G T  + GT   ++PE  L   ++   D ++ G+L+ E  +G
Sbjct: 190 -----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 521 LGEGGFGPVYKGRLLNGQEVAVKRLSSQSG-------QGLEEFKNEMMLIAKLQHRNLVK 573
           LGEG +G V +  +L+ + +  + +             G    K E+ L+ +L+H+N+++
Sbjct: 13  LGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 574 LLGCCV--EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           L+      E+ +  +++EY     +   L    +KR    QA     + +  GL YLH  
Sbjct: 71  LVDVLYNEEKQKMYMVMEYC-VCGMQEMLDSVPEKRFPVCQAHGYFCQ-LIDGLEYLHSQ 128
Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA-- 689
               I+H+D+K  N+LL      KIS  G+A            +   G+  +  PE A  
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 690 LDGLFSIKSDVFSFGILMLETLSG 713
           LD     K D++S G+ +    +G
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 492 KDKGKDSWLPLFS-----LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
           K+K  D++L  +      +  +    E++ +   +G G FG V   R  + ++V   +L 
Sbjct: 48  KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 107
Query: 547 SQ----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-- 600
           S+           F  E  ++A      +V+L     +     +++EYMP   L   +  
Sbjct: 108 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 167
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
           +D  +K    W    T     A+ +L L        IHRD+K  N+LLD   + K++DFG
Sbjct: 168 YDVPEK----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSG 713
              M    E        VGT  Y+SPE       DG +  + D +S G+ + E L G
Sbjct: 219 TC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 492 KDKGKDSWLPLFS-----LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
           K+K  D++L  +      +  +    E++ +   +G G FG V   R  + ++V   +L 
Sbjct: 43  KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 102
Query: 547 SQ----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-- 600
           S+           F  E  ++A      +V+L     +     +++EYMP   L   +  
Sbjct: 103 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 162
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
           +D  +K    W    T     A+ +L L        IHRD+K  N+LLD   + K++DFG
Sbjct: 163 YDVPEK----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSG 713
              M    E        VGT  Y+SPE       DG +  + D +S G+ + E L G
Sbjct: 214 TC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 14/219 (6%)
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLAS--VAAATENFSMQCKLGEGGFGPVYKGRLLN 536
           T   +F   + D  D G D      S A+  ++     +S+  ++G GG   V++     
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 537 GQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEYMP 592
            Q  A+K   L     Q L+ ++NE+  + KLQ  +  +++L    +      +++E   
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-- 137
Query: 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
             ++D+  +   KK +  W+ R +  + + + +  +HQ+    I+H DLK +N L+ +D 
Sbjct: 138 -GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDG 191
Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
             K+ DFG+A     D         VGT  YM PE   D
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
           LGEG +  V     L NG+E AVK +  Q+G        E+  + + Q ++N+++L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
            +     L+ E +   S+   L    K++    +    ++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 639 RDLKASNVLLDM--DMNP-KISDFGLARMFGGDELQGNTKRIV--------GTYGYMSPE 687
           RDLK  N+L +    ++P KI DF L     G +L  +   I         G+  YM+PE
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 688 YA-----LDGLFSIKSDVFSFGILMLETLSG 713
                      +  + D++S G+++   LSG
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 25/237 (10%)
Query: 492 KDKGKDSWLPLFS-----LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS 546
           K+K  D++L  +      +  +    E++ +   +G G FG V   R  + ++V   +L 
Sbjct: 48  KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 107
Query: 547 SQ----SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-- 600
           S+           F  E  ++A      +V+L     +     +++EYMP   L   +  
Sbjct: 108 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 167
Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG 660
           +D  +K    W    T     A+ +L L        IHRD+K  N+LLD   + K++DFG
Sbjct: 168 YDVPEK----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSG 713
              M    E        VGT  Y+SPE       DG +  + D +S G+ + E L G
Sbjct: 219 TC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIA 564
           S++     +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + 
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 565 KLQHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           KLQ  +  +++L    +      +++E     ++D+  +   KK +  W+ R +  + + 
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWE-RKSYWKNML 137
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           + +  +HQ+    I+H DLK +N L+ +D   K+ DFG+A     D         VGT  
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 683 YMSPEYALD 691
           YM PE   D
Sbjct: 194 YMPPEAIKD 202

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIA 564
           S++     +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + 
Sbjct: 22  SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 565 KLQHRN--LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           KLQ  +  +++L    +      +++E   N  L+ +L    KK +  W+ R +  + + 
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPWE-RKSYWKNML 137
Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           + +  +HQ+    I+H DLK +N L+ +D   K+ DFG+A     D         VGT  
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVN 193
Query: 683 YMSPEYALD 691
           YM PE   D
Sbjct: 194 YMPPEAIKD 202

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN-- 570
           +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +++L    +      +++E     ++D+  +   KK +  W+ R +  + + + +  +HQ
Sbjct: 71  IIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 126
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +    I+H DLK +N L+ +D   K+ DFG+A     D         VGT  YM PE A+
Sbjct: 127 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AI 181
Query: 691 DGLFSIKS------------DVFSFGILMLETLSGK 714
             + S +             DV+S G ++     GK
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 107/244 (43%), Gaps = 39/244 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQHR 569
           + + ++  +G G +G V +    L  + VA+K++    +     +    E+ ++ +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 570 NLVKLLGCC----VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           ++VK+L       VE+ +++ ++  + +         P     L  +   T++  +  G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK---TLLYNLLVGV 169
Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF-----GGDEL---------- 670
            Y+H      I+HRDLK +N L++ D + K+ DFGLAR       G  +L          
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 671 ------QGNTKR----IVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSGKKNTGV 719
                   N KR     V T  Y +PE   L   ++   DV+S G +  E L+  K    
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 720 YNAD 723
           Y+AD
Sbjct: 287 YHAD 290

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           E+      LG+G F  ++KG          L+  EV +K L        E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           KL H++LV   G CV   E IL+ E++   SLD +L     K  +    ++ + + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDM-----NP---KISDFGLA-RMFGGDELQGNTK 675
           + +L + +   +IH ++ A N+LL  +      NP   K+SD G++  +   D LQ   +
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---E 179
Query: 676 RIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           RI     ++ PE   +    ++ +D +SFG  + E  SG
Sbjct: 180 RI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN-- 570
           +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +++L    +      +++E     ++D+  +   KK +  W+ R +  + + + +  +HQ
Sbjct: 74  IIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 129
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +    I+H DLK +N L+ +D   K+ DFG+A     D         VGT  YM PE A+
Sbjct: 130 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AI 184
Query: 691 DGLFSIKS------------DVFSFGILMLETLSGK 714
             + S +             DV+S G ++     GK
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-----------RLLNGQEVAVKRLSSQSGQGLEEFKN 558
           A  + + M   LG G  G V              R+++ ++ A+   S++        + 
Sbjct: 146 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG--SAREADPALNVET 203
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVT 616
           E+ ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++ 
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 258
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGN 673
             + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L   
Sbjct: 259 FYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-- 312
Query: 674 TKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 313 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-----------RLLNGQEVAVKRLSSQSGQGLEEFKN 558
           A  + + M   LG G  G V              R+++ ++ A+   S++        + 
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG--SAREADPALNVET 189
Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVT 616
           E+ ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++ 
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 244
Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGN 673
             + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L   
Sbjct: 245 FYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-- 298
Query: 674 TKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 299 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 515 FSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN-- 570
           +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +++L    +      +++E     ++D+  +   KK +  W+ R +  + + + +  +HQ
Sbjct: 70  IIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 125
Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
           +    I+H DLK +N L+ +D   K+ DFG+A     D         VGT  YM PE   
Sbjct: 126 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 691 D 691
           D
Sbjct: 182 D 182

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 31/232 (13%)
Query: 501 PLFSLASV--AAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS---GQGLE 554
           PL S  SV   A  + + M   LG G  G V         ++VA+K +S +    G   E
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 555 E-----FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKR 607
                  + E+ ++ KL H  ++K+     +  +  ++LE M    L    FD     KR
Sbjct: 62  ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR 116
Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARM 664
           L     ++   + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++
Sbjct: 117 LKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 172
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            G   L    + + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 173 LGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQ----HR 569
           LG+GGFG V+ G RL +  +VA+K +      G     +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
            +++LL     Q   +L+LE  P  + D+F +  T+K  LG          +   + + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 630 QYSRFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                 ++HRD+K  N+L+D+     K+ DFG   +   DE   +     GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFD---GTRVYSPPEW 209
Query: 689 -ALDGLFSIKSDVFSFGILMLETLSG 713
            +     ++ + V+S GIL+ + + G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 17/235 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   ++ N + + A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           + +  L     ++    L+++Y     L + L    + +L    AR  I E +    L +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 188
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
               +   +HRD+K  NVLLD++ + +++DFG + +   D+    +   VGT  Y+SPE 
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 689 --ALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             A++   G +  + D +S G+ M E L G+  T  Y        G + N    F
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHEERF 300

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 14/219 (6%)
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLAS--VAAATENFSMQCKLGEGGFGPVYKGRLLN 536
           T   +F   + D  D G D      S A+  ++     +S+  ++G GG   V++     
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79
Query: 537 GQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN--LVKLLGCCVEQGEKILILEYMP 592
            Q  A+K   L     Q L+ ++NE+  + KLQ  +  +++L    +      +++E   
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-- 137
Query: 593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM 652
             ++D+  +   KK +  W+ R +  + + + +  +HQ+    I+H DLK +N L+ +D 
Sbjct: 138 -GNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDG 191
Query: 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
             K+ DFG+A     D         VG   YM PE   D
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L   + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVKLLGC----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            N++ +         E   ++ I++ +    L   +      ++L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--------QGNTKR 676
           +  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR+              Q     
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 677 IVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            V T  Y +PE  L    +S   DV+S G ++ E
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 17/235 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   ++ N + + A+K L+        E   F+ E  ++     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           + +  L     ++    L+++Y     L + L    + +L    AR  I E +    L +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDL-LTLLSKFEDKLPEDMARFYIGEMV----LAI 204
Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
               +   +HRD+K  NVLLD++ + +++DFG + +   D+    +   VGT  Y+SPE 
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 689 --ALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF 738
             A++   G +  + D +S G+ M E L G+  T  Y        G + N    F
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHEERF 316

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L   + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVKLLGC----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            N++ +         E   ++ I++ +    L   +      ++L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--------QGNTKR 676
           +  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR+              Q     
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 677 IVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            V T  Y +PE  L    +S   DV+S G ++ E
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS---GQGLEE-----FKNEM 560
           A  + + M   LG G  G V         ++VA+K +S +    G   E       + E+
Sbjct: 6   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 65
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTII 618
            ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++   
Sbjct: 66  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFY 120
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTK 675
           + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    +
Sbjct: 121 QMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---R 173
Query: 676 RIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS---GQGLEE-----FKNEM 560
           A  + + M   LG G  G V         ++VA+K +S +    G   E       + E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTII 618
            ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++   
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFY 121
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTK 675
           + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    +
Sbjct: 122 QMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---R 174
Query: 676 RIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSS--QSGQGLEEFKNEMMLIAKLQH 568
           + +F ++  LGEG +G V        G+ VA+K++    +    L   + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 569 RNLVKLLGC----CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            N++ +         E   ++ I++ +    L   +      ++L        I    + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL--------QGNTKR 676
           +  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR+              Q     
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 677 IVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
            V T  Y +PE  L    +S   DV+S G ++ E
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS---GQGLEE-----FKNEM 560
           A  + + M   LG G  G V         ++VA+K +S +    G   E       + E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTII 618
            ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++   
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFY 121
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTK 675
           + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    +
Sbjct: 122 QMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---R 174
Query: 676 RIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQS---GQGLEE-----FKNEM 560
           A  + + M   LG G  G V         ++VA+K +S +    G   E       + E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 561 MLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPT--KKRLLGWQARVTII 618
            ++ KL H  ++K+     +  +  ++LE M    L    FD     KRL     ++   
Sbjct: 67  EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFY 121
Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTK 675
           + +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    +
Sbjct: 122 QMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---R 174
Query: 676 RIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSG 713
            + GT  Y++PE  +      ++   D +S G+++   LSG
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 41/239 (17%)
Query: 521 LGEGGFGP-VYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG G  G  VY+G + + ++VAVKR+  +     +  +   +L    +H N+++    C 
Sbjct: 32  LGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYF--CT 86
Query: 580 EQGEKI----------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           E+  +            + EY+  K       +P           +T+++    GL +LH
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQQTTSGLAHLH 135
Query: 630 QYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMFG-GDELQGNTKRIVGTYGY 683
                 I+HRDLK  N+L+ M      +   ISDFGL +    G         + GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 684 MSPEYALDGLF---SIKSDVFSFGILMLETLS-GKKNTGVYNADSFN-LLGYVSNKSLH 737
           ++PE   +      +   D+FS G +    +S G    G       N LLG  S   LH
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           E+      LG+G F  ++KG          L+  EV +K L        E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           KL H++LV   G C    E IL+ E++   SLD +L     K  +    ++ + + +A  
Sbjct: 68  KLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWA 125
Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDM-----NP---KISDFGLA-RMFGGDELQGNTK 675
           + +L + +   +IH ++ A N+LL  +      NP   K+SD G++  +   D LQ   +
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---E 179
Query: 676 RIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSG 713
           RI     ++ PE   +    ++ +D +SFG  + E  SG
Sbjct: 180 RI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 19/186 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSSQ--------SGQGLEEFKNEMML 562
           ++ +S    LG G FG V+        +EV VK +  +            L +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           +++++H N++K+L     QG   L++E      LD+F F     RL        +   I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRL-----DEPLASYIF 136
Query: 623 QGLLYLHQYSRFR-IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
           + L+    Y R + IIHRD+K  N+++  D   K+ DFG A      +L        GT 
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTI 193
Query: 682 GYMSPE 687
            Y +PE
Sbjct: 194 EYCAPE 199

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LGEG F    K     + Q  AVK +S +     ++    + L     H N+VKL     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT-IIEGIAQGLLYLHQYSRFRIIH 638
           +Q    L++E +    L    F+  KK+    +   + I+  +   + ++H      ++H
Sbjct: 77  DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVH 129
Query: 639 RDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           RDLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE      + 
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 696 IKSDVFSFGILMLETLSGK 714
              D++S G+++   LSG+
Sbjct: 188 ESCDLWSLGVILYTMLSGQ 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSSQSGQGLE--EFKNEMMLIAK 565
               +N+ ++  +G G +G VY     N ++ VA+K+++      ++      E+ ++ +
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 566 LQHRNLVKLLGCCVEQG----EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           L+   +++L    +       +++ I+  + +  L      P     L  +   TI+  +
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEEHIKTILYNL 138
Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             G  ++H+     IIHRDLK +N LL+ D + K+ DFGLAR    ++
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-----------L 553
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPTKKRLLGW 611
           +    E+ L+    H N++ L    V   E  +   Y+  + +  D+      ++ ++  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
           Q     +  I  GL  LH+     ++HRDL   N+LL  + +  I DF LAR    D   
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 672 GNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
            N    V    Y +PE  +    F+   D++S G +M E  + K
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQG-----------L 553
           +A + A    +++Q  +  G +G V  G    G  VA+KR+ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 554 EEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL--DVFLFDPTKKRLLGW 611
           +    E+ L+    H N++ L    V   E  +   Y+  + +  D+      ++ ++  
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
           Q     +  I  GL  LH+     ++HRDL   N+LL  + +  I DF LAR    D   
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 672 GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
            N    V    Y +PE  +    F+   D++S G +M E  + K
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 148
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 201
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 182
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 202
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 148
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 201
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 202
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 149
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 202
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 187
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 186
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 187
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 182
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 132
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 185
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 182
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 214
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 187
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 214
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 215
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 32/235 (13%)
Query: 502 LFSLASVAAATEN-------FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGL 553
           + SL + AAA E        F ++   G+G FG V  G+  + G  VA+K++        
Sbjct: 5   MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---- 60
Query: 554 EEFKNE----MMLIAKLQHRNLVKLLGCCVEQGEKI-------LILEYMPNKSLDVFLFD 602
             F+N     M  +A L H N+V+L       GE+        +++EY+P+ +L     +
Sbjct: 61  -RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118
Query: 603 PTKKRLLGWQARVTI-IEGIAQGLLYLHQYSRFRIIHRDLKASNVLL-DMDMNPKISDFG 660
             ++++      + + +  + + +  LH  S   + HRD+K  NVL+ + D   K+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            A+     E   N   I   Y Y +PE    +  ++   D++S G +  E + G+
Sbjct: 178 SAKKLSPSE--PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 229
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 215
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 215
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 162
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 215
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 214
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 161
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 214
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 168
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 221
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 520 KLGEGGFGPV--YKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           KLGEGGF  V   +G L +G   A+KR+     Q  EE + E  +     H N+++L+  
Sbjct: 36  KLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 578 CV-EQG---EKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           C+ E+G   E  L+L +    +L +       K   L     + ++ GI +GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV--------GTYGYM 684
                HRDLK +N+LL  +  P + D G         ++G+ + +          T  Y 
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ-ACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 685 SPEYALDGLFSIKS--------DVFSFGILMLETLSGK 714
           +PE     LFS++S        DV+S G ++   + G+
Sbjct: 211 APE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 229
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE M     D+F F   +  L    AR +    + + + + H  
Sbjct: 76  IRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 186
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 181
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 182 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 234
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 521 LGEGGFGPVYKG-RLLNGQEVAVKRLSSQSGQGLEEFKN------EMMLIAKLQH--RNL 571
           LG GGFG VY G R+ +   VA+K +         E  N      E++L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           ++LL         +LILE  P    D+F F   +  L    AR +    + + + + H  
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 156
Query: 632 SRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++HRD+K  N+L+D++    K+ DFG   +   D +  +     GT  Y  PE+  
Sbjct: 157 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFD---GTRVYSPPEWIR 209
Query: 691 DGLFSIKS-DVFSFGILMLETLSG 713
              +  +S  V+S GIL+ + + G
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCG 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	744
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-112
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-110
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-98
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-79
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-48
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-46
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-45
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-45
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-45
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-45
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-44
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-44
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-44
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-44
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-43
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-43
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-43
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-43
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-42
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-42
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-40
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	2e-11
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	5e-05
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	3e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	5e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	1e-10
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	7e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	4e-10
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	4e-09
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-06
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	1e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	3e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-08
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	1e-07
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	6e-05
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-06
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	4e-06
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-04
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	2e-05
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  342 bits (879), Expect = e-112
 Identities = 93/248 (37%), Positives = 132/248 (53%), Gaps = 16/248 (6%)

Query: 494 KGKDSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSS 547
           +  D+    FS   +   T NF  +       K+GEGGFG VYKG + N   VAVK+L++
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64

Query: 548 ----QSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP 603
                + +  ++F  E+ ++AK QH NLV+LLG   +  +  L+  YMPN SL   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
                L W  R  I +G A G+ +LH+      IHRD+K++N+LLD     KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD 723
                     T RIVGT  YM+PE  L G  + KSD++SFG+++LE ++G       + +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239

Query: 724 SFNLLGYV 731
              LL   
Sbjct: 240 PQLLLDIK 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  335 bits (862), Expect = e-110
 Identities = 98/253 (38%), Positives = 148/253 (58%), Gaps = 6/253 (2%)

Query: 484 FGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 543
           F +V  +   +     L  FSL  +  A++NFS +  LG GGFG VYKGRL +G  VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 544 RLSSQSGQGLE-EFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD 602
           RL  +  QG E +F+ E+ +I+   HRNL++L G C+   E++L+  YM N S+   L +
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 603 PTKKRL-LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL 661
             + +  L W  R  I  G A+GL YLH +   +IIHRD+KA+N+LLD +    + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNT---G 718
           A++    +    T  + GT G+++PEY   G  S K+DVF +G+++LE ++G++      
Sbjct: 181 AKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

Query: 719 VYNADSFNLLGYV 731
           + N D   LL +V
Sbjct: 240 LANDDDVMLLDWV 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  306 bits (785), Expect = 2e-98
 Identities = 85/215 (39%), Positives = 130/215 (60%), Gaps = 4/215 (1%)

Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
             L  +  AT NF  +  +G G FG VYKG L +G +VA+KR + +S QG+EEF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-LGWQARVTIIEGI 621
           ++  +H +LV L+G C E+ E ILI +YM N +L   L+      + + W+ R+ I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
           A+GL YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++     +    +  + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKN 716
           GY+ PEY + G  + KSDV+SFG+++ E L  +  
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  256 bits (657), Expect = 1e-79
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 22/232 (9%)

Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
               ++   +    +      G FG V+K +L   + VAVK    Q  Q   + + E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 563 IAKLQHRNLVKLLGCCVE----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           +  ++H N+++ +G          +  LI  +    SL  FL    K  ++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 619 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ 671
           E +A+GL YLH+         +  I HRD+K+ NVLL  ++   I+DFGLA  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 672 GNTKRIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSGKKNTG 718
           G+T   VGT  YM+PE     +       ++ D+++ G+++ E  S      
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  226 bits (578), Expect = 4e-68
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 36/245 (14%)

Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--M 560
            + +  +   +N  +   +G G +G VYKG L + + VAVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 561 MLIAKLQHRNLVKLLGCCVE-----QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV 615
             +  ++H N+ + +          + E +L++EY PN SL  +L          W +  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 616 TIIEGIAQGLLYLHQ------YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG-- 667
            +   + +GL YLH       + +  I HRDL + NVL+  D    ISDFGL+    G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 668 ----DELQGNTKRIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSGKK 715
                E        VGT  YM+PE  L+G  ++        + D+++ G++  E      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 716 NTGVY 720
           +    
Sbjct: 234 DLFPG 238

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (540), Expect = 6e-63
 Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 6/204 (2%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
            + +++ K+G G FG V++    +G +VAVK L  Q    + + EF  E+ ++ +L+H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V  +G   +     ++ EY+   SL   L     +  L  + R+++   +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                I+HR+LK+ N+L+D     K+ DFGL+R+     L   +K   GT  +M+PE   
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
           D   + KSDV+SFG+++ E  + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (520), Expect = 5e-60
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +   ++  +G G FG V K +    ++VA+K++ S+S    + F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           KL G C+      L++EY    SL   L              ++     +QG+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 633 RFRIIHRDLKASNVLLDMDMN-PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
              +IHRDLK  N+LL       KI DFG A      ++Q +     G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 692 GLFSIKSDVFSFGILMLETLSGKK 715
             +S K DVFS+GI++ E ++ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (514), Expect = 1e-59
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRL----SSQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
            +G GGFG VY+     G EVAVK           Q +E  + E  L A L+H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
           G C+++    L++E+     L+  L      + +     V     IA+G+ YLH  +   
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 636 IIHRDLKASNVLLDMDMNP--------KISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           IIHRDLK+SN+L+   +          KI+DFGLAR +             G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                +FS  SDV+S+G+L+ E L+G+
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (510), Expect = 1e-58
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)

Query: 520 KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
            LG+G FG   K      G+ + +K L     +    F  E+ ++  L+H N++K +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
            +      I EY+   +L   +     +    W  RV+  + IA G+ YLH      IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131

Query: 639 RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR------------IVGTYGYMSP 686
           RDL + N L+  + N  ++DFGLAR+   ++ Q    R            +VG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKK 715
           E      +  K DVFSFGI++ E +    
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (504), Expect = 4e-58
 Identities = 59/218 (27%), Positives = 113/218 (51%), Gaps = 25/218 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQG-------LEEFKNEMMLIA 564
                + ++G+GGFG V+KGRL+ +   VA+K L     +G        +EF+ E+ +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            L H N+VKL G         +++E++P   L   L D  K   + W  ++ ++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMFGGDELQGNTKRIVG 679
           + Y+       I+HRDL++ N+ L        +  K++DFGL++     +   +   ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 680 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSGKK 715
            + +M+PE   A +  ++ K+D +SF +++   L+G+ 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  195 bits (499), Expect = 2e-57
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
           +  +   KL E   G ++KGR   G ++ VK L  +  S +   +F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 571 LVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           ++ +LG C          I  +MP  SL   L + T   +      V     +A+G+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      I    L + +V++D DM  +IS   +   F        +   +    +++PE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178

Query: 689 ALDG----LFSIKSDVFSFGILMLETLSGK 714
           AL           +D++SF +L+ E ++ +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  195 bits (498), Expect = 4e-57
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 13/207 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRN 570
              ++  ++G G FG VYKG+  +G +VAVK L+    + Q L+ FKNE+ ++ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           ++  +G        I + ++    SL   L     K     +  + I    A+G+ YLH 
Sbjct: 82  ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
            S   IIHRDLK++N+ L  D   KI DFGLA            +++ G+  +M+PE   
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                 +S +SDV++FGI++ E ++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (477), Expect = 7e-54
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
            +G+G FG VY GR  +G EVA++ +  +  +   L+ FK E+M   + +H N+V  +G 
Sbjct: 40  LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
           C+      +I      ++L   + D   K +L       I + I +G+ YLH      I+
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152

Query: 638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI---VGTYGYMSPE------- 687
           H+DLK+ NV  D +    I+DFGL  + G  +      ++    G   +++PE       
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGK 714
                   FS  SDVF+ G +  E  + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (465), Expect = 3e-52
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 27/229 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--MMLIAKLQHR 569
             + ++   +G+G +G V++G    G+ VAVK  SS+     + +  E  +     L+H 
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62

Query: 570 NLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           N++  +   +          LI  Y    SL  +L    +   L   + + I+  IA GL
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118

Query: 626 LYLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIV 678
            +LH           I HRDLK+ N+L+  +    I+D GLA M     ++L       V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 679 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN 721
           GT  YM+PE               + D+++FG+++ E      + G+  
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (457), Expect = 8e-51
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNE--MMLIAKLQHRN 570
           +   M  ++G+G +G V+ G+   G++VAVK   +        +  E  +     ++H N
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92

Query: 571 LVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           ++  +   ++         LI +Y  N SL  +L    K   L  ++ + +      GL 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148

Query: 627 YLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVG 679
           +LH           I HRDLK+ N+L+  +    I+D GLA  F    +E+       VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 680 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSGKKNTGV 719
           T  YM PE  LD           I +D++SFG+++ E      + G+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 2e-49
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 32/251 (12%)

Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS 549
           D    G  S LPL    ++A       +Q  +G+G FG V++G+   G+EVAVK  SS+ 
Sbjct: 22  DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE 77

Query: 550 GQGLEEFKNE--MMLIAKLQHRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDP 603
                 +  E  +     L+H N++  +    +         L+ +Y  + SL  +L   
Sbjct: 78  ---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--- 131

Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR-----IIHRDLKASNVLLDMDMNPKISD 658
             +  +  +  + +    A GL +LH           I HRDLK+ N+L+  +    I+D
Sbjct: 132 -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190

Query: 659 FGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLE 709
            GLA       D +       VGT  YM+PE  LD            ++D+++ G++  E
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249

Query: 710 TLSGKKNTGVY 720
                   G++
Sbjct: 250 IARRCSIGGIH 260

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  173 bits (440), Expect = 5e-48
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 11/204 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRN 570
           E+  +  ++G G FG V+ GRL  +   VAVK    +       +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V+L+G C ++    +++E +       FL   T+   L  +  + ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEY 688
                 IHRDL A N L+      KISDFG++R          G  +++     + +PE 
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
              G +S +SDV+SFGIL+ ET S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  170 bits (433), Expect = 5e-48
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 25/231 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
            +     +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           H N+VK  G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
            YL   ++ R IHRDL   N+L++ +   KI DFGL ++   D+    ++   +      
Sbjct: 128 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
               + +PE   +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  171 bits (435), Expect = 6e-48
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 25/231 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
            +     +LG+G FG V   R        G+ VAVK+L   + + L +F+ E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           H N+VK  G C   G +   LI+EY+P  SL  +L     K  +     +     I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
            YL   ++ R IHRDL   N+L++ +   KI DFGL ++   D+    ++   +      
Sbjct: 159 EYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
               + +PE   +  FS+ SDV+SFG+++ E  +  + +    A+   ++G
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  170 bits (433), Expect = 1e-47
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
                   LGEG FG V            G+ VAVK L + +G Q    +K E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 567 QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            H +++K  GCC + G     L++EY+P  SL  +L     +  +G    +   + I +G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
           + YLH  ++   IHRDL A NVLLD D   KI DFGLA+          ++ +       
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                + +PE   +  F   SDV+SFG+ + E L+
Sbjct: 203 -----WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  168 bits (427), Expect = 9e-47
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ 567
            +     +LG+G FG V   R        G  VAVK+L         +F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 568 HRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGI 621
              +VK  G     G +   L++EY+P+  L  FL          RLL + +       I
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK-- 675
            +G+ YL   SR R +HRDL A N+L++ + + KI+DFGLA++   D+    ++   +  
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 676 -RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                   + +PE   D +FS +SDV+SFG+++ E  +
Sbjct: 194 IF------WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (424), Expect = 1e-46
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
                   LGEG FG V   R        G++VAVK L  +SG   + + K E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 567 QHRNLVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            H N+VK  G C E G     LI+E++P+ SL  +L  P  K  +  + ++     I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
           + YL      + +HRDL A NVL++ +   KI DFGL +    D+    ++ +       
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                + +PE  +   F I SDV+SFG+ + E L+
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  165 bits (421), Expect = 2e-46
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77

Query: 573 KLLGCCVEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +LLG  VE+   + I  EYM   SL  +L     + +LG    +     + + + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
                +HRDL A NVL+  D   K+SDFGL +    +                    + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE   +  FS KSDV+SFGIL+ E  S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  164 bits (418), Expect = 3e-46
 Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
              +   ++G G FG V+ G  LN  +VA+K +   +    E+F  E  ++ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G C+EQ    L+ E+M +  L  +L   T++ L   +  + +   + +G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
              +IHRDL A N L+  +   K+SDFG+ R    D+      TK  V    + SPE   
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178

Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              +S KSDV+SFG+LM E  S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  166 bits (422), Expect = 4e-46
 Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 42/241 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIA 622
            + ++ +LLG C+    ++ I + MP   L  ++ +       + LL W         IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           +G+ YL      R++HRDL A NVL+    + KI+DFGLA++ G +E           Y 
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175

Query: 683 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS-GKK-NTGVYNADSFNLL--G 729
                     M+ E  L  +++ +SDV+S+G+ + E ++ G K   G+  ++  ++L  G
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

Query: 730 Y 730
            
Sbjct: 236 E 236

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  165 bits (419), Expect = 5e-46
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 34/225 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSSQSGQGLEEFKNEMMLIAKL 566
            +  ++ +LGEG FG V+     N         VAVK L   +    ++F+ E  L+  L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQA 613
           QH ++VK  G C +    I++ EYM +  L+ FL                  K  LG   
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--EL 670
            + I   IA G++YL   +    +HRDL   N L+  ++  KI DFG++R ++  D   +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            G+T    R      +M PE  +   F+ +SDV+SFG+++ E  +
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  169 bits (429), Expect = 7e-46
 Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 13/201 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 573 KLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +LLG  VE+   + ++ EYM   SL  +L     + +LG    +     + + + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
                +HRDL A NVL+  D   K+SDFGL +       Q   K  V    + +PE   +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360

Query: 692 GLFSIKSDVFSFGILMLETLS 712
             FS KSDV+SFGIL+ E  S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  165 bits (420), Expect = 8e-46
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 33/224 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSSQSGQGLEEFKNEMMLIAKL 566
            +  ++ +LGEG FG V+     N         VAVK L   S    ++F+ E  L+  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------FDPTKKRLLGWQAR 614
           QH+++V+  G C E    +++ EYM +  L+ FL             +      LG    
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQ 671
           + +   +A G++YL   +    +HRDL   N L+   +  KI DFG++R ++  D   + 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217

Query: 672 GNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           G T    R      +M PE  L   F+ +SDV+SFG+++ E  +
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  164 bits (417), Expect = 9e-46
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 11/203 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V+LLG C  +    +I E+M   +L  +L +   ++ +     + +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYA 689
            +   IHRDL A N L+  +   K++DFGL+R+  GD        K  +    + +PE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FSIKSDV++FG+L+ E  +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  163 bits (415), Expect = 1e-45
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 11/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           ++ +   +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G C +Q    +I EYM N  L  +L     +     Q  + + + + + + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
             + +HRDL A N L++     K+SDFGL+R    DE      +K  V    +  PE  +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194

Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              FS KSD+++FG+LM E  S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  163 bits (414), Expect = 1e-45
 Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 11/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E  ++  +LG G FG V  G+     +VAVK +   S    +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           K  G C ++    ++ EY+ N  L  +L   +  + L     + +   + +G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
             + IHRDL A N L+D D+  K+SDFG+ R    D+      TK  V    + +PE   
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178

Query: 691 DGLFSIKSDVFSFGILMLETLS 712
              +S KSDV++FGILM E  S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (415), Expect = 1e-45
 Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L   S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     ++   I I EYM N SL  FL  P     L     + +   IA+G+ ++    
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E    T R    +     +PE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183

Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  163 bits (415), Expect = 1e-45
 Identities = 79/226 (34%), Positives = 109/226 (48%), Gaps = 35/226 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
                  +LGE  FG VYKG L         Q VA+K L     G   EEF++E ML A+
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQ 612
           LQH N+V LLG   +     +I  Y  +  L  FL              D T K  L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--E 669
             V ++  IA G+ YL   S   ++H+DL   NVL+   +N KISD GL R ++  D  +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 670 LQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           L GN+    R      +M+PE  + G FSI SD++S+G+++ E  S
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  162 bits (413), Expect = 7e-45
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 26/213 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSG-QGLEEFKNEMMLIAKL 566
                   LG G FG V+KG  +   E     V +K +  +SG Q  +   + M+ I  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP----TKKRLLGWQARVTIIEGIA 622
            H ++V+LLG C     ++ + +Y+P  SL   +         + LL W         IA
Sbjct: 73  DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRIVG 679
           +G+ YL       ++HR+L A NVLL      +++DFG+A +   D+        K  + 
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI- 181

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              +M+ E    G ++ +SDV+S+G+ + E ++
Sbjct: 182 --KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (410), Expect = 9e-45
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 36/225 (16%)

Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           LG C+      L +L YM +  L  F+     +PT K L+G          +A+G+ YL 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKYL- 144

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
             +  + +HRDL A N +LD     K++DFGLAR    D        +    G      +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGVYN 721
           M+ E      F+ KSDV+SFG+L+ E ++             +  
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  161 bits (410), Expect = 1e-44
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 28/228 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
                   +G+G FG VY G  ++  +     A+K L      Q +E F  E +L+  L 
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 568 HRNLVKLLGCCVEQGEKILI-LEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIA 622
           H N++ L+G  +       + L YM +  L  F+     +PT K L+ +         +A
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL------QVA 134

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY- 681
           +G+ YL   +  + +HRDL A N +LD     K++DFGLAR     E     +       
Sbjct: 135 RGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 682 -GYMSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGVYN 721
             + + E      F+ KSDV+SFG+L+ E L+             + +
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  165 bits (420), Expect = 1e-44
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           KL     ++   I I E+M   SL  FL    +         +     IA+G+ ++    
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
           +   IHRDL+A+N+L+   +  KI+DFGLAR+   +E    T R    +     +PE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358

Query: 691 DGLFSIKSDVFSFGILMLETLS 712
            G F+IKSDV+SFGIL++E ++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  161 bits (410), Expect = 1e-44
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 36/236 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SSQSGQGLEEFKNEMMLIAKL 566
               +   LGEG FG V +G L         VAVK +   + S + +EEF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 567 QHRNLVKLLGCCVEQG-----EKILILEYMPNKSLDVFL---FDPTKKRLLGWQARVTII 618
            H N+++LLG C+E       + ++IL +M    L  +L      T  + +  Q  +  +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTK 675
             IA G+ YL   S    +HRDL A N +L  DM   ++DFGL++ ++ GD        K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGVYN 721
              +      +++ E   D +++ KSDV++FG+ M E  +       G +N  +Y+
Sbjct: 211 MPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  166 bits (421), Expect = 2e-44
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V+LLG C  +    +I E+M   +L  +L +   ++ +     + +   I+  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYA 689
            +   IHR+L A N L+  +   K++DFGL+R+  GD     T      +     +PE  
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FSIKSDV++FG+L+ E  +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT 414

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  161 bits (410), Expect = 2e-44
 Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 38/245 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKL-Q 567
            +   Q  +GEG FG V K R+         A+KR+    S     +F  E+ ++ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTIIE- 619
           H N++ LLG C  +G   L +EY P+ +L  FL        DP         + ++  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 620 -----GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
                 +A+G+ YL   S+ + IHRDL A N+L+  +   KI+DFGL+R  G +     T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199

Query: 675 K-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYNADSFNL 727
                 R      +M+ E     +++  SDV+S+G+L+ E  +L G    G+  A+ +  
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253

Query: 728 L--GY 730
           L  GY
Sbjct: 254 LPQGY 258

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  161 bits (409), Expect = 2e-44
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 31/234 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SSQSGQGLEEFKNEMMLIAKL 566
           + F++   LG+G FG V + +L        +VAVK L     +   +EEF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 567 QHRNLVKLLGCCVEQGEKI------LILEYMPNKSLDVFLFD---PTKKRLLGWQARVTI 617
            H ++ KL+G  +    K       +IL +M +  L  FL           L  Q  V  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNT 674
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFGL+R ++ GD       +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGVYN 721
           K  V    +++ E   D L+++ SDV++FG+ M E ++       G +N  +YN
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  160 bits (408), Expect = 3e-44
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
               ++  +G G  G V  GRL         VA+K L +  + +   +F +E  ++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+++L G        +++ EYM N SLD FL     +        V ++ G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
           L   S    +HRDL A NVL+D ++  K+SDFGL+R+   D                   
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212

Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
                    +PE      FS  SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  160 bits (406), Expect = 7e-44
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           E  +M  +LG+G FG VY+G      +      VA+K +  + S +   EF NE  ++ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------FDPTKKRLLGWQARVTII 618
               ++V+LLG   +    ++I+E M    L  +L        +            + + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD--ELQGNTK 675
             IA G+ YL   +  + +HRDL A N ++  D   KI DFG+ R ++  D     G   
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              R      +MSPE   DG+F+  SDV+SFG+++ E  +
Sbjct: 202 LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  161 bits (408), Expect = 1e-43
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 34/225 (15%)

Query: 520 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
            +G G FG VY G LL+        AVK L        + +F  E +++    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           LG C+      L +L YM +  L  F+     +PT K L+G          +A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKFL- 208

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YM 684
             +  + +HRDL A N +LD     K++DFGLAR     E      +   T       +M
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWM 263

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS-------GKKNTGVYNA 722
           + E      F+ KSDV+SFG+L+ E ++             +   
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  159 bits (404), Expect = 1e-43
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 30/215 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            + ++ +LLG C+    ++ I + MP   L  ++ +   K  +G Q  +     IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--- 683
           YL      R++HRDL A NVL+    + KI+DFGLA++ G +E           Y     
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179

Query: 684 ------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
                 M+ E  L  +++ +SDV+S+G+ + E ++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  159 bits (404), Expect = 1e-43
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + +++E M    L  FL      P++   L     + +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
           A G  YL        IHRD+ A N LL         KI DFG+AR ++        G   
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              +      +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  159 bits (404), Expect = 2e-43
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SSQSGQGLEEFKNEMMLIAKL 566
              + Q  +G G FG VYKG L          VA+K L +  + +   +F  E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            H N+++L G   +    ++I EYM N +LD FL    K         V ++ GIA G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG---- 682
           YL   +    +HRDL A N+L++ ++  K+SDFGL+R+   D     T       G    
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213

Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
             + +PE      F+  SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  157 bits (400), Expect = 2e-43
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 520 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG        + VAVK L   +      +E   E  ++ +L +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           +G C  + E   L++E      L+ +L    + R +  +  + ++  ++ G+ YL     
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYA 689
              +HRDL A NVLL      KISDFGL++    DE     Q + K  V    + +PE  
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192

Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
               FS KSDV+SFG+LM E  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  159 bits (403), Expect = 3e-43
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 43/234 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
            N      +GEG FG V++ R            VAVK L    S     +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL---------------------FDPT 604
             + N+VKLLG C       L+ EYM    L+ FL                         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR- 663
               L    ++ I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFGL+R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 664 MFGGD--ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           ++  D  +  GN     R      +M PE      ++ +SDV+++G+++ E  S
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  158 bits (402), Expect = 3e-43
 Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 42/251 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
           +  ++   LGEG FG V     +            VAVK L    + + L +  +EM ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
             +  T      +      +M+PE   D +++ +SDV+SFG+LM E  TL G    G+  
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

Query: 722 ADSFNLL--GY 730
            + F LL  G+
Sbjct: 266 EELFKLLKEGH 276

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  159 bits (404), Expect = 4e-43
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 29/220 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N ++   LG G FG VY+G++          +VAVK L    S Q   +F  E ++I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGI 621
             H+N+V+ +G  ++   + ++LE M    L  FL      P++   L     + +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
           A G  YL        IHRD+ A N LL         KI DFG+AR ++        G   
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
              +      +M PE  ++G+F+ K+D +SFG+L+ E  S
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  159 bits (404), Expect = 4e-43
 Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 42/251 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
           +  ++   LGEG FG V     +            VAVK L    + + L +  +EM ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L              +   +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
            ++  V+    +A+G+ YL   +  + IHRDL A NVL+  +   KI+DFGLAR +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
             +  T      +      +M+PE   D +++ +SDV+SFG+LM E  TL G    G+  
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311

Query: 722 ADSFNLL--GY 730
            + F LL  G+
Sbjct: 312 EELFKLLKEGH 322

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  156 bits (396), Expect = 5e-43
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
              +LG G FG V +G     ++   VA+K L         EE   E  ++ +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 573 KLLGCCVEQGEKILI-LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +L+G C  Q E +++ +E      L  FL    K+  +       ++  ++ G+ YL   
Sbjct: 74  RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL----QGNTKRIVGTYGYMSPE 687
                +HRDL A NVLL      KISDFGL++  G D+     +   K  +    + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183

Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
                 FS +SDV+S+G+ M E LS
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  156 bits (397), Expect = 5e-43
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 18/210 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL---SSQSGQGLEEFKNEMMLIAK 565
           ++  +  KLG+G FG V +G           VAVK L        + +++F  E+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L HRNL++L G  +    K+ + E  P  SL   L     +              +A+G+
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT---YG 682
            YL      R IHRDL A N+LL      KI DFGL R    ++     +        + 
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           + +PE      FS  SD + FG+ + E  +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  155 bits (395), Expect = 7e-43
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 24/211 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++ +     VA+K   +  S    E+F  E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQ 623
           H ++VKL+G   E    I I+E      L  FL    +      L+ +         ++ 
Sbjct: 75  HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAY------QLST 127

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTY 681
            L YL      R +HRD+ A NVL+  +   K+ DFGL+R             K  +   
Sbjct: 128 ALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI--- 181

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
            +M+PE      F+  SDV+ FG+ M E L 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  156 bits (397), Expect = 1e-42
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 63/265 (23%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +N  +   LGEG FG V K    +         VAVK L  + S   L +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------------------- 600
           + H +++KL G C + G  +LI+EY    SL  FL                         
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 601 --FDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
                T   L+   WQ        I+QG+ YL   +  +++HRDL A N+L+      KI
Sbjct: 143 DERALTMGDLISFAWQ--------ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191

Query: 657 SDFGLAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE- 709
           SDFGL+R ++  D     ++     +      +M+ E   D +++ +SDV+SFG+L+ E 
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEI 245

Query: 710 -TLSGKKNTGVYNADSFNLL--GYV 731
            TL G    G+     FNLL  G+ 
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGHR 270

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  155 bits (394), Expect = 1e-42
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 38/222 (17%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
           E+      LG+G F  ++KG          L+  EV +K L        E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           KL H++LV   G CV   E IL+ E++   SLD +L     K  +    ++ + + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP--------KISDFGLARMFGGDELQGNTKR 676
           + +L       +IH ++ A N+LL  + +         K+SD G++      +       
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 677 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLS 712
                       + PE   +    ++ +D +SFG  + E  S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  156 bits (396), Expect = 1e-42
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 37/228 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           +   +   LG G FG V +            + VAVK L    +        +E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 566 L-QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFL-------------FDPTKKRLLG 610
           +  H N+V LLG C + G  + +I+E+    +L  +L              +   K  L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE 669
            +  +     +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR ++   +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 670 LQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                      +      +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (394), Expect = 1e-42
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
           E+  +   LGEG FG VY+G   N +     VAVK      +    E+F +E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL----FDPTKKRLLGWQARVTIIEGIAQ 623
           H ++VKL+G   E+   I I+E  P   L  +L           L+ +         I +
Sbjct: 72  HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTK---RIV 678
            + YL        +HRD+   N+L+      K+ DFGL+R    ++      T+   +  
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
               +MSPE      F+  SDV+ F + M E LS
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  159 bits (404), Expect = 2e-42
 Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      + L     V +   IA G+ Y+    
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E             + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 693 LFSIKSDVFSFGILMLETLS 712
            F+IKSDV+SFGIL+ E  +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  157 bits (399), Expect = 2e-42
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
            N S+   +G G FG V  GRL    +    VA+K L    + +   +F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+++L G   +    +++ EYM N SLD FL              V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
           L   S    +HRDL A N+L++ ++  K+SDFGL R+   D                   
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208

Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 712
                    SPE      F+  SDV+S+GI++ E +S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (408), Expect = 2e-42
 Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L     E+   I + EYM   SL  FL      + L     V +   IA G+ Y+    
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
           R   +HRDL+A+N+L+  ++  K++DFGLAR+   +E             + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 693 LFSIKSDVFSFGILMLETLS 712
            F+IKSDV+SFGIL+ E  +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  154 bits (391), Expect = 6e-42
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 28/224 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
              S    LG G FG V +       +      VAVK L  S      E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEG---- 620
           L  H N+V LLG C   G  ++I EY     L  FL       +    +   + +     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 621 -----------IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
                      +A+G+ +L   +    IHRDL A N+LL      KI DFGLAR +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
                    +    +M+PE   + +++ +SDV+S+GI + E  S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  155 bits (393), Expect = 2e-41
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 42/251 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SSQSGQGLEEFKNEMMLI 563
           +   +   LGEG FG V     +           +VAVK L S  + + L +  +EM ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L                  +  L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGD 668
             +  V+    +A+G+ YL   +  + IHRDL A NVL+  D   KI+DFGLAR +   D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 669 --ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSGKKNTGVYN 721
             +   N +   +      +M+PE   D +++ +SDV+SFG+L+ E  TL G    GV  
Sbjct: 246 YYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299

Query: 722 ADSFNLL--GY 730
            + F LL  G+
Sbjct: 300 EELFKLLKEGH 310

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (388), Expect = 3e-41
 Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 34/225 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
            N      LG G FG V +       +      VAVK L S+      E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------FDPTKKRLLGWQA 613
           L QH N+V LLG C   G  ++I EY     L  FL                      + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-MFGGDE--L 670
            +     +AQG+ +L   +    IHRD+ A NVLL      KI DFGLAR +       +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +GN +   +      +M+PE   D +++++SDV+S+GIL+ E  S
Sbjct: 223 KGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (377), Expect = 2e-40
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            +F     +G GGFG V+K +  ++G+   +KR+   +    E+ + E+  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 572 VKLLGCCVEQGEKI----------------LILEYMPNKSLDVFLFDPTKKRLLGWQARV 615
           V   GC                        + +E+    +L+ ++     ++L    A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
              + I +G+ Y+H     ++I+RDLK SN+ L      KI DFGL      D   G   
Sbjct: 127 LFEQ-ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179

Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           R  GT  YMSPE      +  + D+++ G+++ E L    
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  156 bits (396), Expect = 2e-40
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 517 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SSQSGQGLEEFKNEMMLIAKLQHRNLV 572
              +LG G FG V +G     ++   VA+K L         EE   E  ++ +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L+G C  +   + ++E      L  FL    K+  +       ++  ++ G+ YL    
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
               +HR+L A NVLL      KISDFGL++  G D+     +   K  +    + +PE 
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510

Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
                FS +SDV+S+G+ M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (393), Expect = 7e-40
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SSQSGQGLEEFKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++ +     VA+K   +  S    E+F  E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H ++VKL+G   E    I I+E      L  FL    +K  L   + +     ++  L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMS 685
           L      R +HRD+ A NVL+  +   K+ DFGL+R             K  +    +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLS 712
           PE      F+  SDV+ FG+ M E L 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  148 bits (376), Expect = 1e-39
 Identities = 68/242 (28%), Positives = 95/242 (39%), Gaps = 59/242 (24%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SSQSGQGLEEFKNEMMLIAK 565
           EN      LG G FG V         +      VAVK L         E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL------------------------ 600
           L  H N+V LLG C   G   LI EY     L  +L                        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 601 --FDPTKKRLL--GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
                T + LL   +Q        +A+G+ +L        +HRDL A NVL+      KI
Sbjct: 165 DLNVLTFEDLLCFAYQ--------VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKI 213

Query: 657 SDFGLAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
            DFGLAR +                +      +M+PE   +G+++IKSDV+S+GIL+ E 
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 711 LS 712
            S
Sbjct: 268 FS 269

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (374), Expect = 2e-39
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           E +    K+GEG FG     +   +G++  +K   +S  S +  EE + E+ ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+V+      E G   ++++Y     L   +           Q     ++ I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-ICLALKHVH 142

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                +I+HRD+K+ N+ L  D   ++ DFG+AR+             +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
            +  ++ KSD+++ G ++ E  + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  145 bits (369), Expect = 5e-39
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
             +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 571 L--VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
              ++L    +      +++E   N  L+ +L    KK +  W+ +      + + +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTI 143

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSGK 714
                            S KSDV+S G ++     GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 7e-39
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
            +F     LG GGFG V++ +  ++    A+KR+         E+   E+  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 571 LVKLLGCCVEQGEKI------------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTII 618
           +V+     +E+                + ++    ++L  ++              + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-- 676
             IA+ + +LH      ++HRDLK SN+   MD   K+ DFGL      DE +       
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 677 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
                    VGT  YMSPE      +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (366), Expect = 7e-39
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           ++G G F  VYKG       EVA    +    +    + FK E  ++  LQH N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 577 CCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
                 +     +L+ E M + +L  +L    + +++  +   +    I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 633 RFRIIHRDLKASNVLLD-MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
              IIHRDLK  N+ +     + KI D GLA +          K ++GT  +M+PE   +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +    DV++FG+ MLE  + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  146 bits (370), Expect = 2e-38
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRNL--VKLL 575
           ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +   ++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
              +      +++E   N  L+ +L    KK +  W+ +      + + +  +HQ+    
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTIHQH---G 175

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-------- 687
           I+H DLK +N L+  D   K+ DFG+A     D         VG   YM PE        
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
                     S KSDV+S G ++     GK
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (366), Expect = 3e-38
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKLQHRN 570
             +S+  ++G GG   V++      Q  A+K   L     Q L+ ++NE+  + KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 571 L--VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
              ++L    +      +++E   N  L+ +L    KK +  W+ +      + + +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKN-MLEAVHTI 124

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
           HQ+    I+H DLK +N L+  D   K+ DFG+A     D         VGT  YM PE 
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSGK 714
                            S KSDV+S G ++     GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 7e-38
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 13/222 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEFKNEMMLIAKLQH 568
            NF ++ K+G G F  VY+   LL+G  VA+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLLY 627
            N++K     +E  E  ++LE      L   +    K++ L  +  V      +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           +H     R++HRD+K +NV +      K+ D GL R F       ++  +VGT  YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLG 729
              +  ++ KSD++S G L+ E  + +     +  D  NL  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYS 245

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  139 bits (352), Expect = 5e-37
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 10/210 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           E++ +   +G G +G   K R   +G+ +  K     S +    +   +E+ L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLL 626
           N+V+     +++    L  ++EY     L   +   TK+R    +  V  ++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 627 YLHQ--YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
             H+       ++HRDLK +NV LD   N K+ DFGLAR+   D     T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           SPE      ++ KSD++S G L+ E  +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (353), Expect = 5e-37
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
           LG+G +G VY GR L N   +A+K +  +  +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 580 EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHR 639
           E G   + +E +P  SL   L           Q      + I +GL YLH     +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 640 DLKASNVLLDMDM-NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---YALDGLFS 695
           D+K  NVL++      KISDFG ++   G  +   T+   GT  YM+PE       G + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-YG 203

Query: 696 IKSDVFSFGILMLETLSGK 714
             +D++S G  ++E  +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 8e-37
 Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 37/231 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
             +F     LG+G FG V K R  L+ +  A+K++     + L    +E+ML+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 571 LVKLLGCCVEQGEKI-------------LILEYMPNKSLDVFLFD--PTKKRLLGWQARV 615
           +V+     +E+   +             + +EY  N +L    +D   ++          
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF---------- 665
            +   I + L Y+H      IIHRDLK  N+ +D   N KI DFGLA+            
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 666 --GGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETLSG 713
                    N    +GT  Y++ E     G ++ K D++S GI+  E +  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  137 bits (348), Expect = 2e-36
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 10/204 (4%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE++++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V  L   +   E  +++EY+   SL     D   +  +       +     Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               ++IHRD+K+ N+LL MD + K++DFG       ++ + +T  +VGT  +M+PE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
              +  K D++S GI+ +E + G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (348), Expect = 3e-36
 Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 14/207 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKL-QH 568
           ++F    +LG G +G V+K R   +G+  AVK      +  +       E+    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
              V+L     E G   L  E     SL           L   Q    + +     L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHL 173

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      ++H D+K +N+ L      K+ DFGL    G        +   G   YM+PE 
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
            L G +   +DVFS G+ +LE     +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  138 bits (349), Expect = 5e-36
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 18/209 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQH 568
             +     LG+GGF   ++       +  A K   +         E+   E+ +   L H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGL 625
           +++V   G   E  + + ++LE    +SL     +    +K L   +AR   +  I  G 
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            YLH+    R+IHRDLK  N+ L+ D+  KI DFGLA     D  +     + GT  Y++
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE       S + DV+S G +M   L GK
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  136 bits (345), Expect = 6e-36
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG+GGF   ++       +  A K   +         E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
              E  + + ++LE    +SL     +    +K L   +AR   +  I  G  YLH+   
Sbjct: 83  F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN-- 134

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
            R+IHRDLK  N+ L+ D+  KI DFGLA     D  +     + GT  Y++PE      
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191

Query: 694 FSIKSDVFSFGILMLETLSGK 714
            S + DV+S G +M   L GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  136 bits (345), Expect = 1e-35
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
                   K+GEG  G V   R   +G++VAVK +  +  Q  E   NE++++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +V++    +   E  +++E++   +L     D   +  L  +   T+ E + Q L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                +IHRD+K+ ++LL +D   K+SDFG       D  +  +  +VGT  +M+PE   
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214

Query: 691 DGLFSIKSDVFSFGILMLE 709
             L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (343), Expect = 3e-35
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 16/214 (7%)

Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIA 564
                     + Q ++G G FG V++ +    G + AVK++  +  +       E++  A
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            L    +V L G   E     + +E +   SL   +    +   L     +  +    +G
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEG 162

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKR---IVGT 680
           L YLH     RI+H D+KA NVLL  D +   + DFG A     D L  +      I GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             +M+PE  +      K D++S   +ML  L+G 
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (341), Expect = 3e-35
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           +++    KLGEGGF  V     L +G   A+KR+     Q  EE + E  +     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 572 VKLLGCCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
           ++L+  C+ +        L+L +    +L   +     +RL      +T      ++ GI
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGI 143

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR-----MFGGDELQGNTKR 676
            +GL  +H        HRDLK +N+LL  +  P + D G        + G  +       
Sbjct: 144 CRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 677 I--VGTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSGK 714
                T  Y +PE      + +      ++DV+S G ++   + G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  133 bits (337), Expect = 7e-35
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
           KLG GG   VY     +   +VA+K +     +    L+ F+ E+   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
               E     L++EY+   +L  ++        L     +     I  G+ + H     R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
           I+HRD+K  N+L+D +   KI DFG+A+      L   T  ++GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190

Query: 696 IKSDVFSFGILMLETLSGK 714
             +D++S GI++ E L G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  133 bits (337), Expect = 8e-35
 Identities = 60/209 (28%), Positives = 111/209 (53%), Gaps = 13/209 (6%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            E + +  +LG+G FG VYK +    G   A K + ++S + LE++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKLLG     G+  +++E+ P  ++D  +     + L   Q +V +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
               RIIHRDLKA NVL+ ++ + +++DFG++        + ++   +GT  +M+PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGK 714
                D  +  K+D++S GI ++E    +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  131 bits (333), Expect = 3e-34
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
           ++     +LG G +G V K R + +GQ +AVKR+ +      +E K  +M     +  + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVD 64

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
               V   G    +G+  + +E M + SLD F      K+++     +       I   I
Sbjct: 65  CPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSI 118

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
            + L +LH  S+  +IHRD+K SNVL++     K+ DFG++     D++  +     G  
Sbjct: 119 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCK 173

Query: 682 GYMSPE----YALDGLFSIKSDVFSFGILMLETLSGK 714
            YM+PE          +S+KSD++S GI M+E    +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  131 bits (332), Expect = 4e-34
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 11/205 (5%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHR 569
            E F+   K+G+G FG V+KG      + VA+K +  +  +  +E+ + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
            + K  G  ++  +  +I+EY+   S      D  +   L      TI+  I +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                + IHRD+KA+NVLL      K++DFG+A      +++ NT   VGT  +M+PE  
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +  K+D++S GI  +E   G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  132 bits (334), Expect = 6e-34
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 19/238 (7%)

Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVA 541
           +  E+  D + + +                ++F    +LG G  G V+K     +G  +A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62

Query: 542 VKRLSSQSGQGLEEFK---NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDV 598
            K +  +             E+ ++ +     +V   G     GE  + +E+M   SLD 
Sbjct: 63  RKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 599 FL--FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
            L       +++LG      +   + +GL YL    + +I+HRD+K SN+L++     K+
Sbjct: 121 VLKKAGRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173

Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            DFG++      +   N+   VGT  YMSPE      +S++SD++S G+ ++E   G+
Sbjct: 174 CDFGVSGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (328), Expect = 7e-34
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEE-FKNEMMLIAKLQH 568
           E+F +   LG+G F  VY+   +  G EVA+K +   +    G+ +  +NE+ +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTK---KRLLGWQARVTIIEGIAQG 624
            ++++L     E    + L+LE   N  +        K   K     +AR   +  I  G
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           +LYLH      I+HRDL  SN+LL  +MN KI+DFGLA        +  T  + GT  Y+
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           SPE A      ++SDV+S G +    L G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (327), Expect = 2e-33
 Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 12/205 (5%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            E F +  KLGEG +G VYK      GQ VA+K++  +    L+E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           +VK  G   +  +  +++EY    S+ D  +     K L   +   TI++   +GL YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIA-TILQSTLKGLEYLH 142

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                R IHRD+KA N+LL+ + + K++DFG+A        + NT  ++GT  +M+PE  
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
            +  ++  +D++S GI  +E   GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 4e-33
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
             + +   LG+G    V++GR    G   A+K  +     + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 571 LVKLLGC--CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +VKL           K+LI+E+ P  SL   L +P+    L     + ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 629 HQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            +     I+HR++K  N++     D     K++DFG AR    DE       + GT  Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182

Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLSGK 714
            P+              +    D++S G+      +G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  127 bits (322), Expect = 9e-33
 Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 13/200 (6%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
            +G GG G VY+    +  + VA+K +S             + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
                 G+  + +  +    L   L    ++  L     V I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 636 IIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDGLF 694
             HRD+K  N+L+  D    + DFG+A     ++L Q      VGT  YM+PE   +   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSESHA 212

Query: 695 SIKSDVFSFGILMLETLSGK 714
           + ++D+++   ++ E L+G 
Sbjct: 213 TYRADIYALTCVLYECLTGS 232

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  128 bits (323), Expect = 1e-32
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
           E+     ++G G +G V K     +GQ +AVKR+ S   +  +E K  +M    ++    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSD 79

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT------IIEGI 621
              +V+  G    +G+  + +E M + S D F     K         +       I    
Sbjct: 80  CPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLAT 134

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
            + L +L      +IIHRD+K SN+LLD   N K+ DFG++        +       G  
Sbjct: 135 VKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCR 189

Query: 682 GYMSPE----YALDGLFSIKSDVFSFGILMLETLSGK 714
            YM+PE     A    + ++SDV+S GI + E  +G+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (319), Expect = 2e-32
 Identities = 45/228 (19%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKNEMMLIAKL-Q 567
           T  F    K+G G FG V+K    L+G   A+KR           +    E+   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARV-TIIEGIAQGLL 626
           H ++V+      E    ++  EY    SL   + +  +      +A +  ++  + +GL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNP-------------------KISDFGLARMFGG 667
           Y+H      ++H D+K SN+ +     P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 668 DELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETLSGK 714
                + +   G   +++ E    +     K+D+F+  + ++     +
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (335), Expect = 2e-32
 Identities = 39/203 (19%), Positives = 76/203 (37%), Gaps = 24/203 (11%)

Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVKLLG 576
            +  GG G +Y      +NG+ V +K L        +     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 577 CCVEQGEKI-----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
                         +++EY+  +SL            L     +  +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
               +++ DLK  N++L  +   K+ D G                + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
           G  ++ +D+++ G  +       
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (325), Expect = 2e-32
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
             + +   LG+G    V++GR    G   A+K  +     + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 571 LVKLLGC--CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           +VKL           K+LI+E+ P  SL   L +P+    L     + ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 629 HQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            +     I+HR++K  N++     D     K++DFG AR    DE       + GT  Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182

Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLSGK 714
            P+              +    D++S G+      +G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 3e-32
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG---LEEFKNEMMLIAKLQHRNLVKLL 575
            LG GG   V+  R L + ++VAVK L +   +       F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 576 --GCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
             G        +  +++EY+   +L   +     +  +  +  + +I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYMSPEYAL 690
            +  IIHRD+K +N+++      K+ DFG+AR           T  ++GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
                 +SDV+S G ++ E L+G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  126 bits (319), Expect = 6e-32
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 25/213 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
            + FS   ++G G FG VY  R + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N ++  GC + +    L++EY    + D  L +  KK L   +    +  G  QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGLAY 169

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTYGYM 684
           LH +    +IHRD+KA N+LL      K+ DFG  + M               VGT  +M
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWM 217

Query: 685 SPE---YALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +G +  K DV+S GI  +E    K
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  125 bits (316), Expect = 6e-32
 Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 30/243 (12%)

Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 543
           G     GK  G  +           A   +     ++G G  G V+K R    G  +AVK
Sbjct: 1   GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56

Query: 544 RLSSQSGQGLEEFKNEMM----LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVF 599
           ++     +  EE K  +M    ++       +V+  G  +   +  + +E M     +  
Sbjct: 57  QMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKL 113

Query: 600 ---LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI 656
              +  P  +R+LG      +   I + L YL    +  +IHRD+K SN+LLD     K+
Sbjct: 114 KKRMQGPIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKL 166

Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 711
            DFG++     D+   +     G   YM+PE           + I++DV+S GI ++E  
Sbjct: 167 CDFGISGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223

Query: 712 SGK 714
           +G+
Sbjct: 224 TGQ 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (314), Expect = 1e-31
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 14/213 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           +++ +Q  +G G    V         ++VA+KR++  +    ++E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSL-----DVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           +V      V + E  L+++ +   S+      +      K  +L      TI+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTYG 682
            YLH   +   IHRD+KA N+LL  D + +I+DFG+ A +  G ++  N  R   VGT  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 683 YMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +M+PE       +  K+D++SFGI  +E  +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (319), Expect = 2e-31
 Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM-MLIAKLQHRNLV 572
           +F  +  LG G  G +    + + ++VAVKR+  +          E+ +L    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 573 KLLGCCVEQGEKI--LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +    C E+  +   + +E     +L  ++        LG +   T+++    GL +LH 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPI-TLLQQTTSGLAHLHS 136

Query: 631 YSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARMFGGDEL-QGNTKRIVGTYGYM 684
                I+HRDLK  N+L+ M      +   ISDFGL +              + GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 685 SPEY---ALDGLFSIKSDVFSFGILMLETLSG 713
           +PE          +   D+FS G +    +S 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (310), Expect = 2e-31
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
           E+F +   LG+G FG VY  R   +   +A+K L      ++G    + + E+ + + L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N+++L G   +     LILEY P  ++  +       +    +   T I  +A  L Y
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTA-TYITELANALSY 124

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
            H     R+IHRD+K  N+LL      KI+DFG +              + GT  Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
                +   K D++S G+L  E L GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (314), Expect = 4e-31
 Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 18/224 (8%)

Query: 504 SLASVAAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSSQSGQGLEEFKN 558
            ++S       + +   +G+G      V   R    G+ V V+R  L + S + +   + 
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 559 EMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTI 617
           E+ +     H N+V      +   E  ++  +M   S  D  L        +   A   I
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYI 133

Query: 618 IEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT--- 674
           ++G+ + L Y+H       +HR +KAS++L+ +D    +S             +      
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 675 --KRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
             K  V    ++SPE     L  +  KSD++S GI   E  +G 
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  129 bits (324), Expect = 4e-31
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNL 571
            + M+ +LG GGFG V +      G++VA+K+   +      E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 572 VKLLGCCVEQGEKI-------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           V       +  +K+       L +EY     L  +L        L      T++  I+  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
           L YLH+    RIIHRDLK  N++L      +  KI D G A+     EL       VGT 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            Y++PE      +++  D +SFG L  E ++G 
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 6e-31
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHR 569
              F +   +G G +G VYKGR +  GQ  A+K +   +G   EE K E+ ++ K   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81

Query: 570 NLVKLLGCCVEQGEKI------LILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIA 622
           N+    G  +++          L++E+    S+ D  L   TK   L  +    I   I 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           +GL +LHQ    ++IHRD+K  NVLL  +   K+ DFG++        + NT   +GT  
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194

Query: 683 YMSPE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
           +M+PE        D  +  KSD++S GI  +E   G 
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (305), Expect = 3e-30
 Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 39/230 (16%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------SQSGQGLEE 555
            ++ +   L +G F  +      + +  A+K+                          ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 556 FKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSL------DVFLFDPTKKRLL 609
           FKNE+ +I  +++   +   G      E  +I EYM N S+         L       + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
               +  II+ +     Y+H  +   I HRD+K SN+L+D +   K+SDFG +      +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

Query: 670 LQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETLSGK 714
           ++G      GTY +M PE      + +G    K D++S GI +       
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 3e-30
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 25/218 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
            L EGGF  VY+ + + +G+E A+KRL S   +       E+  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 578 CVEQGEK-------ILILEYMPNKSL-DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
                E+        L+L  +    L +      ++  L        I     + + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRI----------VG 679
              +  IIHRDLK  N+LL      K+ DFG A           + +             
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 680 TYGYMSPE-YALDGLFSI--KSDVFSFGILMLETLSGK 714
           T  Y +PE   L   F I  K D+++ G ++      +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (304), Expect = 1e-29
 Identities = 30/233 (12%), Positives = 65/233 (27%), Gaps = 43/233 (18%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH-------- 568
           LG+       +      G+   V             +++ K E++ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 569 --------RNLVKLLGCC-----VEQGEKILILEY---MPNKSLDVFLF------DPTKK 606
                    +LVK                + +L      P    ++  F        +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           + L   AR+ +   + + L  LH Y    ++H  L+  +++LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 667 GDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGK 714
           G        R        +            L +   D ++ G+ +       
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (301), Expect = 2e-29
 Identities = 25/249 (10%), Positives = 56/249 (22%), Gaps = 43/249 (17%)

Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SSQSGQGLEEF 556
                + ++       +   L  G    V+  R +   ++ A+K     +  S   LE  
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 557 KNEMMLIAKLQHRNLVKLLGCC--------------------------VEQGEKILILEY 590
                  A+L   +  +                                     +L++  
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 591 MP---NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL 647
                        F    +   G  A   +   + +    L       ++H      N+ 
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226

Query: 648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 705
           +  D    + D       G                Y   E+       F+   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 706 LMLETLSGK 714
            +       
Sbjct: 282 SIYRVWCLF 290

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (300), Expect = 2e-29
 Identities = 35/223 (15%), Positives = 66/223 (29%), Gaps = 24/223 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAK 565
           ++   +   LGEG F  VY+          N Q+  +K     +          M  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLD---VFLFDPTKKRLLGWQARVTIIEGIA 622
                 +K     + Q   +L+ E     +L        +  +K +         +  + 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-ML 182

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLL-----------DMDMNPKISDFGLARMFGGDELQ 671
             +  +H      IIH D+K  N +L           D+     + D G +         
Sbjct: 183 YMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
                   T G+   E   +  ++ + D F     +   L G 
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (304), Expect = 2e-29
 Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 40/224 (17%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEM-MLIAKLQHRNLVKLLGCC 578
            LG G  G V       G+ VAVKR+        +    E+ +L     H N+++    C
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76

Query: 579 VEQGEK--ILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
            E  ++   + LE   N +L   +      D   K    +    +++  IA G+ +LH  
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134

Query: 632 SRFRIIHRDLKASNVLLDM-------------DMNPKISDFGLARMFGGDE--LQGNTKR 676
              +IIHRDLK  N+L+               ++   ISDFGL +     +   + N   
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 677 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSG 713
             GT G+ +PE   +              D+FS G +    LS 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  117 bits (295), Expect = 3e-29
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
           ++F +   LG+G FG VY  R   N   +A+K L      + G    + + E+ + + L+
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGL 625
           H N++++     ++    L+LE+ P   L    +   +K  R    ++  T +E +A  L
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            Y H     ++IHRD+K  N+L+      KI+DFG +           T  + GT  Y+ 
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE         K D++  G+L  E L G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  116 bits (294), Expect = 5e-29
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 33/216 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLIA 564
           E +    K+GEG +G VYK +   G+ VA+KR+       L+            E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTIIE 619
           +L H N+V L+     +    L+ E+M     K LD        ++ ++  +Q       
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            + +G+ + HQ+   RI+HRDLK  N+L++ D   K++DFGLAR F G  ++  T  +V 
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181

Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
           T  Y +P+  +    +S   D++S G +  E ++GK
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (303), Expect = 5e-29
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
           +E +    KLG G +G V   R  +   E A+K +  +S S     +   E+ ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
            N++KL     ++    L++E          LFD    + +     A   II+ +  G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAA-VIIKQVLSGVT 150

Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           YLH+++   I+HRDLK  N+LL   + D   KI DFGL+ +F   +     K  +GT  Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           ++PE  L   +  K DV+S G+++   L+G 
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (300), Expect = 1e-28
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 20/210 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K +  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
            N++KL     +     ++ E          LFD    +KR     A   II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           Y+H++    I+HRDLK  N+LL   + D + KI DFGL+  F  +      K  +GT  Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE  L G +  K DV+S G+++   LSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  119 bits (299), Expect = 1e-28
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
           ++ +  Q  LG+G FG V   +  + GQE AVK +S    +     E    E+ L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGL 625
           H N++KL     ++G   L+ E          LFD   ++KR     A   II  +  G+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAA-RIIRQVLSGI 139

Query: 626 LYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
            Y+H+     I+HRDLK  N+LL     D N +I DFGL+  F   +     K  +GT  
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           Y++PE  L G +  K DV+S G+++   LSG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (288), Expect = 3e-28
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
           + +    K+GEG +G V+K +     + VA+KR+       L++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTII 618
            +L+H+N+V+L        +  L+ E+      K  D      DP   +   +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             + +GL + H      ++HRDLK  N+L++ +   K+++FGLAR F G  ++  +  +V
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKK 715
            T  Y  P+      L+S   D++S G +  E  +  +
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  113 bits (285), Expect = 5e-28
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLIA 564
           E +    K+GEG +G VYK +   G+  A+K++       LE+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTIIE 619
           +L+H N+VKL      +   +L+ E++     K LDV     +    +    Q       
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            +  G+ Y H     R++HRDLK  N+L++ +   KI+DFGLAR F G  ++  T  IV 
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162

Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
           T  Y +P+  +    +S   D++S G +  E ++G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  113 bits (285), Expect = 7e-28
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 28/210 (13%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQHRNLVKLL 575
           LGEG +G V +          AVK L      +   G    K E+ L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 576 G-CCVEQGEKI-LILEYMPNKSLDVFLFD-PTKKRLLGWQARVT---IIEGIAQGLLYLH 629
                E+ +K+ +++EY      +  + D   +KR    QA      +I+G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 I+H+D+K  N+LL      KIS  G+A            +   G+  +  PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 690 L-----DGLFSIKSDVFSFGILMLETLSGK 714
                  G    K D++S G+ +    +G 
Sbjct: 184 NGLDTFSGF---KVDIWSAGVTLYNITTGL 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  113 bits (284), Expect = 8e-28
 Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 20/210 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
            E +++ C LG+G FG V K +  +  QE AVK +  +S   +       E+ L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
            N++KL     +     ++ E          LFD    +KR     A   II+ +  G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVFSGIT 135

Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           Y+H+++   I+HRDLK  N+LL   + D + KI DFGL+  F  +      K  +GT  Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           ++PE  L G +  K DV+S G+++   LSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHR 569
            + F  + KLG G FG V+      +G E  +K ++  +S   +E+ + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGW----QARVTIIEGIAQ 623
           N++K+     +     +++E          L +   + +              +++ +  
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVA-ELMKQMMN 135

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
            L Y H      ++H+DLK  N+L          KI DFGLA +F  DE         GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             YM+PE       + K D++S G++M   L+G
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (281), Expect = 1e-27
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + ++++  +G G +G V            A K++     + ++ FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           +++L     +  +  L++E          LF+    K+      A   I++ +   + Y 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122

Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           H+     + HRDLK  N L      D   K+ DFGLA  F   ++    +  VGT  Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           P+  L+GL+  + D +S G++M   L G
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  113 bits (284), Expect = 1e-27
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 40/222 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
           + +    KLGEG +G VYK    +  + VA+KR+       LE  +         E+ L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----FDPTKKRLLGWQARVTII 618
            +LQHRN+++L           LI EY     L  ++           +   +Q      
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------ 140

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGDELQGN 673
             +  G+ + H     R +HRDLK  N+LL +         KI DFGLAR F G  ++  
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194

Query: 674 TKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
           T  I+ T  Y  PE  L    +S   D++S   +  E L   
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  112 bits (282), Expect = 3e-27
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)

Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-----LEEFKNEMMLI 563
           +++  F    KLG G +  VYKG     G  VA+K +   S +G     + E      L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVFLFDPTKKRLLGWQARVTIIEG 620
            +L+H N+V+L      + +  L+ E+M N   K +D      T + L     +    + 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           + QGL + H+    +I+HRDLK  N+L++     K+ DFGLAR F G  +   +  +V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171

Query: 681 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
             Y +P+  +    +S   D++S G ++ E ++GK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 5e-27
 Identities = 30/239 (12%), Positives = 68/239 (28%), Gaps = 54/239 (22%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSS---QSGQGLEEFKNEMMLIAKLQ--------- 567
           LG+       +      G+   V             +++ K E++ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 568 ----------------HRNLVKLLGCC-VEQGEKILILEYMPNKSLDVF---LFD-PTKK 606
                            + ++++              L      +L  F   L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 607 RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG 666
           + L   AR+ +   + + L  LH Y    ++H  L+  +++LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 667 GDELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSGK 714
                G       + G+  PE                L +   D ++ G+++       
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (287), Expect = 7e-27
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 31/221 (14%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------SQSGQGLEEFK 557
            E++    KLG G +G V   +      E A+K +                  +  EE  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 558 NEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARV 615
           NE+ L+  L H N++KL     ++    L+ E+     L    F+    + +     A  
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQG 672
            I++ I  G+ YLH+++   I+HRD+K  N+LL   +  +N KI DFGL+  F  D    
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205

Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
             +  +GT  Y++PE  L   ++ K DV+S G++M   L G
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (280), Expect = 8e-27
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 45/224 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN--------EMM 561
           + +     LGEG F  VYK R     Q VA+K  +L  +      E K+        E+ 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-----SEAKDGINRTALREIK 64

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPN------KSLDVFLFDPTKKRLLGWQARV 615
           L+ +L H N++ LL     +    L+ ++M        K   + L     K  +      
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                  QGL YLHQ+    I+HRDLK +N+LLD +   K++DFGLA+ F G   +  T 
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 676 RIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
           ++V T  Y +PE     LF  +      D+++ G ++ E L   
Sbjct: 172 QVV-TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  110 bits (277), Expect = 1e-26
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 30/215 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN----EMMLIAK 565
           E +     +GEG +G V K R    G+ VA+K    S       +  K     E+ L+ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTIIEG 620
           L+H NLV LL  C ++    L+ E++ +     L++F    D    +   +Q        
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           I  G+ + H +    IIHRD+K  N+L+      K+ DFG AR       +     +  T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187

Query: 681 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
             Y +PE  + D  +    DV++ G L+ E   G+
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  109 bits (276), Expect = 2e-26
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-----LEEFKNEMMLIAKL 566
           E +    KLGEG +  VYKG+  L    VA+K +  +  +G     + E      L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPN---KSLDV--FLFDPTKKRLLGWQARVTIIEGI 621
           +H N+V L      +    L+ EY+     + LD    + +    +L  +Q        +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
            +GL Y H+    +++HRDLK  N+L++     K++DFGLAR       +     +V T 
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164

Query: 682 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            Y  P+  L    +S + D++  G +  E  +G+
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (277), Expect = 3e-26
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           L+ L     ++ E +LILE++        LFD    +   +     +  +    +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           H++    I+H D+K  N++ +       KI DFGLA     DE     K    T  + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E          +D+++ G+L    LSG
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  108 bits (271), Expect = 3e-26
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LGEG +G V      +  + VAVK +   ++    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
            E   + L LEY     L    FD       +    A+     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
             I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
           +          DV+S GI++   L+G
Sbjct: 184 F--HAE---PVDVWSCGIVLTAMLAG 204

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  108 bits (273), Expect = 3e-26
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
           E +    K+GEG +G V+K R    GQ VA+K+          E           E+ ++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPN---KSLDVF--LFDPTKKRLLGWQARVTII 618
            +L+H NLV LL     +    L+ EY  +     LD +         + + WQ      
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
               Q + + H++     IHRD+K  N+L+      K+ DFG AR+            + 
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164

Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            T  Y SPE  + D  +    DV++ G +  E LSG 
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (274), Expect = 4e-26
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 25/217 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLIAK 565
            + + +   +G+G F  V +      GQ+ AVK     + +S  G   E+ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGW----QARVTIIE 619
           L+H ++V+LL      G   ++ E+M        L      +           A    + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKR 676
            I + L Y H      IIHRD+K   VLL   +     K+  FG+A   G          
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192

Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            VGT  +M+PE      +    DV+  G+++   LSG
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (274), Expect = 6e-26
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
             S    LG G FG V+K      G ++A K + ++  +  EE KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +L      + + +L++EY+        LFD    +   L     +  ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 631 YSRFRIIHRDLKASNVLL-DMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                I+H DLK  N+L  + D    KI DFGLAR +   E     K   GT  +++PE 
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259

Query: 689 ALDGLFSIKSDVFSFGIL--MLETLSG 713
                 S  +D++S G++  ML  LSG
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYML--LSG 284

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (270), Expect = 9e-26
 Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           LGEG +G V      +  + VAVK +   ++    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
            E   + L LEY     L    FD       +    A+     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
             I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
           +          DV+S GI++   L+G
Sbjct: 184 F--HAE---PVDVWSCGIVLTAMLAG 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 1e-25
 Identities = 67/353 (18%), Positives = 117/353 (33%), Gaps = 41/353 (11%)

Query: 383 SNVTEGSGCLMWFGDLLDANRPTRNFTGQSVYIRVPASETGKRKLLWILVILVLPLVLLP 442
            N+ + +  L W    LD        T  ++  R     +      W             
Sbjct: 19  ENILDEAVILSWKPPALDGGSLV---TNYTIEKREAMGGS------WSPCAKSRYTYTTI 69

Query: 443 SF------YIFCRRRRNCKEKETENMETDQDLLAFDINMGITTRTNEFGEVNGDGK---- 492
                   Y F     N   +      T   L+  D          +       GK    
Sbjct: 70  EGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVS 129

Query: 493 ---DKGKDSWLPLFSLASVAAATENFS----MQCKLGEGGFGPVYKGR-LLNGQEVAVKR 544
              D         +    V    ++      +  +LG G FG V++      G   A K 
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189

Query: 545 LSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-- 602
           + +      E  + E+  ++ L+H  LV L     +  E ++I E+M        LF+  
Sbjct: 190 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKV 245

Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFG 660
             +   +     V  +  + +GL ++H+ +    +H DLK  N++     +   K+ DFG
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG 302

Query: 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           L       +   + K   GT  + +PE A        +D++S G+L    LSG
Sbjct: 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 2e-25
 Identities = 58/263 (22%), Positives = 86/263 (32%), Gaps = 66/263 (25%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
            +F     +G GGFG V++ +  ++    A+KR+         E+   E+  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTI------------- 617
           +V+     +E   +    E       D     P           V I             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 618 --IEGIAQGLLY----------LHQYSRFRI-----------------------IH---- 638
                  +  LY          L  +   R                        +H    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 639 --RDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK----------RIVGTYGYMSP 686
             RDLK SN+   MD   K+ DFGL      DE +                VGT  YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
           E      +S K D+FS G+++ E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  107 bits (270), Expect = 2e-25
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 46/229 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN--------EMMLI 563
             +    K+G+G FG V+K R    GQ+VA+K++       +E  K         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 564 AKLQHRNLVKLLGCCVEQGEKI--------LILEYMPN------KSLDVFLFDPTKKRLL 609
             L+H N+V L+  C  +            L+ ++  +       ++ V       KR++
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG--- 666
                      +  GL Y+H+    +I+HRD+KA+NVL+  D   K++DFGLAR F    
Sbjct: 131 -QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 667 GDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
             +    T R+V T  Y  PE  L +  +    D++  G +M E  +  
Sbjct: 179 NSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (271), Expect = 2e-25
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 48/198 (24%)

Query: 519 CKLGEGGFGPVYKGR---LLNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQHRNL 571
           CK+G G +G VYK +     + ++ A+K++     S S         E+ L+ +L+H N+
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80

Query: 572 VKLLGCCVEQGEKI--LILEYM--------------PNKSLDVFLFDPTKKRLLGWQARV 615
           + L    +   ++   L+ +Y                     V L     K LL +Q   
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFG--GDE 669
                I  G+ YLH      ++HRDLK +N+L+  +       KI+D G AR+F      
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 670 LQGNTKRIVGTYGYMSPE 687
           L      +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (268), Expect = 2e-25
 Identities = 49/256 (19%), Positives = 86/256 (33%), Gaps = 60/256 (23%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQSGQGLEEFKNEMMLIAK 565
            + + ++  +G+G +G V            A+K     ++   + + +E  K E+ L+ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVT--------- 616
           L H N+ +L     ++    L++E      L     D     +     +           
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 617 --------------------------------IIEGIAQGLLYLHQYSRFRIIHRDLKAS 644
                                           I+  I   L YLH      I HRD+K  
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197

Query: 645 NVLL--DMDMNPKISDFGLARMFGGDELQGNT--KRIVGTYGYMSPE--YALDGLFSIKS 698
           N L   +     K+ DFGL++ F               GT  +++PE     +  +  K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257

Query: 699 DVFSFGILMLETLSGK 714
           D +S G+L+   L G 
Sbjct: 258 DAWSAGVLLHLLLMGA 273

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 4e-25
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 36/220 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHRN 570
              ++    +G G FG V++ +L+   EVA+K++        + FKN E+ ++  ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93

Query: 571 LVKLLGCCVEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARVT 616
           +V L       G+K       L+LEY+P    ++   +            +L  +Q    
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149

Query: 617 IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTK 675
               + + L Y+H      I HRD+K  N+LLD      K+ DFG A++      + N  
Sbjct: 150 ----LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200

Query: 676 RIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
            I   Y Y +PE       ++   D++S G +M E + G+
Sbjct: 201 YICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 5e-25
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 35/209 (16%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGC 577
           +G+G F  V   R +L G+EVA+K +  +  +   L++   E+ ++  L H N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 578 CVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQY 631
            +E  + + LI+EY     +    FD      R+   +AR     I+  +     Y H  
Sbjct: 83  -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---- 687
            + RI+HRDLKA N+LLD DMN KI+DFG +  F             G   Y +PE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187

Query: 688 --YALDGLFSIKSDVFSFGILMLETLSGK 714
             Y  DG    + DV+S G+++   +SG 
Sbjct: 188 KKY--DGP---EVDVWSLGVILYTLVSGS 211

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (265), Expect = 5e-25
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSSQS---GQGLEEFKNEMMLIA 564
            +S    LG G FG V+        +EV VK     ++          L +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
           +++H N++K+L     QG   L++E   +  LD+F F     RL    A   I   +   
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           + YL       IIHRD+K  N+++  D   K+ DFG A      +L        GT  Y 
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196

Query: 685 SPE------YALDGLFSIKSDVFSFGILM 707
           +PE      Y   G    + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 1e-24
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + F     LG G F  V+  +  L G+  A+K +           +NE+ ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           +V L           L+++ +    L    FD    +       A   +I+ +   + YL
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS-LVIQQVLSAVKYL 122

Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           H+     I+HRDLK  N+L    + +    I+DFGL++M     +        GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE      +S   D +S G++    L G
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCG 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 32/237 (13%)

Query: 496 KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLS 546
           +D+ LP     S     EN+  +  LG G    V +       +E AVK          S
Sbjct: 2   RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59

Query: 547 SQSGQGLEE-FKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD-- 602
           ++  Q L E    E+ ++ K+  H N+++L           L+ + M    L    FD  
Sbjct: 60  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115

Query: 603 PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA 662
             K  L   + R  I+  + + +  LH+     I+HRDLK  N+LLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 663 RMFGGDELQGNTKRIVGTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSG 713
                 E     + + GT  Y++PE            +  + D++S G++M   L+G
Sbjct: 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (259), Expect = 2e-24
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 55/224 (24%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------SQSGQGLEEFKNEMML 562
           +G+G +G V       +    A+K LS                           +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 563 ------IA---KLQHRNLVKLLGCCVEQGEK---ILILEYMPNKSLDVFLFD-PTKKRLL 609
                 IA   KL H N+VKL+   ++   +    ++ E +    +     + PT K L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 610 GWQARVT---IIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF- 665
             QAR     +I+GI     YLH     +IIHRD+K SN+L+  D + KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 705
           G D L       VGT  +M+PE +L     I      DV++ G+
Sbjct: 189 GSDAL---LSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (259), Expect = 2e-24
 Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 20/209 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            E + +   LG G FG V++     + +    K +    G      K E+ ++   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           ++ L        E ++I E++        +F+   T    L  +  V+ +  + + L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           H ++   I H D++  N++     +   KI +FG AR     +     + +     Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172

Query: 687 EYALDGLFSIKSDVFSFGIL--MLETLSG 713
           E     + S  +D++S G L  +L  LSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVL--LSG 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 2e-24
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
            N+V+L     E+    L+ + +        LF+    ++      A    I+ I + + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 119

Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           Y H      I+HR+LK  N+LL         K++DFGLA      E         GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE      +S   D+++ G+++   L G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  105 bits (264), Expect = 3e-24
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHR 569
             +++    +G G FG VY+ +L  +G+ VA+K++        + FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 570 NLVKLLGCCVEQGEKI------LILEYMP---NKSLDVFL-----FDPTKKRLLGWQARV 615
           N+V+L       GEK       L+L+Y+P    +    +            +L  +Q   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--- 164

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNT 674
                + + L Y+H    F I HRD+K  N+LLD D    K+ DFG A+     E   N 
Sbjct: 165 -----LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NV 214

Query: 675 KRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGK 714
             I   Y Y +PE       ++   DV+S G ++ E L G+
Sbjct: 215 SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (263), Expect = 3e-24
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGLEEFKNEMML 562
            + + M   LG G  G V         ++VA++ +S        ++        + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEG 620
           + KL H  ++K+     +  +  ++LE M    L    FD     KRL     +      
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI 677
           +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301

Query: 678 VGTYGYMSPE---YALDGLFSIKSDVFSFGILMLETLSG 713
            GT  Y++PE         ++   D +S G+++   LSG
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (260), Expect = 3e-24
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
            + + +  +LG G F  V K R    G E A K        +S+ G   EE + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
           ++ H N++ L      + + +LILE +        LFD   +K  L  +   + I+ I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVG 679
           G+ YLH      I H DLK  N++L     P    K+ DFGLA            K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
           T  +++PE        +++D++S G++  +L  LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (258), Expect = 3e-24
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 22/214 (10%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
            + + +  +LG G F  V K R    G E A K        +S+ G   EE + E+ ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
           ++ H N++ L      + + +LILE +        LFD   +K  L  +   + I+ I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVG 679
           G+ YLH      I H DLK  N++L     P    K+ DFGLA            K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           T  +++PE        +++D++S G++    LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  102 bits (257), Expect = 4e-24
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKN----EMMLI 563
           AT  +    ++G G +G VYK R   +G  VA+K  R+ +  G G          E+ L+
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65

Query: 564 AKLQ---HRNLVKLLGCCVEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLL 609
            +L+   H N+V+L+  C            L+ E++                     + L
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             Q          +GL +LH      I+HRDLK  N+L+      K++DFGLAR++    
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ- 173

Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
               T  +V T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 174 -MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (256), Expect = 5e-24
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 14/208 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L  +       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 569 RNLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
              VKL      Q ++ L   L Y  N  L    +            R    E I   L 
Sbjct: 90  PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           YLH      IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGK 714
           E   +      SD+++ G ++ + ++G 
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (258), Expect = 6e-24
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 29/220 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSSQSGQGLEE-FKNEMML 562
            + +  +  +G G    V +      G E AVK       RLS +  + + E  + E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 563 IAKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIE 619
           + ++  H +++ L+          L+ + M    L    FD    K  L   + R +I+ 
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
            + + + +LH      I+HRDLK  N+LLD +M  ++SDFG +      E     + + G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261

Query: 680 TYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSG 713
           T GY++PE            +  + D+++ G+++   L+G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (254), Expect = 6e-24
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 28/217 (12%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK------RLSSQSGQGLEEFKNEMMLIA 564
            +++ M  +LG G F  V K R    G+E A K        SS+ G   EE + E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIA 622
           +++H N++ L      + + +LILE +    L    FD    K+ L   +A    ++ I 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEAT-QFLKQIL 118

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIV 678
            G+ YLH     RI H DLK  N++L      +   K+ DFG+A            K I 
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
           GT  +++PE        +++D++S G++  +L  LSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  102 bits (256), Expect = 7e-24
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 26/190 (13%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------SQSGQGLEEFKNEMML 562
            + + M   LG G  G V         ++VA+K +S        ++        + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEG 620
           + KL H  ++K+     +  +  ++LE M    L    FD     KRL     +      
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRI 677
           +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG +++ G   L    + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176

Query: 678 VGTYGYMSPE 687
            GT  Y++PE
Sbjct: 177 CGTPTYLAPE 186

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (255), Expect = 1e-23
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNEMMLIA 564
            + +    +LG G F  V K R    G + A K +      SS+ G   E+ + E+ ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 565 KLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQ 623
           ++QH N++ L      + + ILILE +    L    FD   +K  L  +     ++ I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLL----DMDMNPKISDFGLARMFGGDELQGNTKRIVG 679
           G+ YLH      I H DLK  N++L          KI DFGLA            K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGIL--MLETLSG 713
           T  +++PE        +++D++S G++  +L  LSG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG 213

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (254), Expect = 1e-23
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 26/215 (12%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNEMMLIAKL 566
            + +   LG GGFG VY G  + +   VA+K +                   E++L+ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 567 QHR--NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
                 +++LL         +LILE  P    D+F F   +  L    AR +    + + 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 161

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           + + H      ++HRD+K  N+L+D++    K+ DFG   +              GT  Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVY 214

Query: 684 MSPEYAL----DGLFSIKSDVFSFGILMLETLSGK 714
             PE+       G     + V+S GIL+ + + G 
Sbjct: 215 SPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  101 bits (254), Expect = 1e-23
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 22/199 (11%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRL------SSQSGQGLEEFKNE----MMLIAKLQHR 569
           LG+GGFG V+ G  L +  +VA+K +                   E      + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
            +++LL     Q   +L+LE  P  + D+F +   K  L    +R      +   + + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                 ++HRD+K  N+L+D+     K+ DFG   +   +          GT  Y  PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209

Query: 689 ALDGLFS-IKSDVFSFGIL 706
                +  + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (256), Expect = 1e-23
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
           ++N+ ++ +LG+G F  V +      G E A K +     S +  ++ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLL 626
            N+V+L     E+    L+ + +        LF+    ++      A    I+ I + + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142

Query: 627 YLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           Y H      I+HR+LK  N+LL         K++DFGLA      E         GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +SPE      +S   D+++ G+++   L G
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  101 bits (254), Expect = 1e-23
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 46/227 (20%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSGQGLEEFKN--------EMML 562
           + +    ++GEG +G V+K R     G+ VA+KR+       ++  +         E+ +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 563 IAKLQ---HRNLVKLLGCCV----EQGEKI-LILEYMPN--KSL-----DVFLFDPTKKR 607
           +  L+   H N+V+L   C     ++  K+ L+ E++     +      +  +   T K 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124

Query: 608 LLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG 667
           ++ +Q        + +GL +LH +   R++HRDLK  N+L+      K++DFGLAR++  
Sbjct: 125 MM-FQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
                 T  +V T  Y +PE  L   ++   D++S G +  E    K
Sbjct: 173 Q--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 36/210 (17%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V  G   L G +VAVK   R   +S   + + K E+  +   +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
             +       +++EY+    L    FD      R+   +AR     I+  +     Y H 
Sbjct: 79  V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
             R  ++HRDLK  NVLLD  MN KI+DFGL+ M    E     +   G+  Y +PE   
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVIS 183

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
              Y   G    + D++S G+++   L G 
Sbjct: 184 GRLY--AGP---EVDIWSCGVILYALLCGT 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (254), Expect = 7e-23
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 36/210 (17%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LG G FG V  G+  L G +VAVK L+ Q   S   + + + E+  +   +H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
             +     I +++EY+    L    FD      RL   ++R     I+ G+     Y H 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
             R  ++HRDLK  NVLLD  MN KI+DFGL+ M    E     +   G+  Y +PE   
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVIS 188

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
              Y   G    + D++S G+++   L G 
Sbjct: 189 GRLY--AGP---EVDIWSSGVILYALLCGT 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR-NLVKLL 575
           +LG G F  V +      GQE A K  +   +      E  +E+ ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 576 GCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW---QARVTIIEGIAQGLLYLHQYS 632
                  E ILILEY     +    F      L         + +I+ I +G+ YLHQ  
Sbjct: 96  EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150

Query: 633 RFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
              I+H DLK  N+LL       + KI DFG++R  G        + I+GT  Y++PE  
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205

Query: 690 LDGLFSIKSDVFSFGIL--MLETLSG 713
                +  +D+++ GI+  ML  L+ 
Sbjct: 206 NYDPITTATDMWNIGIIAYML--LTH 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 37/210 (17%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVK---RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           LGEG FG V         Q+VA+K   R   +        + E+  +  L+H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 577 CCVEQGEKI-LILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQ 630
             +     I +++EY   +     LFD    KKR+   + R     II  I     Y H 
Sbjct: 77  V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH- 125

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
             R +I+HRDLK  N+LLD ++N KI+DFGL+ +          K   G+  Y +PE   
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVIN 180

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSGK 714
              Y   G    + DV+S GI++   L G+
Sbjct: 181 GKLY--AGP---EVDVWSCGIVLYVMLVGR 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 47/229 (20%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN----EMMLIAKL 566
            + F ++   G+G FG V  G+    G  VA+K++          F+N     M  +A L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76

Query: 567 QHRNLVKLLGCCVEQGEK-------ILILEYMP---NKSLDVFLFDPTK-----KRLLGW 611
            H N+V+L       GE+        +++EY+P   ++    +            ++  +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP-KISDFGLARMFGGDEL 670
           Q        + + +  LH  S   + HRD+K  NVL++      K+ DFG A+     E 
Sbjct: 137 Q--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKS-----DVFSFGILMLETLSGK 714
             N   I   Y Y +PE     +F  +      D++S G +  E + G+
Sbjct: 188 --NVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  100 bits (250), Expect = 2e-22
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 22/186 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQH 568
           TE + +  +LG+G F  V +   +L GQE A   +     S +  ++ + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQG 624
            N+V+L     E+G   LI + +        LF+    R   +     A    I+ I + 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAR--EYYSEADAS-HCIQQILEA 122

Query: 625 LLYLHQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
           +L+ HQ     ++HR+LK  N+LL         K++DFGLA    G+  Q       GT 
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTP 177

Query: 682 GYMSPE 687
           GY+SPE
Sbjct: 178 GYLSPE 183

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 25/210 (11%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCC 578
           LGEG    V     L+  QE AVK +  Q G        E+ ++ + Q HRN+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 579 VEQGEKILILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII 637
            E+    L+ E M   S+         K+R         +++ +A  L +LH      I 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133

Query: 638 HRDLKASNVLL---DMDMNPKISDFGLARMF-----GGDELQGNTKRIVGTYGYMSPEYA 689
           HRDLK  N+L    +     KI DF L                      G+  YM+PE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-V 192

Query: 690 LDGLFSI------KSDVFSFGILMLETLSG 713
           ++           + D++S G+++   LSG
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (250), Expect = 4e-22
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
             F     LG+GGFG V   ++    ++ A K+L  +     +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           R +V L     E  + + L+L  M    L   ++   +      +A     E I  GL  
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH   R RI++RDLK  N+LLD   + +ISD GLA      +     K  VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
              +  ++   D ++ G L+ E ++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 98.7 bits (246), Expect = 1e-21
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 14/209 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           + F     LG GGFG V+  ++    ++ A K+L+ +     +G +    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKK--RLLGWQARVTIIEGIAQGL 625
           R +V L     E    + L++  M    +   +++  +        +A     + I  GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            +LHQ     II+RDLK  NVLLD D N +ISD GLA      +    TK   GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMA 357

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE  L   +    D F+ G+ + E ++ +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 22/200 (11%), Positives = 59/200 (29%), Gaps = 43/200 (21%)

Query: 520 KLGEGGFGPVYKGR--LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHRNLVKL 574
             G       ++     L  ++VA+  +  Q       L+E  +  + ++++    + ++
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           L     +   +++ E++   SL                A +  ++ +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
            +       S V + +D +  ++                          M          
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179

Query: 695 SIKSDVFSFGILMLETLSGK 714
           + + D+   G  +   L  +
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.6 bits (243), Expect = 3e-21
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNE---MMLIAK 565
            +FS+   +G GGFG VY  R  +  ++ A+K L  +     QG     NE   + L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 566 LQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
                +V +        +K+  IL+ M    L   L             R    E I  G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILG 304

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           L ++H      +++RDLK +N+LLD   + +ISD GLA  F   +        VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357

Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGK 714
           +PE    G+    S D FS G ++ + L G 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 20/209 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           T+ + ++  +G G +    +        E AVK +        EE     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           ++ L     +     ++ E M    L     D    +K     +A   ++  I + + YL
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132

Query: 629 HQYSRFRIIHRDLKASNVLL-DMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
           H      ++HRDLK SN+L  D   NP   +I DFG A+    +   G       T  ++
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +PE      +    D++S G+L+   L+G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           ++ F ++ +LG G    VY+ +     +  A+K L     +  +  + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYL 628
           ++KL        E  L+LE +        LFD    K       A    ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAA-DAVKQILEAVAYL 164

Query: 629 HQYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           H+     I+HRDLK  N+L      D   KI+DFGL+++     L    K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSG 713
           PE      +  + D++S GI+    L G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 30/207 (14%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
            LG G  G V +      GQ+ A+K L         + + E+    +     ++V +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90

Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
                       +I+E M    L    F   ++R        +A   I+  I   + +LH
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145

Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
            ++   I HRD+K  N+L    + D   K++DFG A+    + LQ        T  Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAP 198

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E      +    D++S G++M   L G
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 20/201 (9%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
            LGEG F    K     + Q  AVK +S +        + E+  +   + H N+VKL   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 578 CVEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFR 635
             +Q    L++E +    L    F+    KK     +A   I+  +   + ++H      
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHDVG--- 126

Query: 636 IIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
           ++HRDLK  N+L    + ++  KI DFG AR+   D      K    T  Y +PE     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184

Query: 693 LFSIKSDVFSFGILMLETLSG 713
            +    D++S G+++   LSG
Sbjct: 185 GYDESCDLWSLGVILYTMLSG 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 36/208 (17%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHRNLVKLLGCC 578
           +G G FG     R  L  + VAVK +    G  ++E  + E++    L+H N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 579 VEQGEKILILEYMPNKSLDVFLFD--PTKKRLLGWQARVT---IIEGIAQGLLYLHQYSR 633
           +      +I+EY     L    ++      R    +AR     ++ G++    Y H    
Sbjct: 86  LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134

Query: 634 FRIIHRDLKASNVLLD--MDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---- 687
            +I HRDLK  N LLD       KI DFG ++           K  VGT  Y++PE    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR 191

Query: 688 --YALDGLFSIKSDVFSFGILMLETLSG 713
             Y  DG     +DV+S G+ +   L G
Sbjct: 192 QEY--DGK---IADVWSCGVTLYVMLVG 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 43/207 (20%), Positives = 81/207 (39%), Gaps = 29/207 (14%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGC 577
            LG G  G V +       ++ A+K L         + + E+ L  +     ++V+++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123

Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
                       +++E +    L    F   + R        +A   I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178

Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
             +   I HRD+K  N+L      +   K++DFG A+         +      T  Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSG 713
           E      +    D++S G++M   L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 17/211 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E+F +   +G G FG V   +L N  +V A+K L+        E   F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           + +  L     +    + L+++Y     L + L    + RL    AR  + E +   +  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           +HQ      +HRD+K  N+L+DM+ + +++DFG       D     +   VGT  Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246

Query: 688 YALDGLFSIKS-----DVFSFGILMLETLSG 713
                           D +S G+ M E L G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.6 bits (212), Expect = 5e-18
 Identities = 52/253 (20%), Positives = 100/253 (39%), Gaps = 69/253 (27%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKN-EMMLIAKLQHR 569
           ++ +S+   LG G FG V +   + +G+  A+K++          +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60

Query: 570 NLVKLLGCCVEQGEKI--------------------------------------LILEYM 591
           N++KL+      G++                                       +I+EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 592 P---NKSLDVFLFDPTK-----KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
           P   +K L  F+            +  +Q        + + + ++H      I HRD+K 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ--------LFRAVGFIHS---LGICHRDIKP 169

Query: 644 SNVLLDMDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVF 701
            N+L++   N  K+ DFG A+       + +   I   + Y +PE  L    ++   D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226

Query: 702 SFGILMLETLSGK 714
           S G +  E + GK
Sbjct: 227 SIGCVFGELILGK 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HR 569
            +++ +  KLG G +  V++   + N ++V VK L     +   + K E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 570 NLVKLLGCCVEQGEK--ILILEYMPNKSLDVFL--FDPTKKRLLGWQARVTIIEGIAQGL 625
           N++ L     +   +   L+ E++ N               R   ++        I + L
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKAL 143

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            Y H  S   I+HRD+K  NV++D +    ++ D+GLA        Q    R+   Y + 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FK 197

Query: 685 SPEYALDGLFSIKS-DVFSFGILMLETLSGKK 715
            PE  +D      S D++S G ++   +  K+
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.6 bits (212), Expect = 9e-18
 Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 41/199 (20%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            + + ++  +G G +G V +    L  + VA+K++          F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 562 LIAKLQHRNLVKLLGCCV----EQGEKI-LILEYMPN------KSLDVFLFDPTKKRLLG 610
           ++ +L H ++VK+L   +    E+ +++ ++LE   +      ++  V+L +   K LL 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162

Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
           +         +  G+ Y+H  S   I+HRDLK +N L++ D + K+ DFGLAR     E 
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 671 QGNTKRIVGTYGYMSPEYA 689
             +   I      M+    
Sbjct: 212 GNSQLPISPREDDMNLVTF 230

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 19/213 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           ++F +   +G G F  V   ++    +V A+K ++         +  F+ E  ++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           R + +L     +    + L++EY     L + L     +R+    AR  + E I   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           +H+      +HRD+K  N+LLD   + +++DFG       D     +   VGT  Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233

Query: 688 -------YALDGLFSIKSDVFSFGILMLETLSG 713
                      G +  + D ++ G+   E   G
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            + +     +G G  G V      +  + VA+K+LS         F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
           L+  + H+N++ LL        +E+ + + +++E M     + + + L       LL +Q
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
                   +  G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   +  
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L   +    D++S G +M E + G 
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 9/95 (9%)

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL---QGNTKRI 677
           +A+G+ +L   +  + IHRDL A N+LL      KI DFGLAR    D     +G+ +  
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
           +    +M+PE   D +++I+SDV+SFG+L+ E  S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 9e-13
 Identities = 34/160 (21%), Positives = 56/160 (35%), Gaps = 19/160 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-LEEFKNEM-MLIA 564
           +   +   LG G FG V +            + VAVK L   +         +E+ +LI 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 565 KLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
              H N+V LLG C + G  + +I+E+    +L  +L             R   +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR 663
           G  +         I  DLK     +    +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 38/226 (16%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEE--FKN---------EM 560
              +++Q  +  G +G V  G    G  VA+KR+ +    G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 561 MLIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMPN------KSLDVFLFDPTKKRLL 609
            L+    H N++ L             K+ L+ E M            + +     +  +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
            +         I  GL  LH+     ++HRDL   N+LL  + +  I DF LAR    D 
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
              N    V    Y +PE  +    F+   D++S G +M E  + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLS----SQSGQGLEEFKNEMMLIAKLQ 567
           + F     LG G FG V   +   +G   A+K L      +  Q +E   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
              LVKL     +     +++EY+    +  F       R     AR    + I     Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH      +I+RDLK  N+L+D     +++DFG A+      ++G T  + GT   ++PE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPE 208

Query: 688 YALDGLFSIKSDVFSFGILMLETLSG 713
             L   ++   D ++ G+L+ E  +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            + +     +G G  G V      +  + VA+K+LS         F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113

Query: 562 LIAKLQHRNLVKLL------GCCVEQGEKILILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
           L+  + H+N++ LL          E  +  L++E M     + + + L       LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
                   +  G+ +LH  S   IIHRDLK SN+++  D   KI DFGLAR  G   +  
Sbjct: 173 --------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 219

Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L   +    D++S G +M E +  K
Sbjct: 220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            + +     +G G +G V       +G++VA+K+LS         F++         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
           L+  +QH N++ LL        +       L++ +M     K + +   +   + L+ +Q
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
                   + +GL Y+H      ++HRDLK  N+ ++ D   KI DFGLAR     E+ G
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTG 182

Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L    ++   D++S G +M E L+GK
Sbjct: 183 Y----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEE---FKNEMMLIAKLQH 568
           E++ +   +G G FG V   R  + ++V A+K LS        +   F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             +V+L     +     +++EYMP   L   +   +   +    AR    E +   L  +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
           H       IHRD+K  N+LLD   + K++DFG       + +       VGT  Y+SPE 
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240

Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSG 713
                 DG +  + D +S G+ + E L G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 17/209 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
             F     LG+G FG V   +        A+K L  +     +E      E  ++   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
             L  L     +  +++  ++EY      ++F     ++     +AR    E I   L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDY 263

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
           LH  S   +++RDLK  N++LD D + KI+DFGL +  +  G       K   GT  Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE   D  +    D +  G++M E + G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 43/225 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
              ++    +GEG +G V      LN   VA+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 562 LIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQA 613
           ++ + +H N++ +        +EQ + + ++ + M     K L              +Q 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
                  I +GL Y+H  S   ++HRDLK SN+LL+   + KI DFGLAR+   D    +
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDH 184

Query: 674 TKRI---VGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
           T  +   V T  Y +PE  L+   ++   D++S G ++ E LS +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKN---EMMLIAKLQH 568
           ++F +   +G+G FG V   +  + +++ A+K ++ Q      E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 569 RNLVKLLGCCVEQ-GEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
             LV L      Q  E + ++++ +     D+               ++ I E +   L 
Sbjct: 75  PFLVNLWYSF--QDEEDMFMVVDLLLGG--DLRYHLQQNVHFKEETVKLFICE-LVMALD 129

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           YL      RIIHRD+K  N+LLD   +  I+DF +A M   +        + GT  YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183

Query: 687 EYALDGLFSIKS---DVFSFGILMLETLSGK 714
           E       +  S   D +S G+   E L G+
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 52/234 (22%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
              +     LG GG G V+        + VA+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-----------------FDPT 604
           +I +L H N+VK+       G ++        +   V++                     
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 605 KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLAR 663
             RL  +Q        + +GL Y+H  +   ++HRDLK +N+ ++  D+  KI DFGLAR
Sbjct: 121 HARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 664 MFGGDELQGN--TKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           +           ++ +V T  Y SP   L    ++   D+++ G +  E L+GK
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
           ++F +   LG G FG V+  R  +     A+K L  +    L++     +E ++++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             ++++ G   +  +  +I++Y+    L  F      +R     A+    E +   L YL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      II+RDLK  N+LLD + + KI+DFG A+      +   T  + GT  Y++PE 
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLSG 713
                ++   D +SFGIL+ E L+G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAG 199

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
           ++F +   +G G +  V   RL     + A+K +  +     E+                
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H  LV L   C +   ++  ++EY+     D+      +++L    AR    E I+  L 
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALN 124

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           YLH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D ++ G+LM E ++G+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.9 bits (183), Expect = 1e-14
 Identities = 37/203 (18%), Positives = 61/203 (30%), Gaps = 46/203 (22%)

Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SSQSGQGLEEFKN 558
           S    TE      K+GEG FG V++    +   VA+K +        +    +  EE   
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 559 EMMLIAKLQ---------HRNLVKLLGCCVEQGE--KILILEYM--------PNKSLDVF 599
           E+++  +L              + L      QG    +L+  +          N   D F
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 600 ----------------LFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKA 643
                             +  + +L       +I+  +   L         R  HRDL  
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 644 SNVLLDMDMNPKISDFGLARMFG 666
            NVLL      K+      +   
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 1e-14
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
            +F+    LG+G FG V         E+ AVK L        ++ +  M+    L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
              L +L   C +  +++  ++EY+     D+        R     A     E IA GL 
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRFKEPHAVFYAAE-IAIGLF 456

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           +L       II+RDLK  NV+LD + + KI+DFG+ +  ++ G      TK   GT  Y+
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 509

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D ++FG+L+ E L+G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEM----MLIAKLQ 567
           E+F +   LG+G FG V+        +  A+K L        ++ +  M    +L    +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H  L  +  C  +  E +  ++EY+     D+     +  +    +A     E I  GL 
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAE-IILGLQ 132

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           +LH      I++RDLK  N+LLD D + KI+DFG+ +  M G       T    GT  Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSG 713
           +PE  L   ++   D +SFG+L+ E L G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
           ++F +   +G G +  V   RL     + A++ +  +     E+                
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H  LV L   C +   ++  ++EY+     D+      +++L    AR    E I+  L 
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALN 167

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           YLH+     II+RDLK  NVLLD + + K++D+G+ +  +  GD     T    GT  Y+
Sbjct: 168 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 220

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D ++ G+LM E ++G+
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEF---KNEMMLIAKLQH 568
            +F     LG+G FG V   R        A+K L  +     +E      E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 569 RNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
             L  L     +  +++  ++EY      ++F     ++     +AR    E I   L Y
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE-IVSALEY 120

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
           LH      +++RD+K  N++LD D + KI+DFGL +  +  G       K   GT  Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGK 714
           PE   D  +    D +  G++M E + G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLS----SQSGQGLEEFKNEMMLIA 564
           E F +   LG+GG+G V++ R + G       A+K L      ++ +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 565 KLQHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           +++H  +V L+    + G K+ LILEY+    L  F+    +   +   A   + E I+ 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTY 681
            L +LHQ     II+RDLK  N++L+   + K++DFGL +  +  G      T    GT 
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            YM+PE  +    +   D +S G LM + L+G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 43/223 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
              +     +G G +G V        G +VA+K+L          F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76

Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
           L+  ++H N++ LL        ++      L++ +M     K +        + + L +Q
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
                   + +GL Y+H      IIHRDLK  N+ ++ D   KI DFGLAR     E+ G
Sbjct: 137 --------MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTG 184

Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L+   ++   D++S G +M E ++GK
Sbjct: 185 Y----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.7 bits (182), Expect = 3e-14
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSSQS--GQGLEEFKNEMMLIAKL 566
             F +   LG+G FG V+  + ++G +     A+K L   +   +     K E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 567 QHRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
            H  +VKL     +   K+ LIL+++    L  F     +        +  + E +A  L
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAE-LALAL 139

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
            +LH      II+RDLK  N+LLD + + K++DFGL++  +    +         GT  Y
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYSFCGTVEY 192

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           M+PE       +  +D +SFG+LM E L+G 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
            +F+    LG+G FG V         E+ AVK L        ++ +  M+    L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSL-------DVFLFDPTKKRLLGWQARVTIIE 619
              L +L   C +  +++  ++EY+    L         F             A     E
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---------HAVFYAAE 129

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRI 677
            IA GL +L       II+RDLK  NV+LD + + KI+DFG+ +  ++ G      TK  
Sbjct: 130 -IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTF 181

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            GT  Y++PE      +    D ++FG+L+ E L+G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
            +F     +G+G FG V   R    +   AVK L  ++    +E K+ M     L+  ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H  LV L     +  +K+  +L+Y+     ++F     ++  L  +AR    E IA  L 
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALG 153

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
           YLH  +   I++RDLK  N+LLD   +  ++DFGL +  +         T    GT  Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE      +    D +  G ++ E L G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 41/202 (20%), Positives = 81/202 (40%), Gaps = 41/202 (20%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            +N+ ++  +G G +G VY        + VA+K+++         F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 562 LIAKLQHRNLVKLLGCCVEQGEKI-----LILEYMPN------KSLDVFLFDPTKKRLLG 610
           ++ +L+   +++L    +           ++LE   +      K+  +FL +   K +L 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135

Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
           +         +  G  ++H      IIHRDLK +N LL+ D + K+ DFGLAR    ++ 
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 671 QGNTKRIVGTYGYMSPEYALDG 692
                 +            L  
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 43/223 (19%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
            E +     +G G +G V        G  VAVK+LS         F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80

Query: 562 LIAKLQHRNLVKLL-----GCCVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQ 612
           L+  ++H N++ LL        +E+   + L+   M    N  +          + L +Q
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG 672
                   I +GL Y+H      IIHRDLK SN+ ++ D   KI DFGLAR    DE+ G
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-ADEMTG 188

Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
                V T  Y +PE  L+   ++   D++S G +M E L+G+
Sbjct: 189 Y----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 46/230 (20%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
           + +F ++  LGEG +G V        G+ VA+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 562 LIAKLQHRNLVKLLGC----CVEQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQA 613
           ++   +H N++ +         E   ++ +I E M    ++ +   +      +   +Q 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGN 673
                    + +  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR+        +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 674 TKRI--------VGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGK 714
                       V T  Y +PE  L    +S   DV+S G ++ E    +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSSQSGQGLEEFKNEMM----LIAKLQ 567
           +NF     LG+G FG V   R+    ++ AVK L        ++ +  M     L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 568 HRNLVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           H  L +L  CC +  +++  ++E++     D+       +R    +AR    E I   L+
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAE-IISALM 138

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA--RMFGGDELQGNTKRIVGTYGYM 684
           +LH      II+RDLK  NVLLD + + K++DFG+    +  G      T    GT  Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +PE   + L+    D ++ G+L+ E L G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 34/156 (21%), Positives = 63/156 (40%), Gaps = 26/156 (16%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGC 577
            LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++V+++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 578 CVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGW----QARVTIIEGIAQGLLYLH 629
                       +++E +    L    F   + R        +A   I++ I + + YLH
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134

Query: 630 QYSRFRIIHRDLKASNVLL---DMDMNPKISDFGLA 662
             +   I HRD+K  N+L      +   K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 65.6 bits (160), Expect = 2e-13
 Identities = 22/126 (17%), Positives = 46/126 (36%), Gaps = 19/126 (15%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
           + +T    +  G+ L    + +              L ++      T VW +N       
Sbjct: 2   NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH---STSVWASNTGIL-GK 50

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
                 + + GN V+ +    ++W+++      N V  L++DGN+VI  +         +
Sbjct: 51  KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102

Query: 146 WQSFDY 151
           W +  Y
Sbjct: 103 WSTGTY 108

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 34/198 (17%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKN---------EMM 561
              + +  KLG+G +G V+K      G+ VAVK++        + F+N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 562 LIAKLQ-HRNLVKLLGCCV-EQGEKI-LILEYMP---NKSLDVFLFDPTKKRLLGWQARV 615
           ++ +L  H N+V LL     +    + L+ +YM    +  +   + +P  K+ + +Q   
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117

Query: 616 TIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK 675
                + + + YLH  S   ++HRD+K SN+LL+ + + K++DFGL+R F       N  
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 676 RIVGTYGYMSPEYALDGL 693
            +       + +     L
Sbjct: 170 PLSINENTENFDDDQPIL 187

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLS----SQSGQGLEEFKNEMMLIA 564
           ENF +   LG G +G V+  R ++G +     A+K L      Q  +  E  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 565 KLQHRN-LVKLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
            ++    LV L     +   K+ LIL+Y+    L  F     ++R    + ++ + E I 
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IV 169

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
             L +LH+     II+RD+K  N+LLD + +  ++DFGL++ F  DE +       GT  
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIE 225

Query: 683 YMSPEYALDGLFSIKSDV--FSFGILMLETLSGK 714
           YM+P+    G       V  +S G+LM E L+G 
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 39/201 (19%), Positives = 75/201 (37%), Gaps = 48/201 (23%)

Query: 520 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK 573
            +G+GGFG +Y   + + +         VK   S +G    E K         Q +  ++
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 574 LL-------------GCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRL-------LGW 611
                          G   + G+    +I++      L   +++   KR        L  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159

Query: 612 QARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLARMFGGDE 669
           +  + I+E       Y+H++     +H D+KASN+LL+     ++   D+GLA  +  + 
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 670 L-----QGNTKRIVGTYGYMS 685
           +         +   GT  + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 42/192 (21%), Positives = 73/192 (38%), Gaps = 36/192 (18%)

Query: 514 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           NF +  K+G G FG +  G+ L   + VA+K    +S       +             + 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGL 625
           ++           ++LE +   SL+  LFD   +         +  Q  ++ +E      
Sbjct: 69  QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPK-----ISDFGLARMFGGDELQGNT------ 674
            Y+H  +   +I+RD+K  N L+    N       I DF LA+ +   + +         
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYRE 173

Query: 675 -KRIVGTYGYMS 685
            K + GT  YMS
Sbjct: 174 HKSLTGTARYMS 185

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 41/194 (21%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
            ++ +  ++GEG FG +++G  LLN Q+VA+K     S + Q  +E++   +L       
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIA 622
            +  +     E    +L+++ +   SL+  L D   ++           Q  +  ++   
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKFSVKTVAMAAKQM-LARVQ--- 120

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK-----ISDFGLARMFGGDELQGN---- 673
                +H+ S   +++RD+K  N L+    +       + DFG+ + +  D +       
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPY 172

Query: 674 --TKRIVGTYGYMS 685
              K + GT  YMS
Sbjct: 173 REKKNLSGTARYMS 186

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 60.3 bits (146), Expect = 2e-11
 Identities = 26/124 (20%), Positives = 49/124 (39%), Gaps = 18/124 (14%)

Query: 25  ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
           +D +     +  G  L      +     +        L ++     +  VW +  +    
Sbjct: 1   SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48

Query: 85  DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
               VL + N GNLV+ +  +  IW++N   +  N    L+ D N+VI DNS+     + 
Sbjct: 49  ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102

Query: 145 LWQS 148
           +W +
Sbjct: 103 IWAT 106

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 42.2 bits (99), Expect = 5e-05
 Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 87  NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLW 146
             +  I N  NLVL +  N  +W++    +    V ++++DGNLVI   S      +   
Sbjct: 20  GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNR 78

Query: 147 QSFDY 151
           Q+ +Y
Sbjct: 79  QNGNY 83

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 60.2 bits (146), Expect = 3e-11
 Identities = 25/123 (20%), Positives = 44/123 (35%), Gaps = 19/123 (15%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
           ++++  + +  G  L      + L              ++        VW +N     S 
Sbjct: 2   NSLSSPNSLFTGHSLEV-GPSYRLIMQGDCN-----FVLYDS---GKPVWASNTGGLGSG 52

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
               L   N GNLV+ +Q+N  IW T    +  + V  L+ D N+VI            +
Sbjct: 53  CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102

Query: 146 WQS 148
           W +
Sbjct: 103 WAT 105

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 36/192 (18%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RN 570
             + +  K+G G FG +Y G  +  G+EVA+K    ++         E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQ 623
           +  +  C  E    ++++E +   SL+  LF+   ++        L  Q  ++ IE    
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQM-ISRIE---- 119

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPK---ISDFGLARMFGGDELQGNT------ 674
              Y+H  +    IHRD+K  N L+ +        I DFGLA+ +   + + +       
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRE 171

Query: 675 -KRIVGTYGYMS 685
            K + GT  Y S
Sbjct: 172 NKNLTGTARYAS 183

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 30/216 (13%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFK-------NEMMLIAKLQH 568
           KLG G F  V+  + ++N   VA+K +           +E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 569 RNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQG 624
            +++KLL     +G       ++ E +  ++L   +     + +     +  I + +  G
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143

Query: 625 LLYLHQYSRFRIIHRDLKASNVLLDMDMNP------KISDFGLARMFGGDELQGNTKRIV 678
           L Y+H   R  IIH D+K  NVL+++  +P      KI+D G A  +  +         +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            T  Y SPE  L   +   +D++S   L+ E ++G 
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 59.5 bits (144), Expect = 5e-11
 Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 20/123 (16%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
           + +     +     L +    + L   +        L  +        +W +N DR    
Sbjct: 3   NVLLSGQTLHADHSLQA--GAYTLTIQNKCN-----LVKYQN---GRQIWASNTDR--RG 50

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
               LT+ + GNLV+ +  N  +W +  + +       L+ DG  VI            L
Sbjct: 51  SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102

Query: 146 WQS 148
           W  
Sbjct: 103 WSL 105

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 32/208 (15%), Positives = 71/208 (34%), Gaps = 48/208 (23%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR---------LLNGQEVAVKRLSSQSGQGLEEFKNEMMLI 563
             + ++        G +Y+               Q+ ++K L ++ G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 564 AKLQHRNLVKL-----------LGCCVEQGE-KILILEYMPNKSL-DVFLFDPTKK---- 606
             LQ     KL           +G  V Q + + L+L  +  +SL       P       
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159

Query: 607 --RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLA 662
               +  +  +  +E       +LH+      +H ++ A N+ +D +   ++  + +G A
Sbjct: 160 SVLQVACRL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

Query: 663 RMF--GGDEL---QGNTKRIVGTYGYMS 685
             +   G  +   +G+     G   ++S
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHEGDLEFIS 236

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 58.4 bits (141), Expect = 1e-10
 Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 10/78 (12%)

Query: 71  DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
           +  +W  N       +     +   G LV++   N T+W + V  +  + V  L+ D N+
Sbjct: 48  NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105

Query: 131 VIRDNSSGNTTESYLWQS 148
           VI  ++        LW +
Sbjct: 106 VIYGDA--------LWAT 115

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 50.7 bits (121), Expect = 7e-08
 Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 6/88 (6%)

Query: 61  YLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNP 120
           +        P  +    + +     H     +    NLVL +  N  IW+TN        
Sbjct: 5   FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGC 63

Query: 121 VAQLRDDGNLVIRDNSSGNTTESYLWQS 148
            A L+ DG LV+  N +       +WQS
Sbjct: 64  RAVLQPDGVLVVITNEN-----VTVWQS 86

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 34/184 (18%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGC 577
           K+G G FG +Y G  +   +EVA+K  + ++         E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71

Query: 578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTIIEGIAQGLLYLHQ 630
            VE    +L+++ +   SL+  LF+   ++L       L  Q  +  +E       ++H 
Sbjct: 72  GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQM-INRVE-------FVHS 121

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPK---ISDFGLARMFGGDELQG------NTKRIVGTY 681
            S    +HRD+K  N L+ +        I DFGLA+ +  D            K + GT 
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTA 177

Query: 682 GYMS 685
            Y S
Sbjct: 178 RYAS 181

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 39/198 (19%), Positives = 73/198 (36%), Gaps = 45/198 (22%)

Query: 520 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSSQSGQGLEEFKNEMML-----IAKLQHRN 570
           K+G GGFG +Y        ++ A   VK    ++G    E K    +     I K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 571 LVKLLG----------CCVEQGEKILILEYMPNKSLDVFLFDPTKK------RLLGWQAR 614
            +  LG              +  + +++E +    L   +              LG +  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRM- 160

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI--SDFGLARMFGGDEL-- 670
           + ++E       Y+H+      +H D+KA+N+LL      ++  +D+GL+  +  +    
Sbjct: 161 LDVLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 671 ---QGNTKRIVGTYGYMS 685
              +   K   GT  + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 56.8 bits (137), Expect = 4e-10
 Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 20/123 (16%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
           + +     +  GE L +   R+              L ++     D  +W  N      D
Sbjct: 2   NILYSGETLSPGEFLNN--GRYVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--D 49

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
               L++ + GNLV+ +  N  IW++N   E  N V  L+ D N+VI   +         
Sbjct: 50  RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101

Query: 146 WQS 148
           W +
Sbjct: 102 WAT 104

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 54.1 bits (130), Expect = 4e-09
 Identities = 21/112 (18%), Positives = 43/112 (38%), Gaps = 13/112 (11%)

Query: 21  VSLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRD 80
           +    + +     +    +L +  +  +L            L ++         W +N  
Sbjct: 2   IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLY----GGKYGWQSNTH 50

Query: 81  RPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVI 132
              +  +  L +++KG L++ +    TIWS+   S+    V  L+DDG  VI
Sbjct: 51  G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 46.8 bits (111), Expect = 1e-06
 Identities = 16/71 (22%), Positives = 27/71 (38%), Gaps = 7/71 (9%)

Query: 78  NRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSS 137
             D  ++  N  L +    NLVL        W +N     ++   +L   G L+I+D+  
Sbjct: 16  YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73

Query: 138 GNTTESYLWQS 148
                  +W S
Sbjct: 74  KT-----IWSS 79

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 52.6 bits (126), Expect = 1e-08
 Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 23/126 (18%)

Query: 23  LAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRP 82
           L  + +     +     L +    F+L           Y G W      +      R   
Sbjct: 1   LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNW-----QSNTANNGR--- 49

Query: 83  ISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTE 142
               +  LT+++ G LV+ N    T+W +   S   N  A +  DG LV+   S      
Sbjct: 50  ----DCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99

Query: 143 SYLWQS 148
             +++ 
Sbjct: 100 --VFKI 103

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 51.4 bits (123), Expect = 3e-08
 Identities = 14/117 (11%), Positives = 42/117 (35%), Gaps = 10/117 (8%)

Query: 24  AADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPI 83
             + +  +  + D  +L +  + + L              +  +     +VW +      
Sbjct: 5   VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSG-- 54

Query: 84  SDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNT 140
              +  + + + G L + +    T++ +N   +  + V  L+ +G  V+   +  +T
Sbjct: 55  RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPAVWST 111

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 46/223 (20%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR- 569
           + +   +G+G FG V K    +  + VA+K + ++     Q   E +    L+  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111

Query: 570 -----NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQA 613
                 +V L    + +    L+ E      L   L+D  +            R    Q 
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ- 165

Query: 614 RVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQ 671
                  +   LL+L       IIH DLK  N+LL        KI DFG +    G  + 
Sbjct: 166 -------MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI- 215

Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
              + I   + Y SPE  L   + +  D++S G +++E  +G+
Sbjct: 216 --YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 52.2 bits (124), Expect = 1e-07
 Identities = 16/79 (20%), Positives = 25/79 (31%), Gaps = 10/79 (12%)

Query: 70  PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
            D  VW  N             +   G + +L   N  +W++         V  L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224

Query: 130 LVIRDNSSGNTTESYLWQS 148
           L I   +        LW +
Sbjct: 225 LAIYGGA--------LWTT 235

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 44.1 bits (103), Expect = 6e-05
 Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 6/90 (6%)

Query: 65  WFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQL 124
           +  Q  D      +  + +      L++    NLVL +  +  +WSTN   +     A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVL 187

Query: 125 RDDGNLVIRDNSSGNTTESYLWQSFDYPTD 154
           + +G + +  N +       +W S +  + 
Sbjct: 188 QPNGRMDVLTNQN-----IAVWTSGNSRSA 212

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 21/109 (19%), Positives = 33/109 (30%), Gaps = 3/109 (2%)

Query: 71  DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNL 130
           D  VW +N             + + G LV+L   N   WS+     + N V  L+ D  +
Sbjct: 44  DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100

Query: 131 VIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQS 179
            I      ++  S             +     G D   +      S Q 
Sbjct: 101 TIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL 149

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 48/217 (22%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR------N 570
           +G+G FG V K       Q VA+K + ++     Q  EE +    ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQARVTIIE 619
           ++ +L     +    +  E      L + L++  KK           R            
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHS------- 208

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRI 677
            I Q L  LH   + RIIH DLK  N+LL        K+ DFG +  +    +       
Sbjct: 209 -ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TY 259

Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           + +  Y +PE  L   + +  D++S G ++ E L+G 
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 52/264 (19%), Positives = 88/264 (33%), Gaps = 86/264 (32%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ--------HRN 570
           KLG G F  V+    +   + VA+K + S      E   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQAR-----------VTIIE 619
           +V+LL      G          N +    +F+     LL W  +             II+
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 620 GIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD---------------------------- 651
            + QGL YLH  ++ RIIH D+K  N+LL ++                            
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 652 ---------------------MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                                +  KI+D G A  +            + T  Y S E  +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLI 266

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
              ++  +D++S   +  E  +G 
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 48.1 bits (113), Expect = 4e-06
 Identities = 13/66 (19%), Positives = 25/66 (37%), Gaps = 8/66 (12%)

Query: 87  NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLW 146
                    GNLV+    N  +W ++      + V +L+ +G++ I D          +W
Sbjct: 196 AVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP-------VW 247

Query: 147 QSFDYP 152
             F + 
Sbjct: 248 ARFGFQ 253

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 20/171 (11%)

Query: 22  SLAADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDR 81
            +    +     +  G+ L+S +QRF+L     G      L I         VWVAN  +
Sbjct: 11  GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62

Query: 82  PIS------DHNAVLTISNKGNLVLLNQTNGTIW-----STNVFSEVKNPVAQLRDDGNL 130
           P S      +  A L    +    L + +   +W     +     +       L+DDGN+
Sbjct: 63  PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122

Query: 131 VIRDNSSG-NTTESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSD 180
           V+ D+ +  N T +         +  L  G ++   +          +Q D
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGD 173

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 12/53 (22%), Positives = 20/53 (37%), Gaps = 2/53 (3%)

Query: 87  NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGN 139
           +A   +    NLVL N      + +N      +   +L + G L I   +S  
Sbjct: 21  SAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNT 71

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 13/73 (17%), Positives = 31/73 (42%), Gaps = 5/73 (6%)

Query: 71  DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGT---IWSTNVFSEVKNPVAQLRDD 127
           +   + +N        +  L ++N+G L + +  + T   ++  +V +   N  A L  D
Sbjct: 37  EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94

Query: 128 GNLVIRDNSSGNT 140
            ++ I   +  +T
Sbjct: 95  QHVTIYGPAIWST 107

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 1e-04
 Identities = 41/342 (11%), Positives = 96/342 (28%), Gaps = 109/342 (31%)

Query: 395 FGDLLDANRPTRNFTGQSV--YIRVPASETGKRKLLWIL-------VILVLPLVLLPSF- 444
             D+ D  +     + + +   I    + +G  +L W L       V   +  VL  ++ 
Sbjct: 35  CKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK 92

Query: 445 YIFCRRRRNCKEKE--TENMETDQDLLAFDINMGIT----TRTNEFGEVN---------- 488
           ++    +   ++    T      +D L ++ N        +R   + ++           
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 489 --------GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 540
                   G GK     +W+             ++ +QCK+    F   +         +
Sbjct: 152 NVLIDGVLGSGK-----TWV-------ALDVCLSYKVQCKMDFKIF---W---------L 187

Query: 541 AVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL 600
            +K  +S              ++  LQ   L+  +             ++  N  L    
Sbjct: 188 NLKNCNS-----------PETVLEMLQ--KLLYQIDPNWTSRS-----DHSSNIKLR--- 226

Query: 601 FDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI---- 656
               +  L              + LL    Y    ++  +++ +      +++ KI    
Sbjct: 227 IHSIQAEL--------------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272

Query: 657 SDFGLARMFGGDELQGNTK---RIVGTYGYMSPEYALDGLFS 695
               +      D L   T     +      ++P+     L  
Sbjct: 273 RFKQVT-----DFLSAATTTHISLDHHSMTLTPDEVK-SLLL 308

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 4e-04
 Identities = 97/680 (14%), Positives = 157/680 (23%), Gaps = 258/680 (37%)

Query: 165 DLKNRLERYLSSWQSDD---DPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQWNGAA-F 220
           D+++  +  LS  + D           T RL   +               S Q      F
Sbjct: 37  DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL--------------LSKQEEMVQKF 82

Query: 221 VSAISYTN--FLYEQYLVENQD----EISYWY---------EPF-----NRPSIMT---- 256
           V  +   N  FL      E +        Y           + F     +R         
Sbjct: 83  VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142

Query: 257 --LKLNPSGLLTRQIWNNNG--------------NDWDLVFSFPDE-YCGKYGYCGANTI 299
             L+L P+  +        G                + +      + +      C     
Sbjct: 143 ALLELRPAKNVLID-----GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC----- 192

Query: 300 CSPDQKPICECLEGFKLKSKFNQTGPIKCERSHSSECI---------------GGHQFIK 344
            SP+       LE   L+    Q  P    RS  S  I                   +  
Sbjct: 193 NSPE-----TVLE--MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 345 ----LDNIRAPDFIEVFLNKSMNLQQCAAECLKNC----TCRAYANSNVTEGSGCLMWFG 396
               L N++       F     NL          C    T R      VT          
Sbjct: 246 CLLVLLNVQNAKAWNAF-----NLS---------CKILLTTR---FKQVT---------- 278

Query: 397 DLLDANRPTRNFTGQSVYIRVPASETGKRKLL--WI---------LVILVLPLVL----- 440
           D L A   T        +  +  +    + LL  ++          V+   P  L     
Sbjct: 279 DFLSAATTTHIS---LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335

Query: 441 -LPSFYIFCR----RRRNCKEKET------ENMETD------QDLLAFDINMGITTRTNE 483
            +            +  NC +  T        +E          L  F  +  I T    
Sbjct: 336 SIRDG--LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-- 391

Query: 484 FGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 543
                           L L     + +       +           +K  L+  Q    K
Sbjct: 392 ----------------LSLIWFDVIKSDVMVVVNKL----------HKYSLVEKQP---K 422

Query: 544 RLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDP 603
             +        E K ++     L HR++       V+         Y   K+ D    D 
Sbjct: 423 ESTISIPSIYLELKVKLENEYAL-HRSI-------VDH--------YNIPKTFD--SDDL 464

Query: 604 TKKRLLGWQARVTIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNVLLDMD-MNPKIS 657
               L                  Y + +            R      V LD   +  KI 
Sbjct: 465 IPPYLDQ----------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508

Query: 658 DFGLARMFGG---DELQ-------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVF 701
               A    G   + LQ                +R+V       P+   + + S  +D+ 
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568

Query: 702 SFGILMLETLSGKKNTGVYN 721
               LM E      +  ++ 
Sbjct: 569 RIA-LMAE------DEAIFE 581

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 47/241 (19%), Positives = 80/241 (33%), Gaps = 66/241 (27%)

Query: 515 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR 569
           + +   LGEG FG V +         +VA+K + +          E      ++ K++ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76

Query: 570 ------NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQ 612
                   V +       G   +  E      L    F+  K+           R + +Q
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 613 ARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP------------------ 654
                   +   L +LH     ++ H DLK  N+L                         
Sbjct: 132 --------LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 655 -KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG 713
            +++DFG A  F  +        IV T  Y  PE  L+  ++   DV+S G ++ E   G
Sbjct: 181 IRVADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 714 K 714
            
Sbjct: 236 F 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 8e-04
 Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 60/240 (25%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSG---QGLEEFKNEMMLIAKLQHR- 569
           F +  K+G+G FG V   + + N +  AVK + +          E      ++ K+Q+  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92

Query: 570 ----NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK-----------RLLGWQAR 614
               N+VK  G  +      LI E      L   L++   +           +L   +  
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIE-- 145

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
                 I + L YL    +  + H DLK  N+LLD     K          G       T
Sbjct: 146 ------ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 675 KR--------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           K                     I+ T  Y +PE  L+  + + SD++SFG ++ E  +G 
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	744
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-25
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	3e-22
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-15
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	1e-09
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	4e-15
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	2e-14
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	2e-13
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	5e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-62
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 9/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
              ++  ++G G FG VYKG+      V +  +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
             +G      +  ++ ++    SL   L     +        + I    AQG+ YLH   
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 690
              IIHRDLK++N+ L  D+  KI DFGLA +          +++ G+  +M+PE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 691 -DGLFSIKSDVFSFGILMLETLSGKK 715
               +S +SDV++FGI++ E ++G+ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 5e-62
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 11/206 (5%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQH 568
             ++F    +LG G  G V+K     +G  +A K +  +    +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             +V   G     GE  + +E+M   SLD  L    K   +  Q    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
               + +I+HRD+K SN+L++     K+ DFG++               VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                +S++SD++S G+ ++E   G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 8e-58
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 7/203 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
              +   ++G G FG V+ G  LN  +VA+K +  +     E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G C+EQ    L+ E+M +  L  +L    ++ L   +  + +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA- 120

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
              +IHRDL A N L+  +   K+SDFG+ R    D+   ++        + SPE     
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 693 LFSIKSDVFSFGILMLETLSGKK 715
            +S KSDV+SFG+LM E  S  K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-57
 Identities = 70/203 (34%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E   +  +LG G FG V+ G      +VAVK L  Q     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L      Q    +I EYM N SL  FL  P+  +L      + +   IA+G+ ++ + +
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               IHRDL+A+N+L+   ++ KI+DFGLAR+   +E             + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 693 LFSIKSDVFSFGILMLETLSGKK 715
            F+IKSDV+SFGIL+ E ++  +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-57
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 13/209 (6%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRN 570
            + + +  +LG+G FG VYK +        A K + ++S + LE++  E+ ++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKLL     +    +++E+    ++D  + +   +R L       + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               +IIHRDLKA N+L  +D + K++DFG++        + ++   +GT  +M+PE  +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 691 -----DGLFSIKSDVFSFGILMLETLSGK 714
                D  +  K+DV+S GI ++E    +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (485), Expect = 1e-55
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
            + FS   ++G G FG VY  R + N + VA+K++S    QS +  ++   E+  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H N ++  GC + +    L++EY    + D+       K+ L       +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH +    +IHRD+KA N+LL      K+ DFG A +             VGT  +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 688 YAL---DGLFSIKSDVFSFGILMLETLSGK 714
             L   +G +  K DV+S GI  +E    K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-55
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 10/210 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
           E++ +   +G G +G   K R   +G+ +  K L   S +    +   +E+ L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 570 NLVKLLGCCVEQGEKIL--ILEYMPNKSLDVFLFDPTKKR-LLGWQARVTIIEGIAQGLL 626
           N+V+     +++    L  ++EY     L   +   TK+R  L  +  + ++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 627 YLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
             H+ S     ++HRDLK +NV LD   N K+ DFGLAR+   D      K  VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           SPE      ++ KSD++S G L+ E  +  
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-55
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 9/205 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-SQSGQGLEEFKNEMMLIAKLQHRN 570
           E++ +   LGEG +G V         + VAVK +   ++    E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VK  G   E   + L LEY     L   +        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
                I HRD+K  N+LLD   N KISDFGLA +F  +  +    ++ GT  Y++PE   
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 691 DGLF-SIKSDVFSFGILMLETLSGK 714
              F +   DV+S GI++   L+G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-55
 Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 7/203 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           E+  ++ KLG+G FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L      +    ++ EYM   SL  FL   T K L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
               +HRDL+A+N+L+  ++  K++DFGLAR+   +E             + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 693 LFSIKSDVFSFGILMLETLSGKK 715
            F+IKSDV+SFGIL+ E  +  +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-55
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 7/203 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           ++ +   +LG G FG V  G+     +VA+K +   S    +EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 573 KLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
           +L G C +Q    +I EYM N  L  +L +   +     Q  + + + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118

Query: 633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE  +  
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176

Query: 693 LFSIKSDVFSFGILMLETLSGKK 715
            FS KSD+++FG+LM E  S  K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 8e-55
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 13/204 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +   +   +G+G FG V  G    G +VAVK + + +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 573 KLLGCCVEQGEKI-LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +LLG  VE+   + ++ EYM   SL  +L     + +LG    +     + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
                +HRDL A NVL+  D   K+SDFGL +     E             + +PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 692 GLFSIKSDVFSFGILMLETLSGKK 715
             FS KSDV+SFGIL+ E  S  +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-54
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 10/212 (4%)

Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMML 562
           S+ SV    + ++   K+G+G  G VY    +  GQEVA+++++ Q     E   NE+++
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 563 IAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIA 622
           + + ++ N+V  L   +   E  +++EY+   S    L D   +  +       +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126

Query: 623 QGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
           Q L +LH     ++IHRD+K+ N+LL MD + K++DFG       +  Q     +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           +M+PE      +  K D++S GI+ +E + G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-53
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 23/229 (10%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCV 579
            +G+G FG V++G+   G+EVAVK  SS+  +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 580 EQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ----- 630
           +         L+ +Y  + SL  +L     +  +  +  + +    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
             +  I HRDLK+ N+L+  +    I+D GLA       D +       VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 689 ALDGL------FSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYV 731
             D +         ++D+++ G++  E        G++          V
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-53
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
           E+F +   LG+G FG VY  R   +   +A+K L     +      + + E+ + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
            N+++L G   +     LILEY P  ++   L   +K      Q   T I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H     R+IHRD+K  N+LL      KI+DFG +              + GT  Y+ PE 
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
               +   K D++S G+L  E L GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-53
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 520 KLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLG 576
           ++G G F  VYKG       EVA   L  +  +    + FK E  ++  LQH N+V+   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 577 CCVEQGEK----ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS 632
                 +     +L+ E M + +L  +L    + +++  +   +    I +GL +LH  +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 633 RFRIIHRDLKASNVLL-DMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
              IIHRDLK  N+ +     + KI D GLA +          K ++GT  +M+PE   +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186

Query: 692 GLFSIKSDVFSFGILMLETLSGKK 715
             +    DV++FG+ MLE  + + 
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEY 210

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (463), Expect = 7e-53
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 7/204 (3%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            + +M+ KLG G +G VY+G        VAVK L   + + +EEF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V+LLG C  +    +I E+M   +L  +L +  ++  +     + +   I+  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134

Query: 632 SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
                IHRDL A N L+  +   K++DFGL+R+  GD    +         + +PE    
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 692 GLFSIKSDVFSFGILMLETLSGKK 715
             FSIKSDV++FG+L+ E  +   
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-52
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 12/211 (5%)

Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
             +N  +   +LG G FG V +G         +VA+K L   + +   EE   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L +  +V+L+G C +    +L++E      L  FL    K+  +       ++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
            YL +      +HRDL A NVLL      KISDFGL++  G D+     +        + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           +PE      FS +SDV+S+G+ M E LS  +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (461), Expect = 2e-52
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 22/230 (9%)

Query: 503 FSLASVAAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SSQ 548
           F+      A   F+         ++  +G G FG V  G L         VA+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 549 SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL 608
           + +   +F +E  ++ +  H N++ L G   +    ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 609 LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD 668
                 V ++ GIA G+ YL        +HRDL A N+L++ ++  K+SDFGL+R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 669 ELQGNTKRIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
                    +G      + +PE      F+  SDV+S+GI+M E +S  +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-51
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 520 KLGEGGFGPVYKGRLLN---GQEVAVKRLSSQSGQG--LEEFKNEMMLIAKLQHRNLVKL 574
           +LG G FG V KG        + VAVK L +++      +E   E  ++ +L +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 575 LGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
           +G C E    +L++E      L+ +L    + R +  +  + ++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126

Query: 635 RIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMSPEYALDGL 693
             +HRDL A NVLL      KISDFGL++    DE     +        + +PE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 694 FSIKSDVFSFGILMLETLSGKK 715
           FS KSDV+SFG+LM E  S  +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ 208

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 2e-51
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 31/231 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQGLE-EFKNEMMLIAK 565
            N      +GEG FG V++ R            VAVK L  ++   ++ +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL----------------- 608
             + N+VKLLG C       L+ EYM    L+ FL   +   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 609 ----LGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
               L    ++ I   +A G+ YL +    + +HRDL   N L+  +M  KI+DFGL+R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
               +             +M PE      ++ +SDV+++G+++ E  S   
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 8e-51
 Identities = 67/231 (29%), Positives = 97/231 (41%), Gaps = 31/231 (13%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
           EN      LG G FG V               +VAVK L  ++     E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKK------------------ 606
           L  H N+V LLG C   G   LI EY     L  +L    +K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 607 --RLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM 664
              +L ++  +     +A+G+ +L        +HRDL A NVL+      KI DFGLAR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
              D              +M+PE   +G+++IKSDV+S+GIL+ E  S   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-50
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 10/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
           E+F     LGEG F  V   R L   +E A+K L          +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
              VKL     +  +    L Y  N  L  ++             R       A+ +  L
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTR----FYTAEIVSAL 121

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                  IIHRDLK  N+LL+ DM+ +I+DFG A++   +  Q      VGT  Y+SPE 
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             +      SD+++ G ++ + ++G 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-50
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 13/204 (6%)

Query: 520 KLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHRNLVKL 574
            +G G FG VY G LL+        AVK L+  +  G + +F  E +++    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 575 LGCCVE-QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           LG C+  +G  +++L YM +  L  F+ + T    +       +          +   + 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYALD 691
            + +HRDL A N +LD     K++DFGLAR     E      +        +M+ E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 692 GLFSIKSDVFSFGILMLETLSGKK 715
             F+ KSDV+SFG+L+ E ++   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGA 232

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 8e-50
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 11/205 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           +++ +  +LG G FG V++      G   A K + +      E  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           V L     +  E ++I E+M    L   + D  +   +     V  +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                +H DLK  N++     +   K+ DFGL       +   + K   GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
                   +D++S G+L    LSG 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 26/226 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQG-LEEFKNEMMLIAK 565
              S    LG G FG V +              VAVK L   +     E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 566 L-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL---------------L 609
           L  H N+V LLG C   G  ++I EY     L  FL       +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             +  ++    +A+G+ +L        IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
                        +M+PE   + +++ +SDV+S+GI + E  S   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-49
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 12/209 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-SQSGQGLEEFKNEMMLIAKL 566
             F     LG G FG VYKG  +   E     VA+K L  + S +  +E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            + ++ +LLG C+      LI + MP   L    +    K  +G Q  +     IA+G+ 
Sbjct: 69  DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
           YL      R++HRDL A NVL+    + KI+DFGLA++ G +E + + +       +M+ 
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 687 EYALDGLFSIKSDVFSFGILMLETLSGKK 715
           E  L  +++ +SDV+S+G+ + E ++   
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 3e-48
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 14/211 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAK 565
           ++  +  KLG+G FG V +G           VAVK L        + +++F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           L HRNL++L G         ++ E  P  SL   L       LLG  +R  +   +A+G+
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYM 684
            YL      R IHRDL A N+LL      KI DFGL R    ++      +     + + 
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           +PE      FS  SD + FG+ + E  +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  170 bits (432), Expect = 8e-48
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 11/205 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           + + +  +LG G FG V++      G+    K +++         KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           + L     ++ E +LILE++    L   +    +   +     +  +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
               I+H D+K  N++ +       KI DFGLA     DE+    K    T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
                   +D+++ G+L    LSG 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 8e-48
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-SQSGQGLEEFKNEMMLIAKL-Q 567
            +   Q  +GEG FG V K R+       + A+KR+    S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFL-------------FDPTKKRLLGWQAR 614
           H N++ LLG C  +G   L +EY P+ +L  FL                +    L  Q  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 615 VTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT 674
           +     +A+G+ YL Q    + IHRDL A N+L+  +   KI+DFGL+R           
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
                   +M+ E     +++  SDV+S+G+L+ E +S   
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-47
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 12/210 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSSQSGQG-LEEFKNEMMLIAKL 566
              + Q  +G G FG VYKG L          VA+K L +   +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 567 QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
            H N+++L G   +    ++I EYM N +LD FL +  K         V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMS 685
           YL        +HRDL A N+L++ ++  K+SDFGL+R+   D     T         + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSGKK 715
           PE      F+  SDV+SFGI+M E ++  +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 17/217 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-SQSGQGLEEFKNEMMLIAK 565
           E  +M  +LG+G FG VY+G             VA+K ++ + S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRL-------LGWQARVTII 618
               ++V+LLG   +    ++I+E M    L  +L                     + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 619 EGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIV 678
             IA G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
               +MSPE   DG+F+  SDV+SFG+++ E  +  +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 12/208 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQSGQGL-EEFKNEMMLIAKLQ 567
           E   +   +GEG FG V++G  ++       VA+K   + +   + E+F  E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H ++VKL+G   E     +I+E      L  FL        L   + +     ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           L      R +HRD+ A NVL+  +   K+ DFGL+R            +      +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGKK 715
                 F+  SDV+ FG+ M E L    
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 1e-44
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 26/226 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLI 563
           +   +   LGEG FG V     +           +VAVK L S  + + L +  +EM ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 564 AKL-QHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLF-------------DPTKKRLL 609
             + +H+N++ LLG C + G   +I+EY    +L  +L                  +  L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 610 GWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE 669
             +  V+    +A+G+ YL      + IHRDL A NVL+  D   KI+DFGLAR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
               T        +M+PE   D +++ +SDV+SFG+L+ E  +   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 25/225 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQSGQG--LEEFKNEMMLIA 564
           +   +   LG G FG V +            + VAVK L   +             +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 565 KLQHRNLVKLLGCCVEQGEKILIL-EYMPNKSLDVFLF-------------DPTKKRLLG 610
              H N+V LLG C + G  ++++ E+    +L  +L              +   K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 611 WQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL 670
            +  +     +A+G+ +L      + IHRDL A N+LL      KI DFGLAR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK 715
                       +M+PE   D +++I+SDV+SFG+L+ E  S   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (399), Expect = 5e-44
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 15/212 (7%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQ 567
           ++ + +   LG GG   V+  R L   ++VAVK L    ++       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 568 HRNLVKLLGCCVEQGEKI----LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           H  +V +      +        +++EY+   +L   +        +  +  + +I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG-GDELQGNTKRIVGTYG 682
            L + H   +  IIHRD+K +N+++      K+ DFG+AR           T  ++GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           Y+SPE A       +SDV+S G ++ E L+G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 5e-44
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 7/207 (3%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQG-LEEFKNEMMLIAKLQHR 569
              ++    +GEG +G V      +N   VA+K++S    Q   +    E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N++ +         + +   Y+    +   L+   K + L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEY 688
                 ++HRDLK SN+LL+   + KI DFGLAR+   D          V T  Y +PE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 689 ALDGLFSIKS-DVFSFGILMLETLSGK 714
            L+     KS D++S G ++ E LS +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (404), Expect = 7e-44
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 18/210 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNE---MMLIAK 565
            +FS+   +G GGFG VY  R    G+  A+K L  +     QG     NE   + L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
                +V +        +   IL+ M    L   L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
            ++H      +++RDLK +N+LLD   + +ISD GLA  F   +        VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           PE    G+ +   +D FS G ++ + L G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 12/205 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
           E + +   LG G FG V++     + +    K +  + G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           + L        E ++I E++    +   +   T    L  +  V+ +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 632 SRFRIIHRDLKASNVLLDMDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
               I H D++  N++     +   KI +FG AR     +   N + +     Y +PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
              + S  +D++S G L+   LSG 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (398), Expect = 2e-43
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNEMMLIAKLQH 568
           ++F +   LG G FG V+  R   NG+  A+K L        + +E   +E ++++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             ++++ G   +  +  +I++Y+    L  F      +R     A+       A+  L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                  II+RDLK  N+LLD + + KI+DFG A+      +   T  + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGKK 715
                ++   D +SFGIL+ E L+G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 3e-43
 Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 8/205 (3%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE-FKNEMMLIAKLQHR 569
            + +  +  LG G F  V         + VA+K ++ ++ +G E   +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+V L       G   LI++ +    L   +    +K     +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                    +        LD D    ISDFGL++M     +        GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 690 LDGLFSIKSDVFSFGILMLETLSGK 714
               +S   D +S G++    L G 
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-42
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 13/207 (6%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---SQSGQGLEEFKNE-MMLIAKLQ 567
           E+F +   LG+G FG V+        Q  A+K L          +E    E  +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 568 HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLY 627
           H  L  +      +     ++EY+    L   +                    I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 628 LHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           LH      I++RDLK  N+LLD D + KI+DFG+ +     + + NT    GT  Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 688 YALDGLFSIKSDVFSFGILMLETLSGK 714
             L   ++   D +SFG+L+ E L G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (387), Expect = 2e-42
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 26/219 (11%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGL---------EEFKNEMML 562
           EN+  +  LG G    V +       +E AVK +    G            E    E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 563 IAKLQ-HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           + K+  H N+++L           L+ + M    L  +L   T+K  L  +    I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
            + +  LH   +  I+HRDLK  N+LLD DMN K++DFG +      E     + + GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173

Query: 682 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSGK 714
            Y++PE     +      +  + D++S G++M   L+G 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-41
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 11/206 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           ENF    K+GEG +G VYK R  L G+ VA+K  RL +++         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+VKLL     + +  L+ E++          D +    +      + +  + QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-Y 688
            +   R++HRDLK  N+L++ +   K++DFGLAR FG           V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
                +S   D++S G +  E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (373), Expect = 2e-40
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHRN 570
           E +    K+GEG +G VYK +   G+  A+K  RL  +          E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 571 LVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ 630
           +VKL      +   +L+ E++      +       +  L      + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 631 YSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
               R++HRDLK  N+L++ +   KI+DFGLAR FG    +      + T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 691 -DGLFSIKSDVFSFGILMLETLSGK 714
               +S   D++S G +  E ++G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-40
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 514 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV 572
           +++    +G G FG VY+ +L  +G+ VA+K++             E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 573 KLLGCCVEQGEK------ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLL 626
           +L       GEK       L+L+Y+P     V       K+ L        +  + + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 627 YLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
           Y+H +    I HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190

Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSGK 714
           PE       ++   DV+S G ++ E L G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 43/223 (19%), Positives = 91/223 (40%), Gaps = 18/223 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL 571
            ++ +  ++GEG FG +++G  LLN Q+VA+K    +S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 572 VKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY 631
           +  +    ++G   +++  +   SL+  L      R    +      + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 632 SRFRIIHRDLKASNVLLDMDMNP-----KISDFGLARMFGGDELQGN-----TKRIVGTY 681
               +++RD+K  N L+    +       + DFG+ + +     + +      K + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS 724
            YMS    L    S + D+ + G + +  L G        A +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 520 KLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEE-----FKNEMMLIAKLQHRNLVK 573
            LGEG F  VYK R  N  Q VA+K++        ++        E+ L+ +L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 574 LLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSR 633
           LL     +    L+ ++M                +L        +    QGL YLHQ+  
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 634 FRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-G 692
             I+HRDLK +N+LLD +   K++DFGLA+ FG           V T  Y +PE      
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176

Query: 693 LFSIKSDVFSFGILMLETLSGK 714
           ++ +  D+++ G ++ E L   
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 16/214 (7%)

Query: 511 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSSQSGQGLEEFK-----NEMMLI 563
           A + +    ++GEG +G V+K R L   G+ VA+KR+  Q+G+             +  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 564 AKLQHRNLVKLLGCCVEQGEKILILEYMPNKSLD---VFLFDPTKKRLLGWQARVTIIEG 620
              +H N+V+L   C            +  + +D       D   +  +  +    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 621 IAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
           + +GL +LH     R++HRDLK  N+L+      K++DFGLAR++     Q     +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
             Y +PE  L   ++   D++S G +  E    K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SSQSGQGLEEFKNEMMLIAK 565
           + +    +LG G F  V K R    G + A K +      SS+ G   E+ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 566 LQHRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
           +QH N++ L      + + ILILE +    L        +K  L  +     ++ I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNP----KISDFGLARMFGGDELQGNTKRIVGTY 681
             ++     +I H DLK  N++L     P    KI DFGLA            K I GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            +++PE        +++D++S G++    LSG 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (362), Expect = 8e-39
 Identities = 45/204 (22%), Positives = 81/204 (39%), Gaps = 16/204 (7%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           K+G G FG +Y G  +  G+EVA+K    ++     +   E  +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 579 VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIH 638
             +G+  +++  +   SL+         R    +  + + + +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126

Query: 639 RDLKASNVL---LDMDMNPKISDFGLARMFGGDELQGN-----TKRIVGTYGYMSPEYAL 690
           RD+K  N L           I DFGLA+ +       +      K + GT  Y S    L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 691 DGLFSIKSDVFSFGILMLETLSGK 714
               S + D+ S G +++    G 
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS 210

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-38
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 20/211 (9%)

Query: 515 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEE------FKNEMMLIAKLQ 567
           + +   LG GGFG VY G  + +   VA+K +         E         E++L+ K+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 568 --HRNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
                +++LL         +LILE              T++  L  +   +    + + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            + H      ++HRD+K  N+L+D++    K+ DFG   +              GT  Y 
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176

Query: 685 SPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
            PE+          + V+S GIL+ + + G 
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
             +    K+G+G FG V+K R    GQ+VA+K++   ++          E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 570 NLVKLLGCCVEQGEKI--------LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGI 621
           N+V L+  C  +            L+ ++  +    +      K           +++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 622 AQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR--IVG 679
             GL Y+H+    +I+HRD+KA+NVL+  D   K++DFGLAR F   +     +    V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGK 714
           T  Y  PE  L +  +    D++  G +M E  +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-37
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 12/206 (5%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
            +F     LG+G FG V   R    G+  A+K L  +   +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             L  L            ++EY     L   L     +  +  + R       A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
                  +++RD+K  N++LD D + KI+DFGL +    D      K   GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
             D  +    D +  G++M E + G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 10/206 (4%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSSQSGQGLEEFKNEMMLIAKLQHR 569
           + +    K+GEG +G V+K +     + VA+K  RL             E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 570 NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH 629
           N+V+L        +  L+ E+        F          G      +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 630 QYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
                 ++HRDLK  N+L++ +   K+++FGLAR F G  ++  +  +V  +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 690 LDGLFSIKSDVFSFGILMLETLSGKK 715
              L+S   D++S G +  E  +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (342), Expect = 1e-35
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 15/206 (7%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQH 568
           + F     LG G FG V   +   +G   A+K L  Q     + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 569 RNLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
             LVKL     +     +++EY+    +   L    +               I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 629 HQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
           H      +I+RDLK  N+L+D     +++DFG A+       +G T  + GT   ++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209

Query: 689 ALDGLFSIKSDVFSFGILMLETLSGK 714
            L   ++   D ++ G+L+ E  +G 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 7e-35
 Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 21/203 (10%)

Query: 521 LGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCC 578
           LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++V+++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 579 ----VEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRF 634
                 +   ++++E +    L   + D   +     +A   I++ I + + YLH     
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSI--- 130

Query: 635 RIIHRDLKASNVLLDMDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
            I HRD+K  N+L          K++DFG A+                T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 692 GLFSIKSDVFSFGILMLETLSGK 714
             +    D++S G++M   L G 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-34
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 23/212 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SSQSGQGLEEFKNEMMLIAKLQHR 569
             +     +G G +G V        G +VA+K+L    QS    +    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N++ LL             +  L++ +M      +      K   LG      ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           GL Y+H      IIHRDLK  N+ ++ D   KI DFGLAR     +        V T  Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
            +PE  L+ + ++   D++S G +M E ++GK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 8e-34
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)

Query: 513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----SQSGQGLEEFKNEMMLIA 564
           ENF +   LG G +G V+  R +     G+  A+K L      Q  +  E  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 565 KLQHR-NLVKLLGCCVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
            ++    LV L      + +  LIL+Y+    L   L    +      Q        + +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
            +L L    +  II+RD+K  N+LLD + +  ++DFGL++ F  DE +       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 684 MSPEYALDGL--FSIKSDVFSFGILMLETLSGK 714
           M+P+    G        D +S G+LM E L+G 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (318), Expect = 1e-32
 Identities = 44/208 (21%), Positives = 91/208 (43%), Gaps = 21/208 (10%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRN 570
           +++ +  KLG G +  V++   + N ++V VK L        ++ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 571 LVKLLGCCVEQGEK--ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYL 628
           ++ L     +   +   L+ E++ N            + L  +  R   +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145

Query: 629 HQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
           H      I+HRD+K  NV++D +    ++ D+GLA  +   +        V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 688 YALD-GLFSIKSDVFSFGILMLETLSGK 714
             +D  ++    D++S G ++   +  K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-31
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 513 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQHR 569
           + +     +G G  G V      +  + VA+K+LS   Q+    +    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 570 NLVKLLGCCVEQG------EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
           N++ LL     Q       +  L++E M      V   +         +    ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   +       V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSGK 714
            +PE  L   +    D++S G +M E +  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 512 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--SQSGQGLEEFKNEMMLIAKLQH 568
            E +     +G G +G V        G  VAVK+LS   QS    +    E+ L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 569 RNLVKLLGCCVEQ-----GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQ 623
            N++ LL              + ++ ++    L+    +  K + L       +I  I +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132

Query: 624 GLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
           GL Y+H      IIHRDLK SN+ ++ D   KI DFGLAR              V T  Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184

Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSGK 714
            +PE  L+ + ++   D++S G +M E L+G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (287), Expect = 2e-28
 Identities = 45/210 (21%), Positives = 85/210 (40%), Gaps = 18/210 (8%)

Query: 520 KLGEGGFGPVYKGR-LLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCC 578
           KLG G F  V+  + ++N   VA+K +        E  ++E+ L+ ++   +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 579 VEQGEKIL-------------ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
                K+L             ++ +       + L    + R +       I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDM-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
            Y+H+  R  IIH D+K  NVL+++ D    +    +A +        +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSGK 714
           SPE  L   +   +D++S   L+ E ++G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 38/205 (18%), Positives = 71/205 (34%), Gaps = 35/205 (17%)

Query: 520 KLGEGGFGPVYKGRLLNGQEVAVK--RLSSQSGQ--------GLEEFKNEMMLIAKLQHR 569
            +GEG    V+        E  VK  ++   S +        G   F    +  A+ + R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 570 NLVKLLGCCV----EQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGL 625
            L KL G  V          +++E +  K          +   +  +    +++ I + +
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116

Query: 626 LYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
              +      I+H DL   NVL+  +    I DF  +   G +  +   +R +     Y 
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
           S  Y        + D+ S    +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 90.0 bits (223), Expect = 3e-22
 Identities = 23/118 (19%), Positives = 48/118 (40%), Gaps = 13/118 (11%)

Query: 34  IRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTIS 93
           + +GE L +  Q  ++  +     +   L ++      T VW +N             + 
Sbjct: 4   LTNGEGLYA-GQSLDVEPYHFIMQEDCNLVLYDH---STSVWASNTGILG-KKGCKAVLQ 58

Query: 94  NKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY 151
           + GN V+ +    ++W+++      N V  L++DGN+VI  +         +W +  Y
Sbjct: 59  SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 70.7 bits (173), Expect = 3e-15
 Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 9/97 (9%)

Query: 64  IWFRQVP-DTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVA 122
           I +     D      +  + +      L++    NLVL ++ +  +WSTN   +     A
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70

Query: 123 QLRDDGNLVIRDNSSGNTTESYLWQSFD--YPTDTLL 157
            L+ +G + +  N +       +W S +       + 
Sbjct: 71  VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 54.5 bits (131), Expect = 1e-09
 Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)

Query: 45  QRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT 104
           Q  +L  +         L ++ R   D  VW  N             +   G + +L   
Sbjct: 30  QSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84

Query: 105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNS 136
           N  +W++         V  L+ D NL I   +
Sbjct: 85  NIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 69.7 bits (170), Expect = 4e-15
 Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 20/126 (15%)

Query: 26  DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISD 85
           + +     +  GE L      F              L ++     D  +W  N       
Sbjct: 2   NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR- 50

Query: 86  HNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYL 145
            +  L++   GNLV+ N +N  IW++N   +  N V  L+ D N+VI             
Sbjct: 51  -SCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101

Query: 146 WQSFDY 151
           W +  +
Sbjct: 102 WATGTH 107

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 67.5 bits (164), Expect = 2e-14
 Identities = 26/130 (20%), Positives = 48/130 (36%), Gaps = 18/130 (13%)

Query: 25  ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPIS 84
           +D +     +  G  L      +     +                 +  VW +  +   S
Sbjct: 1   SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50

Query: 85  DHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESY 144
               VL + N GNLV+ + +   IW++N   +  N    L+ D N+VI DNS+     + 
Sbjct: 51  --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102

Query: 145 LWQSFDYPTD 154
           +W +     +
Sbjct: 103 IWATHTNVGN 112

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 65.4 bits (159), Expect = 2e-13
 Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 10/82 (12%)

Query: 70  PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGN 129
            +  +W  N       +     +   G LV++   N T+W + V  +  + V  L+ D N
Sbjct: 47  NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104

Query: 130 LVIRDNSSGNTTESYLWQSFDY 151
           +VI  ++        LW +   
Sbjct: 105 VVIYGDA--------LWATQTV 118

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 55.3 bits (133), Expect = 5e-10
 Identities = 17/113 (15%), Positives = 31/113 (27%), Gaps = 34/113 (30%)

Query: 64  IWF-RQVPDTVVWVANRDRPISDHNAVLTISNKGN------------------------- 97
           I F      +     +  + +   +   T+ +  N                         
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62

Query: 98  -----LVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDN---SSGNTTE 142
                LV+L   N   WS+     + N V  L+ D  + I       SG + +
Sbjct: 63  QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNK 115

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	744
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.8
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.78
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.78
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.6
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.52
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.43
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.3
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.14
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.97
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.83
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.78
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.05
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.71
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.38

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-43  Score=313.81  Aligned_cols=200  Identities=28%  Similarity=0.451  Sum_probs=179.1

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             39652222374681379811004-66405888326778130999999999999813887034777999759599999930
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~  591 (744)
                      ++|++.++||+|+||.||+|+.. +++.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC
Q ss_conf             79991133227687666899999999999999999988449997287047999889928984599742574112898645
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~  671 (744)
                      ++|+|..++.    ...+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf             7980898864----159999999999999999999999879---72267768886887899686425156413213666-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             67432244466018112267987931439999999999994999998888
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC
T ss_conf             -4444444777368266447998801203137299999804889989979

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=323.12  Aligned_cols=223  Identities=28%  Similarity=0.375  Sum_probs=192.1

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             39652222374681379811004-6640588832677---8130999999999999813887034777999759599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCC
Q ss_conf             93079991133227687666899999999999999999988449997287047999889928984599742574112898
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~  668 (744)
                      ||+++|+|..++.   ..+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf             7048987777653---1599999999999999999997621650---884767741236688853886032102422567


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....||..+|
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~~p~~~s  234 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQKIIKLEYDFPEKFF  234 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHTTCCCCCTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCCCCCCCCC
T ss_conf             76433355567755258440026898966623045699999803889989959999--99999718999985479

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=318.71  Aligned_cols=206  Identities=30%  Similarity=0.400  Sum_probs=180.5

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             39652222374681379811004-66405888326778-13099999999999981388703477799975959999993
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      ++|++.++||+|+||.||+|+++ +++.||+|+++... ....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf             46089989721748099999999999799999984566412799999999999857998884696540467436798864


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCC
Q ss_conf             07999113322768766689999999999999999998844999728704799988992898459974257411289864
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~  670 (744)
                      +++|+|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf             58980899975---3799999999999999999999999759---83575468997887899879832314224046886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             567432244466018112267987-931439999999999994999998888886
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       671 ~~~~~~~~gt~~y~APE~~~~~~~-t~~~DvwSlGviL~eLltG~~p~~~~~~~~  724 (744)
                      .......+||+.|+|||++.+..+ +.++||||+||++|||++|++||.......
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~  213 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC  213 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred             CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf             5311132557474287286189999971016173799999982997888898599

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-44  Score=318.53  Aligned_cols=222  Identities=25%  Similarity=0.337  Sum_probs=193.1

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEE
Q ss_conf             039652222374681379811004-6640588832677---813099999999999981388703477799975959999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      -++|++.+.||+|+||.||+++.+ +++.||+|+++..   .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCC
Q ss_conf             99307999113322768766689999999999999999998844999728704799988992898459974257411289
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~  667 (744)
                      |||+++|+|..++.   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             00357986055553---2567759999999999965211343159---62246477784765899888820565200356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             8645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|++||...+...  +...+.+....||..+|
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i~~~~~~~p~~~s  229 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEIRFPRTLS  229 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCTTSC
T ss_pred             CC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCCCCCCCCC
T ss_conf             78--62055100889966665048988833310223067889987899999969999--99998528998986689

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=319.03  Aligned_cols=219  Identities=29%  Similarity=0.398  Sum_probs=189.6

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             39652222374681379811004-6640588832677---8130999999999999813887034777999759599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCC
Q ss_conf             93079991133227687666899999999999999999988449997287047999889928984599742574112898
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf             5047985898875---0489999999999999999999999889---465220234414668998711555633544888


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....+|..+|
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~~~p~~~s  228 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVEFTFPDFVT  228 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTTCCCCCTTSC
T ss_pred             ----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCCCCCCCCCC
T ss_conf             ----5235578876349999758998931440467599999832999988899999--99999718999986689

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-43  Score=312.82  Aligned_cols=214  Identities=25%  Similarity=0.380  Sum_probs=184.6

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             039652222374681379811004-6640588832677813099999999999981388703477799975959999993
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      -++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEEC--CCCEEEEEECCCEECCCC
Q ss_conf             079991133227687666899999999999999999988449997287047999889928--984599742574112898
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM--DMNPKISDFGLARMFGGD  668 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~~~~~  668 (744)
                      +++|+|..++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf             799889999976--2378999999999999999999997569---76000154673641688986999545210442565


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             6456743224446601811226798793143999999999999499999888888643100010366
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKS  735 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~  735 (744)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+  +...+.+..
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~  241 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKSCD  241 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTC
T ss_pred             C---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCC
T ss_conf             4---3200068624218899758998726765546599999985989989979999--999998478

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.7e-43  Score=311.12  Aligned_cols=218  Identities=24%  Similarity=0.318  Sum_probs=186.1

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             039652222374681379811004-6640588832677813099999999999981388703477799975959999993
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      .++|++.++||+|+||.||+|+.. +++.||+|+++.......+.+.+|+.++.+++|||||++++++.+....++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             40359989993177829999999899979999998872646799999999999867997989199999989999999982


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEE--CCCCEEEEEECCCEECCCC
Q ss_conf             07999113322768766689999999999999999998844999728704799988992--8984599742574112898
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD--MDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DFgla~~~~~~  668 (744)
                      +++|+|..++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             899808888986--3899899999999999999999999779---26513144553113467884899525630343788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             64567432244466018112267987931439999999999994999998888886431000103664442
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFY  739 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~  739 (744)
                      .   ......+++.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....++
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~~~~~~~  248 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRCDWEFD  248 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHCCCCCC
T ss_pred             C---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCC
T ss_conf             7---2010047645348999747998976333898999999996889989979999--9999984788989

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-43  Score=314.91  Aligned_cols=218  Identities=28%  Similarity=0.410  Sum_probs=187.6

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             39652222374681379811004-6640588832677---8130999999999999813887034777999759599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.+.||+|+||.||+|+++ +++.||||+++..   .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCC
Q ss_conf             93079991133227687666899999999999999999988449997287047999889928984599742574112898
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~  668 (744)
                      ||+++|+|..++.   ....+....+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf             5037863223432---2221110079999999987655412476---770556810503868998898317521671245


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                           ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...+.+....+|..+|
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~~~~~~~p~~~s  225 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEKILNAELRFPPFFN  225 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHCCCCCCTTSC
T ss_pred             -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCCCCCCCCC
T ss_conf             -----643457634359999838999804304653336899975989999969999--99999708988997789

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=317.53  Aligned_cols=202  Identities=27%  Similarity=0.385  Sum_probs=179.1

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             7039652222374681379811004-6640588832677-8130999999999999813887034777999759599999
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ..++|++.++||+|+||.||+|++. +++.||+|+++.. .....+.+.+|+.+++.++|||||++++++.+..+.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCC
Q ss_conf             9307999113322768766689999999999999999998844-999728704799988992898459974257411289
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQY-SRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~  667 (744)
                      ||+++|+|..++.   ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             7679986899874---24999999999999999999999998599---97144577994687899899954877625678


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             8645674322444660181122679879314399999999999949999988888
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      .    .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             C----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             8----62111377141194687589989488899899999999988899899887

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=313.44  Aligned_cols=205  Identities=28%  Similarity=0.457  Sum_probs=178.8

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             39652222374681379811004-66405888326778130999999999999813887034777999759599999930
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~  591 (744)
                      +.|++.++||+|+||.||+|++. +++.||+|+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC
Q ss_conf             79991133227687666899999999999999999988449997287047999889928984599742574112898645
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~  671 (744)
                      ++|+|..++..  ....+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf             99818899986--2899999999999999999999999889---8871407003148789998997161230357786--


Q ss_pred             CCCCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             6743224446601811226-----7987931439999999999994999998888886
Q 004580          672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       672 ~~~~~~~gt~~y~APE~~~-----~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~  724 (744)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~  222 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR  222 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf             4100102562647999983202578888806657878999999820889999989999

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-42  Score=310.89  Aligned_cols=218  Identities=24%  Similarity=0.325  Sum_probs=187.3

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             39652222374681379811004-6640588832677---8130999999999999813887034777999759599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      ++|++.++||+|+||.||+|+++ +++.||||++...   .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCC
Q ss_conf             93079991133227687666899999999999999999988449997287047999889928984599742574112898
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~  668 (744)
                      ||+.+|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf             2334662266675---1589899999999999999899998599---861767999936077897886101033322566


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                           .....||+.|+|||++.+..++.++|||||||++|||++|++||...+.  ..+...+.+....++..+|
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~s  262 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCCTTCC
T ss_pred             -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH--HHHHHHHHCCCCCCCCCCC
T ss_conf             -----6433676356788997179988533114500789999758899899599--9999998617988976689

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=308.11  Aligned_cols=203  Identities=32%  Similarity=0.498  Sum_probs=174.6

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             0396522223746813798110046640588832677--81309999999999998138870347779997595999999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.++||+|+||.||+|+..  ..||||+++..  .....+.|.+|+.++.+++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCC
Q ss_conf             30799911332276876668999999999999999999884499972870479998899289845997425741128986
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~  669 (744)
                      |+++|+|..++..  ....+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf             5899888999852--3578999999999999999988875099---9516147899798189978875002213335567


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             4567432244466018112267---9879314399999999999949999988888
Q 004580          670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~APE~~~~---~~~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      .........||+.|+|||++.+   ..++.++|||||||++|||+||+.||.....
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             76312566557431799999505689999531516359999999978899899896

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=309.92  Aligned_cols=210  Identities=33%  Similarity=0.481  Sum_probs=178.8

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCCCC------CCEEEEEECCCC-CHHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEECC
Q ss_conf             70396522223746813798110046------640588832677-813099999999999981-3887034777999759
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      ..++|++.++||+|+||.||+|+...      ...||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf             78993970198307881999999857885542049999996633587899999999999997158996868778886299


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf             59999993079991133227687--------------------6668999999999999999999884499972870479
Q 004580          583 EKILILEYMPNKSLDVFLFDPTK--------------------KRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLK  642 (744)
Q Consensus       583 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLk  642 (744)
                      ..++||||+++|+|..++.....                    ...+++..++.++.|++.||.|||+.+   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf             5899997279995999998625777510221000012220012577899999999999999999997399---0505270


Q ss_pred             CCCEEEECCCCEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf             9988992898459974257411289864567432244466018112267987931439999999999994-999998888
Q 004580          643 ASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYN  721 (744)
Q Consensus       643 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~  721 (744)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |++||...+
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             32144345982898514222204577861562343578765783887279999633030003999999838999999989


Q ss_pred             CC
Q ss_conf             88
Q 004580          722 AD  723 (744)
Q Consensus       722 ~~  723 (744)
                      .+
T Consensus       272 ~~  273 (325)
T d1rjba_         272 VD  273 (325)
T ss_dssp             CS
T ss_pred             HH
T ss_conf             89

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-43  Score=311.96  Aligned_cols=215  Identities=25%  Similarity=0.344  Sum_probs=182.0

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             039652222374681379811004-66405888326778-1309999999999998138870347779997595999999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .+.|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899998998889885


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEE---CCCCEEEEEECCCEECC
Q ss_conf             307999113322768766689999999999999999998844999728704799988992---89845997425741128
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD---MDMNPKISDFGLARMFG  666 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~~~  666 (744)
                      |+++|+|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf             268984888653---0367887899999999999987524130---5568704630011046888249983154358725


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             98645674322444660181122679879314399999999999949999988888864310001036644
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLH  737 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~  737 (744)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|++||.......  +...+.+....
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~  227 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQILKAEYE  227 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHTTCCC
T ss_pred             CCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCCC
T ss_conf             897---0440032842259188737999807873451599999985979999989999--99998616877

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-42  Score=306.06  Aligned_cols=221  Identities=25%  Similarity=0.376  Sum_probs=186.9

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHH-HHCCCCEEEEEEEEEECCEEEEE
Q ss_conf             39652222374681379811004-6640588832677---8130999999999999-81388703477799975959999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIA-KLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.++||+|+||+||+|+.+ +++.||||+++..   .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCC
Q ss_conf             99307999113322768766689999999999999999998844999728704799988992898459974257411289
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~  667 (744)
                      |||+++|+|..++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEECCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf             75037980899864---0478999999999999999999998689---34034765404444899630155530232356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             8645674322444660181122679879314399999999999949999988888864310001036644422546
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f~~~~~  743 (744)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+...  +...+.+....+|..+|
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~~~p~~~s  227 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNPFYPRWLE  227 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCCTTSC
T ss_pred             CCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCCCCCCCCCC
T ss_conf             653--3454578777689999827998832320112278989873889999989999--99999718998975679

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-43  Score=312.99  Aligned_cols=210  Identities=27%  Similarity=0.412  Sum_probs=179.6

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEE--CCEEEE
Q ss_conf             039652222374681379811004-6640588832677--81309999999999998138870347779997--595999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--QGEKIL  586 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l  586 (744)
                      .++|++.+.||+|+||.||+++.+ +++.||+|.+...  .+...+.+.+|+.++.+++|||||++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCHHHHHCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEEECCCCCCEEEECCCCEEEEEECCCE
Q ss_conf             99930799911332276-876668999999999999999999884499--972870479998899289845997425741
Q 004580          587 ILEYMPNKSLDVFLFDP-TKKRLLGWQARVTIIEGIAQGLLYLHQYSR--FRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~DLkp~NILl~~~~~~kl~DFgla~  663 (744)
                      ||||+++|+|..++... .....+++..++.++.|++.||.|||+.+.  .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             128986456743224446601811226798793143999999999999499999888888
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~  723 (744)
                      .+.....  ......||+.|+|||++.+..++.++|||||||++|||++|++||...+..
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~  220 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK  220 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH
T ss_conf             2245777--556677882327999983999993898875278999980188998998999

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.8e-42  Score=305.72  Aligned_cols=221  Identities=27%  Similarity=0.355  Sum_probs=179.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHH---HHHHHHHCCCCEEEEEEEEEECCEEE
Q ss_conf             39652222374681379811004-6640588832677---81309999999---99999813887034777999759599
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNE---MMLIAKLQHRNLVKLLGCCVEQGEKI  585 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~E---i~~l~~l~HpnIv~l~~~~~~~~~~~  585 (744)
                      ++|++.++||+|+||.||+|+.. +++.||+|++...   .......+.+|   +.++..++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEEC
Q ss_conf             99993079991133227687666899999999999999999988449997287047999889928984599742574112
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMF  665 (744)
Q Consensus       586 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~  665 (744)
                      +||||+++|+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf             9999148983899987---3255327899999999999999999779---622044422167858896798220102333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf             89864567432244466018112267-987931439999999999994999998888886-4310001036644422546
Q 004580          666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS-FNLLGYVSNKSLHFYLIFS  743 (744)
Q Consensus       666 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~-~~l~~~~~~~~~~f~~~~~  743 (744)
                      ....    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ..+..........++..+|
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s  233 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  233 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred             CCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf             7886----433113455421687603899984410467789999998599988889989999999860468887887789

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-42  Score=307.53  Aligned_cols=202  Identities=32%  Similarity=0.492  Sum_probs=176.8

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             39652222374681379811004664058883267781309999999999998138870347779997595999999307
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  592 (744)
                      ++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             9958888982088829999998899999999987886-768999999999996689975653524315993379998369


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCCC
Q ss_conf             99911332276876668999999999999999999884499972870479998899289845997425741128986456
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~  672 (744)
                      +|+|..++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf             9918997520--1347889999999999999877653164---310443153266668877686553210023688733-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCC
Q ss_conf             74322444660181122679879314399999999999949-99998888
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSG-KKNTGVYN  721 (744)
Q Consensus       673 ~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG-~~p~~~~~  721 (744)
                      ......||..|+|||++.+..++.++||||||+++|||+|+ ++|+...+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~  207 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  207 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred             EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             50430017666785786079998403321059999999878988877899

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-42  Score=310.11  Aligned_cols=203  Identities=31%  Similarity=0.482  Sum_probs=176.0

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCCCC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             70396522223746813798110046-64058883267781309999999999998138870347779997595999999
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ..++|++.++||+|+||.||+|++.. ++.||||+++... ...++|.+|+.++.+++|||||++++++.+.+..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf             5799398659820888089999999999699999977761-039999999999986799988267752745785478763


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCC
Q ss_conf             30799911332276876668999999999999999999884499972870479998899289845997425741128986
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~  669 (744)
                      |+++|+|..++... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             CCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf             14676067775303-5541579999999999999788898789---3057604576899899928983244546537887


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf             45674322444660181122679879314399999999999949999988
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~  719 (744)
                      .. ......++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             22-10355665466692787279998104302178999999867998877

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-42  Score=305.78  Aligned_cols=203  Identities=34%  Similarity=0.503  Sum_probs=173.9

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             03965222237468137981100466405888326778130999999999999813887034777999759599999930
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~  591 (744)
                      .++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+.++.+++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             89938867981079828999999999999999986476-888999999999986799988578731045-9769999957


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC
Q ss_conf             79991133227687666899999999999999999988449997287047999889928984599742574112898645
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~  671 (744)
                      ++|+|..++... ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+......
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf             898288887514-7898878899999999999999997489---546756422515620244042341014773588644


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCC
Q ss_conf             67432244466018112267987931439999999999994999-998888
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKK-NTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~-p~~~~~  721 (744)
                      . .....+++.|+|||++.+..++.++||||||+++|||+||+. |+....
T Consensus       166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~  215 (272)
T d1qpca_         166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (272)
T ss_dssp             C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             C-CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf             2-0356774444582898379998245645257999999968988888889

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=300.56  Aligned_cols=203  Identities=29%  Similarity=0.399  Sum_probs=177.7

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCC------HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEE
Q ss_conf             039652222374681379811004-66405888326778------13099999999999981388703477799975959
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS------GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++|++.++||+|+||.||+|+.+ +++.||||+++...      ....+.+.+|+.++++++|||||++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf             56779827981178959999999999989999998756632134068999999999999867998999388999979989


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCC----CEEEEEEC
Q ss_conf             99999307999113322768766689999999999999999998844999728704799988992898----45997425
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM----NPKISDFG  660 (744)
Q Consensus       585 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFg  660 (744)
                      ++||||+++|+|..++.   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEECCCCCCCCCHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             99998677864310010---3564215578999999999987666254---22113330127982589866646964334


Q ss_pred             CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             741128986456743224446601811226798793143999999999999499999888888
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~  723 (744)
                      ++.......   ......+++.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~  222 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ  222 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHHCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             421057776---312247777430999981899997665221409999997088998899999

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=300.78  Aligned_cols=213  Identities=29%  Similarity=0.472  Sum_probs=177.5

Q ss_pred             HCCCCCCC-CCCCCCCEEEECCCCC---CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEE
Q ss_conf             03965222-2374681379811004---6640588832677-81309999999999998138870347779997595999
Q 004580          512 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .++|.+.+ +||+|+||.||+|.++   ++..||||.++.. .....++|.+|+.++.+++|||||++++++.. +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf             44718878487306080999999960897689999998820397899999999999986799888068656036-80799


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECC
Q ss_conf             99930799911332276876668999999999999999999884499972870479998899289845997425741128
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~  666 (744)
                      ||||+++|+|..++..  .+..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf             9980789968997521--2569999999999999999878998688---1057676466045468854203313421155


Q ss_pred             CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf             9864-567432244466018112267987931439999999999994-99999888888643100010
Q 004580          667 GDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYVS  732 (744)
Q Consensus       667 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~~~l~~~~~  732 (744)
                      .... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  +...+.
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~  226 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE  226 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH
T ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
T ss_conf             434321135621137433586887279999541232201789999938999999979999--999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-42  Score=304.75  Aligned_cols=206  Identities=31%  Similarity=0.474  Sum_probs=176.3

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCC-C---CEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEE
Q ss_conf             396522223746813798110046-6---40588832677-813099999999999981388703477799975959999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.++||+|+||.||+|+++. +   ..||||.+... .....++|.+|+.++.+++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCC
Q ss_conf             99307999113322768766689999999999999999998844999728704799988992898459974257411289
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGG  667 (744)
Q Consensus       588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~  667 (744)
                      |||+++|+|..++..  ....+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf             972279853002104--5679999999999999999889885279---83576150448988999199888443157567


Q ss_pred             CCCCC---CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf             86456---7432244466018112267987931439999999999994-99999888888
Q 004580          668 DELQG---NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNAD  723 (744)
Q Consensus       668 ~~~~~---~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~  723 (744)
                      .....   ......+|+.|+|||.+.+..++.++|||||||++|||+| |++||......
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf             777653650256668830038788836997861214453578999986799999999999

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-41  Score=301.96  Aligned_cols=197  Identities=33%  Similarity=0.506  Sum_probs=172.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             39652222374681379811004-66405888326778---130999999999999813887034777999759599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQS---GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~  588 (744)
                      +.|+..++||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCC
Q ss_conf             93079991133227687666899999999999999999988449997287047999889928984599742574112898
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGD  668 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~  668 (744)
                      ||+++|++..++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf             8069994578997---3799999999999999999999998689---76667884217987999789844365334677-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             64567432244466018112267---987931439999999999994999998888
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~---~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                           .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             -----873134766368899834678886721454558999999987889999979

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-41  Score=298.07  Aligned_cols=212  Identities=30%  Similarity=0.459  Sum_probs=183.6

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             39652222374681379811004664058883267781309999999999998138870347779997595999999307
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMP  592 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~  592 (744)
                      ++|++.++||+|+||.||+|++++++.||||.++... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf             9979968982078839999998899899999987475-778999999999996689860158899850781699997048


Q ss_pred             CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCCC
Q ss_conf             99911332276876668999999999999999999884499972870479998899289845997425741128986456
Q 004580          593 NKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQG  672 (744)
Q Consensus       593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~  672 (744)
                      +|+|..++..  ....+.+..+.+++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf             9938886410--2467768999999999999999875468---434665413588769984798861442023578722-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCCC
Q ss_conf             7432244466018112267987931439999999999994-999998888886431000103
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYVSN  733 (744)
Q Consensus       673 ~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~~~l~~~~~~  733 (744)
                      ......+|..|+|||++.+..++.++||||||+++|||+| |+.||...+.++  +...+.+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~  216 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQ  216 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHT
T ss_pred             EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHH
T ss_conf             52465788775780786379988521033643246739755999988999999--9999980

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=295.77  Aligned_cols=198  Identities=28%  Similarity=0.448  Sum_probs=168.3

Q ss_pred             CCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEE----CCEEEEE
Q ss_conf             652222374681379811004-6640588832677--81309999999999998138870347779997----5959999
Q 004580          515 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE----QGEKILI  587 (744)
Q Consensus       515 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~~lV  587 (744)
                      |++.++||+|+||.||+|++. +++.||+|.+...  .....+.+.+|+.++++++|||||++++++..    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEE-CCCCEEEEEECCCEECC
Q ss_conf             99307999113322768766689999999999999999998844999728704799988992-89845997425741128
Q 004580          588 LEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLD-MDMNPKISDFGLARMFG  666 (744)
Q Consensus       588 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~  666 (744)
                      |||+++|+|..++.   ....+++..++.++.|++.||.|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf             95789894899975---1355469999999999999999999789-9799687674351166799988980057654236


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             9864567432244466018112267987931439999999999994999998888
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      ..    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~  216 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  216 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             CC----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             87----6677553813008988478-99986711007999999987889998765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-41  Score=297.49  Aligned_cols=206  Identities=32%  Similarity=0.503  Sum_probs=176.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCC-CC----EEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEE
Q ss_conf             396522223746813798110046-64----0588832677-81309999999999998138870347779997595999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      ++|++.++||+|+||.||+|++.. ++    +||+|+++.. .....++|.+|+.++.+++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECC
Q ss_conf             99930799911332276876668999999999999999999884499972870479998899289845997425741128
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~  666 (744)
                      ++|++.+++|..++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf             9984268740101113--3457999999999999999999998769---5047621203116799875860255222335


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf             9864567432244466018112267987931439999999999994-999998888886
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS  724 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~  724 (744)
                      ............||+.|+|||++.+..++.++||||||+++|||+| |++||+......
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~  221 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  221 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             44453223651058644670887469998356544079999999977999999999899

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-41  Score=298.94  Aligned_cols=198  Identities=31%  Similarity=0.451  Sum_probs=169.6

Q ss_pred             CCCCCCCCEEEECCCCCC---CCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf             223746813798110046---640588832677--813099999999999981388703477799975959999993079
Q 004580          519 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYMPN  593 (744)
Q Consensus       519 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  593 (744)
                      ++||+|+||.||+|.++.   ++.||||+++..  .....++|.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC-C
Q ss_conf             991133227687666899999999999999999988449997287047999889928984599742574112898645-6
Q 004580          594 KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ-G  672 (744)
Q Consensus       594 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~-~  672 (744)
                      |+|..++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf             96899975---2257899999999999999976687479---55677761131023567512341345331343234432


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf             7432244466018112267987931439999999999994-99999888888
Q 004580          673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNAD  723 (744)
Q Consensus       673 ~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~  723 (744)
                      ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~  217 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  217 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf             2445677842039166537999843443034031328965899999998999

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=293.93  Aligned_cols=216  Identities=21%  Similarity=0.315  Sum_probs=182.3

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             039652222374681379811004-6640588832677813099999999999981388703477799975959999993
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      .++|++.++||+|+||.||+|++. +++.||+|.++... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             010588789831778399999998999699999975786-6599999999999857997989098999889988999953


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECC--CCEEEEEECCCEECCCC
Q ss_conf             0799911332276876668999999999999999999884499972870479998899289--84599742574112898
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD--MNPKISDFGLARMFGGD  668 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DFgla~~~~~~  668 (744)
                      +++|+|..++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf             899808899875--3899999999999999999999998769---97513554443443788518997644111003467


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             6456743224446601811226798793143999999999999499999888888643100010366444
Q 004580          669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNADSFNLLGYVSNKSLHF  738 (744)
Q Consensus       669 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~~~l~~~~~~~~~~f  738 (744)
                      .   ......+++.|+|||.+.+..++.++||||+||++|||++|+.||...+...  +...+.+....|
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~~i~~~~~~~  222 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMNAEYTF  222 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCCCC
T ss_pred             C---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCC
T ss_conf             7---5321223322234021048777840113027999999982899999989999--999998389998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=295.79  Aligned_cols=202  Identities=32%  Similarity=0.481  Sum_probs=172.2

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCC-----CEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEE
Q ss_conf             3965222237468137981100466-----40588832677-81309999999999998138870347779997595999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      +.|++.++||+|+||.||+|.++..     ..||||+++.. ......+|.+|+.++.+++|||||++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECC
Q ss_conf             99930799911332276876668999999999999999999884499972870479998899289845997425741128
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~  666 (744)
                      ||||+.++++..++..  ....+++.+++.++.|++.|+.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf             9972135740222102--3454208999999999998541212123---4257656442788899849984551030035


Q ss_pred             CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf             986456-74322444660181122679879314399999999999949999988
Q 004580          667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGV  719 (744)
Q Consensus       667 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~  719 (744)
                      ...... ......||..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf             787652674267777343488887049999735563448989999967988655

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-41  Score=299.36  Aligned_cols=203  Identities=33%  Similarity=0.508  Sum_probs=174.5

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             03965222237468137981100466405888326778130999999999999813887034777999759599999930
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEYM  591 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~  591 (744)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++.+++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             79979846993079809999999999999999988044-888999999999986666788689999823-9759999944


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC
Q ss_conf             79991133227687666899999999999999999988449997287047999889928984599742574112898645
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~  671 (744)
                      ++|+|..++... ....+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf             799435420000-3553059999999999999999875411---433531230799989992998442555425688733


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             67432244466018112267987931439999999999994999998888
Q 004580          672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       672 ~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                       ......+++.|+|||++....++.++||||||+++|||++|..|+....
T Consensus       170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~  218 (285)
T d1fmka3         170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  218 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             -EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf             -5245455665458089837998917741323589999986899999888

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-40  Score=293.37  Aligned_cols=205  Identities=27%  Similarity=0.398  Sum_probs=177.3

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECC----E
Q ss_conf             039652222374681379811004-6640588832677---8130999999999999813887034777999759----5
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----E  583 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~----~  583 (744)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++..   .....+.+.+|+.++..++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCE
Q ss_conf             99999930799911332276876668999999999999999999884499972870479998899289845997425741
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~  663 (744)
                      .++||||+++++|..++.   ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEEHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             999997788987101120---3589999999999999999999998579---5276346755665754320100344432


Q ss_pred             ECCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             1289864-5674322444660181122679879314399999999999949999988888
Q 004580          664 MFGGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       664 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||+||++||...+.
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  219 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP  219 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH
T ss_conf             212354433334642576243699998399999663202652899999769799899699

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=289.96  Aligned_cols=199  Identities=21%  Similarity=0.291  Sum_probs=169.4

Q ss_pred             HCCCCCCC-CCCCCCCEEEECCCC-CCCCEEEEEECCCCCHHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEE----CCEE
Q ss_conf             03965222-237468137981100-46640588832677813099999999999981-38870347779997----5959
Q 004580          512 TENFSMQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE----QGEK  584 (744)
Q Consensus       512 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~----~~~~  584 (744)
                      .++|++.+ .||+|+||.||+|++ .+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             148798107965454869999998899989999998974-----779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEEC---CCCEEEEEECC
Q ss_conf             999993079991133227687666899999999999999999988449997287047999889928---98459974257
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGL  661 (744)
Q Consensus       585 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgl  661 (744)
                      ++||||+++|+|..++... ....+++.++..++.|++.||.|||+.+   |+||||||+|||++.   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             9999778998499999862-7877579999999999999999999769---86444100220113555566311354551


Q ss_pred             CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             4112898645674322444660181122679879314399999999999949999988888
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      |+......   ......||+.|+|||++.+..++.++|||||||++|||+||++||...+.
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~  218 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  218 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred             EEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH
T ss_conf             23336888---64322677563792777489888888887645167788658899889887

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=296.44  Aligned_cols=222  Identities=28%  Similarity=0.441  Sum_probs=184.7

Q ss_pred             HHHHHHHCCCCCCCCCCCCCCEEEECCCCC------CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCEEEEEEEE
Q ss_conf             778877039652222374681379811004------66405888326778-13099999999999981388703477799
Q 004580          506 ASVAAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQS-GQGLEEFKNEMMLIAKLQHRNLVKLLGCC  578 (744)
Q Consensus       506 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~  578 (744)
                      .+++...++|++.++||+|+||.||+|+.+      +++.||||+++... ....++|.+|+.++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf             31138988938867982078839999998887657788299999988210857999999999999966899765524666


Q ss_pred             EECCEEEEEEEECCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf             97595999999307999113322768---------------------766689999999999999999998844999728
Q 004580          579 VEQGEKILILEYMPNKSLDVFLFDPT---------------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRII  637 (744)
Q Consensus       579 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  637 (744)
                      .+....++++||+++|+|..++....                     ....+++..++.++.|++.||+|||+.+   |+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf             059803899981589929999985275542100001110012103467889899999999999999855413578---68


Q ss_pred             EECCCCCCEEEECCCCEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CC
Q ss_conf             70479998899289845997425741128986456743224446601811226798793143999999999999499-99
Q 004580          638 HRDLKASNVLLDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KN  716 (744)
Q Consensus       638 H~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~-~p  716 (744)
                      ||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf             54884011689899928983314421136776411157777676767989972688980563025236299998068999


Q ss_pred             CCCCCCCCCCCCCCCC
Q ss_conf             9888888643100010
Q 004580          717 TGVYNADSFNLLGYVS  732 (744)
Q Consensus       717 ~~~~~~~~~~l~~~~~  732 (744)
                      |...+..+  +...+.
T Consensus       243 ~~~~~~~e--~~~~v~  256 (301)
T d1lufa_         243 YYGMAHEE--VIYYVR  256 (301)
T ss_dssp             TTTSCHHH--HHHHHH
T ss_pred             CCCCCHHH--HHHHHH
T ss_conf             99989999--999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-39  Score=289.56  Aligned_cols=204  Identities=27%  Similarity=0.356  Sum_probs=176.7

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCH---------HHHHHHHHHHHHHHHHC-CCCEEEEEEEEEE
Q ss_conf             039652222374681379811004-664058883267781---------30999999999999813-8870347779997
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG---------QGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVE  580 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~f~~Ei~~l~~l~-HpnIv~l~~~~~~  580 (744)
                      .++|++.+.||+|+||.||+++.. +++.+|||+++....         ...+.+.+|+.++.+++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEEC
Q ss_conf             59599999930799911332276876668999999999999999999884499972870479998899289845997425
Q 004580          581 QGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFG  660 (744)
Q Consensus       581 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg  660 (744)
                      .+..++||||+++|+|..++.   .+..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCEEEEEECCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf             760599997689866899998---6599999999999999999999998759---9432346254898689983871240


Q ss_pred             CCEECCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             7411289864567432244466018112267------987931439999999999994999998888886
Q 004580          661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       661 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~  724 (744)
                      +++.+....   ......||..|+|||++.+      ..++.++||||+||++|||++|+.||...+...
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             HEEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH
T ss_conf             316726887---2134524678889888605344567889923318565602310322888988999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-40  Score=290.67  Aligned_cols=210  Identities=29%  Similarity=0.431  Sum_probs=175.2

Q ss_pred             HHHCCCCCCCCCCCCCCEEEECCCCC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEEC
Q ss_conf             77039652222374681379811004------6640588832677-813099999999999981-388703477799975
Q 004580          510 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQ  581 (744)
Q Consensus       510 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~~  581 (744)
                      ...++|++.++||+|+||.||+|+..      .++.||||+++.. .....+.+..|...+.++ +|+||+.+++++.+.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf             16799798449841678399999986777555783999999860017178999999999988614998499741154047


Q ss_pred             C-EEEEEEEECCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf             9-5999999307999113322768-------------7666899999999999999999988449997287047999889
Q 004580          582 G-EKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL  647 (744)
Q Consensus       582 ~-~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NIL  647 (744)
                      + ..++||||+++|+|..++....             ....+++.+++.++.|+++||.|||+++   |+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEE
T ss_conf             97579999845899299999853666665322202332146899999999999999999887379---717867731065


Q ss_pred             EECCCCEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCC
Q ss_conf             9289845997425741128986456743224446601811226798793143999999999999499-99988888
Q 004580          648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNA  722 (744)
Q Consensus       648 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~-~p~~~~~~  722 (744)
                      ++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||.....
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf             7799828984575200113566522247516672102036864688996632213678999998688999989998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=289.60  Aligned_cols=213  Identities=28%  Similarity=0.405  Sum_probs=178.2

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCC----CCEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEE
Q ss_conf             0396522223746813798110046----640588832677-81309999999999998138870347779997595999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l  586 (744)
                      .++|++.+.||+|+||.||+|++..    +..||||.++.. .....+.|.+|+.++.+++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECC
Q ss_conf             99930799911332276876668999999999999999999884499972870479998899289845997425741128
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFG  666 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~  666 (744)
                      ||||+++|++..++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf             9984069807765422--4789999999999999987752302267---4414102655320678967876503421336


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCCC
Q ss_conf             9864567432244466018112267987931439999999999994-999998888886431000103
Q 004580          667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYVSN  733 (744)
Q Consensus       667 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~~~l~~~~~~  733 (744)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |++||...+...  +...+.+
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~  224 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIEN  224 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred             CCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--HHHHHHC
T ss_conf             77623-30540058310326675169988745244424789999826999988899999--9999981

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=287.48  Aligned_cols=210  Identities=30%  Similarity=0.429  Sum_probs=179.1

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCC------CCCCEEEEEECCCC-CHHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEECC
Q ss_conf             703965222237468137981100------46640588832677-813099999999999981-3887034777999759
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQG  582 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~~~  582 (744)
                      ..++|++.++||+|+||.||+|++      ..++.||||+++.. ......+|.+|+.++..+ +|||||++++++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf             78996985498206882999999806644778869999998742487799999999999876269998878998983199


Q ss_pred             EEEEEEEECCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf             5999999307999113322768---------------7666899999999999999999988449997287047999889
Q 004580          583 EKILILEYMPNKSLDVFLFDPT---------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL  647 (744)
Q Consensus       583 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NIL  647 (744)
                      ..++||||+++|+|..+++...               ....+++..+..++.||++|++|||+++   ++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf             78999973799879999985356654444453322233458899999999999999999887579---266624102100


Q ss_pred             EECCCCEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf             92898459974257411289864567432244466018112267987931439999999999994-99999888888
Q 004580          648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNAD  723 (744)
Q Consensus       648 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~  723 (744)
                      ++.++.+|++|||.++...............+|+.|+|||.+.+..++.++||||||+++|||+| |++++...+..
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             00257521023401023367886158620135968767788617999974001025899999985899887789989

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=287.18  Aligned_cols=197  Identities=29%  Similarity=0.369  Sum_probs=167.9

Q ss_pred             CCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHH-----HHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             2222374681379811004-6640588832677813-----099999999999981388703477799975959999993
Q 004580          517 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQ-----GLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       517 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      .+++||+|+||+||+|+++ .++.||||+++.....     ..+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCC
Q ss_conf             07999113322768766689999999999999999998844999728704799988992898459974257411289864
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~  670 (744)
                      ++++++....   .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf             3450776554---12667789999999999999998863163---55035776258853778411465761000578755


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             5674322444660181122679-87931439999999999994999998888
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~APE~~~~~-~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                        .....+||+.|+|||++... .++.++|||||||++|||++|++||...+
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             --CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCC
T ss_conf             --43302047333639997267788805643630428999985969999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-39  Score=285.43  Aligned_cols=202  Identities=29%  Similarity=0.418  Sum_probs=172.6

Q ss_pred             CCCCCCCCCCCCCCEEEECCCC-CCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             3965222237468137981100-466405888326778--1309999999999998138870347779997595999999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.++||+|+||.||+|++ .+++.||+|+++...  ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCC
Q ss_conf             30799911332276876668999999999999999999884499972870479998899289845997425741128986
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~  669 (744)
                      |+.++.+.....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||.|+......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ECCCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf             237744555442--02568888999999999999999865288---9921357114011346762103578613436886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             456743224446601811226798-7931439999999999994999998888
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~APE~~~~~~-~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      .  ......|++.|+|||.+.... ++.++|+||+||++|||++|+.||...+
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             C--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC
T ss_conf             4--10010365215411221366577742210333313427966879989889

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=283.05  Aligned_cols=211  Identities=31%  Similarity=0.487  Sum_probs=181.4

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCCCC--------CCEEEEEECCCCC-HHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEE
Q ss_conf             70396522223746813798110046--------6405888326778-13099999999999981-38870347779997
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQS-GQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVE  580 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~  580 (744)
                      ..++|++.+.||+|+||.||+|+...        +..||||+++... .....++.+|...+.++ +|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf             58996970098516782899999857875556675499999988112868899999999999981399969734652201


Q ss_pred             CCEEEEEEEECCCCCHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf             595999999307999113322768-------------7666899999999999999999988449997287047999889
Q 004580          581 QGEKILILEYMPNKSLDVFLFDPT-------------KKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVL  647 (744)
Q Consensus       581 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NIL  647 (744)
                      ....++||||+++|+|..++....             ....+++.+++.++.|++.||.|||+.+   |+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf             88689999736999099999860677643222334574346799999999999999998766379---786302210224


Q ss_pred             EECCCCEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf             92898459974257411289864567432244466018112267987931439999999999994-999998888886
Q 004580          648 LDMDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS  724 (744)
Q Consensus       648 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~  724 (744)
                      ++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |++||...+.+.
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf             547897676221110113555554314667888466326675179888255547758888874017989899999999

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-38  Score=279.61  Aligned_cols=198  Identities=30%  Similarity=0.474  Sum_probs=168.5

Q ss_pred             CCCCCCCCCEEEECCCCCCC----CEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEEC-CEEEEEEEEC
Q ss_conf             22237468137981100466----40588832677-813099999999999981388703477799975-9599999930
Q 004580          518 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-GEKILILEYM  591 (744)
Q Consensus       518 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~  591 (744)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+.++.+++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCCC
Q ss_conf             79991133227687666899999999999999999988449997287047999889928984599742574112898645
Q 004580          592 PNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDELQ  671 (744)
Q Consensus       592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~  671 (744)
                      ++++|..++..  ....+.+..++.++.|+++||.|+|+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf             06741442101--3454048999999999887652003367---625776687576779998899106523225566555


Q ss_pred             C--CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             6--743224446601811226798793143999999999999499999888
Q 004580          672 G--NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       672 ~--~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~  720 (744)
                      .  ......||..|+|||.+....++.++||||||+++|||+||+.||...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             310025655564556768874379997457466199999999789999888

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=287.17  Aligned_cols=207  Identities=28%  Similarity=0.388  Sum_probs=175.1

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCC----CCEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEE
Q ss_conf             0396522223746813798110046----640588832677---813099999999999981388703477799975959
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSSQ---SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEK  584 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  584 (744)
                      .++|++.+.||+|+||.||+|+...    ...||||+++..   .....++|.+|+.++.+++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf             4891997898038883999999988999079999999983555798999999999999986899998789877740-100


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             99999307999113322768766689999999999999999998844999728704799988992898459974257411
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                      ++||||++++++..++..  ....+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             HEEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf             114654238612544421--2689999999999999999998752178---75205668881565565433256115553


Q ss_pred             CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf             2898645-67432244466018112267987931439999999999994-999998888886
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADS  724 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~  724 (744)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~  222 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ  222 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             03588752654763257310799998379999421566148999999968999999969999

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-39  Score=284.37  Aligned_cols=212  Identities=31%  Similarity=0.462  Sum_probs=178.3

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCC-CC--EEEEEECCCC-CHHHHHHHHHHHHHHHHH-CCCCEEEEEEEEEECCEEEEE
Q ss_conf             396522223746813798110046-64--0588832677-813099999999999981-388703477799975959999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSSQ-SGQGLEEFKNEMMLIAKL-QHRNLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lV  587 (744)
                      ++|++.++||+|+||.||+|++++ +.  .||||+++.. .....++|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCE
Q ss_conf             9930799911332276-------------876668999999999999999999884499972870479998899289845
Q 004580          588 LEYMPNKSLDVFLFDP-------------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNP  654 (744)
Q Consensus       588 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~  654 (744)
                      |||+++|+|..+++..             .....+++..+..++.|++.||.|+|+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf             9802898699998640355555123101234578999999999999999987663089---5455505204898688763


Q ss_pred             EEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf             997425741128986456743224446601811226798793143999999999999499-999888888643100010
Q 004580          655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNADSFNLLGYVS  732 (744)
Q Consensus       655 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~-~p~~~~~~~~~~l~~~~~  732 (744)
                      ||+|||+++......   ......+|..|+|||.+.+..++.++||||||+++|||++|. +||...+...  +...+.
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP  240 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGG
T ss_pred             EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
T ss_conf             874344322444223---45530137755553875269999622153138899999836899999999999--999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=282.89  Aligned_cols=204  Identities=26%  Similarity=0.372  Sum_probs=166.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECC----EEEEEE
Q ss_conf             3965222237468137981100466405888326778130999999999999813887034777999759----599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~~lV~  588 (744)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+..++||||+++++++.+..    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             6899988982078819999999-9989999998720046-7999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEEECCCCCCEEEECCCCEEEEEECCCE
Q ss_conf             93079991133227687666899999999999999999988449-----9972870479998899289845997425741
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DFgla~  663 (744)
                      ||+++|+|..++..    ..+++..++.++.+++.||.|+|+..     ..+|+||||||+|||++.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf             64669898999865----89998999999999999999988766520468986615317313578688776887638662


Q ss_pred             ECCCCCC--CCCCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             1289864--56743224446601811226798------79314399999999999949999988888
Q 004580          664 MFGGDEL--QGNTKRIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       664 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~------~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      .......  ........||+.|+|||++.+..      ++.++||||||++||||+||..|+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~  223 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  223 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred             CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf             3467776200135525035476782210565454677767501220159999999628998876631

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-38  Score=282.36  Aligned_cols=209  Identities=29%  Similarity=0.439  Sum_probs=178.5

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCCC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCE
Q ss_conf             7039652222374681379811004------6640588832677-81309999999999998138870347779997595
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGE  583 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~  583 (744)
                      ..++|++.++||+|+||.||+|.+.      .+..||||+++.. .......|.+|+.++.+++||||+++++++.....
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             68991883598207881899999878644778968999998701286899999999999997699988412547842881


Q ss_pred             EEEEEEECCCCCHHHHHCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEE
Q ss_conf             99999930799911332276-------87666899999999999999999988449997287047999889928984599
Q 004580          584 KILILEYMPNKSLDVFLFDP-------TKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKI  656 (744)
Q Consensus       584 ~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl  656 (744)
                      .++||||+++|+|..++...       .....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf             06777604899889998750332113444688799999999999999999876479---654328677540359964999


Q ss_pred             EEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCC
Q ss_conf             7425741128986456743224446601811226798793143999999999999499-99988888
Q 004580          657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGK-KNTGVYNA  722 (744)
Q Consensus       657 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~-~p~~~~~~  722 (744)
                      +|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||+||+ +||...+.
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~  241 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  241 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             4245420235776303134023163237888873699883334443789999999689999999899

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-38  Score=281.40  Aligned_cols=201  Identities=25%  Similarity=0.387  Sum_probs=175.5

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             3965222237468137981100466405888326778--13099999999999981388703477799975959999993
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQS--GQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILEY  590 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~  590 (744)
                      ++|++.++||+|+||.||+|++++++.||||+++...  ....+.+.+|+.++++++||||+++++.+...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCC
Q ss_conf             07999113322768766689999999999999999998844999728704799988992898459974257411289864
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~  670 (744)
                      +.++.+..+.   .....++...+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf             0045678998---60477514456899999999999860574---88267877505686899787323664301146765


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             5674322444660181122679-87931439999999999994999998888
Q 004580          671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       671 ~~~~~~~~gt~~y~APE~~~~~-~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCC
T ss_conf             --41010243110137887178888841002111758999977979989889

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-39  Score=284.93  Aligned_cols=207  Identities=32%  Similarity=0.488  Sum_probs=175.5

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEEC-CEEEEEEEE
Q ss_conf             0396522223746813798110046640588832677813099999999999981388703477799975-959999993
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-GEKILILEY  590 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~  590 (744)
                      .++|++.++||+|+||.||+|++ .+..||||+++...  ..++|.+|++++.+++||||+++++++.+. ...++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             89948857982079808999999-99099999988577--7999999999998678989854987887238928999963


Q ss_pred             CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCCC
Q ss_conf             07999113322768766689999999999999999998844999728704799988992898459974257411289864
Q 004580          591 MPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDEL  670 (744)
Q Consensus       591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~  670 (744)
                      +++|+|..++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+|++|||+++...... 
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC-
T ss_conf             6999899998745-7888899999999999985232113376---5536665676014689977632456003447877-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf             567432244466018112267987931439999999999994-99999888888643100010
Q 004580          671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-GKKNTGVYNADSFNLLGYVS  732 (744)
Q Consensus       671 ~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLlt-G~~p~~~~~~~~~~l~~~~~  732 (744)
                          ....++..|+|||++.+..++.++||||||+++|||+| |++||.......  +...+.
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~  214 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE  214 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT
T ss_pred             ----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH
T ss_conf             ----655666467781787279888588777579999999978999999999999--999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=278.61  Aligned_cols=202  Identities=26%  Similarity=0.404  Sum_probs=166.8

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-C-CCEEEEEECCCCC--HHHHHHHHHHHHHHHHH---CCCCEEEEEEEEEEC---
Q ss_conf             039652222374681379811004-6-6405888326778--13099999999999981---388703477799975---
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSSQS--GQGLEEFKNEMMLIAKL---QHRNLVKLLGCCVEQ---  581 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~--~~~~~~f~~Ei~~l~~l---~HpnIv~l~~~~~~~---  581 (744)
                      .++|++.++||+|+||.||+|++. . ++.||||+++...  ......+.+|+.+++.+   +||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             --CEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEE
Q ss_conf             --959999993079991133227687666899999999999999999988449997287047999889928984599742
Q 004580          582 --GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDF  659 (744)
Q Consensus       582 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF  659 (744)
                        ...++++|+++++.+.....  .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf             6746999997405871444443--03789998999999999999999997588---983579862789858997542100


Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             57411289864567432244466018112267987931439999999999994999998888
Q 004580          660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       660 gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      |+++......   ......||+.|+|||++.+..++.++||||+||++|||++|++||...+
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCC
T ss_conf             0101100234---5777654851148310017988811100032899999987879989989

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=273.32  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=170.8

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCC-CCCCEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECC----EE
Q ss_conf             703965222237468137981100-46640588832677-8130999999999999813887034777999759----59
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG----EK  584 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~----~~  584 (744)
                      .+++|++.++||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+.++..++|||++++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf             38985997899406480999999999994999999803109589999999999999768989885888995056455414


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             99999307999113322768766689999999999999999998844999728704799988992898459974257411
Q 004580          585 ILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       585 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                      +++++++.+++|..++.    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEECCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             99999625986566440----589999999999999999999999789---86777876437887999778754570565


Q ss_pred             CCCCCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             2898645-6743224446601811226-7987931439999999999994999998888
Q 004580          665 FGGDELQ-GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       665 ~~~~~~~-~~~~~~~gt~~y~APE~~~-~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      ....... .......|++.|+|||++. ...++.++||||+|+++|||++|+.||...+
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCC
T ss_conf             04777641010110265200038786047888741010046701337766979978888

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=276.10  Aligned_cols=199  Identities=27%  Similarity=0.379  Sum_probs=165.3

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEEC------CEEE
Q ss_conf             39652222374681379811004-6640588832677813099999999999981388703477799975------9599
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ------GEKI  585 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~------~~~~  585 (744)
                      -+|+..++||+|+||+||+|++. .++.||||+++.....    ..+|+.++.+++||||+++++++...      .+.+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             7767516982176839999999999979999998816068----999999998668989873878997447657731899


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCC-CEEEEEECCCEE
Q ss_conf             9999307999113322768766689999999999999999998844999728704799988992898-459974257411
Q 004580          586 LILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARM  664 (744)
Q Consensus       586 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~  664 (744)
                      +||||++++.+............+++..++.++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf             99841688607888863103689999999999999999999998668---764578860378735897116733660544


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             289864567432244466018112267-987931439999999999994999998888
Q 004580          665 FGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       665 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      +.....   .....|+..|+|||.+.+ ..++.++||||+||++|||++|++||...+
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             CCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCC
T ss_conf             047765---3200255555682776404688821000246527785502879989879

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=272.42  Aligned_cols=203  Identities=27%  Similarity=0.408  Sum_probs=171.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEE--------C
Q ss_conf             39652222374681379811004-6640588832677--81309999999999998138870347779997--------5
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE--------Q  581 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~--------~  581 (744)
                      ++|++.++||+|+||+||+|++. +++.||||++...  .....+++.+|+.++++++|||++++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf             79889999722748299999998999799999984222463789999999999998359996606765402465444457


Q ss_pred             CEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECC
Q ss_conf             95999999307999113322768766689999999999999999998844999728704799988992898459974257
Q 004580          582 GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGL  661 (744)
Q Consensus       582 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl  661 (744)
                      ...++||||++++.+....   .....+....+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf             6389998535787410122---20344330899999999999998852299---88567672220366899687631350


Q ss_pred             CEECCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             4112898645--674322444660181122679-87931439999999999994999998888
Q 004580          662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       662 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      ++.+......  .......||+.|+|||.+.+. .++.++||||+||++|||++|++||...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC
T ss_conf             022355444321135660249787428997079998917870067864661744879989989

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-37  Score=273.66  Aligned_cols=197  Identities=28%  Similarity=0.419  Sum_probs=169.2

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECC------
Q ss_conf             039652222374681379811004-6640588832677--8130999999999999813887034777999759------
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQG------  582 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~------  582 (744)
                      .++|++.++||+|+||.||+|++. +++.||||+++..  .....+.+.+|+.+++.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCC
Q ss_conf             59999993079991133227687666899999999999999999988449997287047999889928984599742574
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla  662 (744)
                      +.++||||+ +.+|..+.    ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEECC-CCCHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf             599998405-52189998----7402269999999999999999987378---764566851111210012211343102


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             112898645674322444660181122679-87931439999999999994999998888
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      +.....     .....+++.|+|||.+.+. .++.++||||+||++|||++|++||...+
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf             206876-----3102455333588998178789965010300389999997869988897

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=278.63  Aligned_cols=198  Identities=24%  Similarity=0.377  Sum_probs=167.0

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCH------HHHHHHHHHHHHHHHHC--CCCEEEEEEEEEECCE
Q ss_conf             39652222374681379811004-664058883267781------30999999999999813--8870347779997595
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSG------QGLEEFKNEMMLIAKLQ--HRNLVKLLGCCVEQGE  583 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~f~~Ei~~l~~l~--HpnIv~l~~~~~~~~~  583 (744)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++....      ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf             83799679840878399999999999799999985688443345567999999999999743589881279999830996


Q ss_pred             EEEEEEECCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECC-CCEEEEEECC
Q ss_conf             9999993079-9911332276876668999999999999999999884499972870479998899289-8459974257
Q 004580          584 KILILEYMPN-KSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMD-MNPKISDFGL  661 (744)
Q Consensus       584 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgl  661 (744)
                      .++||||+.+ +++..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf             8999983368622899986---1589999999999999999999998779---755667611147744788489775465


Q ss_pred             CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             411289864567432244466018112267987-93143999999999999499999888
Q 004580          662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSGKKNTGVY  720 (744)
Q Consensus       662 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~~DvwSlGviL~eLltG~~p~~~~  720 (744)
                      ++......    .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC
T ss_conf             35324445----566565877479999848997886533255403453675688998873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-36  Score=266.80  Aligned_cols=204  Identities=22%  Similarity=0.299  Sum_probs=171.4

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf             039652222374681379811004-664058883267781309999999999998138-870347779997595999999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.++||+|+||.||+|++. +++.||||.+.....  ...+.+|++.+..++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEEC-----CCCEEEEEECCCEE
Q ss_conf             3079991133227687666899999999999999999988449997287047999889928-----98459974257411
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM-----DMNPKISDFGLARM  664 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFgla~~  664 (744)
                      |+ +++|..++..  ....++...+..++.|++.||.|||+.+   |+||||||+|||++.     .+.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf             64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577


Q ss_pred             CCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             289864-----56743224446601811226798793143999999999999499999888888
Q 004580          665 FGGDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       665 ~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~  723 (744)
                      +.....     ........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf             1467665411102467627751026798964888886999898319999998698767885302

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=275.84  Aligned_cols=205  Identities=29%  Similarity=0.414  Sum_probs=174.4

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC----CCCEEEEEECCCC----CHHHHHHHHHHHHHHHHHCC-CCEEEEEEEEEECCE
Q ss_conf             39652222374681379811004----6640588832677----81309999999999998138-870347779997595
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSSQ----SGQGLEEFKNEMMLIAKLQH-RNLVKLLGCCVEQGE  583 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~f~~Ei~~l~~l~H-pnIv~l~~~~~~~~~  583 (744)
                      ++|++.++||+|+||.||+|+..    .++.||+|.++..    .....+.+.+|+.++.+++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCE
Q ss_conf             99999930799911332276876668999999999999999999884499972870479998899289845997425741
Q 004580          584 KILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLAR  663 (744)
Q Consensus       584 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~  663 (744)
                      .++++||+.+++|..++.   ....+.......++.|++.|+.|+|+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEEECCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf             001231234117999987---3045437888888999999998851499---8965477320124699988874132022


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             12898645674322444660181122679--87931439999999999994999998888886
Q 004580          664 MFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSGKKNTGVYNADS  724 (744)
Q Consensus       664 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~~DvwSlGviL~eLltG~~p~~~~~~~~  724 (744)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...+...
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~  239 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN  239 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred             HHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf             20344443-221222333331068760577688713251777799999976899988887777

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8e-36  Score=263.02  Aligned_cols=195  Identities=22%  Similarity=0.372  Sum_probs=167.2

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHC-CCCEEEEEEEEEEC--CEEEEEE
Q ss_conf             39652222374681379811004-66405888326778130999999999999813-88703477799975--9599999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQ--GEKILIL  588 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~  588 (744)
                      ++|++.++||+|+||+||+|+.. +++.||+|+++...   .+++.+|+.++..++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             67189789831748199999988999799999988899---999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCC-CEEEEEECCCEECCC
Q ss_conf             9307999113322768766689999999999999999998844999728704799988992898-459974257411289
Q 004580          589 EYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDM-NPKISDFGLARMFGG  667 (744)
Q Consensus       589 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~  667 (744)
                      ||+++++|..+.      +.++...++.++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf             631798589974------68999999999999999998876433---443456441237748998366415654266468


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             8645674322444660181122679-879314399999999999949999988888
Q 004580          668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSGKKNTGVYNA  722 (744)
Q Consensus       668 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~~DvwSlGviL~eLltG~~p~~~~~~  722 (744)
                      ..   ......+|+.|+|||.+.+. .++.++|+||+|++++||++|+.||.....
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf             87---444322486424761026888888452323354555876048899988760

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-36  Score=265.91  Aligned_cols=204  Identities=23%  Similarity=0.341  Sum_probs=165.6

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEE-EEEEEEECCEEEEEEE
Q ss_conf             039652222374681379811004-66405888326778130999999999999813887034-7779997595999999
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLVK-LLGCCVEQGEKILILE  589 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~~~~~~~~~~~lV~E  589 (744)
                      .++|++.++||+|+||.||+|++. +++.||||++......  +++..|++++..++|++++. +..+..+....++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             88899968985078809999999889989999997210058--8899999999970389960179999951987789998


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEEC---CCCEEEEEECCCEECC
Q ss_conf             3079991133227687666899999999999999999988449997287047999889928---9845997425741128
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDM---DMNPKISDFGLARMFG  666 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgla~~~~  666 (744)
                      |++++ +...+.  .....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+|++|||+|+.+.
T Consensus        84 ~~~~~-l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGPS-LEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCCB-HHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             ECCCC-HHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf             73871-333244--30688768999999999999999999799---4426678766064335777615650467513425


Q ss_pred             CCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             98645-----6743224446601811226798793143999999999999499999888888
Q 004580          667 GDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYNAD  723 (744)
Q Consensus       667 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~~~  723 (744)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~  219 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  219 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHH
T ss_conf             54455410001357767873532999991899898321886177899998498766553057

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-36  Score=265.48  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=171.9

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             39652222374681379811004-6640588832677--81309999999999998138870347779997595999999
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQGEKILILE  589 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lV~E  589 (744)
                      ++|++.++||+|+||.||+|++. +++.||||+++..  ......++.+|+.+++.++||||+++++++.+....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCCEECCCCC
Q ss_conf             30799911332276876668999999999999999999884499972870479998899289845997425741128986
Q 004580          590 YMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLARMFGGDE  669 (744)
Q Consensus       590 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~  669 (744)
                      ++.++++..++.   ....+.+..+..++.|++.||+|||+++   |+||||||+|||++.+..+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf             023322211212---3565403678999999999987743399---8600146761211337826652046011046887


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             456743224446601811226798-7931439999999999994999998
Q 004580          670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTG  718 (744)
Q Consensus       670 ~~~~~~~~~gt~~y~APE~~~~~~-~t~~~DvwSlGviL~eLltG~~p~~  718 (744)
                      .  ......++..|+|||.+.... ++.++||||+||++|||++|+.||.
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             C--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCC
T ss_conf             5--10010344310146675069888804440265418899851899998

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=265.65  Aligned_cols=198  Identities=27%  Similarity=0.332  Sum_probs=170.6

Q ss_pred             HCCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEE------CC
Q ss_conf             039652222374681379811004-6640588832677--81309999999999998138870347779997------59
Q 004580          512 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVE------QG  582 (744)
Q Consensus       512 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~------~~  582 (744)
                      .++|++.++||+|+||+||+|++. .++.||||+++..  ......++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCC
Q ss_conf             59999993079991133227687666899999999999999999988449997287047999889928984599742574
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla  662 (744)
                      +.++||||+.++++...      ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EEEEEEECCCHHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf             26999841446778765------038999999999999999998865221---124567763211365443132010232


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             11289864567432244466018112267987931439999999999994999998888
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      +......   ......+|+.|+|||++.+..++.++||||+||+++||++|++||...+
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC
T ss_conf             1146665---5332214655558133147777877433356625789865989988897

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-36  Score=263.94  Aligned_cols=199  Identities=29%  Similarity=0.397  Sum_probs=169.3

Q ss_pred             HHCCCCCCCCCCCCCCEEEECCCC-CCCCEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEEEEEEEC-----C
Q ss_conf             703965222237468137981100-46640588832677--813099999999999981388703477799975-----9
Q 004580          511 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSSQ--SGQGLEEFKNEMMLIAKLQHRNLVKLLGCCVEQ-----G  582 (744)
Q Consensus       511 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~~~~~~~-----~  582 (744)
                      ..++|++.++||+|+||+||+|++ .+++.||||+++..  .....+++.+|+.+++.++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             89871888898317883999999999997999999882002868999999999999866898742599999634645668


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEEEECCC
Q ss_conf             59999993079991133227687666899999999999999999988449997287047999889928984599742574
Q 004580          583 EKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKISDFGLA  662 (744)
Q Consensus       583 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla  662 (744)
                      ..+++++++.+|+|..++.    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             CEEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             6499999625886232002----245309999999999999999997388---765166776334554322001321000


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             1128986456743224446601811226798-7931439999999999994999998888
Q 004580          663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       663 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                      .....     ......|+..|+|||.+.+.. ++.++||||+|+++|+|++|+.||...+
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~  223 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  223 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             12575-----44443454355583553377567855124320589999976889978898

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.5e-31  Score=233.29  Aligned_cols=200  Identities=24%  Similarity=0.323  Sum_probs=161.1

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHHC-----------CCCEEEEEEEEEE
Q ss_conf             39652222374681379811004-66405888326778130999999999999813-----------8870347779997
Q 004580          513 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-----------HRNLVKLLGCCVE  580 (744)
Q Consensus       513 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~-----------HpnIv~l~~~~~~  580 (744)
                      .+|++.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431-33689999999999840145555542276764789987631


Q ss_pred             C--CEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEEECCC-----
Q ss_conf             5--9599999930799911332276876668999999999999999999884-4999728704799988992898-----
Q 004580          581 Q--GEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNVLLDMDM-----  652 (744)
Q Consensus       581 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~DLkp~NILl~~~~-----  652 (744)
                      .  ...++++++...+..............+....+..++.|++.|+.|||+ .+   |+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf             2565202343200035420000012234678689999999999999888764058---6465677057056305765644


Q ss_pred             -CEEEEEECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             -459974257411289864567432244466018112267987931439999999999994999998888
Q 004580          653 -NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSGKKNTGVYN  721 (744)
Q Consensus       653 -~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~eLltG~~p~~~~~  721 (744)
                       .++++|||.+......     .....|++.|+|||++....++.++|+||+|++++||++|+.||...+
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf             30567531442123445-----422366521057132146677764320123789999987889989875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=2.2e-20  Score=155.69  Aligned_cols=170  Identities=19%  Similarity=0.168  Sum_probs=119.1

Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCH------------------HHHHHHHHHHHHHHHHCCCCEEEEEEE
Q ss_conf             52222374681379811004664058883267781------------------309999999999998138870347779
Q 004580          516 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSG------------------QGLEEFKNEMMLIAKLQHRNLVKLLGC  577 (744)
Q Consensus       516 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~f~~Ei~~l~~l~HpnIv~l~~~  577 (744)
                      .+.++||+|+||.||+|+..+|+.||||+++....                  ........|...+.++.|++++..++.
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EEECCEEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEECCCCEEEE
Q ss_conf             99759599999930799911332276876668999999999999999999884499972870479998899289845997
Q 004580          578 CVEQGEKILILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYSRFRIIHRDLKASNVLLDMDMNPKIS  657 (744)
Q Consensus       578 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~DLkp~NILl~~~~~~kl~  657 (744)
                      .    ..+++|||+++..+..+          .......++.|+++++.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CCEEEEEEECCCCCCCH----------HHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf             2----88899995045654200----------15789999999999999982688---8983689036114289-89998


Q ss_pred             EECCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             425741128986456743224446601811226798793143999999999
Q 004580          658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML  708 (744)
Q Consensus       658 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~~DvwSlGviL~  708 (744)
                      |||.|.............+   ... ...+ ...+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~~~~l~r---d~~-~~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWREILER---DVR-NIIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHH---HHH-HHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCCCCCCCCCCHHHHHH---HHH-HHHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf             7788430899870999987---799-9999-97578998446899999874

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.80  E-value=6.8e-19  Score=145.32  Aligned_cols=112  Identities=23%  Similarity=0.411  Sum_probs=95.5

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCC
Q ss_conf             43115883246997465279907998977999997299997505898079970599998789841899207848995599
Q 004580           25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT  104 (744)
Q Consensus        25 ~~~l~~~~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (744)
                      .|+|.|||.|.+|++|+|  |.|.|.|+.+|+     |.++.   ..++||.||++.+..  .+.|.|+.||+|+|++. 
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~-   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG-   67 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred             CCEECCCCEECCCCEEEE--CCEEEEECCCCC-----EEEEC---CCCEEEECCCCCCCC--CCEEEEECCCCEEEEEC-
T ss_conf             989069999559999987--879999817998-----89873---983899846734788--85799961534999934-


Q ss_pred             CCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCCCCC
Q ss_conf             96399972102467733999169987997089987655302000357840
Q 004580          105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTD  154 (744)
Q Consensus       105 ~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~PtD  154 (744)
                      +..+|++++.......+|+|+|+|||||++.     .+.++|||+.+|++
T Consensus        68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVGN  112 (112)
T ss_dssp             TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCCC
T ss_pred             CCEEEEEEECCCCCCEEEEECCCCCEEEECC-----CCCEEECCCCCCCC
T ss_conf             8749998303688725999967899999989-----99679618885698

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.78  E-value=1e-18  Score=144.09  Aligned_cols=107  Identities=24%  Similarity=0.365  Sum_probs=93.2

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCC
Q ss_conf             43115883246997465279907998977999997299997505898079970599998789841899207848995599
Q 004580           25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT  104 (744)
Q Consensus        25 ~~~l~~~~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (744)
                      +|+|.+||.|.+|++|.  +|.|.|.|+.+|+     |.||.   ..++||.||++.|.  +.+.|.|+.||+|+|++++
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~   68 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS   68 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred             CCCCCCCCEECCCCEEE--CCCEEEEECCCCE-----EEEEE---CCCEEEEECCCCCC--CCCEEEEECCCEEEEECCC
T ss_conf             99956997726999897--2888999878980-----99970---99021570788998--7547998126039997798


Q ss_pred             CCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCC
Q ss_conf             96399972102467733999169987997089987655302000357
Q 004580          105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY  151 (744)
Q Consensus       105 ~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~  151 (744)
                      +.++|+|++.......+|+|+|+|||||++..        +||||+|
T Consensus        69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~~--------~W~S~t~  107 (108)
T d1jpca_          69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------RWATGTH  107 (108)
T ss_dssp             CCEEEECCCCCSCSCEEEEECTTSCEEEEECC--------CCCCCCC
T ss_pred             CCCEEECCCCCCCCCEEEEECCCCCEEEECCC--------CCCCCCC
T ss_conf             55127704558887679999688899996998--------4568888

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.78  E-value=1.3e-18  Score=143.26  Aligned_cols=108  Identities=20%  Similarity=0.364  Sum_probs=93.5

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCC
Q ss_conf             43115883246997465279907998977999997299997505898079970599998789841899207848995599
Q 004580           25 ADTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQT  104 (744)
Q Consensus        25 ~~~l~~~~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~  104 (744)
                      .|+|.+||.|.+|++|.+  |.|.|+|...|+     |.++.   ..++||+||++.|... .+.|.|+.||+|||++.+
T Consensus         1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred             CCCCCCCCEEECCCEEEE--CCEEEEECCCCE-----EEEEE---CCEEEEEECCCCCCCE-EEEEEECCCCEEEEEECC
T ss_conf             989259998828998983--788999448986-----99986---9989998378998751-079999379609999089


Q ss_pred             CCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCC
Q ss_conf             96399972102467733999169987997089987655302000357
Q 004580          105 NGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY  151 (744)
Q Consensus       105 ~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~  151 (744)
                      +.++|+|+++.+...++|+|+|+|||||+++        .+|||+-|
T Consensus        70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred             CCEEEEEEEECCCCCEEEEEECCCCEEEECC--------CEECCCCC
T ss_conf             8679997308899977999947975999799--------87217985

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.60  E-value=1.4e-15  Score=122.17  Aligned_cols=102  Identities=20%  Similarity=0.291  Sum_probs=86.3

Q ss_pred             EEEEECC-CCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCCCCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCC
Q ss_conf             9975058-980799705999987898418992078489955999639997210246773399916998799708998765
Q 004580           63 GIWFRQV-PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTT  141 (744)
Q Consensus        63 ~iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~  141 (744)
                      -|||..+ .++.+|++|++.|+....-+|.|+.||||||++. +.++|++++........+.|+++|||||++.     .
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-----~   84 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-----Q   84 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-----T
T ss_pred             EEEECCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCCCCCCEEEEEECCEEEEEECC-----C
T ss_conf             699828988885628839972174887999968983899649-9689997522477747999907764999929-----9


Q ss_pred             CCEECEECCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEE
Q ss_conf             530200035784002268833520157871589980379999998425632116876499
Q 004580          142 ESYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMC  201 (744)
Q Consensus       142 ~~~~wqSFd~PtDtlLpg~kl~~~~~t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~  201 (744)
                      +.++||||.                               +.++|.|.+.||.+|+..++
T Consensus        85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             CCEEEEECC-------------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf             988998199-------------------------------99998489998889869996

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.52  E-value=8.6e-14  Score=109.86  Aligned_cols=104  Identities=17%  Similarity=0.320  Sum_probs=83.3

Q ss_pred             CCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCCC
Q ss_conf             31158832469974652799079989779999972999975058980799705999987898418992078489955999
Q 004580           26 DTVTPASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTN  105 (744)
Q Consensus        26 ~~l~~~~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~  105 (744)
                      ++|.++|+|.    +.+..|.|.|.|..+|+     |.++ +  ..++||.+|+..+..  .+.|.|+.||+|+|+++++
T Consensus        15 ~~l~~~q~l~----~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g   80 (119)
T d1b2pa_          15 QILHATESLE----ILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNEN   80 (119)
T ss_dssp             CEEETTCEEE----EEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred             CEEECCCEEE----EECCCCEEEEEECCCCC-----EEEE-E--CCEEEEEECCCCCCC--CEEEEEEECCCEEEECCCC
T ss_conf             8882897588----70478538999889982-----9999-7--996799946788774--1699998377799989998


Q ss_pred             CEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCC
Q ss_conf             6399972102467733999169987997089987655302000357
Q 004580          106 GTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDY  151 (744)
Q Consensus       106 ~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~  151 (744)
                      .++|++++.+.....+++|+|||||||++.        .+|||-.+
T Consensus        81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T~  118 (119)
T d1b2pa_          81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQTV  118 (119)
T ss_dssp             CEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCCC
T ss_pred             CEEEECCCCCCCCCEEEEECCCCCEEEECC--------CEECCCCC
T ss_conf             579978876998865999969988999799--------88416974

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.43  E-value=5.8e-14  Score=111.06  Aligned_cols=109  Identities=21%  Similarity=0.257  Sum_probs=72.7

Q ss_pred             EEEECC-CCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCCCCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf             975058-9807997059999878984189920784899559996399972102467733999169987997089987655
Q 004580           64 IWFRQV-PDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTE  142 (744)
Q Consensus        64 iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~  142 (744)
                      |||.-. +.+..|..+.+.++.....+|.|+.||||||+++ +.++|++++. +..+..+.|+++|||||++.     .+
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~-~~~~~~l~l~~dGNLvl~d~-----~~   75 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTA-GATGCRAVLQSDGLLVILTA-----QN   75 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCC-SCSCCBCCBCSSSCBCCBCT-----TT
T ss_pred             EEEECCCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCC-CCCCEEEEEECCCCEEEECC-----CC
T ss_conf             77864789988212469981775988999979983999819-9068971168-99756899944678999905-----89


Q ss_pred             CEECEECCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf             302000357840022688335201578715899803799999984256321168764999909800265078
Q 004580          143 SYLWQSFDYPTDTLLQGMKMGWDLKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ  214 (744)
Q Consensus       143 ~~~wqSFd~PtDtlLpg~kl~~~~~t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~~~~~~~~~~~sg~  214 (744)
                      .++|||+.                               +.+.|.|.+.|+++|+..++    +.++|.+|.
T Consensus        76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt  112 (115)
T d1dlpa1          76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT  112 (115)
T ss_dssp             CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred             CEEEECCC-------------------------------CCCCCCEEEEECCCCCEEEE----CCCEECCCC
T ss_conf             78998188-------------------------------89999789999899869996----897643889

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.30  E-value=2.7e-12  Score=99.47  Aligned_cols=99  Identities=23%  Similarity=0.336  Sum_probs=79.2

Q ss_pred             CCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCCCCEEEE
Q ss_conf             83246997465279907998977999997299997505898079970599998789841899207848995599963999
Q 004580           31 ASFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWS  110 (744)
Q Consensus        31 ~~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws  110 (744)
                      .|.|.+++.|  .+|.|.|.|..+|+     |.++.   ...+||.+|...+   ..+.+.|+.||||||++.++.+||+
T Consensus        14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs   80 (115)
T d1dlpa1          14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS   80 (115)
T ss_dssp             CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred             CCEECCCCCE--ECCCEEEEECCCCE-----EEEEC---CCEEEEECCCCCC---CCEEEEEECCCCEEEECCCCCEEEE
T ss_conf             2124699817--75988999979983-----99981---9906897116899---7568999446789999058978998


Q ss_pred             EEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECC
Q ss_conf             7210246773399916998799708998765530200035
Q 004580          111 TNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFD  150 (744)
Q Consensus       111 ~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd  150 (744)
                      +++.......+++|++|||||||+.        .+|+|-.
T Consensus        81 S~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssgt  112 (115)
T d1dlpa1          81 SGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGT  112 (115)
T ss_dssp             CCCCCCSSCCEEEECSSSCEEEECS--------EEEECSC
T ss_pred             CCCCCCCCCEEEEECCCCCEEEECC--------CEECCCC
T ss_conf             1888999978999989986999689--------7643889

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.14  E-value=1.6e-10  Score=87.08  Aligned_cols=97  Identities=20%  Similarity=0.316  Sum_probs=72.9

Q ss_pred             CCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEECCCCCCCCCCCEEEEEECCCEEEECCCCCEEEEE
Q ss_conf             32469974652799079989779999972999975058980799705999987898418992078489955999639997
Q 004580           32 SFIRDGEKLVSFSQRFELGFFSPGKSKSRYLGIWFRQVPDTVVWVANRDRPISDHNAVLTISNKGNLVLLNQTNGTIWST  111 (744)
Q Consensus        32 ~~l~~~~~l~s~~~~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~  111 (744)
                      +.|.+++.|.  .|.|.|.|...|+     |.++.   ...+||.++..  ..+..+.+.|+.+|||||++.++.++|+|
T Consensus        24 ~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW~S   91 (120)
T d1dlpa2          24 QTLHATQSLQ--LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVWTS   91 (120)
T ss_dssp             CEECSSCCCB--CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred             CEECCCCEEE--CCCEEEEECCCCC-----EEEEC---CCCEEEEECCC--CCCCCEEEEEECCEEEEEECCCCCEEEEE
T ss_conf             2883997217--4887999968983-----89964---99689997522--47774799990776499992999889981


Q ss_pred             EEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEE
Q ss_conf             2102467733999169987997089987655302000
Q 004580          112 NVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQS  148 (744)
Q Consensus       112 ~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqS  148 (744)
                      ++.......+++|++|||||||+.        .+|.|
T Consensus        92 ~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t  120 (120)
T d1dlpa2          92 GNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT  120 (120)
T ss_dssp             CCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred             CCCCCCCCEEEEECCCCCEEEECC--------CCCCC
T ss_conf             999999848999888986999689--------74349

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.97  E-value=2.4e-09  Score=78.90  Aligned_cols=86  Identities=24%  Similarity=0.278  Sum_probs=66.0

Q ss_pred             CEEEEEECCCEEEECCCCCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCCCCCCCCCCCCCCCCCC
Q ss_conf             41899207848995599963999721024677339991699879970899876553020003578400226883352015
Q 004580           88 AVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDLK  167 (744)
Q Consensus        88 ~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~PtDtlLpg~kl~~~~~  167 (744)
                      =.|.|+.||||||+++ +.++|++++.+...+..+.++++|||||++.     .+.++|+|.-                 
T Consensus        32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-----~g~~vWsS~t-----------------   88 (119)
T d1b2pa_          32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSPV-----------------   88 (119)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECSC-----------------
T ss_pred             EEEEECCCCCEEEEEC-CEEEEEECCCCCCCCEEEEEEECCCEEEECC-----CCCEEEECCC-----------------
T ss_conf             8999889982999979-9679994678877416999983777999899-----9857997887-----------------


Q ss_pred             CCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf             78715899803799999984256321168764999909800265078
Q 004580          168 NRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ  214 (744)
Q Consensus       168 t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~~~~~~~~~~~sg~  214 (744)
                                    .-+.|.|.+.|+.+|+..++    +.+.|.|++
T Consensus        89 --------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T  117 (119)
T d1b2pa_          89 --------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT  117 (119)
T ss_dssp             --------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred             --------------CCCCCCEEEEECCCCCEEEE----CCCEECCCC
T ss_conf             --------------69988659999699889997----998841697

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.83  E-value=1e-08  Score=74.49  Aligned_cols=87  Identities=22%  Similarity=0.376  Sum_probs=64.4

Q ss_pred             CCEEEEEECCCEEEECCCCCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCCCCCCCCCCCCCCCCC
Q ss_conf             84189920784899559996399972102467733999169987997089987655302000357840022688335201
Q 004580           87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL  166 (744)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~PtDtlLpg~kl~~~~  166 (744)
                      .-+|.|+.||||||++. +.+||++++........+.|+++|||||++.     .+.++|+|                  
T Consensus        20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-----~g~~vWsS------------------   75 (108)
T d1jpca_          20 SFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-----SNKPIWAS------------------   75 (108)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEEC------------------
T ss_pred             CEEEEECCCCEEEEEEC-CCEEEEECCCCCCCCCEEEEECCCEEEEECC-----CCCCEEEC------------------
T ss_conf             88999878980999709-9021570788998754799812603999779-----85512770------------------


Q ss_pred             CCCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf             578715899803799999984256321168764999909800265078
Q 004580          167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ  214 (744)
Q Consensus       167 ~t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~~~~~~~~~~~sg~  214 (744)
                                   ....+.+.|.+.|+.+|+..++    +.+.|.|+.
T Consensus        76 -------------~t~~~~~~~~l~L~ddGNlVly----~~~~W~S~t  106 (108)
T d1jpca_          76 -------------NTGGQNGNYVCILQKDRNVVIY----GTDRWATGT  106 (108)
T ss_dssp             -------------CCCCSCSCEEEEECTTSCEEEE----ECCCCCCCC
T ss_pred             -------------CCCCCCCCEEEEECCCCCEEEE----CCCCCCCCC
T ss_conf             -------------4558887679999688899996----998456888

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.78  E-value=3.8e-08  Score=70.63  Aligned_cols=88  Identities=23%  Similarity=0.343  Sum_probs=65.4

Q ss_pred             CCEEEEEECCCEEEECCCCCEEEEEEEEC-CCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCCCCCCCCCCCCCCCC
Q ss_conf             84189920784899559996399972102-46773399916998799708998765530200035784002268833520
Q 004580           87 NAVLTISNKGNLVLLNQTNGTIWSTNVFS-EVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWD  165 (744)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~-~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~PtDtlLpg~kl~~~  165 (744)
                      .-.|.|+.||||||+. .+.+||++++.. ...+..+.|+++|||||++.     .+.++|+|-                
T Consensus        20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~s~----------------   77 (109)
T d1kj1a_          20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-----EGRSLWASH----------------   77 (109)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-----SSCEEEECC----------------
T ss_pred             CEEEEECCCCEEEEEE-CCEEEEEECCCCCCCEEEEEEECCCCEEEEEEC-----CCCEEEEEE----------------
T ss_conf             8899944898699986-998999837899875107999937960999908-----986799973----------------


Q ss_pred             CCCCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCCC
Q ss_conf             15787158998037999999842563211687649999098002650789
Q 004580          166 LKNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQW  215 (744)
Q Consensus       166 ~~t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~~~~~~~~~~~sg~w  215 (744)
                                     ...+.|.+.+.|+.+|+..++    +.+.|.|+++
T Consensus        78 ---------------t~~~~~~~~l~L~ddGNlvly----~~~~W~S~t~  108 (109)
T d1kj1a_          78 ---------------SVRGNGNYVLVLQEDGNVVIY----GSDIWSTGTY  108 (109)
T ss_dssp             ---------------CCCCSSCCEEEECTTSCEEEE----CCEEEECCCC
T ss_pred             ---------------EECCCCCEEEEEECCCCEEEE----CCCEECCCCC
T ss_conf             ---------------088999779999479759997----9987217985

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=4.5e-07  Score=63.15  Aligned_cols=148  Identities=17%  Similarity=0.106  Sum_probs=97.5

Q ss_pred             HHHHHCCCCCCCCCCCCCCEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHC-CCCEEEEEEEEEECCEEEE
Q ss_conf             887703965222237468137981100466405888326778130999999999999813-8870347779997595999
Q 004580          508 VAAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQ-HRNLVKLLGCCVEQGEKIL  586 (744)
Q Consensus       508 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l  586 (744)
                      +....+.|+..+..+-++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+....+..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf             997513527997678998771899990-8986999984887653255699999999987606998728999750896499


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q ss_conf             9993079991133227687666899999999999999999988449----------------------------------
Q 004580          587 ILEYMPNKSLDVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLHQYS----------------------------------  632 (744)
Q Consensus       587 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  632 (744)
                      ||+++++.++........        ....++.++++.+..||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEECCCCCCCCCCCCCC--------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf             998604334354334402--------699999989999999855684214357644656555778998776555543033


Q ss_pred             ----------------------CCCEEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             ----------------------99728704799988992898459974257411
Q 004580          633 ----------------------RFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       633 ----------------------~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                                            ...++|+|+.+.|||++++....|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             232005799999999844986781789860047642364996599960231441

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.56  E-value=3.3e-07  Score=64.03  Aligned_cols=89  Identities=24%  Similarity=0.388  Sum_probs=59.6

Q ss_pred             CCEEEEEECCCEEEECCCCCEEEEEEEECCCCCCEEEECCCCCEEEECCCCCCCCCCEECEECCCCCCCCCCCCCCCCCC
Q ss_conf             84189920784899559996399972102467733999169987997089987655302000357840022688335201
Q 004580           87 NAVLTISNKGNLVLLNQTNGTIWSTNVFSEVKNPVAQLRDDGNLVIRDNSSGNTTESYLWQSFDYPTDTLLQGMKMGWDL  166 (744)
Q Consensus        87 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~l~~~gn~v~~~~~~~~~~~~~~wqSFd~PtDtlLpg~kl~~~~  166 (744)
                      .-.|.|+.||||||++ .+.+||+++......+..+.|+.+|||||++..      ..+|.|                  
T Consensus        20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------   74 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------   74 (112)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred             CEEEEECCCCCEEEEC-CCCEEEECCCCCCCCCCEEEEECCCCEEEEECC------CEEEEE------------------
T ss_conf             7999981799889873-983899846734788857999615349999348------749998------------------


Q ss_pred             CCCCCEEEEEECCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf             578715899803799999984256321168764999909800265078
Q 004580          167 KNRLERYLSSWQSDDDPSPGKFTSRLEIKVIPKMCIFNGSVKFACSGQ  214 (744)
Q Consensus       167 ~t~~~~~LtSw~s~~dps~G~f~~~l~~~g~~~~~~~~~~~~~~~sg~  214 (744)
                                   ...-..|.+.+.|+.+|+..++- ....+.|.|+.
T Consensus        75 -------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t  108 (112)
T d1xd5a_          75 -------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT  108 (112)
T ss_dssp             -------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred             -------------EECCCCCCEEEEECCCCCEEEEC-CCCCEEECCCC
T ss_conf             -------------30368872599996789999998-99967961888

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.05  E-value=6e-05  Score=48.33  Aligned_cols=131  Identities=18%  Similarity=0.163  Sum_probs=83.2

Q ss_pred             CCCCCC-CEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCC--CCEEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf             237468-1379811004664058883267781309999999999998138--8703477799975959999993079991
Q 004580          520 KLGEGG-FGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQH--RNLVKLLGCCVEQGEKILILEYMPNKSL  596 (744)
Q Consensus       520 ~LG~G~-fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL  596 (744)
                      .+..|. ...||+....++..+++|.-.....   ..+..|...+..+..  ..+.+++.+..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             76786547758999938987899995896677---689999999999986599988613222456615999874413554


Q ss_pred             HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf             133227687666899999999999999999988-----------------------------------------------
Q 004580          597 DVFLFDPTKKRLLGWQARVTIIEGIAQGLLYLH-----------------------------------------------  629 (744)
Q Consensus       597 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----------------------------------------------  629 (744)
                      ....        ....   ..+.++.+.+..||                                               
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCC--------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             3221--------2689---9999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----HC----CCCCEEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             ----44----999728704799988992898459974257411
Q 004580          630 ----QY----SRFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       630 ----~~----~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                          ..    ..+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=0.00018  Score=45.02  Aligned_cols=76  Identities=9%  Similarity=0.163  Sum_probs=47.8

Q ss_pred             CCCCCCCCEEEECCCCCC-CCEEEEEECCCC-------CHHHHHHHHHHHHHHHHHC-C-C-CEEEEEEEEEECCEEEEE
Q ss_conf             223746813798110046-640588832677-------8130999999999999813-8-8-703477799975959999
Q 004580          519 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSSQ-------SGQGLEEFKNEMMLIAKLQ-H-R-NLVKLLGCCVEQGEKILI  587 (744)
Q Consensus       519 ~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~f~~Ei~~l~~l~-H-p-nIv~l~~~~~~~~~~~lV  587 (744)
                      +.||.|....||+....+ ++.+++|.-...       -+...++...|...+..+. + | .+.+++.  .++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCCEEE
T ss_conf             980798527689999579984899961771303467778887789999999999865057988552899--859887798


Q ss_pred             EEECCCCCH
Q ss_conf             993079991
Q 004580          588 LEYMPNKSL  596 (744)
Q Consensus       588 ~E~~~~gsL  596 (744)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EECCCCCCC
T ss_conf             713577653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.19  E-value=0.004  Score=35.69  Aligned_cols=136  Identities=14%  Similarity=0.123  Sum_probs=74.6

Q ss_pred             CEEEECCCCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCE--EEEE-----EEEEECCEEEEEEEECCCCCHHH
Q ss_conf             1379811004664058883267781309999999999998138870--3477-----79997595999999307999113
Q 004580          526 FGPVYKGRLLNGQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNL--VKLL-----GCCVEQGEKILILEYMPNKSLDV  598 (744)
Q Consensus       526 fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~  598 (744)
                      --.||+++..+|+.+++|..+... ...+++..|...+..|....+  +..+     .........+.+++++++..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             CCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf             202699983899979999847877-8899999999999999855998787520689805665347999986527768899


Q ss_pred             H--------------HC------CCCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCCCC
Q ss_conf             3--------------22------76876668999----------------------9999999999999998-8449997
Q 004580          599 F--------------LF------DPTKKRLLGWQ----------------------ARVTIIEGIAQGLLYL-HQYSRFR  635 (744)
Q Consensus       599 ~--------------l~------~~~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~  635 (744)
                      .              +|      .......++..                      .....+..+...+... ....+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf             99999999899999988630357865567789788766568999874769988989999999999999998454568712


Q ss_pred             EEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             28704799988992898459974257411
Q 004580          636 IIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       636 ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                      +||+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             0247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.71  E-value=0.0037  Score=35.89  Aligned_cols=76  Identities=21%  Similarity=0.329  Sum_probs=44.5

Q ss_pred             CCCCCCCCCCCCCEEEECCCCCC--------CCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEE-EEEEEEEECCEE
Q ss_conf             96522223746813798110046--------640588832677813099999999999981388703-477799975959
Q 004580          514 NFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSSQSGQGLEEFKNEMMLIAKLQHRNLV-KLLGCCVEQGEK  584 (744)
Q Consensus       514 ~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~  584 (744)
                      ++++ +.|+-|-.-.+|+....+        .+.+.+++.. ... ......+|..+++.+.-.++. ++++++.  +  
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS--G--  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCC-HHHHHHHHHHHHHHHHHCCCCCEEEEECC--C--
T ss_conf             1699-991785334348999688775445789817999659-961-16589999999999975799980899818--9--


Q ss_pred             EEEEEECCCCCH
Q ss_conf             999993079991
Q 004580          585 ILILEYMPNKSL  596 (744)
Q Consensus       585 ~lV~E~~~~gsL  596 (744)
                      .+|+||+++..+
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEECCCCC
T ss_conf             569997345548

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.38  E-value=0.11  Score=25.59  Aligned_cols=32  Identities=31%  Similarity=0.266  Sum_probs=27.7

Q ss_pred             CCCEEEECCCCCCEEEECCCCEEEEEECCCEE
Q ss_conf             99728704799988992898459974257411
Q 004580          633 RFRIIHRDLKASNVLLDMDMNPKISDFGLARM  664 (744)
Q Consensus       633 ~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~  664 (744)
                      +.++||+|+.++||+++.+...-++||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             45033378636564020454126742221236